data_2kw5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kw5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.9 -15.03 58.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -165.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.36 -24.6 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.726 0.694 . . . . 0.0 110.28 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 89.7 p -70.0 -47.5 61.91 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.4 m -64.13 -41.29 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.365 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.43 74.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.173 0.989 . . . . 0.0 111.978 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -27.66 67.87 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.52 0.728 . . . . 0.0 109.338 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 23' ' ' SER . 75.5 mm-40 -82.88 -33.07 27.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.678 0.791 . . . . 0.0 110.971 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -73.06 131.09 83.96 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.34 84.11 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.768 2.312 . . . . 0.0 111.877 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.05 29.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.05 -134.24 5.42 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.396 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -89.63 110.48 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -172.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 HG12 ' A' ' 99' ' ' VAL . 36.6 mt -113.58 117.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.689 0.796 . . . . 0.0 110.63 -166.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.541 HD23 ' CD1' ' A' ' 95' ' ' TRP . 48.3 tp -92.01 113.25 25.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.907 0.483 . . . . 0.0 111.033 -173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 56.8 m -92.64 137.74 32.1 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 90' ' ' ILE . 40.8 mt -89.41 161.84 16.08 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 170.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 O-C-N 124.831 1.332 . . . . 0.0 112.842 175.329 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -65.37 -31.62 72.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.464 1.106 . . . . 0.0 110.196 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.3 m-20 -62.51 -30.9 71.62 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.423 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.82 79.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.159 0.583 . . . . 0.0 110.871 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.49 -29.97 69.54 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.668 0.787 . . . . 0.0 112.098 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.22 -48.42 81.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.825 0.85 . . . . 0.0 109.5 172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 50' ' ' LEU . 78.6 mt -66.78 -31.45 72.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.896 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -38.2 77.0 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.275 0.63 . . . . 0.0 111.979 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.664 ' HA ' HG13 ' A' ' 76' ' ' VAL . 38.5 p -70.4 -9.47 56.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 47' ' ' LEU . 72.3 mt -81.27 6.92 12.71 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.481 . . . . 0.0 111.17 171.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 7.58 85.68 Favored Glycine 0 C--N 1.36 1.879 0 CA-C-N 117.681 0.218 . . . . 0.0 113.072 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -92.04 143.42 26.48 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.477 0.711 . . . . 0.0 109.325 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 44.1 mt-10 -84.59 96.81 9.29 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.4 t -96.87 128.29 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.004 0.522 . . . . 0.0 110.474 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.9 t -114.15 111.1 21.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.316 1.446 . . . . 0.0 108.714 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.98 136.1 43.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.018 0.527 . . . . 0.0 111.08 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.03 144.25 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -152.29 139.09 18.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 159.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.76 -13.11 62.18 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.681 0.613 . . . . 0.0 111.046 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -117.82 143.0 46.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.193 1.397 . . . . 0.0 109.741 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -73.89 -22.65 59.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.56 0.744 . . . . 0.0 111.219 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.33 -38.58 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.045 0.538 . . . . 0.0 111.814 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -40.05 40.04 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.369 0.418 . . . . 0.0 112.08 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' HG23 ' A' ' 80' ' ' THR . 91.5 mt -65.6 -52.16 54.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.016 0.926 . . . . 0.0 111.947 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.86 75.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.926 0.89 . . . . 0.0 112.371 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -71.02 -42.03 70.09 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.34 0.656 . . . . 0.0 110.888 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.01 92.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.263 0.625 . . . . 0.0 110.548 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -75.02 -32.14 61.54 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 110.63 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -63.04 -51.1 68.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.57 0.748 . . . . 0.0 110.923 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 tp -65.25 -27.32 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.04 0.837 . . . . 0.0 110.56 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -60.15 -59.63 5.1 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 122.92 0.488 . . . . 0.0 110.597 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.19 -36.44 81.91 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.919 0.888 . . . . 0.0 110.693 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.54 -25.52 63.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.895 0.878 . . . . 0.0 111.666 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -100.33 -3.45 31.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.873 0.869 . . . . 0.0 111.073 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.33 28.27 56.06 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.014 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -132.58 165.53 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.057 0.943 . . . . 0.0 110.749 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -112.22 135.46 52.86 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.607 0.763 . . . . 0.0 111.247 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 71' ' ' ALA . 15.0 mm -110.78 161.33 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 165.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -114.97 112.74 23.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 166.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 64' ' ' LEU . 85.5 m -84.15 110.73 18.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.973 0.909 . . . . 0.0 110.402 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.58 127.17 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 0.0 108.508 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -110.02 95.4 5.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -139.67 -175.15 4.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.657 1.183 . . . . 0.0 109.515 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -143.21 131.15 21.62 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -159.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.756 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 22.0 mt -73.28 -3.53 27.54 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.15 3.34 41.04 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.101 0.96 . . . . 0.0 112.845 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.4 -43.04 0.16 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.006 0.821 . . . . 0.0 112.34 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.54 112.63 4.29 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.756 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.45 -72.32 0.41 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -166.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.603 HG23 HD21 ' A' ' 36' ' ' LEU . 4.6 pt -137.72 111.0 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.534 1.134 . . . . 0.0 109.745 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.84 88.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.2 -1.15 4.04 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.67 -48.18 14.12 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.457 0.703 . . . . 0.0 109.632 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.65 -35.97 60.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.562 0.745 . . . . 0.0 111.844 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CD1' HD23 ' A' ' 34' ' ' LEU . 57.6 m95 -104.16 174.74 5.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.984 0.914 . . . . 0.0 108.978 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -109.22 -45.78 3.68 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.878 0.37 . . . . 0.0 110.691 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.62 162.76 24.13 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.557 ' HB ' ' HA3' ' A' ' 125' ' ' GLY . 90.5 mt -137.2 145.35 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.593 0.757 . . . . 0.0 110.038 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 33' ' ' ILE . 9.0 p -132.94 124.45 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.343 1.057 . . . . 0.0 108.21 165.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 m -120.13 94.98 4.57 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.05 134.17 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.53 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 1.5 p90 -18.78 111.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 126.739 2.016 . . . . 0.0 115.563 -168.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 25.8 p -66.94 106.65 1.98 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.267 -1.788 . . . . 0.0 111.588 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -96.18 97.6 9.66 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 85' ' ' LEU . 91.6 mt -139.54 138.97 21.09 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.37 0.668 . . . . 0.0 110.431 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.0 160.63 43.43 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.34 2.694 . . . . 0.0 110.874 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 t -46.44 -33.25 3.82 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.791 1.236 . . . . 0.0 113.47 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 36.4 m -55.52 -64.2 0.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.678 0.791 . . . . 0.0 111.623 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.14 -22.36 45.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.835 0.454 . . . . 0.0 110.527 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -69.66 -53.92 16.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.659 1.184 . . . . 0.0 110.1 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.07 -11.28 58.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 112.879 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 108' ' ' SER . 15.6 mm100 -81.92 -38.71 24.85 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 117' ' ' VAL . 52.6 tp -76.54 -43.82 37.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -58.8 -44.57 99.12 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 119.457 1.026 . . . . 0.0 112.805 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.69 -28.42 86.35 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.37 2.046 . . . . 0.0 113.745 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.78 -28.01 60.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.204 0.602 . . . . 0.0 111.635 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.1 t -85.37 -27.38 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.848 0.832 . . . . 0.0 109.71 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -73.48 -63.86 1.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.388 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -76.7 -49.37 16.25 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.19 -39.15 32.58 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 114.069 0.387 . . . . 0.0 114.069 -169.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 30.1 tp -78.53 103.25 8.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.66 148.35 51.49 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 165.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.567 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 60.9 Cg_exo -43.24 127.24 5.3 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.152 3.235 . . . . 0.0 115.003 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 128.64 10.04 3.37 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.776 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.557 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -119.18 152.72 17.15 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 164.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.81 136.44 44.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 123.603 0.761 . . . . 0.0 109.861 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.0 113.04 26.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -103.83 107.99 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.4 mt -121.86 121.51 37.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.741 0.816 . . . . 0.0 110.362 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.53 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 36.5 tt0 -115.68 98.98 7.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 168.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.01 174.86 46.17 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.699 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.453 ' HB2' HD22 ' A' ' 150' ' ' LEU . 50.7 m-85 -127.87 160.84 30.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 123.22 0.608 . . . . 0.0 109.695 176.557 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 132' ' ' PHE . 44.0 mt -89.37 111.07 43.31 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.623 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.5 Cg_endo -79.98 108.71 2.27 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 122.017 1.812 . . . . 0.0 110.211 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HA ' HD12 ' A' ' 188' ' ' ILE . 53.6 tttm -105.3 155.32 19.2 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.812 -0.555 . . . . 0.0 110.796 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.402 HD23 HD22 ' A' ' 190' ' ' LEU . 31.8 mt -50.51 -38.06 42.37 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.238 1.015 . . . . 0.0 111.937 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.51 -53.88 20.96 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 125.045 1.466 . . . . 0.0 109.776 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 35.3 m -71.94 -57.62 4.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.74 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 151' ' ' PRO . 73.1 mt -62.21 -54.32 42.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.398 1.079 . . . . 0.0 112.309 -165.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.56 -35.67 81.73 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.645 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 t -61.36 -37.2 82.51 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.718 0.407 . . . . 0.0 111.829 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 155' ' ' THR . 23.4 mm-40 -83.72 -8.02 59.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.672 0.389 . . . . 0.0 111.31 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.5 mt -138.9 71.78 41.66 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.545 0.738 . . . . 0.0 110.125 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.29 -5.55 13.56 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.402 2.735 . . . . 0.0 111.761 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.5 p -89.71 -41.39 11.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.592 1.157 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 15.2 tp -90.62 71.67 6.8 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.623 1.569 . . . . 0.0 110.043 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -63.84 135.07 56.29 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.401 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 33.1 m95 -94.24 128.89 40.97 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.644 1.178 . . . . 0.0 109.999 -166.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.96 -34.25 77.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.543 0.737 . . . . 0.0 110.205 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 70.7 mt -126.14 125.9 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.17 76.87 1.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.052 0.941 . . . . 0.0 109.426 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.96 154.87 35.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.64 117.48 22.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.354 0.662 . . . . 0.0 109.743 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -111.94 130.31 55.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.203 0.601 . . . . 0.0 110.158 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.812 0.845 . . . . 0.0 110.541 -178.407 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.5 mt -122.21 165.87 15.49 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 152' ' ' LYS . 15.4 pt -138.58 141.3 37.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.73 143.81 51.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.206 0.527 . . . . 0.0 110.736 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 54.1 mt -135.08 129.0 33.29 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.597 1.559 . . . . 0.0 108.768 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 30.2 tp -122.14 106.04 10.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.08 140.64 17.86 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 170.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.94 0.896 . . . . 0.0 110.48 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 80.4 tttt -55.9 123.52 14.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 123.742 0.651 . . . . 0.0 109.411 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 CA--C 1.543 0.676 0 O-C-N 123.098 0.249 . . . . 0.0 110.347 179.219 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.5 t80 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.506 0.193 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 47' ' ' LEU . 33.7 tp -58.81 -35.7 73.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.389 0.676 . . . . 0.0 111.809 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.37 -40.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.2 p -79.75 -51.45 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.258 0.551 . . . . 0.0 111.108 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG13 HD23 ' A' ' 191' ' ' LEU . 26.5 m -63.41 -34.24 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.373 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.72 76.87 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.324 1.05 . . . . 0.0 111.987 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.06 -31.84 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.107 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 79.1 mt -69.79 128.21 92.05 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-O 119.003 -0.523 . . . . 0.0 109.735 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.35 115.04 1.54 Allowed 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.859 2.372 . . . . 0.0 111.369 164.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.47 32.67 0.13 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.809 1.644 . . . . 0.0 114.306 -166.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.94 -129.59 5.56 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-O 118.776 -1.014 . . . . 0.0 110.922 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -69.29 111.23 5.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.458 1.129 . . . . 0.0 109.897 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.03 119.5 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 89' ' ' ASP . 56.4 tp -98.24 121.06 39.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.901 0.481 . . . . 0.0 110.598 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -104.73 134.0 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.999 1.32 . . . . 0.0 109.422 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.78 152.58 18.35 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.629 0.372 . . . . 0.0 110.9 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.803 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 123.279 0.632 . . . . 0.0 111.711 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -65.31 -44.69 87.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 110.334 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -65.73 -31.3 72.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.209 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.66 -58.35 8.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.651 0.78 . . . . 0.0 111.659 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.2 p -65.93 -27.34 68.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.961 0.504 . . . . 0.0 112.086 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 51.0 t80 -68.5 -36.9 79.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.889 0.476 . . . . 0.0 110.098 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' HG ' HD23 ' A' ' 21' ' ' LEU . 55.6 mt -68.56 -32.29 72.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.327 0.651 . . . . 0.0 111.054 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.32 -33.87 61.2 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.47 0.308 . . . . 0.0 110.321 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -63.19 -19.2 64.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.149 0.98 . . . . 0.0 111.36 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 84.1 mt -82.07 14.23 2.95 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.89 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 33.7 58.31 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 123.295 0.474 . . . . 0.0 114.163 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -125.44 156.12 39.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.718 0.759 . . . . 0.0 110.628 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.53 97.51 7.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.481 0.712 . . . . 0.0 109.75 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -105.96 119.11 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.116 0.484 . . . . 0.0 111.501 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -84.97 112.3 20.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.32 120.48 40.32 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 81' ' ' VAL . 82.2 t -98.66 121.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.803 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 19.6 t70 -139.47 129.33 24.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -54.74 -26.92 37.22 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.782 1.233 . . . . 0.0 112.987 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.471 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.6 m -113.25 160.68 18.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.779 0.831 . . . . 0.0 111.386 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -69.81 -21.39 63.4 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.526 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 60' ' ' SER . 6.5 m -62.11 -43.8 98.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.183 0 C-N-CA 122.895 0.478 . . . . 0.0 111.992 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.28 -34.88 19.24 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.599 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 71.3 mt -67.66 -58.31 4.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.594 0.758 . . . . 0.0 111.773 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.46 70.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.321 0.649 . . . . 0.0 112.287 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.41 -42.3 71.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.883 0.473 . . . . 0.0 110.529 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.44 95.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.682 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -68.97 -34.97 76.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.559 1.144 . . . . 0.0 111.296 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -54.89 -48.51 72.91 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.087 0.955 . . . . 0.0 110.648 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.86 -29.25 64.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.057 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -58.54 -62.58 1.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.63 0.581 . . . . 0.0 111.069 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.21 -40.12 89.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.239 0.616 . . . . 0.0 111.665 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.95 -40.32 95.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.727 0.811 . . . . 0.0 111.55 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -103.92 -5.46 22.25 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.889 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 43.78 36.23 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.875 0.153 . . . . 0.0 113.206 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.76 172.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.316 1.047 . . . . 0.0 109.499 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.05 132.42 54.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.98 0.512 . . . . 0.0 111.497 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.439 HG12 ' HB1' ' A' ' 71' ' ' ALA . 23.2 mm -114.42 155.76 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 166.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -121.46 108.21 13.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 165.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.7 t -86.62 113.49 22.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.209 0.603 . . . . 0.0 110.855 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.7 t -120.79 139.19 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.307 1.043 . . . . 0.0 109.132 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.05 147.87 27.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.473 ' HG ' ' HB1' ' A' ' 37' ' ' ALA . 58.0 m -67.19 112.68 4.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.419 0.288 . . . . 0.0 111.338 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -144.01 89.06 2.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 165.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.42 -38.55 18.55 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.023 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.64 67.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.845 0.858 . . . . 0.0 112.194 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.22 -34.17 20.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.381 0.672 . . . . 0.0 111.499 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -166.74 117.27 0.92 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.348 0.659 . . . . 0.0 109.831 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.458 ' O ' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -128.84 -64.59 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 98' ' ' ILE . 13.9 pt -139.79 119.24 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.546 0.738 . . . . 0.0 110.279 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.97 86.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 98' ' ' ILE . . . -69.25 2.19 3.11 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.03 -50.3 56.22 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.53 -22.17 47.7 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -107.45 170.85 7.72 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 0.0 109.867 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -98.98 -56.98 2.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.336 0.589 . . . . 0.0 109.793 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.74 158.4 20.02 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.819 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.615 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 59.7 mt -122.73 153.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 128' ' ' ILE . 7.4 p -140.57 136.1 35.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.937 1.295 . . . . 0.0 108.098 167.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 t -143.8 93.63 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.2 mm -66.9 142.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 35.4 p90 -15.65 106.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.363 1.865 . . . . 0.0 115.417 -159.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.4 p -70.23 102.0 2.01 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.395 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -99.22 94.2 6.35 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.3 133.33 25.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.56 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -56.78 161.71 9.82 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.285 2.656 . . . . 0.0 112.36 169.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -40.94 -44.1 2.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.815 1.246 . . . . 0.0 112.85 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 m -54.12 -63.82 1.03 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.311 1.044 . . . . 0.0 112.179 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -75.55 -27.72 58.74 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.581 0.352 . . . . 0.0 111.066 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -65.27 -55.4 18.59 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.26 -35.35 26.61 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.608 1.163 . . . . 0.0 112.592 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.71 -17.07 39.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.962 0.505 . . . . 0.0 111.398 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 117' ' ' VAL . 58.6 tp -78.43 -38.42 41.4 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.904 0.482 . . . . 0.0 111.265 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -57.34 -41.13 89.3 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -29.99 84.69 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.967 1.778 . . . . 0.0 112.515 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -81.95 -26.86 33.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.541 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 113' ' ' LEU . 2.5 t -87.35 -24.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.257 0.551 . . . . 0.0 110.675 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -82.08 -65.45 1.01 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.85 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.55 -45.5 15.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.899 0.88 . . . . 0.0 112.853 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.83 -29.87 64.53 Favored Glycine 0 N--CA 1.479 1.523 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.909 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.73 146.16 50.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.205 0.602 . . . . 0.0 110.286 169.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -129.47 158.21 73.99 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 108.063 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -40.18 110.87 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.392 2.728 . . . . 0.0 114.444 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.49 6.59 6.65 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.804 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.615 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -98.97 140.43 15.01 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 170.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 29.0 m -111.47 130.94 64.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.256 0.55 . . . . 0.0 110.3 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -110.03 107.4 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 24' ' ' VAL . 45.2 mt -110.4 107.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.8 mt -125.73 116.42 21.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -167.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.628 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 45.5 tt0 -105.62 97.64 7.45 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.89 -177.46 46.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.974 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.21 159.05 43.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.942 0.897 . . . . 0.0 108.863 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 123.555 0.742 . . . . 0.0 110.31 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.88 103.24 6.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.98 109.02 2.81 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.617 2.211 . . . . 0.0 110.625 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 188' ' ' ILE . 37.3 mtmm -108.0 162.71 13.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.275 0.63 . . . . 0.0 111.905 -168.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' A' ' 188' ' ' ILE . 24.1 mt -60.15 -36.25 77.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.635 0.774 . . . . 0.0 109.899 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -48.53 -56.93 7.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.719 1.208 . . . . 0.0 110.79 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 57.2 m -71.73 -62.61 1.36 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.739 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 129' ' ' LEU . 24.3 mt -61.74 -55.48 29.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.696 1.198 . . . . 0.0 112.209 -166.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -59.7 -42.05 92.15 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.646 0.779 . . . . 0.0 111.9 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.1 t -63.76 -34.01 76.94 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 155' ' ' THR . 8.5 pt-20 -111.33 18.69 19.0 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.132 0.492 . . . . 0.0 111.251 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -139.74 63.23 25.55 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.108 0.963 . . . . 0.0 108.708 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.43 -8.87 15.01 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.62 2.214 . . . . 0.0 111.919 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.2 t -86.42 -33.09 20.55 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.6 tp -95.13 68.17 3.1 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 108.492 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.39 128.56 36.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.402 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 25.4 m95 -88.23 141.02 28.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 110.014 -163.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.34 -36.67 77.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.966 0.506 . . . . 0.0 109.843 170.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.5 mt -127.22 125.53 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.58 85.52 1.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.34 1.056 . . . . 0.0 108.658 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.09 149.59 28.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.565 0.346 . . . . 0.0 111.193 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.57 113.98 20.65 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.535 0.522 . . . . 0.0 109.633 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.9 mt -109.66 128.94 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.196 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.46 154.01 30.07 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 153' ' ' LEU . 3.4 pt -136.14 116.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -97.86 138.1 35.72 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 34.5 mt -126.35 131.63 51.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.806 1.242 . . . . 0.0 108.1 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.523 HD23 HG13 ' A' ' 24' ' ' VAL . 40.1 tp -127.6 105.65 8.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 168.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.98 133.69 11.99 Favored Glycine 0 C--O 1.214 -1.133 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -144.05 156.87 44.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.809 0.844 . . . . 0.0 109.304 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.15 129.07 39.93 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 CA--C 1.54 0.586 0 O-C-N 123.245 0.34 . . . . 0.0 110.581 -177.815 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 HD22 ' HG ' ' A' ' 47' ' ' LEU . 33.2 tp -59.26 -31.88 69.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.538 0.735 . . . . 0.0 112.509 -174.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 m -54.79 -38.05 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -68.12 -53.08 27.87 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.955 0.883 . . . . 0.0 110.425 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 191' ' ' LEU . 29.7 m -66.97 -29.27 45.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.546 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.91 72.94 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.249 1.02 . . . . 0.0 112.31 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.05 -35.57 79.02 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.021 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -95.2 -7.63 38.55 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 24' ' ' VAL . 57.9 mt -72.06 138.35 82.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.669 ' HG3' ' HD3' ' A' ' 194' ' ' LYS . 33.7 Cg_exo -59.87 131.83 41.77 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.084 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -70.78 30.37 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.02 -148.93 9.27 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -80.39 118.06 21.69 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -107.63 141.95 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.709 0.804 . . . . 0.0 110.197 -167.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.471 HD22 ' CD1' ' A' ' 95' ' ' TRP . 33.0 tp -118.13 116.87 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.329 1.052 . . . . 0.0 109.127 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 26.5 p -107.21 111.93 24.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.277 0.489 . . . . 0.0 110.811 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 HG23 ' A' ' 90' ' ' ILE . 45.5 mt -70.05 143.06 52.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 O-C-N 123.935 0.772 . . . . 0.0 110.041 -179.32 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.195 0 N-CA-C 112.948 -0.061 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 ttp-105 -70.75 -41.14 72.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.764 0.826 . . . . 0.0 109.891 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.43 -40.59 97.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.53 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.68 -57.27 13.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 111.575 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' SG ' HD23 ' A' ' 70' ' ' LEU . 20.1 p -61.67 -43.26 99.19 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.375 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -66.32 -46.18 77.75 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.256 0.348 . . . . 0.0 111.184 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 21' ' ' LEU . 97.3 mt -67.05 -33.0 74.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.051 0.54 . . . . 0.0 110.874 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 -33.1 72.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.991 0.517 . . . . 0.0 110.873 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.782 ' HA ' HG12 ' A' ' 76' ' ' VAL . 63.9 m -75.43 -5.6 45.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.3 mt -88.59 13.15 12.77 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.245 0.618 . . . . 0.0 110.167 167.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.56 39.14 30.77 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.74 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -130.12 154.68 47.24 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.161 0.481 . . . . 0.0 111.888 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.19 89.18 7.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.575 0.75 . . . . 0.0 109.056 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.62 110.14 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.319 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 82.1 m -87.09 112.91 22.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.624 1.17 . . . . 0.0 109.79 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -92.31 125.82 37.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.707 0.803 . . . . 0.0 109.913 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 83' ' ' SER . 5.6 t -105.37 116.45 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 167.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -135.74 133.93 38.51 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.4 -23.86 67.43 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.679 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.521 ' HB3' HG22 ' A' ' 62' ' ' VAL . 15.8 m -104.13 135.85 44.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.057 0.943 . . . . 0.0 109.814 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -73.11 -25.8 61.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 0.0 109.981 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 60' ' ' SER . 21.2 m -67.85 -36.6 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.258 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.98 -36.28 90.74 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.51 -48.23 70.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.402 1.081 . . . . 0.0 111.5 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.39 84.46 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.688 0.795 . . . . 0.0 112.47 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -77.45 -31.58 53.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.263 0.625 . . . . 0.0 111.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.497 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -59.69 -46.89 87.71 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 171.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.46 -40.95 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.169 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -58.4 -53.42 58.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.022 0.929 . . . . 0.0 110.823 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.615 HD23 ' SG ' ' A' ' 45' ' ' CYS . 19.3 tp -65.69 -28.47 69.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.642 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -54.46 17.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.734 0.414 . . . . 0.0 110.812 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -35.63 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.187 0.595 . . . . 0.0 110.769 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.66 -40.48 97.2 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.851 0.719 . . . . 0.0 110.356 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -91.02 -1.39 57.82 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.981 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.69 32.28 37.75 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 49' ' ' SER . 16.3 m -132.71 178.51 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.961 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -132.0 142.16 49.5 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.758 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' A' ' 45' ' ' CYS . 10.0 mm -110.61 170.06 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.97 1.308 . . . . 0.0 108.273 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 71.7 m -121.91 111.89 17.64 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 163.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t -86.08 109.96 19.2 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.592 0.757 . . . . 0.0 111.545 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.22 133.05 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.524 1.129 . . . . 0.0 108.955 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -85.41 132.42 34.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.4 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . 58.2 m -61.36 125.92 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -133.42 87.61 2.41 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.5 mt -91.1 -4.58 56.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.506 0.722 . . . . 0.0 110.674 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.39 3.54 54.25 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.825 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.39 -37.81 0.27 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -162.04 104.53 1.16 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -169.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.5 -65.15 0.99 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -174.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.59 ' HB ' HD12 ' A' ' 98' ' ' ILE . 9.4 pt -136.32 115.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.479 0.712 . . . . 0.0 110.777 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.07 94.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.83 -1.43 2.9 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.2 -51.27 9.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 168.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.47 68.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.37 0.668 . . . . 0.0 111.861 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.471 ' CD1' HD22 ' A' ' 34' ' ' LEU . 24.5 m95 -116.94 145.08 43.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.778 0.831 . . . . 0.0 109.44 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.07 -33.06 44.92 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.178 0.513 . . . . 0.0 110.57 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -139.98 140.11 10.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.872 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.59 HD12 ' HB ' ' A' ' 90' ' ' ILE . 82.1 mt -115.58 143.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 47' ' ' LEU . 7.7 p -135.8 134.58 51.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 164.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 m -136.89 113.77 10.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.1 mm -76.34 144.51 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.698 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 2.9 p90 -20.31 109.36 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.124 1.77 . . . . 0.0 115.148 -173.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.7 t -80.36 113.48 18.58 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 112.896 -1.956 . . . . 0.0 110.313 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HE2' HD12 ' A' ' 149' ' ' LEU . 51.0 t-80 -120.19 98.08 5.9 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -122.1 150.72 57.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.91 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.68 159.53 53.27 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.91 2.407 . . . . 0.0 110.125 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.3 m -37.16 -45.0 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.157 1.783 . . . . 0.0 113.956 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.7 p -49.14 -63.08 1.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 O-C-N 124.675 1.234 . . . . 0.0 111.844 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.24 -22.28 28.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.392 0.677 . . . . 0.0 110.539 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -73.42 -62.93 1.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.129 0.972 . . . . 0.0 110.374 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.31 -15.17 56.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.451 0.7 . . . . 0.0 112.098 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.23 -41.65 27.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.53 ' O ' HG21 ' A' ' 117' ' ' VAL . 46.6 tp -74.86 -48.22 26.1 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.783 -170.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.427 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 34.7 m-85 -66.73 -40.56 32.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.56 -31.74 94.98 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 121.958 1.772 . . . . 0.0 112.281 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -82.65 -14.96 53.77 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.964 0.906 . . . . 0.0 110.057 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 113' ' ' LEU . 22.0 t -80.68 -36.46 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.514 ' HE1' ' HD2' ' A' ' 161' ' ' PRO . 33.0 t80 -57.8 -54.46 46.6 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -71.83 -47.01 56.07 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.806 0.842 . . . . 0.0 112.926 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.09 -45.94 10.99 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 114.276 0.47 . . . . 0.0 114.276 -170.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.1 tp -85.28 95.2 9.12 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -75.75 148.41 82.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 164.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.02 133.27 28.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.201 1.934 . . . . 0.0 110.125 168.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.525 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 128.87 -11.73 6.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -157.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.01 168.08 20.87 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 122.726 -0.279 . . . . 0.0 112.593 166.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.08 137.88 48.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.409 1.083 . . . . 0.0 109.45 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.98 113.33 23.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.472 HD12 HG21 ' A' ' 24' ' ' VAL . 17.9 mt -106.95 109.62 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.934 0.893 . . . . 0.0 108.644 -171.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 156' ' ' LEU . 40.3 mt -125.85 114.1 18.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.995 0.518 . . . . 0.0 109.754 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.698 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 43.2 tt0 -103.47 98.95 8.76 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.505 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.91 -176.68 49.24 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.449 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.441 ' HB2' HD23 ' A' ' 150' ' ' LEU . 36.8 m-85 -132.79 158.61 42.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.215 1.006 . . . . 0.0 108.757 -176.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.582 0.753 . . . . 0.0 110.553 179.434 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.418 HD12 ' HE2' ' A' ' 104' ' ' HIS . 88.8 mt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 132' ' ' PHE . 20.9 mt -83.29 107.83 11.04 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.505 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -68.82 111.88 2.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.923 2.416 . . . . 0.0 111.239 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.13 151.89 20.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.276 0.63 . . . . 0.0 111.482 -169.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' A' ' 188' ' ' ILE . 60.5 mt -60.69 -39.37 88.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.166 0.586 . . . . 0.0 110.486 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.1 -51.39 58.02 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.389 1.076 . . . . 0.0 110.805 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.7 p -71.55 -55.18 8.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.671 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.545 HD12 HD11 ' A' ' 129' ' ' LEU . 55.9 mt -73.51 -46.15 49.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.262 1.025 . . . . 0.0 113.52 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -42.41 96.07 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 m -73.64 -21.94 60.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 19.7 tp10 -74.39 -22.25 59.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.635 0.774 . . . . 0.0 110.521 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.452 HD22 ' HD1' ' A' ' 118' ' ' TYR . 68.6 mt -140.22 65.56 28.69 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.535 0.734 . . . . 0.0 109.377 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.514 ' HD2' ' HE1' ' A' ' 118' ' ' TYR . 95.3 Cg_endo -81.42 2.49 8.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 123.068 2.512 . . . . 0.0 112.09 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 55.1 p -90.47 -33.84 15.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.367 1.067 . . . . 0.0 108.685 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.06 73.12 7.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.999 1.719 . . . . 0.0 111.178 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -50.06 114.15 1.03 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.476 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 35.4 m95 -84.88 128.99 34.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.786 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 84.8 mt -71.18 -36.61 72.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.429 0.692 . . . . 0.0 110.803 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 59.1 mt -125.25 120.74 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.02 70.98 0.95 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -148.23 146.51 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -170.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -73.97 112.42 10.07 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.272 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.9 mt -118.17 137.17 53.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 110.829 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 123.509 0.724 . . . . 0.0 110.005 176.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -127.28 171.94 11.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.657 0.783 . . . . 0.0 109.809 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.5 ' HB ' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -142.82 119.82 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.031 173.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -98.31 140.71 32.18 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 37.4 mt -129.23 133.35 47.49 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 108.453 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 24' ' ' VAL . 46.3 tp -139.76 107.61 5.67 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.69 139.76 17.46 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.531 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 6.1 tp60 -116.72 146.79 42.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.001 0.9 . . . . 0.0 111.677 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.669 ' HD3' ' HG3' ' A' ' 29' ' ' PRO . 21.9 pttm -58.19 115.05 2.68 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.163 165.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 167.813 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.416 0.627 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' ' 47' ' ' LEU . 18.2 tp -59.77 -33.97 72.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.848 1.259 . . . . 0.0 112.492 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 m -52.54 -38.46 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -72.8 -44.72 61.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 0.0 110.938 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG23 HD12 ' A' ' 128' ' ' ILE . 2.4 m -67.97 -33.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.044 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.27 77.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.485 1.114 . . . . 0.0 111.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.7 -33.87 73.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.191 0.596 . . . . 0.0 110.329 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -84.21 -22.52 30.85 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 24' ' ' VAL . 85.7 mt -76.98 131.67 72.63 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.91 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.39 143.93 71.83 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.788 2.326 . . . . 0.0 111.895 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -72.79 30.59 0.06 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.336 1.454 . . . . 0.0 114.371 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.76 177.95 17.35 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 96' ' ' GLU . 66.1 mttm -60.14 118.48 6.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.542 0.737 . . . . 0.0 110.845 -165.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.89 138.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -165.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 90' ' ' ILE . 59.9 tp -110.67 112.43 24.31 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.712 ' SG ' HG11 ' A' ' 54' ' ' VAL . 58.9 m -101.81 109.59 21.38 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 123.772 0.829 . . . . 0.0 110.412 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 89' ' ' ASP . 36.8 mt -76.69 127.31 32.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 165.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -177.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.862 0 CA-C-O 120.014 -0.325 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -61.78 -38.21 87.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.445 0.698 . . . . 0.0 110.821 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.59 -33.61 62.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.182 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.05 66.61 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.297 0.639 . . . . 0.0 110.799 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.447 ' HA ' HD12 ' A' ' 78' ' ' ILE . 6.6 p -70.42 -28.44 65.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.2 t80 -66.88 -33.15 74.97 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' ' 21' ' ' LEU . 31.4 mt -64.59 -36.04 82.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.121 0.569 . . . . 0.0 111.164 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.56 69.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.661 0.267 . . . . 0.0 110.743 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.584 ' HA ' HG12 ' A' ' 76' ' ' VAL . 55.9 m -68.36 -10.86 57.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.531 0.732 . . . . 0.0 111.533 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD12 HD21 ' A' ' 47' ' ' LEU . 65.7 mt -88.13 14.89 8.28 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.643 0.777 . . . . 0.0 110.846 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.16 36.97 44.05 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 123.146 0.403 . . . . 0.0 113.435 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.64 147.34 45.37 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.889 0.476 . . . . 0.0 112.101 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.9 90.64 4.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.902 0.881 . . . . 0.0 108.719 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.712 HG11 ' SG ' ' A' ' 35' ' ' CYS . 65.3 t -102.05 112.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.023 0.529 . . . . 0.0 111.969 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.2 m -85.3 104.88 15.54 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.68 120.95 41.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.268 0.627 . . . . 0.0 109.507 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 83' ' ' SER . 3.6 t -103.81 119.17 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -132.91 144.56 50.24 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.315 0.962 . . . . 0.0 111.32 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 3.0 pp0? -57.98 -18.27 22.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.526 1.53 . . . . 0.0 114.503 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 62' ' ' VAL . 77.5 p -131.2 139.2 49.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 110.409 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -76.83 -17.41 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.405 0.682 . . . . 0.0 110.163 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 60' ' ' SER . 20.1 m -73.5 -29.16 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.151 168.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.97 -28.99 57.77 Favored Glycine 0 C--N 1.359 1.827 0 O-C-N 123.524 0.515 . . . . 0.0 112.342 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.08 -39.97 68.59 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.666 0.787 . . . . 0.0 110.299 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.52 67.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.759 0.824 . . . . 0.0 111.15 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -70.66 -47.53 59.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.225 1.01 . . . . 0.0 109.011 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.56 95.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.119 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -69.83 -35.77 75.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.989 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.12 -46.3 82.77 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.914 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.65 -29.61 66.01 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.154 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.457 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -62.8 -62.27 1.84 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.879 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.11 -23.14 67.06 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.884 0.873 . . . . 0.0 112.028 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.93 -56.12 20.01 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 74' ' ' LYS . 3.9 ttmp? -99.03 8.05 45.37 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.948 -171.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.77 38.19 85.19 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 121.996 -0.44 . . . . 0.0 113.358 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' SER . 32.4 m -121.52 162.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.093 0.957 . . . . 0.0 109.282 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -106.05 129.32 54.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.151 0.58 . . . . 0.0 112.107 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 71' ' ' ALA . 16.2 mm -114.24 160.99 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 166.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -125.2 104.3 8.43 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 p -87.86 121.85 30.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.889 0.476 . . . . 0.0 110.744 -167.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.96 140.4 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 108.704 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -81.61 133.12 35.34 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' HG12 ' A' ' 57' ' ' VAL . 37.7 t -65.55 114.86 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.47 0.481 . . . . 0.0 111.392 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -141.45 88.66 2.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.67 -10.77 50.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.143 0.577 . . . . 0.0 111.23 -166.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.04 -22.34 36.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.476 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.83 -37.66 10.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 110.896 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -171.95 135.54 0.83 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.157 1.383 . . . . 0.0 108.154 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' HD22 ' A' ' 36' ' ' LEU . 1.8 p-10 -135.17 -73.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.605 ' HB ' HD12 ' A' ' 98' ' ' ILE . 3.7 pt -146.63 120.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.441 0.696 . . . . 0.0 110.774 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.34 93.27 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.897 0.479 . . . . 0.0 109.968 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . . . -67.75 -7.0 23.76 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.34 -44.03 59.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.409 0.684 . . . . 0.0 109.229 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.34 -34.42 55.22 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.32 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.52 ' NE1' HD22 ' A' ' 34' ' ' LEU . 74.5 m95 -109.05 149.71 28.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.218 0.607 . . . . 0.0 111.379 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' N ' ' A' ' 32' ' ' LYS . 45.1 mt-10 -91.74 3.69 54.51 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.835 0.854 . . . . 0.0 111.112 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.33 151.44 16.49 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.605 HD12 ' HB ' ' A' ' 90' ' ' ILE . 55.1 mt -128.6 149.12 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.903 0.881 . . . . 0.0 108.853 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -147.66 144.24 19.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 162.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 127' ' ' PHE . 47.4 m -133.24 100.37 4.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.9 mm -70.09 138.96 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.739 1.216 . . . . 0.0 108.705 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -18.18 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.533 1.933 . . . . 0.0 114.723 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.45 106.32 14.23 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -96.42 97.37 9.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.5 mt -124.67 145.7 50.34 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.709 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.17 152.44 71.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.858 2.372 . . . . 0.0 109.926 167.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.4 m -44.18 -40.0 4.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.769 1.227 . . . . 0.0 113.168 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 34.6 m -51.39 -60.81 2.72 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 124.454 1.096 . . . . 0.0 111.002 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.97 -24.15 38.25 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.864 0.466 . . . . 0.0 111.424 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 114' ' ' TYR . 29.2 ttp180 -75.8 -48.67 20.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -68.35 -10.37 54.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.582 0.753 . . . . 0.0 112.81 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 108' ' ' SER . 30.1 mm-40 -88.0 -26.97 22.35 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.014 0.37 . . . . 0.0 110.144 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 117' ' ' VAL . 57.6 tp -78.03 -52.87 8.11 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.867 -174.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 110' ' ' ARG . 29.1 m-85 -66.39 -38.04 18.89 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 24.2 Cg_endo -61.54 -29.43 84.6 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.958 1.772 . . . . 0.0 112.514 167.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -81.57 -22.97 37.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.216 1.007 . . . . 0.0 109.799 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 113' ' ' LEU . 28.6 t -78.18 -39.65 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.886 0.874 . . . . 0.0 109.211 170.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.579 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 13.3 t80 -54.09 -58.61 6.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.817 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.36 -49.54 66.57 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.742 0.817 . . . . 0.0 113.036 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.5 -40.48 32.59 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -165.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 34.1 tp -81.21 115.58 20.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.739 0.815 . . . . 0.0 109.56 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 122' ' ' LYS . 9.0 mmpt? -103.71 159.39 29.46 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.362 1.065 . . . . 0.0 109.363 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.97 113.35 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.623 0 C-N-CA 123.458 2.772 . . . . 0.0 113.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.94 14.01 2.6 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.733 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.57 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.21 150.46 17.17 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 162.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 31.8 m -110.62 133.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.373 0 C-N-CA 123.039 0.535 . . . . 0.0 109.57 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 100' ' ' SER . 0.8 OUTLIER -105.79 112.74 25.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 24' ' ' VAL . 50.3 mt -107.01 107.55 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 96.9 mt -121.41 123.26 41.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -106.02 99.31 8.91 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.636 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -79.97 173.87 55.03 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.102 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.3 157.04 46.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.185 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.88 105.45 12.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.636 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 24.6 Cg_exo -63.56 112.96 1.92 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.123 2.548 . . . . 0.0 112.479 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -95.02 145.83 24.68 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.909 0.884 . . . . 0.0 111.279 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.47 HD23 HD22 ' A' ' 190' ' ' LEU . 41.2 mt -61.03 -51.32 69.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.164 0.586 . . . . 0.0 110.69 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.97 -35.7 47.17 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.533 0.733 . . . . 0.0 112.164 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 m -76.56 -45.87 28.7 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.29 1.036 . . . . 0.0 110.719 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.3 -46.49 13.58 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.094 0.958 . . . . 0.0 112.877 -170.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.7 -39.93 62.47 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.515 . . . . 0.0 111.261 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t -70.89 -33.92 71.06 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -96.47 -7.41 34.85 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.503 HD21 ' HD2' ' A' ' 118' ' ' TYR . 72.4 mt -139.66 62.69 24.1 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.247 0.619 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.579 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 57.3 Cg_endo -81.62 -3.21 11.82 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.138 2.559 . . . . 0.0 113.082 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.5 p -88.46 -30.13 19.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.893 0.877 . . . . 0.0 109.105 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 tp -93.22 75.7 4.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.825 1.65 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -44.5 111.87 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 0.0 111.194 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 54.4 m95 -85.0 129.43 34.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 193' ' ' GLN . 71.8 mt -76.97 -35.66 57.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.572 0.349 . . . . 0.0 110.467 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.85 123.63 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.71 85.55 1.04 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.11 0.964 . . . . 0.0 108.933 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.09 151.09 35.06 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.433 ' HA ' HG21 ' A' ' 188' ' ' ILE . 24.3 t-20 -79.16 103.73 9.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.472 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.07 125.25 50.77 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 109.306 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.02 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.656 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.92 165.02 18.11 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 170' ' ' ASN . 6.3 pt -140.88 116.26 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -102.49 145.57 29.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.584 0.707 . . . . 0.0 110.395 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.47 HD22 HD23 ' A' ' 153' ' ' LEU . 35.7 mt -131.36 135.62 47.38 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.498 -174.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.454 HD23 HG12 ' A' ' 24' ' ' VAL . 43.5 tp -135.46 105.71 6.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.54 139.76 16.81 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 166' ' ' LEU . 5.6 tp60 -136.87 154.28 50.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.879 0.84 . . . . 0.0 111.489 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.533 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 22.1 ptmt -55.35 142.83 30.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.046 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 t80 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.313 0.101 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD22 ' ND2' ' A' ' 43' ' ' ASN . 21.3 tp -59.74 -44.77 93.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.606 0.763 . . . . 0.0 111.559 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 m -43.56 -34.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -50.84 19.5 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.57 0.623 . . . . 0.0 110.329 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 128' ' ' ILE . 1.4 m -59.41 -33.08 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.734 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.8 74.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 0.0 111.776 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.3 -26.75 68.62 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.922 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -89.71 -19.87 24.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.959 0.903 . . . . 0.0 111.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 24' ' ' VAL . 66.7 mt -80.1 135.98 54.23 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 122.972 0.509 . . . . 0.0 109.833 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -58.92 133.27 52.56 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.974 2.45 . . . . 0.0 111.864 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.59 27.17 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.69 -131.76 4.57 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.767 0.712 . . . . 0.0 111.828 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 67.5 mttm -77.15 113.19 14.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.074 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -111.68 120.54 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 109.144 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.473 ' HA ' HG22 ' A' ' 55' ' ' THR . 36.2 tp -93.4 113.19 25.29 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.632 0.373 . . . . 0.0 110.576 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 54.0 t -108.77 107.66 18.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.17 165.39 9.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.76 0.424 . . . . 0.0 111.519 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.253 0.549 . . . . 0.0 110.429 170.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 113.821 0.288 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -69.96 -28.92 65.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.121 0.569 . . . . 0.0 110.792 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' HD22 ' A' ' 21' ' ' LEU . 24.9 t-20 -64.91 -43.64 92.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.228 1.011 . . . . 0.0 110.363 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.83 -47.05 70.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.708 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.9 m -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.662 . . . . 0.0 112.459 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.442 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.3 t80 -68.66 -39.29 80.73 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.058 0.543 . . . . 0.0 109.716 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.27 -34.32 77.17 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.078 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.55 71.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.96 0.504 . . . . 0.0 111.147 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.71 ' HA ' HG13 ' A' ' 76' ' ' VAL . 34.7 t -70.28 -11.28 60.8 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 111.781 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 79.1 mt -85.1 5.84 28.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.76 0.424 . . . . 0.0 110.384 170.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.04 27.95 47.55 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 123.173 0.416 . . . . 0.0 113.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -113.62 151.4 31.78 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.27 0.535 . . . . 0.0 109.697 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 40.9 mt-10 -85.36 87.61 7.41 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.25 104.89 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.297 0.57 . . . . 0.0 109.904 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 34' ' ' LEU . 2.1 t -85.54 111.09 19.7 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.834 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.49 121.2 44.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.932 0.493 . . . . 0.0 109.873 -172.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 3.7 t -89.31 134.54 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.656 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 8.8 t70 -152.83 129.23 10.61 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -62.69 -28.38 69.9 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.238 1.015 . . . . 0.0 112.831 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.437 ' OG ' HG22 ' A' ' 62' ' ' VAL . 10.2 t -102.6 123.8 46.98 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -72.38 -19.79 61.56 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.168 0.587 . . . . 0.0 111.042 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG22 ' OG ' ' A' ' 60' ' ' SER . 18.9 m -66.65 -32.74 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 122.819 0.448 . . . . 0.0 110.685 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.51 -39.84 55.55 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.897 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 ' HB ' ' A' ' 80' ' ' THR . 94.5 mt -62.52 -48.52 79.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 110.983 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -57.6 -46.63 83.8 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -69.96 -38.03 75.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.249 0.62 . . . . 0.0 110.641 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.386 0.612 . . . . 0.0 110.541 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -74.05 -29.65 62.01 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.703 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 69.8 mt-30 -61.91 -45.5 93.46 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.13 0.572 . . . . 0.0 110.168 171.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.52 -26.72 64.66 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 123.882 0.739 . . . . 0.0 110.568 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -63.44 -62.07 1.92 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.185 173.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.24 -37.69 81.17 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.123 0.569 . . . . 0.0 111.036 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.42 -45.86 92.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.608 0.763 . . . . 0.0 110.56 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -97.65 8.65 44.28 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.971 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 37.53 77.45 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-N 116.617 -0.265 . . . . 0.0 113.701 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -130.42 -177.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.914 1.286 . . . . 0.0 109.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -131.18 136.04 47.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.715 HG12 ' HB1' ' A' ' 71' ' ' ALA . 25.7 mm -104.87 165.41 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 42.4 m -125.89 104.58 8.39 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 166.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.414 ' HB ' HD22 ' A' ' 64' ' ' LEU . 45.2 p -88.09 124.43 33.77 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.07 -0.394 . . . . 0.0 111.056 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 24.1 t -118.86 138.32 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.923 1.289 . . . . 0.0 108.555 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -86.42 128.28 34.93 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.779 0.718 . . . . 0.0 110.168 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -63.19 125.21 23.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -143.31 91.4 2.26 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 28.8 mt -82.01 -8.32 59.66 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.566 0.621 . . . . 0.0 111.642 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.16 11.03 31.5 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.571 1.148 . . . . 0.0 110.681 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -143.65 -44.57 0.28 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.302 0.641 . . . . 0.0 111.553 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -166.91 109.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.23 1.412 . . . . 0.0 107.622 -170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -125.71 -71.8 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.266 0.626 . . . . 0.0 109.531 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 ' HB ' HD12 ' A' ' 98' ' ' ILE . 27.6 pt -133.94 121.28 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.386 0.674 . . . . 0.0 110.763 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.55 84.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.674 0.79 . . . . 0.0 109.31 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.66 0.34 10.93 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.824 0.45 . . . . 0.0 111.835 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.57 -47.58 46.97 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.475 1.11 . . . . 0.0 108.696 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.72 65.34 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.503 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -107.49 -166.06 1.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.83 -30.14 3.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.388 0.675 . . . . 0.0 110.568 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.36 166.66 29.08 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.491 HD12 ' HB ' ' A' ' 90' ' ' ILE . 62.6 mt -137.55 141.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 9.8 p -129.4 131.96 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.2 m -143.19 119.82 11.1 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.81 -0.556 . . . . 0.0 109.628 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mm -88.93 148.27 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.656 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 37.1 p90 -16.08 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 126.505 1.922 . . . . 0.0 115.416 -163.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.493 ' SG ' ' OH ' ' A' ' 114' ' ' TYR . 27.1 p -85.46 107.01 17.22 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.658 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -108.92 96.67 6.48 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 68.9 mt -120.41 148.8 48.44 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.144 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 153.93 28.25 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.095 2.53 . . . . 0.0 111.344 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.9 t -49.0 -32.16 8.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.105 0.962 . . . . 0.0 112.076 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 33.7 p -58.56 -60.8 3.23 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.455 1.102 . . . . 0.0 111.968 172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.35 -21.59 55.93 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.527 -174.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -69.99 -52.77 21.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 108.689 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -64.84 -11.78 41.11 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.178 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 108' ' ' SER . 16.2 mm100 -91.65 -38.44 12.44 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.106 -0.371 . . . . 0.0 110.805 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 117' ' ' VAL . 65.9 tp -73.23 -50.34 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.748 0.419 . . . . 0.0 111.744 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.493 ' OH ' ' SG ' ' A' ' 103' ' ' CYS . 39.6 m-85 -68.13 -35.88 8.18 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -54.17 -32.12 68.81 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.017 1.812 . . . . 0.0 113.64 163.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 32.4 mmtp -78.01 -30.71 50.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.462 0.705 . . . . 0.0 110.586 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.526 ' HB ' HD23 ' A' ' 160' ' ' LEU . 3.3 t -78.43 -25.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-O 121.626 0.726 . . . . 0.0 109.643 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -75.66 -64.07 1.16 Allowed 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.893 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -82.07 -50.41 9.11 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.88 51.72 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 116.754 -0.203 . . . . 0.0 113.191 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.625 HD12 ' HA3' ' A' ' 125' ' ' GLY . 39.6 tp -69.75 100.42 1.5 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 122.896 0.478 . . . . 0.0 109.735 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.558 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 mtpp -66.74 149.3 98.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 165.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -42.52 119.21 1.32 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 124.041 3.161 . . . . 0.0 114.93 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.22 12.98 3.33 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.699 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.625 ' HA3' HD12 ' A' ' 121' ' ' LEU . . . -96.76 141.25 15.51 Favored Glycine 0 C--O 1.241 0.551 0 O-C-N 122.053 -0.675 . . . . 0.0 111.531 165.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 28.1 m -109.16 130.88 61.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.852 0.861 . . . . 0.0 108.903 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.436 ' CZ ' ' SG ' ' A' ' 103' ' ' CYS . 0.1 OUTLIER -109.95 111.98 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 24' ' ' VAL . 64.9 mt -103.53 107.91 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 17.1 mt -121.85 114.58 21.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.568 0.747 . . . . 0.0 109.528 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.656 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 28.5 tt0 -105.71 99.38 8.98 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.519 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -83.82 170.38 47.77 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.211 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.466 ' HB2' HD21 ' A' ' 150' ' ' LEU . 57.2 m-85 -133.17 159.12 41.09 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 108.863 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.075 0 C-N-CA 124.058 0.943 . . . . 0.0 110.126 -178.113 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 132' ' ' PHE . 71.0 mt -78.92 112.02 24.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.57 ' HB3' HD13 ' A' ' 156' ' ' LEU . 23.5 Cg_exo -64.74 105.3 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.386 2.724 . . . . 0.0 112.588 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.446 ' HA ' HD13 ' A' ' 188' ' ' ILE . 21.9 ttmm -98.34 146.75 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.802 0.728 . . . . 0.0 111.504 -170.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.441 HD22 ' HB ' ' A' ' 188' ' ' ILE . 31.1 mt -61.11 -48.91 79.46 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -50.84 -47.51 60.22 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.168 0.917 . . . . 0.0 110.673 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.6 m -66.51 -61.94 1.72 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.68 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.57 HD13 ' HB3' ' A' ' 151' ' ' PRO . 22.1 mt -73.52 -42.15 62.11 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.331 0.652 . . . . 0.0 112.355 -165.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -62.19 -34.89 77.3 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.604 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 96.1 p -81.21 -22.23 38.98 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.555 0.216 . . . . 0.0 111.027 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.49 -16.83 57.09 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.042 0.537 . . . . 0.0 110.425 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.526 HD23 ' HB ' ' A' ' 117' ' ' VAL . 86.3 mt -143.5 64.02 13.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.167 0.987 . . . . 0.0 109.026 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.63 -9.97 15.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.021 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.8 t -88.34 -30.1 19.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 109.317 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.2 tp -88.21 70.86 9.24 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.583 1.153 . . . . 0.0 109.286 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -52.7 127.34 22.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.468 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 160' ' ' LEU . 42.1 m95 -92.08 126.76 37.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.664 1.186 . . . . 0.0 109.446 -171.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.28 -32.96 74.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.387 0.675 . . . . 0.0 110.086 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 79.8 mt -126.23 124.85 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.22 82.67 1.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.051 0.94 . . . . 0.0 108.573 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -149.89 151.56 33.64 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.67 114.15 26.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.591 1.156 . . . . 0.0 109.997 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.25 136.79 52.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.807 0.443 . . . . 0.0 110.613 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 123.039 0.535 . . . . 0.0 110.535 177.64 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.671 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 34.8 mt -113.1 157.95 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 152' ' ' LYS . 11.6 pt -138.25 116.19 12.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -95.39 138.57 32.89 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 110.871 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 51.5 mt -128.35 131.73 48.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.119 1.368 . . . . 0.0 108.02 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.1 tp -126.34 110.21 13.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.22 135.76 13.78 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -142.48 149.76 39.63 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 147.16 52.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.943 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 123.388 0.675 . . . . 0.0 111.498 -179.116 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.001 0.429 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 24' ' ' VAL . 36.1 tp -58.16 -43.16 87.25 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.92 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.426 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 5.0 m -52.45 -36.25 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 m -72.54 -50.47 25.45 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.141 0.577 . . . . 0.0 110.465 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.533 HG12 HD21 ' A' ' 191' ' ' LEU . 7.0 m -66.35 -33.54 64.17 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.41 83.66 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.359 1.464 . . . . 0.0 112.199 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.42 -31.82 73.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.926 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -88.18 -18.65 28.26 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 112.117 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 24' ' ' VAL . 60.5 mt -70.39 137.47 86.38 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.825 0.85 . . . . 0.0 111.061 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.79 128.25 29.54 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.745 2.963 . . . . 0.0 112.46 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -76.59 29.6 0.13 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.61 -134.85 4.92 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.881 -0.399 . . . . 0.0 112.243 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 60.8 mttm -84.93 112.73 20.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.526 0.731 . . . . 0.0 109.587 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 54' ' ' VAL . 3.0 mt -116.13 126.75 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -171.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 90' ' ' ILE . 35.4 tp -96.74 117.68 31.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.445 0.298 . . . . 0.0 110.954 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.0 t -100.08 121.44 41.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.691 0.796 . . . . 0.0 110.257 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 90' ' ' ILE . 23.1 mt -101.56 118.98 38.05 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.561 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 125.448 1.717 . . . . 0.0 112.297 172.092 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -55.08 -32.48 61.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.978 1.711 . . . . 0.0 112.552 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -76.4 -54.98 5.97 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.095 0.558 . . . . 0.0 111.04 -173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.85 39.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 0.0 111.935 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HB2' HD23 ' A' ' 70' ' ' LEU . 30.0 p -63.86 -34.8 78.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.323 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.3 t80 -68.33 -50.43 53.41 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.414 0.446 . . . . 0.0 110.398 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HB2' HG21 ' A' ' 54' ' ' VAL . 99.3 mt -65.41 -37.38 86.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.688 0.617 . . . . 0.0 110.366 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.29 65.1 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.79 0.436 . . . . 0.0 111.592 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.442 ' HA ' HG12 ' A' ' 76' ' ' VAL . 41.8 t -66.36 -13.35 60.48 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.992 0.917 . . . . 0.0 110.933 172.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 31.8 mt -90.75 6.92 42.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.541 0.737 . . . . 0.0 111.18 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.49 23.44 58.42 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -100.14 147.56 25.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.66 0.784 . . . . 0.0 110.603 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 41.7 mt-10 -86.79 88.27 7.64 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 47' ' ' LEU . 37.4 t -94.79 106.6 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.07 0.462 . . . . 0.0 111.336 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.509 HG21 ' HB ' ' A' ' 79' ' ' THR . 77.6 p -86.99 103.47 15.38 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . . . -106.06 132.17 52.46 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.967 0.907 . . . . 0.0 111.219 -169.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 81' ' ' VAL . 14.1 t -116.54 120.02 63.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.05 147.3 43.95 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.06 -27.43 67.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.571 0.749 . . . . 0.0 112.35 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.7 m -106.79 125.43 50.99 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.057 0.543 . . . . 0.0 110.325 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 m -70.78 -23.72 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.633 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 60' ' ' SER . 29.3 m -63.0 -32.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.545 0.738 . . . . 0.0 111.63 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.14 -47.65 29.45 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.95 -51.38 59.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.902 0.881 . . . . 0.0 111.764 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.07 -44.93 75.26 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.178 0.991 . . . . 0.0 113.371 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -72.42 -27.12 62.14 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.006 0.191 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.15 95.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.611 0.365 . . . . 0.0 110.129 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HZ1' ' HB3' ' A' ' 68' ' ' LYS . 8.2 mtpm? -69.24 -36.24 76.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.303 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.58 -46.49 86.81 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 16.6 tp -70.21 -22.01 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 123.468 0.48 . . . . 0.0 110.895 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.58 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -59.35 -59.71 5.03 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.25 -37.23 86.73 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.831 0.348 . . . . 0.0 111.394 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 70' ' ' LEU . 44.9 tt0 -60.26 -35.49 75.62 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.739 1.216 . . . . 0.0 111.808 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.26 -20.31 14.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.816 0.447 . . . . 0.0 112.152 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.94 49.23 7.16 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 122.116 -0.365 . . . . 0.0 113.305 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 49' ' ' SER . 34.9 m -123.77 -179.29 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 125.342 1.457 . . . . 0.0 108.515 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.82 137.64 53.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.7 0.4 . . . . 0.0 111.831 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.58 HG12 ' HB1' ' A' ' 71' ' ' ALA . 11.6 mm -112.92 169.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.509 ' HB ' HG21 ' A' ' 55' ' ' THR . 58.8 m -139.77 105.15 5.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 163.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -93.91 130.97 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.544 0.687 . . . . 0.0 111.407 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.597 ' HB ' HG23 ' A' ' 57' ' ' VAL . 41.8 t -116.12 143.29 26.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.682 1.593 . . . . 0.0 107.503 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -79.95 141.4 36.05 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 p -58.49 101.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.03 0.831 . . . . 0.0 111.188 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -141.18 92.8 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 80.8 mt -97.68 -21.7 16.87 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.63 0.372 . . . . 0.0 111.775 -170.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.31 -3.46 57.5 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.299 0.639 . . . . 0.0 111.756 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -125.32 -15.87 6.08 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.577 0.751 . . . . 0.0 111.632 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 60.4 t80 -165.15 147.91 8.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.915 1.286 . . . . 0.0 108.211 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -140.23 -72.71 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.604 1.093 . . . . 0.0 109.054 173.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 34' ' ' LEU . 10.8 pt -145.72 129.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.58 0.752 . . . . 0.0 111.163 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.1 94.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.523 0.729 . . . . 0.0 109.07 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.75 -3.05 10.83 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.539 0.736 . . . . 0.0 112.361 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.54 -41.8 17.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.266 0.627 . . . . 0.0 110.452 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.02 -34.29 66.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.085 0.554 . . . . 0.0 111.71 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.418 ' NE1' HD22 ' A' ' 34' ' ' LEU . 31.8 m95 -107.53 172.63 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.42 -57.67 2.87 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -116.82 168.38 12.77 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.501 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 90' ' ' ILE . 92.1 mt -134.92 131.16 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.562 0.745 . . . . 0.0 108.996 172.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -116.05 104.95 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -101.78 96.29 6.97 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.406 HD13 HD13 ' A' ' 128' ' ' ILE . 34.4 mm -75.44 149.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.015 0.926 . . . . 0.0 110.277 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -17.66 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.092 2.157 . . . . 0.0 113.31 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 50.7 t -95.58 127.1 41.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.287 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -128.95 98.73 5.04 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 109' ' ' LEU . 97.1 mt -124.77 138.95 32.26 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.235 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.64 160.61 20.24 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.721 2.281 . . . . 0.0 111.724 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 m -53.05 -21.91 5.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.36 1.064 . . . . 0.0 113.812 -172.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -63.29 -59.08 5.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.308 0.643 . . . . 0.0 111.432 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.489 ' HB3' HD11 ' A' ' 105' ' ' LEU . 29.5 mt -80.29 -21.13 42.95 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.532 0.333 . . . . 0.0 110.597 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -69.44 -55.77 9.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.467 0.707 . . . . 0.0 110.147 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -28.7 22.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.467 1.107 . . . . 0.0 111.965 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -78.16 -47.61 17.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' HG21 ' A' ' 117' ' ' VAL . 59.9 tp -75.41 -56.75 4.4 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.12 -165.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.423 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 82.9 m-85 -67.87 -38.21 13.84 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.45 -24.07 49.9 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 121.7 1.6 . . . . 0.0 112.321 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -84.64 -15.85 44.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 0.0 109.828 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 90' ' ' ILE . 29.9 t -78.07 -36.84 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.335 0.588 . . . . 0.0 109.463 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -58.16 -58.1 9.94 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.645 170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -64.63 -37.52 87.86 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.52 -50.05 3.27 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.991 0.357 . . . . 0.0 113.991 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.434 HD13 HD12 ' A' ' 98' ' ' ILE . 55.4 tp -101.54 99.0 9.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.636 1.174 . . . . 0.0 110.753 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.44 172.74 8.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 163.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' A' ' 195' ' ' LEU . 39.8 Cg_exo -38.71 130.92 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.276 1.984 . . . . 0.0 110.808 158.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.563 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 131.72 -24.19 4.13 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -158.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -133.64 166.93 23.75 Favored Glycine 0 N--CA 1.467 0.701 0 O-C-N 121.953 -0.733 . . . . 0.0 113.691 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 18.3 m -108.13 135.57 46.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.599 1.16 . . . . 0.0 109.584 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.15 117.21 31.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 24' ' ' VAL . 24.1 mt -112.3 107.93 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.199 1.0 . . . . 0.0 109.439 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 156' ' ' LEU . 84.6 mt -126.64 139.41 53.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.353 0.661 . . . . 0.0 110.985 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -127.0 101.97 6.78 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.92 173.4 43.19 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.455 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -132.61 170.77 14.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.407 1.083 . . . . 0.0 108.748 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.003 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.8 mt . . . . . 0 CA--C 1.551 0.995 0 N-CA-C 111.125 0.046 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.98 115.9 42.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.467 ' HB2' HD11 ' A' ' 156' ' ' LEU . 72.0 Cg_endo -91.15 108.59 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.544 2.163 . . . . 0.0 109.55 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.491 ' HZ1' ' HB2' ' A' ' 152' ' ' LYS . 10.6 mtmp? -96.37 161.39 13.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.712 0.405 . . . . 0.0 111.76 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 190' ' ' LEU . 59.9 mt -56.45 -34.57 66.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.199 1.0 . . . . 0.0 112.551 -170.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.03 -48.72 77.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.243 1.017 . . . . 0.0 109.542 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.1 m -66.02 -49.71 66.78 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.335 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 151' ' ' PRO . 68.3 mt -77.64 -50.74 11.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.917 0.887 . . . . 0.0 112.616 -165.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.5 -36.14 79.66 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.759 0.424 . . . . 0.0 111.033 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.0 t -74.24 -26.98 60.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.908 0.483 . . . . 0.0 111.47 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 10.2 tp10 -76.82 -21.83 54.5 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.305 0.642 . . . . 0.0 110.392 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.58 69.26 72.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.006 0.922 . . . . 0.0 109.11 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.65 0.36 9.42 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.37 2.713 . . . . 0.0 112.389 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.4 t -92.28 -41.91 10.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.8 tp -83.9 72.03 10.44 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.071 1.748 . . . . 0.0 109.745 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.11 124.34 18.4 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.78 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.545 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 25.5 m95 -89.11 130.46 35.55 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.284 1.434 . . . . 0.0 109.985 -169.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.09 -37.82 75.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.122 0.569 . . . . 0.0 110.313 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.93 121.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.84 76.51 1.0 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -145.78 153.12 40.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -91.33 122.18 33.72 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.821 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.0 mt -102.81 131.58 49.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 122.684 0.394 . . . . 0.0 110.606 179.774 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.88 133.69 53.92 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.466 ' HB ' HD22 ' A' ' 153' ' ' LEU . 36.7 pt -123.8 118.78 55.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 118.766 0.712 . . . . 0.0 109.554 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.39 141.42 34.29 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.16 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 153' ' ' LEU . 46.9 mt -129.37 139.78 51.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.657 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.533 HD21 HG12 ' A' ' 24' ' ' VAL . 42.6 tp -145.41 106.17 4.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 168.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.64 146.2 21.41 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -130.0 152.0 49.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.104 0.952 . . . . 0.0 112.236 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.74 112.4 3.69 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.682 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.515 ' H ' ' HB3' ' A' ' 123' ' ' PRO . 3.4 mt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.0 t80 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.998 0.428 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD11 HD22 ' A' ' 47' ' ' LEU . 25.3 tp -60.47 -18.05 48.96 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.203 1.001 . . . . 0.0 113.147 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -76.7 -34.86 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.699 0.681 . . . . 0.0 110.589 -168.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p -69.74 -47.94 61.2 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.9 0.88 . . . . 0.0 109.799 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 191' ' ' LEU . 21.6 m -68.43 -41.07 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.31 72.2 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.634 0.773 . . . . 0.0 112.335 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -73.67 -22.21 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.123 0.569 . . . . 0.0 110.497 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -90.21 -18.92 24.83 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.354 0.662 . . . . 0.0 110.379 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 24' ' ' VAL . 70.1 mt -72.3 129.04 88.04 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.118 0.567 . . . . 0.0 110.097 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.83 153.05 69.06 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.564 2.176 . . . . 0.0 112.41 172.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 51.4 tt0 -68.46 31.1 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.058 1.743 . . . . 0.0 114.654 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -118.64 -156.97 10.31 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.084 -1.01 . . . . 0.0 112.794 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -87.88 121.47 30.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.562 0.745 . . . . 0.0 109.045 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 54' ' ' VAL . 4.3 mt -111.77 148.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.649 0.78 . . . . 0.0 109.592 -168.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.524 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 49.4 tp -106.92 117.28 33.63 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.163 0.438 . . . . 0.0 110.198 171.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 51.1 t -102.98 114.75 29.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.983 0.913 . . . . 0.0 110.072 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.2 mt -81.29 141.29 34.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 123.614 0.766 . . . . 0.0 110.448 177.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -69.66 -31.48 69.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.122 0.569 . . . . 0.0 110.061 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.415 HD22 HD12 ' A' ' 21' ' ' LEU . 17.4 t-20 -62.33 -41.95 98.98 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.66 87.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.758 0.823 . . . . 0.0 111.454 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.403 ' HA ' HD12 ' A' ' 78' ' ' ILE . 66.8 m -60.86 -34.94 75.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.678 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.57 -32.74 66.27 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.285 0.365 . . . . 0.0 110.484 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.526 HD12 HG11 ' A' ' 99' ' ' VAL . 74.3 mt -67.02 -31.6 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.54 72.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.196 0.598 . . . . 0.0 111.253 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.658 ' HA ' HG13 ' A' ' 76' ' ' VAL . 20.1 m -71.99 -4.39 28.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.711 0.804 . . . . 0.0 112.491 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.28 12.49 15.91 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.332 0.653 . . . . 0.0 110.218 168.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.85 56.27 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 114.163 0.425 . . . . 0.0 114.163 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 11.8 m-85 -114.1 152.24 31.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.79 91.81 8.78 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG23 HD13 ' A' ' 33' ' ' ILE . 92.4 t -91.16 111.94 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.254 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.603 HG22 ' HB ' ' A' ' 79' ' ' THR . 40.4 p -84.22 106.64 16.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 108.314 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.9 129.43 46.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.126 0.571 . . . . 0.0 109.935 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.542 HG21 ' HB ' ' A' ' 81' ' ' VAL . 8.4 t -111.39 120.21 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -129.7 137.42 50.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 23.3 mt-30 -60.41 -25.84 66.23 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.626 1.204 . . . . 0.0 112.238 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 62' ' ' VAL . 19.6 m -97.95 116.18 29.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.453 ' HA ' HD11 ' A' ' 64' ' ' LEU . 60.5 p -66.29 -30.69 71.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.607 0.718 . . . . 0.0 109.954 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 60' ' ' SER . 26.7 m -61.76 -35.95 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.674 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.95 -32.86 60.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.587 0.554 . . . . 0.0 112.062 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 61' ' ' SER . 86.5 mt -62.58 -43.57 98.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.792 0.837 . . . . 0.0 110.742 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.28 94.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.256 0.623 . . . . 0.0 111.708 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -70.19 -30.99 68.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.127 0.571 . . . . 0.0 111.166 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 -44.52 90.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.562 0.745 . . . . 0.0 111.036 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.35 -35.18 68.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.684 0.794 . . . . 0.0 110.995 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.08 -47.63 84.55 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.603 0.761 . . . . 0.0 110.246 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.38 -28.46 67.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.725 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -63.99 -61.52 2.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.276 0.63 . . . . 0.0 111.075 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.66 -29.01 70.0 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.116 0.566 . . . . 0.0 111.005 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -65.1 -43.62 91.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.149 0.58 . . . . 0.0 110.143 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -93.64 -2.73 53.64 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.07 34.48 55.38 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.7 -0.227 . . . . 0.0 113.232 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 49' ' ' SER . 33.5 m -127.45 175.34 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.122 0.969 . . . . 0.0 110.09 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.56 131.66 56.01 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.011 0.924 . . . . 0.0 111.103 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.725 HG12 ' HB1' ' A' ' 71' ' ' ALA . 19.8 mm -110.75 164.39 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 161.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.603 ' HB ' HG22 ' A' ' 55' ' ' THR . 88.8 m -131.88 104.59 6.95 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 p -86.87 121.6 29.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.859 0.463 . . . . 0.0 110.273 -168.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.542 ' HB ' HG21 ' A' ' 57' ' ' VAL . 59.6 t -108.62 136.98 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 108.427 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -79.76 128.6 33.62 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 59' ' ' GLN . 80.4 p -59.63 120.21 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.871 0.732 . . . . 0.0 112.326 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.31 85.16 1.95 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 161.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.563 ' HB2' HD22 ' A' ' 109' ' ' LEU . 74.4 mt -84.87 -24.86 28.35 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.233 0.613 . . . . 0.0 110.608 -168.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 -7.67 32.26 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.062 0.945 . . . . 0.0 111.864 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -132.64 -23.43 2.06 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.564 0.746 . . . . 0.0 111.819 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HE2' HG13 ' A' ' 81' ' ' VAL . 38.4 t80 -162.32 116.88 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.286 1.034 . . . . 0.0 109.666 -171.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -125.36 -60.11 1.35 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.605 ' HB ' HD13 ' A' ' 98' ' ' ILE . 34.4 pt -139.99 131.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 118.803 0.729 . . . . 0.0 111.757 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.91 89.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.225 1.01 . . . . 0.0 109.648 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.563 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -70.73 1.01 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.22 -44.27 68.94 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.63 -32.94 64.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.709 0.803 . . . . 0.0 112.566 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.477 ' NE1' HD22 ' A' ' 34' ' ' LEU . 12.7 m95 -109.05 162.69 14.0 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.054 0.542 . . . . 0.0 110.091 -170.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 12.3 tp10 -76.21 -56.86 4.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.35 171.97 17.33 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.605 HD13 ' HB ' ' A' ' 90' ' ' ILE . 74.3 mt -135.89 127.59 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.8 p -114.55 125.11 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -124.39 93.37 3.89 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 128' ' ' ILE . 35.5 mm -65.34 138.79 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -18.47 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.012 1.725 . . . . 0.0 114.098 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.423 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 t -78.44 111.01 14.03 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.849 -171.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -107.81 98.14 7.77 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.423 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 71.3 mt -124.97 140.47 35.92 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.9 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 160.62 45.97 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.921 2.414 . . . . 0.0 110.871 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 m -43.36 -42.41 4.59 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.844 1.258 . . . . 0.0 113.778 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -53.57 -55.42 25.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.143 0.977 . . . . 0.0 112.226 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 85' ' ' LEU . 98.8 mt -83.18 -24.89 32.26 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.214 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.453 HH22 ' HA ' ' A' ' 151' ' ' PRO . 23.9 ttt180 -77.54 -52.57 8.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.054 0.942 . . . . 0.0 109.841 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.07 -22.42 66.85 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 0.0 112.277 170.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -75.76 -35.26 60.22 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.41 0.684 . . . . 0.0 109.611 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.4 tp -65.78 -52.17 53.07 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.592 0.757 . . . . 0.0 111.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -58.44 -44.15 98.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -166.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.28 -31.59 81.95 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.713 1.609 . . . . 0.0 112.003 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -81.94 -15.11 54.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.2 0.6 . . . . 0.0 110.91 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 12.0 t -84.0 -42.87 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -59.26 -59.68 5.08 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.08 -48.33 44.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.821 0.849 . . . . 0.0 113.095 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.58 -35.23 17.33 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -165.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.8 tp -77.99 95.18 4.76 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.89 0.845 . . . . 0.0 110.351 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.563 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -75.04 150.74 85.91 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.986 168.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -42.74 117.72 0.97 Allowed 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 124.667 3.578 . . . . 0.0 115.341 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.47 12.46 3.77 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.137 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -104.68 137.75 13.79 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.3 m -105.85 129.55 58.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.73 0.812 . . . . 0.0 110.458 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.65 112.94 25.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 101' ' ' ILE . 46.6 mt -105.26 109.26 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 156' ' ' LEU . 55.7 mt -123.59 134.38 53.82 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -117.57 102.33 9.08 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.535 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -72.37 140.54 29.7 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.914 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.589 ' HB2' HD21 ' A' ' 150' ' ' LEU . 69.5 m-85 -111.23 164.02 13.32 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.122 0.487 . . . . 0.0 111.297 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.006 -178.829 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 132' ' ' PHE . 62.5 mt -81.73 112.9 38.42 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 167.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.658 ' HB3' HD13 ' A' ' 156' ' ' LEU . 17.0 Cg_exo -69.35 137.73 37.35 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.292 2.661 . . . . 0.0 113.416 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.489 ' HA ' HD13 ' A' ' 188' ' ' ILE . 44.7 mmtm -118.4 148.36 42.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.514 0.726 . . . . 0.0 112.234 171.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 190' ' ' LEU . 39.9 mt -60.92 -42.33 97.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.295 1.038 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -51.78 -45.12 63.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.085 0.865 . . . . 0.0 111.256 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.9 m -77.79 -46.29 22.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.871 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 151' ' ' PRO . 89.4 mt -76.5 -46.29 27.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.833 0.853 . . . . 0.0 113.28 -170.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.525 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.1 tt0 -54.47 -46.0 73.29 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 110.688 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 t -73.03 -22.89 60.56 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.928 0.491 . . . . 0.0 111.769 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -73.51 -30.97 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.42 0.688 . . . . 0.0 110.84 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.61 75.76 76.04 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.69 -11.74 24.17 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.08 2.52 . . . . 0.0 111.549 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -87.51 -39.44 15.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.937 1.295 . . . . 0.0 108.69 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.3 tp -91.52 72.95 5.99 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.075 1.35 . . . . 0.0 110.064 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.23 132.93 55.23 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.525 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 23.4 m95 -94.82 132.33 39.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.509 0.724 . . . . 0.0 109.283 -168.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.84 -30.78 71.05 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.282 0.633 . . . . 0.0 110.337 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.08 127.92 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -146.15 63.42 1.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -108.6 139.17 43.75 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.797 -164.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -96.46 105.91 18.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.078 0.951 . . . . 0.0 109.498 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 47.0 mt -97.18 119.34 35.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.555 0.742 . . . . 0.0 110.902 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 168.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.389 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 73.0 mt -117.65 166.11 12.79 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 152' ' ' LYS . 10.2 pt -149.28 149.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.029 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -129.7 150.53 50.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 111.117 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 153' ' ' LEU . 61.6 mt -130.85 135.2 47.5 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.269 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 24' ' ' VAL . 34.4 tp -129.79 104.68 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 167.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -89.21 128.62 9.26 Favored Glycine 0 C--O 1.208 -1.48 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -142.38 156.19 45.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.747 0.819 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -59.71 127.43 31.93 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.428 0.455 . . . . 0.0 109.978 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 118.751 -0.643 . . . . 0.0 110.031 -171.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.9 t80 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HA ' HG22 ' A' ' 24' ' ' VAL . 56.0 tp -74.17 -41.7 61.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.346 0.659 . . . . 0.0 111.413 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -45.76 -41.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 p -80.5 -51.22 9.05 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.073 0.549 . . . . 0.0 111.091 -174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.522 HG13 HD23 ' A' ' 191' ' ' LEU . 16.7 m -59.52 -35.53 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.933 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' A' ' 28' ' ' ILE . . . -59.17 -39.53 82.79 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 124.476 1.11 . . . . 0.0 111.734 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.21 -27.95 69.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.636 0.775 . . . . 0.0 110.719 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.467 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 87.7 mm-40 -90.17 -7.66 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.691 0.796 . . . . 0.0 112.634 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 24' ' ' VAL . 68.0 mt -87.41 136.26 33.52 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.895 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.01 134.68 43.21 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.778 2.985 . . . . 0.0 113.752 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -77.61 27.89 0.16 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.99 -134.67 5.52 Favored Glycine 0 N--CA 1.475 1.258 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.874 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.98 112.35 18.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.202 0.501 . . . . 0.0 109.734 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.475 HG22 HG11 ' A' ' 99' ' ' VAL . 18.6 mt -115.04 129.46 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -170.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 89' ' ' ASP . 66.1 tp -94.37 114.44 26.49 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.716 0.406 . . . . 0.0 110.836 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 36.2 t -94.35 140.13 30.19 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -90.91 173.71 7.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.777 0.322 . . . . 0.0 111.554 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.653 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.641 0 CA-C-O 120.8 0.111 . . . . 0.0 112.875 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -70.65 -35.7 73.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.98 1.312 . . . . 0.0 111.68 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -64.28 -50.18 68.92 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.597 0.56 . . . . 0.0 110.824 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.75 -50.04 69.38 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.208 0.942 . . . . 0.0 111.508 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.705 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 73.5 m -55.93 -49.02 74.64 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.09 0.956 . . . . 0.0 113.513 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.402 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 41.4 t80 -58.16 -43.17 87.25 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.703 0.627 . . . . 0.0 111.011 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 99' ' ' VAL . 60.9 mt -67.92 -32.61 73.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.778 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.06 -33.6 65.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.92 0.488 . . . . 0.0 111.448 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.589 ' HA ' HG11 ' A' ' 76' ' ' VAL . 19.3 m -65.47 -15.3 62.51 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.06 0.944 . . . . 0.0 111.738 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.1 mt -82.7 3.11 30.44 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.553 0.741 . . . . 0.0 110.831 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.92 16.81 62.55 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-O 119.798 -0.446 . . . . 0.0 113.928 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -103.09 155.11 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.695 0.748 . . . . 0.0 110.881 -173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.1 87.69 6.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.533 0.733 . . . . 0.0 109.207 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.88 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 t -86.01 106.74 17.39 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.928 0.891 . . . . 0.0 109.287 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.56 131.32 53.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.469 0.708 . . . . 0.0 110.438 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -95.46 146.68 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 29.9 t0 -150.14 135.34 17.95 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.11 -11.1 60.42 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.825 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.3 t -113.65 164.48 13.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.033 0.933 . . . . 0.0 109.268 169.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -78.2 -26.57 47.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.991 0.516 . . . . 0.0 112.187 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.8 m -56.87 -43.95 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.83 -34.71 62.22 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.203 0.314 . . . . 0.0 112.474 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 94.3 mt -67.86 -59.46 3.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.702 0.801 . . . . 0.0 111.322 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.46 73.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.109 0.964 . . . . 0.0 112.934 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.24 -45.58 92.68 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.839 0.855 . . . . 0.0 110.416 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.705 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -64.11 -46.51 83.89 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.92 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -71.76 -35.22 70.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.231 1.012 . . . . 0.0 111.02 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.43 -61.23 2.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.397 0.679 . . . . 0.0 111.152 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.37 -22.6 66.25 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.567 0.542 . . . . 0.0 111.17 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.74 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.6 -63.63 1.05 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.984 174.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.93 -30.59 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.04 0.536 . . . . 0.0 110.824 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.39 -31.51 71.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.255 1.022 . . . . 0.0 111.474 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -102.25 1.69 36.15 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.116 0.566 . . . . 0.0 111.417 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.48 67.76 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 122.355 -0.216 . . . . 0.0 113.233 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.7 m -124.08 -179.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 108.182 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.78 131.92 36.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.74 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.7 mm -106.96 166.88 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 166.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -129.42 105.75 8.31 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.3 p -85.69 119.83 26.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.092 0.557 . . . . 0.0 110.924 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.9 124.18 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.044 1.337 . . . . 0.0 109.264 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -100.24 91.7 4.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -142.57 -177.6 5.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.237 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -146.33 136.91 24.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -162.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 14.2 mt -76.19 -8.46 57.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 123.543 0.527 . . . . 0.0 112.389 -166.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -94.77 -0.32 54.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.834 0.454 . . . . 0.0 112.144 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -123.42 -44.17 2.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.824 0.449 . . . . 0.0 110.685 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -169.46 124.52 0.83 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.513 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -134.96 -72.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.059 0.944 . . . . 0.0 109.308 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.576 ' HB ' HD13 ' A' ' 98' ' ' ILE . 10.7 pt -129.55 122.74 56.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 C-N-CA 123.199 0.599 . . . . 0.0 111.616 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.92 94.64 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.698 1.199 . . . . 0.0 108.816 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.25 -0.52 2.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -73.49 -48.05 36.45 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.883 0.473 . . . . 0.0 110.291 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.05 61.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.11 0.564 . . . . 0.0 112.259 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.445 ' NE1' HD23 ' A' ' 34' ' ' LEU . 13.7 m95 -113.17 139.08 49.06 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.009 0.524 . . . . 0.0 109.847 -170.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.97 -40.12 79.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.33 174.65 29.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.025 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' A' ' 90' ' ' ILE . 64.3 mt -132.12 140.56 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 6.2 p -124.84 108.48 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.749 0.82 . . . . 0.0 109.1 167.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.475 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 42.7 m -108.89 89.49 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.59 149.83 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.943 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -17.66 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 127.394 2.278 . . . . 0.0 112.61 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.8 p -99.78 104.78 16.5 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.848 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -96.57 98.07 9.91 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.61 147.83 40.61 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.916 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.613 ' HA ' HD12 ' A' ' 149' ' ' LEU . 46.8 Cg_exo -59.05 149.28 80.78 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.282 1.988 . . . . 0.0 110.099 160.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 11.7 t -57.78 -22.72 48.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.421 0.688 . . . . 0.0 112.187 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t -52.87 -55.82 20.39 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.566 0.746 . . . . 0.0 111.363 168.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.9 mt -81.0 -27.47 35.87 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.472 0.709 . . . . 0.0 110.824 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.619 HH11 ' HB3' ' A' ' 151' ' ' PRO . 11.3 ttp180 -68.48 -56.27 8.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.966 0.906 . . . . 0.0 110.334 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -37.52 63.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.45 1.1 . . . . 0.0 111.328 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 6.2 tp-100 -70.38 -31.9 69.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.107 0.563 . . . . 0.0 110.22 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 117' ' ' VAL . 45.6 tp -76.46 -33.84 58.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.945 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -55.1 -47.33 98.77 Favored Pre-proline 0 CA--C 1.569 1.695 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.79 -29.67 90.5 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.247 1.965 . . . . 0.0 112.672 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -75.26 -31.73 60.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.735 0.814 . . . . 0.0 111.142 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 1.6 t -88.37 -27.23 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.363 0.601 . . . . 0.0 110.735 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.61 -64.61 1.15 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.29 -49.76 10.35 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.69 -33.58 63.36 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 113.711 0.245 . . . . 0.0 113.711 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.5 tp -78.69 131.22 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.297 0.57 . . . . 0.0 109.791 171.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -114.82 161.71 27.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.797 1.239 . . . . 0.0 107.988 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -36.4 114.72 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 124.305 3.337 . . . . 0.0 115.529 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.535 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.52 -0.85 5.97 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.678 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -100.3 148.62 18.45 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 166.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.92 131.7 65.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 C-N-CA 124.493 1.117 . . . . 0.0 109.103 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.7 t80 -109.33 109.13 19.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 24' ' ' VAL . 43.8 mt -111.34 108.07 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.298 1.039 . . . . 0.0 108.608 -170.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 95.1 mt -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.774 0.83 . . . . 0.0 111.144 -172.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.4 101.78 4.93 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.8 118.39 6.06 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.438 ' O ' HD13 ' A' ' 150' ' ' LEU . 27.1 m-85 -78.83 169.4 18.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.415 1.086 . . . . 0.0 109.873 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.584 . . . . 0.0 111.537 -175.625 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 106' ' ' PRO . 13.9 mt . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 132' ' ' PHE . 95.7 mt -74.99 113.25 22.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 123.351 0.407 . . . . 0.0 110.481 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.619 ' HB3' HH11 ' A' ' 110' ' ' ARG . 93.4 Cg_endo -87.01 129.55 2.9 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.258 1.972 . . . . 0.0 111.405 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -81.36 164.37 22.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.718 0.807 . . . . 0.0 111.54 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.487 HD23 ' HB ' ' A' ' 188' ' ' ILE . 81.1 mt -60.62 -41.47 94.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.155 0.582 . . . . 0.0 110.478 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.51 -39.49 67.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.398 0.679 . . . . 0.0 111.471 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.4 p -81.48 -53.6 6.14 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.486 0.314 . . . . 0.0 110.732 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -61.63 -50.59 71.92 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.576 1.15 . . . . 0.0 111.93 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -65.48 -30.81 71.63 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.787 0.835 . . . . 0.0 111.702 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.6 t -73.19 -29.43 62.82 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 122.812 0.445 . . . . 0.0 111.08 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 -10.66 58.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.087 0.555 . . . . 0.0 111.021 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 96.5 mt -141.34 71.03 27.06 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.459 0.704 . . . . 0.0 109.559 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.59 7.38 4.69 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.065 2.51 . . . . 0.0 111.298 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.0 t -90.71 -41.17 11.44 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.4 tp -91.82 71.18 5.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.024 1.33 . . . . 0.0 110.626 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.495 ' HB3' HD23 ' A' ' 195' ' ' LEU . 4.0 t-20 -59.89 129.77 43.47 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.446 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 28.9 m95 -95.54 141.37 29.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.014 0.926 . . . . 0.0 110.765 -164.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.15 -36.81 72.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.172 0.589 . . . . 0.0 110.345 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.88 125.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.24 84.26 1.13 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.664 0.785 . . . . 0.0 109.916 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -155.92 155.59 33.11 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.485 0.314 . . . . 0.0 111.475 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.08 110.98 13.52 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.55 130.37 47.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.275 0.63 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 132' ' ' PHE . 56.4 mt -116.71 163.86 15.49 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.487 ' HB ' HD23 ' A' ' 153' ' ' LEU . 44.4 pt -135.93 139.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -132.69 151.28 52.01 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.976 0.893 . . . . 0.0 111.365 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 64.5 mt -136.29 138.26 41.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 113.329 -1.76 . . . . 0.0 108.791 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.522 HD23 HG13 ' A' ' 24' ' ' VAL . 27.9 tp -129.71 107.52 9.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 168.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.03 139.84 17.26 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.467 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 8.3 tp-100 -140.32 153.02 46.3 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.438 0.695 . . . . 0.0 109.693 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.535 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 18.1 pttp -58.17 128.43 37.09 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.806 0.691 . . . . 0.0 109.254 170.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 164' ' ' ASN . 4.5 mt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.45 ' O ' HG11 ' A' ' 24' ' ' VAL . 43.4 t80 . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.477 ' O ' HG21 ' A' ' 24' ' ' VAL . 37.4 tp -62.22 -47.51 84.11 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.806 0.842 . . . . 0.0 112.065 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.81 -33.67 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -70.39 -50.95 33.42 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.621 0.768 . . . . 0.0 110.903 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.533 HG22 HD12 ' A' ' 128' ' ' ILE . 2.7 m -64.46 -30.13 49.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.558 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 50' ' ' LEU . . . -59.49 -38.17 80.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.625 1.17 . . . . 0.0 111.243 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -70.13 -29.07 65.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.383 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -87.93 -7.23 57.43 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.632 0.773 . . . . 0.0 112.41 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 24' ' ' VAL . 89.9 mt -82.51 123.45 78.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -52.34 133.49 48.32 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.175 2.583 . . . . 0.0 113.131 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -67.1 31.0 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 126.928 2.091 . . . . 0.0 116.138 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.4 -154.34 10.95 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.663 -0.52 . . . . 0.0 112.483 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.09 120.65 19.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.128 0.571 . . . . 0.0 110.572 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 mt -109.07 135.88 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 0.0 110.07 -167.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 55' ' ' THR . 67.9 tp -110.4 118.26 35.8 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.002 0.521 . . . . 0.0 109.714 171.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 42.3 t -96.58 130.86 43.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.227 1.011 . . . . 0.0 109.462 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -95.1 117.56 30.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 164.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.55 0.691 . . . . 0.0 111.012 -169.727 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 113.341 0.096 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -60.6 -34.37 74.11 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.679 0.752 . . . . 0.0 109.903 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.0 p30 -56.15 -48.08 76.97 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.163 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.3 93.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.748 0.819 . . . . 0.0 111.324 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 14.4 m -61.79 -42.27 98.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.668 0.787 . . . . 0.0 112.465 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -64.61 -44.74 89.6 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.791 0.682 . . . . 0.0 109.876 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 99' ' ' VAL . 81.2 mt -67.51 -32.7 73.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 -34.39 67.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.174 0.59 . . . . 0.0 111.59 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.741 ' HA ' HG12 ' A' ' 76' ' ' VAL . 28.4 t -68.71 -9.93 53.39 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.831 0.852 . . . . 0.0 111.7 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD12 ' HB1' ' A' ' 25' ' ' ALA . 85.4 mt -78.54 6.73 7.99 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.329 0.652 . . . . 0.0 111.105 170.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.52 27.69 26.6 Favored Glycine 0 C--N 1.359 1.808 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.962 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -130.52 163.05 27.9 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.492 0.646 . . . . 0.0 111.016 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.97 93.06 6.39 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.61 112.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.7 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 34' ' ' LEU . 57.6 m -86.09 108.84 18.46 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.053 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.4 130.14 47.55 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.957 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.6 116.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 124.87 44.01 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.08 -25.71 46.58 Favored 'General case' 0 CA--C 1.562 1.41 0 O-C-N 124.593 1.183 . . . . 0.0 111.678 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -112.31 121.64 45.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.404 1.082 . . . . 0.0 108.786 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.423 ' HA ' HD12 ' A' ' 64' ' ' LEU . 34.8 p -69.03 -15.28 63.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 112.406 -173.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.5 m -56.48 -44.25 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.434 0.459 . . . . 0.0 110.82 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.86 -30.08 66.36 Favored Glycine 0 C--N 1.358 1.792 0 O-C-N 123.654 0.596 . . . . 0.0 113.036 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 91.1 mt -64.85 -45.96 83.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.749 0.82 . . . . 0.0 110.695 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -62.6 -39.42 93.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.593 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 73.4 mmtt -64.98 -43.44 92.59 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.715 0.406 . . . . 0.0 109.914 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.558 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -57.62 -40.68 79.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.6 -36.42 73.52 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.68 0.792 . . . . 0.0 111.488 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 26.4 mt-30 -57.6 -58.27 9.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.594 0.757 . . . . 0.0 111.718 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 38.2 tp -67.41 -24.94 65.71 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.213 -176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.35 7.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.481 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.39 -27.82 68.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.832 0.453 . . . . 0.0 111.108 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.35 -44.42 92.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.279 1.032 . . . . 0.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 6.19 46.48 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.659 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.52 39.28 50.35 Favored Glycine 0 C--N 1.356 1.65 0 N-CA-C 113.936 0.334 . . . . 0.0 113.936 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 49' ' ' SER . 32.7 m -136.31 175.45 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.117 0.967 . . . . 0.0 109.524 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -129.52 142.67 50.71 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.025 0.44 . . . . 0.0 112.131 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 45' ' ' CYS . 17.7 mm -105.53 169.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.13 1.372 . . . . 0.0 107.43 170.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 m -121.47 105.87 10.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 164.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 64' ' ' LEU . 70.0 p -93.05 111.16 22.7 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 110.655 -165.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.64 124.81 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.6 1.16 . . . . 0.0 110.082 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.51 95.28 6.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -144.34 -174.66 4.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.848 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -144.87 127.52 16.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -158.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD12 HD13 ' A' ' 105' ' ' LEU . 26.5 mt -68.81 -6.06 24.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.151 0.58 . . . . 0.0 112.542 -172.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -96.9 9.98 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.267 1.027 . . . . 0.0 112.6 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.9 -46.44 0.27 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.207 0.603 . . . . 0.0 110.379 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -155.37 122.87 5.59 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.983 1.713 . . . . 0.0 106.594 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -135.39 -71.8 0.47 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 117' ' ' VAL . 14.5 pt -143.25 123.01 9.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.497 0.719 . . . . 0.0 109.904 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.92 84.91 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -67.18 -5.97 15.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.91 -39.27 93.79 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.562 0.745 . . . . 0.0 109.111 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.99 -20.46 24.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.029 0.932 . . . . 0.0 111.9 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -121.7 114.08 20.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 0.0 109.946 -170.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.2 -43.83 81.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.584 0.754 . . . . 0.0 110.337 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.16 151.3 18.24 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.042 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.56 HD13 HD12 ' A' ' 121' ' ' LEU . 73.1 mt -132.07 148.17 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.4 p -135.49 120.79 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.246 1.018 . . . . 0.0 108.417 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.4 m -108.69 93.23 4.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.624 HD12 HD11 ' A' ' 128' ' ' ILE . 23.3 mm -70.44 140.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.829 0.852 . . . . 0.0 109.512 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -14.0 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.03 2.132 . . . . 0.0 113.691 -171.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.77 107.1 19.46 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.25 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -105.5 101.15 10.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 85' ' ' LEU . 82.4 mt -121.35 138.8 28.63 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.47 163.53 35.92 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.158 2.572 . . . . 0.0 110.717 171.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -35.98 -43.46 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 126.105 1.762 . . . . 0.0 114.875 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 p -57.0 -56.49 21.1 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.641 0.776 . . . . 0.0 110.957 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 94.1 mt -84.39 -22.85 30.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.768 0.827 . . . . 0.0 110.555 -172.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -73.51 -61.26 1.89 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.956 0.903 . . . . 0.0 109.656 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.82 -9.62 15.82 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.226 0.611 . . . . 0.0 112.159 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 24.6 tp60 -87.43 -37.77 16.71 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.673 0.389 . . . . 0.0 110.748 170.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HG22 ' A' ' 117' ' ' VAL . 62.7 tp -85.56 -61.27 1.8 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 77.6 m-85 -68.48 -39.57 16.09 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -160.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 45.9 Cg_endo -66.35 -23.96 50.78 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 121.908 1.738 . . . . 0.0 111.894 170.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -83.12 -19.74 36.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.955 0.902 . . . . 0.0 109.286 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.596 HG21 ' HE2' ' A' ' 127' ' ' PHE . 39.1 t -77.0 -38.81 28.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -49.67 -57.83 6.46 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.5 -46.81 62.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.093 0.957 . . . . 0.0 113.004 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.04 -37.65 28.5 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -166.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.754 HD13 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -77.1 109.62 11.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 109.109 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.453 ' HZ3' ' HB2' ' A' ' 122' ' ' LYS . 10.0 mtmp? -79.79 163.83 56.36 Favored Pre-proline 0 C--O 1.247 0.931 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.98 115.41 0.87 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.72 2.28 . . . . 0.0 113.542 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.557 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.6 12.87 2.92 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.943 172.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.754 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -107.91 148.91 16.71 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 117.482 0.641 . . . . 0.0 112.508 166.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.4 139.5 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.126 0.97 . . . . 0.0 109.024 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.596 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.49 121.07 41.6 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 101' ' ' ILE . 55.1 mt -110.91 109.04 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.758 0.823 . . . . 0.0 109.201 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 47.5 mt -125.8 144.0 50.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.933 0.893 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -132.23 102.5 5.8 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.94 -173.37 46.58 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.52 ' HB2' HD21 ' A' ' 150' ' ' LEU . 71.5 m-85 -135.31 158.98 43.0 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 123.594 0.758 . . . . 0.0 111.648 -178.442 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.555 1.146 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 132' ' ' PHE . 48.1 mt -88.38 110.59 37.56 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.594 ' HB2' HD11 ' A' ' 156' ' ' LEU . 5.1 Cg_exo -76.41 104.28 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.581 2.187 . . . . 0.0 109.387 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 188' ' ' ILE . 53.6 mtpt -94.93 160.24 14.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.171 0.588 . . . . 0.0 111.287 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.431 HD22 HD23 ' A' ' 190' ' ' LEU . 71.9 mt -53.26 -37.57 62.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.911 0.884 . . . . 0.0 110.929 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.06 -54.36 20.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.057 1.343 . . . . 0.0 111.74 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -76.24 -45.93 30.53 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.306 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 151' ' ' PRO . 82.7 mt -71.38 -49.73 39.17 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.714 0.806 . . . . 0.0 112.411 -168.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -58.75 -37.69 76.8 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 0.0 111.637 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.0 t -76.62 -17.58 59.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.294 0.238 . . . . 0.0 111.421 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.99 -5.54 55.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.644 0.378 . . . . 0.0 110.619 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 39.3 mt -145.71 59.1 5.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.488 1.115 . . . . 0.0 108.532 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.04 -26.34 21.7 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.06 2.507 . . . . 0.0 112.731 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -90.24 -14.41 33.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.485 0.714 . . . . 0.0 110.209 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 17.7 tp -89.75 69.28 7.64 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.596 1.158 . . . . 0.0 108.628 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.532 ' HB3' HD23 ' A' ' 195' ' ' LEU . 28.2 t30 -61.93 124.62 21.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -88.68 143.53 26.87 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.429 1.091 . . . . 0.0 109.594 -165.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.14 -39.07 72.18 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.172 0.589 . . . . 0.0 109.976 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 75.6 mt -129.14 119.08 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.73 86.05 1.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.747 0.819 . . . . 0.0 109.328 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -160.19 157.96 29.25 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.461 ' HA ' HG21 ' A' ' 188' ' ' ILE . 26.0 p-10 -75.35 104.93 6.12 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 mt -102.04 135.44 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.651 0.263 . . . . 0.0 110.753 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.5 mt -126.56 174.88 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 152' ' ' LYS . 23.8 pt -139.23 139.05 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -127.22 149.94 49.76 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.783 0.802 . . . . 0.0 110.804 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 67.7 mt -133.57 136.53 45.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.395 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -137.25 108.26 6.73 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.7 147.39 22.02 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -142.55 150.88 40.99 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.551 0.74 . . . . 0.0 110.127 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.557 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 13.1 ptmm? -59.96 143.08 52.57 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.532 HD23 ' HB3' ' A' ' 164' ' ' ASN . 9.8 mt . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.61 HD22 ' HG ' ' A' ' 47' ' ' LEU . 24.3 tp -62.78 -47.01 85.33 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.553 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -45.68 -33.78 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -68.76 -51.5 40.53 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.34 0.656 . . . . 0.0 110.135 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 2.5 m -62.4 -32.9 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.466 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.75 74.53 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.519 1.128 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.58 -21.53 61.13 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.306 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.641 ' HB3' HE21 ' A' ' 193' ' ' GLN . 84.1 mm-40 -84.1 -23.4 30.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.392 0.677 . . . . 0.0 111.207 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 24' ' ' VAL . 63.2 mt -82.23 135.22 47.72 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -52.99 145.61 40.63 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.82 2.347 . . . . 0.0 112.043 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -65.5 29.81 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -115.6 -167.39 15.12 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 118.999 0.818 . . . . 0.0 111.818 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -73.36 127.7 33.4 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.852 0.358 . . . . 0.0 110.309 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 HD12 HG23 ' A' ' 28' ' ' ILE . 5.2 mt -113.77 135.93 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.439 -168.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.479 HD22 ' CD1' ' A' ' 95' ' ' TRP . 54.2 tp -98.76 119.99 38.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 6.8 p -110.83 118.64 36.68 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.768 0.827 . . . . 0.0 109.983 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 90' ' ' ILE . 58.2 mt -78.27 135.98 37.66 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 108.808 174.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 CA-C-O 120.404 -0.109 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -69.68 -42.64 73.87 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.526 0.73 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HB3' HD11 ' A' ' 21' ' ' LEU . 14.3 m120 -73.07 -32.76 65.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.203 0.601 . . . . 0.0 110.367 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -58.01 -51.8 68.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.668 0.787 . . . . 0.0 110.569 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 31.0 m -65.9 -32.89 74.65 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.575 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 38.2 t80 -67.81 -32.14 72.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.61 ' HG ' HD22 ' A' ' 21' ' ' LEU . 37.0 mt -65.84 -33.53 76.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.309 0.644 . . . . 0.0 110.531 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.29 70.65 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.862 0.363 . . . . 0.0 110.896 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HG12 ' A' ' 76' ' ' VAL . 35.6 t -65.75 -18.23 65.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.654 0.782 . . . . 0.0 111.579 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.544 HD13 HD22 ' A' ' 47' ' ' LEU . 55.9 mt -89.15 18.93 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.914 0.885 . . . . 0.0 110.794 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.88 19.61 78.68 Favored Glycine 0 C--N 1.362 1.974 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -104.06 148.42 26.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.092 0.557 . . . . 0.0 109.941 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -88.56 88.98 7.8 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.8 t -94.59 109.94 22.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.611 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.59 HG23 ' HB ' ' A' ' 79' ' ' THR . 69.6 p -84.31 112.62 20.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.312 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -106.43 111.65 24.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.834 0.854 . . . . 0.0 111.047 -172.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 34' ' ' LEU . 22.3 t -81.24 126.82 39.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.35 119.58 11.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.46 -18.18 65.12 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.617 0.573 . . . . 0.0 111.957 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.1 m -97.45 130.39 44.56 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.7 p -65.59 -27.71 68.61 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 18.4 m -63.27 -41.0 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.3 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.54 -40.81 94.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.647 0.592 . . . . 0.0 112.328 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.5 -42.16 83.3 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.537 0.735 . . . . 0.0 111.287 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.22 90.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.782 0.833 . . . . 0.0 112.328 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 2.8 mmmp? -65.85 -41.97 91.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.845 0.458 . . . . 0.0 110.134 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.652 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -61.0 -55.4 33.29 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.607 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.37 -23.41 50.81 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.69 -44.52 96.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 45' ' ' CYS . 35.2 tp -69.11 -24.25 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.651 0.594 . . . . 0.0 111.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.14 -51.63 68.25 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.484 0.659 . . . . 0.0 109.434 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -72.58 -30.29 64.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.005 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.22 -53.62 10.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.598 0.759 . . . . 0.0 110.804 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.36 -1.4 55.95 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.5 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 38.77 78.43 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.846 -0.161 . . . . 0.0 113.299 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -112.97 173.99 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.734 0.814 . . . . 0.0 109.849 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.487 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 5.0 ttmp? -111.65 121.1 44.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.15 0.58 . . . . 0.0 111.152 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.536 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.2 mm -107.26 163.41 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 164.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 55' ' ' THR . 29.7 m -133.59 106.13 7.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p -87.04 112.85 22.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.436 0.694 . . . . 0.0 111.083 -166.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.13 126.41 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.013 1.325 . . . . 0.0 109.303 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -104.77 92.34 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -134.21 -176.83 4.33 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -141.14 110.1 6.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.734 -1.121 . . . . 0.0 107.999 -158.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 105' ' ' LEU . 17.7 mt -65.87 -7.69 17.84 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.507 1.123 . . . . 0.0 111.733 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.591 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -57.97 -41.91 83.93 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.325 1.05 . . . . 0.0 112.218 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -151.67 12.36 0.61 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.27 110.24 1.58 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.447 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -138.26 -73.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.501 HG21 HD11 ' A' ' 36' ' ' LEU . 17.7 pt -119.72 117.79 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.49 87.05 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.405 0.682 . . . . 0.0 109.537 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.57 -30.04 4.89 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.231 1.413 . . . . 0.0 114.153 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.51 -46.11 80.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.431 0.692 . . . . 0.0 109.272 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.35 -25.71 51.33 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.479 ' CD1' HD22 ' A' ' 34' ' ' LEU . 47.9 m95 -117.5 166.32 12.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -169.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 11.3 tp10 -94.07 -74.63 0.53 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.855 0.862 . . . . 0.0 109.836 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.87 162.11 17.46 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.514 HD12 HD12 ' A' ' 121' ' ' LEU . 54.1 mt -128.7 147.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -139.24 141.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.893 1.277 . . . . 0.0 107.87 167.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . 50.5 m -136.97 92.31 2.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.432 HD12 HD13 ' A' ' 128' ' ' ILE . 40.7 mm -62.28 133.51 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.55 ' HA ' HD22 ' A' ' 129' ' ' LEU . 14.6 p90 -20.93 102.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.123 2.139 . . . . 0.0 114.148 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 71.0 m -77.95 103.42 7.88 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.058 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -91.09 96.94 10.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 85' ' ' LEU . 86.8 mt -125.65 142.33 41.7 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.201 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.01 159.88 36.48 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.534 2.156 . . . . 0.0 110.707 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.3 p -41.87 -43.14 2.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.5 1.52 . . . . 0.0 113.668 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -55.77 -50.93 69.1 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.209 0.943 . . . . 0.0 112.172 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.92 -33.94 33.74 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.284 0.634 . . . . 0.0 111.714 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.42 -43.63 31.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.583 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.44 -35.0 18.1 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.693 0.797 . . . . 0.0 111.967 165.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.591 HE22 ' HA ' ' A' ' 86' ' ' ALA . 24.9 tt0 -79.47 -33.03 42.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.64 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' O ' HG22 ' A' ' 117' ' ' VAL . 48.1 tp -71.21 -48.61 50.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.891 0.476 . . . . 0.0 111.581 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -60.93 -42.77 88.67 Favored Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -167.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.43 -25.45 48.61 Favored 'Trans proline' 0 C--N 1.396 3.076 0 CA-C-N 121.364 1.523 . . . . 0.0 111.984 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -81.7 -21.17 38.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 122.995 0.518 . . . . 0.0 110.357 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 113' ' ' LEU . 19.3 t -85.03 -35.74 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.595 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 42.4 t80 -48.9 -61.6 1.96 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.125 0.97 . . . . 0.0 112.256 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.417 ' HG3' ' HD1' ' A' ' 118' ' ' TYR . 47.9 mt-30 -95.46 -22.3 17.77 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 172.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.21 -23.86 53.49 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 98' ' ' ILE . 39.7 tp -61.05 124.89 21.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.394 0.678 . . . . 0.0 110.884 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -67.11 133.11 93.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 70.6 Cg_exo -46.65 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.596 2.197 . . . . 0.0 112.297 168.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.16 14.76 8.17 Favored Glycine 0 C--O 1.248 1.005 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.433 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.41 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -95.87 135.56 12.39 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.5 m -109.4 130.4 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.002 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.17 111.59 24.08 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 24' ' ' VAL . 58.1 mt -106.98 108.27 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 102' ' ' PHE . 69.8 mt -124.25 117.49 24.68 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.423 0.689 . . . . 0.0 109.381 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -99.55 98.71 9.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.61 169.16 53.26 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.905 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.438 ' HD1' HD22 ' A' ' 187' ' ' LEU . 7.7 m-85 -133.06 156.02 48.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.898 -179.257 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.0 mt -86.89 102.81 3.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.859 ' HB2' HD13 ' A' ' 156' ' ' LEU . 93.1 Cg_endo -75.69 123.68 7.66 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.858 2.372 . . . . 0.0 112.618 -168.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -102.78 151.37 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.795 0.838 . . . . 0.0 111.839 -168.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 190' ' ' LEU . 32.5 mt -61.0 -54.39 45.58 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.692 . . . . 0.0 111.829 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -52.51 -39.54 61.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.93 0.892 . . . . 0.0 111.181 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 29.3 m -74.7 -57.12 4.12 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.859 HD13 ' HB2' ' A' ' 151' ' ' PRO . 88.8 mt -63.92 -46.43 84.8 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.251 1.021 . . . . 0.0 112.631 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.582 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.5 tt0 -53.38 -35.57 60.48 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 111.837 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.5 t -84.44 -20.88 31.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.694 . . . . 0.0 112.062 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 155' ' ' THR . 41.6 mm-40 -79.53 -16.53 55.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.608 . . . . 0.0 110.875 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 82.1 mt -142.12 66.53 20.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.768 0.827 . . . . 0.0 109.461 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.595 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 13.8 Cg_exo -72.24 -3.84 14.08 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 123.115 2.543 . . . . 0.0 112.635 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 p -85.62 -33.87 21.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.8 tp -99.59 70.49 1.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.361 1.464 . . . . 0.0 111.257 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.03 126.96 22.32 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.582 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 17.4 m95 -91.08 133.26 35.47 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.81 -35.56 77.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.985 0.514 . . . . 0.0 109.7 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 78.1 mt -126.45 123.04 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.22 69.69 1.01 Allowed 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -129.48 145.93 51.38 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.327 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -92.17 112.1 23.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.436 1.094 . . . . 0.0 109.493 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.8 mt -117.25 125.42 51.1 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.456 0.702 . . . . 0.0 110.316 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.438 HD22 ' HD1' ' A' ' 132' ' ' PHE . 52.1 mt -135.36 173.65 11.48 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.411 HD11 ' O ' ' A' ' 151' ' ' PRO . 9.8 pt -145.88 135.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.931 0.892 . . . . 0.0 109.257 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.4 142.25 33.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.664 0.386 . . . . 0.0 110.442 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 153' ' ' LEU . 39.5 mt -129.36 131.42 46.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.7 1.2 . . . . 0.0 109.069 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.86 105.74 7.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.07 138.16 15.24 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.641 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.0 tp-100 -142.55 149.7 39.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.587 0.693 . . . . 0.0 110.219 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.412 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 6.2 tmtm? -66.34 138.93 57.96 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.475 0.791 0 O-C-N 124.557 1.161 . . . . 0.0 109.169 -171.453 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.479 HD23 ' HG ' ' A' ' 47' ' ' LEU . 37.5 tp -62.95 -36.54 83.78 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.763 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 m -44.13 -36.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.239 1.016 . . . . 0.0 113.584 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 m -74.89 -52.43 11.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.521 0.729 . . . . 0.0 110.84 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 128' ' ' ILE . 2.1 m -62.3 -37.06 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.588 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.0 83.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.314 1.446 . . . . 0.0 112.057 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.99 -28.05 68.59 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.813 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.18 -14.6 28.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.211 0.605 . . . . 0.0 112.194 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 24' ' ' VAL . 76.1 mt -77.71 130.58 73.12 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.72 140.71 46.14 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.266 2.644 . . . . 0.0 112.65 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.45 28.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.66 -147.12 8.66 Favored Glycine 0 N--CA 1.468 0.777 0 CA-C-N 118.455 0.571 . . . . 0.0 112.905 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -80.43 119.34 23.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -110.27 139.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.218 1.007 . . . . 0.0 108.555 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 90' ' ' ILE . 26.1 tp -115.42 128.65 56.19 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.968 0.804 . . . . 0.0 111.498 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 32.7 m -94.05 138.0 32.62 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.051 0.94 . . . . 0.0 110.239 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.6 108.95 17.08 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.986 0.514 . . . . 0.0 111.152 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 O-C-N 125.482 1.738 . . . . 0.0 112.501 168.545 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -62.13 -49.09 77.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.336 1.054 . . . . 0.0 111.297 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.404 HD21 HG22 ' A' ' 101' ' ' ILE . 93.5 m-20 -77.69 -32.78 53.23 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.804 -172.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.43 77.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.577 0.751 . . . . 0.0 110.101 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -68.85 -30.47 69.01 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.526 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD1' HD21 ' A' ' 21' ' ' LEU . 57.4 t80 -62.93 -43.53 98.55 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HG ' HD23 ' A' ' 21' ' ' LEU . 89.4 mt -70.36 -30.78 67.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.85 76.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.88 0.472 . . . . 0.0 111.197 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.757 ' HA ' HG11 ' A' ' 76' ' ' VAL . 23.6 p -75.85 -2.44 30.08 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.303 0.641 . . . . 0.0 111.985 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 94.4 mt -86.32 14.97 5.75 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.314 0.646 . . . . 0.0 110.427 164.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.29 47.31 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 123.223 0.44 . . . . 0.0 113.523 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -125.29 157.03 37.66 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.337 0.589 . . . . 0.0 111.065 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.76 88.57 5.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.12 116.57 36.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.237 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.576 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 27.1 m -84.95 112.78 20.89 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 124.761 1.224 . . . . 0.0 107.977 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.27 133.85 46.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 111.174 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.61 HG21 ' HB ' ' A' ' 81' ' ' VAL . 15.1 t -115.66 120.1 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.64 143.8 50.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.05 -20.98 66.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.506 0.722 . . . . 0.0 111.263 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.521 ' HB3' HG22 ' A' ' 62' ' ' VAL . 46.1 m -111.75 124.52 52.51 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.716 1.206 . . . . 0.0 109.003 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.5 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.907 0.883 . . . . 0.0 110.062 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 60' ' ' SER . 19.1 m -66.26 -26.35 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.67 -35.1 33.06 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.157 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.3 -44.79 82.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.031 0.933 . . . . 0.0 110.449 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.26 91.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.924 0.889 . . . . 0.0 111.528 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -66.81 -40.28 87.99 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.295 0.638 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.08 88.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.294 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -70.02 -36.87 75.41 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.431 1.092 . . . . 0.0 111.476 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -61.08 -52.15 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.23 -28.77 69.96 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.984 0.803 . . . . 0.0 110.715 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.32 -62.24 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.981 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -65.77 -26.24 67.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 111.559 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.52 -46.28 90.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.162 0.985 . . . . 0.0 109.786 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -98.81 -0.71 41.99 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.553 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.85 51.23 8.03 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.366 0.506 . . . . 0.0 114.366 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.2 m -138.42 176.29 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.932 0.893 . . . . 0.0 110.618 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -114.74 140.88 48.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.832 0.853 . . . . 0.0 111.937 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.5 157.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.576 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 85.6 m -119.12 103.23 9.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 t -94.62 114.89 26.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.278 0.561 . . . . 0.0 110.535 -163.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' HG21 ' A' ' 57' ' ' VAL . 61.7 t -109.92 139.69 32.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.683 1.193 . . . . 0.0 108.883 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -78.87 132.26 36.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.639 0.775 . . . . 0.0 109.902 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 p -63.61 106.07 0.89 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 111.515 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -144.21 89.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 165.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -78.87 -16.36 57.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.804 0.442 . . . . 0.0 111.047 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . . . -72.22 -27.3 62.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.565 0.746 . . . . 0.0 111.333 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -104.52 -37.12 7.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.262 0.625 . . . . 0.0 111.654 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -161.34 126.25 3.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.378 1.071 . . . . 0.0 108.323 -170.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.01 -70.55 0.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 117' ' ' VAL . 2.9 pt -143.5 118.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.582 0.753 . . . . 0.0 109.778 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.879 0.872 . . . . 0.0 109.685 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 122' ' ' LYS . . . -44.88 -26.67 0.43 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 -44.42 71.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.991 0.516 . . . . 0.0 110.761 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.68 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -140.89 -165.32 1.92 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.223 0.609 . . . . 0.0 111.25 -171.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -118.01 -37.16 3.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.752 0.821 . . . . 0.0 112.42 -169.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.36 172.21 23.94 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 122.369 -0.207 . . . . 0.0 112.862 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.481 HD12 HG22 ' A' ' 90' ' ' ILE . 42.6 mt -134.35 145.83 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.881 0.873 . . . . 0.0 109.233 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -127.3 105.09 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 159.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.9 t -104.19 88.03 2.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 HD11 ' A' ' 21' ' ' LEU . 34.4 mm -71.58 146.16 11.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.656 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -17.54 99.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 126.563 2.414 . . . . 0.0 112.261 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' A' ' 129' ' ' LEU . 28.8 p -99.15 104.83 16.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.158 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -96.67 96.71 8.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.19 139.27 22.28 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.717 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.19 162.03 43.87 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.937 2.425 . . . . 0.0 110.981 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.0 m -34.98 -42.56 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.199 1.8 . . . . 0.0 115.368 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.3 m -70.61 -46.52 63.22 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.241 0.338 . . . . 0.0 110.692 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.52 -35.72 34.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.632 0.373 . . . . 0.0 110.427 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -69.14 -62.73 1.26 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.679 0.792 . . . . 0.0 109.945 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -51.87 -34.06 39.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.918 0.887 . . . . 0.0 113.135 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 53.8 tt0 -78.64 -32.58 47.36 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 117' ' ' VAL . 55.9 tp -71.92 -39.27 69.6 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.457 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -62.86 -38.86 47.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.94 -30.89 67.35 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.819 1.679 . . . . 0.0 111.792 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 116' ' ' LYS . 1.5 mmmp? -80.08 -15.71 56.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.787 0.835 . . . . 0.0 110.209 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.557 ' HA ' HD11 ' A' ' 90' ' ' ILE . 22.3 t -83.84 -40.92 16.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -57.8 -52.39 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -69.95 -42.7 72.88 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.3 -39.86 14.65 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 25.8 tp -69.78 111.84 5.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.916 0.886 . . . . 0.0 110.61 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 19.4 ptmt -85.42 157.95 58.11 Favored Pre-proline 0 C--O 1.247 0.948 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.106 167.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.585 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 83.1 Cg_exo -50.8 112.29 0.73 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.343 2.029 . . . . 0.0 112.291 168.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.576 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 126.61 12.73 3.27 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.319 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.78 147.53 16.37 Favored Glycine 0 C--O 1.246 0.862 0 O-C-N 122.545 -0.385 . . . . 0.0 112.303 168.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 35.1 m -109.44 131.57 59.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 123.548 0.739 . . . . 0.0 110.076 177.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.93 112.54 24.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.53 HD11 HG21 ' A' ' 24' ' ' VAL . 59.6 mt -115.44 112.26 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.132 0.973 . . . . 0.0 109.543 -171.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.551 HD21 ' SG ' ' A' ' 103' ' ' CYS . 96.5 mt -133.33 153.42 51.6 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 37.7 tt0 -132.49 100.76 5.08 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 164.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.23 166.58 49.96 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.779 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.403 ' HB2' HD22 ' A' ' 150' ' ' LEU . 58.0 m-85 -127.29 157.43 39.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 109.383 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.479 0.98 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.403 HD22 ' HB2' ' A' ' 132' ' ' PHE . 56.3 mt -85.63 108.52 16.76 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.492 ' HB2' HD13 ' A' ' 156' ' ' LEU . 12.2 Cg_exo -70.22 122.63 9.18 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.977 2.451 . . . . 0.0 112.53 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -96.61 150.11 21.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.1 0.96 . . . . 0.0 111.282 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.548 HD23 HD22 ' A' ' 190' ' ' LEU . 37.9 mt -57.55 -36.87 72.2 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 122.987 0.515 . . . . 0.0 109.696 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -50.9 -51.37 52.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.534 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -69.75 -48.84 57.88 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.55 -58.73 3.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.396 1.078 . . . . 0.0 112.516 -166.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.27 -31.28 72.35 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.455 0.702 . . . . 0.0 112.091 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.0 t -84.54 -13.85 50.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.065 0.393 . . . . 0.0 111.519 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.85 -45.35 10.94 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.675 0.75 . . . . 0.0 109.317 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.9 mt -104.85 78.89 0.4 Allowed Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.702 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.37 -4.06 7.63 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 123.002 2.468 . . . . 0.0 111.367 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -85.52 -28.62 24.83 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.49 1.116 . . . . 0.0 108.115 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.83 70.81 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.78 1.632 . . . . 0.0 109.015 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.499 ' HB3' HD21 ' A' ' 195' ' ' LEU . 6.8 t30 -60.46 121.42 12.05 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.409 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 16.7 m95 -87.85 141.51 28.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.516 1.126 . . . . 0.0 108.998 -167.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.4 mt -73.42 -35.72 65.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.077 0.551 . . . . 0.0 109.809 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 82.2 mt -126.11 118.09 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.81 76.5 1.07 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -141.3 143.03 33.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.11 112.23 20.49 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.473 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.4 mt -103.86 131.27 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.409 1.083 . . . . 0.0 108.884 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 C--O 1.238 0.462 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 175.067 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 C--O 1.237 0.429 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.0 mt -122.16 144.03 49.2 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 13.4 pt -133.02 116.61 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.15 0.432 . . . . 0.0 110.025 -170.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.61 137.77 36.76 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.067 0.46 . . . . 0.0 109.779 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.548 HD22 HD23 ' A' ' 153' ' ' LEU . 62.9 mt -125.98 146.0 50.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.388 1.075 . . . . 0.0 110.343 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.7 tp -149.88 106.15 3.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -88.48 142.36 17.22 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -142.65 156.76 45.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.649 0.725 . . . . 0.0 111.04 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 68.2 tttt -55.34 135.26 50.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.322 1.449 . . . . 0.0 110.368 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 164' ' ' ASN . 3.5 mt . . . . . 0 C--O 1.245 0.84 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.61 -17.91 57.14 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.695 1.198 . . . . 0.0 112.443 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.69 -37.92 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -71.84 -41.15 68.48 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.031 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.4 m -66.8 -43.5 89.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' HD13 ' A' ' 28' ' ' ILE . . . -57.27 -38.41 73.86 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.18 0.992 . . . . 0.0 112.253 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.61 -21.32 63.59 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.626 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -91.1 -21.86 21.0 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.41 0.684 . . . . 0.0 110.54 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG23 HD13 ' A' ' 33' ' ' ILE . 92.3 mt -74.09 134.2 77.77 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 123.532 0.733 . . . . 0.0 110.51 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.66 136.42 49.68 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.36 2.707 . . . . 0.0 112.111 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.44 28.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.7 -132.81 4.98 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -84.33 112.41 20.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 28' ' ' ILE . 8.9 mt -111.59 119.11 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.691 0.796 . . . . 0.0 109.197 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 55' ' ' THR . 28.7 tp -89.95 108.0 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.667 0.212 . . . . 0.0 110.743 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 49.3 t -94.92 110.39 22.29 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.265 0.626 . . . . 0.0 110.689 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.2 mt -79.02 126.35 30.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.458 0 O-C-N 123.791 0.682 . . . . 0.0 109.816 -177.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -49.78 -38.32 33.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.417 1.487 . . . . 0.0 112.2 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' HG13 ' A' ' 101' ' ' ILE . 29.1 p-10 -64.2 -41.0 97.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.0 72.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.51 0.724 . . . . 0.0 110.719 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 9.9 m -59.55 -38.89 82.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.627 0.771 . . . . 0.0 111.099 173.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -73.2 -33.5 65.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.592 0.757 . . . . 0.0 110.906 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 99' ' ' VAL . 50.6 mt -64.03 -32.36 73.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 110.421 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.17 -31.24 58.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.879 0.472 . . . . 0.0 110.763 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 m -68.37 -6.09 22.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.809 0.844 . . . . 0.0 111.835 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.8 mt -83.89 12.38 6.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.596 0.758 . . . . 0.0 110.646 168.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 34.72 25.44 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 123.285 0.469 . . . . 0.0 113.985 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.4 162.16 26.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.882 0.473 . . . . 0.0 111.387 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -92.99 91.07 7.2 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 165.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.4 112.12 23.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.2 t -83.3 104.4 13.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.28 134.75 42.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.985 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 81' ' ' VAL . 3.3 t -113.71 118.22 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -133.68 142.48 48.03 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -54.31 -32.2 55.98 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.191 0.997 . . . . 0.0 112.364 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.436 ' OG ' HG23 ' A' ' 62' ' ' VAL . 9.1 t -109.03 130.33 55.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.631 0.772 . . . . 0.0 110.005 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 t -74.98 -16.86 60.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.929 0.892 . . . . 0.0 110.991 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.436 HG23 ' OG ' ' A' ' 60' ' ' SER . 9.6 m -63.85 -32.98 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.544 0.337 . . . . 0.0 110.511 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.42 -33.21 56.75 Favored Glycine 0 C--N 1.351 1.382 0 O-C-N 123.538 0.523 . . . . 0.0 112.646 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.09 -48.03 59.38 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.779 0.832 . . . . 0.0 110.413 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.55 86.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.712 0.805 . . . . 0.0 112.047 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -63.35 -39.41 94.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.861 0.864 . . . . 0.0 110.748 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.627 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -60.92 -46.71 89.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.942 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -71.08 -37.14 72.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.635 0.774 . . . . 0.0 111.652 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.63 -55.72 31.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.93 0.892 . . . . 0.0 109.849 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.2 tp -66.61 -25.19 66.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.221 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.487 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -66.09 -52.09 52.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.973 0.509 . . . . 0.0 110.495 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.85 -33.83 73.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.026 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.6 -48.22 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.545 0.528 . . . . 0.0 110.723 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.565 ' HZ3' ' HB2' ' A' ' 74' ' ' LYS . 2.0 ttmp? -87.68 -13.5 42.4 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.96 44.83 13.04 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 121.054 0.252 . . . . 0.0 112.674 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 172.83 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.394 1.078 . . . . 0.0 108.124 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -121.77 141.26 51.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.706 0.403 . . . . 0.0 110.896 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.487 HG12 ' HB1' ' A' ' 71' ' ' ALA . 15.8 mm -109.24 165.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 45.0 m -131.13 104.02 6.84 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 164.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.2 p -86.74 114.33 23.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.884 0.474 . . . . 0.0 111.108 -168.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.493 ' HB ' HG23 ' A' ' 57' ' ' VAL . 53.3 t -104.63 139.01 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.746 1.218 . . . . 0.0 108.108 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -78.9 136.35 37.26 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 p -50.47 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.5 1.12 . . . . 0.0 111.838 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 6.6 m-20 -134.65 91.1 2.73 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 65.7 mt -100.46 -6.71 25.15 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.691 0.758 . . . . 0.0 110.68 -170.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.27 3.44 29.98 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.189 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 32.2 t70 -139.64 -46.38 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -168.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -163.86 100.5 0.88 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -132.84 -58.28 0.92 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.522 0.729 . . . . 0.0 109.343 -164.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.517 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.7 pt -134.35 110.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 123.039 0.535 . . . . 0.0 111.028 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 t -129.2 84.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.559 0.744 . . . . 0.0 109.346 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.65 -1.02 14.61 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.897 0.479 . . . . 0.0 112.176 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -76.16 -45.95 30.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.98 61.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.614 0.766 . . . . 0.0 112.57 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.464 ' CD1' HD23 ' A' ' 34' ' ' LEU . 44.8 m95 -113.79 -177.71 3.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.254 0.622 . . . . 0.0 110.486 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -92.49 -55.83 3.25 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.69 0.796 . . . . 0.0 109.994 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.77 173.84 21.34 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.521 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.8 mt -132.68 139.3 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.5 p -124.06 106.94 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.64 0.734 . . . . 0.0 109.233 165.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.2 m -103.82 94.11 5.25 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HD12 HD13 ' A' ' 128' ' ' ILE . 41.6 mm -68.52 141.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.359 1.063 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -21.63 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 126.032 1.733 . . . . 0.0 113.85 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.497 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 35.8 t -94.53 109.56 21.44 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.615 -168.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -108.52 98.69 8.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.497 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 62.5 mt -114.62 145.53 34.06 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.809 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.73 150.55 69.79 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.833 2.355 . . . . 0.0 110.269 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.6 t -44.9 -33.88 2.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.771 1.228 . . . . 0.0 113.324 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.0 m -59.4 -59.81 4.85 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.312 0.645 . . . . 0.0 111.399 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.66 -24.41 53.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.992 0.517 . . . . 0.0 110.537 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.84 -54.62 14.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.416 1.086 . . . . 0.0 109.57 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -55.75 -28.67 57.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.387 1.075 . . . . 0.0 112.436 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.65 -22.95 24.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.842 0.457 . . . . 0.0 111.078 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.5 tp -71.9 -45.42 61.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.133 0.573 . . . . 0.0 111.172 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -58.58 -41.52 89.48 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -52.79 -38.05 77.22 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 122.449 2.099 . . . . 0.0 112.811 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.55 -23.61 56.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.391 0.677 . . . . 0.0 111.595 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 t -85.46 -28.08 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.362 0.601 . . . . 0.0 110.142 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -75.04 -61.09 2.01 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.291 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -76.99 -47.36 20.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.501 1.12 . . . . 0.0 113.584 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.62 -36.72 22.22 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 114.14 0.416 . . . . 0.0 114.14 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.2 tp -75.36 108.5 8.18 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 1.2 mptm? -82.59 159.53 63.73 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.529 168.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -41.29 113.05 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.305 2.67 . . . . 0.0 113.813 166.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 14.22 3.24 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.235 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -112.32 144.43 17.8 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 121.766 -0.843 . . . . 0.0 111.146 165.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 33.9 m -107.59 132.16 55.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.834 0.854 . . . . 0.0 109.96 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.56 112.79 25.95 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 101' ' ' ILE . 57.9 mt -104.21 109.43 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.546 HD13 HD12 ' A' ' 156' ' ' LEU . 51.7 mt -124.59 120.71 32.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 110.088 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -112.28 102.6 10.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.566 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.65 169.08 40.5 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.668 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.627 ' HD1' HD21 ' A' ' 187' ' ' LEU . 57.1 m-85 -137.73 165.97 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.78 0.832 . . . . 0.0 109.445 -172.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 123.833 0.853 . . . . 0.0 110.072 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.0 mt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.742 0.306 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.24 106.02 5.04 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 166.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.566 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 15.3 Cg_exo -68.29 110.77 2.32 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 123.203 2.602 . . . . 0.0 112.651 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -95.51 147.67 23.3 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.926 0.891 . . . . 0.0 111.311 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.6 mt -59.84 -45.26 92.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.52 0.6 . . . . 0.0 110.428 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.63 -46.77 77.37 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.261 0.976 . . . . 0.0 110.942 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.7 p -71.95 -53.73 12.15 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 129' ' ' LEU . 40.6 mt -70.01 -51.29 33.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.533 1.133 . . . . 0.0 113.274 -169.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.408 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 30.0 tt0 -59.98 -35.06 74.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.679 0.392 . . . . 0.0 111.38 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.7 t -78.04 -28.1 48.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.703 0.401 . . . . 0.0 110.864 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -78.39 -24.15 46.46 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.885 . . . . 0.0 110.768 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.7 mt -131.84 73.27 78.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -82.71 -9.18 11.12 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.252 2.634 . . . . 0.0 112.606 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -91.84 -29.86 16.5 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp -88.4 72.44 8.91 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.624 1.17 . . . . 0.0 110.29 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -53.6 125.69 19.07 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.108 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.408 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 41.9 m95 -91.76 125.12 36.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.541 1.137 . . . . 0.0 108.899 -172.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.96 -34.13 75.98 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.089 0.556 . . . . 0.0 109.983 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 72.7 mt -127.54 122.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.63 76.26 1.01 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -145.98 145.76 30.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 -172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.466 ' H ' HD21 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -74.97 115.54 14.7 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.493 0.717 . . . . 0.0 110.432 174.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.1 mt -107.84 114.56 28.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.082 0.553 . . . . 0.0 111.1 -171.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 133' ' ' ALA . . . . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.627 HD21 ' HD1' ' A' ' 132' ' ' PHE . 25.3 mt -127.61 160.68 30.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 16.3 pt -140.39 142.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -129.42 150.13 50.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.555 0.693 . . . . 0.0 111.147 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 40.7 mt -132.25 140.7 48.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.608 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 34.2 tp -134.03 104.16 6.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.94 136.54 14.07 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.34 155.58 44.48 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.462 0.705 . . . . 0.0 109.883 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -57.1 144.95 32.62 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.476 0.71 . . . . 0.0 110.36 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--O 1.245 0.83 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.005 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -57.69 -19.68 28.73 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.902 1.281 . . . . 0.0 112.838 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.73 -27.8 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 118.973 0.806 . . . . 0.0 108.897 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -72.32 -43.14 64.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.361 1.064 . . . . 0.0 110.615 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.6 m -68.84 -37.47 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.309 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -26.2 68.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.907 0.883 . . . . 0.0 112.63 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -70.34 -28.31 65.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.688 0.795 . . . . 0.0 109.572 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -84.75 -24.08 28.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.783 0.833 . . . . 0.0 111.393 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 HG21 HD12 ' A' ' 33' ' ' ILE . 63.7 mt -72.85 131.42 84.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.263 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -64.72 144.33 83.56 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.817 2.345 . . . . 0.0 112.003 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -69.14 27.49 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' HA3' ' HG3' ' A' ' 96' ' ' GLU . . . -116.61 -140.95 6.94 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 119.065 0.848 . . . . 0.0 112.832 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 41.5 mtpt -83.63 118.48 23.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.378 0.671 . . . . 0.0 109.682 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 28' ' ' ILE . 9.7 mt -115.43 131.92 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.0 tp -97.89 113.85 25.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.8 t -95.34 133.82 38.83 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.881 0.872 . . . . 0.0 108.68 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 90' ' ' ILE . 50.9 mt -101.53 159.06 15.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.566 0.346 . . . . 0.0 111.053 170.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 O-C-N 125.023 1.452 . . . . 0.0 113.061 178.9 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.133 0 N-CA-C 114.288 0.475 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.659 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 51.1 mtp180 -56.43 -34.92 67.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.37 1.068 . . . . 0.0 111.787 168.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.66 -45.25 89.76 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.901 0.88 . . . . 0.0 110.293 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.7 75.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.331 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.659 ' SG ' ' HA ' ' A' ' 42' ' ' ARG . 22.7 p -73.8 -19.78 60.66 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.363 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.61 -50.15 53.72 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.98 -30.55 69.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.399 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.05 0.54 . . . . 0.0 111.956 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.629 ' HA ' HG12 ' A' ' 76' ' ' VAL . 87.7 p -73.56 -3.85 30.39 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.836 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.02 12.08 3.6 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.758 0.823 . . . . 0.0 111.219 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.02 15.97 60.17 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 123.173 0.416 . . . . 0.0 113.932 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.86 157.93 20.8 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.788 0.835 . . . . 0.0 109.869 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 45.1 mt-10 -97.34 90.83 5.22 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.84 110.97 24.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.596 0.712 . . . . 0.0 110.06 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -86.18 114.82 23.32 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.528 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.53 144.65 29.27 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 123.877 0.871 . . . . 0.0 111.268 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -119.89 117.25 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 165.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.64 148.17 51.51 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.229 0.922 . . . . 0.0 111.195 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -56.1 -34.18 65.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.129 1.772 . . . . 0.0 112.473 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.3 p -123.72 140.42 53.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.085 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -73.54 -15.75 61.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.086 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.2 m -63.84 -38.59 82.74 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -41.18 55.31 Favored Glycine 0 C--N 1.357 1.725 0 O-C-N 123.551 0.532 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.45 -41.67 98.91 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.518 0.727 . . . . 0.0 110.435 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.03 76.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.016 0.926 . . . . 0.0 112.532 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 75.0 mmtt -62.61 -39.37 93.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.603 0.361 . . . . 0.0 110.357 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -62.5 -51.34 67.81 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.593 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -71.21 -32.48 68.88 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.305 0.642 . . . . 0.0 111.849 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -58.41 -48.88 79.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.2 0.6 . . . . 0.0 110.703 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.8 tp -68.63 -25.88 65.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 123.269 0.355 . . . . 0.0 110.64 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.498 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.79 -59.29 5.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.023 0.529 . . . . 0.0 110.897 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -58.33 -48.33 80.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.81 0.844 . . . . 0.0 111.839 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 -41.96 88.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.82 0.848 . . . . 0.0 111.191 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -105.56 -12.06 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.137 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.31 44.39 22.45 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 121.907 -0.187 . . . . 0.0 113.509 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -124.55 160.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -104.77 126.4 51.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.674 0.79 . . . . 0.0 110.775 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG21 ' HB1' ' A' ' 67' ' ' ALA . 5.1 mm -117.84 164.89 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -133.98 108.04 8.15 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 p -94.5 125.92 39.45 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.942 0.497 . . . . 0.0 111.303 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.35 140.74 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.359 1.464 . . . . 0.0 107.882 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -82.98 144.17 30.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -62.8 102.9 0.38 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.714 0.806 . . . . 0.0 112.903 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -142.27 89.63 2.18 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.93 -8.39 51.89 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.39 0.676 . . . . 0.0 111.792 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.79 -16.64 50.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.901 0.881 . . . . 0.0 110.763 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.55 -38.42 4.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.416 0.687 . . . . 0.0 110.544 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -151.02 130.16 12.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.667 1.187 . . . . 0.0 107.91 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.98 -75.32 0.51 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 36' ' ' LEU . 12.2 pt -143.27 119.45 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.026 0.93 . . . . 0.0 109.473 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.31 79.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 0.0 108.955 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB1' HD11 ' A' ' 98' ' ' ILE . . . -74.98 0.33 16.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.354 0.662 . . . . 0.0 112.089 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.79 -40.32 83.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 167.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.09 57.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -113.4 176.77 4.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.256 0.622 . . . . 0.0 111.211 -172.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 52.2 mm-40 -90.18 -51.73 5.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.022 0.929 . . . . 0.0 109.883 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.88 178.56 21.12 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.569 HD13 HD12 ' A' ' 121' ' ' LEU . 69.4 mt -131.59 145.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.85 0.86 . . . . 0.0 108.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 8.3 p -130.87 133.61 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 166.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 m -142.41 95.76 2.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.499 HG23 ' HD1' ' A' ' 102' ' ' PHE . 8.7 mm -74.3 153.78 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 129' ' ' LEU . 20.5 p90 -16.02 103.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.202 1.801 . . . . 0.0 115.004 -163.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.4 t -75.41 105.49 6.46 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.984 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -105.13 97.66 7.48 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -125.33 145.76 51.93 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.541 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -56.13 150.7 46.8 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.022 2.481 . . . . 0.0 110.666 163.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.3 t -48.53 -37.82 18.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.652 1.181 . . . . 0.0 112.006 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -53.57 -57.01 12.26 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.905 0.753 . . . . 0.0 111.113 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.71 -24.99 56.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.894 0.478 . . . . 0.0 110.636 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -75.44 -53.91 7.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.737 0.815 . . . . 0.0 110.637 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -60.41 -28.18 68.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.957 0.503 . . . . 0.0 111.723 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -75.74 -30.37 59.2 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' O ' HG21 ' A' ' 117' ' ' VAL . 60.5 tp -74.56 -36.54 63.09 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.839 0.712 . . . . 0.0 111.888 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -54.87 -49.69 90.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.41 -24.92 70.96 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.05 1.833 . . . . 0.0 112.186 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.1 -29.59 61.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.011 0.524 . . . . 0.0 111.142 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 113' ' ' LEU . 5.0 t -85.75 -26.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.153 0.581 . . . . 0.0 110.064 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -69.95 -61.69 1.68 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.41 -49.74 38.85 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.92 -18.11 51.88 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 115.122 0.809 . . . . 0.0 115.122 -163.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.569 HD12 HD13 ' A' ' 98' ' ' ILE . 13.3 tp -76.52 102.41 6.04 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.661 0.73 . . . . 0.0 109.076 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -75.86 145.44 77.91 Favored Pre-proline 0 C--O 1.247 0.951 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -44.19 111.93 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.059 2.506 . . . . 0.0 113.242 174.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.24 11.64 5.6 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.105 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.09 140.61 15.15 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 19.3 m -109.84 129.47 64.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -110.2 108.8 19.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -116.13 113.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.901 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 102' ' ' PHE . 3.6 mp -130.06 147.42 51.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.041 0.448 . . . . 0.0 111.13 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.94 98.47 6.5 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 165.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.85 -179.79 52.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.721 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.405 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.6 m-85 -137.9 158.4 44.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.429 -173.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 123.642 0.777 . . . . 0.0 110.45 178.822 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 132' ' ' PHE . 53.1 mt -78.99 112.58 28.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 166.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 156' ' ' LEU . 60.4 Cg_endo -71.71 93.63 0.69 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.26 1.973 . . . . 0.0 111.274 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.559 ' HA ' HD11 ' A' ' 188' ' ' ILE . 42.9 mtmt -96.78 156.06 16.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.608 -166.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 188' ' ' ILE . 35.3 mt -61.69 -49.85 74.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.345 0.658 . . . . 0.0 110.333 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.19 -40.33 73.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.887 0.742 . . . . 0.0 110.977 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.1 m -65.65 -64.27 0.9 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.696 174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 151' ' ' PRO . 83.5 mt -72.58 -45.16 60.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.704 0.802 . . . . 0.0 112.481 -164.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.565 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 64.0 tt0 -57.84 -42.02 83.55 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.04 0.536 . . . . 0.0 111.877 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -76.83 -26.23 54.11 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -84.66 -12.76 53.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.929 0.892 . . . . 0.0 111.25 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 70.0 mt -134.57 71.6 70.88 Favored Pre-proline 0 N--CA 1.475 0.792 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.56 -3.31 13.21 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.198 2.599 . . . . 0.0 111.002 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.5 t -83.86 -42.26 16.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.677 1.191 . . . . 0.0 107.912 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.6 tp -95.11 71.76 3.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.863 1.265 . . . . 0.0 110.487 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.31 127.86 32.96 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.565 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 36.8 m95 -91.5 137.83 32.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 0.0 109.226 -167.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.81 -32.24 63.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.761 0.424 . . . . 0.0 110.83 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 83.0 mt -132.81 128.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.87 77.63 0.96 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.91 1.284 . . . . 0.0 107.771 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.36 133.42 36.77 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 -169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -80.69 113.5 18.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.343 0.657 . . . . 0.0 110.773 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.3 mt -108.39 135.67 49.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.605 0.762 . . . . 0.0 109.981 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.549 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.89 163.67 19.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.632 0.773 . . . . 0.0 109.122 -169.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 152' ' ' LYS . 7.6 pt -143.82 125.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -97.72 141.55 30.6 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.941 -0.475 . . . . 0.0 111.061 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 37.6 mt -127.57 130.13 48.54 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.387 1.475 . . . . 0.0 108.997 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 24' ' ' VAL . 29.9 tp -125.64 105.08 8.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -93.23 131.35 10.73 Favored Glycine 0 C--O 1.212 -1.221 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 173.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 193' ' ' GLN . 0.0 OUTLIER -141.51 156.55 45.72 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 108.859 176.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -54.49 153.86 5.26 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.975 0.91 . . . . 0.0 110.957 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.245 0.835 0 C-N-CA 122.78 0.432 . . . . 0.0 110.22 175.808 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 t80 . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HG ' ' HB1' ' A' ' 25' ' ' ALA . 14.1 tp -60.2 -22.52 63.07 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.77 0.828 . . . . 0.0 112.286 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 m -40.48 -56.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 124.489 1.116 . . . . 0.0 113.853 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 p -74.93 -50.62 16.18 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 110.681 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.2 m -66.93 -41.4 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.364 -171.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' HG ' ' A' ' 21' ' ' LEU . . . -60.9 -37.26 81.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.918 0.887 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -68.63 -26.78 65.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -92.86 -13.26 29.25 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 73.7 mt -77.68 134.43 65.34 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.237 0.615 . . . . 0.0 110.87 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.77 132.38 47.55 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.326 2.684 . . . . 0.0 111.894 171.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -74.23 29.51 0.08 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.88 -145.68 9.54 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 12.3 mmmm -85.63 118.7 25.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -170.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mt -114.15 134.29 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.8 0.84 . . . . 0.0 110.04 -165.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 HD21 ' NE1' ' A' ' 95' ' ' TRP . 50.8 tp -106.92 127.01 53.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.243 0.617 . . . . 0.0 110.607 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 36.1 m -98.89 137.47 37.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.578 0.751 . . . . 0.0 110.16 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 90' ' ' ILE . 15.7 mt -114.58 116.05 28.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.181 0.593 . . . . 0.0 110.928 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.195 0 O-C-N 125.38 1.675 . . . . 0.0 113.657 165.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -69.37 -35.45 75.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.481 0.658 . . . . 0.0 109.469 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 26.3 m120 -80.8 -31.51 35.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.813 1.245 . . . . 0.0 110.426 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.24 82.73 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.936 0.772 . . . . 0.0 109.682 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.745 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 55.9 m -58.62 -43.18 89.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.462 171.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.4 -31.55 68.81 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.4 0.437 . . . . 0.0 111.096 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.14 -37.02 85.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.953 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.24 73.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.767 0.427 . . . . 0.0 111.227 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.709 ' HA ' HG13 ' A' ' 76' ' ' VAL . 11.7 m -65.99 -15.77 63.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.951 0.9 . . . . 0.0 112.155 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.79 8.72 5.0 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.039 0.535 . . . . 0.0 110.767 172.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.09 8.66 61.4 Favored Glycine 0 C--N 1.362 1.996 0 CA-C-O 119.69 -0.506 . . . . 0.0 114.326 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -105.65 152.37 23.21 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.428 0.614 . . . . 0.0 110.129 -172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 35.5 mt-10 -94.89 90.8 6.14 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.2 t -88.86 118.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.354 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.648 HG21 ' HB ' ' A' ' 79' ' ' THR . 77.1 p -86.04 113.0 21.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -112.3 122.35 47.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.862 0.465 . . . . 0.0 111.196 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.668 HG21 ' HB ' ' A' ' 81' ' ' VAL . 2.6 t -99.25 144.19 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 163.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t70 -124.77 178.19 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -87.24 -27.02 23.2 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.719 0.808 . . . . 0.0 109.851 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.476 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.4 m -119.43 135.97 54.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.954 -1.476 . . . . 0.0 110.559 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -68.64 -22.51 64.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.153 0.981 . . . . 0.0 110.689 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 60' ' ' SER . 17.7 m -64.84 -34.37 69.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.62 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -36.43 73.68 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.24 -43.13 78.59 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.016 0.927 . . . . 0.0 110.835 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -66.75 -37.06 83.89 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.299 0.239 . . . . 0.0 110.813 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.745 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -59.83 -48.49 81.47 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.877 0.736 . . . . 0.0 110.631 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.45 -44.8 74.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.006 0.922 . . . . 0.0 111.237 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.95 -50.87 71.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.337 1.055 . . . . 0.0 111.507 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 15.0 tp -69.61 -23.74 63.56 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.991 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -68.26 -51.27 46.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.728 173.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.17 -36.11 80.85 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.702 0.801 . . . . 0.0 111.191 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -59.07 -54.55 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.995 0.809 . . . . 0.0 110.511 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -85.18 -6.43 59.28 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.15 -169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.17 39.18 58.51 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 120.877 0.154 . . . . 0.0 112.892 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -127.66 167.41 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.568 1.147 . . . . 0.0 109.279 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -115.78 135.4 54.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.457 0.703 . . . . 0.0 112.265 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.589 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.7 mm -111.41 168.48 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 163.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG21 ' A' ' 55' ' ' THR . 60.9 m -132.95 105.59 7.18 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 163.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.4 p -88.27 121.17 30.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.267 0.627 . . . . 0.0 110.119 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.668 ' HB ' HG21 ' A' ' 57' ' ' VAL . 62.6 t -103.13 137.52 31.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -77.32 135.52 38.4 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.93 0.395 . . . . 0.0 110.321 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -43.63 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.909 1.684 . . . . 0.0 112.233 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -145.32 97.47 3.0 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 84.3 mt -102.1 -8.59 21.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.024 0.53 . . . . 0.0 111.193 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -17.31 43.57 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.305 0.642 . . . . 0.0 112.093 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -137.34 -3.2 1.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.711 0.404 . . . . 0.0 112.046 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 87.3 t80 -156.49 143.87 19.08 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 36' ' ' LEU . 7.5 p-10 -150.79 -70.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 36' ' ' LEU . 13.5 pt -142.68 125.55 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.404 0.682 . . . . 0.0 109.538 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 t -130.56 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.408 ' HB3' HD11 ' A' ' 98' ' ' ILE . . . -72.51 0.23 10.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.248 0.619 . . . . 0.0 112.374 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.85 -34.09 77.15 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.444 0.697 . . . . 0.0 109.235 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.61 -18.81 22.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.316 1.046 . . . . 0.0 112.452 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.489 ' NE1' HD21 ' A' ' 34' ' ' LEU . 24.3 m95 -118.69 134.51 55.07 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.821 0.448 . . . . 0.0 110.856 -171.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -73.58 -28.56 61.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.451 0.7 . . . . 0.0 111.137 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.09 163.67 28.64 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.668 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.425 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 75.5 mt -133.9 155.59 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.22 142.89 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.533 1.133 . . . . 0.0 109.225 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -143.62 103.99 4.15 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.55 HD13 HD13 ' A' ' 128' ' ' ILE . 17.7 mm -75.31 145.72 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -16.16 102.83 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.843 2.057 . . . . 0.0 113.891 -171.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 24.4 p -119.77 149.76 41.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.879 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -145.16 101.58 3.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.016 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.24 147.37 33.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.347 0.659 . . . . 0.0 111.114 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.19 162.15 37.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.965 2.443 . . . . 0.0 110.767 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.2 t -39.12 -39.42 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.094 1.758 . . . . 0.0 114.274 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -64.01 -53.17 54.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.026 0.53 . . . . 0.0 111.591 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.9 -22.16 31.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.222 0.609 . . . . 0.0 110.714 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.423 HH22 ' HB3' ' A' ' 151' ' ' PRO . 75.2 ttt180 -77.88 -55.3 5.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 0.0 109.827 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -60.88 -22.12 63.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.035 0.534 . . . . 0.0 112.289 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.64 -33.84 53.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 117' ' ' VAL . 34.7 tp -77.88 -52.7 8.45 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.613 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -56.15 -51.96 76.62 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -168.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.28 -23.35 62.13 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 121.807 1.681 . . . . 0.0 112.109 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -86.99 -25.5 24.24 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.262 1.025 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 10.9 t -80.9 -37.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.363 -0.836 . . . . 0.0 109.403 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.36 -62.12 2.12 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -74.63 -36.64 62.9 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.36 -34.1 7.25 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -166.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 40.2 tp -69.42 104.32 2.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.593 0.697 . . . . 0.0 109.954 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.07 141.19 88.91 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 164.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.47 125.5 12.46 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.753 2.302 . . . . 0.0 112.326 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 129.31 -2.51 6.2 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.711 -177.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -95.03 139.68 14.63 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 165.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.6 m -108.53 129.76 62.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 123.302 0.641 . . . . 0.0 109.555 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 110.97 22.71 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.55 HD13 HD13 ' A' ' 101' ' ' ILE . 77.4 mt -106.77 106.77 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 85.7 mt -129.23 153.68 47.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.16 0.984 . . . . 0.0 110.193 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.08 106.73 4.86 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.91 134.67 23.77 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.658 ' HB2' HD23 ' A' ' 150' ' ' LEU . 64.7 m-85 -89.61 160.04 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.004 0.522 . . . . 0.0 110.95 -172.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.064 -176.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 132' ' ' PHE . 25.6 mt -99.71 103.26 20.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.423 ' HB3' HH22 ' A' ' 110' ' ' ARG . 89.7 Cg_endo -81.22 129.33 6.72 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.611 2.208 . . . . 0.0 112.417 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -92.54 165.58 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.013 0.925 . . . . 0.0 112.173 -177.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' A' ' 188' ' ' ILE . 75.6 mt -56.81 -40.48 76.05 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.942 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.9 -43.57 59.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 0.0 111.037 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 32.5 m -78.41 -54.57 6.04 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.128 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 85.9 mt -72.03 -46.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.051 0.94 . . . . 0.0 112.577 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -60.31 -44.05 95.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.657 0.783 . . . . 0.0 109.784 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.9 t -72.3 -21.41 61.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.819 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -76.9 -23.52 52.55 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.247 0.619 . . . . 0.0 110.542 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 76.3 mt -130.3 75.21 79.51 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.38 -19.48 17.03 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.196 2.598 . . . . 0.0 113.355 -172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -87.87 -42.09 12.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 28.8 tp -69.03 71.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.549 172.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.03 131.29 45.87 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -91.29 135.62 33.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.591 1.156 . . . . 0.0 109.317 -169.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.495 HD12 ' HG2' ' A' ' 193' ' ' GLN . 79.1 mt -72.39 -30.01 64.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.064 0.546 . . . . 0.0 110.13 171.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.9 mt -131.04 120.85 48.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 73.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -143.77 152.31 41.09 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.13 0.491 . . . . 0.0 111.982 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -77.94 105.08 8.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.924 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.21 123.75 50.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.549 0.74 . . . . 0.0 109.595 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.276 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 77.0 mt -117.67 167.66 11.14 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.524 ' HB ' HD21 ' A' ' 153' ' ' LEU . 8.2 pt -142.68 118.62 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.32 145.18 28.45 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 38.3 mt -131.47 131.18 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.889 1.276 . . . . 0.0 109.723 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.09 106.13 6.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.03 139.46 16.95 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.495 ' HG2' HD12 ' A' ' 166' ' ' LEU . 32.7 tp60 -136.11 157.54 46.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.445 ' H ' HE21 ' A' ' 193' ' ' GLN . 59.6 tttp -56.02 120.13 6.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.961 165.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.373 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.67 HD23 ' HG ' ' A' ' 47' ' ' LEU . 20.1 tp -61.81 -33.31 73.89 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.566 1.146 . . . . 0.0 113.077 -174.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -45.9 -40.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -75.87 -46.65 29.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.749 . . . . 0.0 109.85 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -63.23 -35.59 72.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.549 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.9 81.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.397 1.079 . . . . 0.0 111.781 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.87 -29.01 70.43 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.448 172.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.588 ' HB3' HE22 ' A' ' 193' ' ' GLN . 27.1 mm-40 -89.75 -21.37 22.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.451 1.1 . . . . 0.0 112.557 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 24' ' ' VAL . 77.1 mt -79.08 136.13 57.82 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-O 119.301 -0.38 . . . . 0.0 110.307 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.35 133.96 20.09 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 123.776 2.984 . . . . 0.0 113.537 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.18 27.99 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.16 -139.26 6.15 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 118.716 0.689 . . . . 0.0 112.619 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 40.9 ttmt -86.55 114.89 23.66 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 28' ' ' ILE . 11.9 mt -110.64 126.83 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 90' ' ' ILE . 54.2 tp -89.97 114.05 25.82 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 m -88.9 135.22 33.65 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.14 152.29 20.03 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.725 0.41 . . . . 0.0 110.186 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.413 0 O-C-N 125.671 1.857 . . . . 0.0 114.219 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.018 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -72.32 -52.25 17.04 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.421 1.088 . . . . 0.0 110.249 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' HB2' HG13 ' A' ' 101' ' ' ILE . 18.7 m120 -76.07 -29.19 57.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.649 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.43 -57.84 11.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.67 0.788 . . . . 0.0 111.189 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 25.5 p -69.57 -26.98 64.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.362 0.665 . . . . 0.0 112.341 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.2 t80 -60.14 -45.55 92.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.454 0.702 . . . . 0.0 109.465 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.67 ' HG ' HD23 ' A' ' 21' ' ' LEU . 68.9 mt -65.45 -32.63 74.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.863 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.56 74.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.394 0.278 . . . . 0.0 111.515 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.581 ' HA ' HG11 ' A' ' 76' ' ' VAL . 81.3 p -71.62 -6.6 42.14 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 123.245 0.34 . . . . 0.0 111.214 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 47' ' ' LEU . 50.0 mt -90.04 11.97 19.08 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.727 0.811 . . . . 0.0 111.124 168.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.63 21.31 66.75 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.549 0.58 . . . . 0.0 114.549 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.59 141.2 36.84 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.943 0.872 . . . . 0.0 110.917 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 45.6 mt-10 -77.47 88.53 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -90.63 107.31 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.592 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 t -85.22 103.64 14.36 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.71 131.93 45.38 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.623 -169.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.623 HG23 ' HB ' ' A' ' 81' ' ' VAL . 38.5 t -110.61 134.33 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 20.5 t70 -145.85 140.58 27.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 pt20 -68.52 -20.78 64.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.591 0.756 . . . . 0.0 111.661 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 m -112.9 141.49 46.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.959 0.904 . . . . 0.0 109.406 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.9 p -72.13 -15.95 61.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.646 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.38 -32.97 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.824 0.449 . . . . 0.0 111.113 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.17 -36.72 23.63 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.621 0.575 . . . . 0.0 113.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.72 -52.03 14.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.625 0.77 . . . . 0.0 111.25 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.38 -36.71 69.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.683 0.793 . . . . 0.0 112.302 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -64.3 -45.83 86.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.106 0.562 . . . . 0.0 110.572 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -58.69 -47.91 82.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 124.03 0.831 . . . . 0.0 110.59 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.82 -31.83 71.1 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.504 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.589 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -63.55 -51.93 63.3 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.365 0.666 . . . . 0.0 112.474 176.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.8 tp -67.97 -23.27 65.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.314 0.384 . . . . 0.0 110.49 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' A' ' 76' ' ' VAL . . . -61.45 -57.74 10.99 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 122.874 0.47 . . . . 0.0 110.187 172.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.21 -30.55 71.03 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.887 0.875 . . . . 0.0 112.247 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.02 -53.42 26.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.121 0.569 . . . . 0.0 111.257 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -98.04 1.72 48.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.616 0.367 . . . . 0.0 111.437 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.56 43.2 69.65 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 122.321 -0.237 . . . . 0.0 113.484 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 49' ' ' SER . 27.7 m -118.55 169.85 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.579 1.152 . . . . 0.0 109.478 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -112.15 128.7 56.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.891 0.476 . . . . 0.0 111.983 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.8 163.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.637 1.575 . . . . 0.0 107.573 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.5 m -136.53 105.18 5.81 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.0 p -87.34 121.44 29.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.287 -168.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.623 ' HB ' HG23 ' A' ' 57' ' ' VAL . 47.5 t -114.59 135.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.261 1.425 . . . . 0.0 108.834 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.11 130.64 35.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 59' ' ' GLN . 32.5 t -69.21 118.04 11.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.891 0.476 . . . . 0.0 111.961 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -142.99 86.79 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 167.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.1 mt -78.19 -20.93 50.91 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.13 -13.46 61.19 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 112.187 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.57 -29.39 4.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.285 0.634 . . . . 0.0 111.518 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -159.03 125.41 4.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.524 1.13 . . . . 0.0 108.313 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -70.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 34' ' ' LEU . 7.3 pt -140.2 119.22 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.134 0.974 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -130.8 98.33 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.91 0.884 . . . . 0.0 108.722 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.29 -9.53 5.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.85 -52.83 21.58 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.196 0.598 . . . . 0.0 110.812 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.62 -29.34 66.82 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -169.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 98' ' ' ILE . 11.1 p-90 -133.62 176.28 8.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.673 0.789 . . . . 0.0 110.938 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.15 -90.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.301 0.64 . . . . 0.0 111.229 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.87 172.13 41.89 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 118.448 0.567 . . . . 0.0 113.509 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 121' ' ' LEU . 5.9 mt -123.09 150.86 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.55 0.74 . . . . 0.0 109.025 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.1 p -144.46 134.53 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 163.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -133.02 99.2 4.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.4 HG13 ' HB2' ' A' ' 43' ' ' ASN . 30.4 mm -74.88 154.75 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.258 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -18.42 104.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.067 2.147 . . . . 0.0 113.592 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.05 148.96 44.06 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.63 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -147.16 101.64 3.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.09 143.29 26.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.544 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.2 158.57 47.68 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.652 2.234 . . . . 0.0 110.732 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 t -45.59 -36.41 4.69 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.38 1.472 . . . . 0.0 113.737 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 p -56.28 -58.81 6.37 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.355 1.062 . . . . 0.0 111.997 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.25 -19.09 37.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.859 0.864 . . . . 0.0 111.07 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -77.94 -47.25 19.06 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.647 0.779 . . . . 0.0 109.438 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -52.79 -34.49 53.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.903 0.881 . . . . 0.0 111.783 164.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -75.67 -44.27 43.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 117' ' ' VAL . 49.2 tp -92.19 -55.56 3.38 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.67 -40.02 6.24 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 119.623 1.101 . . . . 0.0 112.479 -161.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.37 -28.92 87.71 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 122.281 1.987 . . . . 0.0 112.044 166.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 5.5 tppp? -77.42 -24.77 50.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.396 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 113' ' ' LEU . 41.6 t -72.13 -34.18 49.23 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.364 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -53.93 -62.39 1.69 Allowed 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.69 -33.66 35.24 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.22 57.28 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.533 HD13 HD13 ' A' ' 98' ' ' ILE . 26.8 tp -60.7 128.37 36.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.882 0.473 . . . . 0.0 110.604 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 148.56 34.68 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.74 113.28 1.76 Allowed 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.74 1.626 . . . . 0.0 111.201 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.552 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 128.31 6.15 4.88 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.017 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.427 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -101.53 143.59 16.14 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 164.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.2 m -110.78 130.67 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.566 0.746 . . . . 0.0 109.16 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 129' ' ' LEU . 8.8 t80 -106.61 112.55 25.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 24' ' ' VAL . 55.6 mt -115.43 109.01 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.995 0.918 . . . . 0.0 110.25 -168.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 127' ' ' PHE . 89.0 mt -128.96 133.91 47.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.354 0.662 . . . . 0.0 110.073 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -113.09 98.84 7.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.533 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -88.92 -174.49 46.78 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.721 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -138.56 159.54 41.84 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.08 0.952 . . . . 0.0 108.565 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 123.743 0.817 . . . . 0.0 110.454 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.4 mt -89.75 103.85 7.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.533 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -67.74 103.58 0.86 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.079 2.52 . . . . 0.0 111.729 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' HD11 ' A' ' 188' ' ' ILE . 16.4 ptpt -100.43 152.4 20.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.284 0.493 . . . . 0.0 112.185 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.3 -38.05 87.9 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.79 0.836 . . . . 0.0 110.881 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -48.23 -52.63 20.21 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.267 1.027 . . . . 0.0 111.143 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.0 p -76.41 -61.91 1.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.201 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.69 -46.84 86.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.307 1.043 . . . . 0.0 112.787 -166.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -64.87 -33.27 75.61 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 123.229 0.33 . . . . 0.0 111.185 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.2 t -78.61 -23.32 45.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.568 0.347 . . . . 0.0 111.098 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -86.72 -12.3 48.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.684 0.794 . . . . 0.0 111.251 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.89 64.53 42.47 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.684 0.794 . . . . 0.0 109.156 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.13 4.34 7.15 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.814 2.343 . . . . 0.0 111.786 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 t -87.52 -34.58 18.57 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.456 HD13 HD23 ' A' ' 121' ' ' LEU . 25.7 tp -97.97 73.6 2.26 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 125.973 1.709 . . . . 0.0 110.878 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -57.36 124.28 18.35 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.502 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 12.4 m95 -89.33 139.77 30.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.591 1.156 . . . . 0.0 109.561 -170.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.643 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 96.3 mt -68.09 -44.98 75.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 169.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 79.0 mt -126.4 120.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.37 78.2 1.27 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -143.62 152.57 41.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.004 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.536 ' H ' HD21 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -87.05 120.42 28.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.87 173.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.05 106.36 17.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 123.878 0.871 . . . . 0.0 109.558 -173.399 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.5 mt -122.33 151.7 40.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 152' ' ' LYS . 9.2 pt -139.19 142.84 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -124.94 145.29 49.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.591 0.71 . . . . 0.0 110.5 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.56 135.74 48.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.013 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.463 HD21 HG13 ' A' ' 24' ' ' VAL . 16.6 tp -140.24 105.12 4.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.67 133.2 11.63 Favored Glycine 0 C--O 1.219 -0.783 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.643 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 7.8 tp60 -120.18 146.44 46.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.566 0.683 . . . . 0.0 111.35 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.552 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -62.12 138.17 58.36 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.581 0.551 . . . . 0.0 109.559 168.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--O 1.241 0.657 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.339 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 CA--C 1.549 0.911 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 tp -68.46 -21.39 64.63 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.383 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 m -86.46 -28.91 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 119.007 0.822 . . . . 0.0 109.434 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -74.83 -44.67 48.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.993 0.917 . . . . 0.0 110.001 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 28' ' ' ILE . 19.0 m -64.16 -37.04 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.6 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.02 67.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.16 -26.6 65.84 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.129 0.572 . . . . 0.0 109.728 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.643 ' HB3' HE21 ' A' ' 193' ' ' GLN . 24.0 mm-40 -88.74 -25.96 22.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.973 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 24' ' ' VAL . 47.9 mt -73.71 130.25 83.87 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.26 132.95 29.58 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.231 2.621 . . . . 0.0 112.835 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -74.58 27.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.96 -134.91 5.76 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -82.15 114.91 21.0 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.7 151.2 11.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.9 tp -119.61 120.45 36.73 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 28.5 p -108.7 126.68 53.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.86 -172.42 1.3 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 123.599 0.76 . . . . 0.0 111.056 166.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.162 0 N-CA-C 113.769 0.267 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -61.98 -35.14 77.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.386 0.674 . . . . 0.0 112.049 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -56.15 -52.31 64.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.876 0.735 . . . . 0.0 111.099 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.51 -54.16 50.04 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.317 1.011 . . . . 0.0 111.8 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 6.2 p -67.89 -28.93 67.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.791 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 84.1 t80 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.446 0.698 . . . . 0.0 110.079 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 99' ' ' VAL . 50.9 mt -65.03 -35.85 82.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.829 0.852 . . . . 0.0 111.228 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.45 63.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.394 0.278 . . . . 0.0 111.247 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.511 ' HA ' HG13 ' A' ' 76' ' ' VAL . 50.4 m -61.71 -23.05 65.88 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.355 0.662 . . . . 0.0 111.092 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.0 mt -78.23 12.39 1.92 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.988 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.51 66.59 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.475 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -103.41 152.98 20.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.252 0.526 . . . . 0.0 111.274 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -90.96 91.06 8.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.5 t -98.87 126.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.403 0.681 . . . . 0.0 109.985 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 m -99.77 111.69 24.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.744 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -96.68 139.53 32.61 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.814 0.446 . . . . 0.0 110.304 -172.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 81' ' ' VAL . 16.0 t -118.28 150.09 20.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 164.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 27.8 t0 -157.99 144.57 17.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.288 0.495 . . . . 0.0 109.893 172.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.33 -20.47 66.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.073 0.858 . . . . 0.0 112.02 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.408 ' HB3' HG22 ' A' ' 62' ' ' VAL . 1.9 m -108.92 140.32 42.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.158 0.983 . . . . 0.0 109.325 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 m -69.44 -29.23 66.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.784 0.434 . . . . 0.0 110.85 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 60' ' ' SER . 11.0 m -61.66 -35.25 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.829 0.706 . . . . 0.0 111.976 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.01 -35.37 35.01 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.53 0.519 . . . . 0.0 112.81 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -50.97 62.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.56 0.744 . . . . 0.0 110.435 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.13 76.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.158 0.983 . . . . 0.0 112.589 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -62.93 -43.81 97.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.429 0.692 . . . . 0.0 110.141 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -63.61 -46.02 87.67 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.28 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -67.24 -42.96 83.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.674 0.79 . . . . 0.0 110.782 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.49 -54.52 42.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.31 1.044 . . . . 0.0 111.627 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.506 HD22 ' SG ' ' A' ' 45' ' ' CYS . 30.5 tp -65.95 -28.82 69.19 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.923 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.604 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.78 -62.94 1.32 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.457 0.473 . . . . 0.0 111.062 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.62 -25.57 67.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.145 0.578 . . . . 0.0 111.274 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.79 -54.74 14.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.739 0.415 . . . . 0.0 109.904 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.28 -5.32 58.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.98 0.512 . . . . 0.0 112.083 -171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.58 34.15 40.64 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 121.923 -0.179 . . . . 0.0 113.064 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 49' ' ' SER . 33.0 m -125.21 170.46 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.633 1.173 . . . . 0.0 108.416 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -121.45 138.28 54.35 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mm -116.61 167.2 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -133.99 105.49 6.76 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 165.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.3 p -89.72 137.25 32.5 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.667 0.746 . . . . 0.0 111.576 -167.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 57' ' ' VAL . 58.8 t -125.05 135.0 65.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.324 1.849 . . . . 0.0 107.845 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -83.18 139.84 32.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 p -48.98 109.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.246 1.018 . . . . 0.0 113.144 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -136.58 93.7 2.91 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 90.8 mt -103.15 -35.25 8.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.141 0.577 . . . . 0.0 111.822 -170.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.09 -5.83 50.44 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.045 0.538 . . . . 0.0 112.117 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -116.23 -28.64 6.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.983 0.913 . . . . 0.0 111.174 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 47.3 t80 -157.79 156.09 30.93 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 125.166 1.387 . . . . 0.0 107.696 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.56 -70.58 0.17 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.407 1.458 . . . . 0.0 108.927 163.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 98' ' ' ILE . 13.5 pt -139.5 118.77 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 0.0 110.268 -172.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.42 86.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 122' ' ' LYS . . . -72.2 1.96 6.74 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.29 -47.87 69.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 165.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 -11.79 39.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.066 0.947 . . . . 0.0 111.962 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -120.3 117.77 28.67 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.612 0.765 . . . . 0.0 110.119 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -58.46 -47.62 83.4 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.677 0.791 . . . . 0.0 111.366 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.97 156.28 18.11 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.924 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.627 HD12 ' HB ' ' A' ' 90' ' ' ILE . 55.3 mt -129.47 148.52 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 171.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG13 HD13 ' A' ' 47' ' ' LEU . 4.3 p -135.27 143.12 37.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.759 1.224 . . . . 0.0 107.99 161.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.418 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 50.0 m -143.63 102.17 3.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.66 83.96 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.444 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 27.1 t80 -74.54 117.84 16.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.345 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.5 p -113.49 173.65 6.3 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -55.56 101.23 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.514 0.726 . . . . 0.0 110.721 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.16 139.81 42.37 Favored Pre-proline 0 C--O 1.247 0.961 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.61 144.9 24.16 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.838 2.359 . . . . 0.0 110.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -43.33 -34.61 1.27 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.713 1.205 . . . . 0.0 113.495 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 t -56.55 -64.25 0.93 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.45 1.1 . . . . 0.0 111.506 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.78 -30.74 65.87 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.728 0.411 . . . . 0.0 111.324 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -63.62 -62.4 1.69 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.682 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.49 -30.77 67.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.77 -33.95 64.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.178 0.591 . . . . 0.0 110.516 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.18 -48.48 62.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.855 0.722 . . . . 0.0 111.314 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -57.63 -44.31 99.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -166.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.41 -28.08 83.46 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 122.077 1.778 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' A' ' 116' ' ' LYS . 7.8 mtpm? -88.18 -12.38 44.05 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.026 0.931 . . . . 0.0 111.296 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 3.4 t -85.32 -33.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 165.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -66.07 -61.5 2.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.697 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.8 -47.78 16.04 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.83 -39.34 39.51 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 -166.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.583 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 28.4 tp -70.9 96.2 1.25 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.465 ' H ' ' HB1' ' A' ' 92' ' ' ALA . 30.0 mmmt -67.0 130.13 93.93 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 27.5 Cg_exo -39.85 123.44 1.23 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.422 3.415 . . . . 0.0 114.547 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.99 14.78 2.98 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.704 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.532 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.88 150.47 17.04 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 167.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 20.4 m -109.84 131.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 123.264 0.626 . . . . 0.0 109.943 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.418 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.3 t80 -110.37 113.06 25.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.51 111.7 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.792 0.837 . . . . 0.0 109.865 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 156' ' ' LEU . 2.1 mp -129.18 149.5 50.96 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.302 0.641 . . . . 0.0 110.068 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 45.2 tt0 -135.67 103.64 5.5 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.803 0.689 . . . . 0.0 109.253 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.6 148.33 27.59 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 170.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.419 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.1 m-85 -111.04 168.28 9.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.609 0.763 . . . . 0.0 110.39 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 124.25 1.02 . . . . 0.0 111.861 -176.225 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.419 HD22 ' HB2' ' A' ' 132' ' ' PHE . 59.5 mt -81.72 108.17 10.32 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.699 ' HB2' HD11 ' A' ' 156' ' ' LEU . 65.3 Cg_endo -83.34 123.88 3.55 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.315 2.01 . . . . 0.0 111.79 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -86.65 159.09 19.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.141 0.976 . . . . 0.0 111.95 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.435 HD21 ' HB ' ' A' ' 188' ' ' ILE . 71.7 mt -61.61 -36.63 81.27 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 166.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.23 -50.45 72.82 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.01 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 73.5 p -68.75 -62.33 1.43 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.299 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 151' ' ' PRO . 70.8 mt -61.84 -49.93 74.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.81 1.244 . . . . 0.0 112.952 -166.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.646 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.5 tt0 -58.47 -43.19 88.85 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 123.685 0.616 . . . . 0.0 111.426 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 t -73.13 -23.23 60.46 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.463 0.305 . . . . 0.0 111.594 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 155' ' ' THR . 53.9 mt-10 -80.86 -18.04 48.68 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.684 0.793 . . . . 0.0 111.399 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 97.0 mt -133.65 66.73 74.17 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.311 0.644 . . . . 0.0 110.507 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.35 2.97 7.89 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.783 2.322 . . . . 0.0 112.309 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.1 m -86.02 -35.23 20.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.4 tp -102.14 70.19 1.19 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.002 1.721 . . . . 0.0 110.663 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -64.98 136.88 57.32 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.646 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 19.3 m95 -96.98 136.92 36.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.512 0.725 . . . . 0.0 110.545 -163.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 46.2 mt -68.33 -30.02 68.9 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.634 0.584 . . . . 0.0 109.729 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 67.0 mt -132.01 125.09 54.29 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.38 66.38 0.7 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -128.97 143.71 50.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.655 -162.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -89.96 99.32 12.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.386 1.075 . . . . 0.0 109.535 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.7 mt -108.19 129.92 55.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.359 1.064 . . . . 0.0 111.56 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 123.113 0.565 . . . . 0.0 109.946 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.97 149.48 40.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 19.8 pt -132.54 117.24 30.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -98.55 144.58 27.72 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.375 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 48.6 mt -128.63 137.21 51.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.53 -1.213 . . . . 0.0 109.525 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 24' ' ' VAL . 33.3 tp -135.11 105.08 6.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -90.92 138.14 14.21 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.1 tp-100 -143.52 157.43 44.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.299 0.64 . . . . 0.0 110.752 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.412 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 62.9 tttm -56.29 120.74 8.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.265 1.026 . . . . 0.0 109.207 172.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 N--CA 1.473 0.7 0 C-N-CA 122.58 0.352 . . . . 0.0 111.536 -173.791 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 CA--C 1.558 1.281 0 CA-C-O 121.296 0.57 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.98 -17.73 10.88 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.811 1.244 . . . . 0.0 112.747 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.55 -27.46 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.516 1.053 . . . . 0.0 109.398 -171.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 17.4 m -66.68 -52.69 41.9 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.473 0.709 . . . . 0.0 109.422 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.51 HG13 HD22 ' A' ' 191' ' ' LEU . 19.3 m -65.98 -37.09 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.9 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 28' ' ' ILE . . . -58.68 -42.18 87.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.273 1.029 . . . . 0.0 112.25 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.51 -23.65 64.58 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.858 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.681 ' HB3' HE22 ' A' ' 193' ' ' GLN . 12.5 mm100 -83.91 -14.24 51.52 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.263 0.625 . . . . 0.0 111.366 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -82.89 128.94 63.7 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.275 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.15 140.05 41.82 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.122 2.548 . . . . 0.0 113.063 169.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.21 27.41 0.05 Allowed 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.42 -136.77 6.56 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-O 119.397 -0.669 . . . . 0.0 112.919 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -75.21 112.7 11.75 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -107.92 116.04 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.64 113.79 26.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 110.208 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 8.8 t -104.05 108.57 19.99 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 122.451 0.3 . . . . 0.0 111.531 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.432 HD11 HG23 ' A' ' 90' ' ' ILE . 61.7 mt -81.26 123.41 28.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.646 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 1.359 0 O-C-N 125.153 1.533 . . . . 0.0 111.255 174.538 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtm105 -55.64 -26.69 45.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.786 1.234 . . . . 0.0 113.557 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.72 -54.63 32.51 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.351 0.661 . . . . 0.0 111.304 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.35 74.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.983 0.802 . . . . 0.0 110.808 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 26.5 m -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.906 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.491 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 89.0 t80 -66.14 -51.88 53.7 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.697 0.623 . . . . 0.0 109.6 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.447 HD12 HG12 ' A' ' 99' ' ' VAL . 93.4 mt -61.38 -37.02 81.89 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.437 1.086 . . . . 0.0 110.901 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.71 66.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.312 0.645 . . . . 0.0 112.078 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.673 ' HA ' HG12 ' A' ' 76' ' ' VAL . 96.1 p -70.32 -2.78 14.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.2 mt -82.76 12.96 4.17 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.028 0.531 . . . . 0.0 110.501 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.44 32.82 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 119.846 -0.419 . . . . 0.0 113.925 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.8 158.87 35.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.352 0.576 . . . . 0.0 111.141 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.4 91.31 6.15 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.755 0.822 . . . . 0.0 108.98 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.95 110.45 23.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.993 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.658 HG23 ' HB ' ' A' ' 79' ' ' THR . 47.4 p -84.88 105.48 15.69 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.073 173.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.0 129.2 46.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.245 0.618 . . . . 0.0 110.772 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.25 123.62 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.32 134.44 25.72 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.03 -2.45 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.66 1.184 . . . . 0.0 113.329 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 m -119.93 119.61 33.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.2 m -73.44 -24.95 60.31 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.306 0.642 . . . . 0.0 110.291 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.25 -35.88 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.776 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.01 -35.16 58.03 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.747 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.63 -49.71 69.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.494 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.409 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.611 0.764 . . . . 0.0 112.043 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -66.23 -46.28 77.75 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.874 0.87 . . . . 0.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.519 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -63.59 -40.92 98.17 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.99 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 36.6 ttpt -65.49 -45.05 85.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.462 1.105 . . . . 0.0 110.938 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 -51.55 68.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.105 0.962 . . . . 0.0 110.872 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.37 -30.59 70.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.172 0.92 . . . . 0.0 111.022 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -64.05 -61.37 2.31 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.505 0.503 . . . . 0.0 111.256 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.12 -24.39 65.01 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.341 0.656 . . . . 0.0 110.842 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.44 -35.24 75.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.932 0.893 . . . . 0.0 110.44 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.83 -10.41 45.47 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.39 0.676 . . . . 0.0 111.251 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.63 36.16 20.48 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 113.633 0.213 . . . . 0.0 113.633 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' A' ' 49' ' ' SER . 19.4 m -132.32 174.58 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.373 1.069 . . . . 0.0 110.048 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.25 129.46 54.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.0 0.92 . . . . 0.0 111.814 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.1 mm -108.68 166.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 162.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.658 ' HB ' HG23 ' A' ' 55' ' ' THR . 90.3 m -134.06 110.59 9.74 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 160.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.4 p -81.94 120.47 25.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.65 153.46 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.727 1.211 . . . . 0.0 109.693 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -85.81 103.59 14.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.6 p -46.9 99.92 0.02 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.55 1.14 . . . . 0.0 112.672 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -141.0 96.57 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.79 -15.02 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.033 0.933 . . . . 0.0 112.424 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -18.18 32.32 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.533 0.733 . . . . 0.0 112.651 -174.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.42 -10.9 3.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.759 0.823 . . . . 0.0 111.495 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -151.68 157.62 42.33 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -153.84 -57.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 117' ' ' VAL . 3.1 pt -151.81 134.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.0 109.322 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.457 HG13 ' H ' ' A' ' 93' ' ' ASP . 84.4 t -123.64 150.99 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.305 1.042 . . . . 0.0 108.215 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.27 -29.63 19.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.296 0.57 . . . . 0.0 110.27 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' H ' HG13 ' A' ' 91' ' ' VAL . 23.3 t70 -70.34 -51.66 28.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.262 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.34 -25.9 33.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.161 0.584 . . . . 0.0 112.362 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 57.1 m95 -111.81 107.08 16.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.06 0.457 . . . . 0.0 110.865 -168.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -56.88 12.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.165 1.386 . . . . 0.0 109.525 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.22 143.06 15.63 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.47 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.518 HD12 ' HB ' ' A' ' 90' ' ' ILE . 87.7 mt -124.9 127.26 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -123.12 102.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.308 1.052 . . . . 0.0 109.732 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 m -97.33 91.59 5.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.7 mm -72.37 150.36 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.869 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -17.92 105.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 127.258 2.223 . . . . 0.0 113.46 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 p -111.38 106.26 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.549 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -98.09 99.53 10.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.2 mt -114.81 146.07 35.29 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.735 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.559 ' HA ' HD13 ' A' ' 149' ' ' LEU . 35.8 Cg_exo -61.69 155.4 54.06 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.963 2.442 . . . . 0.0 110.715 167.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -46.3 -38.66 8.96 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.979 0.912 . . . . 0.0 112.752 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.8 m -56.0 -52.41 64.31 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 123.925 0.766 . . . . 0.0 111.986 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.96 -22.04 31.57 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.236 0.615 . . . . 0.0 111.039 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -76.08 -52.43 10.18 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.4 -14.23 62.85 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.746 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.2 -39.56 25.23 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 117' ' ' VAL . 64.2 tp -75.52 -60.25 2.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.033 0.533 . . . . 0.0 111.933 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -58.94 -43.72 97.99 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -164.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.8 -23.38 26.13 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 121.774 1.649 . . . . 0.0 112.04 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -86.17 -14.65 43.4 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.783 0.833 . . . . 0.0 110.16 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.582 ' HA ' HD11 ' A' ' 90' ' ' ILE . 28.9 t -75.27 -40.18 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 166.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.78 -54.16 50.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.109 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.2 -46.79 63.83 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.313 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.58 -57.27 3.92 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.376 0.511 . . . . 0.0 114.376 -172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.446 ' HB2' HD13 ' A' ' 90' ' ' ILE . 6.0 tt -74.6 138.28 42.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.553 0.741 . . . . 0.0 109.817 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -120.05 168.54 10.17 Favored Pre-proline 0 C--O 1.247 0.933 0 C-N-CA 124.622 1.169 . . . . 0.0 108.583 172.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.07 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 122.003 1.802 . . . . 0.0 112.042 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.407 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 133.72 -2.05 4.42 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.176 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -114.52 145.03 18.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 159.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.2 131.5 58.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.87 1.268 . . . . 0.0 109.447 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.37 111.71 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.24 107.82 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 91.3 mt -118.35 141.02 48.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.753 0.821 . . . . 0.0 110.669 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -127.15 101.43 6.51 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 164.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 179.6 53.19 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 164.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.43 ' HD1' HD22 ' A' ' 187' ' ' LEU . 36.0 m-85 -130.16 169.37 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.494 ' HB3' ' HB1' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.116 0.566 . . . . 0.0 110.174 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 106' ' ' PRO . 23.9 mt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 132' ' ' PHE . 88.2 mt -72.88 115.35 39.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 123.307 0.379 . . . . 0.0 110.554 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.447 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 55.6 Cg_endo -93.79 114.11 0.23 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 122.647 2.231 . . . . 0.0 109.988 167.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -73.09 167.93 20.12 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.776 0.43 . . . . 0.0 111.761 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.628 HD21 ' HB ' ' A' ' 188' ' ' ILE . 67.8 mt -61.14 -30.58 70.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 0.0 110.9 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -56.8 -59.38 5.11 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.425 0.69 . . . . 0.0 110.73 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.1 p -65.57 -38.42 89.49 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.592 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.2 -43.68 23.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -173.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.473 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 29.6 tt0 -58.96 -40.02 83.47 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 120.927 0.394 . . . . 0.0 110.905 173.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -80.47 -13.3 59.23 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.438 0.695 . . . . 0.0 111.258 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -74.37 -31.77 62.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.464 0.706 . . . . 0.0 109.861 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 79.8 mt -134.08 74.25 68.55 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.99 -33.58 31.86 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.289 2.659 . . . . 0.0 113.407 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t -82.78 -35.43 26.53 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.5 tp -66.89 71.77 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.674 1.19 . . . . 0.0 111.799 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -51.8 120.93 5.78 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.797 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.473 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 55.3 m95 -87.94 119.7 28.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.508 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.609 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 79.8 mt -68.08 -33.76 75.15 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.846 0.458 . . . . 0.0 110.276 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.6 128.33 69.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.63 81.67 1.34 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -137.62 144.43 41.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.899 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.36 125.53 35.17 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.7 mt -105.75 107.12 17.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.119 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 133' ' ' ALA . . . . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.43 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.7 mt -120.92 144.07 48.63 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.628 ' HB ' HD21 ' A' ' 153' ' ' LEU . 27.3 pt -124.12 116.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.8 1.182 . . . . 0.0 109.944 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -100.04 146.74 26.4 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.692 0.758 . . . . 0.0 110.586 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 46.0 mt -137.07 141.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.073 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.51 HD22 HG13 ' A' ' 24' ' ' VAL . 40.9 tp -134.19 106.35 7.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 168.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.31 140.59 19.2 Favored Glycine 0 CA--C 1.505 -0.551 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.681 HE22 ' HB3' ' A' ' 27' ' ' GLN . 7.4 tp-100 -123.75 148.37 46.68 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 193' ' ' GLN . 0.7 OUTLIER -57.11 115.92 2.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.371 161.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 167.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.654 0.264 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 24' ' ' VAL . 33.7 tp -67.62 -54.4 20.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.131 0.572 . . . . 0.0 111.208 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 m -47.39 -25.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 m -68.36 -49.07 62.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.862 0.865 . . . . 0.0 110.767 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 128' ' ' ILE . 1.5 m -64.77 -36.48 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.032 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.54 66.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.1 -35.24 77.82 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.855 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -82.86 -18.25 41.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.143 0.977 . . . . 0.0 112.466 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 24' ' ' VAL . 74.1 mt -77.02 135.64 66.82 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.965 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.59 142.48 90.38 Favored 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.467 2.778 . . . . 0.0 112.331 171.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.405 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 28.2 pt20 -70.73 28.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.63 -141.87 6.76 Favored Glycine 0 N--CA 1.478 1.447 0 CA-C-N 118.769 0.713 . . . . 0.0 113.338 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 62.0 mttp -76.91 115.32 16.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 54' ' ' VAL . 21.0 mt -107.63 121.45 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HA ' HG22 ' A' ' 55' ' ' THR . 55.6 tp -90.69 111.62 23.04 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.02 0.528 . . . . 0.0 111.289 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 98.6 m -87.19 134.9 33.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.83 152.63 18.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.749 0.419 . . . . 0.0 110.469 167.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.953 0 O-C-N 124.685 1.241 . . . . 0.0 111.779 177.147 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -81.24 -26.38 35.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.257 1.023 . . . . 0.0 109.617 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.552 ' ND2' HG23 ' A' ' 101' ' ' ILE . 79.8 m-20 -67.25 -35.08 78.8 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.943 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -53.42 -57.55 10.23 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.418 1.087 . . . . 0.0 111.813 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.894 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 8.3 p -66.03 -34.13 77.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.976 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.96 -43.09 88.93 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.57 0.544 . . . . 0.0 111.29 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 99' ' ' VAL . 84.9 mt -67.35 -30.78 70.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.47 -36.71 74.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.724 0.41 . . . . 0.0 110.542 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -63.95 -14.63 55.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.207 1.003 . . . . 0.0 112.341 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.0 mt -85.26 17.19 3.17 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.934 0.894 . . . . 0.0 110.705 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 37.73 25.39 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 123.563 0.601 . . . . 0.0 114.436 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 25.2 m-85 -126.69 154.36 44.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.998 0.519 . . . . 0.0 111.318 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 33.5 mt-10 -89.6 86.9 6.84 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 ' HB ' ' A' ' 33' ' ' ILE . 71.2 t -93.23 108.49 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.783 0.802 . . . . 0.0 110.376 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 34' ' ' LEU . 1.8 t -83.69 108.71 16.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.957 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -96.42 132.41 41.99 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.748 0.819 . . . . 0.0 111.359 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.29 120.51 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 22.4 t0 -136.27 134.91 38.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.238 0.472 . . . . 0.0 109.972 174.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -53.8 -24.03 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.771 1.628 . . . . 0.0 112.837 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 t -123.3 164.23 19.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 111.081 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.2 p -77.36 -18.35 57.46 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.096 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.51 -44.39 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.62 -34.01 40.91 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.275 0.359 . . . . 0.0 112.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 93.5 mt -69.02 -47.67 64.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.558 0.743 . . . . 0.0 111.61 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -54.31 -55.67 26.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.815 0.846 . . . . 0.0 111.855 171.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.35 -39.16 66.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.619 0.767 . . . . 0.0 110.842 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.894 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -59.98 -52.51 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.293 177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -69.01 -38.75 79.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 5.7 mm100 -62.51 -45.44 92.97 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.496 0.318 . . . . 0.0 111.395 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 45' ' ' CYS . 32.1 tp -70.92 -27.39 63.73 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.359 0.412 . . . . 0.0 110.785 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.585 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -61.15 -62.4 1.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 110.546 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.97 -30.21 70.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.586 0.754 . . . . 0.0 111.617 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.77 -54.58 25.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.06 0.544 . . . . 0.0 110.718 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HE2' HD12 ' A' ' 70' ' ' LEU . 24.8 ttmm -83.87 -15.71 47.12 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.48 0.712 . . . . 0.0 111.727 -170.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.93 41.97 7.88 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 121.828 -0.225 . . . . 0.0 113.284 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.53 175.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.591 1.156 . . . . 0.0 109.109 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.14 140.69 51.65 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.031 0.378 . . . . 0.0 111.896 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.585 HG12 ' HB1' ' A' ' 71' ' ' ALA . 20.1 mm -115.56 160.75 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.004 1.322 . . . . 0.0 107.555 167.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 90.8 m -127.49 110.12 12.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.8 p -84.24 111.63 19.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.044 0.538 . . . . 0.0 109.822 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 157.25 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.177 1.391 . . . . 0.0 110.698 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.38 103.81 15.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.87 99.26 0.08 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.018 0.437 . . . . 0.0 111.618 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -142.64 91.54 2.32 Favored 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.57 -17.26 61.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.349 0.522 . . . . 0.0 110.839 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.34 -0.9 51.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.543 1.137 . . . . 0.0 112.295 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.04 -32.8 0.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -167.32 107.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.04 -63.4 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.483 1.113 . . . . 0.0 108.21 -171.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' HB ' HD12 ' A' ' 98' ' ' ILE . 29.8 pt -138.64 122.62 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.609 0.763 . . . . 0.0 110.8 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.44 87.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.719 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.95 -1.84 13.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.477 0.711 . . . . 0.0 112.744 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.86 -48.06 67.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.08 -24.41 30.37 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.923 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.475 ' CD2' HG21 ' A' ' 55' ' ' THR . 17.9 m95 -112.85 161.78 16.56 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.113 0.565 . . . . 0.0 109.682 -172.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.74 -58.1 2.85 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.82 16.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.257 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.598 HD12 ' HB ' ' A' ' 90' ' ' ILE . 80.6 mt -134.36 119.36 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.412 HG12 HD12 ' A' ' 47' ' ' LEU . 11.6 p -109.11 133.27 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -125.96 90.9 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.552 HG23 ' ND2' ' A' ' 43' ' ' ASN . 12.2 mm -69.29 155.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.877 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -19.28 103.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 126.215 1.806 . . . . 0.0 113.501 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.28 114.55 11.61 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.271 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -97.76 100.24 11.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.9 mt -93.47 148.76 36.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.708 0.403 . . . . 0.0 110.279 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.57 156.71 55.29 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.156 1.904 . . . . 0.0 110.193 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.8 m -50.83 -33.0 21.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.033 0.933 . . . . 0.0 112.585 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -58.84 -52.99 63.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.899 0.88 . . . . 0.0 111.623 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.7 mt -83.42 -18.66 37.96 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.978 0.511 . . . . 0.0 111.283 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -63.71 -62.88 1.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -67.78 -10.52 53.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.617 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -77.84 -54.18 6.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.786 0.434 . . . . 0.0 109.926 166.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.3 tp -74.71 -49.85 19.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -165.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.401 ' HH ' HD21 ' A' ' 129' ' ' LEU . 96.8 m-85 -67.25 -35.34 8.47 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.53 -33.68 96.85 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.194 1.929 . . . . 0.0 112.794 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 34.3 mmtp -72.64 -27.39 62.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.627 0.771 . . . . 0.0 110.894 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 113' ' ' LEU . 15.0 t -84.01 -34.75 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.727 0.411 . . . . 0.0 110.427 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.48 -61.76 2.35 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.94 -49.2 63.18 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.808 0.843 . . . . 0.0 113.247 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.27 24.07 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -164.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.817 HD11 ' HA3' ' A' ' 125' ' ' GLY . 44.7 tp -70.82 104.37 2.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.463 0.632 . . . . 0.0 110.43 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.71 153.21 78.22 Favored Pre-proline 0 C--O 1.247 0.929 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -48.69 116.03 1.92 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.954 2.436 . . . . 0.0 113.277 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.86 12.23 2.46 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.318 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.817 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -102.24 146.67 16.99 Favored Glycine 0 N--CA 1.441 -0.975 0 O-C-N 122.539 -0.389 . . . . 0.0 112.437 163.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.6 m -116.64 130.88 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.825 0.85 . . . . 0.0 108.767 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.521 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -111.9 113.07 25.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.649 HD13 HG22 ' A' ' 24' ' ' VAL . 14.7 mt -107.62 108.93 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 49.8 mt -113.49 150.3 33.07 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.515 0.726 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.42 138.95 43.76 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 161.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.54 -176.44 14.37 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -102.62 166.69 10.37 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.471 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.57 118.88 64.52 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 123.684 0.615 . . . . 0.0 112.194 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -94.71 98.28 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.916 2.411 . . . . 0.0 109.88 166.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 167.87 20.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.285 0.634 . . . . 0.0 111.335 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.544 HD22 ' HB ' ' A' ' 188' ' ' ILE . 29.8 mt -67.07 -31.54 72.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.243 0.617 . . . . 0.0 110.984 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -55.49 -45.88 76.98 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.84 0.713 . . . . 0.0 111.058 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -84.26 -35.69 23.2 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.698 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 129' ' ' LEU . 40.8 mt -75.21 -47.24 29.16 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.464 0.706 . . . . 0.0 112.022 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.402 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.5 tt0 -60.68 -35.81 77.19 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.72 0.408 . . . . 0.0 111.154 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -71.86 -26.83 62.51 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 111.11 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.57 -15.0 44.05 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.247 1.019 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 78.0 mt -135.67 68.18 65.83 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.03 3.09 8.09 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 123.049 2.499 . . . . 0.0 112.226 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t -90.21 -36.36 14.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.407 1.083 . . . . 0.0 108.59 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.2 tp -94.75 72.32 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.35 1.46 . . . . 0.0 111.715 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -51.78 124.72 13.13 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.283 0.564 . . . . 0.0 110.172 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.53 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 24.9 m95 -93.66 132.88 37.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.665 1.186 . . . . 0.0 109.839 -170.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 85.9 mt -70.64 -35.99 73.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.415 0.686 . . . . 0.0 110.787 173.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.05 121.61 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.44 85.17 1.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.644 0.778 . . . . 0.0 109.165 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.52 149.06 29.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.941 0.401 . . . . 0.0 110.811 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.22 113.39 13.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.0 128.01 53.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.392 0.677 . . . . 0.0 109.508 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 65.8 mt -121.94 172.37 8.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.544 ' HB ' HD22 ' A' ' 153' ' ' LEU . 38.1 pt -135.6 144.9 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -137.17 154.17 50.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.761 0.791 . . . . 0.0 110.945 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 65.0 mt -139.12 146.25 40.44 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 27.6 tp -143.37 111.89 6.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -90.18 148.56 19.79 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.601 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 8.6 tp-100 -134.78 151.16 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.472 0.636 . . . . 0.0 111.242 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.572 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 17.1 pttp -55.99 136.26 52.08 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 167.04 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.5 t80 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.442 ' O ' HG22 ' A' ' 24' ' ' VAL . 41.6 tp -69.88 -51.71 30.96 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.837 0.455 . . . . 0.0 111.098 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 m -45.56 -29.51 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -72.43 -44.18 62.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.436 0.695 . . . . 0.0 110.564 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 28' ' ' ILE . 1.2 m -67.98 -33.75 63.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.004 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.15 73.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.554 1.141 . . . . 0.0 112.241 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -69.07 -23.95 64.1 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.281 0.632 . . . . 0.0 110.632 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.51 -14.29 25.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.63 0.772 . . . . 0.0 111.788 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 24' ' ' VAL . 96.3 mt -83.93 125.77 72.08 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.531 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 18.3 Cg_exo -67.04 157.85 59.71 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.423 2.749 . . . . 0.0 112.848 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -72.54 28.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.4 -144.56 7.8 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 118.364 0.529 . . . . 0.0 113.716 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -70.7 115.44 9.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.65 0.78 . . . . 0.0 109.666 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 50.2 mt -107.21 121.85 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 HD23 HG22 ' A' ' 90' ' ' ILE . 55.3 tp -101.54 111.18 23.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HA ' HG12 ' A' ' 99' ' ' VAL . 51.1 t -102.61 110.12 21.96 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.445 0.698 . . . . 0.0 109.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.0 164.08 26.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.809 0.337 . . . . 0.0 111.695 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 C-N-CA 126.238 1.815 . . . . 0.0 114.814 -175.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.287 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -83.14 -52.95 6.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.819 1.248 . . . . 0.0 110.338 -174.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -61.32 -40.43 94.18 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.815 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.45 11.76 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.203 0.94 . . . . 0.0 111.524 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 70' ' ' LEU . 33.7 m -63.04 -33.78 76.17 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.782 0.833 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 79.4 t80 -63.34 -50.12 71.25 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.723 0.639 . . . . 0.0 110.218 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.493 HD13 HG11 ' A' ' 99' ' ' VAL . 63.9 mt -68.45 -29.48 68.13 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.579 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.44 -40.79 66.78 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.326 0.651 . . . . 0.0 112.006 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.749 ' HA ' HG12 ' A' ' 76' ' ' VAL . 58.1 p -72.2 -3.84 25.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.384 0.674 . . . . 0.0 112.762 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.2 mt -80.61 7.3 10.38 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 122.955 0.502 . . . . 0.0 110.735 165.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.68 24.35 39.17 Favored Glycine 0 C--N 1.361 1.939 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -126.04 162.4 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.059 0.929 . . . . 0.0 111.951 -172.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -88.94 91.45 8.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.24 1.016 . . . . 0.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.28 107.08 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.824 0.821 . . . . 0.0 110.727 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 m -87.27 108.89 19.15 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.188 1.395 . . . . 0.0 108.982 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.18 129.57 48.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.987 0.515 . . . . 0.0 109.643 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 81' ' ' VAL . 3.8 t -111.94 118.52 57.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.53 145.76 51.03 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.729 1.149 . . . . 0.0 110.621 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.02 -31.06 62.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.853 1.661 . . . . 0.0 113.211 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 m -116.13 144.1 44.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 0.0 110.252 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.6 p -68.65 -24.63 64.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.481 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.02 -33.94 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.497 0.719 . . . . 0.0 111.821 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 -30.82 67.62 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.371 0.419 . . . . 0.0 112.237 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.19 -42.31 46.75 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.983 0.913 . . . . 0.0 111.244 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.09 93.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.872 0.869 . . . . 0.0 111.93 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -67.02 -40.15 87.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.86 0.464 . . . . 0.0 110.755 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -56.95 -52.76 63.96 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 124.069 0.856 . . . . 0.0 110.406 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.0 -51.14 63.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 111.856 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.47 -47.45 81.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.918 0.887 . . . . 0.0 111.971 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.8 tp -64.52 -33.38 75.77 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.423 0.452 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.29 -51.03 49.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.413 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -66.52 -29.23 69.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.67 0.788 . . . . 0.0 110.257 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -63.18 -44.94 93.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.949 0.899 . . . . 0.0 110.276 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -85.05 -6.17 59.33 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.438 0.695 . . . . 0.0 111.569 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 40.07 12.32 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 120.391 -0.116 . . . . 0.0 113.226 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 49' ' ' SER . 33.2 m -139.64 174.22 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 124.452 1.101 . . . . 0.0 109.443 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -123.69 144.13 49.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.182 0.593 . . . . 0.0 112.316 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 mm -114.88 161.07 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 166.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.2 m -121.8 104.66 9.73 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 p -92.57 123.19 35.68 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.679 -0.638 . . . . 0.0 110.487 -167.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' A' ' 57' ' ' VAL . 62.1 t -115.61 141.07 34.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.192 1.397 . . . . 0.0 107.819 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -80.06 134.31 36.19 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.2 p -55.24 105.11 0.15 Allowed 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.146 0.978 . . . . 0.0 111.493 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.71 87.04 2.03 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' A' ' 109' ' ' LEU . 88.8 mt -94.24 -9.82 34.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.928 0.491 . . . . 0.0 110.537 -171.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.36 4.38 43.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.903 0.881 . . . . 0.0 110.319 170.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -130.96 -41.49 1.14 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.773 0.829 . . . . 0.0 110.812 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -156.76 121.72 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.234 1.014 . . . . 0.0 108.275 -169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.21 -69.6 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.652 -0.655 . . . . 0.0 109.626 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.525 ' HB ' HD12 ' A' ' 98' ' ' ILE . 18.1 pt -149.88 131.27 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.899 0.879 . . . . 0.0 109.958 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.79 145.63 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.813 1.245 . . . . 0.0 109.171 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -88.41 -30.71 19.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.13 0.572 . . . . 0.0 110.743 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.95 -61.26 2.07 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.712 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.67 -29.27 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.446 ' NE1' HD21 ' A' ' 34' ' ' LEU . 37.3 m95 -113.63 144.69 42.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 109.871 -171.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 29' ' ' PRO . 15.8 tp10 -98.19 -46.3 5.89 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.479 1.112 . . . . 0.0 109.494 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -114.58 141.52 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.354 171.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.525 HD12 ' HB ' ' A' ' 90' ' ' ILE . 63.7 mt -117.99 150.62 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 169.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.493 HG11 HD13 ' A' ' 47' ' ' LEU . 7.0 p -145.9 129.15 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 124.121 0.968 . . . . 0.0 109.01 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.3 m -129.57 94.2 3.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 128' ' ' ILE . 22.1 mm -70.73 143.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -15.26 104.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.404 1.882 . . . . 0.0 114.834 -170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.507 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 45.6 t -100.64 115.78 31.0 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.006 -174.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -121.71 98.41 5.94 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.507 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 95.0 mt -108.79 155.75 40.14 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.386 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HA ' HD11 ' A' ' 149' ' ' LEU . 52.5 Cg_exo -56.02 143.33 83.54 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.589 2.193 . . . . 0.0 110.681 162.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.637 ' H ' HD22 ' A' ' 149' ' ' LEU . 41.4 m -50.14 -24.75 2.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.533 1.133 . . . . 0.0 113.288 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.3 m -56.39 -57.61 11.54 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.414 0.685 . . . . 0.0 110.336 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 89.2 mt -79.71 -32.8 41.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.69 0.796 . . . . 0.0 110.032 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HD3' ' HG3' ' A' ' 151' ' ' PRO . 8.4 tmm_? -74.02 -58.84 3.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.003 1.321 . . . . 0.0 109.959 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -68.55 -10.3 54.87 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.256 0.622 . . . . 0.0 112.373 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -88.5 -33.67 17.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 117' ' ' VAL . 66.3 tp -67.86 -47.74 68.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.708 0.803 . . . . 0.0 111.514 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.49 -39.14 45.86 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.2 -32.08 92.46 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.919 165.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -81.24 -17.89 47.92 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.528 0.731 . . . . 0.0 111.249 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' A' ' 90' ' ' ILE . 9.5 t -83.96 -43.07 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 172.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.03 -48.9 78.22 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.27 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -79.08 -43.68 23.66 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.05 -20.4 16.3 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 116.711 1.444 . . . . 0.0 116.711 -164.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.48 HD11 HD13 ' A' ' 98' ' ' ILE . 16.7 tp -62.26 128.94 38.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.188 0.994 . . . . 0.0 110.025 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 16.7 tttp -70.65 142.39 88.64 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.94 109.05 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.347 1.365 . . . . 0.0 109.494 160.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.08 10.1 6.41 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.559 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.453 ' HA3' HD12 ' A' ' 121' ' ' LEU . . . -97.8 143.02 16.45 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 170.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.0 m -108.55 129.6 62.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 123.973 0.909 . . . . 0.0 109.466 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -112.5 112.19 23.55 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.543 HD13 HD12 ' A' ' 101' ' ' ILE . 95.8 mt -110.25 113.97 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 109.304 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.631 ' HB2' HD12 ' A' ' 190' ' ' LEU . 96.2 mt -124.34 114.91 20.16 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.34 107.96 4.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.29 1.036 . . . . 0.0 108.952 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.0 86.06 0.09 OUTLIER Glycine 0 N--CA 1.479 1.512 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.172 169.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.477 ' O ' HD22 ' A' ' 187' ' ' LEU . 95.3 m-85 -143.29 150.36 39.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.186 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 107' ' ' SER . 13.6 mt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 132' ' ' PHE . 41.1 mt -104.93 98.1 14.6 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.223 0.609 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.572 ' HG2' HD23 ' A' ' 156' ' ' LEU . 90.1 Cg_endo -84.0 126.58 3.89 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.871 165.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -72.82 173.13 9.59 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.749 0.819 . . . . 0.0 111.708 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.53 HD23 HD23 ' A' ' 190' ' ' LEU . 20.1 mt -55.95 -38.53 70.47 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.106 0.562 . . . . 0.0 112.212 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.02 -37.31 74.07 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.705 0.628 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.2 m -73.39 -51.95 15.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.219 0.608 . . . . 0.0 109.914 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.572 HD23 ' HG2' ' A' ' 151' ' ' PRO . 82.7 mt -65.7 -55.65 16.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.576 1.151 . . . . 0.0 112.008 -170.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.591 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.3 tt0 -59.03 -34.81 72.33 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 175.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.9 t -81.06 -13.25 58.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.144 0.429 . . . . 0.0 111.889 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -7.67 29.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.945 0.498 . . . . 0.0 110.315 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 89.2 mt -139.46 59.95 15.52 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.946 1.298 . . . . 0.0 108.079 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.55 -22.58 32.84 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.726 2.284 . . . . 0.0 113.745 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 p -81.83 -40.08 23.02 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.6 tp -70.8 68.5 0.42 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.814 1.246 . . . . 0.0 111.602 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -65.13 140.35 58.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.591 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 22.0 m95 -100.88 135.29 42.56 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.742 0.817 . . . . 0.0 109.349 -167.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.9 mt -72.03 -30.81 65.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.64 0.776 . . . . 0.0 110.44 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.9 mt -130.46 125.45 59.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.39 79.97 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -131.15 142.45 50.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.806 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -88.59 132.44 34.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.878 0.871 . . . . 0.0 109.955 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 34.2 mt -110.05 114.24 27.6 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 27.8 mt -104.27 158.04 16.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.479 ' HB ' HD21 ' A' ' 153' ' ' LEU . 3.7 pt -146.36 124.68 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.944 0.793 . . . . 0.0 110.473 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -93.27 145.56 24.35 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.986 0.914 . . . . 0.0 110.091 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 129' ' ' LEU . 54.9 mt -134.0 143.91 48.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 110.391 172.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.2 tp -142.96 108.29 5.02 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -92.98 146.43 18.1 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.403 HE21 HG11 ' A' ' 126' ' ' VAL . 5.9 tp-100 -147.25 155.83 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.15 0.98 . . . . 0.0 109.683 174.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -61.64 121.45 12.83 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.491 0.186 . . . . 0.0 111.32 -171.116 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 . . . . . 0 CA--C 1.553 1.067 0 CA-C-O 120.782 0.325 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tp -68.59 -43.53 76.3 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.736 0.814 . . . . 0.0 111.505 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.5 m -45.74 -35.32 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -74.36 -46.65 39.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.979 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 21' ' ' LEU . 2.2 m -64.64 -37.14 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.082 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.36 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.313 1.045 . . . . 0.0 111.881 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -58.02 -38.97 77.18 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -82.4 -22.76 35.25 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 24' ' ' VAL . 54.6 mt -75.59 129.31 82.08 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 118.238 0.472 . . . . 0.0 109.949 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.07 130.65 28.48 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.755 2.97 . . . . 0.0 112.296 166.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -77.62 27.71 0.17 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.306 1.443 . . . . 0.0 114.28 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.85 -133.5 5.3 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.498 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -78.0 113.51 15.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 28' ' ' ILE . 34.7 mt -114.24 130.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.456 HD21 ' CD1' ' A' ' 95' ' ' TRP . 52.7 tp -100.09 114.27 27.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 53.6 t -101.48 109.73 21.61 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.29 0.636 . . . . 0.0 109.548 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.23 103.45 3.36 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 167.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.419 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.744 -172.408 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -48.79 -45.03 39.59 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.868 1.667 . . . . 0.0 111.217 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.508 HD21 HD13 ' A' ' 101' ' ' ILE . 2.7 m-20 -64.75 -41.76 95.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.007 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.98 98.66 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.199 0.6 . . . . 0.0 110.92 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.424 ' HA ' HD13 ' A' ' 78' ' ' ILE . 61.9 m -60.46 -39.27 86.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.965 0.906 . . . . 0.0 112.696 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.7 t80 -64.92 -46.64 80.81 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.826 0.703 . . . . 0.0 110.199 177.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 99' ' ' VAL . 70.1 mt -67.62 -33.18 74.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.872 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.21 70.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.145 0.578 . . . . 0.0 111.804 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.762 ' HA ' HG12 ' A' ' 76' ' ' VAL . 93.2 p -72.06 -4.8 30.92 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 81.7 mt -83.84 11.14 8.05 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.265 168.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.09 19.15 78.9 Favored Glycine 0 C--N 1.366 2.218 0 CA-C-N 117.64 0.2 . . . . 0.0 113.174 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -106.44 133.1 51.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 109.257 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.79 90.71 2.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.574 0.702 . . . . 0.0 109.263 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -92.91 108.59 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.814 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.8 p -87.14 111.84 21.34 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.513 1.125 . . . . 0.0 108.607 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.72 126.98 53.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.268 0.627 . . . . 0.0 110.873 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 81' ' ' VAL . 10.9 t -101.69 114.72 41.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 8.5 t70 -116.17 116.21 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.92 -10.67 2.62 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.678 0.791 . . . . 0.0 112.566 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -115.79 124.15 50.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.374 1.07 . . . . 0.0 108.595 169.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 m -72.06 -16.57 62.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.232 0.613 . . . . 0.0 111.568 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 31.5 m -62.97 -35.84 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.198 0.599 . . . . 0.0 111.508 170.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 -35.25 56.45 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 99.2 mt -63.28 -42.65 99.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.085 0.954 . . . . 0.0 111.011 174.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.4 81.13 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.864 0.728 . . . . 0.0 111.756 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 30.3 mmmt -68.08 -45.03 74.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.04 0.536 . . . . 0.0 111.464 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.5 81.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.973 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -69.45 -42.3 75.12 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.144 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.45 -43.44 77.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.256 0.222 . . . . 0.0 110.939 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.38 -28.12 69.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.559 0.744 . . . . 0.0 110.609 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.08 -53.78 33.91 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.164 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.4 -35.28 75.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.817 0.847 . . . . 0.0 110.618 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -37.93 89.29 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.009 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -86.5 -0.32 55.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.94 0.896 . . . . 0.0 110.842 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.82 33.37 33.93 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-N 116.376 -0.375 . . . . 0.0 112.394 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 49' ' ' SER . 32.6 m -142.2 -177.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.887 1.275 . . . . 0.0 109.892 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.16 145.69 36.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.914 0.486 . . . . 0.0 111.587 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 45' ' ' CYS . 10.8 mm -101.71 167.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' THR . 46.1 m -123.21 104.3 9.07 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -91.85 125.98 36.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.107 0.479 . . . . 0.0 111.253 -165.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 57' ' ' VAL . 84.8 t -101.06 124.01 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 109.401 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -97.85 89.3 4.54 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -145.25 -176.01 4.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.188 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -142.97 122.63 13.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -158.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.75 -8.03 39.3 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.773 0.671 . . . . 0.0 111.894 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.96 60.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.436 1.094 . . . . 0.0 112.459 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -130.45 -24.67 2.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.148 0.579 . . . . 0.0 112.084 -166.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -162.76 127.02 3.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.695 1.198 . . . . 0.0 108.168 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.41 ' O ' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -141.34 -65.89 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.1 pt -140.42 127.88 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.361 0.664 . . . . 0.0 110.994 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.55 148.96 17.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 124.546 1.138 . . . . 0.0 109.639 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -90.25 -35.71 15.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.149 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.31 -44.33 30.0 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.645 -171.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.03 44.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.456 ' CD1' HD21 ' A' ' 34' ' ' LEU . 11.6 m95 -123.26 134.13 54.12 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -169.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.39 -55.79 6.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.396 0.678 . . . . 0.0 109.971 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.63 164.44 12.19 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.109 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 121' ' ' LEU . 84.7 mt -134.45 145.44 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.499 HG12 HD13 ' A' ' 47' ' ' LEU . 10.1 p -128.09 128.8 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 166.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -113.4 91.34 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 128' ' ' ILE . 49.9 mm -68.56 136.13 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.104 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -14.03 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.413 2.321 . . . . 0.0 112.888 -171.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 29.1 t -95.18 106.13 18.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 112.324 -2.216 . . . . 0.0 109.93 -169.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.45 99.73 9.8 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 75.7 mt -118.11 145.91 38.04 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.682 0.793 . . . . 0.0 110.585 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.63 158.15 58.12 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.693 2.262 . . . . 0.0 110.144 168.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 33.4 t -45.02 -30.58 1.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.822 1.649 . . . . 0.0 113.246 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 p -57.07 -58.27 8.9 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.2 1.0 . . . . 0.0 110.86 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 80.9 mt -83.29 -22.46 32.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.74 0.816 . . . . 0.0 110.236 -175.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.439 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 29.1 ttt180 -69.02 -65.13 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.129 1.372 . . . . 0.0 109.717 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -55.41 -29.64 58.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.113 0.565 . . . . 0.0 111.642 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.54 -42.35 64.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.864 0.466 . . . . 0.0 110.699 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 117' ' ' VAL . 51.2 tp -67.99 -44.99 75.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.47 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -61.2 -41.67 81.7 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -167.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.81 -28.03 75.65 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 122.016 1.811 . . . . 0.0 112.292 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -84.87 -14.88 46.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 0.0 110.971 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.657 ' HB ' HD23 ' A' ' 160' ' ' LEU . 4.7 t -86.51 -42.82 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.1 -56.17 24.12 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.511 0.324 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.5 -39.85 19.96 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.3 -25.7 25.52 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -166.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -66.24 117.65 8.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.803 0.802 . . . . 0.0 109.188 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 62.0 tttm -69.67 133.93 88.5 Favored Pre-proline 0 C--O 1.246 0.883 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.54 112.3 0.66 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.629 2.219 . . . . 0.0 111.143 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 125.08 13.21 3.67 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.864 -173.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -100.48 139.85 14.62 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 168.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 32.7 m -109.08 138.88 34.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.762 0.825 . . . . 0.0 109.932 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.53 113.37 25.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.584 HD13 HD12 ' A' ' 101' ' ' ILE . 24.3 mt -107.88 108.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 79.7 mt -130.87 152.04 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.815 0.846 . . . . 0.0 111.315 -174.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 43.9 tt0 -140.61 104.05 4.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.51 167.16 54.79 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -131.08 167.62 18.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.494 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.41 1.484 . . . . 0.0 113.123 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.8 mt -97.88 100.92 9.43 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.86 120.76 4.34 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.573 1.515 . . . . 0.0 110.245 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -87.89 171.58 10.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.684 0.794 . . . . 0.0 111.775 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 190' ' ' LEU . 32.2 mt -59.23 -40.97 87.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -48.54 -50.9 30.11 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.74 1.216 . . . . 0.0 110.857 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 26.6 m -65.88 -62.36 1.54 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.701 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.57 -46.56 53.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 112.707 -162.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.1 tt0 -53.4 -46.11 69.59 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 123.44 0.462 . . . . 0.0 111.025 171.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.3 t -70.77 -32.42 69.54 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.525 0.33 . . . . 0.0 111.841 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -85.7 -5.61 59.24 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.131 0.572 . . . . 0.0 111.951 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.657 HD23 ' HB ' ' A' ' 117' ' ' VAL . 82.7 mt -140.51 74.68 28.04 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 -45.72 24.03 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.859 3.039 . . . . 0.0 113.156 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 m -84.85 -29.82 24.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.778 0.431 . . . . 0.0 110.499 -171.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.1 tp -70.21 68.54 0.34 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.054 0.942 . . . . 0.0 111.455 170.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -62.63 133.38 54.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.524 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 32.2 m95 -95.77 129.65 42.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.811 0.844 . . . . 0.0 109.401 -167.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.43 -33.73 76.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.67 0.788 . . . . 0.0 110.378 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 80.6 mt -132.7 121.93 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.23 84.57 1.13 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -150.42 148.66 29.03 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.08 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -86.35 116.48 24.54 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.089 0.956 . . . . 0.0 108.691 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.5 mt -110.68 125.06 53.06 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.351 1.06 . . . . 0.0 108.362 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 122.85 0.46 . . . . 0.0 110.004 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.516 ' H ' ' HB3' ' A' ' 133' ' ' ALA . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.64 149.53 32.71 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 22.1 pt -134.17 118.7 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.354 0.525 . . . . 0.0 110.062 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.68 138.6 31.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.834 0.349 . . . . 0.0 110.323 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.462 HD22 HD21 ' A' ' 153' ' ' LEU . 49.5 mt -129.51 128.38 42.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.532 1.133 . . . . 0.0 109.41 173.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.404 HD22 HG13 ' A' ' 24' ' ' VAL . 23.7 tp -125.13 106.23 9.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.11 139.97 16.56 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 171.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -144.68 152.64 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 19.5 pttm -57.64 155.19 10.23 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 123.75 0.656 . . . . 0.0 110.089 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.818 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -52.98 -72.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.534 1.133 . . . . 0.0 112.385 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -174.02 141.55 0.79 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.672 0.789 . . . . 0.0 109.092 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -118.99 125.12 48.65 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -77.11 132.62 38.95 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.472 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -74.93 102.95 4.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.9 p -73.7 75.06 1.55 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.623 0.769 . . . . 0.0 111.167 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -80.87 -26.46 36.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 0.0 110.52 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -75.25 92.48 2.74 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.402 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.8 160.67 27.27 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.09 92.31 1.61 Allowed 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.53 127.06 31.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -75.44 117.89 17.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.372 0.669 . . . . 0.0 111.375 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.59 85.5 0.27 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 124.103 0.877 . . . . 0.0 111.682 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -133.33 139.41 46.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.361 1.064 . . . . 0.0 109.06 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.77 121.39 77.39 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.892 -0.575 . . . . 0.0 109.452 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.06 121.96 10.29 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.026 2.484 . . . . 0.0 112.452 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -121.52 148.0 45.06 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.35 1.06 . . . . 0.0 109.209 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.42 -79.52 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.473 0.709 . . . . 0.0 110.901 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.51 -48.37 27.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.467 0.707 . . . . 0.0 112.141 -172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.9 -15.03 58.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -165.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.36 -24.6 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.726 0.694 . . . . 0.0 110.28 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 89.7 p -70.0 -47.5 61.91 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.4 m -64.13 -41.29 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.365 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.43 74.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.173 0.989 . . . . 0.0 111.978 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -27.66 67.87 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.52 0.728 . . . . 0.0 109.338 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 23' ' ' SER . 75.5 mm-40 -82.88 -33.07 27.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.678 0.791 . . . . 0.0 110.971 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -73.06 131.09 83.96 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.34 84.11 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.768 2.312 . . . . 0.0 111.877 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.05 29.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.05 -134.24 5.42 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.396 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -89.63 110.48 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -172.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 HG12 ' A' ' 99' ' ' VAL . 36.6 mt -113.58 117.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.689 0.796 . . . . 0.0 110.63 -166.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.541 HD23 ' CD1' ' A' ' 95' ' ' TRP . 48.3 tp -92.01 113.25 25.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.907 0.483 . . . . 0.0 111.033 -173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 56.8 m -92.64 137.74 32.1 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 90' ' ' ILE . 40.8 mt -89.41 161.84 16.08 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 170.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.34 124.32 5.62 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.831 1.332 . . . . 0.0 112.842 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.27 142.77 18.5 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.54 -27.2 60.77 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.578 0.549 . . . . 0.0 113.494 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -120.04 89.82 3.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 110.066 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.24 20.57 16.24 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.9 168.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -65.37 -31.62 72.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.464 1.106 . . . . 0.0 110.196 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.3 m-20 -62.51 -30.9 71.62 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.423 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.82 79.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.159 0.583 . . . . 0.0 110.871 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.49 -29.97 69.54 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.668 0.787 . . . . 0.0 112.098 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.22 -48.42 81.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.825 0.85 . . . . 0.0 109.5 172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 50' ' ' LEU . 78.6 mt -66.78 -31.45 72.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.896 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -38.2 77.0 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.275 0.63 . . . . 0.0 111.979 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.664 ' HA ' HG13 ' A' ' 76' ' ' VAL . 38.5 p -70.4 -9.47 56.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 47' ' ' LEU . 72.3 mt -81.27 6.92 12.71 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.481 . . . . 0.0 111.17 171.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 7.58 85.68 Favored Glycine 0 C--N 1.36 1.879 0 CA-C-N 117.681 0.218 . . . . 0.0 113.072 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -92.04 143.42 26.48 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.477 0.711 . . . . 0.0 109.325 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 44.1 mt-10 -84.59 96.81 9.29 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.4 t -96.87 128.29 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.004 0.522 . . . . 0.0 110.474 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.9 t -114.15 111.1 21.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.316 1.446 . . . . 0.0 108.714 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.98 136.1 43.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.018 0.527 . . . . 0.0 111.08 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.03 144.25 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -152.29 139.09 18.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 159.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.76 -13.11 62.18 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.681 0.613 . . . . 0.0 111.046 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -117.82 143.0 46.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.193 1.397 . . . . 0.0 109.741 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -73.89 -22.65 59.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.56 0.744 . . . . 0.0 111.219 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.33 -38.58 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.045 0.538 . . . . 0.0 111.814 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -40.05 40.04 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.369 0.418 . . . . 0.0 112.08 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' HG23 ' A' ' 80' ' ' THR . 91.5 mt -65.6 -52.16 54.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.016 0.926 . . . . 0.0 111.947 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.86 75.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.926 0.89 . . . . 0.0 112.371 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -71.02 -42.03 70.09 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.34 0.656 . . . . 0.0 110.888 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.01 92.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.263 0.625 . . . . 0.0 110.548 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -75.02 -32.14 61.54 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 110.63 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -63.04 -51.1 68.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.57 0.748 . . . . 0.0 110.923 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 tp -65.25 -27.32 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.04 0.837 . . . . 0.0 110.56 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -60.15 -59.63 5.1 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 122.92 0.488 . . . . 0.0 110.597 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.19 -36.44 81.91 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.919 0.888 . . . . 0.0 110.693 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.54 -25.52 63.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.895 0.878 . . . . 0.0 111.666 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -100.33 -3.45 31.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.873 0.869 . . . . 0.0 111.073 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.33 28.27 56.06 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.014 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.664 HG13 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -132.58 165.53 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.057 0.943 . . . . 0.0 110.749 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -112.22 135.46 52.86 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.607 0.763 . . . . 0.0 111.247 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 71' ' ' ALA . 15.0 mm -110.78 161.33 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 165.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -114.97 112.74 23.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 166.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 64' ' ' LEU . 85.5 m -84.15 110.73 18.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.973 0.909 . . . . 0.0 110.402 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.58 127.17 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 0.0 108.508 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -110.02 95.4 5.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -139.67 -175.15 4.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.657 1.183 . . . . 0.0 109.515 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -143.21 131.15 21.62 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -159.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.756 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 22.0 mt -73.28 -3.53 27.54 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.15 3.34 41.04 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.101 0.96 . . . . 0.0 112.845 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.4 -43.04 0.16 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.006 0.821 . . . . 0.0 112.34 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.54 112.63 4.29 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.756 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.45 -72.32 0.41 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -166.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.603 HG23 HD21 ' A' ' 36' ' ' LEU . 4.6 pt -137.72 111.0 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.534 1.134 . . . . 0.0 109.745 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.84 88.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.2 -1.15 4.04 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.67 -48.18 14.12 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.457 0.703 . . . . 0.0 109.632 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.65 -35.97 60.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.562 0.745 . . . . 0.0 111.844 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.541 ' CD1' HD23 ' A' ' 34' ' ' LEU . 57.6 m95 -104.16 174.74 5.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.984 0.914 . . . . 0.0 108.978 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -109.22 -45.78 3.68 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.878 0.37 . . . . 0.0 110.691 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.62 162.76 24.13 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.557 ' HB ' ' HA3' ' A' ' 125' ' ' GLY . 90.5 mt -137.2 145.35 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.593 0.757 . . . . 0.0 110.038 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 33' ' ' ILE . 9.0 p -132.94 124.45 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.343 1.057 . . . . 0.0 108.21 165.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 m -120.13 94.98 4.57 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.05 134.17 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.53 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 1.5 p90 -18.78 111.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 126.739 2.016 . . . . 0.0 115.563 -168.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 25.8 p -66.94 106.65 1.98 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.267 -1.788 . . . . 0.0 111.588 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -96.18 97.6 9.66 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 85' ' ' LEU . 91.6 mt -139.54 138.97 21.09 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.37 0.668 . . . . 0.0 110.431 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.0 160.63 43.43 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.34 2.694 . . . . 0.0 110.874 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 t -46.44 -33.25 3.82 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.791 1.236 . . . . 0.0 113.47 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 36.4 m -55.52 -64.2 0.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.678 0.791 . . . . 0.0 111.623 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.14 -22.36 45.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.835 0.454 . . . . 0.0 110.527 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -69.66 -53.92 16.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.659 1.184 . . . . 0.0 110.1 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.07 -11.28 58.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 112.879 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 108' ' ' SER . 15.6 mm100 -81.92 -38.71 24.85 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 117' ' ' VAL . 52.6 tp -76.54 -43.82 37.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -58.8 -44.57 99.12 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 119.457 1.026 . . . . 0.0 112.805 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.69 -28.42 86.35 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.37 2.046 . . . . 0.0 113.745 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.78 -28.01 60.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.204 0.602 . . . . 0.0 111.635 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.1 t -85.37 -27.38 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.848 0.832 . . . . 0.0 109.71 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -73.48 -63.86 1.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.388 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -76.7 -49.37 16.25 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.19 -39.15 32.58 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 114.069 0.387 . . . . 0.0 114.069 -169.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 30.1 tp -78.53 103.25 8.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.66 148.35 51.49 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 165.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.567 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 60.9 Cg_exo -43.24 127.24 5.3 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.152 3.235 . . . . 0.0 115.003 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 128.64 10.04 3.37 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.776 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.557 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -119.18 152.72 17.15 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 164.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.81 136.44 44.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 123.603 0.761 . . . . 0.0 109.861 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.0 113.04 26.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -103.83 107.99 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.4 mt -121.86 121.51 37.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.741 0.816 . . . . 0.0 110.362 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.53 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 36.5 tt0 -115.68 98.98 7.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 168.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.01 174.86 46.17 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.699 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.453 ' HB2' HD22 ' A' ' 150' ' ' LEU . 50.7 m-85 -127.87 160.84 30.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.46 157.58 67.39 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.22 0.608 . . . . 0.0 109.695 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.19 -11.18 28.82 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.405 2.07 . . . . 0.0 112.914 174.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.57 -8.52 58.24 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.819 0.847 . . . . 0.0 112.1 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -74.96 -56.57 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.471 HD21 HD23 ' A' ' 150' ' ' LEU . 12.6 mt -65.36 -23.8 67.08 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.21 -23.59 62.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.66 0.784 . . . . 0.0 111.44 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -61.54 -19.07 61.72 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.15 22.14 8.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.514 1.126 . . . . 0.0 110.133 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.66 HG23 HD11 ' A' ' 175' ' ' LEU . 20.6 p -80.71 -29.45 36.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.252 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.19 177.24 40.3 Favored Glycine 0 C--O 1.243 0.66 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.982 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 176.95 144.66 5.37 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.265 -0.741 . . . . 0.0 111.732 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.22 -42.76 5.32 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.614 2.209 . . . . 0.0 112.207 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 145' ' ' LYS . 4.0 ttmp? -165.19 -46.76 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.765 0.826 . . . . 0.0 109.608 175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.09 152.17 10.78 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.423 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.504 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -59.25 -8.38 1.62 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.893 1.277 . . . . 0.0 113.467 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.18 -43.53 82.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 0.0 110.64 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.1 mt -77.7 10.95 2.33 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.17 0.988 . . . . 0.0 112.904 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.504 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 44.0 mt -89.37 111.07 43.31 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.623 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.5 Cg_endo -79.98 108.71 2.27 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 122.017 1.812 . . . . 0.0 110.211 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HA ' HD12 ' A' ' 188' ' ' ILE . 53.6 tttm -105.3 155.32 19.2 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.812 -0.555 . . . . 0.0 110.796 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.402 HD23 HD22 ' A' ' 190' ' ' LEU . 31.8 mt -50.51 -38.06 42.37 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.238 1.015 . . . . 0.0 111.937 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.51 -53.88 20.96 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 125.045 1.466 . . . . 0.0 109.776 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 35.3 m -71.94 -57.62 4.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.74 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 151' ' ' PRO . 73.1 mt -62.21 -54.32 42.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.398 1.079 . . . . 0.0 112.309 -165.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.56 -35.67 81.73 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.645 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 t -61.36 -37.2 82.51 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.718 0.407 . . . . 0.0 111.829 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 155' ' ' THR . 23.4 mm-40 -83.72 -8.02 59.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.672 0.389 . . . . 0.0 111.31 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.5 mt -138.9 71.78 41.66 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.545 0.738 . . . . 0.0 110.125 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.29 -5.55 13.56 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.402 2.735 . . . . 0.0 111.761 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.5 p -89.71 -41.39 11.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.592 1.157 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 15.2 tp -90.62 71.67 6.8 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.623 1.569 . . . . 0.0 110.043 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -63.84 135.07 56.29 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.401 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 33.1 m95 -94.24 128.89 40.97 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.644 1.178 . . . . 0.0 109.999 -166.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.96 -34.25 77.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.543 0.737 . . . . 0.0 110.205 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 70.7 mt -126.14 125.9 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.17 76.87 1.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.052 0.941 . . . . 0.0 109.426 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.96 154.87 35.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.64 117.48 22.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.354 0.662 . . . . 0.0 109.743 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -111.94 130.31 55.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.203 0.601 . . . . 0.0 110.158 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -91.75 136.19 33.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.812 0.845 . . . . 0.0 110.541 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -132.7 131.94 41.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 108.923 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -79.85 130.62 35.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.009 0.524 . . . . 0.0 110.475 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.66 HD11 HG23 ' A' ' 141' ' ' THR . 65.3 mt -82.31 153.32 25.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.598 0.759 . . . . 0.0 109.581 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -69.36 93.79 0.67 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.157 0.583 . . . . 0.0 110.881 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.57 173.89 10.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.667 0.787 . . . . 0.0 110.7 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.57 33.48 0.36 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -114.45 -54.15 2.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.935 0.894 . . . . 0.0 110.454 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -79.26 -17.67 54.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.939 0.896 . . . . 0.0 111.887 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 58.22 8.95 0.88 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.851 1.661 . . . . 0.0 113.053 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -142.77 18.65 1.99 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.433 1.093 . . . . 0.0 109.207 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.0 67.09 3.66 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.24 177.44 4.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.124 1.37 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.578 ' HB1' HD22 ' A' ' 175' ' ' LEU . . . -134.02 132.5 40.16 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -93.77 108.88 20.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.5 mt -122.21 165.87 15.49 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 152' ' ' LYS . 15.4 pt -138.58 141.3 37.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.73 143.81 51.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.206 0.527 . . . . 0.0 110.736 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 54.1 mt -135.08 129.0 33.29 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.597 1.559 . . . . 0.0 108.768 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 30.2 tp -122.14 106.04 10.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.08 140.64 17.86 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 170.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.94 0.896 . . . . 0.0 110.48 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 80.4 tttt -55.9 123.52 14.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 123.742 0.651 . . . . 0.0 109.411 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 197' ' ' HIS . 19.4 mt -75.61 103.84 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.098 0.249 . . . . 0.0 110.347 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.59 -31.29 72.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.447 0.641 . . . . 0.0 109.966 165.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 195' ' ' LEU . 21.6 p80 -85.95 123.08 30.88 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.946 169.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -73.29 162.03 29.82 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -60.82 114.88 3.28 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -78.87 109.96 13.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.401 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -159.75 -179.05 7.51 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.916 0.886 . . . . 0.0 110.445 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.2 p80 . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.42 0.629 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -141.02 24.56 2.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.066 0.936 . . . . 0.0 108.894 172.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -92.03 -2.92 56.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.782 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -77.84 -49.09 14.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 0.0 109.584 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -143.56 93.13 2.44 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.77 0.828 . . . . 0.0 109.658 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -144.62 19.11 1.68 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.003 0.921 . . . . 0.0 109.238 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -75.97 -4.0 38.68 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.465 1.106 . . . . 0.0 112.834 -170.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.45 113.01 7.16 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.632 0.773 . . . . 0.0 110.84 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -90.64 -21.78 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.669 0.787 . . . . 0.0 111.31 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.68 -52.55 5.08 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.38 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -74.42 82.67 1.94 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.738 0.78 . . . . 0.0 110.453 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -165.61 -41.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.814 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 73.37 -46.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 126.026 1.73 . . . . 0.0 113.592 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.41 -32.65 57.9 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-O 121.171 0.317 . . . . 0.0 112.605 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.2 p -120.33 79.29 1.45 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 163.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.55 156.08 55.63 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.596 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -38.9 -41.6 1.79 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 124.571 3.514 . . . . 0.0 115.309 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.32 118.28 24.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.745 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -103.38 141.86 35.22 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.27 -21.36 62.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.963 0.505 . . . . 0.0 110.902 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 47' ' ' LEU . 33.7 tp -58.81 -35.7 73.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.389 0.676 . . . . 0.0 111.809 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.37 -40.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.2 p -79.75 -51.45 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.258 0.551 . . . . 0.0 111.108 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG13 HD23 ' A' ' 191' ' ' LEU . 26.5 m -63.41 -34.24 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.373 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.72 76.87 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.324 1.05 . . . . 0.0 111.987 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.06 -31.84 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.107 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 79.1 mt -69.79 128.21 92.05 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-O 119.003 -0.523 . . . . 0.0 109.735 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.35 115.04 1.54 Allowed 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.859 2.372 . . . . 0.0 111.369 164.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.47 32.67 0.13 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.809 1.644 . . . . 0.0 114.306 -166.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.94 -129.59 5.56 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-O 118.776 -1.014 . . . . 0.0 110.922 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -69.29 111.23 5.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.458 1.129 . . . . 0.0 109.897 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.03 119.5 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 89' ' ' ASP . 56.4 tp -98.24 121.06 39.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.901 0.481 . . . . 0.0 110.598 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -104.73 134.0 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.999 1.32 . . . . 0.0 109.422 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 66.1 mt -95.78 152.58 18.35 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.629 0.372 . . . . 0.0 110.9 171.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.803 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -78.04 -165.92 0.73 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.279 0.632 . . . . 0.0 111.711 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 64.22 22.62 12.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.34 1.056 . . . . 0.0 110.992 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.53 -31.2 0.1 Allowed Glycine 0 C--N 1.343 0.948 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.334 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 43' ' ' ASN . 67.7 tt0 -129.56 141.39 50.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.298 0.639 . . . . 0.0 111.465 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.07 -51.69 0.03 OUTLIER Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -65.31 -44.69 87.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 110.334 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 19.6 m120 -65.73 -31.3 72.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.209 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.66 -58.35 8.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.651 0.78 . . . . 0.0 111.659 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.2 p -65.93 -27.34 68.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.961 0.504 . . . . 0.0 112.086 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 51.0 t80 -68.5 -36.9 79.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.889 0.476 . . . . 0.0 110.098 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' HG ' HD23 ' A' ' 21' ' ' LEU . 55.6 mt -68.56 -32.29 72.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.327 0.651 . . . . 0.0 111.054 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.32 -33.87 61.2 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.47 0.308 . . . . 0.0 110.321 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -63.19 -19.2 64.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.149 0.98 . . . . 0.0 111.36 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 84.1 mt -82.07 14.23 2.95 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.89 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 33.7 58.31 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 123.295 0.474 . . . . 0.0 114.163 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -125.44 156.12 39.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.718 0.759 . . . . 0.0 110.628 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.53 97.51 7.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.481 0.712 . . . . 0.0 109.75 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -105.96 119.11 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.116 0.484 . . . . 0.0 111.501 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -84.97 112.3 20.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.32 120.48 40.32 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 81' ' ' VAL . 82.2 t -98.66 121.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.803 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 19.6 t70 -139.47 129.33 24.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -54.74 -26.92 37.22 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.782 1.233 . . . . 0.0 112.987 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.471 ' HB2' HG23 ' A' ' 62' ' ' VAL . 47.6 m -113.25 160.68 18.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.779 0.831 . . . . 0.0 111.386 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -69.81 -21.39 63.4 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.526 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 60' ' ' SER . 6.5 m -62.11 -43.8 98.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.183 0 C-N-CA 122.895 0.478 . . . . 0.0 111.992 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.28 -34.88 19.24 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.599 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 71.3 mt -67.66 -58.31 4.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.594 0.758 . . . . 0.0 111.773 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.46 70.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.321 0.649 . . . . 0.0 112.287 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.41 -42.3 71.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.883 0.473 . . . . 0.0 110.529 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.44 95.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.682 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -68.97 -34.97 76.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.559 1.144 . . . . 0.0 111.296 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -54.89 -48.51 72.91 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.087 0.955 . . . . 0.0 110.648 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.86 -29.25 64.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.057 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -58.54 -62.58 1.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.63 0.581 . . . . 0.0 111.069 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.21 -40.12 89.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.239 0.616 . . . . 0.0 111.665 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.95 -40.32 95.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.727 0.811 . . . . 0.0 111.55 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -103.92 -5.46 22.25 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.889 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 43.78 36.23 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.875 0.153 . . . . 0.0 113.206 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.76 172.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.316 1.047 . . . . 0.0 109.499 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.05 132.42 54.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.98 0.512 . . . . 0.0 111.497 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.439 HG12 ' HB1' ' A' ' 71' ' ' ALA . 23.2 mm -114.42 155.76 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 166.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -121.46 108.21 13.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 165.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.7 t -86.62 113.49 22.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.209 0.603 . . . . 0.0 110.855 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.7 t -120.79 139.19 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.307 1.043 . . . . 0.0 109.132 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.05 147.87 27.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.473 ' HG ' ' HB1' ' A' ' 37' ' ' ALA . 58.0 m -67.19 112.68 4.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.419 0.288 . . . . 0.0 111.338 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -144.01 89.06 2.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 165.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.42 -38.55 18.55 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.023 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.64 67.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.845 0.858 . . . . 0.0 112.194 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.22 -34.17 20.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.381 0.672 . . . . 0.0 111.499 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -166.74 117.27 0.92 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.348 0.659 . . . . 0.0 109.831 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.458 ' O ' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -128.84 -64.59 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 98' ' ' ILE . 13.9 pt -139.79 119.24 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.546 0.738 . . . . 0.0 110.279 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.97 86.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 98' ' ' ILE . . . -69.25 2.19 3.11 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.03 -50.3 56.22 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.53 -22.17 47.7 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -107.45 170.85 7.72 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 0.0 109.867 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -98.98 -56.98 2.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.336 0.589 . . . . 0.0 109.793 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.74 158.4 20.02 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.819 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.615 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 59.7 mt -122.73 153.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 128' ' ' ILE . 7.4 p -140.57 136.1 35.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.937 1.295 . . . . 0.0 108.098 167.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 t -143.8 93.63 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 40' ' ' GLU . 26.2 mm -66.9 142.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 35.4 p90 -15.65 106.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.363 1.865 . . . . 0.0 115.417 -159.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.4 p -70.23 102.0 2.01 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.395 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -99.22 94.2 6.35 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.3 133.33 25.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.56 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -56.78 161.71 9.82 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.285 2.656 . . . . 0.0 112.36 169.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -40.94 -44.1 2.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.815 1.246 . . . . 0.0 112.85 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 m -54.12 -63.82 1.03 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.311 1.044 . . . . 0.0 112.179 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -75.55 -27.72 58.74 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.581 0.352 . . . . 0.0 111.066 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -65.27 -55.4 18.59 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.26 -35.35 26.61 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.608 1.163 . . . . 0.0 112.592 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.71 -17.07 39.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.962 0.505 . . . . 0.0 111.398 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 117' ' ' VAL . 58.6 tp -78.43 -38.42 41.4 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.904 0.482 . . . . 0.0 111.265 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -57.34 -41.13 89.3 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -29.99 84.69 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.967 1.778 . . . . 0.0 112.515 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -81.95 -26.86 33.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.541 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 113' ' ' LEU . 2.5 t -87.35 -24.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.257 0.551 . . . . 0.0 110.675 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -82.08 -65.45 1.01 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.85 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.55 -45.5 15.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.899 0.88 . . . . 0.0 112.853 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.83 -29.87 64.53 Favored Glycine 0 N--CA 1.479 1.523 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.909 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.73 146.16 50.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.205 0.602 . . . . 0.0 110.286 169.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -129.47 158.21 73.99 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 108.063 170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -40.18 110.87 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.392 2.728 . . . . 0.0 114.444 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.49 6.59 6.65 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.804 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.615 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -98.97 140.43 15.01 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 170.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 29.0 m -111.47 130.94 64.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.256 0.55 . . . . 0.0 110.3 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -110.03 107.4 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 24' ' ' VAL . 45.2 mt -110.4 107.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.8 mt -125.73 116.42 21.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -167.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.628 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 45.5 tt0 -105.62 97.64 7.45 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.89 -177.46 46.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.974 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.21 159.05 43.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.942 0.897 . . . . 0.0 108.863 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.78 163.3 22.74 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 123.555 0.742 . . . . 0.0 110.31 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.626 ' HA ' HD23 ' A' ' 147' ' ' LEU . 71.7 Cg_exo -53.9 -16.3 8.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.476 2.784 . . . . 0.0 115.393 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.68 -22.84 59.82 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.071 0.548 . . . . 0.0 111.995 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -66.4 -56.49 10.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -162.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.452 HD22 HD22 ' A' ' 150' ' ' LEU . 26.3 mt -65.86 -21.5 66.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 123.279 0.362 . . . . 0.0 111.383 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -65.17 -22.56 66.93 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.176 0.59 . . . . 0.0 112.056 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -68.17 -6.05 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 52.33 22.14 1.93 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.575 1.55 . . . . 0.0 113.169 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.7 m -95.54 0.64 53.27 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.301 1.04 . . . . 0.0 109.091 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.83 145.6 5.07 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.143 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.66 81.69 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.563 ' HB2' HD13 ' A' ' 149' ' ' LEU . 22.5 Cg_exo -63.08 -26.01 73.31 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.724 2.283 . . . . 0.0 112.856 -173.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -174.24 -49.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.517 1.127 . . . . 0.0 108.405 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -171.58 162.37 6.43 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.475 0.71 . . . . 0.0 109.703 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -63.93 2.56 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.89 -36.7 80.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 144' ' ' PRO . 30.3 mt -76.09 3.62 10.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.525 0.73 . . . . 0.0 111.894 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 22.0 mt -90.88 103.24 6.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.98 109.02 2.81 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.617 2.211 . . . . 0.0 110.625 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 188' ' ' ILE . 37.3 mtmm -108.0 162.71 13.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.275 0.63 . . . . 0.0 111.905 -168.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' A' ' 188' ' ' ILE . 24.1 mt -60.15 -36.25 77.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.635 0.774 . . . . 0.0 109.899 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -48.53 -56.93 7.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.719 1.208 . . . . 0.0 110.79 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 57.2 m -71.73 -62.61 1.36 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.739 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 129' ' ' LEU . 24.3 mt -61.74 -55.48 29.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.696 1.198 . . . . 0.0 112.209 -166.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -59.7 -42.05 92.15 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.646 0.779 . . . . 0.0 111.9 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.1 t -63.76 -34.01 76.94 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 155' ' ' THR . 8.5 pt-20 -111.33 18.69 19.0 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.132 0.492 . . . . 0.0 111.251 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -139.74 63.23 25.55 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.108 0.963 . . . . 0.0 108.708 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.43 -8.87 15.01 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.62 2.214 . . . . 0.0 111.919 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.2 t -86.42 -33.09 20.55 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.6 tp -95.13 68.17 3.1 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 108.492 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.39 128.56 36.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.402 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 25.4 m95 -88.23 141.02 28.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 110.014 -163.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.34 -36.67 77.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.966 0.506 . . . . 0.0 109.843 170.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.5 mt -127.22 125.53 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.58 85.52 1.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.34 1.056 . . . . 0.0 108.658 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.09 149.59 28.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.565 0.346 . . . . 0.0 111.193 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.57 113.98 20.65 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.535 0.522 . . . . 0.0 109.633 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.9 mt -109.66 128.94 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.409 ' HG3' ' HG3' ' A' ' 184' ' ' LYS . 41.6 tt0 -95.77 120.28 35.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -121.64 123.13 41.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.92 128.82 34.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.162 0.585 . . . . 0.0 111.134 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 185' ' ' ALA . 66.9 mt -76.72 169.45 18.28 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.949 0.899 . . . . 0.0 109.072 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -53.68 111.24 0.69 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.854 0.462 . . . . 0.0 109.981 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -116.67 150.68 37.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.131 0.572 . . . . 0.0 110.703 -173.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.57 36.68 0.14 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -142.09 -175.36 4.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.099 0.96 . . . . 0.0 110.626 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -90.29 1.49 56.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.552 0.741 . . . . 0.0 111.323 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -111.19 121.36 45.1 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.34 82.2 1.04 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.346 0.593 . . . . 0.0 110.639 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.86 94.49 0.36 Allowed Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.353 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.439 ' HA ' ' H ' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -111.05 -175.45 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.967 0.907 . . . . 0.0 109.869 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.465 ' HB2' HD22 ' A' ' 175' ' ' LEU . . . -126.02 130.25 50.79 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.29 109.35 20.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.46 154.01 30.07 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 153' ' ' LEU . 3.4 pt -136.14 116.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -97.86 138.1 35.72 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 34.5 mt -126.35 131.63 51.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.806 1.242 . . . . 0.0 108.1 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.523 HD23 HG13 ' A' ' 24' ' ' VAL . 40.1 tp -127.6 105.65 8.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 168.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.98 133.69 11.99 Favored Glycine 0 C--O 1.214 -1.133 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -144.05 156.87 44.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.809 0.844 . . . . 0.0 109.304 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.15 129.07 39.93 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.21 109.76 2.76 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.245 0.34 . . . . 0.0 110.581 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.95 160.83 14.04 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.652 0.381 . . . . 0.0 110.914 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 69.75 23.32 5.75 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.389 1.076 . . . . 0.0 109.477 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -138.75 88.31 2.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.183 0.993 . . . . 0.0 108.707 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -80.9 163.44 23.36 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.189 0.595 . . . . 0.0 110.555 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -76.54 132.28 39.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -148.48 114.34 5.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 108.996 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.015 0.926 . . . . 0.0 108.535 -176.198 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 mmt . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -150.88 116.62 5.49 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.041 0.936 . . . . 0.0 109.301 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.78 101.88 13.74 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.563 ' HG3' ' HD2' ' A' ' 6' ' ' PHE . 15.0 tp10 -68.85 84.76 0.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.826 0.85 . . . . 0.0 108.987 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 60.08 3.0 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.769 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HD2' ' HG3' ' A' ' 4' ' ' GLU . 51.6 p90 -69.4 -17.67 63.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.19 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.0 t -52.72 -33.72 49.15 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.0 1.32 . . . . 0.0 111.255 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -118.68 91.76 3.64 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.3 m -61.38 -40.71 95.36 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.227 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -152.4 139.1 18.81 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -90.26 15.68 9.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.727 0.811 . . . . 0.0 112.462 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.06 142.99 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.818 0.447 . . . . 0.0 109.834 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.74 69.51 1.48 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.411 0.624 . . . . 0.0 110.231 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.9 91.47 0.6 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 165.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.67 HG21 ' HG3' ' A' ' 16' ' ' GLU . 20.0 m -72.39 -77.85 0.09 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.449 0.699 . . . . 0.0 111.387 -166.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.67 ' HG3' HG21 ' A' ' 15' ' ' THR . 44.5 mt-10 -126.86 106.99 22.48 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 123.398 0.679 . . . . 0.0 111.049 -170.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 22' ' ' VAL . 20.2 Cg_exo -66.29 135.03 38.36 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.121 2.547 . . . . 0.0 111.403 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 21' ' ' LEU . 24.6 p-10 -130.88 -164.67 1.46 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.893 0.477 . . . . 0.0 109.838 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -43.25 -53.01 5.39 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.37 1.468 . . . . 0.0 114.381 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -172.44 -22.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.31 0.644 . . . . 0.0 110.494 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.609 ' HB3' HD22 ' A' ' 18' ' ' ASN . 33.2 tp -59.26 -31.88 69.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.538 0.735 . . . . 0.0 112.509 -174.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.539 HG13 ' HA ' ' A' ' 17' ' ' PRO . 5.7 m -54.79 -38.05 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -68.12 -53.08 27.87 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.955 0.883 . . . . 0.0 110.425 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 191' ' ' LEU . 29.7 m -66.97 -29.27 45.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.546 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.91 72.94 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.249 1.02 . . . . 0.0 112.31 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.05 -35.57 79.02 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.021 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -95.2 -7.63 38.55 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 24' ' ' VAL . 57.9 mt -72.06 138.35 82.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.669 ' HG3' ' HD3' ' A' ' 194' ' ' LYS . 33.7 Cg_exo -59.87 131.83 41.77 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.084 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -70.78 30.37 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.02 -148.93 9.27 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -80.39 118.06 21.69 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -107.63 141.95 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.709 0.804 . . . . 0.0 110.197 -167.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.471 HD22 ' CD1' ' A' ' 95' ' ' TRP . 33.0 tp -118.13 116.87 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.329 1.052 . . . . 0.0 109.127 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 26.5 p -107.21 111.93 24.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.277 0.489 . . . . 0.0 110.811 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 HG23 ' A' ' 90' ' ' ILE . 45.5 mt -70.05 143.06 52.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.46 161.9 41.81 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.935 0.772 . . . . 0.0 110.041 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -115.58 -18.01 11.02 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.59 -9.21 0.03 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.943 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -137.9 122.7 18.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.596 1.159 . . . . 0.0 108.874 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 67' ' ' ALA . . . -97.2 39.4 2.8 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.379 0.425 . . . . 0.0 112.948 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 ttp-105 -70.75 -41.14 72.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.764 0.826 . . . . 0.0 109.891 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.43 -40.59 97.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.53 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.68 -57.27 13.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 111.575 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' SG ' HD23 ' A' ' 70' ' ' LEU . 20.1 p -61.67 -43.26 99.19 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.375 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -66.32 -46.18 77.75 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.256 0.348 . . . . 0.0 111.184 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 21' ' ' LEU . 97.3 mt -67.05 -33.0 74.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.051 0.54 . . . . 0.0 110.874 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 -33.1 72.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.991 0.517 . . . . 0.0 110.873 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.782 ' HA ' HG12 ' A' ' 76' ' ' VAL . 63.9 m -75.43 -5.6 45.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.3 mt -88.59 13.15 12.77 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.245 0.618 . . . . 0.0 110.167 167.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.56 39.14 30.77 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.74 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -130.12 154.68 47.24 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.161 0.481 . . . . 0.0 111.888 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.19 89.18 7.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.575 0.75 . . . . 0.0 109.056 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.62 110.14 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.319 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 82.1 m -87.09 112.91 22.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.624 1.17 . . . . 0.0 109.79 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -92.31 125.82 37.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.707 0.803 . . . . 0.0 109.913 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 83' ' ' SER . 5.6 t -105.37 116.45 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 167.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -135.74 133.93 38.51 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.4 -23.86 67.43 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.679 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.521 ' HB3' HG22 ' A' ' 62' ' ' VAL . 15.8 m -104.13 135.85 44.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.057 0.943 . . . . 0.0 109.814 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -73.11 -25.8 61.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 0.0 109.981 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 60' ' ' SER . 21.2 m -67.85 -36.6 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.258 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.98 -36.28 90.74 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.51 -48.23 70.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.402 1.081 . . . . 0.0 111.5 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.39 84.46 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.688 0.795 . . . . 0.0 112.47 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -77.45 -31.58 53.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.263 0.625 . . . . 0.0 111.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.497 ' HB3' ' HA3' ' A' ' 41' ' ' GLY . . . -59.69 -46.89 87.71 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 171.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.46 -40.95 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.169 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -58.4 -53.42 58.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.022 0.929 . . . . 0.0 110.823 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.615 HD23 ' SG ' ' A' ' 45' ' ' CYS . 19.3 tp -65.69 -28.47 69.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.642 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -54.46 17.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.734 0.414 . . . . 0.0 110.812 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -35.63 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.187 0.595 . . . . 0.0 110.769 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.66 -40.48 97.2 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.851 0.719 . . . . 0.0 110.356 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -91.02 -1.39 57.82 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.981 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.69 32.28 37.75 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 49' ' ' SER . 16.3 m -132.71 178.51 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.961 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -132.0 142.16 49.5 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.758 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' A' ' 45' ' ' CYS . 10.0 mm -110.61 170.06 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.97 1.308 . . . . 0.0 108.273 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 71.7 m -121.91 111.89 17.64 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 163.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t -86.08 109.96 19.2 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.592 0.757 . . . . 0.0 111.545 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.22 133.05 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.524 1.129 . . . . 0.0 108.955 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -85.41 132.42 34.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.4 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . 58.2 m -61.36 125.92 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -133.42 87.61 2.41 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.5 mt -91.1 -4.58 56.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.506 0.722 . . . . 0.0 110.674 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.39 3.54 54.25 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.825 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.39 -37.81 0.27 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -162.04 104.53 1.16 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -169.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.5 -65.15 0.99 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -174.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.59 ' HB ' HD12 ' A' ' 98' ' ' ILE . 9.4 pt -136.32 115.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.479 0.712 . . . . 0.0 110.777 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.07 94.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.83 -1.43 2.9 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.2 -51.27 9.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 168.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.55 -31.47 68.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.37 0.668 . . . . 0.0 111.861 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.471 ' CD1' HD22 ' A' ' 34' ' ' LEU . 24.5 m95 -116.94 145.08 43.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.778 0.831 . . . . 0.0 109.44 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.07 -33.06 44.92 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.178 0.513 . . . . 0.0 110.57 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -139.98 140.11 10.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.872 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.59 HD12 ' HB ' ' A' ' 90' ' ' ILE . 82.1 mt -115.58 143.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 47' ' ' LEU . 7.7 p -135.8 134.58 51.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 164.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 m -136.89 113.77 10.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.1 mm -76.34 144.51 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.698 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 2.9 p90 -20.31 109.36 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.124 1.77 . . . . 0.0 115.148 -173.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.7 t -80.36 113.48 18.58 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 112.896 -1.956 . . . . 0.0 110.313 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HE2' HD12 ' A' ' 149' ' ' LEU . 51.0 t-80 -120.19 98.08 5.9 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -122.1 150.72 57.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.91 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.68 159.53 53.27 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.91 2.407 . . . . 0.0 110.125 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.3 m -37.16 -45.0 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.157 1.783 . . . . 0.0 113.956 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.7 p -49.14 -63.08 1.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 O-C-N 124.675 1.234 . . . . 0.0 111.844 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.24 -22.28 28.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.392 0.677 . . . . 0.0 110.539 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -73.42 -62.93 1.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.129 0.972 . . . . 0.0 110.374 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.31 -15.17 56.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.451 0.7 . . . . 0.0 112.098 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.23 -41.65 27.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' O ' HG21 ' A' ' 117' ' ' VAL . 46.6 tp -74.86 -48.22 26.1 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.783 -170.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.427 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 34.7 m-85 -66.73 -40.56 32.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.56 -31.74 94.98 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 121.958 1.772 . . . . 0.0 112.281 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -82.65 -14.96 53.77 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.964 0.906 . . . . 0.0 110.057 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 113' ' ' LEU . 22.0 t -80.68 -36.46 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.514 ' HE1' ' HD2' ' A' ' 161' ' ' PRO . 33.0 t80 -57.8 -54.46 46.6 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -71.83 -47.01 56.07 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.806 0.842 . . . . 0.0 112.926 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.09 -45.94 10.99 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 114.276 0.47 . . . . 0.0 114.276 -170.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.1 tp -85.28 95.2 9.12 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -75.75 148.41 82.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 164.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.02 133.27 28.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.201 1.934 . . . . 0.0 110.125 168.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.525 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 128.87 -11.73 6.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -157.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.01 168.08 20.87 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 122.726 -0.279 . . . . 0.0 112.593 166.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.08 137.88 48.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.409 1.083 . . . . 0.0 109.45 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.98 113.33 23.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.472 HD12 HG21 ' A' ' 24' ' ' VAL . 17.9 mt -106.95 109.62 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.934 0.893 . . . . 0.0 108.644 -171.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 156' ' ' LEU . 40.3 mt -125.85 114.1 18.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.995 0.518 . . . . 0.0 109.754 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.698 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 43.2 tt0 -103.47 98.95 8.76 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.505 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.91 -176.68 49.24 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.449 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.441 ' HB2' HD23 ' A' ' 150' ' ' LEU . 36.8 m-85 -132.79 158.61 42.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.215 1.006 . . . . 0.0 108.757 -176.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.57 159.52 30.28 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 123.582 0.753 . . . . 0.0 110.553 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.516 ' HA ' HD22 ' A' ' 147' ' ' LEU . 73.3 Cg_exo -55.09 -18.43 17.4 Favored 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.85 3.034 . . . . 0.0 116.482 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -83.92 -5.82 59.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.869 -0.519 . . . . 0.0 112.179 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -73.85 -49.98 22.49 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.965 -0.46 . . . . 0.0 111.2 -169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.451 HD13 ' HG ' ' A' ' 147' ' ' LEU . 18.2 mt -69.86 -25.84 63.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -70.27 -23.55 62.9 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.305 1.042 . . . . 0.0 111.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.58 -7.5 15.19 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.129 0.572 . . . . 0.0 111.586 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 68.45 37.77 2.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.049 1.34 . . . . 0.0 109.23 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.8 p -79.04 -20.04 49.92 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.219 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.6 122.88 2.56 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.769 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.41 95.42 1.15 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-O 118.821 -0.988 . . . . 0.0 111.539 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.55 -20.02 60.41 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.989 2.459 . . . . 0.0 112.541 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -159.6 -62.31 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -179.27 166.39 1.49 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.159 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.595 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -60.49 -1.85 0.42 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.706 1.602 . . . . 0.0 112.93 172.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -61.67 -40.16 93.95 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.36 1.464 . . . . 0.0 110.742 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.418 HD12 ' HE2' ' A' ' 104' ' ' HIS . 88.8 mt -74.89 -1.7 23.55 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 20.9 mt -83.29 107.83 11.04 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.505 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -68.82 111.88 2.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.923 2.416 . . . . 0.0 111.239 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.13 151.89 20.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.276 0.63 . . . . 0.0 111.482 -169.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' A' ' 188' ' ' ILE . 60.5 mt -60.69 -39.37 88.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.166 0.586 . . . . 0.0 110.486 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.1 -51.39 58.02 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.389 1.076 . . . . 0.0 110.805 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.7 p -71.55 -55.18 8.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.671 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.545 HD12 HD11 ' A' ' 129' ' ' LEU . 55.9 mt -73.51 -46.15 49.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.262 1.025 . . . . 0.0 113.52 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -42.41 96.07 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 m -73.64 -21.94 60.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 19.7 tp10 -74.39 -22.25 59.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.635 0.774 . . . . 0.0 110.521 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.452 HD22 ' HD1' ' A' ' 118' ' ' TYR . 68.6 mt -140.22 65.56 28.69 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.535 0.734 . . . . 0.0 109.377 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.514 ' HD2' ' HE1' ' A' ' 118' ' ' TYR . 95.3 Cg_endo -81.42 2.49 8.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 123.068 2.512 . . . . 0.0 112.09 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 55.1 p -90.47 -33.84 15.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.367 1.067 . . . . 0.0 108.685 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.06 73.12 7.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.999 1.719 . . . . 0.0 111.178 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -50.06 114.15 1.03 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.476 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 35.4 m95 -84.88 128.99 34.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.786 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 84.8 mt -71.18 -36.61 72.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.429 0.692 . . . . 0.0 110.803 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 59.1 mt -125.25 120.74 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.02 70.98 0.95 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -148.23 146.51 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -170.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -73.97 112.42 10.07 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.272 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.9 mt -118.17 137.17 53.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 110.829 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -94.68 127.32 40.57 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.509 0.724 . . . . 0.0 110.005 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -109.25 123.01 48.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.662 0.785 . . . . 0.0 109.64 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -73.29 110.33 7.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.375 0.67 . . . . 0.0 110.792 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.74 167.84 20.1 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.981 0.912 . . . . 0.0 110.304 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -75.7 71.46 2.57 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.91 154.75 5.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.318 -164.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -168.58 34.94 0.2 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 120.268 -0.185 . . . . 0.0 112.838 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 91.89 0.12 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.235 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.3 t80 68.02 -76.1 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.669 1.588 . . . . 0.0 110.334 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -136.03 -16.5 1.68 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -70.77 90.6 0.79 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -147.39 13.21 1.4 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.94 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.469 ' HD3' ' H ' ' A' ' 184' ' ' LYS . 0.1 OUTLIER -133.4 176.27 8.68 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.892 0.877 . . . . 0.0 110.069 -174.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -125.75 132.05 52.41 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.98 106.01 15.31 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -127.28 171.94 11.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.657 0.783 . . . . 0.0 109.809 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.5 ' HB ' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -142.82 119.82 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.031 173.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -98.31 140.71 32.18 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 37.4 mt -129.23 133.35 47.49 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 108.453 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 24' ' ' VAL . 46.3 tp -139.76 107.61 5.67 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.69 139.76 17.46 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.531 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 6.1 tp60 -116.72 146.79 42.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.001 0.9 . . . . 0.0 111.677 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.669 ' HD3' ' HG3' ' A' ' 29' ' ' PRO . 21.9 pttm -58.19 115.05 2.68 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.163 165.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.03 140.07 26.25 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 167.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -34.39 124.99 0.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.721 1.208 . . . . 0.0 113.228 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -72.53 80.02 1.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.204 1.002 . . . . 0.0 111.619 -176.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -93.47 -55.55 3.25 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.512 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -127.41 17.83 7.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.237 0.615 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -140.06 103.94 4.73 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 197' ' ' HIS . 32.2 m170 64.24 150.88 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.524 1.13 . . . . 0.0 111.845 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.245 1.018 . . . . 0.0 108.352 177.358 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mtp . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -87.02 70.74 10.3 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.919 0.866 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -110.93 161.01 16.27 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 -144.39 0.11 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.547 1.139 . . . . 0.0 109.172 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER 49.31 79.52 0.08 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.925 1.69 . . . . 0.0 112.338 -174.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -147.58 77.26 1.43 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -143.31 77.83 1.58 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -86.33 -13.55 46.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.669 0.788 . . . . 0.0 109.792 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -54.62 95.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.546 1.539 . . . . 0.0 112.178 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.53 94.15 4.98 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.055 0.931 . . . . 0.0 110.618 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -127.66 114.21 17.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.689 175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.22 25.05 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.963 0.887 . . . . 0.0 108.81 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -59.98 105.33 0.38 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.791 1.236 . . . . 0.0 112.05 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.75 44.64 1.46 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.48 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -70.97 149.48 46.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.892 0.877 . . . . 0.0 110.973 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -140.17 75.78 28.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.24 124.77 1.77 Allowed 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.661 2.241 . . . . 0.0 111.142 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -106.55 143.48 34.6 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 22' ' ' VAL . 15.3 t70 -156.66 173.18 17.33 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.892 0.877 . . . . 0.0 109.084 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -59.9 -29.51 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.727 0.811 . . . . 0.0 110.527 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' ' 47' ' ' LEU . 18.2 tp -59.77 -33.97 72.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.848 1.259 . . . . 0.0 112.492 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 19' ' ' ASP . 11.0 m -52.54 -38.46 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -72.8 -44.72 61.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 0.0 110.938 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG23 HD12 ' A' ' 128' ' ' ILE . 2.4 m -67.97 -33.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.044 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.27 77.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.485 1.114 . . . . 0.0 111.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.7 -33.87 73.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.191 0.596 . . . . 0.0 110.329 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -84.21 -22.52 30.85 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 24' ' ' VAL . 85.7 mt -76.98 131.67 72.63 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.91 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.39 143.93 71.83 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.788 2.326 . . . . 0.0 111.895 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -72.79 30.59 0.06 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.336 1.454 . . . . 0.0 114.371 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.76 177.95 17.35 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 96' ' ' GLU . 66.1 mttm -60.14 118.48 6.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.542 0.737 . . . . 0.0 110.845 -165.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.89 138.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -165.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 90' ' ' ILE . 59.9 tp -110.67 112.43 24.31 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.712 ' SG ' HG11 ' A' ' 54' ' ' VAL . 58.9 m -101.81 109.59 21.38 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 123.772 0.829 . . . . 0.0 110.412 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 89' ' ' ASP . 36.8 mt -76.69 127.31 32.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 165.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.2 86.58 2.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 103' ' ' CYS . 15.9 tp10 -106.02 73.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.094 0.949 . . . . 0.0 109.39 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.29 -40.56 1.27 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.487 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HG3' ' HG2' ' A' ' 42' ' ' ARG . 12.8 tp10 -159.91 133.95 7.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.245 0.618 . . . . 0.0 110.158 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.54 25.32 8.16 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.707 0.63 . . . . 0.0 113.7 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HG2' ' HG3' ' A' ' 40' ' ' GLU . 17.0 ptt180 -61.78 -38.21 87.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.445 0.698 . . . . 0.0 110.821 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.59 -33.61 62.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.182 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.05 66.61 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.297 0.639 . . . . 0.0 110.799 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.447 ' HA ' HD12 ' A' ' 78' ' ' ILE . 6.6 p -70.42 -28.44 65.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.2 t80 -66.88 -33.15 74.97 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' ' 21' ' ' LEU . 31.4 mt -64.59 -36.04 82.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.121 0.569 . . . . 0.0 111.164 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.56 69.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.661 0.267 . . . . 0.0 110.743 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.584 ' HA ' HG12 ' A' ' 76' ' ' VAL . 55.9 m -68.36 -10.86 57.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.531 0.732 . . . . 0.0 111.533 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD12 HD21 ' A' ' 47' ' ' LEU . 65.7 mt -88.13 14.89 8.28 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.643 0.777 . . . . 0.0 110.846 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.16 36.97 44.05 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 123.146 0.403 . . . . 0.0 113.435 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.64 147.34 45.37 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.889 0.476 . . . . 0.0 112.101 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.9 90.64 4.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.902 0.881 . . . . 0.0 108.719 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.712 HG11 ' SG ' ' A' ' 35' ' ' CYS . 65.3 t -102.05 112.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.023 0.529 . . . . 0.0 111.969 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.2 m -85.3 104.88 15.54 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.68 120.95 41.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.268 0.627 . . . . 0.0 109.507 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 83' ' ' SER . 3.6 t -103.81 119.17 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -132.91 144.56 50.24 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.315 0.962 . . . . 0.0 111.32 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 3.0 pp0? -57.98 -18.27 22.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.526 1.53 . . . . 0.0 114.503 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 62' ' ' VAL . 77.5 p -131.2 139.2 49.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 110.409 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -76.83 -17.41 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.405 0.682 . . . . 0.0 110.163 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 60' ' ' SER . 20.1 m -73.5 -29.16 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.151 168.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.97 -28.99 57.77 Favored Glycine 0 C--N 1.359 1.827 0 O-C-N 123.524 0.515 . . . . 0.0 112.342 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.08 -39.97 68.59 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.666 0.787 . . . . 0.0 110.299 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.52 67.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.759 0.824 . . . . 0.0 111.15 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -70.66 -47.53 59.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.225 1.01 . . . . 0.0 109.011 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.56 95.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.119 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -69.83 -35.77 75.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.989 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.12 -46.3 82.77 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.914 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.65 -29.61 66.01 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.154 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.457 ' HB3' HG12 ' A' ' 78' ' ' ILE . . . -62.8 -62.27 1.84 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.879 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.11 -23.14 67.06 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.884 0.873 . . . . 0.0 112.028 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.93 -56.12 20.01 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.512 ' HZ3' ' HB2' ' A' ' 74' ' ' LYS . 3.9 ttmp? -99.03 8.05 45.37 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.948 -171.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.77 38.19 85.19 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 121.996 -0.44 . . . . 0.0 113.358 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 49' ' ' SER . 32.4 m -121.52 162.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.093 0.957 . . . . 0.0 109.282 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -106.05 129.32 54.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.151 0.58 . . . . 0.0 112.107 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 71' ' ' ALA . 16.2 mm -114.24 160.99 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 166.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -125.2 104.3 8.43 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 p -87.86 121.85 30.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.889 0.476 . . . . 0.0 110.744 -167.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.96 140.4 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 108.704 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -81.61 133.12 35.34 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' HG12 ' A' ' 57' ' ' VAL . 37.7 t -65.55 114.86 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.47 0.481 . . . . 0.0 111.392 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -141.45 88.66 2.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.67 -10.77 50.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.143 0.577 . . . . 0.0 111.23 -166.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.04 -22.34 36.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.476 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.83 -37.66 10.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 110.896 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -171.95 135.54 0.83 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.157 1.383 . . . . 0.0 108.154 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' HD22 ' A' ' 36' ' ' LEU . 1.8 p-10 -135.17 -73.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.605 ' HB ' HD12 ' A' ' 98' ' ' ILE . 3.7 pt -146.63 120.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.441 0.696 . . . . 0.0 110.774 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.34 93.27 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.897 0.479 . . . . 0.0 109.968 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 122' ' ' LYS . . . -67.75 -7.0 23.76 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.34 -44.03 59.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.409 0.684 . . . . 0.0 109.229 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.34 -34.42 55.22 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.32 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.52 ' NE1' HD22 ' A' ' 34' ' ' LEU . 74.5 m95 -109.05 149.71 28.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.218 0.607 . . . . 0.0 111.379 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' N ' ' A' ' 32' ' ' LYS . 45.1 mt-10 -91.74 3.69 54.51 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.835 0.854 . . . . 0.0 111.112 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.33 151.44 16.49 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.605 HD12 ' HB ' ' A' ' 90' ' ' ILE . 55.1 mt -128.6 149.12 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.903 0.881 . . . . 0.0 108.853 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -147.66 144.24 19.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 162.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 127' ' ' PHE . 47.4 m -133.24 100.37 4.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.9 mm -70.09 138.96 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.739 1.216 . . . . 0.0 108.705 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -18.18 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.533 1.933 . . . . 0.0 114.723 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 26.3 p -82.45 106.32 14.23 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.619 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -96.42 97.37 9.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.5 mt -124.67 145.7 50.34 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.709 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.17 152.44 71.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.858 2.372 . . . . 0.0 109.926 167.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.4 m -44.18 -40.0 4.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.769 1.227 . . . . 0.0 113.168 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 34.6 m -51.39 -60.81 2.72 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 124.454 1.096 . . . . 0.0 111.002 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.97 -24.15 38.25 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.864 0.466 . . . . 0.0 111.424 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 114' ' ' TYR . 29.2 ttp180 -75.8 -48.67 20.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -68.35 -10.37 54.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.582 0.753 . . . . 0.0 112.81 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 108' ' ' SER . 30.1 mm-40 -88.0 -26.97 22.35 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.014 0.37 . . . . 0.0 110.144 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 117' ' ' VAL . 57.6 tp -78.03 -52.87 8.11 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.867 -174.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 110' ' ' ARG . 29.1 m-85 -66.39 -38.04 18.89 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 24.2 Cg_endo -61.54 -29.43 84.6 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.958 1.772 . . . . 0.0 112.514 167.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -81.57 -22.97 37.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.216 1.007 . . . . 0.0 109.799 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 113' ' ' LEU . 28.6 t -78.18 -39.65 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.886 0.874 . . . . 0.0 109.211 170.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.579 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 13.3 t80 -54.09 -58.61 6.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.817 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.36 -49.54 66.57 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.742 0.817 . . . . 0.0 113.036 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.5 -40.48 32.59 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -165.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 34.1 tp -81.21 115.58 20.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.739 0.815 . . . . 0.0 109.56 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 122' ' ' LYS . 9.0 mmpt? -103.71 159.39 29.46 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.362 1.065 . . . . 0.0 109.363 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.97 113.35 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.623 0 C-N-CA 123.458 2.772 . . . . 0.0 113.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.94 14.01 2.6 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.733 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.57 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.21 150.46 17.17 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 162.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 31.8 m -110.62 133.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.373 0 C-N-CA 123.039 0.535 . . . . 0.0 109.57 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 100' ' ' SER . 0.8 OUTLIER -105.79 112.74 25.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 24' ' ' VAL . 50.3 mt -107.01 107.55 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 96.9 mt -121.41 123.26 41.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -106.02 99.31 8.91 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.636 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -79.97 173.87 55.03 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.102 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.3 157.04 46.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.46 163.54 24.26 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.185 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.652 ' HA ' HD23 ' A' ' 147' ' ' LEU . 20.7 Cg_endo -61.01 -4.28 3.62 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.847 2.364 . . . . 0.0 115.569 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.4 -12.06 52.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.926 0.49 . . . . 0.0 111.758 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -69.28 -56.94 6.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.602 -167.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 140' ' ' ASN . 15.2 mt -62.97 -21.3 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.345 0.403 . . . . 0.0 111.187 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.4 -32.85 74.02 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.186 0.994 . . . . 0.0 112.186 172.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.93 7.06 13.12 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.958 0.903 . . . . 0.0 112.411 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 137' ' ' LEU . 66.0 t30 -68.98 153.88 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.167 0.587 . . . . 0.0 112.46 -164.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -79.24 -0.25 31.38 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.285 1.034 . . . . 0.0 111.624 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.43 179.05 28.39 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.969 0.319 . . . . 0.0 112.322 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -121.31 94.59 0.54 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.941 -0.921 . . . . 0.0 111.196 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.47 -124.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.024 2.483 . . . . 0.0 111.14 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -129.21 -38.45 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.174 0.897 . . . . 0.0 110.573 178.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -168.96 153.86 5.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.487 0.715 . . . . 0.0 109.185 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -60.52 -3.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.201 1.4 . . . . 0.0 113.591 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.81 -39.65 81.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.957 0.903 . . . . 0.0 109.838 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.8 mt -82.71 12.82 4.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.888 0.475 . . . . 0.0 111.937 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.484 HD23 HD23 ' A' ' 137' ' ' LEU . 25.7 mt -90.88 105.45 12.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.636 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 24.6 Cg_exo -63.56 112.96 1.92 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.123 2.548 . . . . 0.0 112.479 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -95.02 145.83 24.68 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.909 0.884 . . . . 0.0 111.279 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.47 HD23 HD22 ' A' ' 190' ' ' LEU . 41.2 mt -61.03 -51.32 69.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.164 0.586 . . . . 0.0 110.69 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.97 -35.7 47.17 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.533 0.733 . . . . 0.0 112.164 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 m -76.56 -45.87 28.7 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.29 1.036 . . . . 0.0 110.719 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.3 -46.49 13.58 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.094 0.958 . . . . 0.0 112.877 -170.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.7 -39.93 62.47 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.515 . . . . 0.0 111.261 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t -70.89 -33.92 71.06 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -96.47 -7.41 34.85 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.503 HD21 ' HD2' ' A' ' 118' ' ' TYR . 72.4 mt -139.66 62.69 24.1 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.247 0.619 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.579 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 57.3 Cg_endo -81.62 -3.21 11.82 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.138 2.559 . . . . 0.0 113.082 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.5 p -88.46 -30.13 19.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.893 0.877 . . . . 0.0 109.105 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 tp -93.22 75.7 4.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.825 1.65 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -44.5 111.87 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 0.0 111.194 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 54.4 m95 -85.0 129.43 34.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 193' ' ' GLN . 71.8 mt -76.97 -35.66 57.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.572 0.349 . . . . 0.0 110.467 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.85 123.63 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.71 85.55 1.04 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.11 0.964 . . . . 0.0 108.933 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.09 151.09 35.06 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.433 ' HA ' HG21 ' A' ' 188' ' ' ILE . 24.3 t-20 -79.16 103.73 9.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.472 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.07 125.25 50.77 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 109.306 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.85 142.44 27.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -145.14 132.84 21.01 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -74.86 139.03 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.437 0.695 . . . . 0.0 109.992 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.0 mt -79.23 169.59 17.91 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.793 1.237 . . . . 0.0 110.14 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.09 -52.33 65.72 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 171.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -172.24 111.61 0.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.112 -1.404 . . . . 0.0 107.592 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 -0.23 3.84 Favored Glycine 0 N--CA 1.475 1.27 0 CA-C-O 119.968 -0.351 . . . . 0.0 113.889 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -159.67 -167.35 1.98 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.352 0.661 . . . . 0.0 110.824 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -118.66 -36.49 3.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.891 0.876 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -77.69 -54.79 5.96 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -166.83 116.0 0.87 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -75.44 79.56 1.07 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -99.3 167.64 10.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.291 1.036 . . . . 0.0 110.117 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -150.49 132.47 15.19 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -91.36 125.3 36.07 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.92 165.02 18.11 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 170' ' ' ASN . 6.3 pt -140.88 116.26 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -102.49 145.57 29.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.584 0.707 . . . . 0.0 110.395 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.47 HD22 HD23 ' A' ' 153' ' ' LEU . 35.7 mt -131.36 135.62 47.38 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.498 -174.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.454 HD23 HG12 ' A' ' 24' ' ' VAL . 43.5 tp -135.46 105.71 6.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.54 139.76 16.81 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 166' ' ' LEU . 5.6 tp60 -136.87 154.28 50.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.879 0.84 . . . . 0.0 111.489 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.533 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 22.1 ptmt -55.35 142.83 30.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.2 mt -70.12 99.49 1.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.5 36.76 2.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.561 1.172 . . . . 0.0 108.698 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -167.95 162.5 13.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.227 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -78.67 149.31 32.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.562 . . . . 0.0 111.094 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -65.43 95.55 0.21 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.326 0.651 . . . . 0.0 109.274 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -144.22 62.61 1.34 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.612 1.196 . . . . 0.0 109.222 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -112.32 23.44 13.64 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.527 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 125.83 1.652 . . . . 0.0 107.256 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -158.77 140.17 13.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.688 0.795 . . . . 0.0 109.018 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -75.98 89.04 2.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.177 0.989 . . . . 0.0 109.819 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -87.77 44.81 1.22 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.071 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.18 101.35 13.09 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -151.27 146.61 26.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.605 0.762 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m -149.9 -65.32 0.21 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.362 1.065 . . . . 0.0 108.335 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 49.93 71.51 0.4 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.019 1.328 . . . . 0.0 111.329 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -149.06 73.45 1.21 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.13 157.21 18.9 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.888 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -158.72 159.78 35.63 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.318 0.58 . . . . 0.0 111.919 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.89 157.7 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.978 1.311 . . . . 0.0 107.487 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -149.18 135.63 19.36 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -165.41 46.03 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.586 0.554 . . . . 0.0 112.879 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.6 t -154.67 14.67 0.43 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.136 0.975 . . . . 0.0 110.472 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.85 95.53 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 125.527 1.531 . . . . 0.0 109.618 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.88 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.915 2.41 . . . . 0.0 114.402 -168.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -96.57 14.98 22.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.412 0.685 . . . . 0.0 109.861 166.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.09 155.27 39.92 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.861 1.664 . . . . 0.0 111.676 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.47 -43.48 26.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.096 0.959 . . . . 0.0 110.799 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD22 ' ND2' ' A' ' 43' ' ' ASN . 21.3 tp -59.74 -44.77 93.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.606 0.763 . . . . 0.0 111.559 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 m -43.56 -34.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -50.84 19.5 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.57 0.623 . . . . 0.0 110.329 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 128' ' ' ILE . 1.4 m -59.41 -33.08 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.734 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.8 74.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 0.0 111.776 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.3 -26.75 68.62 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.922 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -89.71 -19.87 24.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.959 0.903 . . . . 0.0 111.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 24' ' ' VAL . 66.7 mt -80.1 135.98 54.23 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 122.972 0.509 . . . . 0.0 109.833 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -58.92 133.27 52.56 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.974 2.45 . . . . 0.0 111.864 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.59 27.17 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.69 -131.76 4.57 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.767 0.712 . . . . 0.0 111.828 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 67.5 mttm -77.15 113.19 14.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.074 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -111.68 120.54 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 109.144 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.473 ' HA ' HG22 ' A' ' 55' ' ' THR . 36.2 tp -93.4 113.19 25.29 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.632 0.373 . . . . 0.0 110.576 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 54.0 t -108.77 107.66 18.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.17 165.39 9.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.76 0.424 . . . . 0.0 111.519 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 58' ' ' ASP . . . -57.87 -25.9 61.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.253 0.549 . . . . 0.0 110.429 170.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -68.52 82.33 0.27 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 161.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 101' ' ' ILE . . . 173.67 -156.81 24.72 Favored Glycine 0 C--O 1.241 0.55 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.551 -170.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -148.86 140.36 23.41 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.8 -51.56 52.68 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.56 0.538 . . . . 0.0 113.821 -171.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -69.96 -28.92 65.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.121 0.569 . . . . 0.0 110.792 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' ND2' HD22 ' A' ' 21' ' ' LEU . 24.9 t-20 -64.91 -43.64 92.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.228 1.011 . . . . 0.0 110.363 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.83 -47.05 70.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.708 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.9 m -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.662 . . . . 0.0 112.459 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.442 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.3 t80 -68.66 -39.29 80.73 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.058 0.543 . . . . 0.0 109.716 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.27 -34.32 77.17 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.078 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.55 71.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.96 0.504 . . . . 0.0 111.147 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.71 ' HA ' HG13 ' A' ' 76' ' ' VAL . 34.7 t -70.28 -11.28 60.8 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 111.781 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 79.1 mt -85.1 5.84 28.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.76 0.424 . . . . 0.0 110.384 170.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.04 27.95 47.55 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 123.173 0.416 . . . . 0.0 113.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -113.62 151.4 31.78 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.27 0.535 . . . . 0.0 109.697 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 40.9 mt-10 -85.36 87.61 7.41 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.25 104.89 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.297 0.57 . . . . 0.0 109.904 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 34' ' ' LEU . 2.1 t -85.54 111.09 19.7 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.834 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.49 121.2 44.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.932 0.493 . . . . 0.0 109.873 -172.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 3.7 t -89.31 134.54 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.656 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 8.8 t70 -152.83 129.23 10.61 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -62.69 -28.38 69.9 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.238 1.015 . . . . 0.0 112.831 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.437 ' OG ' HG22 ' A' ' 62' ' ' VAL . 10.2 t -102.6 123.8 46.98 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -72.38 -19.79 61.56 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.168 0.587 . . . . 0.0 111.042 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG22 ' OG ' ' A' ' 60' ' ' SER . 18.9 m -66.65 -32.74 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 122.819 0.448 . . . . 0.0 110.685 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.51 -39.84 55.55 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.897 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.414 HD22 ' HB ' ' A' ' 80' ' ' THR . 94.5 mt -62.52 -48.52 79.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 110.983 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -57.6 -46.63 83.8 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -69.96 -38.03 75.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.249 0.62 . . . . 0.0 110.641 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.386 0.612 . . . . 0.0 110.541 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -74.05 -29.65 62.01 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.703 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 69.8 mt-30 -61.91 -45.5 93.46 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.13 0.572 . . . . 0.0 110.168 171.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.52 -26.72 64.66 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 123.882 0.739 . . . . 0.0 110.568 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -63.44 -62.07 1.92 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.185 173.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.24 -37.69 81.17 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.123 0.569 . . . . 0.0 111.036 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.42 -45.86 92.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.608 0.763 . . . . 0.0 110.56 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -97.65 8.65 44.28 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.971 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 37.53 77.45 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-N 116.617 -0.265 . . . . 0.0 113.701 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -130.42 -177.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.914 1.286 . . . . 0.0 109.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -131.18 136.04 47.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.715 HG12 ' HB1' ' A' ' 71' ' ' ALA . 25.7 mm -104.87 165.41 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 42.4 m -125.89 104.58 8.39 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 166.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.414 ' HB ' HD22 ' A' ' 64' ' ' LEU . 45.2 p -88.09 124.43 33.77 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.07 -0.394 . . . . 0.0 111.056 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 24.1 t -118.86 138.32 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.923 1.289 . . . . 0.0 108.555 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -86.42 128.28 34.93 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.779 0.718 . . . . 0.0 110.168 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 m -63.19 125.21 23.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -143.31 91.4 2.26 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 28.8 mt -82.01 -8.32 59.66 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.566 0.621 . . . . 0.0 111.642 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.16 11.03 31.5 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.571 1.148 . . . . 0.0 110.681 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -143.65 -44.57 0.28 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.302 0.641 . . . . 0.0 111.553 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -166.91 109.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.23 1.412 . . . . 0.0 107.622 -170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -125.71 -71.8 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.266 0.626 . . . . 0.0 109.531 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 ' HB ' HD12 ' A' ' 98' ' ' ILE . 27.6 pt -133.94 121.28 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.386 0.674 . . . . 0.0 110.763 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.55 84.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.674 0.79 . . . . 0.0 109.31 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.66 0.34 10.93 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.824 0.45 . . . . 0.0 111.835 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.57 -47.58 46.97 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.475 1.11 . . . . 0.0 108.696 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.72 65.34 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.503 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -107.49 -166.06 1.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.83 -30.14 3.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.388 0.675 . . . . 0.0 110.568 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.36 166.66 29.08 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.491 HD12 ' HB ' ' A' ' 90' ' ' ILE . 62.6 mt -137.55 141.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 9.8 p -129.4 131.96 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.2 m -143.19 119.82 11.1 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.81 -0.556 . . . . 0.0 109.628 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 11.8 mm -88.93 148.27 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.656 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 37.1 p90 -16.08 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 126.505 1.922 . . . . 0.0 115.416 -163.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.493 ' SG ' ' OH ' ' A' ' 114' ' ' TYR . 27.1 p -85.46 107.01 17.22 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.658 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -108.92 96.67 6.48 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 68.9 mt -120.41 148.8 48.44 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.144 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 153.93 28.25 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.095 2.53 . . . . 0.0 111.344 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.9 t -49.0 -32.16 8.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.105 0.962 . . . . 0.0 112.076 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 33.7 p -58.56 -60.8 3.23 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.455 1.102 . . . . 0.0 111.968 172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.35 -21.59 55.93 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.527 -174.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -69.99 -52.77 21.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 108.689 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -64.84 -11.78 41.11 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.178 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 108' ' ' SER . 16.2 mm100 -91.65 -38.44 12.44 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.106 -0.371 . . . . 0.0 110.805 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 117' ' ' VAL . 65.9 tp -73.23 -50.34 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.748 0.419 . . . . 0.0 111.744 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.493 ' OH ' ' SG ' ' A' ' 103' ' ' CYS . 39.6 m-85 -68.13 -35.88 8.18 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -54.17 -32.12 68.81 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.017 1.812 . . . . 0.0 113.64 163.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 32.4 mmtp -78.01 -30.71 50.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.462 0.705 . . . . 0.0 110.586 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.526 ' HB ' HD23 ' A' ' 160' ' ' LEU . 3.3 t -78.43 -25.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-O 121.626 0.726 . . . . 0.0 109.643 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -75.66 -64.07 1.16 Allowed 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.893 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -82.07 -50.41 9.11 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.88 51.72 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 116.754 -0.203 . . . . 0.0 113.191 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.625 HD12 ' HA3' ' A' ' 125' ' ' GLY . 39.6 tp -69.75 100.42 1.5 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 122.896 0.478 . . . . 0.0 109.735 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.558 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 mtpp -66.74 149.3 98.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 165.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -42.52 119.21 1.32 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 124.041 3.161 . . . . 0.0 114.93 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.22 12.98 3.33 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.699 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.625 ' HA3' HD12 ' A' ' 121' ' ' LEU . . . -96.76 141.25 15.51 Favored Glycine 0 C--O 1.241 0.551 0 O-C-N 122.053 -0.675 . . . . 0.0 111.531 165.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 28.1 m -109.16 130.88 61.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.852 0.861 . . . . 0.0 108.903 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.436 ' CZ ' ' SG ' ' A' ' 103' ' ' CYS . 0.1 OUTLIER -109.95 111.98 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 24' ' ' VAL . 64.9 mt -103.53 107.91 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 17.1 mt -121.85 114.58 21.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.568 0.747 . . . . 0.0 109.528 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.656 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 28.5 tt0 -105.71 99.38 8.98 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.519 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -83.82 170.38 47.77 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.211 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.466 ' HB2' HD21 ' A' ' 150' ' ' LEU . 57.2 m-85 -133.17 159.12 41.09 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 108.863 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.43 166.62 17.74 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.058 0.943 . . . . 0.0 110.126 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.641 ' HA ' HD22 ' A' ' 147' ' ' LEU . 32.3 Cg_endo -61.31 -6.06 6.17 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 123.167 2.578 . . . . 0.0 114.439 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -82.97 -7.99 59.61 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.709 0.803 . . . . 0.0 111.914 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -68.52 -61.5 1.8 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 0.0 111.733 -172.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.75 -17.71 64.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 123.608 0.567 . . . . 0.0 110.231 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -64.57 -46.58 82.14 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.326 0.65 . . . . 0.0 110.509 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -56.31 -53.22 59.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.358 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -154.7 152.27 29.73 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.6 t -80.27 41.51 0.53 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 124.316 1.047 . . . . 0.0 112.087 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.47 48.36 2.19 Favored Glycine 0 C--N 1.363 2.081 0 C-N-CA 123.605 0.622 . . . . 0.0 113.108 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.66 137.72 11.43 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 118.8 -1.0 . . . . 0.0 110.646 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.91 -10.51 29.07 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.682 2.255 . . . . 0.0 113.577 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -171.41 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.367 1.334 0 CA-C-N 118.18 0.445 . . . . 0.0 110.386 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.13 158.84 22.36 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 109.696 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -56.44 -9.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.77 1.628 . . . . 0.0 113.257 173.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.01 -33.74 72.41 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.198 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -83.76 1.21 43.94 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.192 0.997 . . . . 0.0 112.038 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 132' ' ' PHE . 71.0 mt -78.92 112.02 24.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.57 ' HB3' HD13 ' A' ' 156' ' ' LEU . 23.5 Cg_exo -64.74 105.3 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.386 2.724 . . . . 0.0 112.588 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.446 ' HA ' HD13 ' A' ' 188' ' ' ILE . 21.9 ttmm -98.34 146.75 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.802 0.728 . . . . 0.0 111.504 -170.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.441 HD22 ' HB ' ' A' ' 188' ' ' ILE . 31.1 mt -61.11 -48.91 79.46 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -50.84 -47.51 60.22 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.168 0.917 . . . . 0.0 110.673 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.6 m -66.51 -61.94 1.72 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.68 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.57 HD13 ' HB3' ' A' ' 151' ' ' PRO . 22.1 mt -73.52 -42.15 62.11 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.331 0.652 . . . . 0.0 112.355 -165.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -62.19 -34.89 77.3 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.604 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 96.1 p -81.21 -22.23 38.98 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.555 0.216 . . . . 0.0 111.027 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.49 -16.83 57.09 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.042 0.537 . . . . 0.0 110.425 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.526 HD23 ' HB ' ' A' ' 117' ' ' VAL . 86.3 mt -143.5 64.02 13.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.167 0.987 . . . . 0.0 109.026 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.63 -9.97 15.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.021 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.8 t -88.34 -30.1 19.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 109.317 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.2 tp -88.21 70.86 9.24 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.583 1.153 . . . . 0.0 109.286 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -52.7 127.34 22.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.468 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 160' ' ' LEU . 42.1 m95 -92.08 126.76 37.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.664 1.186 . . . . 0.0 109.446 -171.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.28 -32.96 74.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.387 0.675 . . . . 0.0 110.086 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 79.8 mt -126.23 124.85 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.22 82.67 1.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.051 0.94 . . . . 0.0 108.573 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -149.89 151.56 33.64 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.67 114.15 26.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.591 1.156 . . . . 0.0 109.997 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.25 136.79 52.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.807 0.443 . . . . 0.0 110.613 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.96 125.87 34.34 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.039 0.535 . . . . 0.0 110.535 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.585 ' HB2' HD13 ' A' ' 187' ' ' LEU . 30.8 ttm180 -92.99 131.9 37.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.041 0.536 . . . . 0.0 110.101 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -83.8 98.36 9.67 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.53 155.77 34.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.941 0.896 . . . . 0.0 111.228 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.81 -45.55 94.01 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.358 0.663 . . . . 0.0 111.014 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.93 146.67 28.34 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.178 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -89.46 139.32 15.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.913 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -75.47 -77.03 0.13 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -94.72 -55.87 2.97 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -117.97 -71.2 0.75 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -107.73 171.2 7.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.292 0.637 . . . . 0.0 109.603 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -103.38 121.08 6.98 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -107.92 156.47 19.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.836 0.854 . . . . 0.0 109.673 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -147.51 133.07 18.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.67 118.28 23.76 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' A' ' 173' ' ' ARG . 34.8 mt -113.1 157.95 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 152' ' ' LYS . 11.6 pt -138.25 116.19 12.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -95.39 138.57 32.89 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 110.871 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 51.5 mt -128.35 131.73 48.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.119 1.368 . . . . 0.0 108.02 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.1 tp -126.34 110.21 13.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.22 135.76 13.78 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -142.48 149.76 39.63 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 147.16 52.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.943 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.64 153.84 43.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.388 0.675 . . . . 0.0 111.498 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.503 ' HG3' ' HB3' ' A' ' 199' ' ' HIS . 33.7 tt0 66.56 16.53 10.43 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.806 1.242 . . . . 0.0 112.044 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -58.04 -43.96 87.11 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.131 0.572 . . . . 0.0 112.374 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -90.58 -31.05 16.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.786 0.435 . . . . 0.0 111.071 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.503 ' HB3' ' HG3' ' A' ' 196' ' ' GLU . 32.9 t-80 -63.08 -50.97 68.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.981 0.513 . . . . 0.0 110.733 -176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -84.01 151.99 24.68 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 165.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -84.37 125.69 32.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.991 0.516 . . . . 0.0 109.961 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.598 0.759 . . . . 0.0 109.795 177.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.34 -73.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.833 0.453 . . . . 0.0 111.325 -171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -152.83 93.72 1.79 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -94.12 117.63 30.38 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -145.11 120.67 10.4 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -134.15 145.44 49.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.388 0.675 . . . . 0.0 109.497 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.5 p -158.32 159.84 36.34 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.986 0.914 . . . . 0.0 109.811 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -154.56 122.72 5.98 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.698 0.799 . . . . 0.0 109.699 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -93.44 85.58 4.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.733 0.813 . . . . 0.0 110.09 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.23 162.35 14.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.32 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -138.01 142.23 40.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.67 0.788 . . . . 0.0 109.627 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 18.26 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.557 0.743 . . . . 0.0 110.047 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 76.1 t80 -64.5 140.07 58.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.947 0.499 . . . . 0.0 111.138 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.16 41.67 0.03 OUTLIER Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.411 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -161.41 157.57 25.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.209 0.504 . . . . 0.0 111.208 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -163.32 84.87 1.37 Allowed Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.17 162.69 34.7 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.762 2.975 . . . . 0.0 114.419 -164.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -107.28 148.85 28.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.469 0.708 . . . . 0.0 110.178 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 22' ' ' VAL . 21.8 t70 -170.78 -179.63 2.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.731 0.812 . . . . 0.0 109.067 -170.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -58.94 -28.68 66.49 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.238 0.615 . . . . 0.0 109.849 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 24' ' ' VAL . 36.1 tp -58.16 -43.16 87.25 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.92 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 19' ' ' ASP . 5.0 m -52.45 -36.25 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 m -72.54 -50.47 25.45 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.141 0.577 . . . . 0.0 110.465 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.533 HG12 HD21 ' A' ' 191' ' ' LEU . 7.0 m -66.35 -33.54 64.17 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.41 83.66 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.359 1.464 . . . . 0.0 112.199 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.42 -31.82 73.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.926 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -88.18 -18.65 28.26 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 112.117 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 24' ' ' VAL . 60.5 mt -70.39 137.47 86.38 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.825 0.85 . . . . 0.0 111.061 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.79 128.25 29.54 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.745 2.963 . . . . 0.0 112.46 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -76.59 29.6 0.13 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.61 -134.85 4.92 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.881 -0.399 . . . . 0.0 112.243 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 60.8 mttm -84.93 112.73 20.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.526 0.731 . . . . 0.0 109.587 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 54' ' ' VAL . 3.0 mt -116.13 126.75 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -171.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 90' ' ' ILE . 35.4 tp -96.74 117.68 31.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.445 0.298 . . . . 0.0 110.954 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 44.0 t -100.08 121.44 41.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.691 0.796 . . . . 0.0 110.257 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.47 HD12 HG23 ' A' ' 90' ' ' ILE . 23.1 mt -101.56 118.98 38.05 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.561 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 49.37 85.01 0.03 OUTLIER 'General case' 0 C--N 1.361 1.067 0 O-C-N 125.448 1.717 . . . . 0.0 112.297 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.591 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.1 pt-20 -93.68 -3.66 51.99 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.68 3.77 Favored Glycine 0 C--N 1.345 1.031 0 C-N-CA 123.612 0.625 . . . . 0.0 112.124 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.35 151.95 36.74 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.672 1.189 . . . . 0.0 108.135 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.0 1.84 9.74 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -55.08 -32.48 61.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.978 1.711 . . . . 0.0 112.552 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -76.4 -54.98 5.97 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.095 0.558 . . . . 0.0 111.04 -173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.85 39.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 0.0 111.935 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.48 ' HB2' HD23 ' A' ' 70' ' ' LEU . 30.0 p -63.86 -34.8 78.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.323 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.3 t80 -68.33 -50.43 53.41 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.414 0.446 . . . . 0.0 110.398 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HB2' HG21 ' A' ' 54' ' ' VAL . 99.3 mt -65.41 -37.38 86.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.688 0.617 . . . . 0.0 110.366 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.29 65.1 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.79 0.436 . . . . 0.0 111.592 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.442 ' HA ' HG12 ' A' ' 76' ' ' VAL . 41.8 t -66.36 -13.35 60.48 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.992 0.917 . . . . 0.0 110.933 172.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 31.8 mt -90.75 6.92 42.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.541 0.737 . . . . 0.0 111.18 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.49 23.44 58.42 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -100.14 147.56 25.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.66 0.784 . . . . 0.0 110.603 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 41.7 mt-10 -86.79 88.27 7.64 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 47' ' ' LEU . 37.4 t -94.79 106.6 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.07 0.462 . . . . 0.0 111.336 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.509 HG21 ' HB ' ' A' ' 79' ' ' THR . 77.6 p -86.99 103.47 15.38 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . . . -106.06 132.17 52.46 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.967 0.907 . . . . 0.0 111.219 -169.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 81' ' ' VAL . 14.1 t -116.54 120.02 63.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.05 147.3 43.95 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.06 -27.43 67.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.571 0.749 . . . . 0.0 112.35 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.7 m -106.79 125.43 50.99 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.057 0.543 . . . . 0.0 110.325 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 m -70.78 -23.72 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.633 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 60' ' ' SER . 29.3 m -63.0 -32.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.545 0.738 . . . . 0.0 111.63 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.14 -47.65 29.45 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.95 -51.38 59.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.902 0.881 . . . . 0.0 111.764 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.07 -44.93 75.26 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.178 0.991 . . . . 0.0 113.371 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -72.42 -27.12 62.14 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.006 0.191 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.15 95.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.611 0.365 . . . . 0.0 110.129 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HZ1' ' HB3' ' A' ' 68' ' ' LYS . 8.2 mtpm? -69.24 -36.24 76.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.303 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.58 -46.49 86.81 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 16.6 tp -70.21 -22.01 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 123.468 0.48 . . . . 0.0 110.895 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.58 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -59.35 -59.71 5.03 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.25 -37.23 86.73 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.831 0.348 . . . . 0.0 111.394 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 70' ' ' LEU . 44.9 tt0 -60.26 -35.49 75.62 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.739 1.216 . . . . 0.0 111.808 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.26 -20.31 14.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.816 0.447 . . . . 0.0 112.152 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.94 49.23 7.16 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 122.116 -0.365 . . . . 0.0 113.305 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 49' ' ' SER . 34.9 m -123.77 -179.29 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 125.342 1.457 . . . . 0.0 108.515 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.82 137.64 53.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.7 0.4 . . . . 0.0 111.831 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.58 HG12 ' HB1' ' A' ' 71' ' ' ALA . 11.6 mm -112.92 169.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.509 ' HB ' HG21 ' A' ' 55' ' ' THR . 58.8 m -139.77 105.15 5.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 163.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -93.91 130.97 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.544 0.687 . . . . 0.0 111.407 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.597 ' HB ' HG23 ' A' ' 57' ' ' VAL . 41.8 t -116.12 143.29 26.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.682 1.593 . . . . 0.0 107.503 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -79.95 141.4 36.05 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 p -58.49 101.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.03 0.831 . . . . 0.0 111.188 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -141.18 92.8 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 80.8 mt -97.68 -21.7 16.87 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.63 0.372 . . . . 0.0 111.775 -170.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.31 -3.46 57.5 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.299 0.639 . . . . 0.0 111.756 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -125.32 -15.87 6.08 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.577 0.751 . . . . 0.0 111.632 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 60.4 t80 -165.15 147.91 8.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.915 1.286 . . . . 0.0 108.211 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -140.23 -72.71 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.604 1.093 . . . . 0.0 109.054 173.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HA ' HD21 ' A' ' 34' ' ' LEU . 10.8 pt -145.72 129.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.58 0.752 . . . . 0.0 111.163 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.1 94.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.523 0.729 . . . . 0.0 109.07 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.75 -3.05 10.83 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.539 0.736 . . . . 0.0 112.361 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.54 -41.8 17.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.266 0.627 . . . . 0.0 110.452 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.02 -34.29 66.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.085 0.554 . . . . 0.0 111.71 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.418 ' NE1' HD22 ' A' ' 34' ' ' LEU . 31.8 m95 -107.53 172.63 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.42 -57.67 2.87 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -116.82 168.38 12.77 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.501 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 90' ' ' ILE . 92.1 mt -134.92 131.16 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.562 0.745 . . . . 0.0 108.996 172.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -116.05 104.95 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -101.78 96.29 6.97 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.406 HD13 HD13 ' A' ' 128' ' ' ILE . 34.4 mm -75.44 149.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.015 0.926 . . . . 0.0 110.277 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -17.66 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.092 2.157 . . . . 0.0 113.31 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 50.7 t -95.58 127.1 41.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.287 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -128.95 98.73 5.04 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 109' ' ' LEU . 97.1 mt -124.77 138.95 32.26 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.235 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.64 160.61 20.24 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.721 2.281 . . . . 0.0 111.724 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 m -53.05 -21.91 5.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.36 1.064 . . . . 0.0 113.812 -172.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -63.29 -59.08 5.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.308 0.643 . . . . 0.0 111.432 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.489 ' HB3' HD11 ' A' ' 105' ' ' LEU . 29.5 mt -80.29 -21.13 42.95 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.532 0.333 . . . . 0.0 110.597 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -69.44 -55.77 9.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.467 0.707 . . . . 0.0 110.147 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -28.7 22.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.467 1.107 . . . . 0.0 111.965 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -78.16 -47.61 17.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' HG21 ' A' ' 117' ' ' VAL . 59.9 tp -75.41 -56.75 4.4 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.12 -165.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.423 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 82.9 m-85 -67.87 -38.21 13.84 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.45 -24.07 49.9 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 121.7 1.6 . . . . 0.0 112.321 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -84.64 -15.85 44.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 0.0 109.828 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 90' ' ' ILE . 29.9 t -78.07 -36.84 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.335 0.588 . . . . 0.0 109.463 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -58.16 -58.1 9.94 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.645 170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -64.63 -37.52 87.86 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.52 -50.05 3.27 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.991 0.357 . . . . 0.0 113.991 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.434 HD13 HD12 ' A' ' 98' ' ' ILE . 55.4 tp -101.54 99.0 9.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.636 1.174 . . . . 0.0 110.753 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.44 172.74 8.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 163.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.515 ' HB3' ' H ' ' A' ' 195' ' ' LEU . 39.8 Cg_exo -38.71 130.92 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.276 1.984 . . . . 0.0 110.808 158.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.563 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 131.72 -24.19 4.13 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -158.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -133.64 166.93 23.75 Favored Glycine 0 N--CA 1.467 0.701 0 O-C-N 121.953 -0.733 . . . . 0.0 113.691 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 18.3 m -108.13 135.57 46.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.599 1.16 . . . . 0.0 109.584 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.15 117.21 31.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 24' ' ' VAL . 24.1 mt -112.3 107.93 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.199 1.0 . . . . 0.0 109.439 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 156' ' ' LEU . 84.6 mt -126.64 139.41 53.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.353 0.661 . . . . 0.0 110.985 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -127.0 101.97 6.78 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.92 173.4 43.19 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.455 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -132.61 170.77 14.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.407 1.083 . . . . 0.0 108.748 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.43 172.32 6.09 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.67 1.03 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.056 0 C-N-CA 121.922 1.748 . . . . 0.0 114.686 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -38.96 29.35 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.465 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 58.6 tp60 -76.79 -44.73 31.57 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.292 0.496 . . . . 0.0 110.27 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.797 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 9.5 mt -65.99 -11.63 49.26 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-N 118.993 0.815 . . . . 0.0 113.091 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -76.05 -19.18 58.83 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 122.72 0.408 . . . . 0.0 109.928 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.471 ' HH ' HD12 ' A' ' 175' ' ' LEU . 5.4 m-85 -90.44 -44.85 9.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.909 0.884 . . . . 0.0 108.892 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' A' ' 137' ' ' LEU . 3.6 m-20 -63.4 124.58 21.65 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.289 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.3 m -104.94 -8.9 18.3 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.286 0.634 . . . . 0.0 109.69 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.5 -132.71 1.42 Allowed Glycine 0 C--N 1.357 1.705 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.88 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.73 -169.79 20.95 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.998 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.2 -167.78 0.42 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.446 2.764 . . . . 0.0 113.106 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.7 mttp 107.99 -1.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 127.934 2.494 . . . . 0.0 109.935 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.558 ' HB2' HD23 ' A' ' 137' ' ' LEU . 39.0 m-20 -110.5 -90.89 0.47 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.797 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 6.8 mp -100.24 10.42 41.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.271 0.628 . . . . 0.0 112.567 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.72 -27.07 68.05 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.482 1.134 . . . . 0.0 108.633 157.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.8 mt -88.89 27.28 1.36 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.125 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 147' ' ' LEU . 83.6 mt -71.98 115.9 42.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 169.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.467 ' HB2' HD11 ' A' ' 156' ' ' LEU . 72.0 Cg_endo -91.15 108.59 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.544 2.163 . . . . 0.0 109.55 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.491 ' HZ1' ' HB2' ' A' ' 152' ' ' LYS . 10.6 mtmp? -96.37 161.39 13.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.712 0.405 . . . . 0.0 111.76 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 190' ' ' LEU . 59.9 mt -56.45 -34.57 66.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.199 1.0 . . . . 0.0 112.551 -170.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.03 -48.72 77.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.243 1.017 . . . . 0.0 109.542 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.1 m -66.02 -49.71 66.78 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.335 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 151' ' ' PRO . 68.3 mt -77.64 -50.74 11.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.917 0.887 . . . . 0.0 112.616 -165.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.5 -36.14 79.66 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.759 0.424 . . . . 0.0 111.033 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.0 t -74.24 -26.98 60.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.908 0.483 . . . . 0.0 111.47 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 10.2 tp10 -76.82 -21.83 54.5 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.305 0.642 . . . . 0.0 110.392 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.58 69.26 72.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.006 0.922 . . . . 0.0 109.11 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.65 0.36 9.42 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.37 2.713 . . . . 0.0 112.389 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.4 t -92.28 -41.91 10.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.8 tp -83.9 72.03 10.44 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.071 1.748 . . . . 0.0 109.745 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.11 124.34 18.4 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.78 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.545 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 25.5 m95 -89.11 130.46 35.55 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.284 1.434 . . . . 0.0 109.985 -169.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.09 -37.82 75.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.122 0.569 . . . . 0.0 110.313 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.93 121.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.84 76.51 1.0 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -145.78 153.12 40.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -91.33 122.18 33.72 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.821 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.0 mt -102.81 131.58 49.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.81 128.88 34.82 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.684 0.394 . . . . 0.0 110.606 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -100.29 125.82 46.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -80.38 102.7 9.76 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.507 ' HB3' ' HG2' ' A' ' 177' ' ' GLU . 59.2 mt -74.34 132.79 42.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.617 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.3 5.84 13.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.831 0.852 . . . . 0.0 111.899 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 175' ' ' LEU . 15.0 mm-40 -58.87 -54.59 45.39 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.922 0.889 . . . . 0.0 110.631 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.15 48.01 79.38 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.95 10.0 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.028 0.931 . . . . 0.0 112.374 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.1 t80 75.45 -66.2 0.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.181 1.792 . . . . 0.0 110.964 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -75.08 -14.85 60.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.691 0.797 . . . . 0.0 110.949 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.23 139.97 20.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.503 0.721 . . . . 0.0 109.505 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.75 -3.49 0.95 Allowed Glycine 0 C--N 1.344 1.026 0 O-C-N 123.677 0.611 . . . . 0.0 112.874 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.88 -176.47 3.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.512 0.656 . . . . 0.0 111.875 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.76 133.03 17.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 109.3 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -84.73 110.36 18.72 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.88 133.69 53.92 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.466 ' HB ' HD22 ' A' ' 153' ' ' LEU . 36.7 pt -123.8 118.78 55.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 118.766 0.712 . . . . 0.0 109.554 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.39 141.42 34.29 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.16 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 153' ' ' LEU . 46.9 mt -129.37 139.78 51.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.657 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.533 HD21 HG12 ' A' ' 24' ' ' VAL . 42.6 tp -145.41 106.17 4.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 168.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.64 146.2 21.41 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -130.0 152.0 49.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.104 0.952 . . . . 0.0 112.236 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.74 112.4 3.69 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.682 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.515 ' H ' ' HB3' ' A' ' 123' ' ' PRO . 3.4 mt -67.45 143.62 56.14 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 138.36 57.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -70.8 84.39 0.65 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.954 0.883 . . . . 0.0 110.908 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -105.66 153.9 21.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 113.867 -1.515 . . . . 0.0 107.735 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -85.69 75.5 10.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 0.0 111.139 -173.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -91.41 87.27 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -98.15 174.54 6.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.239 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 69.9 m80 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.451 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -88.76 69.85 8.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.527 0.68 . . . . 0.0 110.937 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -173.28 19.08 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.817 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.27 110.67 3.13 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.718 0.807 . . . . 0.0 109.582 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -146.07 60.92 1.25 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.324 1.059 . . . . 0.0 108.958 -170.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -61.94 128.98 38.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.833 -167.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m 62.73 18.92 11.04 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.526 1.13 . . . . 0.0 112.422 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.341 0.0 OUTLIER 51.03 -59.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 128.191 2.596 . . . . 0.0 116.078 -175.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t 68.44 13.79 9.03 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.674 1.19 . . . . 0.0 111.303 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -96.32 92.59 6.41 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.379 1.072 . . . . 0.0 108.817 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -75.33 82.7 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.449 0.7 . . . . 0.0 110.283 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.7 m -84.24 161.77 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.076 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -128.72 143.78 51.01 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.662 0.785 . . . . 0.0 109.661 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.01 -115.76 0.65 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 171.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -111.36 139.76 46.51 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 117.384 0.592 . . . . 0.0 110.623 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.11 126.43 92.75 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.991 0.917 . . . . 0.0 110.163 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.41 162.55 35.92 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.335 2.69 . . . . 0.0 114.138 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -92.17 84.07 5.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.836 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.59 -92.82 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.931 1.292 . . . . 0.0 113.635 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -78.25 -19.48 53.63 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.206 1.003 . . . . 0.0 110.847 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD11 HD22 ' A' ' 47' ' ' LEU . 25.3 tp -60.47 -18.05 48.96 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.203 1.001 . . . . 0.0 113.147 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -76.7 -34.86 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.699 0.681 . . . . 0.0 110.589 -168.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p -69.74 -47.94 61.2 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.9 0.88 . . . . 0.0 109.799 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 191' ' ' LEU . 21.6 m -68.43 -41.07 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.31 72.2 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.634 0.773 . . . . 0.0 112.335 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -73.67 -22.21 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.123 0.569 . . . . 0.0 110.497 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -90.21 -18.92 24.83 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.354 0.662 . . . . 0.0 110.379 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 24' ' ' VAL . 70.1 mt -72.3 129.04 88.04 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.118 0.567 . . . . 0.0 110.097 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.83 153.05 69.06 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.564 2.176 . . . . 0.0 112.41 172.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.464 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 51.4 tt0 -68.46 31.1 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.058 1.743 . . . . 0.0 114.654 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -118.64 -156.97 10.31 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.084 -1.01 . . . . 0.0 112.794 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -87.88 121.47 30.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.562 0.745 . . . . 0.0 109.045 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 54' ' ' VAL . 4.3 mt -111.77 148.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.649 0.78 . . . . 0.0 109.592 -168.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.524 ' HA ' ' HG1' ' A' ' 55' ' ' THR . 49.4 tp -106.92 117.28 33.63 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.163 0.438 . . . . 0.0 110.198 171.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 51.1 t -102.98 114.75 29.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.983 0.913 . . . . 0.0 110.072 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.2 mt -81.29 141.29 34.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.75 153.0 37.57 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.614 0.766 . . . . 0.0 110.448 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.57 11.05 8.53 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.555 1.142 . . . . 0.0 109.206 173.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.4 -175.17 30.06 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.536 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -63.19 99.85 0.2 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.004 0.522 . . . . 0.0 111.11 -177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.04 73.97 2.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.465 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -69.66 -31.48 69.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.122 0.569 . . . . 0.0 110.061 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 HD22 HD12 ' A' ' 21' ' ' LEU . 17.4 t-20 -62.33 -41.95 98.98 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.66 87.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.758 0.823 . . . . 0.0 111.454 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.403 ' HA ' HD12 ' A' ' 78' ' ' ILE . 66.8 m -60.86 -34.94 75.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.678 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.57 -32.74 66.27 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.285 0.365 . . . . 0.0 110.484 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.526 HD12 HG11 ' A' ' 99' ' ' VAL . 74.3 mt -67.02 -31.6 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.54 72.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.196 0.598 . . . . 0.0 111.253 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.658 ' HA ' HG13 ' A' ' 76' ' ' VAL . 20.1 m -71.99 -4.39 28.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.711 0.804 . . . . 0.0 112.491 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.28 12.49 15.91 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.332 0.653 . . . . 0.0 110.218 168.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.85 56.27 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 114.163 0.425 . . . . 0.0 114.163 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 11.8 m-85 -114.1 152.24 31.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.79 91.81 8.78 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG23 HD13 ' A' ' 33' ' ' ILE . 92.4 t -91.16 111.94 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.254 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.603 HG22 ' HB ' ' A' ' 79' ' ' THR . 40.4 p -84.22 106.64 16.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 108.314 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.9 129.43 46.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.126 0.571 . . . . 0.0 109.935 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.542 HG21 ' HB ' ' A' ' 81' ' ' VAL . 8.4 t -111.39 120.21 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -129.7 137.42 50.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 23.3 mt-30 -60.41 -25.84 66.23 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.626 1.204 . . . . 0.0 112.238 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 62' ' ' VAL . 19.6 m -97.95 116.18 29.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.453 ' HA ' HD11 ' A' ' 64' ' ' LEU . 60.5 p -66.29 -30.69 71.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.607 0.718 . . . . 0.0 109.954 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 60' ' ' SER . 26.7 m -61.76 -35.95 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.674 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.95 -32.86 60.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.587 0.554 . . . . 0.0 112.062 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 61' ' ' SER . 86.5 mt -62.58 -43.57 98.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.792 0.837 . . . . 0.0 110.742 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.28 94.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.256 0.623 . . . . 0.0 111.708 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -70.19 -30.99 68.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.127 0.571 . . . . 0.0 111.166 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 -44.52 90.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.562 0.745 . . . . 0.0 111.036 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.35 -35.18 68.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.684 0.794 . . . . 0.0 110.995 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.08 -47.63 84.55 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.603 0.761 . . . . 0.0 110.246 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.38 -28.46 67.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.725 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -63.99 -61.52 2.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.276 0.63 . . . . 0.0 111.075 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.66 -29.01 70.0 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.116 0.566 . . . . 0.0 111.005 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -65.1 -43.62 91.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.149 0.58 . . . . 0.0 110.143 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -93.64 -2.73 53.64 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.07 34.48 55.38 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.7 -0.227 . . . . 0.0 113.232 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 49' ' ' SER . 33.5 m -127.45 175.34 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.122 0.969 . . . . 0.0 110.09 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.56 131.66 56.01 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.011 0.924 . . . . 0.0 111.103 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.725 HG12 ' HB1' ' A' ' 71' ' ' ALA . 19.8 mm -110.75 164.39 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 161.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.603 ' HB ' HG22 ' A' ' 55' ' ' THR . 88.8 m -131.88 104.59 6.95 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 p -86.87 121.6 29.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.859 0.463 . . . . 0.0 110.273 -168.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.542 ' HB ' HG21 ' A' ' 57' ' ' VAL . 59.6 t -108.62 136.98 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 108.427 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -79.76 128.6 33.62 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 59' ' ' GLN . 80.4 p -59.63 120.21 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.871 0.732 . . . . 0.0 112.326 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.31 85.16 1.95 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 161.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' HB2' HD22 ' A' ' 109' ' ' LEU . 74.4 mt -84.87 -24.86 28.35 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.233 0.613 . . . . 0.0 110.608 -168.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 -7.67 32.26 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.062 0.945 . . . . 0.0 111.864 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -132.64 -23.43 2.06 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.564 0.746 . . . . 0.0 111.819 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HE2' HG13 ' A' ' 81' ' ' VAL . 38.4 t80 -162.32 116.88 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.286 1.034 . . . . 0.0 109.666 -171.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -125.36 -60.11 1.35 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.605 ' HB ' HD13 ' A' ' 98' ' ' ILE . 34.4 pt -139.99 131.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 118.803 0.729 . . . . 0.0 111.757 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.91 89.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.225 1.01 . . . . 0.0 109.648 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.563 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -70.73 1.01 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.22 -44.27 68.94 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.63 -32.94 64.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.709 0.803 . . . . 0.0 112.566 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.477 ' NE1' HD22 ' A' ' 34' ' ' LEU . 12.7 m95 -109.05 162.69 14.0 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.054 0.542 . . . . 0.0 110.091 -170.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 12.3 tp10 -76.21 -56.86 4.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.35 171.97 17.33 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.605 HD13 ' HB ' ' A' ' 90' ' ' ILE . 74.3 mt -135.89 127.59 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.8 p -114.55 125.11 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -124.39 93.37 3.89 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 128' ' ' ILE . 35.5 mm -65.34 138.79 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -18.47 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.012 1.725 . . . . 0.0 114.098 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.423 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 t -78.44 111.01 14.03 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.849 -171.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -107.81 98.14 7.77 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.423 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 71.3 mt -124.97 140.47 35.92 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.9 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 160.62 45.97 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.921 2.414 . . . . 0.0 110.871 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 m -43.36 -42.41 4.59 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.844 1.258 . . . . 0.0 113.778 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -53.57 -55.42 25.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.143 0.977 . . . . 0.0 112.226 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 85' ' ' LEU . 98.8 mt -83.18 -24.89 32.26 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.214 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.453 HH22 ' HA ' ' A' ' 151' ' ' PRO . 23.9 ttt180 -77.54 -52.57 8.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.054 0.942 . . . . 0.0 109.841 -174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.07 -22.42 66.85 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 0.0 112.277 170.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -75.76 -35.26 60.22 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.41 0.684 . . . . 0.0 109.611 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.4 tp -65.78 -52.17 53.07 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.592 0.757 . . . . 0.0 111.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -58.44 -44.15 98.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -166.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.28 -31.59 81.95 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.713 1.609 . . . . 0.0 112.003 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -81.94 -15.11 54.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.2 0.6 . . . . 0.0 110.91 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 12.0 t -84.0 -42.87 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -59.26 -59.68 5.08 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.08 -48.33 44.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.821 0.849 . . . . 0.0 113.095 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.58 -35.23 17.33 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -165.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.8 tp -77.99 95.18 4.76 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.89 0.845 . . . . 0.0 110.351 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.563 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -75.04 150.74 85.91 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.986 168.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -42.74 117.72 0.97 Allowed 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 124.667 3.578 . . . . 0.0 115.341 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.47 12.46 3.77 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.137 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -104.68 137.75 13.79 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.3 m -105.85 129.55 58.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.73 0.812 . . . . 0.0 110.458 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.65 112.94 25.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 101' ' ' ILE . 46.6 mt -105.26 109.26 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 156' ' ' LEU . 55.7 mt -123.59 134.38 53.82 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -117.57 102.33 9.08 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.535 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -72.37 140.54 29.7 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.914 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.589 ' HB2' HD21 ' A' ' 150' ' ' LEU . 69.5 m-85 -111.23 164.02 13.32 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.122 0.487 . . . . 0.0 111.297 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.87 166.72 32.29 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.006 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.565 ' HA ' HD23 ' A' ' 147' ' ' LEU . 49.1 Cg_endo -64.62 -0.68 3.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.495 2.13 . . . . 0.0 112.872 172.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -82.21 -7.85 59.63 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.383 1.473 . . . . 0.0 111.654 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.497 HE21 ' HA3' ' A' ' 142' ' ' GLY . 53.5 tp60 -72.5 -63.49 1.14 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.726 0.41 . . . . 0.0 111.139 -166.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.546 ' HB3' ' HA2' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -88.66 -9.62 51.44 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.493 0.317 . . . . 0.0 110.655 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -62.72 -50.7 70.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -73.66 -17.67 61.12 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 0.0 110.848 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.4 t30 67.32 27.44 8.24 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.314 1.445 . . . . 0.0 110.307 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -85.66 -2.38 58.13 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.802 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.497 ' HA3' HE21 ' A' ' 136' ' ' GLN . . . -176.93 82.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 137' ' ' LEU . . . -109.9 106.19 2.12 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.836 -0.98 . . . . 0.0 112.253 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.41 -75.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.082 1.854 . . . . 0.0 111.257 173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HB3' ' HZ3' ' A' ' 145' ' ' LYS . 4.2 mmmp? -137.96 -44.82 0.52 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.233 1.013 . . . . 0.0 109.343 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.422 ' C ' HD11 ' A' ' 137' ' ' LEU . 28.3 t70 -156.73 152.4 26.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.67 0.788 . . . . 0.0 109.172 -174.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 134' ' ' PRO . 1.1 mt -57.53 -9.72 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.36 1.464 . . . . 0.0 113.05 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.25 -36.75 68.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.463 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -83.96 4.13 31.07 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.891 0.876 . . . . 0.0 111.731 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 132' ' ' PHE . 62.5 mt -81.73 112.9 38.42 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 167.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.658 ' HB3' HD13 ' A' ' 156' ' ' LEU . 17.0 Cg_exo -69.35 137.73 37.35 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.292 2.661 . . . . 0.0 113.416 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.489 ' HA ' HD13 ' A' ' 188' ' ' ILE . 44.7 mmtm -118.4 148.36 42.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.514 0.726 . . . . 0.0 112.234 171.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 190' ' ' LEU . 39.9 mt -60.92 -42.33 97.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.295 1.038 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -51.78 -45.12 63.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.085 0.865 . . . . 0.0 111.256 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.9 m -77.79 -46.29 22.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.871 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 151' ' ' PRO . 89.4 mt -76.5 -46.29 27.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.833 0.853 . . . . 0.0 113.28 -170.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.525 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.1 tt0 -54.47 -46.0 73.29 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 110.688 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 t -73.03 -22.89 60.56 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.928 0.491 . . . . 0.0 111.769 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -73.51 -30.97 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.42 0.688 . . . . 0.0 110.84 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.61 75.76 76.04 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.69 -11.74 24.17 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.08 2.52 . . . . 0.0 111.549 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -87.51 -39.44 15.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.937 1.295 . . . . 0.0 108.69 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.3 tp -91.52 72.95 5.99 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.075 1.35 . . . . 0.0 110.064 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.23 132.93 55.23 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.525 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 23.4 m95 -94.82 132.33 39.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.509 0.724 . . . . 0.0 109.283 -168.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.84 -30.78 71.05 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.282 0.633 . . . . 0.0 110.337 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.08 127.92 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -146.15 63.42 1.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -108.6 139.17 43.75 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.797 -164.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -96.46 105.91 18.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.078 0.951 . . . . 0.0 109.498 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 47.0 mt -97.18 119.34 35.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.555 0.742 . . . . 0.0 110.902 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.13 121.58 21.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.47 ' HB3' ' HB2' ' A' ' 185' ' ' ALA . 9.1 ttt180 -91.02 142.83 27.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.971 0.509 . . . . 0.0 110.529 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 183' ' ' GLY . 95.3 m-20 -101.69 99.72 10.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.828 0.851 . . . . 0.0 109.171 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 185' ' ' ALA . 46.5 mt -78.01 109.52 12.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.021 0.928 . . . . 0.0 110.395 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -67.23 140.23 57.4 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.05 44.49 5.85 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.544 1.152 . . . . 0.0 110.388 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 129.55 49.1 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.611 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.07 59.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.701 1.2 . . . . 0.0 112.586 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.71 28.77 8.23 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 0.0 109.201 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 8.6 m170 55.88 40.99 30.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 0.0 109.904 -165.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -67.55 -63.49 1.05 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.419 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 174' ' ' ASN . . . 63.45 11.61 41.89 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.445 -0.798 . . . . 0.0 114.553 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.8 147.44 50.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 117.845 0.823 . . . . 0.0 112.061 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 173' ' ' ARG . . . -156.42 157.25 35.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.437 1.495 . . . . 0.0 108.536 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.06 121.14 41.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.389 . . . . 0.0 109.956 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 73.0 mt -117.65 166.11 12.79 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 152' ' ' LYS . 10.2 pt -149.28 149.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.029 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -129.7 150.53 50.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 111.117 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 153' ' ' LEU . 61.6 mt -130.85 135.2 47.5 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.269 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 24' ' ' VAL . 34.4 tp -129.79 104.68 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 167.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -89.21 128.62 9.26 Favored Glycine 0 C--O 1.208 -1.48 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -142.38 156.19 45.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.747 0.819 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -59.71 127.43 31.93 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.428 0.455 . . . . 0.0 109.978 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.8 mt -76.83 96.34 4.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.751 -0.643 . . . . 0.0 110.031 -171.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 45.63 125.32 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.175 1.916 . . . . 0.0 116.175 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -59.85 -27.68 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.208 0.528 . . . . 0.0 110.386 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -112.44 85.23 2.11 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 167.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -49.27 -60.15 3.07 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.936 1.295 . . . . 0.0 112.519 -168.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -80.2 117.09 20.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -59.35 -22.43 61.3 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.063 0.945 . . . . 0.0 111.996 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 79.6 t60 . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 124.861 1.264 . . . . 0.0 110.886 174.163 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -78.77 140.9 38.18 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -171.8 66.91 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.721 1.208 . . . . 0.0 108.339 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.86 74.81 8.97 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.796 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -110.34 100.97 9.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.99 128.79 17.3 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -149.34 122.26 8.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.126 0.57 . . . . 0.0 110.114 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -129.75 92.47 3.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.012 0.925 . . . . 0.0 108.608 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -140.06 39.56 1.95 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.534 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.02 42.15 1.07 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.043 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -74.19 107.82 6.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 109.233 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.56 117.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.857 0.863 . . . . 0.0 110.476 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.58 120.02 20.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.262 0.625 . . . . 0.0 109.362 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.02 92.91 0.1 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -154.59 147.24 24.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.736 0.815 . . . . 0.0 109.721 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -109.54 102.9 51.49 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HB3' ' CD1' ' A' ' 46' ' ' PHE . 30.0 Cg_endo -91.12 -173.08 0.53 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.261 2.641 . . . . 0.0 114.323 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -88.63 143.37 26.98 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.731 165.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 22' ' ' VAL . 6.2 p-10 -70.59 -26.39 63.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.073 0.549 . . . . 0.0 112.228 -171.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -83.31 -23.25 32.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HA ' HG22 ' A' ' 24' ' ' VAL . 56.0 tp -74.17 -41.7 61.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.346 0.659 . . . . 0.0 111.413 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 19' ' ' ASP . 15.6 m -45.76 -41.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 p -80.5 -51.22 9.05 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.073 0.549 . . . . 0.0 111.091 -174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG13 HD23 ' A' ' 191' ' ' LEU . 16.7 m -59.52 -35.53 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.933 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' A' ' 28' ' ' ILE . . . -59.17 -39.53 82.79 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 124.476 1.11 . . . . 0.0 111.734 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.21 -27.95 69.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.636 0.775 . . . . 0.0 110.719 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.467 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 87.7 mm-40 -90.17 -7.66 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.691 0.796 . . . . 0.0 112.634 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 24' ' ' VAL . 68.0 mt -87.41 136.26 33.52 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.895 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.01 134.68 43.21 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.778 2.985 . . . . 0.0 113.752 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -77.61 27.89 0.16 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.99 -134.67 5.52 Favored Glycine 0 N--CA 1.475 1.258 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.874 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.98 112.35 18.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.202 0.501 . . . . 0.0 109.734 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.475 HG22 HG11 ' A' ' 99' ' ' VAL . 18.6 mt -115.04 129.46 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -170.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 89' ' ' ASP . 66.1 tp -94.37 114.44 26.49 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.716 0.406 . . . . 0.0 110.836 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 36.2 t -94.35 140.13 30.19 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -90.91 173.71 7.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.777 0.322 . . . . 0.0 111.554 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -57.64 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.653 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -91.84 -21.39 20.66 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 109.603 173.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.23 90.58 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.73 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -95.25 -49.37 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.117 0.567 . . . . 0.0 110.041 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.79 -28.38 5.46 Favored Glycine 0 CA--C 1.54 1.641 0 O-C-N 123.812 0.695 . . . . 0.0 112.875 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -70.65 -35.7 73.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.98 1.312 . . . . 0.0 111.68 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -64.28 -50.18 68.92 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.597 0.56 . . . . 0.0 110.824 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.75 -50.04 69.38 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.208 0.942 . . . . 0.0 111.508 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.705 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 73.5 m -55.93 -49.02 74.64 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.09 0.956 . . . . 0.0 113.513 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 41.4 t80 -58.16 -43.17 87.25 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.703 0.627 . . . . 0.0 111.011 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 99' ' ' VAL . 60.9 mt -67.92 -32.61 73.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.778 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.06 -33.6 65.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.92 0.488 . . . . 0.0 111.448 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.589 ' HA ' HG11 ' A' ' 76' ' ' VAL . 19.3 m -65.47 -15.3 62.51 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.06 0.944 . . . . 0.0 111.738 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.1 mt -82.7 3.11 30.44 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.553 0.741 . . . . 0.0 110.831 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.92 16.81 62.55 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-O 119.798 -0.446 . . . . 0.0 113.928 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -103.09 155.11 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.695 0.748 . . . . 0.0 110.881 -173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.1 87.69 6.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.533 0.733 . . . . 0.0 109.207 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.88 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 t -86.01 106.74 17.39 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.928 0.891 . . . . 0.0 109.287 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.56 131.32 53.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.469 0.708 . . . . 0.0 110.438 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -95.46 146.68 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 29.9 t0 -150.14 135.34 17.95 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.11 -11.1 60.42 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.825 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.3 t -113.65 164.48 13.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.033 0.933 . . . . 0.0 109.268 169.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -78.2 -26.57 47.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.991 0.516 . . . . 0.0 112.187 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.8 m -56.87 -43.95 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.83 -34.71 62.22 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.203 0.314 . . . . 0.0 112.474 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 94.3 mt -67.86 -59.46 3.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.702 0.801 . . . . 0.0 111.322 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.46 73.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.109 0.964 . . . . 0.0 112.934 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.24 -45.58 92.68 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.839 0.855 . . . . 0.0 110.416 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.705 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -64.11 -46.51 83.89 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.92 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -71.76 -35.22 70.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.231 1.012 . . . . 0.0 111.02 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.43 -61.23 2.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.397 0.679 . . . . 0.0 111.152 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.37 -22.6 66.25 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.567 0.542 . . . . 0.0 111.17 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.74 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.6 -63.63 1.05 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.984 174.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.93 -30.59 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.04 0.536 . . . . 0.0 110.824 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.39 -31.51 71.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.255 1.022 . . . . 0.0 111.474 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -102.25 1.69 36.15 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.116 0.566 . . . . 0.0 111.417 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.48 67.76 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 122.355 -0.216 . . . . 0.0 113.233 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.7 m -124.08 -179.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 108.182 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.78 131.92 36.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.74 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.7 mm -106.96 166.88 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 166.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -129.42 105.75 8.31 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.3 p -85.69 119.83 26.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.092 0.557 . . . . 0.0 110.924 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.9 124.18 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.044 1.337 . . . . 0.0 109.264 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -100.24 91.7 4.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -142.57 -177.6 5.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.237 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -146.33 136.91 24.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -162.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 14.2 mt -76.19 -8.46 57.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 123.543 0.527 . . . . 0.0 112.389 -166.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -94.77 -0.32 54.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.834 0.454 . . . . 0.0 112.144 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -123.42 -44.17 2.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.824 0.449 . . . . 0.0 110.685 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -169.46 124.52 0.83 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.513 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -134.96 -72.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.059 0.944 . . . . 0.0 109.308 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.576 ' HB ' HD13 ' A' ' 98' ' ' ILE . 10.7 pt -129.55 122.74 56.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 C-N-CA 123.199 0.599 . . . . 0.0 111.616 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.92 94.64 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.698 1.199 . . . . 0.0 108.816 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.25 -0.52 2.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -73.49 -48.05 36.45 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.883 0.473 . . . . 0.0 110.291 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.05 61.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.11 0.564 . . . . 0.0 112.259 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.445 ' NE1' HD23 ' A' ' 34' ' ' LEU . 13.7 m95 -113.17 139.08 49.06 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.009 0.524 . . . . 0.0 109.847 -170.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.97 -40.12 79.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.33 174.65 29.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.025 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' A' ' 90' ' ' ILE . 64.3 mt -132.12 140.56 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 6.2 p -124.84 108.48 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.749 0.82 . . . . 0.0 109.1 167.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.475 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 42.7 m -108.89 89.49 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 32.1 mm -70.59 149.83 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.943 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -17.66 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 127.394 2.278 . . . . 0.0 112.61 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.8 p -99.78 104.78 16.5 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.848 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -96.57 98.07 9.91 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.61 147.83 40.61 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.916 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.613 ' HA ' HD12 ' A' ' 149' ' ' LEU . 46.8 Cg_exo -59.05 149.28 80.78 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.282 1.988 . . . . 0.0 110.099 160.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 11.7 t -57.78 -22.72 48.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.421 0.688 . . . . 0.0 112.187 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t -52.87 -55.82 20.39 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.566 0.746 . . . . 0.0 111.363 168.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.9 mt -81.0 -27.47 35.87 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.472 0.709 . . . . 0.0 110.824 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.619 HH11 ' HB3' ' A' ' 151' ' ' PRO . 11.3 ttp180 -68.48 -56.27 8.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.966 0.906 . . . . 0.0 110.334 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -37.52 63.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.45 1.1 . . . . 0.0 111.328 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 6.2 tp-100 -70.38 -31.9 69.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.107 0.563 . . . . 0.0 110.22 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 117' ' ' VAL . 45.6 tp -76.46 -33.84 58.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.945 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -55.1 -47.33 98.77 Favored Pre-proline 0 CA--C 1.569 1.695 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.79 -29.67 90.5 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.247 1.965 . . . . 0.0 112.672 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -75.26 -31.73 60.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.735 0.814 . . . . 0.0 111.142 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 1.6 t -88.37 -27.23 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.363 0.601 . . . . 0.0 110.735 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.61 -64.61 1.15 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.29 -49.76 10.35 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.69 -33.58 63.36 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 113.711 0.245 . . . . 0.0 113.711 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.5 tp -78.69 131.22 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.297 0.57 . . . . 0.0 109.791 171.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -114.82 161.71 27.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.797 1.239 . . . . 0.0 107.988 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -36.4 114.72 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 124.305 3.337 . . . . 0.0 115.529 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.535 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.52 -0.85 5.97 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.678 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -100.3 148.62 18.45 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 166.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.92 131.7 65.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 C-N-CA 124.493 1.117 . . . . 0.0 109.103 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.7 t80 -109.33 109.13 19.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 24' ' ' VAL . 43.8 mt -111.34 108.07 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.298 1.039 . . . . 0.0 108.608 -170.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 95.1 mt -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.774 0.83 . . . . 0.0 111.144 -172.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.4 101.78 4.93 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.8 118.39 6.06 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.438 ' O ' HD13 ' A' ' 150' ' ' LEU . 27.1 m-85 -78.83 169.4 18.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.415 1.086 . . . . 0.0 109.873 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.15 133.87 39.96 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.584 . . . . 0.0 111.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.83 -17.56 44.21 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.621 2.881 . . . . 0.0 112.337 174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -54.35 -31.02 53.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.825 1.25 . . . . 0.0 111.484 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.683 ' HB3' HD23 ' A' ' 147' ' ' LEU . 61.1 tp60 -60.08 -58.55 8.05 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 123.639 0.587 . . . . 0.0 110.757 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 14.9 mt -57.75 -35.54 70.85 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.245 0.545 . . . . 0.0 111.5 172.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -71.54 -15.51 62.29 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.933 -170.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -55.91 -43.62 77.47 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 123.003 0.521 . . . . 0.0 110.901 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.72 169.75 8.33 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 172.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -79.12 2.86 19.36 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.29 133.25 1.55 Allowed Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.791 -0.524 . . . . 0.0 111.791 174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.61 64.32 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.222 -0.765 . . . . 0.0 111.553 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.14 -169.53 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.332 2.688 . . . . 0.0 112.389 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 tptm 90.37 1.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.812 1.245 . . . . 0.0 109.777 171.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -131.32 -90.77 0.43 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 136' ' ' GLN . 4.8 mp -80.65 22.88 0.55 Allowed 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.428 ' N ' HD11 ' A' ' 137' ' ' LEU . 31.3 t70 -85.08 -29.44 24.88 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 164.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 106' ' ' PRO . 13.9 mt -84.69 24.41 1.03 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.045 2.138 . . . . 0.0 111.931 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 147' ' ' LEU . 95.7 mt -74.99 113.25 22.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 123.351 0.407 . . . . 0.0 110.481 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.619 ' HB3' HH11 ' A' ' 110' ' ' ARG . 93.4 Cg_endo -87.01 129.55 2.9 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.258 1.972 . . . . 0.0 111.405 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -81.36 164.37 22.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.718 0.807 . . . . 0.0 111.54 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.487 HD23 ' HB ' ' A' ' 188' ' ' ILE . 81.1 mt -60.62 -41.47 94.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.155 0.582 . . . . 0.0 110.478 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.51 -39.49 67.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.398 0.679 . . . . 0.0 111.471 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.4 p -81.48 -53.6 6.14 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.486 0.314 . . . . 0.0 110.732 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -61.63 -50.59 71.92 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.576 1.15 . . . . 0.0 111.93 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -65.48 -30.81 71.63 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.787 0.835 . . . . 0.0 111.702 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.6 t -73.19 -29.43 62.82 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 122.812 0.445 . . . . 0.0 111.08 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 -10.66 58.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.087 0.555 . . . . 0.0 111.021 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 96.5 mt -141.34 71.03 27.06 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.459 0.704 . . . . 0.0 109.559 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.59 7.38 4.69 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.065 2.51 . . . . 0.0 111.298 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.0 t -90.71 -41.17 11.44 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.4 tp -91.82 71.18 5.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.024 1.33 . . . . 0.0 110.626 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.495 ' HB3' HD23 ' A' ' 195' ' ' LEU . 4.0 t-20 -59.89 129.77 43.47 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.446 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 28.9 m95 -95.54 141.37 29.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.014 0.926 . . . . 0.0 110.765 -164.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.15 -36.81 72.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.172 0.589 . . . . 0.0 110.345 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.88 125.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.24 84.26 1.13 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.664 0.785 . . . . 0.0 109.916 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -155.92 155.59 33.11 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.485 0.314 . . . . 0.0 111.475 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.08 110.98 13.52 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.55 130.37 47.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.275 0.63 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 146.09 24.07 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -133.75 138.99 46.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.49 0.716 . . . . 0.0 109.666 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.46 117.1 18.59 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.133 0.573 . . . . 0.0 110.552 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.64 170.4 9.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.835 0.854 . . . . 0.0 110.373 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.81 106.52 0.5 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.38 119.97 20.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.13 0.572 . . . . 0.0 109.791 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -66.32 -67.48 1.99 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.24 -72.86 0.03 OUTLIER 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.463 0.705 . . . . 0.0 109.963 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -86.7 -38.26 17.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.147 0.579 . . . . 0.0 110.076 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -71.95 126.2 29.14 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -65.72 140.03 58.42 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.35 1.031 . . . . 0.0 110.638 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -85.21 63.04 4.42 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.861 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.12 161.75 28.51 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.84 0.856 . . . . 0.0 111.28 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.78 134.37 38.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.429 1.091 . . . . 0.0 109.061 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.18 100.38 12.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 132' ' ' PHE . 56.4 mt -116.71 163.86 15.49 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.487 ' HB ' HD23 ' A' ' 153' ' ' LEU . 44.4 pt -135.93 139.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -132.69 151.28 52.01 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.976 0.893 . . . . 0.0 111.365 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 64.5 mt -136.29 138.26 41.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 113.329 -1.76 . . . . 0.0 108.791 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.522 HD23 HG13 ' A' ' 24' ' ' VAL . 27.9 tp -129.71 107.52 9.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 168.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.03 139.84 17.26 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.467 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 8.3 tp-100 -140.32 153.02 46.3 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.438 0.695 . . . . 0.0 109.693 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.535 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 18.1 pttp -58.17 128.43 37.09 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.806 0.691 . . . . 0.0 109.254 170.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 164' ' ' ASN . 4.5 mt -69.6 111.05 5.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -50.04 70.69 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.872 0.733 . . . . 0.0 109.493 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -107.73 112.33 24.95 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -77.43 76.49 3.97 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -79.39 121.9 25.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.481 -170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -139.48 96.83 3.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 64.88 101.27 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.439 1.496 . . . . 0.0 110.262 -169.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.702 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -85.81 170.33 12.51 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.243 0.617 . . . . 0.0 110.057 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -144.67 144.75 31.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.73 0.412 . . . . 0.0 110.196 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.6 71.42 7.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -87.94 150.6 23.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.042 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -163.11 127.51 2.97 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.1 m -129.67 105.07 7.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 108.922 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.05 179.12 4.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.231 0.612 . . . . 0.0 111.512 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -137.55 127.6 25.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.094 0.558 . . . . 0.0 110.341 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.21 100.86 6.91 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.981 0.912 . . . . 0.0 109.784 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -151.41 95.27 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.4 m -91.91 137.31 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.114 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -163.76 147.08 9.98 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 0.0 109.51 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.76 89.08 0.11 Allowed Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 t -62.39 123.54 18.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.534 0.734 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.05 98.79 40.49 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 124.059 0.944 . . . . 0.0 108.583 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.52 112.4 3.45 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.384 2.056 . . . . 0.0 109.934 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -51.96 116.97 2.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.187 0.995 . . . . 0.0 111.056 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.3 t70 -155.88 173.74 16.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.954 0.502 . . . . 0.0 110.867 -167.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.45 ' O ' HG11 ' A' ' 24' ' ' VAL . 43.4 t80 -63.99 -41.04 97.64 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.509 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.477 ' O ' HG21 ' A' ' 24' ' ' VAL . 37.4 tp -62.22 -47.51 84.11 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.806 0.842 . . . . 0.0 112.065 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 19' ' ' ASP . 5.9 m -54.81 -33.67 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -70.39 -50.95 33.42 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.621 0.768 . . . . 0.0 110.903 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.533 HG22 HD12 ' A' ' 128' ' ' ILE . 2.7 m -64.46 -30.13 49.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.558 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 50' ' ' LEU . . . -59.49 -38.17 80.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.625 1.17 . . . . 0.0 111.243 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -70.13 -29.07 65.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.383 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -87.93 -7.23 57.43 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.632 0.773 . . . . 0.0 112.41 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 24' ' ' VAL . 89.9 mt -82.51 123.45 78.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -52.34 133.49 48.32 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.175 2.583 . . . . 0.0 113.131 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -67.1 31.0 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 126.928 2.091 . . . . 0.0 116.138 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.4 -154.34 10.95 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.663 -0.52 . . . . 0.0 112.483 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.09 120.65 19.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.128 0.571 . . . . 0.0 110.572 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 mt -109.07 135.88 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 0.0 110.07 -167.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 55' ' ' THR . 67.9 tp -110.4 118.26 35.8 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.002 0.521 . . . . 0.0 109.714 171.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 42.3 t -96.58 130.86 43.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.227 1.011 . . . . 0.0 109.462 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -95.1 117.56 30.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 164.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.9 163.72 13.59 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.55 0.691 . . . . 0.0 111.012 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.71 21.53 3.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.879 -175.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.19 134.9 7.43 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 76.37 -47.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.851 1.661 . . . . 0.0 112.988 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 32.63 84.84 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 113.341 0.096 . . . . 0.0 113.341 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -60.6 -34.37 74.11 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.679 0.752 . . . . 0.0 109.903 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.0 p30 -56.15 -48.08 76.97 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.163 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.3 93.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.748 0.819 . . . . 0.0 111.324 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 14.4 m -61.79 -42.27 98.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.668 0.787 . . . . 0.0 112.465 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -64.61 -44.74 89.6 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.791 0.682 . . . . 0.0 109.876 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 99' ' ' VAL . 81.2 mt -67.51 -32.7 73.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 -34.39 67.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.174 0.59 . . . . 0.0 111.59 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.741 ' HA ' HG12 ' A' ' 76' ' ' VAL . 28.4 t -68.71 -9.93 53.39 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.831 0.852 . . . . 0.0 111.7 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD12 ' HB1' ' A' ' 25' ' ' ALA . 85.4 mt -78.54 6.73 7.99 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.329 0.652 . . . . 0.0 111.105 170.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.52 27.69 26.6 Favored Glycine 0 C--N 1.359 1.808 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.962 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -130.52 163.05 27.9 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.492 0.646 . . . . 0.0 111.016 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.97 93.06 6.39 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.61 112.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.7 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 34' ' ' LEU . 57.6 m -86.09 108.84 18.46 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.053 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.4 130.14 47.55 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.957 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.6 116.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 124.87 44.01 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.08 -25.71 46.58 Favored 'General case' 0 CA--C 1.562 1.41 0 O-C-N 124.593 1.183 . . . . 0.0 111.678 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -112.31 121.64 45.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.404 1.082 . . . . 0.0 108.786 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.423 ' HA ' HD12 ' A' ' 64' ' ' LEU . 34.8 p -69.03 -15.28 63.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 112.406 -173.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.5 m -56.48 -44.25 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.434 0.459 . . . . 0.0 110.82 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.86 -30.08 66.36 Favored Glycine 0 C--N 1.358 1.792 0 O-C-N 123.654 0.596 . . . . 0.0 113.036 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 91.1 mt -64.85 -45.96 83.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.749 0.82 . . . . 0.0 110.695 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -62.6 -39.42 93.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.593 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 73.4 mmtt -64.98 -43.44 92.59 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.715 0.406 . . . . 0.0 109.914 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.558 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -57.62 -40.68 79.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.6 -36.42 73.52 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.68 0.792 . . . . 0.0 111.488 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 26.4 mt-30 -57.6 -58.27 9.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.594 0.757 . . . . 0.0 111.718 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 38.2 tp -67.41 -24.94 65.71 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.213 -176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.35 7.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.481 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.39 -27.82 68.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.832 0.453 . . . . 0.0 111.108 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.35 -44.42 92.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.279 1.032 . . . . 0.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 6.19 46.48 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.659 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.52 39.28 50.35 Favored Glycine 0 C--N 1.356 1.65 0 N-CA-C 113.936 0.334 . . . . 0.0 113.936 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 49' ' ' SER . 32.7 m -136.31 175.45 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.117 0.967 . . . . 0.0 109.524 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -129.52 142.67 50.71 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.025 0.44 . . . . 0.0 112.131 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 45' ' ' CYS . 17.7 mm -105.53 169.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.13 1.372 . . . . 0.0 107.43 170.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 m -121.47 105.87 10.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 164.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 64' ' ' LEU . 70.0 p -93.05 111.16 22.7 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 110.655 -165.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.64 124.81 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.6 1.16 . . . . 0.0 110.082 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.51 95.28 6.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -144.34 -174.66 4.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.848 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -144.87 127.52 16.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -158.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD12 HD13 ' A' ' 105' ' ' LEU . 26.5 mt -68.81 -6.06 24.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.151 0.58 . . . . 0.0 112.542 -172.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -96.9 9.98 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.267 1.027 . . . . 0.0 112.6 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.9 -46.44 0.27 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.207 0.603 . . . . 0.0 110.379 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -155.37 122.87 5.59 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.983 1.713 . . . . 0.0 106.594 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -135.39 -71.8 0.47 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 117' ' ' VAL . 14.5 pt -143.25 123.01 9.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.497 0.719 . . . . 0.0 109.904 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.92 84.91 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -67.18 -5.97 15.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.91 -39.27 93.79 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.562 0.745 . . . . 0.0 109.111 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.99 -20.46 24.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.029 0.932 . . . . 0.0 111.9 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -121.7 114.08 20.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 0.0 109.946 -170.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.2 -43.83 81.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.584 0.754 . . . . 0.0 110.337 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.16 151.3 18.24 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.042 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.56 HD13 HD12 ' A' ' 121' ' ' LEU . 73.1 mt -132.07 148.17 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.4 p -135.49 120.79 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.246 1.018 . . . . 0.0 108.417 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.4 m -108.69 93.23 4.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.624 HD12 HD11 ' A' ' 128' ' ' ILE . 23.3 mm -70.44 140.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.829 0.852 . . . . 0.0 109.512 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -14.0 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.03 2.132 . . . . 0.0 113.691 -171.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.77 107.1 19.46 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.25 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -105.5 101.15 10.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 85' ' ' LEU . 82.4 mt -121.35 138.8 28.63 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.47 163.53 35.92 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.158 2.572 . . . . 0.0 110.717 171.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -35.98 -43.46 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 126.105 1.762 . . . . 0.0 114.875 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 p -57.0 -56.49 21.1 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.641 0.776 . . . . 0.0 110.957 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 94.1 mt -84.39 -22.85 30.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.768 0.827 . . . . 0.0 110.555 -172.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -73.51 -61.26 1.89 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.956 0.903 . . . . 0.0 109.656 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.82 -9.62 15.82 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.226 0.611 . . . . 0.0 112.159 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 24.6 tp60 -87.43 -37.77 16.71 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.673 0.389 . . . . 0.0 110.748 170.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HG22 ' A' ' 117' ' ' VAL . 62.7 tp -85.56 -61.27 1.8 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 77.6 m-85 -68.48 -39.57 16.09 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -160.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 45.9 Cg_endo -66.35 -23.96 50.78 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 121.908 1.738 . . . . 0.0 111.894 170.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -83.12 -19.74 36.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.955 0.902 . . . . 0.0 109.286 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.596 HG21 ' HE2' ' A' ' 127' ' ' PHE . 39.1 t -77.0 -38.81 28.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -49.67 -57.83 6.46 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.5 -46.81 62.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.093 0.957 . . . . 0.0 113.004 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.04 -37.65 28.5 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -166.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.754 HD13 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -77.1 109.62 11.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 109.109 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.453 ' HZ3' ' HB2' ' A' ' 122' ' ' LYS . 10.0 mtmp? -79.79 163.83 56.36 Favored Pre-proline 0 C--O 1.247 0.931 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.98 115.41 0.87 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.72 2.28 . . . . 0.0 113.542 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.557 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.6 12.87 2.92 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.943 172.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.754 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -107.91 148.91 16.71 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 117.482 0.641 . . . . 0.0 112.508 166.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.4 139.5 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.126 0.97 . . . . 0.0 109.024 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.596 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.49 121.07 41.6 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 101' ' ' ILE . 55.1 mt -110.91 109.04 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.758 0.823 . . . . 0.0 109.201 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 47.5 mt -125.8 144.0 50.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.933 0.893 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -132.23 102.5 5.8 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.94 -173.37 46.58 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.52 ' HB2' HD21 ' A' ' 150' ' ' LEU . 71.5 m-85 -135.31 158.98 43.0 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.0 161.91 56.41 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.594 0.758 . . . . 0.0 111.648 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.03 -24.05 71.61 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.159 2.572 . . . . 0.0 113.431 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.39 -14.25 57.38 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.516 -0.766 . . . . 0.0 113.053 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 132' ' ' PHE . 9.1 tp-100 -70.91 -60.66 2.11 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.455 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 3.7 mt -75.32 -8.6 57.09 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.127 0.489 . . . . 0.0 110.071 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.65 -17.01 61.2 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.563 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -61.17 -54.62 42.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -170.54 -162.07 0.27 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -75.72 3.48 9.69 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.843 1.202 . . . . 0.0 112.191 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.18 98.7 0.06 OUTLIER Glycine 0 C--N 1.358 1.78 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 171.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.73 -170.99 39.26 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -166.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.96 -57.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.91 2.407 . . . . 0.0 111.04 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -157.42 -44.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.727 1.211 . . . . 0.0 109.594 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -167.92 152.3 6.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.586 0.755 . . . . 0.0 109.509 -166.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.455 ' HG ' ' HB2' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -61.09 -6.79 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.91 -36.85 78.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.065 0.46 . . . . 0.0 110.346 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.37 12.04 1.36 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.02 0.928 . . . . 0.0 113.048 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 132' ' ' PHE . 48.1 mt -88.38 110.59 37.56 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.594 ' HB2' HD11 ' A' ' 156' ' ' LEU . 5.1 Cg_exo -76.41 104.28 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.581 2.187 . . . . 0.0 109.387 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HA ' HD12 ' A' ' 188' ' ' ILE . 53.6 mtpt -94.93 160.24 14.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.171 0.588 . . . . 0.0 111.287 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.431 HD22 HD23 ' A' ' 190' ' ' LEU . 71.9 mt -53.26 -37.57 62.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.911 0.884 . . . . 0.0 110.929 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.06 -54.36 20.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.057 1.343 . . . . 0.0 111.74 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -76.24 -45.93 30.53 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.306 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 151' ' ' PRO . 82.7 mt -71.38 -49.73 39.17 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.714 0.806 . . . . 0.0 112.411 -168.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -58.75 -37.69 76.8 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 0.0 111.637 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.0 t -76.62 -17.58 59.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.294 0.238 . . . . 0.0 111.421 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.99 -5.54 55.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.644 0.378 . . . . 0.0 110.619 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 39.3 mt -145.71 59.1 5.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.488 1.115 . . . . 0.0 108.532 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.04 -26.34 21.7 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.06 2.507 . . . . 0.0 112.731 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -90.24 -14.41 33.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.485 0.714 . . . . 0.0 110.209 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 17.7 tp -89.75 69.28 7.64 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.596 1.158 . . . . 0.0 108.628 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.532 ' HB3' HD23 ' A' ' 195' ' ' LEU . 28.2 t30 -61.93 124.62 21.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -88.68 143.53 26.87 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.429 1.091 . . . . 0.0 109.594 -165.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.14 -39.07 72.18 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.172 0.589 . . . . 0.0 109.976 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 75.6 mt -129.14 119.08 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.73 86.05 1.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.747 0.819 . . . . 0.0 109.328 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -160.19 157.96 29.25 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.461 ' HA ' HG21 ' A' ' 188' ' ' ILE . 26.0 p-10 -75.35 104.93 6.12 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 mt -102.04 135.44 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 159.02 18.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.651 0.263 . . . . 0.0 110.753 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -141.88 134.78 28.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.32 114.85 7.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.671 0.788 . . . . 0.0 110.5 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.407 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 59.6 mt -82.43 167.44 18.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.465 0.706 . . . . 0.0 109.601 168.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.14 -19.9 19.03 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 160.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -76.66 124.64 27.95 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.032 0.933 . . . . 0.0 110.709 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 182' ' ' GLN . . . -87.5 67.52 3.26 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.43 -148.38 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.214 1.006 . . . . 0.0 110.867 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -51.58 -43.09 62.32 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.584 0.754 . . . . 0.0 109.393 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -104.26 120.28 40.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.452 ' HA ' ' HA2' ' A' ' 178' ' ' GLY . 35.8 tt0 -67.66 103.56 1.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.561 0.745 . . . . 0.0 110.968 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 175' ' ' LEU . . . 64.09 18.61 62.74 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.435 -0.802 . . . . 0.0 114.517 174.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -130.9 146.97 52.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.427 0.691 . . . . 0.0 109.419 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.52 140.58 44.87 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.841 0.856 . . . . 0.0 110.137 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.48 114.8 28.69 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.5 mt -126.56 174.88 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 152' ' ' LYS . 23.8 pt -139.23 139.05 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -127.22 149.94 49.76 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.783 0.802 . . . . 0.0 110.804 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 67.7 mt -133.57 136.53 45.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.395 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -137.25 108.26 6.73 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.7 147.39 22.02 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -142.55 150.88 40.99 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.551 0.74 . . . . 0.0 110.127 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.557 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 13.1 ptmm? -59.96 143.08 52.57 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.532 HD23 ' HB3' ' A' ' 164' ' ' ASN . 9.8 mt -88.56 161.44 16.95 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.426 ' HB2' ' NZ ' ' A' ' 194' ' ' LYS . 22.5 tt0 -157.29 55.32 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.283 1.04 . . . . 0.0 109.895 173.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -143.5 38.69 1.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -65.66 170.46 5.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.329 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 67.49 81.19 0.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.163 1.385 . . . . 0.0 111.208 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -103.22 174.47 5.85 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 165.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -80.01 151.32 30.04 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.737 0.415 . . . . 0.0 110.848 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 36.9 m80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.856 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -62.13 127.04 29.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.055 0.542 . . . . 0.0 110.693 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.68 143.98 25.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.622 0.769 . . . . 0.0 112.098 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -140.11 80.65 1.77 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.044 1.338 . . . . 0.0 108.54 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -73.12 137.69 45.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.575 0.75 . . . . 0.0 109.866 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.4 137.98 24.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.252 0.621 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -150.67 107.62 3.56 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -78.71 86.85 4.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.457 0.703 . . . . 0.0 110.675 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -82.89 69.62 9.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.008 0.908 . . . . 0.0 109.265 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.6 7.74 19.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.397 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.09 136.34 34.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.976 0.91 . . . . 0.0 109.379 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.87 64.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.926 0.869 . . . . 0.0 109.03 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -87.3 71.88 9.92 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.095 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.0 24.22 0.08 OUTLIER Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.239 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.9 p -70.77 101.84 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.68 0.792 . . . . 0.0 110.082 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.79 123.92 66.66 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.571 0.748 . . . . 0.0 110.028 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.34 -168.24 0.42 Allowed 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.862 2.375 . . . . 0.0 111.478 166.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -113.31 121.75 45.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.64 0.776 . . . . 0.0 110.125 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -176.95 -177.84 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.579 1.152 . . . . 0.0 108.519 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.86 -34.99 20.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 165.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.61 HD22 ' HG ' ' A' ' 47' ' ' LEU . 24.3 tp -62.78 -47.01 85.33 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.553 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -45.68 -33.78 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -68.76 -51.5 40.53 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.34 0.656 . . . . 0.0 110.135 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 21' ' ' LEU . 2.5 m -62.4 -32.9 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.466 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.75 74.53 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.519 1.128 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.58 -21.53 61.13 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.306 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.641 ' HB3' HE21 ' A' ' 193' ' ' GLN . 84.1 mm-40 -84.1 -23.4 30.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.392 0.677 . . . . 0.0 111.207 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 24' ' ' VAL . 63.2 mt -82.23 135.22 47.72 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -52.99 145.61 40.63 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.82 2.347 . . . . 0.0 112.043 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -65.5 29.81 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -115.6 -167.39 15.12 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 118.999 0.818 . . . . 0.0 111.818 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -73.36 127.7 33.4 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.852 0.358 . . . . 0.0 110.309 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 HD12 HG23 ' A' ' 28' ' ' ILE . 5.2 mt -113.77 135.93 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.439 -168.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.479 HD22 ' CD1' ' A' ' 95' ' ' TRP . 54.2 tp -98.76 119.99 38.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 6.8 p -110.83 118.64 36.68 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.768 0.827 . . . . 0.0 109.983 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 90' ' ' ILE . 58.2 mt -78.27 135.98 37.66 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 168.91 23.66 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 108.808 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 10.76 0.97 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.965 0.506 . . . . 0.0 111.652 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.39 -31.85 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 C-N-CA 121.944 -0.169 . . . . 0.0 113.276 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.89 151.75 20.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.996 0.918 . . . . 0.0 110.171 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.17 65.26 0.31 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 113.366 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -69.68 -42.64 73.87 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.526 0.73 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HB3' HD11 ' A' ' 21' ' ' LEU . 14.3 m120 -73.07 -32.76 65.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.203 0.601 . . . . 0.0 110.367 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -58.01 -51.8 68.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.668 0.787 . . . . 0.0 110.569 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 31.0 m -65.9 -32.89 74.65 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.575 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 38.2 t80 -67.81 -32.14 72.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.61 ' HG ' HD22 ' A' ' 21' ' ' LEU . 37.0 mt -65.84 -33.53 76.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.309 0.644 . . . . 0.0 110.531 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.29 70.65 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.862 0.363 . . . . 0.0 110.896 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HG12 ' A' ' 76' ' ' VAL . 35.6 t -65.75 -18.23 65.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.654 0.782 . . . . 0.0 111.579 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.544 HD13 HD22 ' A' ' 47' ' ' LEU . 55.9 mt -89.15 18.93 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.914 0.885 . . . . 0.0 110.794 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.88 19.61 78.68 Favored Glycine 0 C--N 1.362 1.974 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -104.06 148.42 26.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.092 0.557 . . . . 0.0 109.941 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -88.56 88.98 7.8 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.8 t -94.59 109.94 22.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.611 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.59 HG23 ' HB ' ' A' ' 79' ' ' THR . 69.6 p -84.31 112.62 20.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.312 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -106.43 111.65 24.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.834 0.854 . . . . 0.0 111.047 -172.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 34' ' ' LEU . 22.3 t -81.24 126.82 39.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.35 119.58 11.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.46 -18.18 65.12 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.617 0.573 . . . . 0.0 111.957 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.1 m -97.45 130.39 44.56 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.7 p -65.59 -27.71 68.61 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 18.4 m -63.27 -41.0 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.3 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.54 -40.81 94.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.647 0.592 . . . . 0.0 112.328 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.5 -42.16 83.3 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.537 0.735 . . . . 0.0 111.287 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.22 90.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.782 0.833 . . . . 0.0 112.328 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 2.8 mmmp? -65.85 -41.97 91.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.845 0.458 . . . . 0.0 110.134 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.652 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -61.0 -55.4 33.29 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.607 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.37 -23.41 50.81 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.69 -44.52 96.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 45' ' ' CYS . 35.2 tp -69.11 -24.25 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.651 0.594 . . . . 0.0 111.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.14 -51.63 68.25 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.484 0.659 . . . . 0.0 109.434 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -72.58 -30.29 64.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.005 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.22 -53.62 10.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.598 0.759 . . . . 0.0 110.804 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.36 -1.4 55.95 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.5 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 38.77 78.43 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.846 -0.161 . . . . 0.0 113.299 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -112.97 173.99 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.734 0.814 . . . . 0.0 109.849 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.487 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 5.0 ttmp? -111.65 121.1 44.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.15 0.58 . . . . 0.0 111.152 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.536 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.2 mm -107.26 163.41 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 164.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.59 ' HB ' HG23 ' A' ' 55' ' ' THR . 29.7 m -133.59 106.13 7.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p -87.04 112.85 22.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.436 0.694 . . . . 0.0 111.083 -166.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.13 126.41 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.013 1.325 . . . . 0.0 109.303 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -104.77 92.34 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -134.21 -176.83 4.33 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -141.14 110.1 6.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.734 -1.121 . . . . 0.0 107.999 -158.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 105' ' ' LEU . 17.7 mt -65.87 -7.69 17.84 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.507 1.123 . . . . 0.0 111.733 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.591 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -57.97 -41.91 83.93 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.325 1.05 . . . . 0.0 112.218 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -151.67 12.36 0.61 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.27 110.24 1.58 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.447 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -138.26 -73.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.501 HG21 HD11 ' A' ' 36' ' ' LEU . 17.7 pt -119.72 117.79 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.49 87.05 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.405 0.682 . . . . 0.0 109.537 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.57 -30.04 4.89 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.231 1.413 . . . . 0.0 114.153 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.51 -46.11 80.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.431 0.692 . . . . 0.0 109.272 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.35 -25.71 51.33 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.479 ' CD1' HD22 ' A' ' 34' ' ' LEU . 47.9 m95 -117.5 166.32 12.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -169.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 11.3 tp10 -94.07 -74.63 0.53 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.855 0.862 . . . . 0.0 109.836 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.87 162.11 17.46 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.514 HD12 HD12 ' A' ' 121' ' ' LEU . 54.1 mt -128.7 147.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -139.24 141.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.893 1.277 . . . . 0.0 107.87 167.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . 50.5 m -136.97 92.31 2.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.432 HD12 HD13 ' A' ' 128' ' ' ILE . 40.7 mm -62.28 133.51 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.55 ' HA ' HD22 ' A' ' 129' ' ' LEU . 14.6 p90 -20.93 102.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.123 2.139 . . . . 0.0 114.148 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 71.0 m -77.95 103.42 7.88 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.058 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -91.09 96.94 10.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 85' ' ' LEU . 86.8 mt -125.65 142.33 41.7 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.201 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.01 159.88 36.48 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.534 2.156 . . . . 0.0 110.707 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.3 p -41.87 -43.14 2.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.5 1.52 . . . . 0.0 113.668 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -55.77 -50.93 69.1 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.209 0.943 . . . . 0.0 112.172 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.92 -33.94 33.74 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.284 0.634 . . . . 0.0 111.714 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.42 -43.63 31.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.583 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.44 -35.0 18.1 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.693 0.797 . . . . 0.0 111.967 165.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.591 HE22 ' HA ' ' A' ' 86' ' ' ALA . 24.9 tt0 -79.47 -33.03 42.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.64 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' O ' HG22 ' A' ' 117' ' ' VAL . 48.1 tp -71.21 -48.61 50.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.891 0.476 . . . . 0.0 111.581 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -60.93 -42.77 88.67 Favored Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -167.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.43 -25.45 48.61 Favored 'Trans proline' 0 C--N 1.396 3.076 0 CA-C-N 121.364 1.523 . . . . 0.0 111.984 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -81.7 -21.17 38.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 122.995 0.518 . . . . 0.0 110.357 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 113' ' ' LEU . 19.3 t -85.03 -35.74 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.595 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 42.4 t80 -48.9 -61.6 1.96 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.125 0.97 . . . . 0.0 112.256 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.417 ' HG3' ' HD1' ' A' ' 118' ' ' TYR . 47.9 mt-30 -95.46 -22.3 17.77 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 172.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.21 -23.86 53.49 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 98' ' ' ILE . 39.7 tp -61.05 124.89 21.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.394 0.678 . . . . 0.0 110.884 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -67.11 133.11 93.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 70.6 Cg_exo -46.65 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.596 2.197 . . . . 0.0 112.297 168.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.16 14.76 8.17 Favored Glycine 0 C--O 1.248 1.005 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.433 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.41 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -95.87 135.56 12.39 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.5 m -109.4 130.4 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.002 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.17 111.59 24.08 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 24' ' ' VAL . 58.1 mt -106.98 108.27 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.55 HD22 ' HA ' ' A' ' 102' ' ' PHE . 69.8 mt -124.25 117.49 24.68 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.423 0.689 . . . . 0.0 109.381 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -99.55 98.71 9.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.61 169.16 53.26 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.905 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.438 ' HD1' HD22 ' A' ' 187' ' ' LEU . 7.7 m-85 -133.06 156.02 48.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.0 171.75 4.15 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.898 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.612 ' HA ' HD21 ' A' ' 147' ' ' LEU . 90.7 Cg_exo -45.27 -21.29 0.64 Allowed 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 124.169 3.246 . . . . 0.0 116.247 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -76.54 -6.67 52.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.915 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.404 ' O ' HG22 ' A' ' 141' ' ' THR . 8.6 tp-100 -76.34 -63.61 1.29 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -173.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.89 -11.92 59.88 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.404 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -63.62 -39.74 95.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.173 0.989 . . . . 0.0 111.78 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.72 11.85 8.3 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.237 0.615 . . . . 0.0 111.085 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.5 p30 42.84 43.93 3.66 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.358 1.863 . . . . 0.0 113.485 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 136' ' ' GLN . 15.1 t -89.48 3.22 53.07 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.003 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.46 159.08 20.84 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.35 74.77 0.08 OUTLIER Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.04 -19.12 45.91 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.973 2.449 . . . . 0.0 112.559 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -163.12 -60.27 0.04 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.915 0.886 . . . . 0.0 108.764 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -177.2 166.08 2.33 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.288 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.69 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -60.64 -2.29 0.5 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.977 1.311 . . . . 0.0 112.435 173.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.71 -33.33 72.73 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.905 1.282 . . . . 0.0 111.34 168.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.5 1.79 44.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.478 0.711 . . . . 0.0 112.685 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.69 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 29.0 mt -86.89 102.81 3.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.859 ' HB2' HD13 ' A' ' 156' ' ' LEU . 93.1 Cg_endo -75.69 123.68 7.66 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.858 2.372 . . . . 0.0 112.618 -168.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -102.78 151.37 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.795 0.838 . . . . 0.0 111.839 -168.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.475 HD23 HD22 ' A' ' 190' ' ' LEU . 32.5 mt -61.0 -54.39 45.58 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.692 . . . . 0.0 111.829 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -52.51 -39.54 61.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.93 0.892 . . . . 0.0 111.181 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 29.3 m -74.7 -57.12 4.12 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.859 HD13 ' HB2' ' A' ' 151' ' ' PRO . 88.8 mt -63.92 -46.43 84.8 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.251 1.021 . . . . 0.0 112.631 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.582 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.5 tt0 -53.38 -35.57 60.48 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 111.837 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.5 t -84.44 -20.88 31.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.694 . . . . 0.0 112.062 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 155' ' ' THR . 41.6 mm-40 -79.53 -16.53 55.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.608 . . . . 0.0 110.875 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 82.1 mt -142.12 66.53 20.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.768 0.827 . . . . 0.0 109.461 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.595 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 13.8 Cg_exo -72.24 -3.84 14.08 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 123.115 2.543 . . . . 0.0 112.635 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 p -85.62 -33.87 21.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.8 tp -99.59 70.49 1.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.361 1.464 . . . . 0.0 111.257 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.03 126.96 22.32 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.582 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 17.4 m95 -91.08 133.26 35.47 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.81 -35.56 77.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.985 0.514 . . . . 0.0 109.7 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 78.1 mt -126.45 123.04 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.22 69.69 1.01 Allowed 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -129.48 145.93 51.38 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.327 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -92.17 112.1 23.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.436 1.094 . . . . 0.0 109.493 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.8 mt -117.25 125.42 51.1 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.456 0.702 . . . . 0.0 110.316 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -88.5 124.9 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.401 ' HG2' HD23 ' A' ' 175' ' ' LEU . 35.3 ttm180 -90.16 125.45 35.46 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -80.28 96.9 6.77 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.401 HD23 ' HG2' ' A' ' 173' ' ' ARG . 37.8 mt -68.67 145.83 53.53 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.915 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -78.91 2.39 20.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.003 0.521 . . . . 0.0 110.63 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -49.51 -38.1 29.11 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.48 -82.96 0.33 Allowed Glycine 0 N--CA 1.476 1.321 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.592 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 63.94 163.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.072 1.349 . . . . 0.0 113.402 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -67.3 -48.98 66.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.65 0.78 . . . . 0.0 112.358 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -88.03 -59.77 2.15 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.03 138.47 1.71 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.288 0.993 . . . . 0.0 109.138 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.61 98.32 0.94 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -132.17 170.43 15.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.83 0.824 . . . . 0.0 111.508 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -157.28 131.2 8.19 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.186 -1.825 . . . . 0.0 106.486 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.72 130.38 35.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.438 HD22 ' HD1' ' A' ' 132' ' ' PHE . 52.1 mt -135.36 173.65 11.48 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.411 HD11 ' O ' ' A' ' 151' ' ' PRO . 9.8 pt -145.88 135.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.931 0.892 . . . . 0.0 109.257 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.4 142.25 33.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.664 0.386 . . . . 0.0 110.442 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.475 HD22 HD23 ' A' ' 153' ' ' LEU . 39.5 mt -129.36 131.42 46.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.7 1.2 . . . . 0.0 109.069 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.86 105.74 7.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.07 138.16 15.24 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.641 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.0 tp-100 -142.55 149.7 39.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.587 0.693 . . . . 0.0 110.219 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.412 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 6.2 tmtm? -66.34 138.93 57.96 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.25 101.34 0.16 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.557 1.161 . . . . 0.0 109.169 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 65.93 80.92 0.21 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.06 1.344 . . . . 0.0 110.724 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -81.65 -29.01 33.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.532 0.733 . . . . 0.0 112.241 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -138.1 37.45 2.33 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.478 0.656 . . . . 0.0 109.458 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.56 70.15 7.22 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.035 0.921 . . . . 0.0 109.32 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -155.78 -178.2 7.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.72 1.608 . . . . 0.0 107.799 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -74.6 124.19 26.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.747 0.419 . . . . 0.0 110.878 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 . . . . . 0 N--CA 1.481 1.109 0 C-N-CA 123.094 0.558 . . . . 0.0 109.853 172.254 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -123.41 35.15 4.92 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.417 0.687 . . . . 0.0 110.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.19 29.61 6.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.198 0.599 . . . . 0.0 110.934 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.38 101.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.52 0.728 . . . . 0.0 110.22 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -143.2 87.92 1.99 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.509 0.724 . . . . 0.0 109.963 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -160.57 119.2 2.59 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.92 0.888 . . . . 0.0 108.801 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 85.83 1.5 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -71.0 92.16 0.92 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.157 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 p -78.34 109.49 12.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.805 0.842 . . . . 0.0 110.989 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.65 141.23 26.64 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.301 0.64 . . . . 0.0 111.193 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -172.07 127.85 0.59 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.748 1.219 . . . . 0.0 108.092 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.47 135.65 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 0.0 110.724 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.24 150.09 9.07 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.008 1.323 . . . . 0.0 108.07 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.59 90.74 0.08 OUTLIER Glycine 0 C--O 1.239 0.451 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -135.57 158.42 44.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.765 0.826 . . . . 0.0 108.85 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.42 160.77 66.65 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 109.628 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.38 17.6 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 123.402 2.734 . . . . 0.0 114.727 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -138.36 44.3 2.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.343 1.068 . . . . 0.0 109.047 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.58 84.71 0.86 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.319 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -177.4 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.69 1.596 . . . . 0.0 106.721 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.479 HD23 ' HG ' ' A' ' 47' ' ' LEU . 37.5 tp -62.95 -36.54 83.78 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.763 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 m -44.13 -36.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.239 1.016 . . . . 0.0 113.584 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 m -74.89 -52.43 11.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.521 0.729 . . . . 0.0 110.84 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 128' ' ' ILE . 2.1 m -62.3 -37.06 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.588 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.0 83.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.314 1.446 . . . . 0.0 112.057 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.99 -28.05 68.59 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.813 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.18 -14.6 28.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.211 0.605 . . . . 0.0 112.194 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 24' ' ' VAL . 76.1 mt -77.71 130.58 73.12 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.72 140.71 46.14 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.266 2.644 . . . . 0.0 112.65 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.45 28.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.66 -147.12 8.66 Favored Glycine 0 N--CA 1.468 0.777 0 CA-C-N 118.455 0.571 . . . . 0.0 112.905 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -80.43 119.34 23.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -110.27 139.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.218 1.007 . . . . 0.0 108.555 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 90' ' ' ILE . 26.1 tp -115.42 128.65 56.19 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.968 0.804 . . . . 0.0 111.498 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 32.7 m -94.05 138.0 32.62 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.051 0.94 . . . . 0.0 110.239 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.6 108.95 17.08 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.986 0.514 . . . . 0.0 111.152 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 43.45 63.91 1.4 Allowed 'General case' 0 N--CA 1.485 1.282 0 O-C-N 125.482 1.738 . . . . 0.0 112.501 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.81 -58.43 3.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.44 0.638 . . . . 0.0 111.086 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.39 100.39 2.49 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 78.11 4.4 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.069 1.348 . . . . 0.0 113.9 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.6 19.24 41.14 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -62.13 -49.09 77.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.336 1.054 . . . . 0.0 111.297 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.404 HD21 HG22 ' A' ' 101' ' ' ILE . 93.5 m-20 -77.69 -32.78 53.23 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.804 -172.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.43 77.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.577 0.751 . . . . 0.0 110.101 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -68.85 -30.47 69.01 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.526 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD1' HD21 ' A' ' 21' ' ' LEU . 57.4 t80 -62.93 -43.53 98.55 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HG ' HD23 ' A' ' 21' ' ' LEU . 89.4 mt -70.36 -30.78 67.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.85 76.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.88 0.472 . . . . 0.0 111.197 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.757 ' HA ' HG11 ' A' ' 76' ' ' VAL . 23.6 p -75.85 -2.44 30.08 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.303 0.641 . . . . 0.0 111.985 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 94.4 mt -86.32 14.97 5.75 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.314 0.646 . . . . 0.0 110.427 164.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.29 47.31 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 123.223 0.44 . . . . 0.0 113.523 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -125.29 157.03 37.66 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.337 0.589 . . . . 0.0 111.065 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.76 88.57 5.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.12 116.57 36.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.237 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.576 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 27.1 m -84.95 112.78 20.89 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 124.761 1.224 . . . . 0.0 107.977 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.27 133.85 46.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 111.174 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.61 HG21 ' HB ' ' A' ' 81' ' ' VAL . 15.1 t -115.66 120.1 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.64 143.8 50.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.05 -20.98 66.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.506 0.722 . . . . 0.0 111.263 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.521 ' HB3' HG22 ' A' ' 62' ' ' VAL . 46.1 m -111.75 124.52 52.51 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.716 1.206 . . . . 0.0 109.003 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.5 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.907 0.883 . . . . 0.0 110.062 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 60' ' ' SER . 19.1 m -66.26 -26.35 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.67 -35.1 33.06 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.157 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.3 -44.79 82.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.031 0.933 . . . . 0.0 110.449 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.26 91.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.924 0.889 . . . . 0.0 111.528 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -66.81 -40.28 87.99 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.295 0.638 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.08 88.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.294 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -70.02 -36.87 75.41 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.431 1.092 . . . . 0.0 111.476 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -61.08 -52.15 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.23 -28.77 69.96 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.984 0.803 . . . . 0.0 110.715 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.32 -62.24 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.981 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -65.77 -26.24 67.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 111.559 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.52 -46.28 90.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.162 0.985 . . . . 0.0 109.786 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -98.81 -0.71 41.99 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.553 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.85 51.23 8.03 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.366 0.506 . . . . 0.0 114.366 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.2 m -138.42 176.29 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.932 0.893 . . . . 0.0 110.618 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -114.74 140.88 48.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.832 0.853 . . . . 0.0 111.937 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.5 157.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.576 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 85.6 m -119.12 103.23 9.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 t -94.62 114.89 26.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.278 0.561 . . . . 0.0 110.535 -163.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' HG21 ' A' ' 57' ' ' VAL . 61.7 t -109.92 139.69 32.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.683 1.193 . . . . 0.0 108.883 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -78.87 132.26 36.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.639 0.775 . . . . 0.0 109.902 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 p -63.61 106.07 0.89 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 111.515 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -144.21 89.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 165.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -78.87 -16.36 57.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.804 0.442 . . . . 0.0 111.047 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . . . -72.22 -27.3 62.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.565 0.746 . . . . 0.0 111.333 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -104.52 -37.12 7.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.262 0.625 . . . . 0.0 111.654 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -161.34 126.25 3.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.378 1.071 . . . . 0.0 108.323 -170.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.01 -70.55 0.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 ' HA ' ' A' ' 117' ' ' VAL . 2.9 pt -143.5 118.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.582 0.753 . . . . 0.0 109.778 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.879 0.872 . . . . 0.0 109.685 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 122' ' ' LYS . . . -44.88 -26.67 0.43 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 -44.42 71.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.991 0.516 . . . . 0.0 110.761 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.68 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -140.89 -165.32 1.92 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.223 0.609 . . . . 0.0 111.25 -171.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -118.01 -37.16 3.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.752 0.821 . . . . 0.0 112.42 -169.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.36 172.21 23.94 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 122.369 -0.207 . . . . 0.0 112.862 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.481 HD12 HG22 ' A' ' 90' ' ' ILE . 42.6 mt -134.35 145.83 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.881 0.873 . . . . 0.0 109.233 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -127.3 105.09 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 159.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.9 t -104.19 88.03 2.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.424 HD11 HD11 ' A' ' 21' ' ' LEU . 34.4 mm -71.58 146.16 11.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.656 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -17.54 99.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 126.563 2.414 . . . . 0.0 112.261 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' A' ' 129' ' ' LEU . 28.8 p -99.15 104.83 16.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.158 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -96.67 96.71 8.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.19 139.27 22.28 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.717 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.19 162.03 43.87 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.937 2.425 . . . . 0.0 110.981 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.0 m -34.98 -42.56 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.199 1.8 . . . . 0.0 115.368 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.3 m -70.61 -46.52 63.22 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.241 0.338 . . . . 0.0 110.692 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.52 -35.72 34.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.632 0.373 . . . . 0.0 110.427 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -69.14 -62.73 1.26 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.679 0.792 . . . . 0.0 109.945 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -51.87 -34.06 39.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.918 0.887 . . . . 0.0 113.135 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 53.8 tt0 -78.64 -32.58 47.36 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 117' ' ' VAL . 55.9 tp -71.92 -39.27 69.6 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.457 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -62.86 -38.86 47.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.94 -30.89 67.35 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.819 1.679 . . . . 0.0 111.792 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HZ2' ' HB3' ' A' ' 116' ' ' LYS . 1.5 mmmp? -80.08 -15.71 56.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.787 0.835 . . . . 0.0 110.209 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.557 ' HA ' HD11 ' A' ' 90' ' ' ILE . 22.3 t -83.84 -40.92 16.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -57.8 -52.39 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -69.95 -42.7 72.88 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.3 -39.86 14.65 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 25.8 tp -69.78 111.84 5.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.916 0.886 . . . . 0.0 110.61 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 19.4 ptmt -85.42 157.95 58.11 Favored Pre-proline 0 C--O 1.247 0.948 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.106 167.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.585 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 83.1 Cg_exo -50.8 112.29 0.73 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.343 2.029 . . . . 0.0 112.291 168.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.576 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 126.61 12.73 3.27 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.319 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.78 147.53 16.37 Favored Glycine 0 C--O 1.246 0.862 0 O-C-N 122.545 -0.385 . . . . 0.0 112.303 168.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 35.1 m -109.44 131.57 59.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 123.548 0.739 . . . . 0.0 110.076 177.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.93 112.54 24.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.53 HD11 HG21 ' A' ' 24' ' ' VAL . 59.6 mt -115.44 112.26 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.132 0.973 . . . . 0.0 109.543 -171.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.551 HD21 ' SG ' ' A' ' 103' ' ' CYS . 96.5 mt -133.33 153.42 51.6 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 37.7 tt0 -132.49 100.76 5.08 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 164.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.23 166.58 49.96 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.779 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.403 ' HB2' HD22 ' A' ' 150' ' ' LEU . 58.0 m-85 -127.29 157.43 39.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 109.383 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 186' ' ' ALA . . . -89.35 164.59 29.5 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.504 ' HA ' HD21 ' A' ' 147' ' ' LEU . 38.5 Cg_exo -61.01 -0.83 1.36 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.96 2.44 . . . . 0.0 114.248 173.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.02 -19.62 47.25 Favored 'General case' 0 CA--C 1.571 1.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.625 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.52 -63.18 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 113.126 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.549 HD13 ' HG ' ' A' ' 147' ' ' LEU . 15.5 mt -71.01 -11.49 61.0 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -73.46 -40.86 63.83 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.185 0.994 . . . . 0.0 111.136 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -68.69 -58.03 4.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.155 0.502 . . . . 0.0 110.189 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -127.93 134.36 49.32 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -84.99 40.18 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.819 0.847 . . . . 0.0 111.76 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.37 53.93 2.76 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 121.61 0.561 . . . . 0.0 111.926 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.23 125.65 7.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 118.46 -1.189 . . . . 0.0 111.83 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.76 -35.1 90.49 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.445 2.097 . . . . 0.0 110.671 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -169.92 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.076 1.35 . . . . 0.0 108.638 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -169.71 158.83 7.78 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.281 -173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.549 ' HG ' HD13 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -61.32 -7.25 2.74 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.326 1.45 . . . . 0.0 112.847 175.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.5 -37.31 83.21 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.377 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.88 8.61 14.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.514 0.726 . . . . 0.0 112.261 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 56.3 mt -85.63 108.52 16.76 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.492 ' HB2' HD13 ' A' ' 156' ' ' LEU . 12.2 Cg_exo -70.22 122.63 9.18 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.977 2.451 . . . . 0.0 112.53 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -96.61 150.11 21.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.1 0.96 . . . . 0.0 111.282 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.548 HD23 HD22 ' A' ' 190' ' ' LEU . 37.9 mt -57.55 -36.87 72.2 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 122.987 0.515 . . . . 0.0 109.696 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -50.9 -51.37 52.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.534 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -69.75 -48.84 57.88 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.55 -58.73 3.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.396 1.078 . . . . 0.0 112.516 -166.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.27 -31.28 72.35 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.455 0.702 . . . . 0.0 112.091 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.0 t -84.54 -13.85 50.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.065 0.393 . . . . 0.0 111.519 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.85 -45.35 10.94 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.675 0.75 . . . . 0.0 109.317 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.9 mt -104.85 78.89 0.4 Allowed Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.702 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.37 -4.06 7.63 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 123.002 2.468 . . . . 0.0 111.367 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -85.52 -28.62 24.83 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.49 1.116 . . . . 0.0 108.115 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.83 70.81 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.78 1.632 . . . . 0.0 109.015 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.499 ' HB3' HD21 ' A' ' 195' ' ' LEU . 6.8 t30 -60.46 121.42 12.05 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.409 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 16.7 m95 -87.85 141.51 28.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.516 1.126 . . . . 0.0 108.998 -167.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.4 mt -73.42 -35.72 65.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.077 0.551 . . . . 0.0 109.809 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 82.2 mt -126.11 118.09 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.81 76.5 1.07 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -141.3 143.03 33.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.11 112.23 20.49 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.473 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.4 mt -103.86 131.27 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.409 1.083 . . . . 0.0 108.884 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.74 122.99 37.91 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -120.23 131.6 55.02 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -77.72 133.02 38.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.446 0.699 . . . . 0.0 109.635 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 183' ' ' GLY . 17.4 mt -105.68 170.33 7.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.253 1.421 . . . . 0.0 108.788 -174.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.32 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.323 0.649 . . . . 0.0 111.062 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -162.18 157.74 23.55 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.44 1.096 . . . . 0.0 109.382 -173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.43 154.39 48.1 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.461 0.476 . . . . 0.0 112.802 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.7 70.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 112.855 -172.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -66.1 -27.81 68.34 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.121 0.569 . . . . 0.0 112.048 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -101.3 -61.17 1.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.883 0.473 . . . . 0.0 110.924 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.08 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.891 1.276 . . . . 0.0 109.85 -167.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.66 99.27 0.52 Allowed Glycine 0 C--O 1.208 -1.531 0 O-C-N 123.645 0.591 . . . . 0.0 112.966 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -87.76 147.91 24.97 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -149.42 132.86 16.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.03 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 133' ' ' ALA . . . -79.03 109.64 13.52 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.0 mt -122.16 144.03 49.2 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 13.4 pt -133.02 116.61 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.15 0.432 . . . . 0.0 110.025 -170.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.61 137.77 36.76 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.067 0.46 . . . . 0.0 109.779 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.548 HD22 HD23 ' A' ' 153' ' ' LEU . 62.9 mt -125.98 146.0 50.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.388 1.075 . . . . 0.0 110.343 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.7 tp -149.88 106.15 3.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -88.48 142.36 17.22 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -142.65 156.76 45.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.649 0.725 . . . . 0.0 111.04 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 68.2 tttt -55.34 135.26 50.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.322 1.449 . . . . 0.0 110.368 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 164' ' ' ASN . 3.5 mt -86.17 125.04 33.23 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 164.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.484 ' HA ' ' HE2' ' A' ' 194' ' ' LYS . 9.2 tp10 -58.15 107.83 0.53 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.511 0.672 . . . . 0.0 110.21 -171.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -93.58 46.15 1.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.923 1.289 . . . . 0.0 109.128 -166.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . 0.254 28.8 p-80 41.72 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.505 1.922 . . . . 0.0 113.372 -168.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -129.1 159.58 35.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.716 1.207 . . . . 0.0 109.209 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -67.33 -2.96 6.87 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.938 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 63.92 32.24 13.32 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.788 1.235 . . . . 0.0 111.836 165.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 . . . . . 0 C--O 1.252 1.189 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.351 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -143.94 135.73 26.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.427 1.091 . . . . 0.0 108.408 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -100.01 100.96 11.91 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.77 0.795 . . . . 0.0 110.778 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -98.61 165.88 11.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.661 0.785 . . . . 0.0 109.923 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.48 73.19 8.53 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -73.63 132.45 42.78 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 p -66.98 101.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.944 0.898 . . . . 0.0 111.03 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.79 119.07 4.16 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.002 0.921 . . . . 0.0 109.945 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.5 t -84.63 67.88 10.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.458 0.703 . . . . 0.0 112.115 -164.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.31 72.05 8.13 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 38.8 t80 -69.99 125.29 26.32 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.46 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.46 136.51 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -66.01 93.51 0.2 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.043 0.537 . . . . 0.0 111.028 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.34 53.06 0.75 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.2 m -112.75 99.16 7.7 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.149 0.98 . . . . 0.0 109.326 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -147.32 70.55 11.81 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.48 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.407 ' HG3' ' HE2' ' A' ' 46' ' ' PHE . 5.9 Cg_exo -80.42 -74.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.928 2.418 . . . . 0.0 111.472 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 54.72 76.0 0.27 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.665 1.186 . . . . 0.0 111.941 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -167.76 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.764 0.425 . . . . 0.0 111.639 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.1 t80 174.24 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.976 1.31 . . . . 0.0 107.65 -165.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.61 -17.91 57.14 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.695 1.198 . . . . 0.0 112.443 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.69 -37.92 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -71.84 -41.15 68.48 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.031 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.4 m -66.8 -43.5 89.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' HD13 ' A' ' 28' ' ' ILE . . . -57.27 -38.41 73.86 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.18 0.992 . . . . 0.0 112.253 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.61 -21.32 63.59 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.626 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -91.1 -21.86 21.0 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.41 0.684 . . . . 0.0 110.54 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG23 HD13 ' A' ' 33' ' ' ILE . 92.3 mt -74.09 134.2 77.77 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 123.532 0.733 . . . . 0.0 110.51 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.66 136.42 49.68 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.36 2.707 . . . . 0.0 112.111 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.44 28.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.7 -132.81 4.98 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -84.33 112.41 20.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 28' ' ' ILE . 8.9 mt -111.59 119.11 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.691 0.796 . . . . 0.0 109.197 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.53 ' HA ' HG23 ' A' ' 55' ' ' THR . 28.7 tp -89.95 108.0 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.667 0.212 . . . . 0.0 110.743 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 49.3 t -94.92 110.39 22.29 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.265 0.626 . . . . 0.0 110.689 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.2 mt -79.02 126.35 30.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 154.96 38.57 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.791 0.682 . . . . 0.0 109.816 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.25 32.74 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.23 -76.28 0.02 OUTLIER Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.504 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -80.9 -60.46 2.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.901 0.481 . . . . 0.0 111.351 -167.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 -51.43 4.37 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.881 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -49.78 -38.32 33.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.417 1.487 . . . . 0.0 112.2 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' ND2' HG13 ' A' ' 101' ' ' ILE . 29.1 p-10 -64.2 -41.0 97.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.0 72.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.51 0.724 . . . . 0.0 110.719 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 9.9 m -59.55 -38.89 82.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.627 0.771 . . . . 0.0 111.099 173.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.407 ' HE2' ' HG3' ' A' ' 17' ' ' PRO . 73.0 t80 -73.2 -33.5 65.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.592 0.757 . . . . 0.0 110.906 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 99' ' ' VAL . 50.6 mt -64.03 -32.36 73.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 110.421 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.17 -31.24 58.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.879 0.472 . . . . 0.0 110.763 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 m -68.37 -6.09 22.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.809 0.844 . . . . 0.0 111.835 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.8 mt -83.89 12.38 6.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.596 0.758 . . . . 0.0 110.646 168.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 34.72 25.44 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 123.285 0.469 . . . . 0.0 113.985 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.4 162.16 26.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.882 0.473 . . . . 0.0 111.387 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -92.99 91.07 7.2 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 165.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.7 t -88.4 112.12 23.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.2 t -83.3 104.4 13.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.28 134.75 42.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.985 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 81' ' ' VAL . 3.3 t -113.71 118.22 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -133.68 142.48 48.03 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -54.31 -32.2 55.98 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.191 0.997 . . . . 0.0 112.364 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.436 ' OG ' HG23 ' A' ' 62' ' ' VAL . 9.1 t -109.03 130.33 55.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.631 0.772 . . . . 0.0 110.005 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 t -74.98 -16.86 60.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.929 0.892 . . . . 0.0 110.991 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.436 HG23 ' OG ' ' A' ' 60' ' ' SER . 9.6 m -63.85 -32.98 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.544 0.337 . . . . 0.0 110.511 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.42 -33.21 56.75 Favored Glycine 0 C--N 1.351 1.382 0 O-C-N 123.538 0.523 . . . . 0.0 112.646 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.09 -48.03 59.38 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.779 0.832 . . . . 0.0 110.413 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.55 86.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.712 0.805 . . . . 0.0 112.047 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -63.35 -39.41 94.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.861 0.864 . . . . 0.0 110.748 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.627 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -60.92 -46.71 89.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.942 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -71.08 -37.14 72.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.635 0.774 . . . . 0.0 111.652 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.63 -55.72 31.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.93 0.892 . . . . 0.0 109.849 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.2 tp -66.61 -25.19 66.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.221 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.487 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -66.09 -52.09 52.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.973 0.509 . . . . 0.0 110.495 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.85 -33.83 73.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.026 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.6 -48.22 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.545 0.528 . . . . 0.0 110.723 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.565 ' HZ3' ' HB2' ' A' ' 74' ' ' LYS . 2.0 ttmp? -87.68 -13.5 42.4 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.96 44.83 13.04 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 121.054 0.252 . . . . 0.0 112.674 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 172.83 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.394 1.078 . . . . 0.0 108.124 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -121.77 141.26 51.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.706 0.403 . . . . 0.0 110.896 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.487 HG12 ' HB1' ' A' ' 71' ' ' ALA . 15.8 mm -109.24 165.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 45.0 m -131.13 104.02 6.84 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 164.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.2 p -86.74 114.33 23.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.884 0.474 . . . . 0.0 111.108 -168.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.493 ' HB ' HG23 ' A' ' 57' ' ' VAL . 53.3 t -104.63 139.01 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.746 1.218 . . . . 0.0 108.108 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -78.9 136.35 37.26 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 p -50.47 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.5 1.12 . . . . 0.0 111.838 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 6.6 m-20 -134.65 91.1 2.73 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 65.7 mt -100.46 -6.71 25.15 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.691 0.758 . . . . 0.0 110.68 -170.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.27 3.44 29.98 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.189 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 32.2 t70 -139.64 -46.38 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -168.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -163.86 100.5 0.88 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -132.84 -58.28 0.92 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.522 0.729 . . . . 0.0 109.343 -164.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.517 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.7 pt -134.35 110.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 123.039 0.535 . . . . 0.0 111.028 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 t -129.2 84.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.559 0.744 . . . . 0.0 109.346 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.65 -1.02 14.61 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.897 0.479 . . . . 0.0 112.176 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -76.16 -45.95 30.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.98 61.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.614 0.766 . . . . 0.0 112.57 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.464 ' CD1' HD23 ' A' ' 34' ' ' LEU . 44.8 m95 -113.79 -177.71 3.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.254 0.622 . . . . 0.0 110.486 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -92.49 -55.83 3.25 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.69 0.796 . . . . 0.0 109.994 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.77 173.84 21.34 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.521 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.8 mt -132.68 139.3 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.5 p -124.06 106.94 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.64 0.734 . . . . 0.0 109.233 165.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.2 m -103.82 94.11 5.25 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HD12 HD13 ' A' ' 128' ' ' ILE . 41.6 mm -68.52 141.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.359 1.063 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -21.63 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 126.032 1.733 . . . . 0.0 113.85 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.497 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 35.8 t -94.53 109.56 21.44 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.615 -168.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -108.52 98.69 8.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.497 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 62.5 mt -114.62 145.53 34.06 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.809 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.73 150.55 69.79 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.833 2.355 . . . . 0.0 110.269 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.6 t -44.9 -33.88 2.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.771 1.228 . . . . 0.0 113.324 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.0 m -59.4 -59.81 4.85 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.312 0.645 . . . . 0.0 111.399 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.66 -24.41 53.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.992 0.517 . . . . 0.0 110.537 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.84 -54.62 14.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.416 1.086 . . . . 0.0 109.57 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -55.75 -28.67 57.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.387 1.075 . . . . 0.0 112.436 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.65 -22.95 24.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.842 0.457 . . . . 0.0 111.078 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.5 tp -71.9 -45.42 61.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.133 0.573 . . . . 0.0 111.172 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -58.58 -41.52 89.48 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -52.79 -38.05 77.22 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 122.449 2.099 . . . . 0.0 112.811 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.55 -23.61 56.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.391 0.677 . . . . 0.0 111.595 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 t -85.46 -28.08 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.362 0.601 . . . . 0.0 110.142 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -75.04 -61.09 2.01 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.291 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -76.99 -47.36 20.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.501 1.12 . . . . 0.0 113.584 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.62 -36.72 22.22 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 114.14 0.416 . . . . 0.0 114.14 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.2 tp -75.36 108.5 8.18 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 1.2 mptm? -82.59 159.53 63.73 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.529 168.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -41.29 113.05 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.305 2.67 . . . . 0.0 113.813 166.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 14.22 3.24 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.235 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -112.32 144.43 17.8 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 121.766 -0.843 . . . . 0.0 111.146 165.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 33.9 m -107.59 132.16 55.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.834 0.854 . . . . 0.0 109.96 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.56 112.79 25.95 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 101' ' ' ILE . 57.9 mt -104.21 109.43 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.546 HD13 HD12 ' A' ' 156' ' ' LEU . 51.7 mt -124.59 120.71 32.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 110.088 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -112.28 102.6 10.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.566 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.65 169.08 40.5 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.668 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.627 ' HD1' HD21 ' A' ' 187' ' ' LEU . 57.1 m-85 -137.73 165.97 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.78 0.832 . . . . 0.0 109.445 -172.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 186' ' ' ALA . . . -76.91 164.15 60.98 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.833 0.853 . . . . 0.0 110.072 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.507 ' HA ' HD21 ' A' ' 147' ' ' LEU . 38.1 Cg_endo -63.88 -2.3 4.37 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.237 1.958 . . . . 0.0 113.03 169.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.9 -6.75 59.34 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.506 1.122 . . . . 0.0 111.846 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -63.68 -59.93 3.96 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.209 -0.307 . . . . 0.0 111.177 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.07 -12.3 60.86 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.363 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -68.59 -29.03 67.47 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -61.16 -30.05 70.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 61.08 42.39 12.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.001 1.321 . . . . 0.0 110.004 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 76.1 p -109.19 -6.58 15.52 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.94 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.18 153.6 14.93 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.75 98.8 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.222 -0.765 . . . . 0.0 111.848 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.22 -36.4 36.56 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.721 2.28 . . . . 0.0 112.1 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -168.14 -55.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.201 1.0 . . . . 0.0 108.718 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -162.64 159.24 24.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.343 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 134' ' ' PRO . 0.5 OUTLIER -61.04 -3.18 0.74 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.52 1.528 . . . . 0.0 112.903 175.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.3 -38.0 79.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.91 0.884 . . . . 0.0 109.746 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.61 9.46 21.2 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.158 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 79.3 mt -81.24 106.02 5.04 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.566 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 15.3 Cg_exo -68.29 110.77 2.32 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 123.203 2.602 . . . . 0.0 112.651 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -95.51 147.67 23.3 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.926 0.891 . . . . 0.0 111.311 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.6 mt -59.84 -45.26 92.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.52 0.6 . . . . 0.0 110.428 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.63 -46.77 77.37 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.261 0.976 . . . . 0.0 110.942 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.7 p -71.95 -53.73 12.15 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 129' ' ' LEU . 40.6 mt -70.01 -51.29 33.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.533 1.133 . . . . 0.0 113.274 -169.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 30.0 tt0 -59.98 -35.06 74.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.679 0.392 . . . . 0.0 111.38 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.7 t -78.04 -28.1 48.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.703 0.401 . . . . 0.0 110.864 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -78.39 -24.15 46.46 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.885 . . . . 0.0 110.768 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.7 mt -131.84 73.27 78.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -82.71 -9.18 11.12 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.252 2.634 . . . . 0.0 112.606 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -91.84 -29.86 16.5 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp -88.4 72.44 8.91 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.624 1.17 . . . . 0.0 110.29 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -53.6 125.69 19.07 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.108 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.408 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 41.9 m95 -91.76 125.12 36.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.541 1.137 . . . . 0.0 108.899 -172.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.96 -34.13 75.98 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.089 0.556 . . . . 0.0 109.983 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 72.7 mt -127.54 122.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.63 76.26 1.01 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -145.98 145.76 30.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 -172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.466 ' H ' HD21 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -74.97 115.54 14.7 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.493 0.717 . . . . 0.0 110.432 174.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.1 mt -107.84 114.56 28.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 45.7 mt-10 -91.83 127.33 37.25 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.082 0.553 . . . . 0.0 111.1 -171.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -101.57 134.5 44.6 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.342 0.657 . . . . 0.0 110.784 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -64.34 108.31 1.57 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.105 0.962 . . . . 0.0 111.655 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 185' ' ' ALA . 46.7 mt -92.87 167.87 11.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.583 0.753 . . . . 0.0 111.73 177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -149.83 41.69 0.85 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.0 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -33.3 66.49 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.902 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.87 47.39 83.44 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.284 0.365 . . . . 0.0 113.398 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -127.54 -69.91 0.72 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.193 0.597 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -167.12 -35.71 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 0.0 109.832 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -58.82 147.64 32.83 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.905 . . . . 0.0 111.66 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -58.44 156.27 10.63 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.739 0.816 . . . . 0.0 111.604 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.7 17.88 2.54 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.8 178.47 6.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 110.508 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -126.41 134.24 51.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.484 0.713 . . . . 0.0 109.795 -170.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.564 ' HB1' ' HB1' ' A' ' 133' ' ' ALA . . . -78.89 99.74 6.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.627 HD21 ' HD1' ' A' ' 132' ' ' PHE . 25.3 mt -127.61 160.68 30.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 16.3 pt -140.39 142.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -129.42 150.13 50.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.555 0.693 . . . . 0.0 111.147 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 40.7 mt -132.25 140.7 48.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.608 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 34.2 tp -134.03 104.16 6.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.94 136.54 14.07 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.34 155.58 44.48 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.462 0.705 . . . . 0.0 109.883 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -57.1 144.95 32.62 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.476 0.71 . . . . 0.0 110.36 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.59 138.26 54.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 57.22 72.23 0.53 Allowed 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -75.09 70.03 2.03 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 122.165 0.983 . . . . 0.0 108.665 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -164.5 131.68 3.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.977 1.711 . . . . 0.0 107.404 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -70.81 125.56 27.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -73.44 131.73 42.15 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 111.063 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -128.59 129.43 45.92 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 61.2 t60 . . . . . 0 C--O 1.25 1.118 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.285 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -136.21 43.95 2.47 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.307 1.051 . . . . 0.0 108.396 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -62.78 116.67 5.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.42 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.66 104.08 13.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.841 0.857 . . . . 0.0 110.217 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 53.63 0.79 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.388 0.675 . . . . 0.0 109.282 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -81.25 98.17 7.98 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.197 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -152.29 139.85 19.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -133.57 104.57 6.44 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.912 0.885 . . . . 0.0 108.712 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -92.09 98.33 11.48 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -166.64 125.87 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.934 0.493 . . . . 0.0 110.105 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -157.87 150.39 22.56 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.014 0.526 . . . . 0.0 110.883 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -167.05 122.4 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.051 0.94 . . . . 0.0 109.801 170.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -162.29 142.95 10.19 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.823 0.849 . . . . 0.0 109.029 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.27 173.23 32.83 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 123.439 0.462 . . . . 0.0 112.409 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -123.99 68.38 1.05 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.318 1.047 . . . . 0.0 109.164 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.71 126.46 92.2 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.502 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.98 121.17 8.77 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.182 2.588 . . . . 0.0 112.562 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.28 151.31 26.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.458 0.703 . . . . 0.0 110.517 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -168.07 175.66 6.52 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -52.42 -25.29 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.633 1.173 . . . . 0.0 111.169 165.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -57.69 -19.68 28.73 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.902 1.281 . . . . 0.0 112.838 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.73 -27.8 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 118.973 0.806 . . . . 0.0 108.897 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -72.32 -43.14 64.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.361 1.064 . . . . 0.0 110.615 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.6 m -68.84 -37.47 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.309 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -26.2 68.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.907 0.883 . . . . 0.0 112.63 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -70.34 -28.31 65.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.688 0.795 . . . . 0.0 109.572 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -84.75 -24.08 28.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.783 0.833 . . . . 0.0 111.393 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 HG21 HD12 ' A' ' 33' ' ' ILE . 63.7 mt -72.85 131.42 84.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.263 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -64.72 144.33 83.56 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.817 2.345 . . . . 0.0 112.003 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -69.14 27.49 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' HA3' ' HG3' ' A' ' 96' ' ' GLU . . . -116.61 -140.95 6.94 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 119.065 0.848 . . . . 0.0 112.832 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 41.5 mtpt -83.63 118.48 23.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.378 0.671 . . . . 0.0 109.682 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 28' ' ' ILE . 9.7 mt -115.43 131.92 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.0 tp -97.89 113.85 25.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.8 t -95.34 133.82 38.83 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.881 0.872 . . . . 0.0 108.68 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 90' ' ' ILE . 50.9 mt -101.53 159.06 15.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.566 0.346 . . . . 0.0 111.053 170.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.77 113.82 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 125.023 1.452 . . . . 0.0 113.061 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 -33.14 3.76 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.191 0.996 . . . . 0.0 111.235 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.47 -65.67 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -121.91 121.15 36.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.789 0.836 . . . . 0.0 108.889 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.8 -0.24 2.74 Favored Glycine 0 CA--C 1.548 2.133 0 N-CA-C 114.288 0.475 . . . . 0.0 114.288 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.659 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 51.1 mtp180 -56.43 -34.92 67.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.37 1.068 . . . . 0.0 111.787 168.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.66 -45.25 89.76 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.901 0.88 . . . . 0.0 110.293 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.7 75.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.331 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.659 ' SG ' ' HA ' ' A' ' 42' ' ' ARG . 22.7 p -73.8 -19.78 60.66 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.363 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.61 -50.15 53.72 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.98 -30.55 69.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.399 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.05 0.54 . . . . 0.0 111.956 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.629 ' HA ' HG12 ' A' ' 76' ' ' VAL . 87.7 p -73.56 -3.85 30.39 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.836 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.02 12.08 3.6 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.758 0.823 . . . . 0.0 111.219 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.02 15.97 60.17 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 123.173 0.416 . . . . 0.0 113.932 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.86 157.93 20.8 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.788 0.835 . . . . 0.0 109.869 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 45.1 mt-10 -97.34 90.83 5.22 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.84 110.97 24.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.596 0.712 . . . . 0.0 110.06 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -86.18 114.82 23.32 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.528 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.53 144.65 29.27 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 123.877 0.871 . . . . 0.0 111.268 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -119.89 117.25 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 165.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.64 148.17 51.51 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.229 0.922 . . . . 0.0 111.195 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -56.1 -34.18 65.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.129 1.772 . . . . 0.0 112.473 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.3 p -123.72 140.42 53.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.085 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -73.54 -15.75 61.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.086 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.2 m -63.84 -38.59 82.74 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -41.18 55.31 Favored Glycine 0 C--N 1.357 1.725 0 O-C-N 123.551 0.532 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.45 -41.67 98.91 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.518 0.727 . . . . 0.0 110.435 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.03 76.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.016 0.926 . . . . 0.0 112.532 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 75.0 mmtt -62.61 -39.37 93.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.603 0.361 . . . . 0.0 110.357 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -62.5 -51.34 67.81 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.593 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -71.21 -32.48 68.88 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.305 0.642 . . . . 0.0 111.849 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -58.41 -48.88 79.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.2 0.6 . . . . 0.0 110.703 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.8 tp -68.63 -25.88 65.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 123.269 0.355 . . . . 0.0 110.64 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.498 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.79 -59.29 5.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.023 0.529 . . . . 0.0 110.897 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -58.33 -48.33 80.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.81 0.844 . . . . 0.0 111.839 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 -41.96 88.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.82 0.848 . . . . 0.0 111.191 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -105.56 -12.06 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.137 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.31 44.39 22.45 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 121.907 -0.187 . . . . 0.0 113.509 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -124.55 160.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -104.77 126.4 51.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.674 0.79 . . . . 0.0 110.775 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG21 ' HB1' ' A' ' 67' ' ' ALA . 5.1 mm -117.84 164.89 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -133.98 108.04 8.15 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 p -94.5 125.92 39.45 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.942 0.497 . . . . 0.0 111.303 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.35 140.74 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.359 1.464 . . . . 0.0 107.882 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -82.98 144.17 30.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -62.8 102.9 0.38 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.714 0.806 . . . . 0.0 112.903 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -142.27 89.63 2.18 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.93 -8.39 51.89 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.39 0.676 . . . . 0.0 111.792 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.79 -16.64 50.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.901 0.881 . . . . 0.0 110.763 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.55 -38.42 4.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.416 0.687 . . . . 0.0 110.544 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -151.02 130.16 12.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.667 1.187 . . . . 0.0 107.91 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.98 -75.32 0.51 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 36' ' ' LEU . 12.2 pt -143.27 119.45 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.026 0.93 . . . . 0.0 109.473 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.31 79.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 0.0 108.955 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB1' HD11 ' A' ' 98' ' ' ILE . . . -74.98 0.33 16.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.354 0.662 . . . . 0.0 112.089 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.79 -40.32 83.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 167.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.09 57.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -113.4 176.77 4.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.256 0.622 . . . . 0.0 111.211 -172.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 52.2 mm-40 -90.18 -51.73 5.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.022 0.929 . . . . 0.0 109.883 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.88 178.56 21.12 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.569 HD13 HD12 ' A' ' 121' ' ' LEU . 69.4 mt -131.59 145.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.85 0.86 . . . . 0.0 108.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 8.3 p -130.87 133.61 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 166.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 m -142.41 95.76 2.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.499 HG23 ' HD1' ' A' ' 102' ' ' PHE . 8.7 mm -74.3 153.78 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 129' ' ' LEU . 20.5 p90 -16.02 103.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.202 1.801 . . . . 0.0 115.004 -163.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.4 t -75.41 105.49 6.46 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.984 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -105.13 97.66 7.48 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -125.33 145.76 51.93 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.541 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -56.13 150.7 46.8 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.022 2.481 . . . . 0.0 110.666 163.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.3 t -48.53 -37.82 18.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.652 1.181 . . . . 0.0 112.006 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -53.57 -57.01 12.26 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.905 0.753 . . . . 0.0 111.113 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.71 -24.99 56.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.894 0.478 . . . . 0.0 110.636 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -75.44 -53.91 7.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.737 0.815 . . . . 0.0 110.637 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -60.41 -28.18 68.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.957 0.503 . . . . 0.0 111.723 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -75.74 -30.37 59.2 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' O ' HG21 ' A' ' 117' ' ' VAL . 60.5 tp -74.56 -36.54 63.09 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.839 0.712 . . . . 0.0 111.888 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -54.87 -49.69 90.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.41 -24.92 70.96 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.05 1.833 . . . . 0.0 112.186 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.1 -29.59 61.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.011 0.524 . . . . 0.0 111.142 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 113' ' ' LEU . 5.0 t -85.75 -26.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.153 0.581 . . . . 0.0 110.064 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -69.95 -61.69 1.68 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.41 -49.74 38.85 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.92 -18.11 51.88 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 115.122 0.809 . . . . 0.0 115.122 -163.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.569 HD12 HD13 ' A' ' 98' ' ' ILE . 13.3 tp -76.52 102.41 6.04 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.661 0.73 . . . . 0.0 109.076 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -75.86 145.44 77.91 Favored Pre-proline 0 C--O 1.247 0.951 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -44.19 111.93 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.059 2.506 . . . . 0.0 113.242 174.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.24 11.64 5.6 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.105 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.09 140.61 15.15 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 19.3 m -109.84 129.47 64.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -110.2 108.8 19.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -116.13 113.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.901 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 102' ' ' PHE . 3.6 mp -130.06 147.42 51.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.041 0.448 . . . . 0.0 111.13 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.94 98.47 6.5 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 165.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.85 -179.79 52.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.721 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.405 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.6 m-85 -137.9 158.4 44.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.429 -173.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.39 169.14 8.12 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.642 0.777 . . . . 0.0 110.45 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.556 ' HA ' HD22 ' A' ' 147' ' ' LEU . 36.9 Cg_exo -41.63 -26.16 0.38 Allowed 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 124.628 3.552 . . . . 0.0 115.972 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.48 -19.26 62.95 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.559 0.744 . . . . 0.0 112.839 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -67.68 -53.44 27.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.093 0.406 . . . . 0.0 111.832 -165.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.411 HD22 ' HA3' ' A' ' 143' ' ' GLY . 7.7 mt -82.87 -16.86 45.93 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.348 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.75 -45.41 86.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.576 0.751 . . . . 0.0 109.228 170.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.38 -26.28 60.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.8 t30 61.87 39.52 13.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.098 1.359 . . . . 0.0 110.11 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -96.17 37.13 1.26 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.072 0.949 . . . . 0.0 110.183 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 144.5 9.72 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' A' ' 137' ' ' LEU . . . 169.33 145.43 4.63 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.724 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.458 ' HB2' HD13 ' A' ' 149' ' ' LEU . 16.3 Cg_exo -70.22 -59.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.219 2.612 . . . . 0.0 112.389 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -158.14 -32.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.695 0.398 . . . . 0.0 111.625 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -158.37 153.61 25.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.616 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 1.4 mt -57.09 -13.47 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.865 1.666 . . . . 0.0 113.567 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.24 -38.24 85.93 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.078 172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 144' ' ' PRO . 56.0 mt -90.25 13.79 14.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.41 0.684 . . . . 0.0 112.306 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 53.1 mt -78.99 112.58 28.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 166.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 156' ' ' LEU . 60.4 Cg_endo -71.71 93.63 0.69 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.26 1.973 . . . . 0.0 111.274 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.559 ' HA ' HD11 ' A' ' 188' ' ' ILE . 42.9 mtmt -96.78 156.06 16.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.608 -166.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 188' ' ' ILE . 35.3 mt -61.69 -49.85 74.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.345 0.658 . . . . 0.0 110.333 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.19 -40.33 73.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.887 0.742 . . . . 0.0 110.977 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.1 m -65.65 -64.27 0.9 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.696 174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 151' ' ' PRO . 83.5 mt -72.58 -45.16 60.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.704 0.802 . . . . 0.0 112.481 -164.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.565 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 64.0 tt0 -57.84 -42.02 83.55 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.04 0.536 . . . . 0.0 111.877 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -76.83 -26.23 54.11 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -84.66 -12.76 53.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.929 0.892 . . . . 0.0 111.25 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 70.0 mt -134.57 71.6 70.88 Favored Pre-proline 0 N--CA 1.475 0.792 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.56 -3.31 13.21 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.198 2.599 . . . . 0.0 111.002 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.5 t -83.86 -42.26 16.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.677 1.191 . . . . 0.0 107.912 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.6 tp -95.11 71.76 3.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.863 1.265 . . . . 0.0 110.487 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.31 127.86 32.96 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.565 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 36.8 m95 -91.5 137.83 32.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 0.0 109.226 -167.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.81 -32.24 63.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.761 0.424 . . . . 0.0 110.83 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 83.0 mt -132.81 128.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.87 77.63 0.96 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.91 1.284 . . . . 0.0 107.771 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.36 133.42 36.77 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 -169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -80.69 113.5 18.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.343 0.657 . . . . 0.0 110.773 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.3 mt -108.39 135.67 49.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.605 0.762 . . . . 0.0 109.981 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.92 123.6 36.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.517 ' HB3' ' HB1' ' A' ' 185' ' ' ALA . 37.5 ttt180 -98.64 122.7 42.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -85.53 98.01 10.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.4 144.6 49.74 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.485 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.86 153.44 41.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 164.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 66.38 77.78 0.28 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.897 0.879 . . . . 0.0 109.585 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.23 78.53 0.04 OUTLIER Glycine 0 C--N 1.344 0.972 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.738 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 105.8 4.12 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.353 0.661 . . . . 0.0 110.44 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 51.3 t80 73.25 -78.5 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.161 1.384 . . . . 0.0 110.769 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.21 124.5 25.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.902 0.881 . . . . 0.0 111.05 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 59.26 18.8 6.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.673 1.589 . . . . 0.0 112.768 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -99.39 15.54 60.0 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' HE2' ' HB1' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -97.37 163.29 12.95 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.95 0.9 . . . . 0.0 111.218 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 173' ' ' ARG . . . -131.06 130.39 43.17 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.428 ' HB1' ' HE2' ' A' ' 184' ' ' LYS . . . -89.77 104.29 16.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.89 163.67 19.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.632 0.773 . . . . 0.0 109.122 -169.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 152' ' ' LYS . 7.6 pt -143.82 125.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -97.72 141.55 30.6 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.941 -0.475 . . . . 0.0 111.061 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 37.6 mt -127.57 130.13 48.54 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.387 1.475 . . . . 0.0 108.997 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 24' ' ' VAL . 29.9 tp -125.64 105.08 8.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -93.23 131.35 10.73 Favored Glycine 0 C--O 1.212 -1.221 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 173.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 193' ' ' GLN . 0.0 OUTLIER -141.51 156.55 45.72 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 108.859 176.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -54.49 153.86 5.26 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.975 0.91 . . . . 0.0 110.957 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.96 165.97 16.71 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.78 0.432 . . . . 0.0 110.22 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -167.57 115.86 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -64.92 88.93 0.07 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.084 0.945 . . . . 0.0 108.507 170.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -123.41 145.01 49.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.048 -167.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -73.93 74.11 1.65 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.626 . . . . 0.0 109.407 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -78.65 152.15 31.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.556 -171.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -68.56 138.3 55.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.661 -173.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--O 1.255 1.392 0 C-N-CA 124.03 0.932 . . . . 0.0 108.523 173.22 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -87.53 76.16 9.01 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.179 0.591 . . . . 0.0 109.516 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -149.34 101.71 3.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.638 0.775 . . . . 0.0 109.691 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -94.58 96.34 9.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.451 0.701 . . . . 0.0 109.528 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 97.22 8.99 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -125.22 98.37 5.62 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -144.62 80.69 1.64 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.517 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -86.16 125.77 33.75 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.858 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.4 p -62.25 123.49 18.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.962 0.905 . . . . 0.0 110.96 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 21.8 13.28 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.786 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -52.02 145.26 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.136 1.374 . . . . 0.0 112.296 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.89 134.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.874 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.15 101.26 7.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.281 0.632 . . . . 0.0 110.02 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.99 74.8 1.58 Allowed Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.846 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -139.55 153.17 47.38 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.095 0.958 . . . . 0.0 108.971 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -158.58 108.12 1.64 Allowed Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 119.105 -0.474 . . . . 0.0 109.747 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.29 161.84 32.67 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.879 2.386 . . . . 0.0 112.357 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -132.62 -8.08 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.727 0.811 . . . . 0.0 111.74 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -106.3 -156.92 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.405 0.682 . . . . 0.0 109.47 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.44 -25.09 67.78 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 118.564 0.62 . . . . 0.0 111.747 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HG ' ' HB1' ' A' ' 25' ' ' ALA . 14.1 tp -60.2 -22.52 63.07 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.77 0.828 . . . . 0.0 112.286 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 m -40.48 -56.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 124.489 1.116 . . . . 0.0 113.853 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 p -74.93 -50.62 16.18 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 110.681 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.2 m -66.93 -41.4 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.364 -171.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' HG ' ' A' ' 21' ' ' LEU . . . -60.9 -37.26 81.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.918 0.887 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -68.63 -26.78 65.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -92.86 -13.26 29.25 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 73.7 mt -77.68 134.43 65.34 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.237 0.615 . . . . 0.0 110.87 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.77 132.38 47.55 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.326 2.684 . . . . 0.0 111.894 171.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -74.23 29.51 0.08 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.88 -145.68 9.54 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 12.3 mmmm -85.63 118.7 25.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -170.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mt -114.15 134.29 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.8 0.84 . . . . 0.0 110.04 -165.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD21 ' NE1' ' A' ' 95' ' ' TRP . 50.8 tp -106.92 127.01 53.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.243 0.617 . . . . 0.0 110.607 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 36.1 m -98.89 137.47 37.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.578 0.751 . . . . 0.0 110.16 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 90' ' ' ILE . 15.7 mt -114.58 116.05 28.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.181 0.593 . . . . 0.0 110.928 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . 46.98 78.65 0.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 125.38 1.675 . . . . 0.0 113.657 165.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.3 -77.06 0.26 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.41 -68.39 0.26 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.24 -36.05 4.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.126 0.97 . . . . 0.0 109.759 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 44.79 7.57 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.355 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -69.37 -35.45 75.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.481 0.658 . . . . 0.0 109.469 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 26.3 m120 -80.8 -31.51 35.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.813 1.245 . . . . 0.0 110.426 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.24 82.73 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.936 0.772 . . . . 0.0 109.682 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.745 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 55.9 m -58.62 -43.18 89.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.462 171.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.4 -31.55 68.81 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.4 0.437 . . . . 0.0 111.096 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.14 -37.02 85.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.953 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.24 73.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.767 0.427 . . . . 0.0 111.227 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.709 ' HA ' HG13 ' A' ' 76' ' ' VAL . 11.7 m -65.99 -15.77 63.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.951 0.9 . . . . 0.0 112.155 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.79 8.72 5.0 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.039 0.535 . . . . 0.0 110.767 172.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.09 8.66 61.4 Favored Glycine 0 C--N 1.362 1.996 0 CA-C-O 119.69 -0.506 . . . . 0.0 114.326 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -105.65 152.37 23.21 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.428 0.614 . . . . 0.0 110.129 -172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 35.5 mt-10 -94.89 90.8 6.14 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.2 t -88.86 118.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.354 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.648 HG21 ' HB ' ' A' ' 79' ' ' THR . 77.1 p -86.04 113.0 21.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -112.3 122.35 47.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.862 0.465 . . . . 0.0 111.196 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.668 HG21 ' HB ' ' A' ' 81' ' ' VAL . 2.6 t -99.25 144.19 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 163.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t70 -124.77 178.19 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -87.24 -27.02 23.2 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.719 0.808 . . . . 0.0 109.851 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.476 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.4 m -119.43 135.97 54.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.954 -1.476 . . . . 0.0 110.559 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -68.64 -22.51 64.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.153 0.981 . . . . 0.0 110.689 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 60' ' ' SER . 17.7 m -64.84 -34.37 69.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.62 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -36.43 73.68 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.24 -43.13 78.59 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.016 0.927 . . . . 0.0 110.835 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -66.75 -37.06 83.89 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.299 0.239 . . . . 0.0 110.813 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.745 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -59.83 -48.49 81.47 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.877 0.736 . . . . 0.0 110.631 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.45 -44.8 74.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.006 0.922 . . . . 0.0 111.237 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.95 -50.87 71.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.337 1.055 . . . . 0.0 111.507 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.411 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 15.0 tp -69.61 -23.74 63.56 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.991 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -68.26 -51.27 46.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.728 173.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.17 -36.11 80.85 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.702 0.801 . . . . 0.0 111.191 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -59.07 -54.55 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.995 0.809 . . . . 0.0 110.511 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -85.18 -6.43 59.28 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.15 -169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.17 39.18 58.51 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 120.877 0.154 . . . . 0.0 112.892 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -127.66 167.41 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.568 1.147 . . . . 0.0 109.279 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -115.78 135.4 54.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.457 0.703 . . . . 0.0 112.265 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.589 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.7 mm -111.41 168.48 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 163.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG21 ' A' ' 55' ' ' THR . 60.9 m -132.95 105.59 7.18 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 163.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.4 p -88.27 121.17 30.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.267 0.627 . . . . 0.0 110.119 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.668 ' HB ' HG21 ' A' ' 57' ' ' VAL . 62.6 t -103.13 137.52 31.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -77.32 135.52 38.4 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.93 0.395 . . . . 0.0 110.321 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -43.63 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.909 1.684 . . . . 0.0 112.233 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -145.32 97.47 3.0 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 84.3 mt -102.1 -8.59 21.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.024 0.53 . . . . 0.0 111.193 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -17.31 43.57 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.305 0.642 . . . . 0.0 112.093 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -137.34 -3.2 1.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.711 0.404 . . . . 0.0 112.046 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 87.3 t80 -156.49 143.87 19.08 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 36' ' ' LEU . 7.5 p-10 -150.79 -70.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 36' ' ' LEU . 13.5 pt -142.68 125.55 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.404 0.682 . . . . 0.0 109.538 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 t -130.56 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.408 ' HB3' HD11 ' A' ' 98' ' ' ILE . . . -72.51 0.23 10.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.248 0.619 . . . . 0.0 112.374 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.85 -34.09 77.15 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.444 0.697 . . . . 0.0 109.235 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.61 -18.81 22.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.316 1.046 . . . . 0.0 112.452 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.489 ' NE1' HD21 ' A' ' 34' ' ' LEU . 24.3 m95 -118.69 134.51 55.07 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.821 0.448 . . . . 0.0 110.856 -171.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -73.58 -28.56 61.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.451 0.7 . . . . 0.0 111.137 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.09 163.67 28.64 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.668 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.425 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 75.5 mt -133.9 155.59 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.22 142.89 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.533 1.133 . . . . 0.0 109.225 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -143.62 103.99 4.15 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.55 HD13 HD13 ' A' ' 128' ' ' ILE . 17.7 mm -75.31 145.72 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -16.16 102.83 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.843 2.057 . . . . 0.0 113.891 -171.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 24.4 p -119.77 149.76 41.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.879 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -145.16 101.58 3.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.016 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.24 147.37 33.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.347 0.659 . . . . 0.0 111.114 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.19 162.15 37.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.965 2.443 . . . . 0.0 110.767 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.2 t -39.12 -39.42 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.094 1.758 . . . . 0.0 114.274 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -64.01 -53.17 54.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.026 0.53 . . . . 0.0 111.591 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.9 -22.16 31.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.222 0.609 . . . . 0.0 110.714 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.423 HH22 ' HB3' ' A' ' 151' ' ' PRO . 75.2 ttt180 -77.88 -55.3 5.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 0.0 109.827 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -60.88 -22.12 63.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.035 0.534 . . . . 0.0 112.289 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.64 -33.84 53.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 117' ' ' VAL . 34.7 tp -77.88 -52.7 8.45 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.613 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -56.15 -51.96 76.62 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -168.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.28 -23.35 62.13 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 121.807 1.681 . . . . 0.0 112.109 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -86.99 -25.5 24.24 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.262 1.025 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 10.9 t -80.9 -37.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.363 -0.836 . . . . 0.0 109.403 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.36 -62.12 2.12 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -74.63 -36.64 62.9 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.36 -34.1 7.25 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -166.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 40.2 tp -69.42 104.32 2.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.593 0.697 . . . . 0.0 109.954 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.07 141.19 88.91 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 164.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.47 125.5 12.46 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.753 2.302 . . . . 0.0 112.326 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 129.31 -2.51 6.2 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.711 -177.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -95.03 139.68 14.63 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 165.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.6 m -108.53 129.76 62.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 123.302 0.641 . . . . 0.0 109.555 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 110.97 22.71 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.55 HD13 HD13 ' A' ' 101' ' ' ILE . 77.4 mt -106.77 106.77 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 85.7 mt -129.23 153.68 47.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.16 0.984 . . . . 0.0 110.193 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.08 106.73 4.86 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.91 134.67 23.77 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.658 ' HB2' HD23 ' A' ' 150' ' ' LEU . 64.7 m-85 -89.61 160.04 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.004 0.522 . . . . 0.0 110.95 -172.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.94 152.39 94.99 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.064 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.57 ' HA ' HD23 ' A' ' 147' ' ' LEU . 30.7 Cg_endo -64.1 -17.36 59.49 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 C-N-CA 121.814 1.676 . . . . 0.0 111.122 162.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -73.83 -25.19 59.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.321 1.048 . . . . 0.0 111.287 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -64.06 -61.61 2.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.729 0.412 . . . . 0.0 111.799 -165.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.6 mt -79.21 -16.43 56.55 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -60.43 -35.25 75.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.183 0.993 . . . . 0.0 110.492 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -74.25 15.6 0.31 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.922 0.889 . . . . 0.0 112.846 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 65.74 35.77 6.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.402 1.081 . . . . 0.0 111.245 172.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.1 p -80.39 -24.45 39.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.649 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.18 64.39 3.28 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.772 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.2 -159.85 1.05 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HB2' HD11 ' A' ' 149' ' ' LEU . 25.7 Cg_endo -58.17 -25.48 71.85 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.75 2.966 . . . . 0.0 114.254 -170.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -173.13 -48.35 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.468 0.707 . . . . 0.0 109.187 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.55 157.87 2.15 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.403 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 134' ' ' PRO . 1.5 mt -58.63 -9.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.923 1.289 . . . . 0.0 113.228 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.38 -40.02 92.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.765 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 144' ' ' PRO . 17.3 mt -80.91 17.76 1.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 132' ' ' PHE . 25.6 mt -99.71 103.26 20.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.423 ' HB3' HH22 ' A' ' 110' ' ' ARG . 89.7 Cg_endo -81.22 129.33 6.72 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.611 2.208 . . . . 0.0 112.417 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.408 ' HA ' HD13 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -92.54 165.58 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.013 0.925 . . . . 0.0 112.173 -177.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' A' ' 188' ' ' ILE . 75.6 mt -56.81 -40.48 76.05 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.942 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.9 -43.57 59.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 0.0 111.037 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 32.5 m -78.41 -54.57 6.04 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.128 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 85.9 mt -72.03 -46.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.051 0.94 . . . . 0.0 112.577 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -60.31 -44.05 95.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.657 0.783 . . . . 0.0 109.784 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.9 t -72.3 -21.41 61.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.819 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -76.9 -23.52 52.55 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.247 0.619 . . . . 0.0 110.542 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 76.3 mt -130.3 75.21 79.51 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.38 -19.48 17.03 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.196 2.598 . . . . 0.0 113.355 -172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -87.87 -42.09 12.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 28.8 tp -69.03 71.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.549 172.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.03 131.29 45.87 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -91.29 135.62 33.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.591 1.156 . . . . 0.0 109.317 -169.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.495 HD12 ' HG2' ' A' ' 193' ' ' GLN . 79.1 mt -72.39 -30.01 64.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.064 0.546 . . . . 0.0 110.13 171.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.9 mt -131.04 120.85 48.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 73.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -143.77 152.31 41.09 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.13 0.491 . . . . 0.0 111.982 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -77.94 105.08 8.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.924 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.21 123.75 50.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.549 0.74 . . . . 0.0 109.595 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -86.34 122.7 30.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -98.04 125.06 42.83 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.52 98.31 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.6 mt -50.53 120.26 4.5 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.131 1.372 . . . . 0.0 110.556 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 108.95 1.9 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.737 0.648 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.19 -55.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.668 0.787 . . . . 0.0 109.202 -173.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.76 52.54 14.77 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.892 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -168.9 1.7 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.085 0.954 . . . . 0.0 111.338 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.62 0.724 . . . . 0.0 109.543 174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -87.64 159.08 18.69 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.477 169.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.35 -25.43 67.15 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.632 0.373 . . . . 0.0 111.926 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.33 70.83 0.99 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 124.251 0.97 . . . . 0.0 111.48 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -111.88 176.05 5.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.954 0.902 . . . . 0.0 110.794 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -157.59 132.67 8.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.647 0.779 . . . . 0.0 109.006 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.67 108.82 16.33 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 77.0 mt -117.67 167.66 11.14 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.524 ' HB ' HD21 ' A' ' 153' ' ' LEU . 8.2 pt -142.68 118.62 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.32 145.18 28.45 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 38.3 mt -131.47 131.18 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.889 1.276 . . . . 0.0 109.723 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.09 106.13 6.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.03 139.46 16.95 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.495 ' HG2' HD12 ' A' ' 166' ' ' LEU . 32.7 tp60 -136.11 157.54 46.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.445 ' H ' HE21 ' A' ' 193' ' ' GLN . 59.6 tttp -56.02 120.13 6.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.961 165.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.56 135.33 54.96 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -150.48 166.0 31.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.02 -8.03 45.8 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.134 0.574 . . . . 0.0 111.854 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -67.99 101.12 1.06 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -85.98 141.87 29.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.325 0.65 . . . . 0.0 109.638 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -83.51 -49.39 9.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -146.95 -167.57 2.81 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.715 1.206 . . . . 0.0 109.636 174.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 62.0 t60 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 124.984 1.314 . . . . 0.0 110.057 178.168 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -162.92 141.29 8.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.755 0.822 . . . . 0.0 109.279 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.28 122.35 33.11 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.745 0.818 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -65.71 101.21 0.6 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -77.38 95.91 4.53 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.733 0.778 . . . . 0.0 111.116 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -61.77 -21.7 64.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.07 0.948 . . . . 0.0 112.309 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -66.53 100.7 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -158.48 151.51 22.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 m -70.09 92.66 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.126 0.57 . . . . 0.0 111.108 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -69.67 -15.46 63.18 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.538 0.735 . . . . 0.0 110.553 172.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -54.59 -19.61 6.32 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.168 1.387 . . . . 0.0 113.199 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.28 97.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -66.4 -59.36 3.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.357 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.46 74.49 0.49 Allowed Glycine 0 C--N 1.35 1.358 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -166.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -42.54 110.95 0.2 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.518 1.527 . . . . 0.0 112.999 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.8 99.41 5.7 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.601 1.16 . . . . 0.0 109.059 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HD2' ' HE2' ' A' ' 46' ' ' PHE . 77.5 Cg_endo -78.9 -179.26 5.3 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.992 2.461 . . . . 0.0 113.477 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.8 65.67 6.03 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.033 171.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -88.77 153.71 20.86 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -58.58 -30.68 67.36 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.954 0.502 . . . . 0.0 110.934 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.67 HD23 ' HG ' ' A' ' 47' ' ' LEU . 20.1 tp -61.81 -33.31 73.89 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.566 1.146 . . . . 0.0 113.077 -174.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -45.9 -40.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -75.87 -46.65 29.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.749 . . . . 0.0 109.85 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -63.23 -35.59 72.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.549 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.9 81.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.397 1.079 . . . . 0.0 111.781 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.87 -29.01 70.43 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.448 172.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.588 ' HB3' HE22 ' A' ' 193' ' ' GLN . 27.1 mm-40 -89.75 -21.37 22.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.451 1.1 . . . . 0.0 112.557 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 24' ' ' VAL . 77.1 mt -79.08 136.13 57.82 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-O 119.301 -0.38 . . . . 0.0 110.307 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.35 133.96 20.09 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 123.776 2.984 . . . . 0.0 113.537 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.18 27.99 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.16 -139.26 6.15 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 118.716 0.689 . . . . 0.0 112.619 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 40.9 ttmt -86.55 114.89 23.66 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 28' ' ' ILE . 11.9 mt -110.64 126.83 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 90' ' ' ILE . 54.2 tp -89.97 114.05 25.82 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 m -88.9 135.22 33.65 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.14 152.29 20.03 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.725 0.41 . . . . 0.0 110.186 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . -30.84 104.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 125.671 1.857 . . . . 0.0 114.219 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 7.3 pt-20 -103.75 -157.15 0.6 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.975 0.91 . . . . 0.0 109.659 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.21 -65.1 2.16 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.541 -0.299 . . . . 0.0 112.721 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 -19.7 10.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -162.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 21.11 59.37 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -72.32 -52.25 17.04 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.421 1.088 . . . . 0.0 110.249 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' HB2' HG13 ' A' ' 101' ' ' ILE . 18.7 m120 -76.07 -29.19 57.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.649 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.43 -57.84 11.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.67 0.788 . . . . 0.0 111.189 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.768 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 25.5 p -69.57 -26.98 64.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.362 0.665 . . . . 0.0 112.341 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.571 ' HE2' ' HD2' ' A' ' 17' ' ' PRO . 38.2 t80 -60.14 -45.55 92.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.454 0.702 . . . . 0.0 109.465 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.67 ' HG ' HD23 ' A' ' 21' ' ' LEU . 68.9 mt -65.45 -32.63 74.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.863 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.56 74.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.394 0.278 . . . . 0.0 111.515 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.581 ' HA ' HG11 ' A' ' 76' ' ' VAL . 81.3 p -71.62 -6.6 42.14 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 123.245 0.34 . . . . 0.0 111.214 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 47' ' ' LEU . 50.0 mt -90.04 11.97 19.08 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.727 0.811 . . . . 0.0 111.124 168.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.63 21.31 66.75 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.549 0.58 . . . . 0.0 114.549 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.59 141.2 36.84 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.943 0.872 . . . . 0.0 110.917 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 45.6 mt-10 -77.47 88.53 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -90.63 107.31 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.592 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.5 t -85.22 103.64 14.36 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.71 131.93 45.38 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.623 -169.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.623 HG23 ' HB ' ' A' ' 81' ' ' VAL . 38.5 t -110.61 134.33 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 20.5 t70 -145.85 140.58 27.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 pt20 -68.52 -20.78 64.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.591 0.756 . . . . 0.0 111.661 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 m -112.9 141.49 46.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.959 0.904 . . . . 0.0 109.406 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.9 p -72.13 -15.95 61.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.646 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.38 -32.97 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.824 0.449 . . . . 0.0 111.113 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.17 -36.72 23.63 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.621 0.575 . . . . 0.0 113.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.72 -52.03 14.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.625 0.77 . . . . 0.0 111.25 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.38 -36.71 69.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.683 0.793 . . . . 0.0 112.302 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -64.3 -45.83 86.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.106 0.562 . . . . 0.0 110.572 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -58.69 -47.91 82.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 124.03 0.831 . . . . 0.0 110.59 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.82 -31.83 71.1 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.504 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.589 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -63.55 -51.93 63.3 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.365 0.666 . . . . 0.0 112.474 176.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.8 tp -67.97 -23.27 65.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.314 0.384 . . . . 0.0 110.49 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.468 ' HA ' HG23 ' A' ' 76' ' ' VAL . . . -61.45 -57.74 10.99 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 122.874 0.47 . . . . 0.0 110.187 172.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.21 -30.55 71.03 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.887 0.875 . . . . 0.0 112.247 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.02 -53.42 26.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.121 0.569 . . . . 0.0 111.257 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -98.04 1.72 48.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.616 0.367 . . . . 0.0 111.437 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.56 43.2 69.65 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 122.321 -0.237 . . . . 0.0 113.484 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 49' ' ' SER . 27.7 m -118.55 169.85 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.579 1.152 . . . . 0.0 109.478 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -112.15 128.7 56.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.891 0.476 . . . . 0.0 111.983 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.8 163.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.637 1.575 . . . . 0.0 107.573 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.5 m -136.53 105.18 5.81 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.0 p -87.34 121.44 29.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.287 -168.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.623 ' HB ' HG23 ' A' ' 57' ' ' VAL . 47.5 t -114.59 135.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.261 1.425 . . . . 0.0 108.834 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.11 130.64 35.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HB3' ' HA ' ' A' ' 59' ' ' GLN . 32.5 t -69.21 118.04 11.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.891 0.476 . . . . 0.0 111.961 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -142.99 86.79 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 167.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.1 mt -78.19 -20.93 50.91 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.13 -13.46 61.19 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 112.187 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.57 -29.39 4.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.285 0.634 . . . . 0.0 111.518 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -159.03 125.41 4.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.524 1.13 . . . . 0.0 108.313 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -70.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 34' ' ' LEU . 7.3 pt -140.2 119.22 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.134 0.974 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -130.8 98.33 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.91 0.884 . . . . 0.0 108.722 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.29 -9.53 5.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.85 -52.83 21.58 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.196 0.598 . . . . 0.0 110.812 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.62 -29.34 66.82 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -169.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.429 ' CZ3' HG12 ' A' ' 98' ' ' ILE . 11.1 p-90 -133.62 176.28 8.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.673 0.789 . . . . 0.0 110.938 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.15 -90.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.301 0.64 . . . . 0.0 111.229 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.87 172.13 41.89 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 118.448 0.567 . . . . 0.0 113.509 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 121' ' ' LEU . 5.9 mt -123.09 150.86 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.55 0.74 . . . . 0.0 109.025 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.1 p -144.46 134.53 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 163.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -133.02 99.2 4.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 30.4 mm -74.88 154.75 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.258 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -18.42 104.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.067 2.147 . . . . 0.0 113.592 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.05 148.96 44.06 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.63 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -147.16 101.64 3.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.09 143.29 26.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.544 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.2 158.57 47.68 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.652 2.234 . . . . 0.0 110.732 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 t -45.59 -36.41 4.69 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.38 1.472 . . . . 0.0 113.737 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 p -56.28 -58.81 6.37 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.355 1.062 . . . . 0.0 111.997 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.25 -19.09 37.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.859 0.864 . . . . 0.0 111.07 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -77.94 -47.25 19.06 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.647 0.779 . . . . 0.0 109.438 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -52.79 -34.49 53.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.903 0.881 . . . . 0.0 111.783 164.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -75.67 -44.27 43.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 117' ' ' VAL . 49.2 tp -92.19 -55.56 3.38 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.67 -40.02 6.24 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 119.623 1.101 . . . . 0.0 112.479 -161.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.37 -28.92 87.71 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 122.281 1.987 . . . . 0.0 112.044 166.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 5.5 tppp? -77.42 -24.77 50.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.396 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 113' ' ' LEU . 41.6 t -72.13 -34.18 49.23 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.364 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -53.93 -62.39 1.69 Allowed 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.69 -33.66 35.24 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.22 57.28 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.533 HD13 HD13 ' A' ' 98' ' ' ILE . 26.8 tp -60.7 128.37 36.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.882 0.473 . . . . 0.0 110.604 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 148.56 34.68 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.74 113.28 1.76 Allowed 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.74 1.626 . . . . 0.0 111.201 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.552 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 128.31 6.15 4.88 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.017 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.427 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -101.53 143.59 16.14 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 164.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.2 m -110.78 130.67 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.566 0.746 . . . . 0.0 109.16 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 129' ' ' LEU . 8.8 t80 -106.61 112.55 25.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 24' ' ' VAL . 55.6 mt -115.43 109.01 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.995 0.918 . . . . 0.0 110.25 -168.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 127' ' ' PHE . 89.0 mt -128.96 133.91 47.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.354 0.662 . . . . 0.0 110.073 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -113.09 98.84 7.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -88.92 -174.49 46.78 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.721 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -138.56 159.54 41.84 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.08 0.952 . . . . 0.0 108.565 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.28 162.96 22.95 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.743 0.817 . . . . 0.0 110.454 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -59.45 -12.77 18.08 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.22 2.614 . . . . 0.0 114.347 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.21 -11.86 59.88 Favored 'General case' 0 CA--C 1.563 1.452 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.46 -57.71 4.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.368 0.667 . . . . 0.0 112.459 -167.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.42 -13.45 60.39 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -69.15 -23.98 64.02 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.657 0.783 . . . . 0.0 110.336 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -80.27 9.9 5.18 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.749 0.82 . . . . 0.0 112.722 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 64.98 33.99 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -77.55 -27.56 51.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.917 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.32 58.97 7.82 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.614 0.571 . . . . 0.0 112.075 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.9 -170.46 1.83 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 114.521 0.568 . . . . 0.0 114.521 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.05 -36.83 77.81 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.876 3.05 . . . . 0.0 114.453 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -163.53 -54.47 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.364 0.666 . . . . 0.0 109.384 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -160.37 156.66 26.56 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.964 -167.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.653 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -58.17 -8.54 1.12 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.141 1.377 . . . . 0.0 113.536 179.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.35 -35.11 79.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.049 0.94 . . . . 0.0 110.707 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.9 mt -88.58 13.37 12.27 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.078 0.951 . . . . 0.0 112.053 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.653 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 36.4 mt -89.75 103.85 7.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.533 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -67.74 103.58 0.86 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.079 2.52 . . . . 0.0 111.729 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' HD11 ' A' ' 188' ' ' ILE . 16.4 ptpt -100.43 152.4 20.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.284 0.493 . . . . 0.0 112.185 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.3 -38.05 87.9 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.79 0.836 . . . . 0.0 110.881 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -48.23 -52.63 20.21 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.267 1.027 . . . . 0.0 111.143 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.0 p -76.41 -61.91 1.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.201 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.69 -46.84 86.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.307 1.043 . . . . 0.0 112.787 -166.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -64.87 -33.27 75.61 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 123.229 0.33 . . . . 0.0 111.185 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.2 t -78.61 -23.32 45.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.568 0.347 . . . . 0.0 111.098 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -86.72 -12.3 48.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.684 0.794 . . . . 0.0 111.251 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.89 64.53 42.47 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.684 0.794 . . . . 0.0 109.156 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.13 4.34 7.15 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.814 2.343 . . . . 0.0 111.786 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 t -87.52 -34.58 18.57 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.456 HD13 HD23 ' A' ' 121' ' ' LEU . 25.7 tp -97.97 73.6 2.26 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 125.973 1.709 . . . . 0.0 110.878 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -57.36 124.28 18.35 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.502 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 12.4 m95 -89.33 139.77 30.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.591 1.156 . . . . 0.0 109.561 -170.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.643 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 96.3 mt -68.09 -44.98 75.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 169.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 79.0 mt -126.4 120.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.37 78.2 1.27 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -143.62 152.57 41.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.004 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.536 ' H ' HD21 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -87.05 120.42 28.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.87 173.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.05 106.36 17.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -85.88 123.51 31.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.878 0.871 . . . . 0.0 109.558 -173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -96.13 130.26 43.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.673 1.189 . . . . 0.0 110.486 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -81.0 106.41 12.97 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.76 160.15 22.36 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.0 125.44 44.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.73 177.24 11.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.362 0.665 . . . . 0.0 109.852 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.07 59.17 0.55 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -149.91 -170.57 3.68 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 109.941 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -92.78 9.81 33.54 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.35 0.66 . . . . 0.0 110.892 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.25 148.95 39.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.154 0.982 . . . . 0.0 110.071 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -63.01 94.85 0.07 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.8 34.77 2.94 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.887 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -109.64 -177.31 3.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.238 1.015 . . . . 0.0 109.155 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -147.82 131.12 16.54 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.25 111.54 22.37 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.5 mt -122.33 151.7 40.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 152' ' ' LYS . 9.2 pt -139.19 142.84 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -124.94 145.29 49.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.591 0.71 . . . . 0.0 110.5 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.56 135.74 48.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.013 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.463 HD21 HG13 ' A' ' 24' ' ' VAL . 16.6 tp -140.24 105.12 4.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.67 133.2 11.63 Favored Glycine 0 C--O 1.219 -0.783 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.643 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 7.8 tp60 -120.18 146.44 46.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.566 0.683 . . . . 0.0 111.35 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.552 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -62.12 138.17 58.36 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.581 0.551 . . . . 0.0 109.559 168.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.1 mt -72.99 146.24 46.12 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.81 -3.49 6.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.607 0.763 . . . . 0.0 112.152 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -51.22 -36.77 43.29 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.946 1.299 . . . . 0.0 111.028 165.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -93.35 133.69 36.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.44 0.696 . . . . 0.0 110.085 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -69.23 147.07 51.77 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.753 0.658 . . . . 0.0 110.478 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -84.08 -49.76 8.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.9 t60 58.35 78.22 0.26 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.274 1.43 . . . . 0.0 110.219 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 CA--C 1.549 0.913 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 179.21 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.925 0.393 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -93.5 154.22 18.02 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.547 0.739 . . . . 0.0 109.92 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -94.53 147.17 23.55 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.184 0.594 . . . . 0.0 110.758 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.13 118.37 29.61 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.759 0.824 . . . . 0.0 109.395 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -68.12 106.77 2.5 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.607 0.763 . . . . 0.0 109.759 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.55 117.93 19.47 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.4 t -67.08 152.95 44.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.992 0.917 . . . . 0.0 110.586 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -114.19 142.61 46.03 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.1 t -150.65 85.77 1.38 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.024 0.53 . . . . 0.0 109.745 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.21 95.55 4.73 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.659 0.783 . . . . 0.0 109.197 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -80.43 67.71 6.37 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.13 113.21 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -163.86 89.7 0.58 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.89 78.1 0.36 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -139.53 105.1 5.1 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.267 0.627 . . . . 0.0 110.43 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -151.81 71.91 8.02 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.933 0.893 . . . . 0.0 109.021 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.24 161.17 13.27 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.009 2.473 . . . . 0.0 110.616 172.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.84 78.61 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.728 0.775 . . . . 0.0 109.535 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.676 ' HB2' HG12 ' A' ' 22' ' ' VAL . 12.2 m-20 -124.63 163.17 22.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.188 0.995 . . . . 0.0 109.789 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.15 -34.54 78.28 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 tp -68.46 -21.39 64.63 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.383 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.676 HG12 ' HB2' ' A' ' 19' ' ' ASP . 11.2 m -86.46 -28.91 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 119.007 0.822 . . . . 0.0 109.434 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -74.83 -44.67 48.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.993 0.917 . . . . 0.0 110.001 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 28' ' ' ILE . 19.0 m -64.16 -37.04 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.6 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.02 67.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.16 -26.6 65.84 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.129 0.572 . . . . 0.0 109.728 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.643 ' HB3' HE21 ' A' ' 193' ' ' GLN . 24.0 mm-40 -88.74 -25.96 22.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.973 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 24' ' ' VAL . 47.9 mt -73.71 130.25 83.87 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.26 132.95 29.58 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.231 2.621 . . . . 0.0 112.835 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -74.58 27.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.96 -134.91 5.76 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -82.15 114.91 21.0 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.7 151.2 11.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.9 tp -119.61 120.45 36.73 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 28.5 p -108.7 126.68 53.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.86 -172.42 1.3 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . -48.84 88.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.599 0.76 . . . . 0.0 111.056 166.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.625 ' HB3' HD21 ' A' ' 43' ' ' ASN . 7.7 mm-40 -67.0 154.69 40.55 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.375 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -24.42 54.16 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 123.591 0.557 . . . . 0.0 113.105 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' A' ' 42' ' ' ARG . 43.7 tt0 -150.43 145.86 26.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.23 1.012 . . . . 0.0 109.247 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.5 -22.92 66.27 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.214 0.435 . . . . 0.0 113.769 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 70.8 mtt180 -61.98 -35.14 77.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.386 0.674 . . . . 0.0 112.049 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.625 HD21 ' HB3' ' A' ' 38' ' ' GLU . 53.5 m-20 -56.15 -52.31 64.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.876 0.735 . . . . 0.0 111.099 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.51 -54.16 50.04 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.317 1.011 . . . . 0.0 111.8 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 6.2 p -67.89 -28.93 67.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.791 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 84.1 t80 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.446 0.698 . . . . 0.0 110.079 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 99' ' ' VAL . 50.9 mt -65.03 -35.85 82.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.829 0.852 . . . . 0.0 111.228 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.45 63.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.394 0.278 . . . . 0.0 111.247 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.511 ' HA ' HG13 ' A' ' 76' ' ' VAL . 50.4 m -61.71 -23.05 65.88 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.355 0.662 . . . . 0.0 111.092 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.0 mt -78.23 12.39 1.92 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.988 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.51 66.59 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.475 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -103.41 152.98 20.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.252 0.526 . . . . 0.0 111.274 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -90.96 91.06 8.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.5 t -98.87 126.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.403 0.681 . . . . 0.0 109.985 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 m -99.77 111.69 24.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.744 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -96.68 139.53 32.61 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.814 0.446 . . . . 0.0 110.304 -172.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 81' ' ' VAL . 16.0 t -118.28 150.09 20.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 164.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 27.8 t0 -157.99 144.57 17.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.288 0.495 . . . . 0.0 109.893 172.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.33 -20.47 66.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.073 0.858 . . . . 0.0 112.02 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.408 ' HB3' HG22 ' A' ' 62' ' ' VAL . 1.9 m -108.92 140.32 42.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.158 0.983 . . . . 0.0 109.325 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 m -69.44 -29.23 66.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.784 0.434 . . . . 0.0 110.85 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 60' ' ' SER . 11.0 m -61.66 -35.25 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.829 0.706 . . . . 0.0 111.976 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.01 -35.37 35.01 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.53 0.519 . . . . 0.0 112.81 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -50.97 62.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.56 0.744 . . . . 0.0 110.435 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.13 76.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.158 0.983 . . . . 0.0 112.589 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -62.93 -43.81 97.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.429 0.692 . . . . 0.0 110.141 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -63.61 -46.02 87.67 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.28 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -67.24 -42.96 83.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.674 0.79 . . . . 0.0 110.782 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.49 -54.52 42.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.31 1.044 . . . . 0.0 111.627 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.506 HD22 ' SG ' ' A' ' 45' ' ' CYS . 30.5 tp -65.95 -28.82 69.19 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.923 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.604 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.78 -62.94 1.32 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.457 0.473 . . . . 0.0 111.062 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.62 -25.57 67.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.145 0.578 . . . . 0.0 111.274 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.79 -54.74 14.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.739 0.415 . . . . 0.0 109.904 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.28 -5.32 58.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.98 0.512 . . . . 0.0 112.083 -171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.58 34.15 40.64 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 121.923 -0.179 . . . . 0.0 113.064 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 49' ' ' SER . 33.0 m -125.21 170.46 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.633 1.173 . . . . 0.0 108.416 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -121.45 138.28 54.35 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mm -116.61 167.2 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -133.99 105.49 6.76 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 165.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.3 p -89.72 137.25 32.5 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.667 0.746 . . . . 0.0 111.576 -167.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 57' ' ' VAL . 58.8 t -125.05 135.0 65.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.324 1.849 . . . . 0.0 107.845 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -83.18 139.84 32.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 p -48.98 109.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.246 1.018 . . . . 0.0 113.144 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -136.58 93.7 2.91 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 90.8 mt -103.15 -35.25 8.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.141 0.577 . . . . 0.0 111.822 -170.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.09 -5.83 50.44 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.045 0.538 . . . . 0.0 112.117 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -116.23 -28.64 6.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.983 0.913 . . . . 0.0 111.174 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 47.3 t80 -157.79 156.09 30.93 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 125.166 1.387 . . . . 0.0 107.696 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.56 -70.58 0.17 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.407 1.458 . . . . 0.0 108.927 163.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 98' ' ' ILE . 13.5 pt -139.5 118.77 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 0.0 110.268 -172.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.42 86.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 122' ' ' LYS . . . -72.2 1.96 6.74 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.29 -47.87 69.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 165.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 -11.79 39.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.066 0.947 . . . . 0.0 111.962 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -120.3 117.77 28.67 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.612 0.765 . . . . 0.0 110.119 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -58.46 -47.62 83.4 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.677 0.791 . . . . 0.0 111.366 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.97 156.28 18.11 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.924 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.627 HD12 ' HB ' ' A' ' 90' ' ' ILE . 55.3 mt -129.47 148.52 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 171.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG13 HD13 ' A' ' 47' ' ' LEU . 4.3 p -135.27 143.12 37.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.759 1.224 . . . . 0.0 107.99 161.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.418 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 50.0 m -143.63 102.17 3.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.66 83.96 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.444 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 27.1 t80 -74.54 117.84 16.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.345 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.5 p -113.49 173.65 6.3 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -55.56 101.23 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.514 0.726 . . . . 0.0 110.721 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.16 139.81 42.37 Favored Pre-proline 0 C--O 1.247 0.961 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.61 144.9 24.16 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.838 2.359 . . . . 0.0 110.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -43.33 -34.61 1.27 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.713 1.205 . . . . 0.0 113.495 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 t -56.55 -64.25 0.93 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.45 1.1 . . . . 0.0 111.506 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.78 -30.74 65.87 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.728 0.411 . . . . 0.0 111.324 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -63.62 -62.4 1.69 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.682 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.49 -30.77 67.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.77 -33.95 64.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.178 0.591 . . . . 0.0 110.516 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.18 -48.48 62.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.855 0.722 . . . . 0.0 111.314 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -57.63 -44.31 99.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -166.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.41 -28.08 83.46 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 122.077 1.778 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' A' ' 116' ' ' LYS . 7.8 mtpm? -88.18 -12.38 44.05 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.026 0.931 . . . . 0.0 111.296 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 3.4 t -85.32 -33.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 165.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -66.07 -61.5 2.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.697 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.8 -47.78 16.04 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.83 -39.34 39.51 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 -166.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.583 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 28.4 tp -70.9 96.2 1.25 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.465 ' H ' ' HB1' ' A' ' 92' ' ' ALA . 30.0 mmmt -67.0 130.13 93.93 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 27.5 Cg_exo -39.85 123.44 1.23 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.422 3.415 . . . . 0.0 114.547 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.99 14.78 2.98 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.704 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.532 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.88 150.47 17.04 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 167.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 20.4 m -109.84 131.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 123.264 0.626 . . . . 0.0 109.943 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.418 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.3 t80 -110.37 113.06 25.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.51 111.7 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.792 0.837 . . . . 0.0 109.865 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 156' ' ' LEU . 2.1 mp -129.18 149.5 50.96 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.302 0.641 . . . . 0.0 110.068 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 45.2 tt0 -135.67 103.64 5.5 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.803 0.689 . . . . 0.0 109.253 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.6 148.33 27.59 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 170.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.419 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.1 m-85 -111.04 168.28 9.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.609 0.763 . . . . 0.0 110.39 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.35 164.07 62.2 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.25 1.02 . . . . 0.0 111.861 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.69 ' HA ' HD22 ' A' ' 147' ' ' LEU . 83.5 Cg_exo -50.29 -21.84 7.61 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.398 2.732 . . . . 0.0 113.715 165.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.01 -24.76 62.44 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.752 1.221 . . . . 0.0 112.092 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -71.27 -57.72 4.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -163.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -61.36 -37.09 82.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.543 0.737 . . . . 0.0 110.273 177.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -60.0 -43.33 95.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.66 1.225 . . . . 0.0 110.842 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -78.36 -21.34 49.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.439 0.696 . . . . 0.0 110.409 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.71 20.76 12.39 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.369 1.468 . . . . 0.0 111.057 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.5 p -88.13 8.43 26.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.17 0.988 . . . . 0.0 111.908 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.87 52.66 0.02 OUTLIER Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.31 3.7 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.121 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -71.75 -71.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.7 2.267 . . . . 0.0 112.907 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -128.04 -52.21 1.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.908 0.883 . . . . 0.0 109.517 -173.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.82 150.92 25.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.099 0.959 . . . . 0.0 108.551 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.69 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.1 mt -52.4 -9.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.18 1.792 . . . . 0.0 113.812 173.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.46 -39.25 79.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.129 0.571 . . . . 0.0 110.206 171.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.69 1.65 22.21 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 123.41 0.684 . . . . 0.0 112.491 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 59.5 mt -81.72 108.17 10.32 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.699 ' HB2' HD11 ' A' ' 156' ' ' LEU . 65.3 Cg_endo -83.34 123.88 3.55 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.315 2.01 . . . . 0.0 111.79 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -86.65 159.09 19.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.141 0.976 . . . . 0.0 111.95 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.435 HD21 ' HB ' ' A' ' 188' ' ' ILE . 71.7 mt -61.61 -36.63 81.27 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 166.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.23 -50.45 72.82 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.01 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.443 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 73.5 p -68.75 -62.33 1.43 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.299 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 151' ' ' PRO . 70.8 mt -61.84 -49.93 74.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.81 1.244 . . . . 0.0 112.952 -166.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.646 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.5 tt0 -58.47 -43.19 88.85 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 123.685 0.616 . . . . 0.0 111.426 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 t -73.13 -23.23 60.46 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.463 0.305 . . . . 0.0 111.594 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 155' ' ' THR . 53.9 mt-10 -80.86 -18.04 48.68 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.684 0.793 . . . . 0.0 111.399 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 97.0 mt -133.65 66.73 74.17 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.311 0.644 . . . . 0.0 110.507 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.35 2.97 7.89 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.783 2.322 . . . . 0.0 112.309 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.1 m -86.02 -35.23 20.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.4 tp -102.14 70.19 1.19 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.002 1.721 . . . . 0.0 110.663 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -64.98 136.88 57.32 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.646 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 19.3 m95 -96.98 136.92 36.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.512 0.725 . . . . 0.0 110.545 -163.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 46.2 mt -68.33 -30.02 68.9 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.634 0.584 . . . . 0.0 109.729 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 67.0 mt -132.01 125.09 54.29 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.38 66.38 0.7 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -128.97 143.71 50.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.655 -162.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -89.96 99.32 12.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.386 1.075 . . . . 0.0 109.535 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.7 mt -108.19 129.92 55.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.359 1.064 . . . . 0.0 111.56 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 131.14 41.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.113 0.565 . . . . 0.0 109.946 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 184' ' ' LYS . 21.4 ttt180 -107.63 131.94 53.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.98 0.912 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -71.93 104.53 3.53 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.696 0.623 . . . . 0.0 111.709 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.478 HD13 ' HB3' ' A' ' 185' ' ' ALA . 17.4 mt -83.66 169.23 15.54 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.594 165.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.36 141.83 58.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.469 0.308 . . . . 0.0 110.672 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.572 ' HG3' ' HA ' ' A' ' 182' ' ' GLN . 35.5 tt0 -94.59 143.73 26.19 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.444 0.698 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.48 -64.42 0.01 OUTLIER Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.58 -172.36 3.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.909 0.884 . . . . 0.0 110.156 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -53.39 -33.22 52.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.192 0.597 . . . . 0.0 110.569 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -59.66 93.7 0.02 OUTLIER 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.737 -1.12 . . . . 0.0 107.991 167.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.572 ' HA ' ' HG3' ' A' ' 177' ' ' GLU . 9.4 pt20 -70.69 3.15 3.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.781 0.832 . . . . 0.0 112.907 -174.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.22 61.22 1.2 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.078 167.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -127.03 172.03 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.336 0.589 . . . . 0.0 110.177 158.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 175' ' ' LEU . . . -145.3 132.36 20.35 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.193 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.99 107.31 6.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.058 0.849 . . . . 0.0 108.959 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.97 149.48 40.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 19.8 pt -132.54 117.24 30.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -98.55 144.58 27.72 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.375 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 48.6 mt -128.63 137.21 51.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.53 -1.213 . . . . 0.0 109.525 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 24' ' ' VAL . 33.3 tp -135.11 105.08 6.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -90.92 138.14 14.21 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.1 tp-100 -143.52 157.43 44.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.299 0.64 . . . . 0.0 110.752 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.412 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 62.9 tttm -56.29 120.74 8.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.265 1.026 . . . . 0.0 109.207 172.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.99 116.14 10.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.58 0.352 . . . . 0.0 111.536 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.51 132.87 12.79 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.732 0.645 . . . . 0.0 109.835 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.64 32.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.673 1.189 . . . . 0.0 107.98 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' ' 201' ' ' HIS . 34.1 t60 68.35 114.71 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.693 1.597 . . . . 0.0 109.056 -166.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.02 150.86 40.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.035 0.534 . . . . 0.0 109.795 174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 15.3 m170 70.77 11.35 7.16 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.818 1.247 . . . . 0.0 111.749 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.492 ' HB3' ' O ' ' A' ' 198' ' ' HIS . 16.5 t-80 -109.66 110.51 21.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.564 1.145 . . . . 0.0 107.975 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.646 0.778 . . . . 0.0 109.084 -179.168 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.075 0.464 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -159.12 156.21 28.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.682 0.793 . . . . 0.0 110.099 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . 8.0 p-10 -160.58 142.66 12.65 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.476 1.11 . . . . 0.0 108.686 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.45 125.06 9.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 111.876 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -133.67 155.7 49.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.278 1.431 . . . . 0.0 107.544 165.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -156.14 127.65 7.21 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 111.38 23.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.561 0.745 . . . . 0.0 109.437 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -87.56 152.59 22.08 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.711 0.804 . . . . 0.0 108.854 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 t -145.91 98.3 3.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -84.4 83.42 8.0 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.12 0.568 . . . . 0.0 109.513 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -61.44 125.22 22.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.335 1.054 . . . . 0.0 111.532 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.27 111.95 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.715 0.806 . . . . 0.0 109.33 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -93.13 108.5 20.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.262 1.025 . . . . 0.0 109.34 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.54 105.49 2.83 Favored Glycine 0 N--CA 1.467 0.761 0 O-C-N 123.624 0.577 . . . . 0.0 111.963 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -90.24 79.92 6.31 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.294 0.568 . . . . 0.0 110.302 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -93.16 114.84 63.89 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.416 0.687 . . . . 0.0 110.546 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.01 -177.31 3.56 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.745 2.297 . . . . 0.0 111.906 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.45 139.59 16.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.089 0.956 . . . . 0.0 108.987 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -162.07 177.49 9.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.217 0.607 . . . . 0.0 109.768 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.3 -23.51 65.75 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.486 1.114 . . . . 0.0 110.245 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.98 -17.73 10.88 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.811 1.244 . . . . 0.0 112.747 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.55 -27.46 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.516 1.053 . . . . 0.0 109.398 -171.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 17.4 m -66.68 -52.69 41.9 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.473 0.709 . . . . 0.0 109.422 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.51 HG13 HD22 ' A' ' 191' ' ' LEU . 19.3 m -65.98 -37.09 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.9 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 28' ' ' ILE . . . -58.68 -42.18 87.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.273 1.029 . . . . 0.0 112.25 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.51 -23.65 64.58 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.858 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.681 ' HB3' HE22 ' A' ' 193' ' ' GLN . 12.5 mm100 -83.91 -14.24 51.52 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.263 0.625 . . . . 0.0 111.366 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -82.89 128.94 63.7 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.275 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.15 140.05 41.82 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.122 2.548 . . . . 0.0 113.063 169.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.21 27.41 0.05 Allowed 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.42 -136.77 6.56 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-O 119.397 -0.669 . . . . 0.0 112.919 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -75.21 112.7 11.75 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -107.92 116.04 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.64 113.79 26.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 110.208 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 8.8 t -104.05 108.57 19.99 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 122.451 0.3 . . . . 0.0 111.531 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.432 HD11 HG23 ' A' ' 90' ' ' ILE . 61.7 mt -81.26 123.41 28.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.646 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 45.85 68.82 0.53 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 125.153 1.533 . . . . 0.0 111.255 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -68.87 169.11 12.14 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.156 -169.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.45 68.83 3.48 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.75 -174.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 60.79 74.4 0.45 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.561 1.144 . . . . 0.0 113.5 166.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.2 -73.81 0.54 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtm105 -55.64 -26.69 45.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.786 1.234 . . . . 0.0 113.557 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.464 HD21 ' HB2' ' A' ' 38' ' ' GLU . 4.8 t30 -63.72 -54.63 32.51 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.351 0.661 . . . . 0.0 111.304 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.35 74.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.983 0.802 . . . . 0.0 110.808 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 26.5 m -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.906 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.491 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 89.0 t80 -66.14 -51.88 53.7 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.697 0.623 . . . . 0.0 109.6 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.447 HD12 HG12 ' A' ' 99' ' ' VAL . 93.4 mt -61.38 -37.02 81.89 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.437 1.086 . . . . 0.0 110.901 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.71 66.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.312 0.645 . . . . 0.0 112.078 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.673 ' HA ' HG12 ' A' ' 76' ' ' VAL . 96.1 p -70.32 -2.78 14.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.2 mt -82.76 12.96 4.17 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.028 0.531 . . . . 0.0 110.501 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.44 32.82 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 119.846 -0.419 . . . . 0.0 113.925 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.8 158.87 35.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.352 0.576 . . . . 0.0 111.141 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.4 91.31 6.15 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.755 0.822 . . . . 0.0 108.98 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.95 110.45 23.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.993 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.658 HG23 ' HB ' ' A' ' 79' ' ' THR . 47.4 p -84.88 105.48 15.69 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.073 173.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.0 129.2 46.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.245 0.618 . . . . 0.0 110.772 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.25 123.62 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.32 134.44 25.72 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.03 -2.45 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.66 1.184 . . . . 0.0 113.329 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 m -119.93 119.61 33.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.2 m -73.44 -24.95 60.31 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.306 0.642 . . . . 0.0 110.291 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.25 -35.88 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.776 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.01 -35.16 58.03 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.747 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.63 -49.71 69.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.494 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.611 0.764 . . . . 0.0 112.043 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -66.23 -46.28 77.75 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.874 0.87 . . . . 0.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.519 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -63.59 -40.92 98.17 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.99 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 36.6 ttpt -65.49 -45.05 85.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.462 1.105 . . . . 0.0 110.938 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 -51.55 68.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.105 0.962 . . . . 0.0 110.872 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.37 -30.59 70.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.172 0.92 . . . . 0.0 111.022 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -64.05 -61.37 2.31 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.505 0.503 . . . . 0.0 111.256 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.12 -24.39 65.01 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.341 0.656 . . . . 0.0 110.842 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.44 -35.24 75.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.932 0.893 . . . . 0.0 110.44 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.83 -10.41 45.47 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.39 0.676 . . . . 0.0 111.251 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.63 36.16 20.48 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 113.633 0.213 . . . . 0.0 113.633 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' A' ' 49' ' ' SER . 19.4 m -132.32 174.58 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.373 1.069 . . . . 0.0 110.048 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.25 129.46 54.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.0 0.92 . . . . 0.0 111.814 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.1 mm -108.68 166.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 162.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.658 ' HB ' HG23 ' A' ' 55' ' ' THR . 90.3 m -134.06 110.59 9.74 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 160.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.4 p -81.94 120.47 25.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.65 153.46 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.727 1.211 . . . . 0.0 109.693 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -85.81 103.59 14.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.6 p -46.9 99.92 0.02 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.55 1.14 . . . . 0.0 112.672 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -141.0 96.57 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.79 -15.02 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.033 0.933 . . . . 0.0 112.424 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -18.18 32.32 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.533 0.733 . . . . 0.0 112.651 -174.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.42 -10.9 3.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.759 0.823 . . . . 0.0 111.495 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -151.68 157.62 42.33 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -153.84 -57.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 117' ' ' VAL . 3.1 pt -151.81 134.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.0 109.322 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.457 HG13 ' H ' ' A' ' 93' ' ' ASP . 84.4 t -123.64 150.99 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.305 1.042 . . . . 0.0 108.215 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.27 -29.63 19.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.296 0.57 . . . . 0.0 110.27 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' H ' HG13 ' A' ' 91' ' ' VAL . 23.3 t70 -70.34 -51.66 28.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.262 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.34 -25.9 33.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.161 0.584 . . . . 0.0 112.362 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 57.1 m95 -111.81 107.08 16.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.06 0.457 . . . . 0.0 110.865 -168.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -56.88 12.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.165 1.386 . . . . 0.0 109.525 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.22 143.06 15.63 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.47 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.518 HD12 ' HB ' ' A' ' 90' ' ' ILE . 87.7 mt -124.9 127.26 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -123.12 102.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.308 1.052 . . . . 0.0 109.732 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 m -97.33 91.59 5.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.7 mm -72.37 150.36 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.869 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -17.92 105.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 127.258 2.223 . . . . 0.0 113.46 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 p -111.38 106.26 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.549 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -98.09 99.53 10.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.2 mt -114.81 146.07 35.29 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.735 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.559 ' HA ' HD13 ' A' ' 149' ' ' LEU . 35.8 Cg_exo -61.69 155.4 54.06 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.963 2.442 . . . . 0.0 110.715 167.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -46.3 -38.66 8.96 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.979 0.912 . . . . 0.0 112.752 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.8 m -56.0 -52.41 64.31 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 123.925 0.766 . . . . 0.0 111.986 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.96 -22.04 31.57 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.236 0.615 . . . . 0.0 111.039 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -76.08 -52.43 10.18 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.4 -14.23 62.85 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.746 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.2 -39.56 25.23 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 117' ' ' VAL . 64.2 tp -75.52 -60.25 2.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.033 0.533 . . . . 0.0 111.933 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -58.94 -43.72 97.99 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -164.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.8 -23.38 26.13 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 121.774 1.649 . . . . 0.0 112.04 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -86.17 -14.65 43.4 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.783 0.833 . . . . 0.0 110.16 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.582 ' HA ' HD11 ' A' ' 90' ' ' ILE . 28.9 t -75.27 -40.18 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 166.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.78 -54.16 50.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.109 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.2 -46.79 63.83 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.313 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.58 -57.27 3.92 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.376 0.511 . . . . 0.0 114.376 -172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.446 ' HB2' HD13 ' A' ' 90' ' ' ILE . 6.0 tt -74.6 138.28 42.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.553 0.741 . . . . 0.0 109.817 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -120.05 168.54 10.17 Favored Pre-proline 0 C--O 1.247 0.933 0 C-N-CA 124.622 1.169 . . . . 0.0 108.583 172.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.07 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 122.003 1.802 . . . . 0.0 112.042 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.407 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 133.72 -2.05 4.42 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.176 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -114.52 145.03 18.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 159.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.2 131.5 58.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.87 1.268 . . . . 0.0 109.447 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -106.37 111.71 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.24 107.82 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 91.3 mt -118.35 141.02 48.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.753 0.821 . . . . 0.0 110.669 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -127.15 101.43 6.51 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 164.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 179.6 53.19 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 164.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.43 ' HD1' HD22 ' A' ' 187' ' ' LEU . 36.0 m-85 -130.16 169.37 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.494 ' HB3' ' HB1' ' A' ' 186' ' ' ALA . . . -100.9 154.31 37.23 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.116 0.566 . . . . 0.0 110.174 172.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.08 -6.77 5.38 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.409 2.74 . . . . 0.0 114.023 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -25.59 7.94 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.099 0.96 . . . . 0.0 112.535 171.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.552 ' HB3' HD23 ' A' ' 147' ' ' LEU . 56.4 tp60 -78.42 -50.75 11.14 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 118.797 -0.62 . . . . 0.0 110.388 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.724 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 32.3 mt -61.38 -13.24 18.33 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 119.136 0.88 . . . . 0.0 112.797 171.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.68 -33.73 76.29 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.03 -50.1 5.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.624 0.77 . . . . 0.0 109.939 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.48 86.88 2.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 p -82.05 -25.37 34.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.871 -166.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -114.44 65.92 0.28 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.682 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.78 59.24 0.51 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.567 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.74 144.18 34.77 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.296 1.997 . . . . 0.0 109.396 170.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.556 ' HB3' ' HZ2' ' A' ' 145' ' ' LYS . 6.0 ttpm? 84.44 22.87 0.11 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.86 1.264 . . . . 0.0 108.707 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -119.13 -74.46 0.61 Allowed 'General case' 0 C--N 1.347 0.496 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.724 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 5.7 mp -104.6 6.52 34.58 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.913 -0.492 . . . . 0.0 111.916 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.29 -31.15 67.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.349 -1.469 . . . . 0.0 109.97 161.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 106' ' ' PRO . 23.9 mt -92.34 25.37 2.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.451 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 147' ' ' LEU . 88.2 mt -72.88 115.35 39.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 123.307 0.379 . . . . 0.0 110.554 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.447 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 55.6 Cg_endo -93.79 114.11 0.23 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 122.647 2.231 . . . . 0.0 109.988 167.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -73.09 167.93 20.12 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.776 0.43 . . . . 0.0 111.761 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.628 HD21 ' HB ' ' A' ' 188' ' ' ILE . 67.8 mt -61.14 -30.58 70.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 0.0 110.9 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -56.8 -59.38 5.11 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.425 0.69 . . . . 0.0 110.73 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.1 p -65.57 -38.42 89.49 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.592 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.2 -43.68 23.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -173.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.473 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 29.6 tt0 -58.96 -40.02 83.47 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 120.927 0.394 . . . . 0.0 110.905 173.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -80.47 -13.3 59.23 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.438 0.695 . . . . 0.0 111.258 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -74.37 -31.77 62.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.464 0.706 . . . . 0.0 109.861 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 79.8 mt -134.08 74.25 68.55 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.99 -33.58 31.86 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.289 2.659 . . . . 0.0 113.407 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t -82.78 -35.43 26.53 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.5 tp -66.89 71.77 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.674 1.19 . . . . 0.0 111.799 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -51.8 120.93 5.78 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.797 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.473 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 55.3 m95 -87.94 119.7 28.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.508 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.609 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 79.8 mt -68.08 -33.76 75.15 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.846 0.458 . . . . 0.0 110.276 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.6 128.33 69.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.63 81.67 1.34 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -137.62 144.43 41.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.899 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.36 125.53 35.17 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.7 mt -105.75 107.12 17.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.8 119.33 28.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -98.81 129.6 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 110.109 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -73.38 104.03 4.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.001 0.92 . . . . 0.0 110.469 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 185' ' ' ALA . 13.5 mt -75.03 108.53 7.82 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 33.5 t70 61.31 94.59 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.295 1.038 . . . . 0.0 110.506 -170.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.65 30.37 4.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.796 0.838 . . . . 0.0 110.413 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.91 -67.45 2.19 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.758 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.47 -52.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.016 0.526 . . . . 0.0 111.862 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -98.74 -36.52 9.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -164.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -63.09 -68.55 0.33 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 118.13 0.423 . . . . 0.0 110.433 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 58.59 18.32 5.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.421 1.088 . . . . 0.0 112.105 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.52 34.69 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -123.16 -172.59 2.53 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 0.0 110.877 -172.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 175' ' ' LEU . . . -166.9 131.52 2.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 133' ' ' ALA . . . -83.5 138.71 33.31 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.43 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.7 mt -120.92 144.07 48.63 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.628 ' HB ' HD21 ' A' ' 153' ' ' LEU . 27.3 pt -124.12 116.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.8 1.182 . . . . 0.0 109.944 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -100.04 146.74 26.4 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.692 0.758 . . . . 0.0 110.586 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 46.0 mt -137.07 141.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.073 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.51 HD22 HG13 ' A' ' 24' ' ' VAL . 40.9 tp -134.19 106.35 7.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 168.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.31 140.59 19.2 Favored Glycine 0 CA--C 1.505 -0.551 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.681 HE22 ' HB3' ' A' ' 27' ' ' GLN . 7.4 tp-100 -123.75 148.37 46.68 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 193' ' ' GLN . 0.7 OUTLIER -57.11 115.92 2.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.371 161.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.3 mt -61.22 116.13 4.35 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 167.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -58.66 132.55 54.17 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.023 0.827 . . . . 0.0 109.777 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.59 83.17 0.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 124.058 0.849 . . . . 0.0 109.313 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -82.58 78.63 9.18 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.39 1.076 . . . . 0.0 109.461 -177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -77.27 109.89 11.53 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.764 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -145.87 176.43 9.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.288 0.635 . . . . 0.0 110.359 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -73.09 87.76 1.4 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.407 0.683 . . . . 0.0 109.775 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 . . . . . 0 C--O 1.245 0.849 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 171.703 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -79.76 157.17 27.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.6 99.67 7.44 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.539 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -90.17 69.14 7.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -157.11 145.15 19.27 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.104 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -138.23 157.67 45.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.673 0.789 . . . . 0.0 111.061 -173.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 p -91.86 103.21 15.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.998 0.919 . . . . 0.0 108.877 171.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -67.55 115.95 7.72 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.141 0.576 . . . . 0.0 109.94 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 t -123.24 30.49 6.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 110.262 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.5 105.01 2.48 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.422 0.689 . . . . 0.0 109.73 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -91.67 159.65 15.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.387 0.675 . . . . 0.0 110.127 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.63 116.37 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -109.21 139.06 44.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.091 0.556 . . . . 0.0 110.444 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.06 148.51 5.94 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.587 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -172.03 112.37 0.3 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.547 1.939 . . . . 0.0 107.579 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -120.79 73.73 24.54 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.192 0.597 . . . . 0.0 110.83 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.03 124.75 0.94 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.819 2.346 . . . . 0.0 110.961 167.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -68.91 110.6 4.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.162 0.585 . . . . 0.0 109.907 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 22' ' ' VAL . 22.3 t70 -142.13 170.69 15.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.596 0.758 . . . . 0.0 110.302 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.85 -34.19 77.58 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.983 0.913 . . . . 0.0 110.773 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 24' ' ' VAL . 33.7 tp -67.62 -54.4 20.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.131 0.572 . . . . 0.0 111.208 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 19' ' ' ASP . 14.4 m -47.39 -25.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 m -68.36 -49.07 62.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.862 0.865 . . . . 0.0 110.767 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.649 HG22 HD13 ' A' ' 128' ' ' ILE . 1.5 m -64.77 -36.48 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.032 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.54 66.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.1 -35.24 77.82 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.855 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -82.86 -18.25 41.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.143 0.977 . . . . 0.0 112.466 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 24' ' ' VAL . 74.1 mt -77.02 135.64 66.82 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.965 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.59 142.48 90.38 Favored 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.467 2.778 . . . . 0.0 112.331 171.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.405 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 28.2 pt20 -70.73 28.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.63 -141.87 6.76 Favored Glycine 0 N--CA 1.478 1.447 0 CA-C-N 118.769 0.713 . . . . 0.0 113.338 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 62.0 mttp -76.91 115.32 16.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 54' ' ' VAL . 21.0 mt -107.63 121.45 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HA ' HG22 ' A' ' 55' ' ' THR . 55.6 tp -90.69 111.62 23.04 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.02 0.528 . . . . 0.0 111.289 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 98.6 m -87.19 134.9 33.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.83 152.63 18.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.749 0.419 . . . . 0.0 110.469 167.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.47 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.685 1.241 . . . . 0.0 111.779 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.08 -165.92 1.46 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.423 1.089 . . . . 0.0 109.858 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.26 -56.68 20.32 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.239 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -135.67 129.13 32.27 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.926 0.89 . . . . 0.0 109.397 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.76 36.86 2.47 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.43 0.538 . . . . 0.0 114.152 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -81.24 -26.38 35.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.257 1.023 . . . . 0.0 109.617 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.552 ' ND2' HG23 ' A' ' 101' ' ' ILE . 79.8 m-20 -67.25 -35.08 78.8 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.943 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -53.42 -57.55 10.23 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.418 1.087 . . . . 0.0 111.813 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.894 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 8.3 p -66.03 -34.13 77.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.976 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.96 -43.09 88.93 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.57 0.544 . . . . 0.0 111.29 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.412 HD12 HG12 ' A' ' 99' ' ' VAL . 84.9 mt -67.35 -30.78 70.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.47 -36.71 74.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.724 0.41 . . . . 0.0 110.542 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -63.95 -14.63 55.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.207 1.003 . . . . 0.0 112.341 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.0 mt -85.26 17.19 3.17 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.934 0.894 . . . . 0.0 110.705 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 37.73 25.39 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 123.563 0.601 . . . . 0.0 114.436 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 25.2 m-85 -126.69 154.36 44.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.998 0.519 . . . . 0.0 111.318 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 33.5 mt-10 -89.6 86.9 6.84 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 ' HB ' ' A' ' 33' ' ' ILE . 71.2 t -93.23 108.49 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.783 0.802 . . . . 0.0 110.376 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 34' ' ' LEU . 1.8 t -83.69 108.71 16.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.957 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -96.42 132.41 41.99 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.748 0.819 . . . . 0.0 111.359 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.29 120.51 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 22.4 t0 -136.27 134.91 38.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.238 0.472 . . . . 0.0 109.972 174.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -53.8 -24.03 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.771 1.628 . . . . 0.0 112.837 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 t -123.3 164.23 19.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 111.081 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.2 p -77.36 -18.35 57.46 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.096 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.51 -44.39 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.62 -34.01 40.91 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.275 0.359 . . . . 0.0 112.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 93.5 mt -69.02 -47.67 64.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.558 0.743 . . . . 0.0 111.61 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -54.31 -55.67 26.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.815 0.846 . . . . 0.0 111.855 171.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.35 -39.16 66.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.619 0.767 . . . . 0.0 110.842 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.894 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -59.98 -52.51 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.293 177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -69.01 -38.75 79.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 5.7 mm100 -62.51 -45.44 92.97 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.496 0.318 . . . . 0.0 111.395 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 HD22 ' HB2' ' A' ' 45' ' ' CYS . 32.1 tp -70.92 -27.39 63.73 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.359 0.412 . . . . 0.0 110.785 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.585 ' HB1' HG12 ' A' ' 78' ' ' ILE . . . -61.15 -62.4 1.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 110.546 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.97 -30.21 70.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.586 0.754 . . . . 0.0 111.617 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.77 -54.58 25.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.06 0.544 . . . . 0.0 110.718 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HE2' HD12 ' A' ' 70' ' ' LEU . 24.8 ttmm -83.87 -15.71 47.12 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.48 0.712 . . . . 0.0 111.727 -170.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.93 41.97 7.88 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 121.828 -0.225 . . . . 0.0 113.284 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.53 175.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.591 1.156 . . . . 0.0 109.109 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.14 140.69 51.65 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.031 0.378 . . . . 0.0 111.896 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.585 HG12 ' HB1' ' A' ' 71' ' ' ALA . 20.1 mm -115.56 160.75 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.004 1.322 . . . . 0.0 107.555 167.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 90.8 m -127.49 110.12 12.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 164.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.8 p -84.24 111.63 19.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.044 0.538 . . . . 0.0 109.822 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 157.25 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.177 1.391 . . . . 0.0 110.698 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.38 103.81 15.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.87 99.26 0.08 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.018 0.437 . . . . 0.0 111.618 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -142.64 91.54 2.32 Favored 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.57 -17.26 61.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.349 0.522 . . . . 0.0 110.839 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.34 -0.9 51.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.543 1.137 . . . . 0.0 112.295 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.04 -32.8 0.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -167.32 107.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.04 -63.4 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.483 1.113 . . . . 0.0 108.21 -171.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' HB ' HD12 ' A' ' 98' ' ' ILE . 29.8 pt -138.64 122.62 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.609 0.763 . . . . 0.0 110.8 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.44 87.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.719 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.95 -1.84 13.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.477 0.711 . . . . 0.0 112.744 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.86 -48.06 67.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.08 -24.41 30.37 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.923 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.475 ' CD2' HG21 ' A' ' 55' ' ' THR . 17.9 m95 -112.85 161.78 16.56 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.113 0.565 . . . . 0.0 109.682 -172.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.74 -58.1 2.85 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.82 16.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.257 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.598 HD12 ' HB ' ' A' ' 90' ' ' ILE . 80.6 mt -134.36 119.36 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.412 HG12 HD12 ' A' ' 47' ' ' LEU . 11.6 p -109.11 133.27 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -125.96 90.9 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.552 HG23 ' ND2' ' A' ' 43' ' ' ASN . 12.2 mm -69.29 155.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.877 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -19.28 103.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 126.215 1.806 . . . . 0.0 113.501 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.28 114.55 11.61 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.271 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -97.76 100.24 11.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.9 mt -93.47 148.76 36.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.708 0.403 . . . . 0.0 110.279 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.57 156.71 55.29 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.156 1.904 . . . . 0.0 110.193 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.8 m -50.83 -33.0 21.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.033 0.933 . . . . 0.0 112.585 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -58.84 -52.99 63.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.899 0.88 . . . . 0.0 111.623 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.7 mt -83.42 -18.66 37.96 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.978 0.511 . . . . 0.0 111.283 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -63.71 -62.88 1.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -67.78 -10.52 53.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.617 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -77.84 -54.18 6.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.786 0.434 . . . . 0.0 109.926 166.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.3 tp -74.71 -49.85 19.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -165.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.401 ' HH ' HD21 ' A' ' 129' ' ' LEU . 96.8 m-85 -67.25 -35.34 8.47 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.53 -33.68 96.85 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.194 1.929 . . . . 0.0 112.794 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 34.3 mmtp -72.64 -27.39 62.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.627 0.771 . . . . 0.0 110.894 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 113' ' ' LEU . 15.0 t -84.01 -34.75 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.727 0.411 . . . . 0.0 110.427 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.48 -61.76 2.35 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.94 -49.2 63.18 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.808 0.843 . . . . 0.0 113.247 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.27 24.07 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -164.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.817 HD11 ' HA3' ' A' ' 125' ' ' GLY . 44.7 tp -70.82 104.37 2.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.463 0.632 . . . . 0.0 110.43 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.71 153.21 78.22 Favored Pre-proline 0 C--O 1.247 0.929 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -48.69 116.03 1.92 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.954 2.436 . . . . 0.0 113.277 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.86 12.23 2.46 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.318 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.817 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -102.24 146.67 16.99 Favored Glycine 0 N--CA 1.441 -0.975 0 O-C-N 122.539 -0.389 . . . . 0.0 112.437 163.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.6 m -116.64 130.88 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.825 0.85 . . . . 0.0 108.767 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.521 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -111.9 113.07 25.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.649 HD13 HG22 ' A' ' 24' ' ' VAL . 14.7 mt -107.62 108.93 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 49.8 mt -113.49 150.3 33.07 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.515 0.726 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.42 138.95 43.76 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 161.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.54 -176.44 14.37 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -102.62 166.69 10.37 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -116.2 169.26 7.28 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.78 60.76 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.635 2.224 . . . . 0.0 112.915 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.637 ' HG3' ' H ' ' A' ' 186' ' ' ALA . 2.7 tm-20 -97.12 -63.98 1.08 Allowed 'General case' 0 C--N 1.349 0.575 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.425 ' HB3' HD21 ' A' ' 147' ' ' LEU . 53.7 tp60 -65.64 -49.17 69.67 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.963 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.716 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 7.3 mt -66.59 -10.15 42.66 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 118.748 0.704 . . . . 0.0 111.394 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -80.06 -46.45 16.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.824 0.45 . . . . 0.0 110.51 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -84.56 -15.58 45.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -113.28 152.08 30.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 m -80.95 -27.76 35.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.72 116.96 0.77 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.46 69.04 0.41 Allowed Glycine 0 CA--C 1.535 1.337 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.29 130.37 12.92 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.562 2.175 . . . . 0.0 110.594 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 148' ' ' ASP . 94.4 mttt 86.56 15.19 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.453 1.501 . . . . 0.0 110.855 172.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -110.41 -89.66 0.49 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.716 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 4.2 mp -96.62 27.0 4.09 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 118.514 0.597 . . . . 0.0 110.614 168.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 145' ' ' LYS . 23.6 t70 -87.07 -34.61 19.09 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.24 25.16 0.62 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.497 1.919 . . . . 0.0 113.096 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 147' ' ' LEU . 95.1 mt -68.57 118.88 64.52 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 123.684 0.615 . . . . 0.0 112.194 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -94.71 98.28 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.916 2.411 . . . . 0.0 109.88 166.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 167.87 20.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.285 0.634 . . . . 0.0 111.335 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.544 HD22 ' HB ' ' A' ' 188' ' ' ILE . 29.8 mt -67.07 -31.54 72.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.243 0.617 . . . . 0.0 110.984 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -55.49 -45.88 76.98 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.84 0.713 . . . . 0.0 111.058 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -84.26 -35.69 23.2 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.698 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 129' ' ' LEU . 40.8 mt -75.21 -47.24 29.16 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.464 0.706 . . . . 0.0 112.022 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.402 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.5 tt0 -60.68 -35.81 77.19 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.72 0.408 . . . . 0.0 111.154 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -71.86 -26.83 62.51 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 111.11 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.57 -15.0 44.05 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.247 1.019 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 78.0 mt -135.67 68.18 65.83 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.03 3.09 8.09 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 123.049 2.499 . . . . 0.0 112.226 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t -90.21 -36.36 14.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.407 1.083 . . . . 0.0 108.59 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.2 tp -94.75 72.32 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.35 1.46 . . . . 0.0 111.715 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -51.78 124.72 13.13 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.283 0.564 . . . . 0.0 110.172 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.53 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 24.9 m95 -93.66 132.88 37.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.665 1.186 . . . . 0.0 109.839 -170.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 85.9 mt -70.64 -35.99 73.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.415 0.686 . . . . 0.0 110.787 173.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.05 121.61 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.44 85.17 1.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.644 0.778 . . . . 0.0 109.165 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.52 149.06 29.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.941 0.401 . . . . 0.0 110.811 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.22 113.39 13.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.0 128.01 53.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.392 0.677 . . . . 0.0 109.508 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 9.5 pt-20 -92.23 120.37 32.73 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -96.64 125.17 40.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.096 0.558 . . . . 0.0 109.987 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -72.37 121.02 18.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.813 0.845 . . . . 0.0 111.023 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.25 159.22 15.72 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.322 1.049 . . . . 0.0 110.785 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -54.08 137.76 39.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.788 1.235 . . . . 0.0 112.404 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.82 90.08 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.969 0.907 . . . . 0.0 110.159 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.2 43.19 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.807 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -147.41 148.39 31.25 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.592 0.757 . . . . 0.0 109.999 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -65.45 -39.91 92.6 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -62.64 117.84 6.81 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.076 0.951 . . . . 0.0 108.612 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -59.34 149.98 27.48 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.907 0.483 . . . . 0.0 110.562 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.79 74.78 0.76 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 124.167 0.917 . . . . 0.0 115.253 -168.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -152.49 164.47 37.5 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.55 0.74 . . . . 0.0 110.698 162.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -143.64 129.23 19.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.014 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.637 ' H ' ' HG3' ' A' ' 135' ' ' GLU . . . -76.38 108.65 9.48 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 65.8 mt -121.94 172.37 8.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.544 ' HB ' HD22 ' A' ' 153' ' ' LEU . 38.1 pt -135.6 144.9 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -137.17 154.17 50.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.761 0.791 . . . . 0.0 110.945 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 65.0 mt -139.12 146.25 40.44 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 27.6 tp -143.37 111.89 6.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -90.18 148.56 19.79 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.601 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 8.6 tp-100 -134.78 151.16 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.472 0.636 . . . . 0.0 111.242 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.572 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 17.1 pttp -55.99 136.26 52.08 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.64 116.84 10.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 167.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 200' ' ' HIS . 2.6 tp10 -66.22 92.67 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 123.86 0.725 . . . . 0.0 110.217 -171.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -89.45 52.53 2.37 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.176 0.988 . . . . 0.0 110.154 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -176.84 -169.57 0.27 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.262 2.225 . . . . 0.0 106.596 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -61.63 147.02 47.13 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.923 0.783 . . . . 0.0 109.831 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 196' ' ' GLU . 19.4 p-80 -56.12 154.17 8.11 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.531 0.732 . . . . 0.0 112.3 -172.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -54.52 107.83 0.32 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.899 0.749 . . . . 0.0 110.277 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.1 p80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.18 176.407 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -81.69 81.97 7.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.599 0.759 . . . . 0.0 110.486 -171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.87 88.49 7.7 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -132.51 141.97 49.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.36 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -166.92 102.75 0.55 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -127.56 120.78 28.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.666 0.786 . . . . 0.0 109.563 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.7 t -152.64 97.98 2.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.301 0.64 . . . . 0.0 110.576 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -100.98 89.86 3.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.301 1.04 . . . . 0.0 109.636 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 p -84.39 93.53 8.29 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.13 144.31 27.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.533 0.733 . . . . 0.0 111.333 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -165.35 131.69 2.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.763 0.825 . . . . 0.0 109.354 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 m -86.44 86.76 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 122.186 0.993 . . . . 0.0 110.923 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -144.96 117.51 8.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.324 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.53 47.91 0.28 Allowed Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.118 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 p -81.19 148.68 29.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.719 0.807 . . . . 0.0 110.282 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -151.88 67.39 7.13 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.098 0.559 . . . . 0.0 109.696 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.423 ' HB2' HG21 ' A' ' 22' ' ' VAL . 77.5 Cg_endo -99.21 124.3 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.928 2.419 . . . . 0.0 112.382 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -103.64 86.46 2.63 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.433 0.635 . . . . 0.0 109.752 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.83 161.16 42.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.597 1.159 . . . . 0.0 108.445 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.23 -54.3 35.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.471 0.708 . . . . 0.0 111.535 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.442 ' O ' HG22 ' A' ' 24' ' ' VAL . 41.6 tp -69.88 -51.71 30.96 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.837 0.455 . . . . 0.0 111.098 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 17' ' ' PRO . 11.3 m -45.56 -29.51 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -72.43 -44.18 62.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.436 0.695 . . . . 0.0 110.564 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 28' ' ' ILE . 1.2 m -67.98 -33.75 63.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.004 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.15 73.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.554 1.141 . . . . 0.0 112.241 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -69.07 -23.95 64.1 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.281 0.632 . . . . 0.0 110.632 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.51 -14.29 25.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.63 0.772 . . . . 0.0 111.788 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 24' ' ' VAL . 96.3 mt -83.93 125.77 72.08 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.531 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 18.3 Cg_exo -67.04 157.85 59.71 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.423 2.749 . . . . 0.0 112.848 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -72.54 28.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.4 -144.56 7.8 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 118.364 0.529 . . . . 0.0 113.716 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -70.7 115.44 9.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.65 0.78 . . . . 0.0 109.666 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 50.2 mt -107.21 121.85 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD23 HG22 ' A' ' 90' ' ' ILE . 55.3 tp -101.54 111.18 23.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HA ' HG12 ' A' ' 99' ' ' VAL . 51.1 t -102.61 110.12 21.96 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.445 0.698 . . . . 0.0 109.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.0 164.08 26.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.809 0.337 . . . . 0.0 111.695 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -37.51 118.31 0.63 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.238 1.815 . . . . 0.0 114.814 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -124.36 -18.44 5.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.14 0.976 . . . . 0.0 110.837 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.69 -37.29 3.52 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.37 -44.78 20.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 0.0 112.439 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.97 85.84 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.398 -162.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -83.14 -52.95 6.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.819 1.248 . . . . 0.0 110.338 -174.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 15.1 m120 -61.32 -40.43 94.18 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.815 -174.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.45 11.76 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.203 0.94 . . . . 0.0 111.524 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 70' ' ' LEU . 33.7 m -63.04 -33.78 76.17 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.782 0.833 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 79.4 t80 -63.34 -50.12 71.25 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.723 0.639 . . . . 0.0 110.218 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.493 HD13 HG11 ' A' ' 99' ' ' VAL . 63.9 mt -68.45 -29.48 68.13 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.579 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.44 -40.79 66.78 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.326 0.651 . . . . 0.0 112.006 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.749 ' HA ' HG12 ' A' ' 76' ' ' VAL . 58.1 p -72.2 -3.84 25.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.384 0.674 . . . . 0.0 112.762 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.2 mt -80.61 7.3 10.38 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 122.955 0.502 . . . . 0.0 110.735 165.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.68 24.35 39.17 Favored Glycine 0 C--N 1.361 1.939 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -126.04 162.4 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.059 0.929 . . . . 0.0 111.951 -172.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -88.94 91.45 8.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.24 1.016 . . . . 0.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.28 107.08 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.824 0.821 . . . . 0.0 110.727 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 m -87.27 108.89 19.15 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.188 1.395 . . . . 0.0 108.982 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.18 129.57 48.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.987 0.515 . . . . 0.0 109.643 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 81' ' ' VAL . 3.8 t -111.94 118.52 57.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.53 145.76 51.03 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.729 1.149 . . . . 0.0 110.621 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.02 -31.06 62.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.853 1.661 . . . . 0.0 113.211 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 m -116.13 144.1 44.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 0.0 110.252 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.6 p -68.65 -24.63 64.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.481 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.02 -33.94 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.497 0.719 . . . . 0.0 111.821 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 -30.82 67.62 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.371 0.419 . . . . 0.0 112.237 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.19 -42.31 46.75 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.983 0.913 . . . . 0.0 111.244 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.09 93.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.872 0.869 . . . . 0.0 111.93 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -67.02 -40.15 87.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.86 0.464 . . . . 0.0 110.755 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -56.95 -52.76 63.96 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 124.069 0.856 . . . . 0.0 110.406 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.0 -51.14 63.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 111.856 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.47 -47.45 81.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.918 0.887 . . . . 0.0 111.971 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.8 tp -64.52 -33.38 75.77 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.423 0.452 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.29 -51.03 49.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.413 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -66.52 -29.23 69.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.67 0.788 . . . . 0.0 110.257 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -63.18 -44.94 93.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.949 0.899 . . . . 0.0 110.276 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -85.05 -6.17 59.33 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.438 0.695 . . . . 0.0 111.569 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 40.07 12.32 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 120.391 -0.116 . . . . 0.0 113.226 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 49' ' ' SER . 33.2 m -139.64 174.22 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 124.452 1.101 . . . . 0.0 109.443 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -123.69 144.13 49.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.182 0.593 . . . . 0.0 112.316 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 mm -114.88 161.07 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 166.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.2 m -121.8 104.66 9.73 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 p -92.57 123.19 35.68 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.679 -0.638 . . . . 0.0 110.487 -167.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' A' ' 57' ' ' VAL . 62.1 t -115.61 141.07 34.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.192 1.397 . . . . 0.0 107.819 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -80.06 134.31 36.19 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.2 p -55.24 105.11 0.15 Allowed 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.146 0.978 . . . . 0.0 111.493 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.71 87.04 2.03 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' A' ' 109' ' ' LEU . 88.8 mt -94.24 -9.82 34.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.928 0.491 . . . . 0.0 110.537 -171.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.36 4.38 43.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.903 0.881 . . . . 0.0 110.319 170.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -130.96 -41.49 1.14 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.773 0.829 . . . . 0.0 110.812 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -156.76 121.72 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.234 1.014 . . . . 0.0 108.275 -169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.21 -69.6 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.652 -0.655 . . . . 0.0 109.626 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.525 ' HB ' HD12 ' A' ' 98' ' ' ILE . 18.1 pt -149.88 131.27 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.899 0.879 . . . . 0.0 109.958 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.79 145.63 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.813 1.245 . . . . 0.0 109.171 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -88.41 -30.71 19.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.13 0.572 . . . . 0.0 110.743 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.95 -61.26 2.07 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.712 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.67 -29.27 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.446 ' NE1' HD21 ' A' ' 34' ' ' LEU . 37.3 m95 -113.63 144.69 42.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 109.871 -171.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 29' ' ' PRO . 15.8 tp10 -98.19 -46.3 5.89 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.479 1.112 . . . . 0.0 109.494 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -114.58 141.52 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.354 171.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.525 HD12 ' HB ' ' A' ' 90' ' ' ILE . 63.7 mt -117.99 150.62 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 169.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.493 HG11 HD13 ' A' ' 47' ' ' LEU . 7.0 p -145.9 129.15 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 124.121 0.968 . . . . 0.0 109.01 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.3 m -129.57 94.2 3.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 22.1 mm -70.73 143.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -15.26 104.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.404 1.882 . . . . 0.0 114.834 -170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.507 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 45.6 t -100.64 115.78 31.0 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.006 -174.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -121.71 98.41 5.94 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.507 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 95.0 mt -108.79 155.75 40.14 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.386 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HA ' HD11 ' A' ' 149' ' ' LEU . 52.5 Cg_exo -56.02 143.33 83.54 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.589 2.193 . . . . 0.0 110.681 162.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.637 ' H ' HD22 ' A' ' 149' ' ' LEU . 41.4 m -50.14 -24.75 2.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.533 1.133 . . . . 0.0 113.288 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.3 m -56.39 -57.61 11.54 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.414 0.685 . . . . 0.0 110.336 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 89.2 mt -79.71 -32.8 41.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.69 0.796 . . . . 0.0 110.032 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HD3' ' HG3' ' A' ' 151' ' ' PRO . 8.4 tmm_? -74.02 -58.84 3.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.003 1.321 . . . . 0.0 109.959 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -68.55 -10.3 54.87 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.256 0.622 . . . . 0.0 112.373 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -88.5 -33.67 17.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 117' ' ' VAL . 66.3 tp -67.86 -47.74 68.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.708 0.803 . . . . 0.0 111.514 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.49 -39.14 45.86 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.2 -32.08 92.46 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.919 165.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -81.24 -17.89 47.92 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.528 0.731 . . . . 0.0 111.249 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' A' ' 90' ' ' ILE . 9.5 t -83.96 -43.07 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 172.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.03 -48.9 78.22 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.27 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -79.08 -43.68 23.66 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.05 -20.4 16.3 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 116.711 1.444 . . . . 0.0 116.711 -164.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.48 HD11 HD13 ' A' ' 98' ' ' ILE . 16.7 tp -62.26 128.94 38.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.188 0.994 . . . . 0.0 110.025 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 16.7 tttp -70.65 142.39 88.64 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.94 109.05 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.347 1.365 . . . . 0.0 109.494 160.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.08 10.1 6.41 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.559 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.453 ' HA3' HD12 ' A' ' 121' ' ' LEU . . . -97.8 143.02 16.45 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 170.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.0 m -108.55 129.6 62.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 123.973 0.909 . . . . 0.0 109.466 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -112.5 112.19 23.55 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.543 HD13 HD12 ' A' ' 101' ' ' ILE . 95.8 mt -110.25 113.97 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 109.304 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.631 ' HB2' HD12 ' A' ' 190' ' ' LEU . 96.2 mt -124.34 114.91 20.16 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.34 107.96 4.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.29 1.036 . . . . 0.0 108.952 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.0 86.06 0.09 OUTLIER Glycine 0 N--CA 1.479 1.512 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.172 169.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.477 ' O ' HD22 ' A' ' 187' ' ' LEU . 95.3 m-85 -143.29 150.36 39.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 136' ' ' GLN . . . -175.51 167.65 1.73 Allowed Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.74 -46.24 9.34 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 121.392 1.395 . . . . 0.0 110.572 165.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -3.88 57.58 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -176.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 26.2 tp60 -45.95 -63.58 0.94 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -170.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.551 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 9.9 mt -82.49 -15.22 53.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.587 0.755 . . . . 0.0 111.57 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.56 -20.13 62.94 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.531 0.732 . . . . 0.0 111.296 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.433 ' HB3' HG21 ' A' ' 141' ' ' THR . 6.7 m-30 -53.66 -34.96 60.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.869 1.268 . . . . 0.0 112.503 172.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.3 t30 71.45 -0.81 2.99 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.159 1.383 . . . . 0.0 111.834 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 139' ' ' TYR . 12.0 t -112.61 -8.93 13.79 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.26 1.024 . . . . 0.0 109.95 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -143.94 74.53 0.32 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 137' ' ' LEU . . . 177.4 117.47 0.52 Allowed Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.282 -1.288 . . . . 0.0 111.524 -173.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.5 -20.32 65.81 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.7 2.267 . . . . 0.0 114.548 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.631 ' HG2' HD13 ' A' ' 149' ' ' LEU . 11.7 ptmm? -168.22 -38.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.929 0.786 . . . . 0.0 111.43 170.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.513 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 31.8 t70 178.79 151.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.39 0.676 . . . . 0.0 110.3 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -52.62 -6.95 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 126.411 1.884 . . . . 0.0 115.786 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.94 -30.42 58.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.398 0.679 . . . . 0.0 111.224 168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 107' ' ' SER . 13.6 mt -79.53 8.49 6.28 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.766 1.226 . . . . 0.0 112.449 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 132' ' ' PHE . 41.1 mt -104.93 98.1 14.6 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.223 0.609 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.572 ' HG2' HD23 ' A' ' 156' ' ' LEU . 90.1 Cg_endo -84.0 126.58 3.89 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.871 165.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -72.82 173.13 9.59 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.749 0.819 . . . . 0.0 111.708 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.53 HD23 HD23 ' A' ' 190' ' ' LEU . 20.1 mt -55.95 -38.53 70.47 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.106 0.562 . . . . 0.0 112.212 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.02 -37.31 74.07 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.705 0.628 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.2 m -73.39 -51.95 15.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.219 0.608 . . . . 0.0 109.914 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.572 HD23 ' HG2' ' A' ' 151' ' ' PRO . 82.7 mt -65.7 -55.65 16.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.576 1.151 . . . . 0.0 112.008 -170.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.591 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.3 tt0 -59.03 -34.81 72.33 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 175.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.9 t -81.06 -13.25 58.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.144 0.429 . . . . 0.0 111.889 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -7.67 29.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.945 0.498 . . . . 0.0 110.315 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 89.2 mt -139.46 59.95 15.52 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.946 1.298 . . . . 0.0 108.079 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.55 -22.58 32.84 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.726 2.284 . . . . 0.0 113.745 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 p -81.83 -40.08 23.02 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.6 tp -70.8 68.5 0.42 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.814 1.246 . . . . 0.0 111.602 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -65.13 140.35 58.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.591 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 22.0 m95 -100.88 135.29 42.56 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.742 0.817 . . . . 0.0 109.349 -167.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.9 mt -72.03 -30.81 65.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.64 0.776 . . . . 0.0 110.44 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.9 mt -130.46 125.45 59.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.39 79.97 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -131.15 142.45 50.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.806 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -88.59 132.44 34.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.878 0.871 . . . . 0.0 109.955 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 34.2 mt -110.05 114.24 27.6 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.1 121.06 15.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.694 ' HB3' ' HB1' ' A' ' 185' ' ' ALA . 52.5 ttt180 -90.2 121.53 32.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.33 99.87 12.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.24 141.16 28.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.611 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.35 122.67 22.41 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.926 0.766 . . . . 0.0 109.708 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.62 139.62 58.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.404 0.682 . . . . 0.0 110.272 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.62 -49.83 0.09 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.82 -39.65 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.07 170.78 11.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.614 1.165 . . . . 0.0 109.54 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -64.66 -30.12 71.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.73 0.812 . . . . 0.0 109.6 168.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -104.57 177.58 4.81 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 124.602 1.161 . . . . 0.0 110.354 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.52 113.81 0.3 Allowed Glycine 0 C--N 1.334 0.471 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -159.66 178.52 9.75 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' A' ' 173' ' ' ARG . . . -155.71 173.91 16.06 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -130.22 114.78 16.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 27.8 mt -104.27 158.04 16.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.479 ' HB ' HD21 ' A' ' 153' ' ' LEU . 3.7 pt -146.36 124.68 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.944 0.793 . . . . 0.0 110.473 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -93.27 145.56 24.35 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.986 0.914 . . . . 0.0 110.091 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 129' ' ' LEU . 54.9 mt -134.0 143.91 48.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 110.391 172.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.2 tp -142.96 108.29 5.02 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -92.98 146.43 18.1 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.403 HE21 HG11 ' A' ' 126' ' ' VAL . 5.9 tp-100 -147.25 155.83 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.15 0.98 . . . . 0.0 109.683 174.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 197' ' ' HIS . 23.1 pttm -61.64 121.45 12.83 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.26 97.7 0.2 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.491 0.186 . . . . 0.0 111.32 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 29.33 37.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.754 2.022 . . . . 0.0 115.884 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 194' ' ' LYS . 10.3 t-80 -64.57 107.58 1.44 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -40.05 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 125.702 1.877 . . . . 0.0 113.088 -158.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -125.64 154.47 42.27 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.837 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -48.7 126.81 12.58 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 124.48 1.113 . . . . 0.0 109.502 162.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -50.72 -31.34 16.3 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.462 1.105 . . . . 0.0 111.99 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 C--O 1.257 1.497 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.723 172.915 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -156.34 52.27 0.53 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.66 85.64 3.31 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.086 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -94.85 26.32 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 mtt85 -81.44 34.04 0.37 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.544 1.138 . . . . 0.0 112.054 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -74.85 84.85 2.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.5 p -106.49 23.9 13.45 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.518 1.127 . . . . 0.0 109.706 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -73.01 92.54 1.67 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.378 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 p -160.94 147.93 15.26 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.854 -172.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -154.86 130.74 10.09 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -135.89 68.97 1.43 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.477 0.711 . . . . 0.0 109.847 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.95 98.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.87 116.17 23.17 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.13 175.29 44.29 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.191 0.307 . . . . 0.0 112.877 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.596 HG23 ' HD3' ' A' ' 17' ' ' PRO . 8.8 t -170.03 -31.86 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.827 1.251 . . . . 0.0 109.319 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 55.39 78.48 0.38 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.522 1.529 . . . . 0.0 112.433 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.596 ' HD3' HG23 ' A' ' 15' ' ' THR . 74.0 Cg_endo -72.81 151.09 50.88 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.902 1.734 . . . . 0.0 110.519 163.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -73.2 83.12 1.34 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.283 0.633 . . . . 0.0 109.782 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -142.48 177.59 8.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.063 0.945 . . . . 0.0 111.696 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -88.51 -30.2 19.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.737 1.215 . . . . 0.0 110.156 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tp -68.59 -43.53 76.3 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.736 0.814 . . . . 0.0 111.505 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.5 m -45.74 -35.32 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -74.36 -46.65 39.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.979 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 21' ' ' LEU . 2.2 m -64.64 -37.14 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.082 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.36 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.313 1.045 . . . . 0.0 111.881 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -58.02 -38.97 77.18 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -82.4 -22.76 35.25 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 24' ' ' VAL . 54.6 mt -75.59 129.31 82.08 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 118.238 0.472 . . . . 0.0 109.949 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.07 130.65 28.48 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.755 2.97 . . . . 0.0 112.296 166.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -77.62 27.71 0.17 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.306 1.443 . . . . 0.0 114.28 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.85 -133.5 5.3 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.498 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -78.0 113.51 15.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 28' ' ' ILE . 34.7 mt -114.24 130.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.456 HD21 ' CD1' ' A' ' 95' ' ' TRP . 52.7 tp -100.09 114.27 27.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 53.6 t -101.48 109.73 21.61 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.29 0.636 . . . . 0.0 109.548 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.23 103.45 3.36 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 167.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.49 111.38 22.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.744 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -139.11 -54.8 0.59 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.312 1.045 . . . . 0.0 108.232 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.13 -77.95 0.17 Allowed Glycine 0 C--N 1.353 1.512 0 O-C-N 123.956 0.785 . . . . 0.0 112.638 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 46.0 mt-10 -138.67 128.95 25.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.609 0.763 . . . . 0.0 110.343 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.13 -17.48 77.3 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 31.5 ttt180 -48.79 -45.03 39.59 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.868 1.667 . . . . 0.0 111.217 167.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.508 HD21 HD13 ' A' ' 101' ' ' ILE . 2.7 m-20 -64.75 -41.76 95.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.007 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.98 98.66 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.199 0.6 . . . . 0.0 110.92 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.424 ' HA ' HD13 ' A' ' 78' ' ' ILE . 61.9 m -60.46 -39.27 86.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.965 0.906 . . . . 0.0 112.696 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.7 t80 -64.92 -46.64 80.81 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.826 0.703 . . . . 0.0 110.199 177.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.499 HD13 HG12 ' A' ' 99' ' ' VAL . 70.1 mt -67.62 -33.18 74.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.872 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.21 70.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.145 0.578 . . . . 0.0 111.804 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.762 ' HA ' HG12 ' A' ' 76' ' ' VAL . 93.2 p -72.06 -4.8 30.92 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 81.7 mt -83.84 11.14 8.05 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.265 168.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.09 19.15 78.9 Favored Glycine 0 C--N 1.366 2.218 0 CA-C-N 117.64 0.2 . . . . 0.0 113.174 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -106.44 133.1 51.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 109.257 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.79 90.71 2.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.574 0.702 . . . . 0.0 109.263 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -92.91 108.59 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.814 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.8 p -87.14 111.84 21.34 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.513 1.125 . . . . 0.0 108.607 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.72 126.98 53.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.268 0.627 . . . . 0.0 110.873 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 81' ' ' VAL . 10.9 t -101.69 114.72 41.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 8.5 t70 -116.17 116.21 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.92 -10.67 2.62 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.678 0.791 . . . . 0.0 112.566 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -115.79 124.15 50.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.374 1.07 . . . . 0.0 108.595 169.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 m -72.06 -16.57 62.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.232 0.613 . . . . 0.0 111.568 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 31.5 m -62.97 -35.84 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.198 0.599 . . . . 0.0 111.508 170.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 -35.25 56.45 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 99.2 mt -63.28 -42.65 99.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.085 0.954 . . . . 0.0 111.011 174.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.4 81.13 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.864 0.728 . . . . 0.0 111.756 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 30.3 mmmt -68.08 -45.03 74.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.04 0.536 . . . . 0.0 111.464 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.5 81.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.973 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -69.45 -42.3 75.12 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.144 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.45 -43.44 77.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.256 0.222 . . . . 0.0 110.939 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.38 -28.12 69.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.559 0.744 . . . . 0.0 110.609 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.08 -53.78 33.91 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.164 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.4 -35.28 75.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.817 0.847 . . . . 0.0 110.618 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -37.93 89.29 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.009 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -86.5 -0.32 55.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.94 0.896 . . . . 0.0 110.842 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.82 33.37 33.93 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-N 116.376 -0.375 . . . . 0.0 112.394 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 49' ' ' SER . 32.6 m -142.2 -177.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.887 1.275 . . . . 0.0 109.892 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.16 145.69 36.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.914 0.486 . . . . 0.0 111.587 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 45' ' ' CYS . 10.8 mm -101.71 167.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' THR . 46.1 m -123.21 104.3 9.07 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -91.85 125.98 36.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.107 0.479 . . . . 0.0 111.253 -165.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 57' ' ' VAL . 84.8 t -101.06 124.01 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 109.401 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -97.85 89.3 4.54 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -145.25 -176.01 4.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.188 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -142.97 122.63 13.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -158.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.75 -8.03 39.3 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.773 0.671 . . . . 0.0 111.894 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.96 60.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.436 1.094 . . . . 0.0 112.459 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -130.45 -24.67 2.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.148 0.579 . . . . 0.0 112.084 -166.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -162.76 127.02 3.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.695 1.198 . . . . 0.0 108.168 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.41 ' O ' HD22 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -141.34 -65.89 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.1 pt -140.42 127.88 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.361 0.664 . . . . 0.0 110.994 -172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.55 148.96 17.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 124.546 1.138 . . . . 0.0 109.639 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -90.25 -35.71 15.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.149 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.31 -44.33 30.0 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.645 -171.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.03 44.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.456 ' CD1' HD21 ' A' ' 34' ' ' LEU . 11.6 m95 -123.26 134.13 54.12 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -169.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.39 -55.79 6.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.396 0.678 . . . . 0.0 109.971 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.63 164.44 12.19 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.109 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 121' ' ' LEU . 84.7 mt -134.45 145.44 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.499 HG12 HD13 ' A' ' 47' ' ' LEU . 10.1 p -128.09 128.8 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 166.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -113.4 91.34 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 128' ' ' ILE . 49.9 mm -68.56 136.13 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.104 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -14.03 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.413 2.321 . . . . 0.0 112.888 -171.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 29.1 t -95.18 106.13 18.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 112.324 -2.216 . . . . 0.0 109.93 -169.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.45 99.73 9.8 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 75.7 mt -118.11 145.91 38.04 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.682 0.793 . . . . 0.0 110.585 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.63 158.15 58.12 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.693 2.262 . . . . 0.0 110.144 168.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 33.4 t -45.02 -30.58 1.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.822 1.649 . . . . 0.0 113.246 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 p -57.07 -58.27 8.9 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.2 1.0 . . . . 0.0 110.86 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 80.9 mt -83.29 -22.46 32.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.74 0.816 . . . . 0.0 110.236 -175.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.439 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 29.1 ttt180 -69.02 -65.13 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.129 1.372 . . . . 0.0 109.717 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -55.41 -29.64 58.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.113 0.565 . . . . 0.0 111.642 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.54 -42.35 64.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.864 0.466 . . . . 0.0 110.699 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 117' ' ' VAL . 51.2 tp -67.99 -44.99 75.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.47 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -61.2 -41.67 81.7 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -167.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.81 -28.03 75.65 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 122.016 1.811 . . . . 0.0 112.292 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -84.87 -14.88 46.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 0.0 110.971 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.657 ' HB ' HD23 ' A' ' 160' ' ' LEU . 4.7 t -86.51 -42.82 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.1 -56.17 24.12 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.511 0.324 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.5 -39.85 19.96 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.3 -25.7 25.52 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -166.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -66.24 117.65 8.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.803 0.802 . . . . 0.0 109.188 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 62.0 tttm -69.67 133.93 88.5 Favored Pre-proline 0 C--O 1.246 0.883 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.54 112.3 0.66 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.629 2.219 . . . . 0.0 111.143 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 125.08 13.21 3.67 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.864 -173.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 121' ' ' LEU . . . -100.48 139.85 14.62 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 168.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 32.7 m -109.08 138.88 34.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.762 0.825 . . . . 0.0 109.932 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.53 113.37 25.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.584 HD13 HD12 ' A' ' 101' ' ' ILE . 24.3 mt -107.88 108.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 79.7 mt -130.87 152.04 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.815 0.846 . . . . 0.0 111.315 -174.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 43.9 tt0 -140.61 104.05 4.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.51 167.16 54.79 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -131.08 167.62 18.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.494 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 186' ' ' ALA . . . -59.4 155.09 39.36 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.41 1.484 . . . . 0.0 113.123 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -56.6 -25.16 57.83 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.933 2.422 . . . . 0.0 113.579 166.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.07 -30.06 68.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.302 1.041 . . . . 0.0 113.586 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.649 ' HG3' HD23 ' A' ' 137' ' ' LEU . 54.6 tp60 -54.57 -62.97 1.31 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -161.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.649 HD23 ' HG3' ' A' ' 136' ' ' GLN . 7.0 mt -90.41 -10.33 44.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.038 0.835 . . . . 0.0 110.643 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -49.98 -24.17 2.43 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.925 1.69 . . . . 0.0 114.929 -164.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -52.91 -33.55 50.96 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.684 1.194 . . . . 0.0 110.809 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -115.48 148.5 39.38 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.5 m -134.81 -3.58 2.55 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.083 0.553 . . . . 0.0 110.84 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.06 -95.63 0.13 Allowed Glycine 0 C--N 1.356 1.661 0 CA-C-N 116.789 -0.187 . . . . 0.0 112.658 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.39 -157.76 32.7 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-O 118.202 -1.332 . . . . 0.0 111.192 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -41.55 137.09 2.72 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.56 2.84 . . . . 0.0 112.828 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 137' ' ' LEU . 52.8 mtmt 76.55 66.44 0.05 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.73 1.612 . . . . 0.0 108.144 -154.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -149.78 15.0 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.18 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' A' ' 137' ' ' LEU . 0.5 OUTLIER 62.93 -1.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 126.098 1.759 . . . . 0.0 115.744 -175.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.59 -24.37 60.06 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.985 0.421 . . . . 0.0 109.945 171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.18 -7.36 51.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.947 0.899 . . . . 0.0 112.762 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 45.8 mt -97.88 100.92 9.43 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.86 120.76 4.34 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.573 1.515 . . . . 0.0 110.245 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -87.89 171.58 10.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.684 0.794 . . . . 0.0 111.775 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 190' ' ' LEU . 32.2 mt -59.23 -40.97 87.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -48.54 -50.9 30.11 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.74 1.216 . . . . 0.0 110.857 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 26.6 m -65.88 -62.36 1.54 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.701 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.2 mt -72.57 -46.56 53.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 112.707 -162.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.1 tt0 -53.4 -46.11 69.59 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 123.44 0.462 . . . . 0.0 111.025 171.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.3 t -70.77 -32.42 69.54 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.525 0.33 . . . . 0.0 111.841 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -85.7 -5.61 59.24 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.131 0.572 . . . . 0.0 111.951 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.657 HD23 ' HB ' ' A' ' 117' ' ' VAL . 82.7 mt -140.51 74.68 28.04 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 -45.72 24.03 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.859 3.039 . . . . 0.0 113.156 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 m -84.85 -29.82 24.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.778 0.431 . . . . 0.0 110.499 -171.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.1 tp -70.21 68.54 0.34 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.054 0.942 . . . . 0.0 111.455 170.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -62.63 133.38 54.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.524 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 32.2 m95 -95.77 129.65 42.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.811 0.844 . . . . 0.0 109.401 -167.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.43 -33.73 76.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.67 0.788 . . . . 0.0 110.378 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 80.6 mt -132.7 121.93 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.23 84.57 1.13 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -150.42 148.66 29.03 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.08 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -86.35 116.48 24.54 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.089 0.956 . . . . 0.0 108.691 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.5 mt -110.68 125.06 53.06 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.351 1.06 . . . . 0.0 108.362 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -91.34 124.07 35.26 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 122.85 0.46 . . . . 0.0 110.004 -178.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -94.03 139.68 30.65 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.168 0.587 . . . . 0.0 110.146 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.34 98.91 11.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 109.664 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.22 169.59 17.16 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.116 0.966 . . . . 0.0 109.186 169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.63 120.2 13.04 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.61 146.97 53.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.71 -45.38 0.15 Allowed Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.79 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.52 96.41 0.37 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 0.0 110.333 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 26.0 t80 59.93 47.8 9.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.664 1.186 . . . . 0.0 109.398 -172.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 69.03 3.29 3.97 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.37 1.468 . . . . 0.0 113.116 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.56 155.69 50.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.86 0.464 . . . . 0.0 111.32 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.36 69.3 0.52 Allowed Glycine 0 C--O 1.219 -0.835 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -93.44 157.02 16.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.972 0.909 . . . . 0.0 111.032 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -141.08 130.1 23.27 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 167.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.516 ' H ' ' HB3' ' A' ' 133' ' ' ALA . . . -89.13 103.85 16.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.64 149.53 32.71 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 22.1 pt -134.17 118.7 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.354 0.525 . . . . 0.0 110.062 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.68 138.6 31.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.834 0.349 . . . . 0.0 110.323 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.462 HD22 HD21 ' A' ' 153' ' ' LEU . 49.5 mt -129.51 128.38 42.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.532 1.133 . . . . 0.0 109.41 173.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.404 HD22 HG13 ' A' ' 24' ' ' VAL . 23.7 tp -125.13 106.23 9.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.11 139.97 16.56 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 171.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -144.68 152.64 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.584 ' HE2' ' HB3' ' A' ' 196' ' ' GLU . 19.5 pttm -57.64 155.19 10.23 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 123.75 0.656 . . . . 0.0 110.089 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 mt -79.7 130.92 35.77 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.584 ' HB3' ' HE2' ' A' ' 194' ' ' LYS . 0.9 OUTLIER -120.07 48.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 122.54 1.162 . . . . 0.0 108.826 174.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -77.05 75.28 3.62 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.199 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 55.53 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 112.393 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 196' ' ' GLU . 11.3 m-70 -91.97 176.99 6.31 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.423 0.63 . . . . 0.0 111.204 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -65.5 -22.97 66.78 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.858 167.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -62.17 105.89 0.66 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.409 0.683 . . . . 0.0 109.716 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 CA--C 1.551 0.996 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.285 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.9 -15.03 58.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -165.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.36 -24.6 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.726 0.694 . . . . 0.0 110.28 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 89.7 p -70.0 -47.5 61.91 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.4 m -64.13 -41.29 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.365 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.43 74.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.173 0.989 . . . . 0.0 111.978 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -27.66 67.87 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.52 0.728 . . . . 0.0 109.338 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 23' ' ' SER . 75.5 mm-40 -82.88 -33.07 27.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.678 0.791 . . . . 0.0 110.971 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -73.06 131.09 83.96 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.34 84.11 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.768 2.312 . . . . 0.0 111.877 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.05 29.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.05 -134.24 5.42 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.396 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -89.63 110.48 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -172.133 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG22 HG12 ' A' ' 99' ' ' VAL . 36.6 mt -113.58 117.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.689 0.796 . . . . 0.0 110.63 -166.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 95' ' ' TRP . 48.3 tp -92.01 113.25 25.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.907 0.483 . . . . 0.0 111.033 -173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 56.8 m -92.64 137.74 32.1 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 90' ' ' ILE . 40.8 mt -89.41 161.84 16.08 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 170.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 O-C-N 124.831 1.332 . . . . 0.0 112.842 175.329 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -65.37 -31.62 72.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.464 1.106 . . . . 0.0 110.196 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.3 m-20 -62.51 -30.9 71.62 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.423 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.82 79.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.159 0.583 . . . . 0.0 110.871 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.49 -29.97 69.54 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.668 0.787 . . . . 0.0 112.098 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.22 -48.42 81.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.825 0.85 . . . . 0.0 109.5 172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 50' ' ' LEU . 78.6 mt -66.78 -31.45 72.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.896 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -38.2 77.0 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.275 0.63 . . . . 0.0 111.979 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 38.5 p -70.4 -9.47 56.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 47' ' ' LEU . 72.3 mt -81.27 6.92 12.71 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.481 . . . . 0.0 111.17 171.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 7.58 85.68 Favored Glycine 0 C--N 1.36 1.879 0 CA-C-N 117.681 0.218 . . . . 0.0 113.072 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -92.04 143.42 26.48 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.477 0.711 . . . . 0.0 109.325 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 44.1 mt-10 -84.59 96.81 9.29 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.4 t -96.87 128.29 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.004 0.522 . . . . 0.0 110.474 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.9 t -114.15 111.1 21.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.316 1.446 . . . . 0.0 108.714 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.98 136.1 43.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.018 0.527 . . . . 0.0 111.08 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.03 144.25 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -152.29 139.09 18.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 159.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.76 -13.11 62.18 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.681 0.613 . . . . 0.0 111.046 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -117.82 143.0 46.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.193 1.397 . . . . 0.0 109.741 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -73.89 -22.65 59.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.56 0.744 . . . . 0.0 111.219 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.33 -38.58 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.045 0.538 . . . . 0.0 111.814 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -40.05 40.04 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.369 0.418 . . . . 0.0 112.08 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 80' ' ' THR . 91.5 mt -65.6 -52.16 54.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.016 0.926 . . . . 0.0 111.947 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.86 75.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.926 0.89 . . . . 0.0 112.371 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -71.02 -42.03 70.09 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.34 0.656 . . . . 0.0 110.888 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.01 92.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.263 0.625 . . . . 0.0 110.548 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -75.02 -32.14 61.54 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 110.63 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -63.04 -51.1 68.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.57 0.748 . . . . 0.0 110.923 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 tp -65.25 -27.32 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.04 0.837 . . . . 0.0 110.56 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -60.15 -59.63 5.1 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 122.92 0.488 . . . . 0.0 110.597 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.19 -36.44 81.91 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.919 0.888 . . . . 0.0 110.693 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.54 -25.52 63.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.895 0.878 . . . . 0.0 111.666 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -100.33 -3.45 31.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.873 0.869 . . . . 0.0 111.073 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.33 28.27 56.06 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.014 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -132.58 165.53 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.057 0.943 . . . . 0.0 110.749 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -112.22 135.46 52.86 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.607 0.763 . . . . 0.0 111.247 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.628 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.0 mm -110.78 161.33 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 165.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -114.97 112.74 23.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 166.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 64' ' ' LEU . 85.5 m -84.15 110.73 18.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.973 0.909 . . . . 0.0 110.402 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.58 127.17 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 0.0 108.508 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -110.02 95.4 5.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -139.67 -175.15 4.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.657 1.183 . . . . 0.0 109.515 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -143.21 131.15 21.62 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -159.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 22.0 mt -73.28 -3.53 27.54 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.15 3.34 41.04 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.101 0.96 . . . . 0.0 112.845 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.4 -43.04 0.16 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.006 0.821 . . . . 0.0 112.34 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.54 112.63 4.29 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.76 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.45 -72.32 0.41 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -166.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG23 HD21 ' A' ' 36' ' ' LEU . 4.6 pt -137.72 111.0 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.534 1.134 . . . . 0.0 109.745 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 94' ' ' ALA . 47.3 t -124.84 88.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.2 -1.15 4.04 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.67 -48.18 14.12 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.457 0.703 . . . . 0.0 109.632 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -75.65 -35.97 60.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.562 0.745 . . . . 0.0 111.844 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CD1' HD22 ' A' ' 34' ' ' LEU . 57.6 m95 -104.16 174.74 5.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.984 0.914 . . . . 0.0 108.978 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -109.22 -45.78 3.68 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.878 0.37 . . . . 0.0 110.691 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.62 162.76 24.13 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.6 ' HB ' ' HA3' ' A' ' 125' ' ' GLY . 90.5 mt -137.2 145.35 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.593 0.757 . . . . 0.0 110.038 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.466 HG12 HG22 ' A' ' 33' ' ' ILE . 9.0 p -132.94 124.45 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.343 1.057 . . . . 0.0 108.21 165.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 m -120.13 94.98 4.57 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.05 134.17 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.525 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 1.5 p90 -18.78 111.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 126.739 2.016 . . . . 0.0 115.563 -168.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 25.8 p -66.94 106.65 1.98 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.267 -1.788 . . . . 0.0 111.588 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -96.18 97.6 9.66 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 85' ' ' LEU . 91.6 mt -139.54 138.97 21.09 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.37 0.668 . . . . 0.0 110.431 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.0 160.63 43.43 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.34 2.694 . . . . 0.0 110.874 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 t -46.44 -33.25 3.82 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.791 1.236 . . . . 0.0 113.47 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 36.4 m -55.52 -64.2 0.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.678 0.791 . . . . 0.0 111.623 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.14 -22.36 45.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.835 0.454 . . . . 0.0 110.527 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -69.66 -53.92 16.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.659 1.184 . . . . 0.0 110.1 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.07 -11.28 58.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 112.879 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 108' ' ' SER . 15.6 mm100 -81.92 -38.71 24.85 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.6 tp -76.54 -43.82 37.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -58.8 -44.57 99.12 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 119.457 1.026 . . . . 0.0 112.805 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.69 -28.42 86.35 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.37 2.046 . . . . 0.0 113.745 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.78 -28.01 60.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.204 0.602 . . . . 0.0 111.635 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.1 t -85.37 -27.38 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.848 0.832 . . . . 0.0 109.71 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -73.48 -63.86 1.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.388 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.7 -49.37 16.25 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.19 -39.15 32.58 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 114.069 0.387 . . . . 0.0 114.069 -169.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 30.1 tp -78.53 103.25 8.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.66 148.35 51.49 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 165.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.583 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 60.9 Cg_exo -43.24 127.24 5.3 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.152 3.235 . . . . 0.0 115.003 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 128.64 10.04 3.37 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.776 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -119.18 152.72 17.15 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 164.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.81 136.44 44.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 123.603 0.761 . . . . 0.0 109.861 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.0 113.04 26.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -103.83 107.99 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.4 mt -121.86 121.51 37.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.741 0.816 . . . . 0.0 110.362 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 36.5 tt0 -115.68 98.98 7.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 168.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.01 174.86 46.17 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.699 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.464 ' HB2' HD22 ' A' ' 150' ' ' LEU . 50.7 m-85 -127.87 160.84 30.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 123.22 0.608 . . . . 0.0 109.695 176.557 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 132' ' ' PHE . 44.0 mt -89.37 111.07 43.31 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.639 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.5 Cg_endo -79.98 108.71 2.27 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 122.017 1.812 . . . . 0.0 110.211 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.597 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 tttm -105.3 155.32 19.2 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.812 -0.555 . . . . 0.0 110.796 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.8 mt -50.51 -38.06 42.37 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.238 1.015 . . . . 0.0 111.937 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.51 -53.88 20.96 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 125.045 1.466 . . . . 0.0 109.776 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 35.3 m -71.94 -57.62 4.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.74 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.639 HD11 ' HB2' ' A' ' 151' ' ' PRO . 73.1 mt -62.21 -54.32 42.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.398 1.079 . . . . 0.0 112.309 -165.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.56 -35.67 81.73 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.645 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 t -61.36 -37.2 82.51 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.718 0.407 . . . . 0.0 111.829 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 155' ' ' THR . 23.4 mm-40 -83.72 -8.02 59.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.672 0.389 . . . . 0.0 111.31 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.5 mt -138.9 71.78 41.66 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.545 0.738 . . . . 0.0 110.125 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.29 -5.55 13.56 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.402 2.735 . . . . 0.0 111.761 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.5 p -89.71 -41.39 11.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.592 1.157 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 15.2 tp -90.62 71.67 6.8 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.623 1.569 . . . . 0.0 110.043 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -63.84 135.07 56.29 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.406 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 33.1 m95 -94.24 128.89 40.97 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.644 1.178 . . . . 0.0 109.999 -166.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.96 -34.25 77.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.543 0.737 . . . . 0.0 110.205 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 70.7 mt -126.14 125.9 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.17 76.87 1.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.052 0.941 . . . . 0.0 109.426 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.96 154.87 35.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.64 117.48 22.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.354 0.662 . . . . 0.0 109.743 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -111.94 130.31 55.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.203 0.601 . . . . 0.0 110.158 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.812 0.845 . . . . 0.0 110.541 -178.407 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.5 mt -122.21 165.87 15.49 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 152' ' ' LYS . 15.4 pt -138.58 141.3 37.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -127.73 143.81 51.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.206 0.527 . . . . 0.0 110.736 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 54.1 mt -135.08 129.0 33.29 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.597 1.559 . . . . 0.0 108.768 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 24' ' ' VAL . 30.2 tp -122.14 106.04 10.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.08 140.64 17.86 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 170.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.94 0.896 . . . . 0.0 110.48 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 80.4 tttt -55.9 123.52 14.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 123.742 0.651 . . . . 0.0 109.411 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 CA--C 1.543 0.676 0 O-C-N 123.098 0.249 . . . . 0.0 110.347 179.219 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.5 t80 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.506 0.193 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.584 HD21 ' HG ' ' A' ' 47' ' ' LEU . 33.7 tp -58.81 -35.7 73.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.389 0.676 . . . . 0.0 111.809 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.37 -40.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.2 p -79.75 -51.45 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.258 0.551 . . . . 0.0 111.108 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 128' ' ' ILE . 26.5 m -63.41 -34.24 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.373 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.72 76.87 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.324 1.05 . . . . 0.0 111.987 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.06 -31.84 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.107 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HB3' HE21 ' A' ' 193' ' ' GLN . 29.8 mm-40 -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.848 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 24' ' ' VAL . 79.1 mt -69.79 128.21 92.05 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-O 119.003 -0.523 . . . . 0.0 109.735 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.35 115.04 1.54 Allowed 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.859 2.372 . . . . 0.0 111.369 164.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.47 32.67 0.13 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.809 1.644 . . . . 0.0 114.306 -166.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.94 -129.59 5.56 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-O 118.776 -1.014 . . . . 0.0 110.922 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -69.29 111.23 5.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.458 1.129 . . . . 0.0 109.897 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.03 119.5 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 89' ' ' ASP . 56.4 tp -98.24 121.06 39.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.901 0.481 . . . . 0.0 110.598 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -104.73 134.0 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.999 1.32 . . . . 0.0 109.422 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.78 152.58 18.35 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.629 0.372 . . . . 0.0 110.9 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 123.279 0.632 . . . . 0.0 111.711 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -65.31 -44.69 87.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 110.334 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -65.73 -31.3 72.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.209 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.66 -58.35 8.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.651 0.78 . . . . 0.0 111.659 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.2 p -65.93 -27.34 68.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.961 0.504 . . . . 0.0 112.086 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 51.0 t80 -68.5 -36.9 79.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.889 0.476 . . . . 0.0 110.098 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 21' ' ' LEU . 55.6 mt -68.56 -32.29 72.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.327 0.651 . . . . 0.0 111.054 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.32 -33.87 61.2 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.47 0.308 . . . . 0.0 110.321 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -63.19 -19.2 64.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.149 0.98 . . . . 0.0 111.36 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 84.1 mt -82.07 14.23 2.95 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.89 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 33.7 58.31 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 123.295 0.474 . . . . 0.0 114.163 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -125.44 156.12 39.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.718 0.759 . . . . 0.0 110.628 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.53 97.51 7.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.481 0.712 . . . . 0.0 109.75 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -105.96 119.11 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.116 0.484 . . . . 0.0 111.501 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -84.97 112.3 20.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.32 120.48 40.32 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 81' ' ' VAL . 82.2 t -98.66 121.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.84 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 19.6 t70 -139.47 129.33 24.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -54.74 -26.92 37.22 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.782 1.233 . . . . 0.0 112.987 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.491 ' HB2' HG22 ' A' ' 62' ' ' VAL . 47.6 m -113.25 160.68 18.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.779 0.831 . . . . 0.0 111.386 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -69.81 -21.39 63.4 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.526 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 60' ' ' SER . 6.5 m -62.11 -43.8 98.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.183 0 C-N-CA 122.895 0.478 . . . . 0.0 111.992 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.28 -34.88 19.24 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 71.3 mt -67.66 -58.31 4.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.594 0.758 . . . . 0.0 111.773 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.46 70.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.321 0.649 . . . . 0.0 112.287 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.41 -42.3 71.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.883 0.473 . . . . 0.0 110.529 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.44 95.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.682 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -68.97 -34.97 76.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.559 1.144 . . . . 0.0 111.296 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -54.89 -48.51 72.91 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.087 0.955 . . . . 0.0 110.648 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.86 -29.25 64.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.057 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -58.54 -62.58 1.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.63 0.581 . . . . 0.0 111.069 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.21 -40.12 89.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.239 0.616 . . . . 0.0 111.665 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.95 -40.32 95.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.727 0.811 . . . . 0.0 111.55 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -103.92 -5.46 22.25 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.889 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 43.78 36.23 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.875 0.153 . . . . 0.0 113.206 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.76 172.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.316 1.047 . . . . 0.0 109.499 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.05 132.42 54.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.98 0.512 . . . . 0.0 111.497 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 71' ' ' ALA . 23.2 mm -114.42 155.76 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 166.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -121.46 108.21 13.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 165.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.7 t -86.62 113.49 22.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.209 0.603 . . . . 0.0 110.855 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 57' ' ' VAL . 24.7 t -120.79 139.19 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.307 1.043 . . . . 0.0 109.132 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.05 147.87 27.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 m -67.19 112.68 4.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.419 0.288 . . . . 0.0 111.338 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -144.01 89.06 2.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 165.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.42 -38.55 18.55 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.023 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.64 67.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.845 0.858 . . . . 0.0 112.194 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.22 -34.17 20.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.381 0.672 . . . . 0.0 111.499 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -166.74 117.27 0.92 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.348 0.659 . . . . 0.0 109.831 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -128.84 -64.59 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.9 pt -139.79 119.24 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.546 0.738 . . . . 0.0 110.279 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.97 86.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -69.25 2.19 3.11 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.03 -50.3 56.22 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.53 -22.17 47.7 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 34' ' ' LEU . 68.7 m95 -107.45 170.85 7.72 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 0.0 109.867 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -98.98 -56.98 2.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.336 0.589 . . . . 0.0 109.793 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.74 158.4 20.02 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.819 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.688 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 59.7 mt -122.73 153.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.57 136.1 35.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.937 1.295 . . . . 0.0 108.098 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 t -143.8 93.63 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.2 mm -66.9 142.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.703 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 35.4 p90 -15.65 106.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.363 1.865 . . . . 0.0 115.417 -159.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.4 p -70.23 102.0 2.01 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.395 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -99.22 94.2 6.35 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.3 133.33 25.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.56 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -56.78 161.71 9.82 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.285 2.656 . . . . 0.0 112.36 169.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -40.94 -44.1 2.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.815 1.246 . . . . 0.0 112.85 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 m -54.12 -63.82 1.03 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.311 1.044 . . . . 0.0 112.179 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -75.55 -27.72 58.74 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.581 0.352 . . . . 0.0 111.066 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -65.27 -55.4 18.59 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.26 -35.35 26.61 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.608 1.163 . . . . 0.0 112.592 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.71 -17.07 39.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.962 0.505 . . . . 0.0 111.398 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 117' ' ' VAL . 58.6 tp -78.43 -38.42 41.4 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.904 0.482 . . . . 0.0 111.265 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -57.34 -41.13 89.3 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -29.99 84.69 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.967 1.778 . . . . 0.0 112.515 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -81.95 -26.86 33.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.541 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 113' ' ' LEU . 2.5 t -87.35 -24.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.257 0.551 . . . . 0.0 110.675 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -82.08 -65.45 1.01 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.85 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.55 -45.5 15.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.899 0.88 . . . . 0.0 112.853 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.83 -29.87 64.53 Favored Glycine 0 N--CA 1.479 1.523 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.909 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.73 146.16 50.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.205 0.602 . . . . 0.0 110.286 169.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 39.4 mmtm -129.47 158.21 73.99 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 108.063 170.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 194' ' ' LYS . 34.5 Cg_exo -40.18 110.87 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.392 2.728 . . . . 0.0 114.444 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.49 6.59 6.65 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.804 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.688 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -98.97 140.43 15.01 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 170.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 29.0 m -111.47 130.94 64.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.256 0.55 . . . . 0.0 110.3 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -110.03 107.4 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 24' ' ' VAL . 45.2 mt -110.4 107.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 156' ' ' LEU . 29.8 mt -125.73 116.42 21.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -167.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.703 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 45.5 tt0 -105.62 97.64 7.45 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.89 -177.46 46.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.974 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 150' ' ' LEU . 31.5 m-85 -138.21 159.05 43.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.942 0.897 . . . . 0.0 108.863 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 123.555 0.742 . . . . 0.0 110.31 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 132' ' ' PHE . 22.0 mt -90.88 103.24 6.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.98 109.02 2.81 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.617 2.211 . . . . 0.0 110.625 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' HD11 ' A' ' 188' ' ' ILE . 37.3 mtmm -108.0 162.71 13.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.275 0.63 . . . . 0.0 111.905 -168.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 188' ' ' ILE . 24.1 mt -60.15 -36.25 77.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.635 0.774 . . . . 0.0 109.899 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -48.53 -56.93 7.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.719 1.208 . . . . 0.0 110.79 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 57.2 m -71.73 -62.61 1.36 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.739 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 129' ' ' LEU . 24.3 mt -61.74 -55.48 29.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.696 1.198 . . . . 0.0 112.209 -166.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -59.7 -42.05 92.15 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.646 0.779 . . . . 0.0 111.9 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.1 t -63.76 -34.01 76.94 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 155' ' ' THR . 8.5 pt-20 -111.33 18.69 19.0 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.132 0.492 . . . . 0.0 111.251 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -139.74 63.23 25.55 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.108 0.963 . . . . 0.0 108.708 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.43 -8.87 15.01 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.62 2.214 . . . . 0.0 111.919 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.2 t -86.42 -33.09 20.55 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.6 tp -95.13 68.17 3.1 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 108.492 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.39 128.56 36.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 25.4 m95 -88.23 141.02 28.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 110.014 -163.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.34 -36.67 77.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.966 0.506 . . . . 0.0 109.843 170.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.5 mt -127.22 125.53 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.58 85.52 1.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.34 1.056 . . . . 0.0 108.658 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.09 149.59 28.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.565 0.346 . . . . 0.0 111.193 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.57 113.98 20.65 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.535 0.522 . . . . 0.0 109.633 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.9 mt -109.66 128.94 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.196 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.46 154.01 30.07 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 152' ' ' LYS . 3.4 pt -136.14 116.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -97.86 138.1 35.72 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 34.5 mt -126.35 131.63 51.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.806 1.242 . . . . 0.0 108.1 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.515 HD22 HG12 ' A' ' 24' ' ' VAL . 40.1 tp -127.6 105.65 8.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 168.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.98 133.69 11.99 Favored Glycine 0 C--O 1.214 -1.133 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 27' ' ' GLN . 6.5 tp-100 -144.05 156.87 44.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.809 0.844 . . . . 0.0 109.304 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 123' ' ' PRO . 22.8 pttp -60.15 129.07 39.93 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 CA--C 1.54 0.586 0 O-C-N 123.245 0.34 . . . . 0.0 110.581 -177.815 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.477 HD21 ' HG ' ' A' ' 47' ' ' LEU . 33.2 tp -59.26 -31.88 69.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.538 0.735 . . . . 0.0 112.509 -174.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 m -54.79 -38.05 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -68.12 -53.08 27.87 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.955 0.883 . . . . 0.0 110.425 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 128' ' ' ILE . 29.7 m -66.97 -29.27 45.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.546 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.91 72.94 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.249 1.02 . . . . 0.0 112.31 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.05 -35.57 79.02 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.021 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -95.2 -7.63 38.55 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' VAL . 57.9 mt -72.06 138.35 82.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.69 ' HG3' ' HD3' ' A' ' 194' ' ' LYS . 33.7 Cg_exo -59.87 131.83 41.77 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.084 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -70.78 30.37 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.02 -148.93 9.27 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -80.39 118.06 21.69 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -107.63 141.95 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.709 0.804 . . . . 0.0 110.197 -167.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 95' ' ' TRP . 33.0 tp -118.13 116.87 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.329 1.052 . . . . 0.0 109.127 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 26.5 p -107.21 111.93 24.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.277 0.489 . . . . 0.0 110.811 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -70.05 143.06 52.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 O-C-N 123.935 0.772 . . . . 0.0 110.041 -179.32 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.195 0 N-CA-C 112.948 -0.061 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 ttp-105 -70.75 -41.14 72.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.764 0.826 . . . . 0.0 109.891 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.43 -40.59 97.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.53 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.68 -57.27 13.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 111.575 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.651 ' SG ' HD23 ' A' ' 70' ' ' LEU . 20.1 p -61.67 -43.26 99.19 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.375 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -66.32 -46.18 77.75 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.256 0.348 . . . . 0.0 111.184 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' ' 21' ' ' LEU . 97.3 mt -67.05 -33.0 74.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.051 0.54 . . . . 0.0 110.874 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 -33.1 72.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.991 0.517 . . . . 0.0 110.873 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 63.9 m -75.43 -5.6 45.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.3 mt -88.59 13.15 12.77 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.245 0.618 . . . . 0.0 110.167 167.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.56 39.14 30.77 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.74 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -130.12 154.68 47.24 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.161 0.481 . . . . 0.0 111.888 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.19 89.18 7.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.575 0.75 . . . . 0.0 109.056 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.62 110.14 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.319 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 82.1 m -87.09 112.91 22.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.624 1.17 . . . . 0.0 109.79 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -92.31 125.82 37.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.707 0.803 . . . . 0.0 109.913 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' CG1' ' HA ' ' A' ' 83' ' ' SER . 5.6 t -105.37 116.45 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 167.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -135.74 133.93 38.51 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.4 -23.86 67.43 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.679 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.542 ' HB3' HG22 ' A' ' 62' ' ' VAL . 15.8 m -104.13 135.85 44.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.057 0.943 . . . . 0.0 109.814 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -73.11 -25.8 61.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 0.0 109.981 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 60' ' ' SER . 21.2 m -67.85 -36.6 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.258 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.98 -36.28 90.74 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.51 -48.23 70.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.402 1.081 . . . . 0.0 111.5 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.39 84.46 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.688 0.795 . . . . 0.0 112.47 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -77.45 -31.58 53.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.263 0.625 . . . . 0.0 111.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.69 -46.89 87.71 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 171.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.46 -40.95 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.169 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.4 -53.42 58.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.022 0.929 . . . . 0.0 110.823 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.651 HD23 ' SG ' ' A' ' 45' ' ' CYS . 19.3 tp -65.69 -28.47 69.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.642 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -54.46 17.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.734 0.414 . . . . 0.0 110.812 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -35.63 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.187 0.595 . . . . 0.0 110.769 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.66 -40.48 97.2 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.851 0.719 . . . . 0.0 110.356 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -91.02 -1.39 57.82 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.981 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.69 32.28 37.75 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 16.3 m -132.71 178.51 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.961 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -132.0 142.16 49.5 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.758 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.0 mm -110.61 170.06 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.97 1.308 . . . . 0.0 108.273 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 71.7 m -121.91 111.89 17.64 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 163.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t -86.08 109.96 19.2 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.592 0.757 . . . . 0.0 111.545 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.22 133.05 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.524 1.129 . . . . 0.0 108.955 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -85.41 132.42 34.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . 58.2 m -61.36 125.92 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -133.42 87.61 2.41 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.5 mt -91.1 -4.58 56.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.506 0.722 . . . . 0.0 110.674 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.39 3.54 54.25 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.825 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.39 -37.81 0.27 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -162.04 104.53 1.16 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -169.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.5 -65.15 0.99 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -174.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 98' ' ' ILE . 9.4 pt -136.32 115.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.479 0.712 . . . . 0.0 110.777 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 94' ' ' ALA . 61.4 t -128.07 94.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.83 -1.43 2.9 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.2 -51.27 9.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 168.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -70.55 -31.47 68.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.37 0.668 . . . . 0.0 111.861 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.488 ' CD1' HD22 ' A' ' 34' ' ' LEU . 24.5 m95 -116.94 145.08 43.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.778 0.831 . . . . 0.0 109.44 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.07 -33.06 44.92 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.178 0.513 . . . . 0.0 110.57 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -139.98 140.11 10.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.872 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 90' ' ' ILE . 82.1 mt -115.58 143.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' LEU . 7.7 p -135.8 134.58 51.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 164.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 m -136.89 113.77 10.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 128' ' ' ILE . 37.1 mm -76.34 144.51 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.735 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 2.9 p90 -20.31 109.36 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.124 1.77 . . . . 0.0 115.148 -173.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.415 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.7 t -80.36 113.48 18.58 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 112.896 -1.956 . . . . 0.0 110.313 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -120.19 98.08 5.9 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -122.1 150.72 57.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.91 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.68 159.53 53.27 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.91 2.407 . . . . 0.0 110.125 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.3 m -37.16 -45.0 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.157 1.783 . . . . 0.0 113.956 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.7 p -49.14 -63.08 1.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 O-C-N 124.675 1.234 . . . . 0.0 111.844 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.24 -22.28 28.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.392 0.677 . . . . 0.0 110.539 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -73.42 -62.93 1.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.129 0.972 . . . . 0.0 110.374 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.31 -15.17 56.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.451 0.7 . . . . 0.0 112.098 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.23 -41.65 27.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 117' ' ' VAL . 46.6 tp -74.86 -48.22 26.1 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.783 -170.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.449 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 34.7 m-85 -66.73 -40.56 32.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.56 -31.74 94.98 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 121.958 1.772 . . . . 0.0 112.281 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -82.65 -14.96 53.77 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.964 0.906 . . . . 0.0 110.057 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 113' ' ' LEU . 22.0 t -80.68 -36.46 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.506 ' HE1' ' HD2' ' A' ' 161' ' ' PRO . 33.0 t80 -57.8 -54.46 46.6 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -71.83 -47.01 56.07 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.806 0.842 . . . . 0.0 112.926 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.09 -45.94 10.99 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 114.276 0.47 . . . . 0.0 114.276 -170.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.1 tp -85.28 95.2 9.12 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -75.75 148.41 82.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 164.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.02 133.27 28.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.201 1.934 . . . . 0.0 110.125 168.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 128.87 -11.73 6.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -157.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.01 168.08 20.87 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 122.726 -0.279 . . . . 0.0 112.593 166.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.08 137.88 48.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.409 1.083 . . . . 0.0 109.45 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.98 113.33 23.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 24' ' ' VAL . 17.9 mt -106.95 109.62 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.934 0.893 . . . . 0.0 108.644 -171.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 156' ' ' LEU . 40.3 mt -125.85 114.1 18.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.995 0.518 . . . . 0.0 109.754 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.735 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 43.2 tt0 -103.47 98.95 8.76 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.91 -176.68 49.24 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.449 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.449 ' HB2' HD22 ' A' ' 150' ' ' LEU . 36.8 m-85 -132.79 158.61 42.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.215 1.006 . . . . 0.0 108.757 -176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.582 0.753 . . . . 0.0 110.553 179.434 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 132' ' ' PHE . 20.9 mt -83.29 107.83 11.04 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -68.82 111.88 2.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.923 2.416 . . . . 0.0 111.239 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.13 151.89 20.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.276 0.63 . . . . 0.0 111.482 -169.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.504 HD21 ' HB ' ' A' ' 188' ' ' ILE . 60.5 mt -60.69 -39.37 88.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.166 0.586 . . . . 0.0 110.486 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.1 -51.39 58.02 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.389 1.076 . . . . 0.0 110.805 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.7 p -71.55 -55.18 8.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.671 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 129' ' ' LEU . 55.9 mt -73.51 -46.15 49.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.262 1.025 . . . . 0.0 113.52 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -64.42 -42.41 96.07 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 m -73.64 -21.94 60.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 19.7 tp10 -74.39 -22.25 59.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.635 0.774 . . . . 0.0 110.521 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.456 HD23 ' HD1' ' A' ' 118' ' ' TYR . 68.6 mt -140.22 65.56 28.69 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.535 0.734 . . . . 0.0 109.377 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.506 ' HD2' ' HE1' ' A' ' 118' ' ' TYR . 95.3 Cg_endo -81.42 2.49 8.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 123.068 2.512 . . . . 0.0 112.09 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 55.1 p -90.47 -33.84 15.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.367 1.067 . . . . 0.0 108.685 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.06 73.12 7.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.999 1.719 . . . . 0.0 111.178 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -50.06 114.15 1.03 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.476 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 35.4 m95 -84.88 128.99 34.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.786 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 84.8 mt -71.18 -36.61 72.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.429 0.692 . . . . 0.0 110.803 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 59.1 mt -125.25 120.74 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.02 70.98 0.95 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -148.23 146.51 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -170.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -73.97 112.42 10.07 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.272 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.9 mt -118.17 137.17 53.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 110.829 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 123.509 0.724 . . . . 0.0 110.005 176.898 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -127.28 171.94 11.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.657 0.783 . . . . 0.0 109.809 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.504 ' HB ' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -142.82 119.82 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.031 173.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -98.31 140.71 32.18 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 37.4 mt -129.23 133.35 47.49 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 108.453 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.47 HD22 HG12 ' A' ' 24' ' ' VAL . 46.3 tp -139.76 107.61 5.67 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.69 139.76 17.46 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 6.1 tp60 -116.72 146.79 42.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.001 0.9 . . . . 0.0 111.677 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.69 ' HD3' ' HG3' ' A' ' 29' ' ' PRO . 21.9 pttm -58.19 115.05 2.68 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.163 165.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 167.813 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.416 0.627 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 47' ' ' LEU . 18.2 tp -59.77 -33.97 72.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.848 1.259 . . . . 0.0 112.492 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 m -52.54 -38.46 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -72.8 -44.72 61.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 0.0 110.938 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 128' ' ' ILE . 2.4 m -67.97 -33.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.044 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.27 77.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.485 1.114 . . . . 0.0 111.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.7 -33.87 73.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.191 0.596 . . . . 0.0 110.329 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -84.21 -22.52 30.85 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' VAL . 85.7 mt -76.98 131.67 72.63 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.91 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.39 143.93 71.83 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.788 2.326 . . . . 0.0 111.895 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -72.79 30.59 0.06 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.336 1.454 . . . . 0.0 114.371 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.76 177.95 17.35 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 96' ' ' GLU . 66.1 mttm -60.14 118.48 6.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.542 0.737 . . . . 0.0 110.845 -165.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.89 138.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -165.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 90' ' ' ILE . 59.9 tp -110.67 112.43 24.31 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.73 ' SG ' HG13 ' A' ' 54' ' ' VAL . 58.9 m -101.81 109.59 21.38 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 123.772 0.829 . . . . 0.0 110.412 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 89' ' ' ASP . 36.8 mt -76.69 127.31 32.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 165.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -177.863 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.862 0 CA-C-O 120.014 -0.325 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -61.78 -38.21 87.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.445 0.698 . . . . 0.0 110.821 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -74.59 -33.61 62.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.182 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.05 66.61 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.297 0.639 . . . . 0.0 110.799 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.6 p -70.42 -28.44 65.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.2 t80 -66.88 -33.15 74.97 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' A' ' 21' ' ' LEU . 31.4 mt -64.59 -36.04 82.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.121 0.569 . . . . 0.0 111.164 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.56 69.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.661 0.267 . . . . 0.0 110.743 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.601 ' HA ' HG11 ' A' ' 76' ' ' VAL . 55.9 m -68.36 -10.86 57.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.531 0.732 . . . . 0.0 111.533 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 47' ' ' LEU . 65.7 mt -88.13 14.89 8.28 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.643 0.777 . . . . 0.0 110.846 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.16 36.97 44.05 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 123.146 0.403 . . . . 0.0 113.435 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.64 147.34 45.37 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.889 0.476 . . . . 0.0 112.101 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.9 90.64 4.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.902 0.881 . . . . 0.0 108.719 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.73 HG13 ' SG ' ' A' ' 35' ' ' CYS . 65.3 t -102.05 112.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.023 0.529 . . . . 0.0 111.969 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.2 m -85.3 104.88 15.54 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.68 120.95 41.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.268 0.627 . . . . 0.0 109.507 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 83' ' ' SER . 3.6 t -103.81 119.17 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -132.91 144.56 50.24 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.315 0.962 . . . . 0.0 111.32 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 3.0 pp0? -57.98 -18.27 22.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.526 1.53 . . . . 0.0 114.503 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 62' ' ' VAL . 77.5 p -131.2 139.2 49.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 110.409 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -76.83 -17.41 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.405 0.682 . . . . 0.0 110.163 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 60' ' ' SER . 20.1 m -73.5 -29.16 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.151 168.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.97 -28.99 57.77 Favored Glycine 0 C--N 1.359 1.827 0 O-C-N 123.524 0.515 . . . . 0.0 112.342 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.08 -39.97 68.59 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.666 0.787 . . . . 0.0 110.299 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.52 67.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.759 0.824 . . . . 0.0 111.15 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -70.66 -47.53 59.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.225 1.01 . . . . 0.0 109.011 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.56 95.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.119 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -69.83 -35.77 75.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.989 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.12 -46.3 82.77 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.914 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.65 -29.61 66.01 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.154 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -62.8 -62.27 1.84 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.879 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.11 -23.14 67.06 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.884 0.873 . . . . 0.0 112.028 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.93 -56.12 20.01 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -99.03 8.05 45.37 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.948 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.77 38.19 85.19 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 121.996 -0.44 . . . . 0.0 113.358 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.4 m -121.52 162.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.093 0.957 . . . . 0.0 109.282 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -106.05 129.32 54.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.151 0.58 . . . . 0.0 112.107 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 71' ' ' ALA . 16.2 mm -114.24 160.99 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 166.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -125.2 104.3 8.43 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 p -87.86 121.85 30.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.889 0.476 . . . . 0.0 110.744 -167.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.96 140.4 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 108.704 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -81.61 133.12 35.34 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 57' ' ' VAL . 37.7 t -65.55 114.86 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.47 0.481 . . . . 0.0 111.392 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -141.45 88.66 2.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.67 -10.77 50.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.143 0.577 . . . . 0.0 111.23 -166.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.04 -22.34 36.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.476 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.83 -37.66 10.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 110.896 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -171.95 135.54 0.83 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.157 1.383 . . . . 0.0 108.154 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' O ' HD21 ' A' ' 36' ' ' LEU . 1.8 p-10 -135.17 -73.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' A' ' 98' ' ' ILE . 3.7 pt -146.63 120.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.441 0.696 . . . . 0.0 110.774 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 94' ' ' ALA . 44.2 t -130.34 93.27 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.897 0.479 . . . . 0.0 109.968 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.0 23.76 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.34 -44.03 59.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.409 0.684 . . . . 0.0 109.229 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.406 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -77.34 -34.42 55.22 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.32 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.538 ' NE1' HD22 ' A' ' 34' ' ' LEU . 74.5 m95 -109.05 149.71 28.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.218 0.607 . . . . 0.0 111.379 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' N ' ' A' ' 32' ' ' LYS . 45.1 mt-10 -91.74 3.69 54.51 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.835 0.854 . . . . 0.0 111.112 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.33 151.44 16.49 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.1 mt -128.6 149.12 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.903 0.881 . . . . 0.0 108.853 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -147.66 144.24 19.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 162.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 127' ' ' PHE . 47.4 m -133.24 100.37 4.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.9 mm -70.09 138.96 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.739 1.216 . . . . 0.0 108.705 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -18.18 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.533 1.933 . . . . 0.0 114.723 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.45 106.32 14.23 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -96.42 97.37 9.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.5 mt -124.67 145.7 50.34 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.709 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.17 152.44 71.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.858 2.372 . . . . 0.0 109.926 167.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.4 m -44.18 -40.0 4.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.769 1.227 . . . . 0.0 113.168 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 34.6 m -51.39 -60.81 2.72 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 124.454 1.096 . . . . 0.0 111.002 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.97 -24.15 38.25 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.864 0.466 . . . . 0.0 111.424 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 114' ' ' TYR . 29.2 ttp180 -75.8 -48.67 20.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -68.35 -10.37 54.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.582 0.753 . . . . 0.0 112.81 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 108' ' ' SER . 30.1 mm-40 -88.0 -26.97 22.35 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.014 0.37 . . . . 0.0 110.144 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 117' ' ' VAL . 57.6 tp -78.03 -52.87 8.11 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.867 -174.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 110' ' ' ARG . 29.1 m-85 -66.39 -38.04 18.89 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 24.2 Cg_endo -61.54 -29.43 84.6 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.958 1.772 . . . . 0.0 112.514 167.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -81.57 -22.97 37.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.216 1.007 . . . . 0.0 109.799 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.533 HG22 HD11 ' A' ' 90' ' ' ILE . 28.6 t -78.18 -39.65 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.886 0.874 . . . . 0.0 109.211 170.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.59 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 13.3 t80 -54.09 -58.61 6.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.817 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.36 -49.54 66.57 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.742 0.817 . . . . 0.0 113.036 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.5 -40.48 32.59 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -165.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 34.1 tp -81.21 115.58 20.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.739 0.815 . . . . 0.0 109.56 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.55 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 9.0 mmpt? -103.71 159.39 29.46 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.362 1.065 . . . . 0.0 109.363 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.97 113.35 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.623 0 C-N-CA 123.458 2.772 . . . . 0.0 113.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.556 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.94 14.01 2.6 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.733 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.609 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.21 150.46 17.17 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 162.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 31.8 m -110.62 133.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.373 0 C-N-CA 123.039 0.535 . . . . 0.0 109.57 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 100' ' ' SER . 0.8 OUTLIER -105.79 112.74 25.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 24' ' ' VAL . 50.3 mt -107.01 107.55 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 96.9 mt -121.41 123.26 41.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -106.02 99.31 8.91 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.622 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -79.97 173.87 55.03 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.102 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.3 157.04 46.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.185 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.88 105.45 12.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.622 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 24.6 Cg_exo -63.56 112.96 1.92 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.123 2.548 . . . . 0.0 112.479 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -95.02 145.83 24.68 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.909 0.884 . . . . 0.0 111.279 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 HD21 ' A' ' 190' ' ' LEU . 41.2 mt -61.03 -51.32 69.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.164 0.586 . . . . 0.0 110.69 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.97 -35.7 47.17 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.533 0.733 . . . . 0.0 112.164 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 m -76.56 -45.87 28.7 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.29 1.036 . . . . 0.0 110.719 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' PRO . 83.2 mt -82.3 -46.49 13.58 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.094 0.958 . . . . 0.0 112.877 -170.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.7 -39.93 62.47 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.515 . . . . 0.0 111.261 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t -70.89 -33.92 71.06 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -96.47 -7.41 34.85 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 118' ' ' TYR . 72.4 mt -139.66 62.69 24.1 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.247 0.619 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.59 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 57.3 Cg_endo -81.62 -3.21 11.82 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.138 2.559 . . . . 0.0 113.082 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.5 p -88.46 -30.13 19.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.893 0.877 . . . . 0.0 109.105 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 tp -93.22 75.7 4.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.825 1.65 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -44.5 111.87 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 0.0 111.194 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.457 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 54.4 m95 -85.0 129.43 34.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD11 ' HG2' ' A' ' 193' ' ' GLN . 71.8 mt -76.97 -35.66 57.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.572 0.349 . . . . 0.0 110.467 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.85 123.63 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.71 85.55 1.04 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.11 0.964 . . . . 0.0 108.933 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.09 151.09 35.06 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 188' ' ' ILE . 13.5 t30 -79.16 103.73 9.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.472 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.07 125.25 50.77 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 109.306 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.02 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.656 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.92 165.02 18.11 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.43 ' HB ' HD21 ' A' ' 153' ' ' LEU . 6.3 pt -140.88 116.26 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -102.49 145.57 29.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.584 0.707 . . . . 0.0 110.395 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.471 HD21 HD22 ' A' ' 153' ' ' LEU . 35.7 mt -131.36 135.62 47.38 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.498 -174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 24' ' ' VAL . 43.5 tp -135.46 105.71 6.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.54 139.76 16.81 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HG2' HD11 ' A' ' 166' ' ' LEU . 5.6 tp60 -136.87 154.28 50.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.879 0.84 . . . . 0.0 111.489 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 22.1 ptmt -55.35 142.83 30.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.046 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 t80 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.313 0.101 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 ' ND2' ' A' ' 43' ' ' ASN . 21.3 tp -59.74 -44.77 93.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.606 0.763 . . . . 0.0 111.559 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 m -43.56 -34.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -50.84 19.5 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.57 0.623 . . . . 0.0 110.329 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 128' ' ' ILE . 1.4 m -59.41 -33.08 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.734 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.8 74.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 0.0 111.776 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.3 -26.75 68.62 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.922 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -89.71 -19.87 24.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.959 0.903 . . . . 0.0 111.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 66.7 mt -80.1 135.98 54.23 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 122.972 0.509 . . . . 0.0 109.833 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -58.92 133.27 52.56 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.974 2.45 . . . . 0.0 111.864 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.59 27.17 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.69 -131.76 4.57 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.767 0.712 . . . . 0.0 111.828 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 67.5 mttm -77.15 113.19 14.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.074 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 99' ' ' VAL . 21.1 mt -111.68 120.54 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 109.144 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' THR . 36.2 tp -93.4 113.19 25.29 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.632 0.373 . . . . 0.0 110.576 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 54.0 t -108.77 107.66 18.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.17 165.39 9.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.76 0.424 . . . . 0.0 111.519 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.253 0.549 . . . . 0.0 110.429 170.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 113.821 0.288 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -69.96 -28.92 65.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.121 0.569 . . . . 0.0 110.792 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' HD22 ' A' ' 21' ' ' LEU . 24.9 t-20 -64.91 -43.64 92.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.228 1.011 . . . . 0.0 110.363 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.83 -47.05 70.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.708 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.9 m -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.662 . . . . 0.0 112.459 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.3 t80 -68.66 -39.29 80.73 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.058 0.543 . . . . 0.0 109.716 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.27 -34.32 77.17 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.078 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.55 71.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.96 0.504 . . . . 0.0 111.147 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG11 ' A' ' 76' ' ' VAL . 34.7 t -70.28 -11.28 60.8 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 111.781 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 79.1 mt -85.1 5.84 28.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.76 0.424 . . . . 0.0 110.384 170.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.04 27.95 47.55 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 123.173 0.416 . . . . 0.0 113.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -113.62 151.4 31.78 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.27 0.535 . . . . 0.0 109.697 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 40.9 mt-10 -85.36 87.61 7.41 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.25 104.89 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.297 0.57 . . . . 0.0 109.904 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.1 t -85.54 111.09 19.7 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.834 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.49 121.2 44.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.932 0.493 . . . . 0.0 109.873 -172.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 3.7 t -89.31 134.54 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 t70 -152.83 129.23 10.61 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -62.69 -28.38 69.9 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.238 1.015 . . . . 0.0 112.831 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.444 ' OG ' HG22 ' A' ' 62' ' ' VAL . 10.2 t -102.6 123.8 46.98 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -72.38 -19.79 61.56 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.168 0.587 . . . . 0.0 111.042 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' OG ' ' A' ' 60' ' ' SER . 18.9 m -66.65 -32.74 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 122.819 0.448 . . . . 0.0 110.685 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.51 -39.84 55.55 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.897 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 80' ' ' THR . 94.5 mt -62.52 -48.52 79.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 110.983 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -57.6 -46.63 83.8 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -69.96 -38.03 75.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.249 0.62 . . . . 0.0 110.641 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.386 0.612 . . . . 0.0 110.541 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -74.05 -29.65 62.01 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.703 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 69.8 mt-30 -61.91 -45.5 93.46 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.13 0.572 . . . . 0.0 110.168 171.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.52 -26.72 64.66 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 123.882 0.739 . . . . 0.0 110.568 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.44 -62.07 1.92 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.185 173.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.24 -37.69 81.17 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.123 0.569 . . . . 0.0 111.036 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.42 -45.86 92.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.608 0.763 . . . . 0.0 110.56 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -97.65 8.65 44.28 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.971 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 37.53 77.45 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-N 116.617 -0.265 . . . . 0.0 113.701 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -130.42 -177.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.914 1.286 . . . . 0.0 109.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -131.18 136.04 47.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.746 HG12 ' HB2' ' A' ' 71' ' ' ALA . 25.7 mm -104.87 165.41 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 42.4 m -125.89 104.58 8.39 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 166.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.461 ' HB ' HD22 ' A' ' 64' ' ' LEU . 45.2 p -88.09 124.43 33.77 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.07 -0.394 . . . . 0.0 111.056 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 24.1 t -118.86 138.32 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.923 1.289 . . . . 0.0 108.555 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -86.42 128.28 34.93 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.779 0.718 . . . . 0.0 110.168 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 57' ' ' VAL . 47.3 m -63.19 125.21 23.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -143.31 91.4 2.26 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 28.8 mt -82.01 -8.32 59.66 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.566 0.621 . . . . 0.0 111.642 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.16 11.03 31.5 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.571 1.148 . . . . 0.0 110.681 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -143.65 -44.57 0.28 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.302 0.641 . . . . 0.0 111.553 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -166.91 109.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.23 1.412 . . . . 0.0 107.622 -170.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -125.71 -71.8 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.266 0.626 . . . . 0.0 109.531 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 98' ' ' ILE . 27.6 pt -133.94 121.28 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.386 0.674 . . . . 0.0 110.763 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.55 84.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.674 0.79 . . . . 0.0 109.31 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.66 0.34 10.93 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.824 0.45 . . . . 0.0 111.835 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.57 -47.58 46.97 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.475 1.11 . . . . 0.0 108.696 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.72 65.34 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.503 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -107.49 -166.06 1.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.83 -30.14 3.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.388 0.675 . . . . 0.0 110.568 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.36 166.66 29.08 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 90' ' ' ILE . 62.6 mt -137.55 141.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 9.8 p -129.4 131.96 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.2 m -143.19 119.82 11.1 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.81 -0.556 . . . . 0.0 109.628 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mm -88.93 148.27 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.697 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 37.1 p90 -16.08 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 126.505 1.922 . . . . 0.0 115.416 -163.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.434 ' SG ' HD21 ' A' ' 129' ' ' LEU . 27.1 p -85.46 107.01 17.22 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.658 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -108.92 96.67 6.48 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 68.9 mt -120.41 148.8 48.44 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.144 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 153.93 28.25 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.095 2.53 . . . . 0.0 111.344 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.9 t -49.0 -32.16 8.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.105 0.962 . . . . 0.0 112.076 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 33.7 p -58.56 -60.8 3.23 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.455 1.102 . . . . 0.0 111.968 172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.35 -21.59 55.93 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.527 -174.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -69.99 -52.77 21.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 108.689 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -64.84 -11.78 41.11 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.178 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 108' ' ' SER . 16.2 mm100 -91.65 -38.44 12.44 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.106 -0.371 . . . . 0.0 110.805 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.9 tp -73.23 -50.34 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.748 0.419 . . . . 0.0 111.744 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 156' ' ' LEU . 39.6 m-85 -68.13 -35.88 8.18 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -54.17 -32.12 68.81 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.017 1.812 . . . . 0.0 113.64 163.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 32.4 mmtp -78.01 -30.71 50.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.462 0.705 . . . . 0.0 110.586 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.553 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.3 t -78.43 -25.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-O 121.626 0.726 . . . . 0.0 109.643 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -75.66 -64.07 1.16 Allowed 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.893 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -82.07 -50.41 9.11 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.88 51.72 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 116.754 -0.203 . . . . 0.0 113.191 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 125' ' ' GLY . 39.6 tp -69.75 100.42 1.5 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 122.896 0.478 . . . . 0.0 109.735 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.655 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 mtpp -66.74 149.3 98.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 165.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -42.52 119.21 1.32 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 124.041 3.161 . . . . 0.0 114.93 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.22 12.98 3.33 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.699 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -96.76 141.25 15.51 Favored Glycine 0 C--O 1.241 0.551 0 O-C-N 122.053 -0.675 . . . . 0.0 111.531 165.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 28.1 m -109.16 130.88 61.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.852 0.861 . . . . 0.0 108.903 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.95 111.98 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 24' ' ' VAL . 64.9 mt -103.53 107.91 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 17.1 mt -121.85 114.58 21.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.568 0.747 . . . . 0.0 109.528 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.697 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 28.5 tt0 -105.71 99.38 8.98 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -83.82 170.38 47.77 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.211 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.475 ' HB2' HD22 ' A' ' 150' ' ' LEU . 57.2 m-85 -133.17 159.12 41.09 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 108.863 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.075 0 C-N-CA 124.058 0.943 . . . . 0.0 110.126 -178.113 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 132' ' ' PHE . 71.0 mt -78.92 112.02 24.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 156' ' ' LEU . 23.5 Cg_exo -64.74 105.3 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.386 2.724 . . . . 0.0 112.588 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HA ' HD11 ' A' ' 188' ' ' ILE . 21.9 ttmm -98.34 146.75 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.802 0.728 . . . . 0.0 111.504 -170.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.1 mt -61.11 -48.91 79.46 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -50.84 -47.51 60.22 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.168 0.917 . . . . 0.0 110.673 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.6 m -66.51 -61.94 1.72 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.68 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 151' ' ' PRO . 22.1 mt -73.52 -42.15 62.11 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.331 0.652 . . . . 0.0 112.355 -165.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -62.19 -34.89 77.3 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.604 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 96.1 p -81.21 -22.23 38.98 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.555 0.216 . . . . 0.0 111.027 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.49 -16.83 57.09 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.042 0.537 . . . . 0.0 110.425 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 117' ' ' VAL . 86.3 mt -143.5 64.02 13.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.167 0.987 . . . . 0.0 109.026 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.63 -9.97 15.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.021 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.8 t -88.34 -30.1 19.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 109.317 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.2 tp -88.21 70.86 9.24 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.583 1.153 . . . . 0.0 109.286 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -52.7 127.34 22.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.468 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.44 ' HZ2' ' HB2' ' A' ' 160' ' ' LEU . 42.1 m95 -92.08 126.76 37.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.664 1.186 . . . . 0.0 109.446 -171.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.28 -32.96 74.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.387 0.675 . . . . 0.0 110.086 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 79.8 mt -126.23 124.85 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.22 82.67 1.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.051 0.94 . . . . 0.0 108.573 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -149.89 151.56 33.64 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.67 114.15 26.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.591 1.156 . . . . 0.0 109.997 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.25 136.79 52.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.807 0.443 . . . . 0.0 110.613 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 123.039 0.535 . . . . 0.0 110.535 177.64 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.671 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 34.8 mt -113.1 157.95 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' LYS . 11.6 pt -138.25 116.19 12.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -95.39 138.57 32.89 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 110.871 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 51.5 mt -128.35 131.73 48.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.119 1.368 . . . . 0.0 108.02 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.1 tp -126.34 110.21 13.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.22 135.76 13.78 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.536 ' NE2' ' HG3' ' A' ' 194' ' ' LYS . 54.3 tp60 -142.48 149.76 39.63 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.536 ' HG3' ' NE2' ' A' ' 193' ' ' GLN . 0.0 OUTLIER -63.65 147.16 52.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.943 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 123.388 0.675 . . . . 0.0 111.498 -179.116 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.001 0.429 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.16 -43.16 87.25 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.92 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 5.0 m -52.45 -36.25 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 m -72.54 -50.47 25.45 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.141 0.577 . . . . 0.0 110.465 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.548 HG12 HD22 ' A' ' 191' ' ' LEU . 7.0 m -66.35 -33.54 64.17 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.41 83.66 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.359 1.464 . . . . 0.0 112.199 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.42 -31.82 73.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.926 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -88.18 -18.65 28.26 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 112.117 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' VAL . 60.5 mt -70.39 137.47 86.38 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.825 0.85 . . . . 0.0 111.061 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.79 128.25 29.54 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.745 2.963 . . . . 0.0 112.46 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -76.59 29.6 0.13 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.61 -134.85 4.92 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.881 -0.399 . . . . 0.0 112.243 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 60.8 mttm -84.93 112.73 20.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.526 0.731 . . . . 0.0 109.587 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG22 HG12 ' A' ' 99' ' ' VAL . 3.0 mt -116.13 126.75 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -171.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 90' ' ' ILE . 35.4 tp -96.74 117.68 31.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.445 0.298 . . . . 0.0 110.954 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.0 t -100.08 121.44 41.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.691 0.796 . . . . 0.0 110.257 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 89' ' ' ASP . 23.1 mt -101.56 118.98 38.05 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.561 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 125.448 1.717 . . . . 0.0 112.297 172.092 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -55.08 -32.48 61.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.978 1.711 . . . . 0.0 112.552 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -76.4 -54.98 5.97 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.095 0.558 . . . . 0.0 111.04 -173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.85 39.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 0.0 111.935 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB2' HD23 ' A' ' 70' ' ' LEU . 30.0 p -63.86 -34.8 78.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.323 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.3 t80 -68.33 -50.43 53.41 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.414 0.446 . . . . 0.0 110.398 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 99.3 mt -65.41 -37.38 86.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.688 0.617 . . . . 0.0 110.366 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.29 65.1 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.79 0.436 . . . . 0.0 111.592 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 76' ' ' VAL . 41.8 t -66.36 -13.35 60.48 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.992 0.917 . . . . 0.0 110.933 172.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 31.8 mt -90.75 6.92 42.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.541 0.737 . . . . 0.0 111.18 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.49 23.44 58.42 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -100.14 147.56 25.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.66 0.784 . . . . 0.0 110.603 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 41.7 mt-10 -86.79 88.27 7.64 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 37.4 t -94.79 106.6 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.07 0.462 . . . . 0.0 111.336 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.489 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.6 p -86.99 103.47 15.38 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . . . -106.06 132.17 52.46 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.967 0.907 . . . . 0.0 111.219 -169.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.1 t -116.54 120.02 63.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.05 147.3 43.95 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.06 -27.43 67.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.571 0.749 . . . . 0.0 112.35 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.589 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.7 m -106.79 125.43 50.99 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.057 0.543 . . . . 0.0 110.325 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 m -70.78 -23.72 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.633 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' SER . 29.3 m -63.0 -32.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.545 0.738 . . . . 0.0 111.63 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.14 -47.65 29.45 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.95 -51.38 59.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.902 0.881 . . . . 0.0 111.764 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.07 -44.93 75.26 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.178 0.991 . . . . 0.0 113.371 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -72.42 -27.12 62.14 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.006 0.191 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.15 95.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.611 0.365 . . . . 0.0 110.129 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.2 mtpm? -69.24 -36.24 76.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.303 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.58 -46.49 86.81 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 16.6 tp -70.21 -22.01 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 123.468 0.48 . . . . 0.0 110.895 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -59.35 -59.71 5.03 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.25 -37.23 86.73 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.831 0.348 . . . . 0.0 111.394 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 70' ' ' LEU . 44.9 tt0 -60.26 -35.49 75.62 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.739 1.216 . . . . 0.0 111.808 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.26 -20.31 14.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.816 0.447 . . . . 0.0 112.152 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.94 49.23 7.16 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 122.116 -0.365 . . . . 0.0 113.305 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.9 m -123.77 -179.29 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 125.342 1.457 . . . . 0.0 108.515 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.82 137.64 53.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.7 0.4 . . . . 0.0 111.831 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 71' ' ' ALA . 11.6 mm -112.92 169.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 55' ' ' THR . 58.8 m -139.77 105.15 5.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 163.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -93.91 130.97 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.544 0.687 . . . . 0.0 111.407 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 57' ' ' VAL . 41.8 t -116.12 143.29 26.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.682 1.593 . . . . 0.0 107.503 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -79.95 141.4 36.05 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 p -58.49 101.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.03 0.831 . . . . 0.0 111.188 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -141.18 92.8 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 80.8 mt -97.68 -21.7 16.87 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.63 0.372 . . . . 0.0 111.775 -170.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.31 -3.46 57.5 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.299 0.639 . . . . 0.0 111.756 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -125.32 -15.87 6.08 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.577 0.751 . . . . 0.0 111.632 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 60.4 t80 -165.15 147.91 8.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.915 1.286 . . . . 0.0 108.211 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.461 ' O ' HD21 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -140.23 -72.71 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.604 1.093 . . . . 0.0 109.054 173.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 117' ' ' VAL . 10.8 pt -145.72 129.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.58 0.752 . . . . 0.0 111.163 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 94' ' ' ALA . 25.4 t -135.1 94.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.523 0.729 . . . . 0.0 109.07 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.75 -3.05 10.83 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.539 0.736 . . . . 0.0 112.361 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.54 -41.8 17.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.266 0.627 . . . . 0.0 110.452 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -73.02 -34.29 66.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.085 0.554 . . . . 0.0 111.71 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' NE1' HD22 ' A' ' 34' ' ' LEU . 31.8 m95 -107.53 172.63 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.42 -57.67 2.87 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -116.82 168.38 12.77 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.501 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 90' ' ' ILE . 92.1 mt -134.92 131.16 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.562 0.745 . . . . 0.0 108.996 172.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -116.05 104.95 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -101.78 96.29 6.97 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 128' ' ' ILE . 34.4 mm -75.44 149.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.015 0.926 . . . . 0.0 110.277 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -17.66 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.092 2.157 . . . . 0.0 113.31 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 50.7 t -95.58 127.1 41.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.287 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -128.95 98.73 5.04 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 109' ' ' LEU . 97.1 mt -124.77 138.95 32.26 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.235 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.64 160.61 20.24 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.721 2.281 . . . . 0.0 111.724 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 38.1 m -53.05 -21.91 5.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.36 1.064 . . . . 0.0 113.812 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -63.29 -59.08 5.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.308 0.643 . . . . 0.0 111.432 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.498 ' HB3' HD13 ' A' ' 105' ' ' LEU . 29.5 mt -80.29 -21.13 42.95 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.532 0.333 . . . . 0.0 110.597 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 15.8 ttm180 -69.44 -55.77 9.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.467 0.707 . . . . 0.0 110.147 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -52.66 -28.7 22.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.467 1.107 . . . . 0.0 111.965 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -78.16 -47.61 17.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.9 tp -75.41 -56.75 4.4 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.12 -165.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.448 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 82.9 m-85 -67.87 -38.21 13.84 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 42.8 Cg_endo -66.45 -24.07 49.9 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 121.7 1.6 . . . . 0.0 112.321 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -84.64 -15.85 44.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 0.0 109.828 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.572 ' HA ' HD11 ' A' ' 90' ' ' ILE . 29.9 t -78.07 -36.84 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.335 0.588 . . . . 0.0 109.463 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -58.16 -58.1 9.94 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.645 170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -64.63 -37.52 87.86 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.52 -50.05 3.27 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.991 0.357 . . . . 0.0 113.991 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.519 HD13 HD12 ' A' ' 98' ' ' ILE . 55.4 tp -101.54 99.0 9.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.636 1.174 . . . . 0.0 110.753 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.44 172.74 8.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 163.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' A' ' 195' ' ' LEU . 39.8 Cg_exo -38.71 130.92 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.276 1.984 . . . . 0.0 110.808 158.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 131.72 -24.19 4.13 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -158.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -133.64 166.93 23.75 Favored Glycine 0 N--CA 1.467 0.701 0 O-C-N 121.953 -0.733 . . . . 0.0 113.691 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 18.3 m -108.13 135.57 46.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.599 1.16 . . . . 0.0 109.584 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.15 117.21 31.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 24' ' ' VAL . 24.1 mt -112.3 107.93 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.199 1.0 . . . . 0.0 109.439 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 156' ' ' LEU . 84.6 mt -126.64 139.41 53.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.353 0.661 . . . . 0.0 110.985 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -127.0 101.97 6.78 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.92 173.4 43.19 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.455 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -132.61 170.77 14.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.407 1.083 . . . . 0.0 108.748 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.003 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.8 mt . . . . . 0 CA--C 1.551 0.995 0 N-CA-C 111.125 0.046 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.98 115.9 42.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 156' ' ' LEU . 72.0 Cg_endo -91.15 108.59 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.544 2.163 . . . . 0.0 109.55 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 10.6 mtmp? -96.37 161.39 13.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.712 0.405 . . . . 0.0 111.76 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 188' ' ' ILE . 59.9 mt -56.45 -34.57 66.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.199 1.0 . . . . 0.0 112.551 -170.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.03 -48.72 77.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.243 1.017 . . . . 0.0 109.542 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.1 m -66.02 -49.71 66.78 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.335 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 129' ' ' LEU . 68.3 mt -77.64 -50.74 11.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.917 0.887 . . . . 0.0 112.616 -165.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.5 -36.14 79.66 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.759 0.424 . . . . 0.0 111.033 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.0 t -74.24 -26.98 60.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.908 0.483 . . . . 0.0 111.47 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 10.2 tp10 -76.82 -21.83 54.5 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.305 0.642 . . . . 0.0 110.392 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.58 69.26 72.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.006 0.922 . . . . 0.0 109.11 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.65 0.36 9.42 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.37 2.713 . . . . 0.0 112.389 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.4 t -92.28 -41.91 10.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.8 tp -83.9 72.03 10.44 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.071 1.748 . . . . 0.0 109.745 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 195' ' ' LEU . 27.6 t-20 -57.11 124.34 18.4 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.78 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.551 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 25.5 m95 -89.11 130.46 35.55 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.284 1.434 . . . . 0.0 109.985 -169.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.09 -37.82 75.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.122 0.569 . . . . 0.0 110.313 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.93 121.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.84 76.51 1.0 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -145.78 153.12 40.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -91.33 122.18 33.72 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.821 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.0 mt -102.81 131.58 49.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 122.684 0.394 . . . . 0.0 110.606 179.774 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.88 133.69 53.92 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 153' ' ' LEU . 36.7 pt -123.8 118.78 55.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 118.766 0.712 . . . . 0.0 109.554 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.39 141.42 34.29 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.16 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 153' ' ' LEU . 46.9 mt -129.37 139.78 51.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.657 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.548 HD22 HG12 ' A' ' 24' ' ' VAL . 42.6 tp -145.41 106.17 4.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 168.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.64 146.2 21.41 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -130.0 152.0 49.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.104 0.952 . . . . 0.0 112.236 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.74 112.4 3.69 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.682 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.528 ' H ' ' HB3' ' A' ' 123' ' ' PRO . 3.4 mt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.0 t80 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.998 0.428 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 47' ' ' LEU . 25.3 tp -60.47 -18.05 48.96 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.203 1.001 . . . . 0.0 113.147 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -76.7 -34.86 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.699 0.681 . . . . 0.0 110.589 -168.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p -69.74 -47.94 61.2 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.9 0.88 . . . . 0.0 109.799 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 191' ' ' LEU . 21.6 m -68.43 -41.07 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.31 72.2 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.634 0.773 . . . . 0.0 112.335 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -73.67 -22.21 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.123 0.569 . . . . 0.0 110.497 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -90.21 -18.92 24.83 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.354 0.662 . . . . 0.0 110.379 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 24' ' ' VAL . 70.1 mt -72.3 129.04 88.04 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.118 0.567 . . . . 0.0 110.097 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.83 153.05 69.06 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.564 2.176 . . . . 0.0 112.41 172.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 51.4 tt0 -68.46 31.1 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.058 1.743 . . . . 0.0 114.654 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -118.64 -156.97 10.31 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.084 -1.01 . . . . 0.0 112.794 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -87.88 121.47 30.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.562 0.745 . . . . 0.0 109.045 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 54' ' ' VAL . 4.3 mt -111.77 148.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.649 0.78 . . . . 0.0 109.592 -168.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD22 ' NE1' ' A' ' 95' ' ' TRP . 49.4 tp -106.92 117.28 33.63 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.163 0.438 . . . . 0.0 110.198 171.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 51.1 t -102.98 114.75 29.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.983 0.913 . . . . 0.0 110.072 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.2 mt -81.29 141.29 34.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 123.614 0.766 . . . . 0.0 110.448 177.985 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -69.66 -31.48 69.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.122 0.569 . . . . 0.0 110.061 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.33 -41.95 98.98 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.522 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.66 87.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.758 0.823 . . . . 0.0 111.454 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.86 -34.94 75.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.678 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.57 -32.74 66.27 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.285 0.365 . . . . 0.0 110.484 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 99' ' ' VAL . 74.3 mt -67.02 -31.6 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.54 72.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.196 0.598 . . . . 0.0 111.253 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.591 ' HA ' HG11 ' A' ' 76' ' ' VAL . 20.1 m -71.99 -4.39 28.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.711 0.804 . . . . 0.0 112.491 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.28 12.49 15.91 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.332 0.653 . . . . 0.0 110.218 168.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.85 56.27 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 114.163 0.425 . . . . 0.0 114.163 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 11.8 m-85 -114.1 152.24 31.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.79 91.81 8.78 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 33' ' ' ILE . 92.4 t -91.16 111.94 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.254 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 40.4 p -84.22 106.64 16.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 108.314 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.9 129.43 46.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.126 0.571 . . . . 0.0 109.935 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG22 ' HB ' ' A' ' 81' ' ' VAL . 8.4 t -111.39 120.21 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' H ' HD21 ' A' ' 64' ' ' LEU . 41.8 t0 -129.7 137.42 50.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 75.8 mt-30 -60.41 -25.84 66.23 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.626 1.204 . . . . 0.0 112.238 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.6 m -97.95 116.18 29.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.465 ' HA ' HD12 ' A' ' 64' ' ' LEU . 60.5 p -66.29 -30.69 71.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.607 0.718 . . . . 0.0 109.954 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 60' ' ' SER . 26.7 m -61.76 -35.95 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.674 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.95 -32.86 60.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.587 0.554 . . . . 0.0 112.062 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 61' ' ' SER . 86.5 mt -62.58 -43.57 98.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.792 0.837 . . . . 0.0 110.742 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.28 94.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.256 0.623 . . . . 0.0 111.708 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -70.19 -30.99 68.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.127 0.571 . . . . 0.0 111.166 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 -44.52 90.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.562 0.745 . . . . 0.0 111.036 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.35 -35.18 68.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.684 0.794 . . . . 0.0 110.995 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.08 -47.63 84.55 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.603 0.761 . . . . 0.0 110.246 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.38 -28.46 67.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.826 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.99 -61.52 2.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.276 0.63 . . . . 0.0 111.075 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.66 -29.01 70.0 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.116 0.566 . . . . 0.0 111.005 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -65.1 -43.62 91.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.149 0.58 . . . . 0.0 110.143 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -93.64 -2.73 53.64 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.07 34.48 55.38 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.7 -0.227 . . . . 0.0 113.232 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.5 m -127.45 175.34 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.122 0.969 . . . . 0.0 110.09 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.56 131.66 56.01 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.011 0.924 . . . . 0.0 111.103 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.826 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.8 mm -110.75 164.39 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 161.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 88.8 m -131.88 104.59 6.95 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 p -86.87 121.6 29.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.859 0.463 . . . . 0.0 110.273 -168.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 57' ' ' VAL . 59.6 t -108.62 136.98 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 108.427 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -79.76 128.6 33.62 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 59' ' ' GLN . 80.4 p -59.63 120.21 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.871 0.732 . . . . 0.0 112.326 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.31 85.16 1.95 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 161.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.577 ' HB2' HD22 ' A' ' 109' ' ' LEU . 74.4 mt -84.87 -24.86 28.35 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.233 0.613 . . . . 0.0 110.608 -168.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 -7.67 32.26 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.062 0.945 . . . . 0.0 111.864 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -132.64 -23.43 2.06 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.564 0.746 . . . . 0.0 111.819 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 81' ' ' VAL . 38.4 t80 -162.32 116.88 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.286 1.034 . . . . 0.0 109.666 -171.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -125.36 -60.11 1.35 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' HB ' HD13 ' A' ' 98' ' ' ILE . 34.4 pt -139.99 131.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 118.803 0.729 . . . . 0.0 111.757 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.91 89.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.225 1.01 . . . . 0.0 109.648 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.639 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -70.73 1.01 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.22 -44.27 68.94 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.63 -32.94 64.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.709 0.803 . . . . 0.0 112.566 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.494 ' NE1' HD22 ' A' ' 34' ' ' LEU . 12.7 m95 -109.05 162.69 14.0 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.054 0.542 . . . . 0.0 110.091 -170.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 12.3 tp10 -76.21 -56.86 4.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.35 171.97 17.33 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 90' ' ' ILE . 74.3 mt -135.89 127.59 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 47' ' ' LEU . 7.8 p -114.55 125.11 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -124.39 93.37 3.89 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.547 HD13 HD12 ' A' ' 128' ' ' ILE . 35.5 mm -65.34 138.79 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -18.47 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.012 1.725 . . . . 0.0 114.098 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 t -78.44 111.01 14.03 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.849 -171.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -107.81 98.14 7.77 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.42 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 71.3 mt -124.97 140.47 35.92 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.9 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 160.62 45.97 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.921 2.414 . . . . 0.0 110.871 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 m -43.36 -42.41 4.59 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.844 1.258 . . . . 0.0 113.778 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -53.57 -55.42 25.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.143 0.977 . . . . 0.0 112.226 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 85' ' ' LEU . 98.8 mt -83.18 -24.89 32.26 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.214 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -77.54 -52.57 8.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.054 0.942 . . . . 0.0 109.841 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.07 -22.42 66.85 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 0.0 112.277 170.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -75.76 -35.26 60.22 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.41 0.684 . . . . 0.0 109.611 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.4 tp -65.78 -52.17 53.07 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.592 0.757 . . . . 0.0 111.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -58.44 -44.15 98.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -166.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.28 -31.59 81.95 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.713 1.609 . . . . 0.0 112.003 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -81.94 -15.11 54.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.2 0.6 . . . . 0.0 110.91 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 12.0 t -84.0 -42.87 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -59.26 -59.68 5.08 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.08 -48.33 44.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.821 0.849 . . . . 0.0 113.095 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.58 -35.23 17.33 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -165.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.8 tp -77.99 95.18 4.76 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.89 0.845 . . . . 0.0 110.351 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.639 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -75.04 150.74 85.91 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.986 168.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -42.74 117.72 0.97 Allowed 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 124.667 3.578 . . . . 0.0 115.341 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.47 12.46 3.77 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.137 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.68 137.75 13.79 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.3 m -105.85 129.55 58.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.73 0.812 . . . . 0.0 110.458 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.65 112.94 25.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 101' ' ' ILE . 46.6 mt -105.26 109.26 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.59 HD13 HD13 ' A' ' 156' ' ' LEU . 55.7 mt -123.59 134.38 53.82 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -117.57 102.33 9.08 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.532 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -72.37 140.54 29.7 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.914 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 150' ' ' LEU . 69.5 m-85 -111.23 164.02 13.32 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.122 0.487 . . . . 0.0 111.297 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.006 -178.829 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 132' ' ' PHE . 62.5 mt -81.73 112.9 38.42 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 167.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.678 ' HB3' HD11 ' A' ' 156' ' ' LEU . 17.0 Cg_exo -69.35 137.73 37.35 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.292 2.661 . . . . 0.0 113.416 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.519 ' HA ' HD11 ' A' ' 188' ' ' ILE . 44.7 mmtm -118.4 148.36 42.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.514 0.726 . . . . 0.0 112.234 171.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 190' ' ' LEU . 39.9 mt -60.92 -42.33 97.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.295 1.038 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -51.78 -45.12 63.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.085 0.865 . . . . 0.0 111.256 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.9 m -77.79 -46.29 22.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.871 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.678 HD11 ' HB3' ' A' ' 151' ' ' PRO . 89.4 mt -76.5 -46.29 27.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.833 0.853 . . . . 0.0 113.28 -170.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.536 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 62.2 tt0 -54.47 -46.0 73.29 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 110.688 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 t -73.03 -22.89 60.56 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.928 0.491 . . . . 0.0 111.769 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -73.51 -30.97 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.42 0.688 . . . . 0.0 110.84 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.1 mt -131.61 75.76 76.04 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.69 -11.74 24.17 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.08 2.52 . . . . 0.0 111.549 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -87.51 -39.44 15.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.937 1.295 . . . . 0.0 108.69 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 21.3 tp -91.52 72.95 5.99 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.075 1.35 . . . . 0.0 110.064 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.23 132.93 55.23 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.536 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 23.4 m95 -94.82 132.33 39.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.509 0.724 . . . . 0.0 109.283 -168.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.84 -30.78 71.05 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.282 0.633 . . . . 0.0 110.337 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.08 127.92 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -146.15 63.42 1.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -108.6 139.17 43.75 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.797 -164.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -96.46 105.91 18.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.078 0.951 . . . . 0.0 109.498 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 47.0 mt -97.18 119.34 35.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.555 0.742 . . . . 0.0 110.902 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 168.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.389 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 73.0 mt -117.65 166.11 12.79 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 152' ' ' LYS . 10.2 pt -149.28 149.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.029 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -129.7 150.53 50.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 111.117 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 153' ' ' LEU . 61.6 mt -130.85 135.2 47.5 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.269 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 24' ' ' VAL . 34.4 tp -129.79 104.68 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 167.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -89.21 128.62 9.26 Favored Glycine 0 C--O 1.208 -1.48 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -142.38 156.19 45.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.747 0.819 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -59.71 127.43 31.93 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.428 0.455 . . . . 0.0 109.978 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 118.751 -0.643 . . . . 0.0 110.031 -171.714 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.9 t80 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HA ' HG22 ' A' ' 24' ' ' VAL . 56.0 tp -74.17 -41.7 61.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.346 0.659 . . . . 0.0 111.413 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -45.76 -41.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 p -80.5 -51.22 9.05 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.073 0.549 . . . . 0.0 111.091 -174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 128' ' ' ILE . 16.7 m -59.52 -35.53 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.933 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -59.17 -39.53 82.79 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 124.476 1.11 . . . . 0.0 111.734 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.21 -27.95 69.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.636 0.775 . . . . 0.0 110.719 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 87.7 mm-40 -90.17 -7.66 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.691 0.796 . . . . 0.0 112.634 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' VAL . 68.0 mt -87.41 136.26 33.52 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.895 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.01 134.68 43.21 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.778 2.985 . . . . 0.0 113.752 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -77.61 27.89 0.16 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.99 -134.67 5.52 Favored Glycine 0 N--CA 1.475 1.258 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.874 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.98 112.35 18.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.202 0.501 . . . . 0.0 109.734 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG22 HG12 ' A' ' 99' ' ' VAL . 18.6 mt -115.04 129.46 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -170.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 89' ' ' ASP . 66.1 tp -94.37 114.44 26.49 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.716 0.406 . . . . 0.0 110.836 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 36.2 t -94.35 140.13 30.19 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -90.91 173.71 7.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.777 0.322 . . . . 0.0 111.554 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.653 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.641 0 CA-C-O 120.8 0.111 . . . . 0.0 112.875 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -70.65 -35.7 73.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.98 1.312 . . . . 0.0 111.68 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -64.28 -50.18 68.92 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.597 0.56 . . . . 0.0 110.824 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.75 -50.04 69.38 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.208 0.942 . . . . 0.0 111.508 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.717 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 73.5 m -55.93 -49.02 74.64 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.09 0.956 . . . . 0.0 113.513 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 41.4 t80 -58.16 -43.17 87.25 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.703 0.627 . . . . 0.0 111.011 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.444 HD13 HG11 ' A' ' 99' ' ' VAL . 60.9 mt -67.92 -32.61 73.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.778 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.06 -33.6 65.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.92 0.488 . . . . 0.0 111.448 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.592 ' HA ' HG11 ' A' ' 76' ' ' VAL . 19.3 m -65.47 -15.3 62.51 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.06 0.944 . . . . 0.0 111.738 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.1 mt -82.7 3.11 30.44 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.553 0.741 . . . . 0.0 110.831 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.92 16.81 62.55 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-O 119.798 -0.446 . . . . 0.0 113.928 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -103.09 155.11 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.695 0.748 . . . . 0.0 110.881 -173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.1 87.69 6.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.533 0.733 . . . . 0.0 109.207 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.88 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HA ' ' A' ' 34' ' ' LEU . 3.3 t -86.01 106.74 17.39 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.928 0.891 . . . . 0.0 109.287 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.56 131.32 53.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.469 0.708 . . . . 0.0 110.438 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -95.46 146.68 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 29.9 t0 -150.14 135.34 17.95 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -73.11 -11.1 60.42 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.825 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.3 t -113.65 164.48 13.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.033 0.933 . . . . 0.0 109.268 169.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -78.2 -26.57 47.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.991 0.516 . . . . 0.0 112.187 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.8 m -56.87 -43.95 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.83 -34.71 62.22 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.203 0.314 . . . . 0.0 112.474 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 94.3 mt -67.86 -59.46 3.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.702 0.801 . . . . 0.0 111.322 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.46 73.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.109 0.964 . . . . 0.0 112.934 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.24 -45.58 92.68 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.839 0.855 . . . . 0.0 110.416 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.717 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -64.11 -46.51 83.89 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.92 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -71.76 -35.22 70.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.231 1.012 . . . . 0.0 111.02 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.43 -61.23 2.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.397 0.679 . . . . 0.0 111.152 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.37 -22.6 66.25 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.567 0.542 . . . . 0.0 111.17 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.6 -63.63 1.05 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.984 174.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.93 -30.59 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.04 0.536 . . . . 0.0 110.824 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.39 -31.51 71.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.255 1.022 . . . . 0.0 111.474 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -102.25 1.69 36.15 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.116 0.566 . . . . 0.0 111.417 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.48 67.76 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 122.355 -0.216 . . . . 0.0 113.233 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.7 m -124.08 -179.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 108.182 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.78 131.92 36.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.749 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.7 mm -106.96 166.88 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 166.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -129.42 105.75 8.31 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.3 p -85.69 119.83 26.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.092 0.557 . . . . 0.0 110.924 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.9 124.18 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.044 1.337 . . . . 0.0 109.264 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -100.24 91.7 4.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -142.57 -177.6 5.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.237 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -146.33 136.91 24.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -162.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 14.2 mt -76.19 -8.46 57.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 123.543 0.527 . . . . 0.0 112.389 -166.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -94.77 -0.32 54.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.834 0.454 . . . . 0.0 112.144 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -123.42 -44.17 2.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.824 0.449 . . . . 0.0 110.685 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -169.46 124.52 0.83 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.514 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -134.96 -72.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.059 0.944 . . . . 0.0 109.308 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' HB ' HD13 ' A' ' 98' ' ' ILE . 10.7 pt -129.55 122.74 56.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 C-N-CA 123.199 0.599 . . . . 0.0 111.616 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.92 94.64 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.698 1.199 . . . . 0.0 108.816 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.25 -0.52 2.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -73.49 -48.05 36.45 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.883 0.473 . . . . 0.0 110.291 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.05 61.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.11 0.564 . . . . 0.0 112.259 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.498 ' CD1' HD22 ' A' ' 34' ' ' LEU . 13.7 m95 -113.17 139.08 49.06 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.009 0.524 . . . . 0.0 109.847 -170.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.97 -40.12 79.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.33 174.65 29.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.025 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.546 HD13 ' HB ' ' A' ' 90' ' ' ILE . 64.3 mt -132.12 140.56 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 6.2 p -124.84 108.48 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.749 0.82 . . . . 0.0 109.1 167.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.493 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 42.7 m -108.89 89.49 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.59 149.83 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.943 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -17.66 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 127.394 2.278 . . . . 0.0 112.61 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.8 p -99.78 104.78 16.5 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.848 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -96.57 98.07 9.91 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.61 147.83 40.61 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.916 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 149' ' ' LEU . 46.8 Cg_exo -59.05 149.28 80.78 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.282 1.988 . . . . 0.0 110.099 160.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 11.7 t -57.78 -22.72 48.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.421 0.688 . . . . 0.0 112.187 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t -52.87 -55.82 20.39 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.566 0.746 . . . . 0.0 111.363 168.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.9 mt -81.0 -27.47 35.87 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.472 0.709 . . . . 0.0 110.824 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 151' ' ' PRO . 11.3 ttp180 -68.48 -56.27 8.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.966 0.906 . . . . 0.0 110.334 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -37.52 63.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.45 1.1 . . . . 0.0 111.328 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 6.2 tp-100 -70.38 -31.9 69.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.107 0.563 . . . . 0.0 110.22 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 117' ' ' VAL . 45.6 tp -76.46 -33.84 58.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.945 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -55.1 -47.33 98.77 Favored Pre-proline 0 CA--C 1.569 1.695 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.79 -29.67 90.5 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.247 1.965 . . . . 0.0 112.672 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -75.26 -31.73 60.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.735 0.814 . . . . 0.0 111.142 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 1.6 t -88.37 -27.23 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.363 0.601 . . . . 0.0 110.735 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.61 -64.61 1.15 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.29 -49.76 10.35 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.69 -33.58 63.36 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 113.711 0.245 . . . . 0.0 113.711 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.5 tp -78.69 131.22 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.297 0.57 . . . . 0.0 109.791 171.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -114.82 161.71 27.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.797 1.239 . . . . 0.0 107.988 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -36.4 114.72 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 124.305 3.337 . . . . 0.0 115.529 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.52 -0.85 5.97 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.678 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -100.3 148.62 18.45 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 166.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.92 131.7 65.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 C-N-CA 124.493 1.117 . . . . 0.0 109.103 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.7 t80 -109.33 109.13 19.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.569 HD13 HG21 ' A' ' 24' ' ' VAL . 43.8 mt -111.34 108.07 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.298 1.039 . . . . 0.0 108.608 -170.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 95.1 mt -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.774 0.83 . . . . 0.0 111.144 -172.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.4 101.78 4.93 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.8 118.39 6.06 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 187' ' ' LEU . 27.1 m-85 -78.83 169.4 18.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.415 1.086 . . . . 0.0 109.873 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.584 . . . . 0.0 111.537 -175.625 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 106' ' ' PRO . 13.9 mt . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 132' ' ' PHE . 95.7 mt -74.99 113.25 22.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 123.351 0.407 . . . . 0.0 110.481 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.65 ' HB3' HH11 ' A' ' 110' ' ' ARG . 93.4 Cg_endo -87.01 129.55 2.9 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.258 1.972 . . . . 0.0 111.405 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -81.36 164.37 22.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.718 0.807 . . . . 0.0 111.54 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 188' ' ' ILE . 81.1 mt -60.62 -41.47 94.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.155 0.582 . . . . 0.0 110.478 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.51 -39.49 67.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.398 0.679 . . . . 0.0 111.471 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.4 p -81.48 -53.6 6.14 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.486 0.314 . . . . 0.0 110.732 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -61.63 -50.59 71.92 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.576 1.15 . . . . 0.0 111.93 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -65.48 -30.81 71.63 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.787 0.835 . . . . 0.0 111.702 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.6 t -73.19 -29.43 62.82 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 122.812 0.445 . . . . 0.0 111.08 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 -10.66 58.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.087 0.555 . . . . 0.0 111.021 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 96.5 mt -141.34 71.03 27.06 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.459 0.704 . . . . 0.0 109.559 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.59 7.38 4.69 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.065 2.51 . . . . 0.0 111.298 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.0 t -90.71 -41.17 11.44 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.4 tp -91.82 71.18 5.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.024 1.33 . . . . 0.0 110.626 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB3' HD22 ' A' ' 195' ' ' LEU . 63.5 t30 -59.89 129.77 43.47 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 28.9 m95 -95.54 141.37 29.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.014 0.926 . . . . 0.0 110.765 -164.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.15 -36.81 72.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.172 0.589 . . . . 0.0 110.345 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 68.1 mt -126.88 125.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.24 84.26 1.13 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.664 0.785 . . . . 0.0 109.916 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -155.92 155.59 33.11 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.485 0.314 . . . . 0.0 111.475 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.08 110.98 13.52 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.55 130.37 47.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.275 0.63 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 132' ' ' PHE . 56.4 mt -116.71 163.86 15.49 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 153' ' ' LEU . 44.4 pt -135.93 139.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -132.69 151.28 52.01 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.976 0.893 . . . . 0.0 111.365 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 165' ' ' TRP . 64.5 mt -136.29 138.26 41.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 113.329 -1.76 . . . . 0.0 108.791 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.514 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -129.71 107.52 9.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 168.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.03 139.84 17.26 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 8.3 tp-100 -140.32 153.02 46.3 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.438 0.695 . . . . 0.0 109.693 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.543 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 18.1 pttp -58.17 128.43 37.09 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.806 0.691 . . . . 0.0 109.254 170.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 164' ' ' ASN . 4.5 mt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 24' ' ' VAL . 43.4 t80 . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 24' ' ' VAL . 37.4 tp -62.22 -47.51 84.11 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.806 0.842 . . . . 0.0 112.065 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.81 -33.67 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -70.39 -50.95 33.42 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.621 0.768 . . . . 0.0 110.903 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 128' ' ' ILE . 2.7 m -64.46 -30.13 49.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.558 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -59.49 -38.17 80.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.625 1.17 . . . . 0.0 111.243 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -70.13 -29.07 65.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.383 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -87.93 -7.23 57.43 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.632 0.773 . . . . 0.0 112.41 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 24' ' ' VAL . 89.9 mt -82.51 123.45 78.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -52.34 133.49 48.32 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.175 2.583 . . . . 0.0 113.131 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.1 31.0 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 126.928 2.091 . . . . 0.0 116.138 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.4 -154.34 10.95 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.663 -0.52 . . . . 0.0 112.483 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.09 120.65 19.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.128 0.571 . . . . 0.0 110.572 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 mt -109.07 135.88 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 0.0 110.07 -167.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 55' ' ' THR . 67.9 tp -110.4 118.26 35.8 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.002 0.521 . . . . 0.0 109.714 171.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 42.3 t -96.58 130.86 43.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.227 1.011 . . . . 0.0 109.462 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -95.1 117.56 30.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 164.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.55 0.691 . . . . 0.0 111.012 -169.727 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 113.341 0.096 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -60.6 -34.37 74.11 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.679 0.752 . . . . 0.0 109.903 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.0 p30 -56.15 -48.08 76.97 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.163 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.3 93.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.748 0.819 . . . . 0.0 111.324 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 14.4 m -61.79 -42.27 98.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.668 0.787 . . . . 0.0 112.465 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -64.61 -44.74 89.6 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.791 0.682 . . . . 0.0 109.876 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 43' ' ' ASN . 81.2 mt -67.51 -32.7 73.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 -34.39 67.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.174 0.59 . . . . 0.0 111.59 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.749 ' HA ' HG11 ' A' ' 76' ' ' VAL . 28.4 t -68.71 -9.93 53.39 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.831 0.852 . . . . 0.0 111.7 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 25' ' ' ALA . 85.4 mt -78.54 6.73 7.99 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.329 0.652 . . . . 0.0 111.105 170.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.52 27.69 26.6 Favored Glycine 0 C--N 1.359 1.808 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.962 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -130.52 163.05 27.9 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.492 0.646 . . . . 0.0 111.016 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.97 93.06 6.39 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.61 112.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.7 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 34' ' ' LEU . 57.6 m -86.09 108.84 18.46 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.053 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.4 130.14 47.55 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.957 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.6 116.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' H ' HD21 ' A' ' 64' ' ' LEU . 14.0 t0 -123.17 124.87 44.01 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.08 -25.71 46.58 Favored 'General case' 0 CA--C 1.562 1.41 0 O-C-N 124.593 1.183 . . . . 0.0 111.678 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -112.31 121.64 45.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.404 1.082 . . . . 0.0 108.786 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' HD12 ' A' ' 64' ' ' LEU . 34.8 p -69.03 -15.28 63.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 112.406 -173.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.5 m -56.48 -44.25 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.434 0.459 . . . . 0.0 110.82 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.86 -30.08 66.36 Favored Glycine 0 C--N 1.358 1.792 0 O-C-N 123.654 0.596 . . . . 0.0 113.036 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 91.1 mt -64.85 -45.96 83.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.749 0.82 . . . . 0.0 110.695 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -62.6 -39.42 93.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.593 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 73.4 mmtt -64.98 -43.44 92.59 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.715 0.406 . . . . 0.0 109.914 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.571 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -57.62 -40.68 79.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.6 -36.42 73.52 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.68 0.792 . . . . 0.0 111.488 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 77.3 mt-30 -57.6 -58.27 9.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.594 0.757 . . . . 0.0 111.718 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 38.2 tp -67.41 -24.94 65.71 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.213 -176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.35 7.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.481 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.39 -27.82 68.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.832 0.453 . . . . 0.0 111.108 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.35 -44.42 92.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.279 1.032 . . . . 0.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 6.19 46.48 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.659 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.52 39.28 50.35 Favored Glycine 0 C--N 1.356 1.65 0 N-CA-C 113.936 0.334 . . . . 0.0 113.936 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.7 m -136.31 175.45 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.117 0.967 . . . . 0.0 109.524 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -129.52 142.67 50.71 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.025 0.44 . . . . 0.0 112.131 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 45' ' ' CYS . 17.7 mm -105.53 169.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.13 1.372 . . . . 0.0 107.43 170.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 m -121.47 105.87 10.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 164.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' LEU . 70.0 p -93.05 111.16 22.7 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 110.655 -165.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.64 124.81 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.6 1.16 . . . . 0.0 110.082 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -100.51 95.28 6.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -144.34 -174.66 4.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.848 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -144.87 127.52 16.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -158.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 105' ' ' LEU . 26.5 mt -68.81 -6.06 24.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.151 0.58 . . . . 0.0 112.542 -172.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -96.9 9.98 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.267 1.027 . . . . 0.0 112.6 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.9 -46.44 0.27 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.207 0.603 . . . . 0.0 110.379 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -155.37 122.87 5.59 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.983 1.713 . . . . 0.0 106.594 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 1.9 p-10 -135.39 -71.8 0.47 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 117' ' ' VAL . 14.5 pt -143.25 123.01 9.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.497 0.719 . . . . 0.0 109.904 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.92 84.91 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.18 -5.97 15.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.91 -39.27 93.79 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.562 0.745 . . . . 0.0 109.111 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.99 -20.46 24.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.029 0.932 . . . . 0.0 111.9 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD22 ' A' ' 34' ' ' LEU . 51.9 m95 -121.7 114.08 20.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 0.0 109.946 -170.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.2 -43.83 81.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.584 0.754 . . . . 0.0 110.337 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.16 151.3 18.24 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.042 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 121' ' ' LEU . 73.1 mt -132.07 148.17 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.4 p -135.49 120.79 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.246 1.018 . . . . 0.0 108.417 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.4 m -108.69 93.23 4.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.639 HD13 HD12 ' A' ' 128' ' ' ILE . 23.3 mm -70.44 140.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.829 0.852 . . . . 0.0 109.512 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -14.0 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.03 2.132 . . . . 0.0 113.691 -171.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.77 107.1 19.46 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.25 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -105.5 101.15 10.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 85' ' ' LEU . 82.4 mt -121.35 138.8 28.63 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.47 163.53 35.92 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.158 2.572 . . . . 0.0 110.717 171.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -35.98 -43.46 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 126.105 1.762 . . . . 0.0 114.875 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 p -57.0 -56.49 21.1 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.641 0.776 . . . . 0.0 110.957 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 94.1 mt -84.39 -22.85 30.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.768 0.827 . . . . 0.0 110.555 -172.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -73.51 -61.26 1.89 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.956 0.903 . . . . 0.0 109.656 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.82 -9.62 15.82 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.226 0.611 . . . . 0.0 112.159 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 24.6 tp60 -87.43 -37.77 16.71 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.673 0.389 . . . . 0.0 110.748 170.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 117' ' ' VAL . 62.7 tp -85.56 -61.27 1.8 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 77.6 m-85 -68.48 -39.57 16.09 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -160.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 45.9 Cg_endo -66.35 -23.96 50.78 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 121.908 1.738 . . . . 0.0 111.894 170.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -83.12 -19.74 36.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.955 0.902 . . . . 0.0 109.286 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 127' ' ' PHE . 39.1 t -77.0 -38.81 28.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -49.67 -57.83 6.46 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.5 -46.81 62.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.093 0.957 . . . . 0.0 113.004 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.04 -37.65 28.5 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -166.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -77.1 109.62 11.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 109.109 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -79.79 163.83 56.36 Favored Pre-proline 0 C--O 1.247 0.931 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.98 115.41 0.87 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.72 2.28 . . . . 0.0 113.542 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.571 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.6 12.87 2.92 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.943 172.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -107.91 148.91 16.71 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 117.482 0.641 . . . . 0.0 112.508 166.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.4 139.5 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.126 0.97 . . . . 0.0 109.024 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.49 121.07 41.6 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 24' ' ' VAL . 55.1 mt -110.91 109.04 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.758 0.823 . . . . 0.0 109.201 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 156' ' ' LEU . 47.5 mt -125.8 144.0 50.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.933 0.893 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -132.23 102.5 5.8 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.94 -173.37 46.58 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.566 ' HB2' HD22 ' A' ' 150' ' ' LEU . 71.5 m-85 -135.31 158.98 43.0 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 123.594 0.758 . . . . 0.0 111.648 -178.442 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.555 1.146 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 132' ' ' PHE . 48.1 mt -88.38 110.59 37.56 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.599 ' HB2' HD11 ' A' ' 156' ' ' LEU . 5.1 Cg_exo -76.41 104.28 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.581 2.187 . . . . 0.0 109.387 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 mtpt -94.93 160.24 14.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.171 0.588 . . . . 0.0 111.287 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 HD21 ' A' ' 190' ' ' LEU . 71.9 mt -53.26 -37.57 62.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.911 0.884 . . . . 0.0 110.929 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.06 -54.36 20.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.057 1.343 . . . . 0.0 111.74 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -76.24 -45.93 30.53 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.306 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 129' ' ' LEU . 82.7 mt -71.38 -49.73 39.17 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.714 0.806 . . . . 0.0 112.411 -168.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -58.75 -37.69 76.8 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 0.0 111.637 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.0 t -76.62 -17.58 59.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.294 0.238 . . . . 0.0 111.421 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.99 -5.54 55.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.644 0.378 . . . . 0.0 110.619 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 39.3 mt -145.71 59.1 5.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.488 1.115 . . . . 0.0 108.532 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.04 -26.34 21.7 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.06 2.507 . . . . 0.0 112.731 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -90.24 -14.41 33.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.485 0.714 . . . . 0.0 110.209 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 17.7 tp -89.75 69.28 7.64 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.596 1.158 . . . . 0.0 108.628 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.568 ' HB3' HD21 ' A' ' 195' ' ' LEU . 28.2 t30 -61.93 124.62 21.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -88.68 143.53 26.87 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.429 1.091 . . . . 0.0 109.594 -165.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.14 -39.07 72.18 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.172 0.589 . . . . 0.0 109.976 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 75.6 mt -129.14 119.08 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.73 86.05 1.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.747 0.819 . . . . 0.0 109.328 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -160.19 157.96 29.25 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 188' ' ' ILE . 26.0 p-10 -75.35 104.93 6.12 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 mt -102.04 135.44 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.651 0.263 . . . . 0.0 110.753 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.5 mt -126.56 174.88 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 152' ' ' LYS . 23.8 pt -139.23 139.05 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -127.22 149.94 49.76 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.783 0.802 . . . . 0.0 110.804 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 67.7 mt -133.57 136.53 45.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.395 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.478 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -137.25 108.26 6.73 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.7 147.39 22.02 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -142.55 150.88 40.99 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.551 0.74 . . . . 0.0 110.127 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 13.1 ptmm? -59.96 143.08 52.57 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 164' ' ' ASN . 9.8 mt . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.627 HD21 ' HG ' ' A' ' 47' ' ' LEU . 24.3 tp -62.78 -47.01 85.33 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.553 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -45.68 -33.78 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -68.76 -51.5 40.53 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.34 0.656 . . . . 0.0 110.135 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 128' ' ' ILE . 2.5 m -62.4 -32.9 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.466 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.75 74.53 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.519 1.128 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.58 -21.53 61.13 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.306 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.705 ' HB3' HE21 ' A' ' 193' ' ' GLN . 84.1 mm-40 -84.1 -23.4 30.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.392 0.677 . . . . 0.0 111.207 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 24' ' ' VAL . 63.2 mt -82.23 135.22 47.72 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -52.99 145.61 40.63 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.82 2.347 . . . . 0.0 112.043 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -65.5 29.81 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -115.6 -167.39 15.12 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 118.999 0.818 . . . . 0.0 111.818 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -73.36 127.7 33.4 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.852 0.358 . . . . 0.0 110.309 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.492 HG22 HG12 ' A' ' 99' ' ' VAL . 5.2 mt -113.77 135.93 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.439 -168.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.515 HD22 ' CD1' ' A' ' 95' ' ' TRP . 54.2 tp -98.76 119.99 38.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 6.8 p -110.83 118.64 36.68 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.768 0.827 . . . . 0.0 109.983 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 90' ' ' ILE . 58.2 mt -78.27 135.98 37.66 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 108.808 174.914 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 CA-C-O 120.404 -0.109 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -69.68 -42.64 73.87 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.526 0.73 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD13 ' A' ' 21' ' ' LEU . 92.5 m-20 -73.07 -32.76 65.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.203 0.601 . . . . 0.0 110.367 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -58.01 -51.8 68.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.668 0.787 . . . . 0.0 110.569 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 31.0 m -65.9 -32.89 74.65 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.575 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 38.2 t80 -67.81 -32.14 72.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.627 ' HG ' HD21 ' A' ' 21' ' ' LEU . 37.0 mt -65.84 -33.53 76.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.309 0.644 . . . . 0.0 110.531 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.29 70.65 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.862 0.363 . . . . 0.0 110.896 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.63 ' HA ' HG11 ' A' ' 76' ' ' VAL . 35.6 t -65.75 -18.23 65.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.654 0.782 . . . . 0.0 111.579 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 47' ' ' LEU . 55.9 mt -89.15 18.93 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.914 0.885 . . . . 0.0 110.794 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.88 19.61 78.68 Favored Glycine 0 C--N 1.362 1.974 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -104.06 148.42 26.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.092 0.557 . . . . 0.0 109.941 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -88.56 88.98 7.8 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.8 t -94.59 109.94 22.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.611 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 79' ' ' THR . 69.6 p -84.31 112.62 20.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.312 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.594 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -106.43 111.65 24.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.834 0.854 . . . . 0.0 111.047 -172.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.49 HG23 HD11 ' A' ' 34' ' ' LEU . 22.3 t -81.24 126.82 39.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.35 119.58 11.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.46 -18.18 65.12 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.617 0.573 . . . . 0.0 111.957 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.1 m -97.45 130.39 44.56 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.7 p -65.59 -27.71 68.61 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 18.4 m -63.27 -41.0 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.3 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.54 -40.81 94.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.647 0.592 . . . . 0.0 112.328 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.5 -42.16 83.3 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.537 0.735 . . . . 0.0 111.287 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.22 90.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.782 0.833 . . . . 0.0 112.328 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 2.8 mmmp? -65.85 -41.97 91.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.845 0.458 . . . . 0.0 110.134 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -61.0 -55.4 33.29 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.607 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.37 -23.41 50.81 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.69 -44.52 96.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' A' ' 45' ' ' CYS . 35.2 tp -69.11 -24.25 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.651 0.594 . . . . 0.0 111.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.14 -51.63 68.25 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.484 0.659 . . . . 0.0 109.434 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -72.58 -30.29 64.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.005 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.22 -53.62 10.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.598 0.759 . . . . 0.0 110.804 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.36 -1.4 55.95 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.5 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 38.77 78.43 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.846 -0.161 . . . . 0.0 113.299 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -112.97 173.99 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.734 0.814 . . . . 0.0 109.849 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -111.65 121.1 44.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.15 0.58 . . . . 0.0 111.152 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.2 mm -107.26 163.41 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 164.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 55' ' ' THR . 29.7 m -133.59 106.13 7.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p -87.04 112.85 22.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.436 0.694 . . . . 0.0 111.083 -166.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.13 126.41 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.013 1.325 . . . . 0.0 109.303 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -104.77 92.34 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -134.21 -176.83 4.33 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -141.14 110.1 6.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.734 -1.121 . . . . 0.0 107.999 -158.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 105' ' ' LEU . 17.7 mt -65.87 -7.69 17.84 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.507 1.123 . . . . 0.0 111.733 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -41.91 83.93 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.325 1.05 . . . . 0.0 112.218 172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -151.67 12.36 0.61 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.27 110.24 1.58 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.438 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -138.26 -73.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.493 HG23 HD11 ' A' ' 36' ' ' LEU . 17.7 pt -119.72 117.79 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.49 87.05 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.405 0.682 . . . . 0.0 109.537 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.57 -30.04 4.89 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.231 1.413 . . . . 0.0 114.153 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.51 -46.11 80.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.431 0.692 . . . . 0.0 109.272 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.35 -25.71 51.33 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.515 ' CD1' HD22 ' A' ' 34' ' ' LEU . 47.9 m95 -117.5 166.32 12.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -169.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 11.3 tp10 -94.07 -74.63 0.53 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.855 0.862 . . . . 0.0 109.836 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.87 162.11 17.46 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.495 HD12 HD12 ' A' ' 121' ' ' LEU . 54.1 mt -128.7 147.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 33' ' ' ILE . 7.2 p -139.24 141.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.893 1.277 . . . . 0.0 107.87 167.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . 50.5 m -136.97 92.31 2.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 128' ' ' ILE . 40.7 mm -62.28 133.51 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 129' ' ' LEU . 14.6 p90 -20.93 102.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.123 2.139 . . . . 0.0 114.148 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 71.0 m -77.95 103.42 7.88 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.058 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -91.09 96.94 10.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 85' ' ' LEU . 86.8 mt -125.65 142.33 41.7 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.201 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.01 159.88 36.48 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.534 2.156 . . . . 0.0 110.707 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.3 p -41.87 -43.14 2.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.5 1.52 . . . . 0.0 113.668 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -55.77 -50.93 69.1 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.209 0.943 . . . . 0.0 112.172 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.92 -33.94 33.74 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.284 0.634 . . . . 0.0 111.714 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.42 -43.63 31.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.583 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.44 -35.0 18.1 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.693 0.797 . . . . 0.0 111.967 165.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -79.47 -33.03 42.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.64 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 117' ' ' VAL . 48.1 tp -71.21 -48.61 50.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.891 0.476 . . . . 0.0 111.581 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -60.93 -42.77 88.67 Favored Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -167.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.43 -25.45 48.61 Favored 'Trans proline' 0 C--N 1.396 3.076 0 CA-C-N 121.364 1.523 . . . . 0.0 111.984 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -81.7 -21.17 38.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 122.995 0.518 . . . . 0.0 110.357 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 113' ' ' LEU . 19.3 t -85.03 -35.74 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 42.4 t80 -48.9 -61.6 1.96 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.125 0.97 . . . . 0.0 112.256 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.425 ' HG3' ' HD1' ' A' ' 118' ' ' TYR . 47.9 mt-30 -95.46 -22.3 17.77 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 172.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.21 -23.86 53.49 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD12 HD12 ' A' ' 98' ' ' ILE . 39.7 tp -61.05 124.89 21.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.394 0.678 . . . . 0.0 110.884 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -67.11 133.11 93.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.65 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.596 2.197 . . . . 0.0 112.297 168.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.16 14.76 8.17 Favored Glycine 0 C--O 1.248 1.005 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.433 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -95.87 135.56 12.39 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.5 m -109.4 130.4 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.002 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.17 111.59 24.08 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 24' ' ' VAL . 58.1 mt -106.98 108.27 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 102' ' ' PHE . 69.8 mt -124.25 117.49 24.68 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.423 0.689 . . . . 0.0 109.381 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -99.55 98.71 9.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.61 169.16 53.26 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.905 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.439 ' HD1' HD22 ' A' ' 187' ' ' LEU . 7.7 m-85 -133.06 156.02 48.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.898 -179.257 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.0 mt -86.89 102.81 3.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.882 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.1 Cg_endo -75.69 123.68 7.66 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.858 2.372 . . . . 0.0 112.618 -168.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -102.78 151.37 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.795 0.838 . . . . 0.0 111.839 -168.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 190' ' ' LEU . 32.5 mt -61.0 -54.39 45.58 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.692 . . . . 0.0 111.829 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -52.51 -39.54 61.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.93 0.892 . . . . 0.0 111.181 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 29.3 m -74.7 -57.12 4.12 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 151' ' ' PRO . 88.8 mt -63.92 -46.43 84.8 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.251 1.021 . . . . 0.0 112.631 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.602 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.5 tt0 -53.38 -35.57 60.48 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 111.837 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.5 t -84.44 -20.88 31.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.694 . . . . 0.0 112.062 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 155' ' ' THR . 41.6 mm-40 -79.53 -16.53 55.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.608 . . . . 0.0 110.875 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 82.1 mt -142.12 66.53 20.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.768 0.827 . . . . 0.0 109.461 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.591 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 13.8 Cg_exo -72.24 -3.84 14.08 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 123.115 2.543 . . . . 0.0 112.635 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 p -85.62 -33.87 21.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.8 tp -99.59 70.49 1.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.361 1.464 . . . . 0.0 111.257 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.402 ' HB3' HD22 ' A' ' 195' ' ' LEU . 26.5 t-20 -53.03 126.96 22.32 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.602 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 17.4 m95 -91.08 133.26 35.47 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.81 -35.56 77.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.985 0.514 . . . . 0.0 109.7 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 78.1 mt -126.45 123.04 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.22 69.69 1.01 Allowed 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -129.48 145.93 51.38 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.327 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -92.17 112.1 23.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.436 1.094 . . . . 0.0 109.493 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.8 mt -117.25 125.42 51.1 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.456 0.702 . . . . 0.0 110.316 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.439 HD22 ' HD1' ' A' ' 132' ' ' PHE . 52.1 mt -135.36 173.65 11.48 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 151' ' ' PRO . 9.8 pt -145.88 135.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.931 0.892 . . . . 0.0 109.257 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.4 142.25 33.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.664 0.386 . . . . 0.0 110.442 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 153' ' ' LEU . 39.5 mt -129.36 131.42 46.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.7 1.2 . . . . 0.0 109.069 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.86 105.74 7.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.07 138.16 15.24 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.705 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.0 tp-100 -142.55 149.7 39.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.587 0.693 . . . . 0.0 110.219 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -66.34 138.93 57.96 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 164' ' ' ASN . 5.6 mt . . . . . 0 N--CA 1.475 0.791 0 O-C-N 124.557 1.161 . . . . 0.0 109.169 -171.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.474 HD21 ' HG ' ' A' ' 47' ' ' LEU . 37.5 tp -62.95 -36.54 83.78 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.763 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 m -44.13 -36.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.239 1.016 . . . . 0.0 113.584 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 m -74.89 -52.43 11.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.521 0.729 . . . . 0.0 110.84 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 128' ' ' ILE . 2.1 m -62.3 -37.06 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.588 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.0 83.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.314 1.446 . . . . 0.0 112.057 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.99 -28.05 68.59 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.813 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.18 -14.6 28.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.211 0.605 . . . . 0.0 112.194 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 76.1 mt -77.71 130.58 73.12 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.72 140.71 46.14 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.266 2.644 . . . . 0.0 112.65 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.45 28.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.66 -147.12 8.66 Favored Glycine 0 N--CA 1.468 0.777 0 CA-C-N 118.455 0.571 . . . . 0.0 112.905 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -80.43 119.34 23.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -110.27 139.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.218 1.007 . . . . 0.0 108.555 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 26.1 tp -115.42 128.65 56.19 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.968 0.804 . . . . 0.0 111.498 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 32.7 m -94.05 138.0 32.62 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.051 0.94 . . . . 0.0 110.239 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.6 108.95 17.08 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.986 0.514 . . . . 0.0 111.152 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 O-C-N 125.482 1.738 . . . . 0.0 112.501 168.545 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -62.13 -49.09 77.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.336 1.054 . . . . 0.0 111.297 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.69 -32.78 53.23 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.804 -172.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.43 77.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.577 0.751 . . . . 0.0 110.101 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -68.85 -30.47 69.01 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.526 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 21' ' ' LEU . 57.4 t80 -62.93 -43.53 98.55 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HG ' HD21 ' A' ' 21' ' ' LEU . 89.4 mt -70.36 -30.78 67.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.85 76.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.88 0.472 . . . . 0.0 111.197 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 23.6 p -75.85 -2.44 30.08 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.303 0.641 . . . . 0.0 111.985 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 94.4 mt -86.32 14.97 5.75 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.314 0.646 . . . . 0.0 110.427 164.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.29 47.31 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 123.223 0.44 . . . . 0.0 113.523 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -125.29 157.03 37.66 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.337 0.589 . . . . 0.0 111.065 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.76 88.57 5.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.12 116.57 36.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.237 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 27.1 m -84.95 112.78 20.89 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 124.761 1.224 . . . . 0.0 107.977 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.27 133.85 46.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 111.174 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 81' ' ' VAL . 15.1 t -115.66 120.1 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.64 143.8 50.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.05 -20.98 66.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.506 0.722 . . . . 0.0 111.263 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 62' ' ' VAL . 46.1 m -111.75 124.52 52.51 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.716 1.206 . . . . 0.0 109.003 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.5 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.907 0.883 . . . . 0.0 110.062 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 60' ' ' SER . 19.1 m -66.26 -26.35 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.67 -35.1 33.06 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.157 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.3 -44.79 82.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.031 0.933 . . . . 0.0 110.449 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.26 91.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.924 0.889 . . . . 0.0 111.528 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -66.81 -40.28 87.99 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.295 0.638 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.08 88.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.294 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -70.02 -36.87 75.41 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.431 1.092 . . . . 0.0 111.476 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -61.08 -52.15 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.23 -28.77 69.96 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.984 0.803 . . . . 0.0 110.715 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.32 -62.24 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.981 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.77 -26.24 67.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 111.559 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.52 -46.28 90.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.162 0.985 . . . . 0.0 109.786 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -98.81 -0.71 41.99 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.553 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.85 51.23 8.03 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.366 0.506 . . . . 0.0 114.366 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.2 m -138.42 176.29 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.932 0.893 . . . . 0.0 110.618 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -114.74 140.88 48.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.832 0.853 . . . . 0.0 111.937 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.5 157.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 85.6 m -119.12 103.23 9.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 t -94.62 114.89 26.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.278 0.561 . . . . 0.0 110.535 -163.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 57' ' ' VAL . 61.7 t -109.92 139.69 32.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.683 1.193 . . . . 0.0 108.883 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -78.87 132.26 36.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.639 0.775 . . . . 0.0 109.902 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 p -63.61 106.07 0.89 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 111.515 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -144.21 89.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 165.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -78.87 -16.36 57.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.804 0.442 . . . . 0.0 111.047 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.22 -27.3 62.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.565 0.746 . . . . 0.0 111.333 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -104.52 -37.12 7.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.262 0.625 . . . . 0.0 111.654 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -161.34 126.25 3.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.378 1.071 . . . . 0.0 108.323 -170.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.01 -70.55 0.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 117' ' ' VAL . 2.9 pt -143.5 118.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.582 0.753 . . . . 0.0 109.778 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.879 0.872 . . . . 0.0 109.685 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 122' ' ' LYS . . . -44.88 -26.67 0.43 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 -44.42 71.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.991 0.516 . . . . 0.0 110.761 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.68 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -140.89 -165.32 1.92 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.223 0.609 . . . . 0.0 111.25 -171.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -118.01 -37.16 3.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.752 0.821 . . . . 0.0 112.42 -169.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.36 172.21 23.94 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 122.369 -0.207 . . . . 0.0 112.862 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.536 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 42.6 mt -134.35 145.83 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.881 0.873 . . . . 0.0 109.233 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -127.3 105.09 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 159.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.9 t -104.19 88.03 2.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.434 HD11 HD13 ' A' ' 21' ' ' LEU . 34.4 mm -71.58 146.16 11.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.656 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -17.54 99.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 126.563 2.414 . . . . 0.0 112.261 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.558 ' SG ' HD21 ' A' ' 129' ' ' LEU . 28.8 p -99.15 104.83 16.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.158 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -96.67 96.71 8.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.4 mt -112.19 139.27 22.28 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.717 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 105' ' ' LEU . 11.7 Cg_exo -71.19 162.03 43.87 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.937 2.425 . . . . 0.0 110.981 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 149' ' ' LEU . 14.0 m -34.98 -42.56 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.199 1.8 . . . . 0.0 115.368 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.3 m -70.61 -46.52 63.22 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.241 0.338 . . . . 0.0 110.692 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.52 -35.72 34.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.632 0.373 . . . . 0.0 110.427 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -69.14 -62.73 1.26 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.679 0.792 . . . . 0.0 109.945 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -51.87 -34.06 39.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.918 0.887 . . . . 0.0 113.135 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.64 -32.58 47.36 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 117' ' ' VAL . 55.9 tp -71.92 -39.27 69.6 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.457 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -62.86 -38.86 47.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.94 -30.89 67.35 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.819 1.679 . . . . 0.0 111.792 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.08 -15.71 56.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.787 0.835 . . . . 0.0 110.209 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.616 ' HA ' HD11 ' A' ' 90' ' ' ILE . 22.3 t -83.84 -40.92 16.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -57.8 -52.39 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -69.95 -42.7 72.88 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.3 -39.86 14.65 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 25.8 tp -69.78 111.84 5.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.916 0.886 . . . . 0.0 110.61 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 19.4 ptmt -85.42 157.95 58.11 Favored Pre-proline 0 C--O 1.247 0.948 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.106 167.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.588 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 83.1 Cg_exo -50.8 112.29 0.73 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.343 2.029 . . . . 0.0 112.291 168.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 126.61 12.73 3.27 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.319 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.78 147.53 16.37 Favored Glycine 0 C--O 1.246 0.862 0 O-C-N 122.545 -0.385 . . . . 0.0 112.303 168.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 35.1 m -109.44 131.57 59.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 123.548 0.739 . . . . 0.0 110.076 177.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.93 112.54 24.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 24' ' ' VAL . 59.6 mt -115.44 112.26 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.132 0.973 . . . . 0.0 109.543 -171.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' SG ' ' A' ' 103' ' ' CYS . 96.5 mt -133.33 153.42 51.6 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 37.7 tt0 -132.49 100.76 5.08 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 164.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 151' ' ' PRO . . . -80.23 166.58 49.96 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.779 175.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.413 ' HB2' HD22 ' A' ' 150' ' ' LEU . 58.0 m-85 -127.29 157.43 39.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 109.383 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.479 0.98 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 107' ' ' SER . 71.8 mt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 132' ' ' PHE . 56.3 mt -85.63 108.52 16.76 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.511 ' HB2' HD11 ' A' ' 156' ' ' LEU . 12.2 Cg_exo -70.22 122.63 9.18 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.977 2.451 . . . . 0.0 112.53 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -96.61 150.11 21.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.1 0.96 . . . . 0.0 111.282 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.583 HD22 HD21 ' A' ' 190' ' ' LEU . 37.9 mt -57.55 -36.87 72.2 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 122.987 0.515 . . . . 0.0 109.696 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -50.9 -51.37 52.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.534 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -69.75 -48.84 57.88 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.55 -58.73 3.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.396 1.078 . . . . 0.0 112.516 -166.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.27 -31.28 72.35 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.455 0.702 . . . . 0.0 112.091 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.0 t -84.54 -13.85 50.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.065 0.393 . . . . 0.0 111.519 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.85 -45.35 10.94 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.675 0.75 . . . . 0.0 109.317 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.9 mt -104.85 78.89 0.4 Allowed Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.702 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.37 -4.06 7.63 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 123.002 2.468 . . . . 0.0 111.367 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -85.52 -28.62 24.83 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.49 1.116 . . . . 0.0 108.115 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.83 70.81 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.78 1.632 . . . . 0.0 109.015 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 195' ' ' LEU . 6.8 t30 -60.46 121.42 12.05 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.425 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 16.7 m95 -87.85 141.51 28.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.516 1.126 . . . . 0.0 108.998 -167.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.4 mt -73.42 -35.72 65.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.077 0.551 . . . . 0.0 109.809 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 82.2 mt -126.11 118.09 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.81 76.5 1.07 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -141.3 143.03 33.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.11 112.23 20.49 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.473 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.4 mt -103.86 131.27 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.409 1.083 . . . . 0.0 108.884 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 C--O 1.238 0.462 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 175.067 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 C--O 1.237 0.429 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.0 mt -122.16 144.03 49.2 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 13.4 pt -133.02 116.61 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.15 0.432 . . . . 0.0 110.025 -170.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.61 137.77 36.76 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.067 0.46 . . . . 0.0 109.779 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 153' ' ' LEU . 62.9 mt -125.98 146.0 50.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.388 1.075 . . . . 0.0 110.343 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 23.7 tp -149.88 106.15 3.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -88.48 142.36 17.22 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -142.65 156.76 45.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.649 0.725 . . . . 0.0 111.04 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 68.2 tttt -55.34 135.26 50.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.322 1.449 . . . . 0.0 110.368 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 164' ' ' ASN . 3.5 mt . . . . . 0 C--O 1.245 0.84 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.61 -17.91 57.14 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.695 1.198 . . . . 0.0 112.443 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.69 -37.92 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -71.84 -41.15 68.48 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.031 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.4 m -66.8 -43.5 89.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -57.27 -38.41 73.86 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.18 0.992 . . . . 0.0 112.253 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.61 -21.32 63.59 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.626 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -91.1 -21.86 21.0 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.41 0.684 . . . . 0.0 110.54 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 92.3 mt -74.09 134.2 77.77 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 123.532 0.733 . . . . 0.0 110.51 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.66 136.42 49.68 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.36 2.707 . . . . 0.0 112.111 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.44 28.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.7 -132.81 4.98 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -84.33 112.41 20.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HG12 ' A' ' 99' ' ' VAL . 8.9 mt -111.59 119.11 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.691 0.796 . . . . 0.0 109.197 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 90' ' ' ILE . 28.7 tp -89.95 108.0 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.667 0.212 . . . . 0.0 110.743 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 49.3 t -94.92 110.39 22.29 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.265 0.626 . . . . 0.0 110.689 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.2 mt -79.02 126.35 30.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.458 0 O-C-N 123.791 0.682 . . . . 0.0 109.816 -177.985 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -49.78 -38.32 33.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.417 1.487 . . . . 0.0 112.2 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.422 ' ND2' HG13 ' A' ' 101' ' ' ILE . 29.1 p-10 -64.2 -41.0 97.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.0 72.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.51 0.724 . . . . 0.0 110.719 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 9.9 m -59.55 -38.89 82.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.627 0.771 . . . . 0.0 111.099 173.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -73.2 -33.5 65.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.592 0.757 . . . . 0.0 110.906 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HG11 ' A' ' 99' ' ' VAL . 50.6 mt -64.03 -32.36 73.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 110.421 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.17 -31.24 58.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.879 0.472 . . . . 0.0 110.763 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 m -68.37 -6.09 22.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.809 0.844 . . . . 0.0 111.835 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.8 mt -83.89 12.38 6.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.596 0.758 . . . . 0.0 110.646 168.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 34.72 25.44 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 123.285 0.469 . . . . 0.0 113.985 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.4 162.16 26.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.882 0.473 . . . . 0.0 111.387 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -92.99 91.07 7.2 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 165.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 33' ' ' ILE . 85.7 t -88.4 112.12 23.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.2 t -83.3 104.4 13.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.28 134.75 42.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.985 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.501 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.3 t -113.71 118.22 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -133.68 142.48 48.03 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -54.31 -32.2 55.98 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.191 0.997 . . . . 0.0 112.364 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' HG22 ' A' ' 62' ' ' VAL . 9.1 t -109.03 130.33 55.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.631 0.772 . . . . 0.0 110.005 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 t -74.98 -16.86 60.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.929 0.892 . . . . 0.0 110.991 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.461 HG22 ' OG ' ' A' ' 60' ' ' SER . 9.6 m -63.85 -32.98 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.544 0.337 . . . . 0.0 110.511 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.42 -33.21 56.75 Favored Glycine 0 C--N 1.351 1.382 0 O-C-N 123.538 0.523 . . . . 0.0 112.646 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.09 -48.03 59.38 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.779 0.832 . . . . 0.0 110.413 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.55 86.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.712 0.805 . . . . 0.0 112.047 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -63.35 -39.41 94.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.861 0.864 . . . . 0.0 110.748 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -60.92 -46.71 89.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.942 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -71.08 -37.14 72.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.635 0.774 . . . . 0.0 111.652 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.63 -55.72 31.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.93 0.892 . . . . 0.0 109.849 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.2 tp -66.61 -25.19 66.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.221 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.09 -52.09 52.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.973 0.509 . . . . 0.0 110.495 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.85 -33.83 73.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.026 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.6 -48.22 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.545 0.528 . . . . 0.0 110.723 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 74' ' ' LYS . 2.0 ttmp? -87.68 -13.5 42.4 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.96 44.83 13.04 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 121.054 0.252 . . . . 0.0 112.674 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 172.83 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.394 1.078 . . . . 0.0 108.124 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -121.77 141.26 51.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.706 0.403 . . . . 0.0 110.896 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.8 mm -109.24 165.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 45.0 m -131.13 104.02 6.84 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 164.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.2 p -86.74 114.33 23.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.884 0.474 . . . . 0.0 111.108 -168.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' HB ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -104.63 139.01 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.746 1.218 . . . . 0.0 108.108 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -78.9 136.35 37.26 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 p -50.47 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.5 1.12 . . . . 0.0 111.838 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 6.6 m-20 -134.65 91.1 2.73 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 65.7 mt -100.46 -6.71 25.15 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.691 0.758 . . . . 0.0 110.68 -170.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.27 3.44 29.98 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.189 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 32.2 t70 -139.64 -46.38 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -168.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -163.86 100.5 0.88 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.634 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -132.84 -58.28 0.92 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.522 0.729 . . . . 0.0 109.343 -164.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 34' ' ' LEU . 4.7 pt -134.35 110.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 123.039 0.535 . . . . 0.0 111.028 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 t -129.2 84.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.559 0.744 . . . . 0.0 109.346 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.529 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.65 -1.02 14.61 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.897 0.479 . . . . 0.0 112.176 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -76.16 -45.95 30.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.98 61.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.614 0.766 . . . . 0.0 112.57 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.508 ' CD1' HD22 ' A' ' 34' ' ' LEU . 44.8 m95 -113.79 -177.71 3.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.254 0.622 . . . . 0.0 110.486 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -92.49 -55.83 3.25 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.69 0.796 . . . . 0.0 109.994 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.77 173.84 21.34 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.521 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.8 mt -132.68 139.3 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 47' ' ' LEU . 7.5 p -124.06 106.94 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.64 0.734 . . . . 0.0 109.233 165.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.2 m -103.82 94.11 5.25 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.449 HD13 HD12 ' A' ' 128' ' ' ILE . 41.6 mm -68.52 141.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.359 1.063 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 8.2 p90 -21.63 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 126.032 1.733 . . . . 0.0 113.85 -172.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.494 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 35.8 t -94.53 109.56 21.44 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.615 -168.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -108.52 98.69 8.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.494 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 62.5 mt -114.62 145.53 34.06 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.809 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.73 150.55 69.79 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.833 2.355 . . . . 0.0 110.269 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.6 t -44.9 -33.88 2.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.771 1.228 . . . . 0.0 113.324 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.0 m -59.4 -59.81 4.85 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.312 0.645 . . . . 0.0 111.399 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.66 -24.41 53.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.992 0.517 . . . . 0.0 110.537 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.84 -54.62 14.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.416 1.086 . . . . 0.0 109.57 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -55.75 -28.67 57.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.387 1.075 . . . . 0.0 112.436 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.65 -22.95 24.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.842 0.457 . . . . 0.0 111.078 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.5 tp -71.9 -45.42 61.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.133 0.573 . . . . 0.0 111.172 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -58.58 -41.52 89.48 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -52.79 -38.05 77.22 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 122.449 2.099 . . . . 0.0 112.811 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.55 -23.61 56.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.391 0.677 . . . . 0.0 111.595 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 t -85.46 -28.08 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.362 0.601 . . . . 0.0 110.142 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -75.04 -61.09 2.01 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.291 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -76.99 -47.36 20.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.501 1.12 . . . . 0.0 113.584 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.62 -36.72 22.22 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 114.14 0.416 . . . . 0.0 114.14 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.2 tp -75.36 108.5 8.18 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 1.2 mptm? -82.59 159.53 63.73 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.529 168.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -41.29 113.05 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.305 2.67 . . . . 0.0 113.813 166.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 14.22 3.24 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.235 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -112.32 144.43 17.8 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 121.766 -0.843 . . . . 0.0 111.146 165.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 33.9 m -107.59 132.16 55.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.834 0.854 . . . . 0.0 109.96 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.56 112.79 25.95 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.449 HD12 HD13 ' A' ' 101' ' ' ILE . 57.9 mt -104.21 109.43 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 156' ' ' LEU . 51.7 mt -124.59 120.71 32.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 110.088 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 37.8 tt0 -112.28 102.6 10.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.57 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.65 169.08 40.5 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.668 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.635 ' HD1' HD22 ' A' ' 187' ' ' LEU . 57.1 m-85 -137.73 165.97 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.78 0.832 . . . . 0.0 109.445 -172.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.572 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 123.833 0.853 . . . . 0.0 110.072 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 105' ' ' LEU . 24.0 mt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.742 0.306 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.24 106.02 5.04 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 166.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.57 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 15.3 Cg_exo -68.29 110.77 2.32 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 123.203 2.602 . . . . 0.0 112.651 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -95.51 147.67 23.3 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.926 0.891 . . . . 0.0 111.311 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.6 mt -59.84 -45.26 92.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.52 0.6 . . . . 0.0 110.428 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.63 -46.77 77.37 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.261 0.976 . . . . 0.0 110.942 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.7 p -71.95 -53.73 12.15 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 129' ' ' LEU . 40.6 mt -70.01 -51.29 33.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.533 1.133 . . . . 0.0 113.274 -169.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 30.0 tt0 -59.98 -35.06 74.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.679 0.392 . . . . 0.0 111.38 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.7 t -78.04 -28.1 48.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.703 0.401 . . . . 0.0 110.864 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -78.39 -24.15 46.46 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.885 . . . . 0.0 110.768 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.7 mt -131.84 73.27 78.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -82.71 -9.18 11.12 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.252 2.634 . . . . 0.0 112.606 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -91.84 -29.86 16.5 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp -88.4 72.44 8.91 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.624 1.17 . . . . 0.0 110.29 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -53.6 125.69 19.07 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.108 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.406 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 41.9 m95 -91.76 125.12 36.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.541 1.137 . . . . 0.0 108.899 -172.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.96 -34.13 75.98 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.089 0.556 . . . . 0.0 109.983 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 72.7 mt -127.54 122.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.63 76.26 1.01 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -145.98 145.76 30.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 -172.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -74.97 115.54 14.7 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.493 0.717 . . . . 0.0 110.432 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.1 mt -107.84 114.56 28.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.082 0.553 . . . . 0.0 111.1 -171.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.635 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.3 mt -127.61 160.68 30.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 16.3 pt -140.39 142.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -129.42 150.13 50.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.555 0.693 . . . . 0.0 111.147 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 40.7 mt -132.25 140.7 48.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.608 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 34.2 tp -134.03 104.16 6.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.94 136.54 14.07 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.34 155.58 44.48 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.462 0.705 . . . . 0.0 109.883 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -57.1 144.95 32.62 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.476 0.71 . . . . 0.0 110.36 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--O 1.245 0.83 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.005 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -57.69 -19.68 28.73 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.902 1.281 . . . . 0.0 112.838 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.73 -27.8 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 118.973 0.806 . . . . 0.0 108.897 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -72.32 -43.14 64.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.361 1.064 . . . . 0.0 110.615 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.6 m -68.84 -37.47 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.309 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -26.2 68.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.907 0.883 . . . . 0.0 112.63 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -70.34 -28.31 65.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.688 0.795 . . . . 0.0 109.572 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -84.75 -24.08 28.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.783 0.833 . . . . 0.0 111.393 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 33' ' ' ILE . 63.7 mt -72.85 131.42 84.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.263 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -64.72 144.33 83.56 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.817 2.345 . . . . 0.0 112.003 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -69.14 27.49 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.526 ' HA3' ' HG3' ' A' ' 96' ' ' GLU . . . -116.61 -140.95 6.94 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 119.065 0.848 . . . . 0.0 112.832 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 41.5 mtpt -83.63 118.48 23.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.378 0.671 . . . . 0.0 109.682 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.571 HD13 HG21 ' A' ' 28' ' ' ILE . 9.7 mt -115.43 131.92 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.409 HD22 ' NE1' ' A' ' 95' ' ' TRP . 33.0 tp -97.89 113.85 25.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.8 t -95.34 133.82 38.83 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.881 0.872 . . . . 0.0 108.68 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -101.53 159.06 15.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.566 0.346 . . . . 0.0 111.053 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 O-C-N 125.023 1.452 . . . . 0.0 113.061 178.9 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.133 0 N-CA-C 114.288 0.475 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.667 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 51.1 mtp180 -56.43 -34.92 67.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.37 1.068 . . . . 0.0 111.787 168.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.66 -45.25 89.76 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.901 0.88 . . . . 0.0 110.293 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.7 75.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.331 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 42' ' ' ARG . 22.7 p -73.8 -19.78 60.66 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.363 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.61 -50.15 53.72 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.98 -30.55 69.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.399 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.05 0.54 . . . . 0.0 111.956 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.646 ' HA ' HG11 ' A' ' 76' ' ' VAL . 87.7 p -73.56 -3.85 30.39 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.836 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.02 12.08 3.6 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.758 0.823 . . . . 0.0 111.219 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.02 15.97 60.17 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 123.173 0.416 . . . . 0.0 113.932 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.86 157.93 20.8 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.788 0.835 . . . . 0.0 109.869 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 45.1 mt-10 -97.34 90.83 5.22 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 33' ' ' ILE . 61.9 t -94.84 110.97 24.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.596 0.712 . . . . 0.0 110.06 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -86.18 114.82 23.32 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.528 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.53 144.65 29.27 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 123.877 0.871 . . . . 0.0 111.268 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -119.89 117.25 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 165.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.64 148.17 51.51 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.229 0.922 . . . . 0.0 111.195 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -56.1 -34.18 65.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.129 1.772 . . . . 0.0 112.473 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.3 p -123.72 140.42 53.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.085 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -73.54 -15.75 61.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.086 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.2 m -63.84 -38.59 82.74 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -41.18 55.31 Favored Glycine 0 C--N 1.357 1.725 0 O-C-N 123.551 0.532 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.45 -41.67 98.91 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.518 0.727 . . . . 0.0 110.435 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.03 76.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.016 0.926 . . . . 0.0 112.532 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 75.0 mmtt -62.61 -39.37 93.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.603 0.361 . . . . 0.0 110.357 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -62.5 -51.34 67.81 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.593 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -71.21 -32.48 68.88 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.305 0.642 . . . . 0.0 111.849 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -58.41 -48.88 79.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.2 0.6 . . . . 0.0 110.703 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.8 tp -68.63 -25.88 65.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 123.269 0.355 . . . . 0.0 110.64 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.79 -59.29 5.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.023 0.529 . . . . 0.0 110.897 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -58.33 -48.33 80.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.81 0.844 . . . . 0.0 111.839 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 -41.96 88.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.82 0.848 . . . . 0.0 111.191 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -105.56 -12.06 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.137 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.31 44.39 22.45 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 121.907 -0.187 . . . . 0.0 113.509 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -124.55 160.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -104.77 126.4 51.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.674 0.79 . . . . 0.0 110.775 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.643 HG21 ' HB1' ' A' ' 67' ' ' ALA . 5.1 mm -117.84 164.89 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -133.98 108.04 8.15 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 p -94.5 125.92 39.45 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.942 0.497 . . . . 0.0 111.303 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.35 140.74 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.359 1.464 . . . . 0.0 107.882 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -82.98 144.17 30.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -62.8 102.9 0.38 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.714 0.806 . . . . 0.0 112.903 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -142.27 89.63 2.18 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.93 -8.39 51.89 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.39 0.676 . . . . 0.0 111.792 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.79 -16.64 50.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.901 0.881 . . . . 0.0 110.763 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.55 -38.42 4.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.416 0.687 . . . . 0.0 110.544 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -151.02 130.16 12.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.667 1.187 . . . . 0.0 107.91 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.98 -75.32 0.51 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 pt -143.27 119.45 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.026 0.93 . . . . 0.0 109.473 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.31 79.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 0.0 108.955 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -74.98 0.33 16.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.354 0.662 . . . . 0.0 112.089 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.79 -40.32 83.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 167.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.09 57.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.409 ' NE1' HD22 ' A' ' 34' ' ' LEU . 23.7 m95 -113.4 176.77 4.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.256 0.622 . . . . 0.0 111.211 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 52.2 mm-40 -90.18 -51.73 5.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.022 0.929 . . . . 0.0 109.883 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.88 178.56 21.12 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 121' ' ' LEU . 69.4 mt -131.59 145.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.85 0.86 . . . . 0.0 108.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 8.3 p -130.87 133.61 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 166.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 m -142.41 95.76 2.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' HD1' ' A' ' 102' ' ' PHE . 8.7 mm -74.3 153.78 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HD1' HG22 ' A' ' 101' ' ' ILE . 20.5 p90 -16.02 103.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.202 1.801 . . . . 0.0 115.004 -163.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.4 t -75.41 105.49 6.46 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.984 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -105.13 97.66 7.48 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -125.33 145.76 51.93 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.541 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -56.13 150.7 46.8 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.022 2.481 . . . . 0.0 110.666 163.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.3 t -48.53 -37.82 18.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.652 1.181 . . . . 0.0 112.006 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -53.57 -57.01 12.26 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.905 0.753 . . . . 0.0 111.113 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.71 -24.99 56.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.894 0.478 . . . . 0.0 110.636 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -75.44 -53.91 7.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.737 0.815 . . . . 0.0 110.637 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -60.41 -28.18 68.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.957 0.503 . . . . 0.0 111.723 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -75.74 -30.37 59.2 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 60.5 tp -74.56 -36.54 63.09 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.839 0.712 . . . . 0.0 111.888 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -54.87 -49.69 90.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.41 -24.92 70.96 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.05 1.833 . . . . 0.0 112.186 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.1 -29.59 61.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.011 0.524 . . . . 0.0 111.142 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' LEU . 5.0 t -85.75 -26.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.153 0.581 . . . . 0.0 110.064 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -69.95 -61.69 1.68 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.41 -49.74 38.85 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.92 -18.11 51.88 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 115.122 0.809 . . . . 0.0 115.122 -163.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 98' ' ' ILE . 13.3 tp -76.52 102.41 6.04 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.661 0.73 . . . . 0.0 109.076 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -75.86 145.44 77.91 Favored Pre-proline 0 C--O 1.247 0.951 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -44.19 111.93 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.059 2.506 . . . . 0.0 113.242 174.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.24 11.64 5.6 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.105 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.09 140.61 15.15 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 19.3 m -109.84 129.47 64.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -110.2 108.8 19.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -116.13 113.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.901 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 102' ' ' PHE . 3.6 mp -130.06 147.42 51.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.041 0.448 . . . . 0.0 111.13 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.94 98.47 6.5 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 165.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.85 -179.79 52.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.721 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.6 m-85 -137.9 158.4 44.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.429 -173.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 123.642 0.777 . . . . 0.0 110.45 178.822 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 132' ' ' PHE . 53.1 mt -78.99 112.58 28.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 166.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HB2' HD11 ' A' ' 156' ' ' LEU . 60.4 Cg_endo -71.71 93.63 0.69 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.26 1.973 . . . . 0.0 111.274 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.573 ' HA ' HD11 ' A' ' 188' ' ' ILE . 42.9 mtmt -96.78 156.06 16.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.608 -166.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 188' ' ' ILE . 35.3 mt -61.69 -49.85 74.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.345 0.658 . . . . 0.0 110.333 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.19 -40.33 73.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.887 0.742 . . . . 0.0 110.977 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.1 m -65.65 -64.27 0.9 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.696 174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 151' ' ' PRO . 83.5 mt -72.58 -45.16 60.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.704 0.802 . . . . 0.0 112.481 -164.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 64.0 tt0 -57.84 -42.02 83.55 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.04 0.536 . . . . 0.0 111.877 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -76.83 -26.23 54.11 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -84.66 -12.76 53.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.929 0.892 . . . . 0.0 111.25 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 70.0 mt -134.57 71.6 70.88 Favored Pre-proline 0 N--CA 1.475 0.792 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.56 -3.31 13.21 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.198 2.599 . . . . 0.0 111.002 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.5 t -83.86 -42.26 16.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.677 1.191 . . . . 0.0 107.912 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.6 tp -95.11 71.76 3.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.863 1.265 . . . . 0.0 110.487 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.31 127.86 32.96 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.58 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 36.8 m95 -91.5 137.83 32.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 0.0 109.226 -167.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.81 -32.24 63.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.761 0.424 . . . . 0.0 110.83 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 83.0 mt -132.81 128.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.87 77.63 0.96 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.91 1.284 . . . . 0.0 107.771 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.36 133.42 36.77 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 -169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.69 113.5 18.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.343 0.657 . . . . 0.0 110.773 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.3 mt -108.39 135.67 49.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.605 0.762 . . . . 0.0 109.981 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.549 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.89 163.67 19.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.632 0.773 . . . . 0.0 109.122 -169.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 152' ' ' LYS . 7.6 pt -143.82 125.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -97.72 141.55 30.6 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.941 -0.475 . . . . 0.0 111.061 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 37.6 mt -127.57 130.13 48.54 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.387 1.475 . . . . 0.0 108.997 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.419 HD22 HG12 ' A' ' 24' ' ' VAL . 29.9 tp -125.64 105.08 8.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -93.23 131.35 10.73 Favored Glycine 0 C--O 1.212 -1.221 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 173.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -141.51 156.55 45.72 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 108.859 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -54.49 153.86 5.26 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.975 0.91 . . . . 0.0 110.957 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.245 0.835 0 C-N-CA 122.78 0.432 . . . . 0.0 110.22 175.808 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 t80 . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 25' ' ' ALA . 14.1 tp -60.2 -22.52 63.07 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.77 0.828 . . . . 0.0 112.286 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 m -40.48 -56.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 124.489 1.116 . . . . 0.0 113.853 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 p -74.93 -50.62 16.18 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 110.681 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.2 m -66.93 -41.4 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.364 -171.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -60.9 -37.26 81.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.918 0.887 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -68.63 -26.78 65.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 12.7 mm100 -92.86 -13.26 29.25 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 24' ' ' VAL . 73.7 mt -77.68 134.43 65.34 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.237 0.615 . . . . 0.0 110.87 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.77 132.38 47.55 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.326 2.684 . . . . 0.0 111.894 171.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -74.23 29.51 0.08 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.88 -145.68 9.54 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 12.3 mmmm -85.63 118.7 25.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -170.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mt -114.15 134.29 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.8 0.84 . . . . 0.0 110.04 -165.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.511 HD22 ' NE1' ' A' ' 95' ' ' TRP . 50.8 tp -106.92 127.01 53.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.243 0.617 . . . . 0.0 110.607 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 36.1 m -98.89 137.47 37.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.578 0.751 . . . . 0.0 110.16 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 89' ' ' ASP . 15.7 mt -114.58 116.05 28.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.181 0.593 . . . . 0.0 110.928 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.195 0 O-C-N 125.38 1.675 . . . . 0.0 113.657 165.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -69.37 -35.45 75.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.481 0.658 . . . . 0.0 109.469 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -80.8 -31.51 35.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.813 1.245 . . . . 0.0 110.426 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.24 82.73 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.936 0.772 . . . . 0.0 109.682 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 55.9 m -58.62 -43.18 89.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.462 171.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.4 -31.55 68.81 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.4 0.437 . . . . 0.0 111.096 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.14 -37.02 85.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.953 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.24 73.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.767 0.427 . . . . 0.0 111.227 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 11.7 m -65.99 -15.77 63.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.951 0.9 . . . . 0.0 112.155 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.79 8.72 5.0 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.039 0.535 . . . . 0.0 110.767 172.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.09 8.66 61.4 Favored Glycine 0 C--N 1.362 1.996 0 CA-C-O 119.69 -0.506 . . . . 0.0 114.326 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -105.65 152.37 23.21 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.428 0.614 . . . . 0.0 110.129 -172.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 35.5 mt-10 -94.89 90.8 6.14 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.2 t -88.86 118.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.354 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.1 p -86.04 113.0 21.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -112.3 122.35 47.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.862 0.465 . . . . 0.0 111.196 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.6 t -99.25 144.19 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 163.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t70 -124.77 178.19 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -87.24 -27.02 23.2 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.719 0.808 . . . . 0.0 109.851 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.4 m -119.43 135.97 54.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.954 -1.476 . . . . 0.0 110.559 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -68.64 -22.51 64.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.153 0.981 . . . . 0.0 110.689 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 60' ' ' SER . 17.7 m -64.84 -34.37 69.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.62 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -36.43 73.68 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.24 -43.13 78.59 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.016 0.927 . . . . 0.0 110.835 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -66.75 -37.06 83.89 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.299 0.239 . . . . 0.0 110.813 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -59.83 -48.49 81.47 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.877 0.736 . . . . 0.0 110.631 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.45 -44.8 74.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.006 0.922 . . . . 0.0 111.237 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.95 -50.87 71.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.337 1.055 . . . . 0.0 111.507 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 15.0 tp -69.61 -23.74 63.56 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.991 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -68.26 -51.27 46.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.728 173.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.17 -36.11 80.85 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.702 0.801 . . . . 0.0 111.191 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -59.07 -54.55 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.995 0.809 . . . . 0.0 110.511 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -85.18 -6.43 59.28 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.15 -169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.17 39.18 58.51 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 120.877 0.154 . . . . 0.0 112.892 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -127.66 167.41 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.568 1.147 . . . . 0.0 109.279 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -115.78 135.4 54.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.457 0.703 . . . . 0.0 112.265 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.7 mm -111.41 168.48 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 163.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 60.9 m -132.95 105.59 7.18 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 163.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.4 p -88.27 121.17 30.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.267 0.627 . . . . 0.0 110.119 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.683 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.6 t -103.13 137.52 31.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -77.32 135.52 38.4 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.93 0.395 . . . . 0.0 110.321 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -43.63 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.909 1.684 . . . . 0.0 112.233 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -145.32 97.47 3.0 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 84.3 mt -102.1 -8.59 21.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.024 0.53 . . . . 0.0 111.193 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -17.31 43.57 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.305 0.642 . . . . 0.0 112.093 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -137.34 -3.2 1.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.711 0.404 . . . . 0.0 112.046 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 87.3 t80 -156.49 143.87 19.08 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' O ' HD21 ' A' ' 36' ' ' LEU . 7.5 p-10 -150.79 -70.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 36' ' ' LEU . 13.5 pt -142.68 125.55 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.404 0.682 . . . . 0.0 109.538 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 t -130.56 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -72.51 0.23 10.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.248 0.619 . . . . 0.0 112.374 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.85 -34.09 77.15 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.444 0.697 . . . . 0.0 109.235 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.61 -18.81 22.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.316 1.046 . . . . 0.0 112.452 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.511 ' NE1' HD22 ' A' ' 34' ' ' LEU . 24.3 m95 -118.69 134.51 55.07 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.821 0.448 . . . . 0.0 110.856 -171.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -73.58 -28.56 61.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.451 0.7 . . . . 0.0 111.137 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.09 163.67 28.64 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.668 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 92' ' ' ALA . 75.5 mt -133.9 155.59 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.22 142.89 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.533 1.133 . . . . 0.0 109.225 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -143.62 103.99 4.15 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 128' ' ' ILE . 17.7 mm -75.31 145.72 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -16.16 102.83 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.843 2.057 . . . . 0.0 113.891 -171.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 24.4 p -119.77 149.76 41.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.879 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -145.16 101.58 3.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.016 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.24 147.37 33.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.347 0.659 . . . . 0.0 111.114 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.19 162.15 37.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.965 2.443 . . . . 0.0 110.767 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.2 t -39.12 -39.42 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.094 1.758 . . . . 0.0 114.274 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -64.01 -53.17 54.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.026 0.53 . . . . 0.0 111.591 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.9 -22.16 31.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.222 0.609 . . . . 0.0 110.714 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.421 HH22 ' HB3' ' A' ' 151' ' ' PRO . 75.2 ttt180 -77.88 -55.3 5.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 0.0 109.827 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -60.88 -22.12 63.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.035 0.534 . . . . 0.0 112.289 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.64 -33.84 53.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.7 tp -77.88 -52.7 8.45 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.613 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -56.15 -51.96 76.62 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -168.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.28 -23.35 62.13 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 121.807 1.681 . . . . 0.0 112.109 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -86.99 -25.5 24.24 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.262 1.025 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 10.9 t -80.9 -37.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.363 -0.836 . . . . 0.0 109.403 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.36 -62.12 2.12 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -74.63 -36.64 62.9 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.36 -34.1 7.25 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -166.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 40.2 tp -69.42 104.32 2.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.593 0.697 . . . . 0.0 109.954 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.07 141.19 88.91 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 164.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.47 125.5 12.46 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.753 2.302 . . . . 0.0 112.326 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 129.31 -2.51 6.2 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.711 -177.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -95.03 139.68 14.63 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 165.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.6 m -108.53 129.76 62.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 123.302 0.641 . . . . 0.0 109.555 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 110.97 22.71 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 101' ' ' ILE . 77.4 mt -106.77 106.77 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 85.7 mt -129.23 153.68 47.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.16 0.984 . . . . 0.0 110.193 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.08 106.73 4.86 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.91 134.67 23.77 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.669 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.7 m-85 -89.61 160.04 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.004 0.522 . . . . 0.0 110.95 -172.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.064 -176.73 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 132' ' ' PHE . 25.6 mt -99.71 103.26 20.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HB3' HH22 ' A' ' 110' ' ' ARG . 89.7 Cg_endo -81.22 129.33 6.72 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.611 2.208 . . . . 0.0 112.417 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -92.54 165.58 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.013 0.925 . . . . 0.0 112.173 -177.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 188' ' ' ILE . 75.6 mt -56.81 -40.48 76.05 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.942 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.9 -43.57 59.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 0.0 111.037 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 32.5 m -78.41 -54.57 6.04 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.128 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.4 HD13 HD13 ' A' ' 129' ' ' LEU . 85.9 mt -72.03 -46.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.051 0.94 . . . . 0.0 112.577 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -60.31 -44.05 95.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.657 0.783 . . . . 0.0 109.784 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.9 t -72.3 -21.41 61.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.819 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -76.9 -23.52 52.55 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.247 0.619 . . . . 0.0 110.542 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 76.3 mt -130.3 75.21 79.51 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.38 -19.48 17.03 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.196 2.598 . . . . 0.0 113.355 -172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -87.87 -42.09 12.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 28.8 tp -69.03 71.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.549 172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.03 131.29 45.87 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -91.29 135.62 33.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.591 1.156 . . . . 0.0 109.317 -169.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.479 HD11 ' HG2' ' A' ' 193' ' ' GLN . 79.1 mt -72.39 -30.01 64.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.064 0.546 . . . . 0.0 110.13 171.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.9 mt -131.04 120.85 48.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 73.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -143.77 152.31 41.09 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.13 0.491 . . . . 0.0 111.982 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -77.94 105.08 8.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.924 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.21 123.75 50.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.549 0.74 . . . . 0.0 109.595 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.276 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 77.0 mt -117.67 167.66 11.14 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.531 ' HB ' HD21 ' A' ' 153' ' ' LEU . 8.2 pt -142.68 118.62 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.32 145.18 28.45 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 38.3 mt -131.47 131.18 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.889 1.276 . . . . 0.0 109.723 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.09 106.13 6.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.03 139.46 16.95 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.553 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 7.9 tp-100 -136.11 157.54 46.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.445 ' HB2' ' N ' ' A' ' 124' ' ' GLY . 59.6 tttp -56.02 120.13 6.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.961 165.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.373 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' HG ' ' A' ' 47' ' ' LEU . 20.1 tp -61.81 -33.31 73.89 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.566 1.146 . . . . 0.0 113.077 -174.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -45.9 -40.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -75.87 -46.65 29.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.749 . . . . 0.0 109.85 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -63.23 -35.59 72.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.549 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.9 81.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.397 1.079 . . . . 0.0 111.781 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.87 -29.01 70.43 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.448 172.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.604 ' HB3' HE22 ' A' ' 193' ' ' GLN . 27.1 mm-40 -89.75 -21.37 22.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.451 1.1 . . . . 0.0 112.557 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 24' ' ' VAL . 77.1 mt -79.08 136.13 57.82 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-O 119.301 -0.38 . . . . 0.0 110.307 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.35 133.96 20.09 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 123.776 2.984 . . . . 0.0 113.537 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.18 27.99 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.16 -139.26 6.15 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 118.716 0.689 . . . . 0.0 112.619 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 40.9 ttmt -86.55 114.89 23.66 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 28' ' ' ILE . 11.9 mt -110.64 126.83 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 90' ' ' ILE . 54.2 tp -89.97 114.05 25.82 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 m -88.9 135.22 33.65 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.14 152.29 20.03 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.725 0.41 . . . . 0.0 110.186 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.413 0 O-C-N 125.671 1.857 . . . . 0.0 114.219 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.018 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -72.32 -52.25 17.04 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.421 1.088 . . . . 0.0 110.249 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 101' ' ' ILE . 40.2 m-80 -76.07 -29.19 57.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.649 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.43 -57.84 11.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.67 0.788 . . . . 0.0 111.189 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.782 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 25.5 p -69.57 -26.98 64.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.362 0.665 . . . . 0.0 112.341 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 21' ' ' LEU . 38.2 t80 -60.14 -45.55 92.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.454 0.702 . . . . 0.0 109.465 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.681 ' HG ' HD21 ' A' ' 21' ' ' LEU . 68.9 mt -65.45 -32.63 74.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.863 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.56 74.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.394 0.278 . . . . 0.0 111.515 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.594 ' HA ' HG11 ' A' ' 76' ' ' VAL . 81.3 p -71.62 -6.6 42.14 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 123.245 0.34 . . . . 0.0 111.214 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' LEU . 50.0 mt -90.04 11.97 19.08 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.727 0.811 . . . . 0.0 111.124 168.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.63 21.31 66.75 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.549 0.58 . . . . 0.0 114.549 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.59 141.2 36.84 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.943 0.872 . . . . 0.0 110.917 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 45.6 mt-10 -77.47 88.53 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -90.63 107.31 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.592 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 34' ' ' LEU . 5.5 t -85.22 103.64 14.36 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.71 131.93 45.38 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.623 -169.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 81' ' ' VAL . 38.5 t -110.61 134.33 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 20.5 t70 -145.85 140.58 27.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 pt20 -68.52 -20.78 64.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.591 0.756 . . . . 0.0 111.661 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 m -112.9 141.49 46.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.959 0.904 . . . . 0.0 109.406 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.9 p -72.13 -15.95 61.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.646 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.38 -32.97 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.824 0.449 . . . . 0.0 111.113 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.17 -36.72 23.63 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.621 0.575 . . . . 0.0 113.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.72 -52.03 14.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.625 0.77 . . . . 0.0 111.25 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.38 -36.71 69.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.683 0.793 . . . . 0.0 112.302 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -64.3 -45.83 86.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.106 0.562 . . . . 0.0 110.572 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.782 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -58.69 -47.91 82.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 124.03 0.831 . . . . 0.0 110.59 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.82 -31.83 71.1 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.504 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -63.55 -51.93 63.3 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.365 0.666 . . . . 0.0 112.474 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 27.8 tp -67.97 -23.27 65.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.314 0.384 . . . . 0.0 110.49 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' A' ' 76' ' ' VAL . . . -61.45 -57.74 10.99 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 122.874 0.47 . . . . 0.0 110.187 172.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.21 -30.55 71.03 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.887 0.875 . . . . 0.0 112.247 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.02 -53.42 26.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.121 0.569 . . . . 0.0 111.257 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -98.04 1.72 48.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.616 0.367 . . . . 0.0 111.437 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.56 43.2 69.65 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 122.321 -0.237 . . . . 0.0 113.484 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 49' ' ' SER . 27.7 m -118.55 169.85 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.579 1.152 . . . . 0.0 109.478 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -112.15 128.7 56.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.891 0.476 . . . . 0.0 111.983 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.8 163.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.637 1.575 . . . . 0.0 107.573 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.5 m -136.53 105.18 5.81 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.0 p -87.34 121.44 29.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.287 -168.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 57' ' ' VAL . 47.5 t -114.59 135.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.261 1.425 . . . . 0.0 108.834 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.11 130.64 35.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 59' ' ' GLN . 32.5 t -69.21 118.04 11.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.891 0.476 . . . . 0.0 111.961 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -142.99 86.79 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 167.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.1 mt -78.19 -20.93 50.91 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.13 -13.46 61.19 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 112.187 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.57 -29.39 4.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.285 0.634 . . . . 0.0 111.518 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -159.03 125.41 4.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.524 1.13 . . . . 0.0 108.313 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -70.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.519 HG22 HD23 ' A' ' 34' ' ' LEU . 7.3 pt -140.2 119.22 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.134 0.974 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -130.8 98.33 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.91 0.884 . . . . 0.0 108.722 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.29 -9.53 5.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.85 -52.83 21.58 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.196 0.598 . . . . 0.0 110.812 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.62 -29.34 66.82 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -169.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CZ3' HG12 ' A' ' 98' ' ' ILE . 11.1 p-90 -133.62 176.28 8.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.673 0.789 . . . . 0.0 110.938 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.15 -90.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.301 0.64 . . . . 0.0 111.229 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.87 172.13 41.89 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 118.448 0.567 . . . . 0.0 113.509 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 121' ' ' LEU . 5.9 mt -123.09 150.86 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.55 0.74 . . . . 0.0 109.025 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.408 HG12 HG22 ' A' ' 33' ' ' ILE . 14.1 p -144.46 134.53 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 163.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -133.02 99.2 4.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 43' ' ' ASN . 30.4 mm -74.88 154.75 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.258 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -18.42 104.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.067 2.147 . . . . 0.0 113.592 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.05 148.96 44.06 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.63 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.419 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 6.3 p-80 -147.16 101.64 3.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.09 143.29 26.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.544 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.2 158.57 47.68 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.652 2.234 . . . . 0.0 110.732 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 t -45.59 -36.41 4.69 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.38 1.472 . . . . 0.0 113.737 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 p -56.28 -58.81 6.37 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.355 1.062 . . . . 0.0 111.997 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.25 -19.09 37.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.859 0.864 . . . . 0.0 111.07 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -77.94 -47.25 19.06 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.647 0.779 . . . . 0.0 109.438 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -52.79 -34.49 53.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.903 0.881 . . . . 0.0 111.783 164.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -75.67 -44.27 43.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 117' ' ' VAL . 49.2 tp -92.19 -55.56 3.38 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.67 -40.02 6.24 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 119.623 1.101 . . . . 0.0 112.479 -161.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.37 -28.92 87.71 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 122.281 1.987 . . . . 0.0 112.044 166.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 5.5 tppp? -77.42 -24.77 50.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.396 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 113' ' ' LEU . 41.6 t -72.13 -34.18 49.23 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.364 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -53.93 -62.39 1.69 Allowed 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.69 -33.66 35.24 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.22 57.28 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 98' ' ' ILE . 26.8 tp -60.7 128.37 36.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.882 0.473 . . . . 0.0 110.604 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 148.56 34.68 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.74 113.28 1.76 Allowed 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.74 1.626 . . . . 0.0 111.201 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 128.31 6.15 4.88 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.017 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -101.53 143.59 16.14 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 164.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.2 m -110.78 130.67 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.566 0.746 . . . . 0.0 109.16 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CE2' HD11 ' A' ' 129' ' ' LEU . 8.8 t80 -106.61 112.55 25.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 24' ' ' VAL . 55.6 mt -115.43 109.01 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.995 0.918 . . . . 0.0 110.25 -168.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 127' ' ' PHE . 89.0 mt -128.96 133.91 47.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.354 0.662 . . . . 0.0 110.073 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -113.09 98.84 7.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.522 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -88.92 -174.49 46.78 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.721 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.408 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.6 m-85 -138.56 159.54 41.84 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.08 0.952 . . . . 0.0 108.565 -177.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 123.743 0.817 . . . . 0.0 110.454 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 132' ' ' PHE . 36.4 mt -89.75 103.85 7.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -67.74 103.58 0.86 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.079 2.52 . . . . 0.0 111.729 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 188' ' ' ILE . 16.4 ptpt -100.43 152.4 20.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.284 0.493 . . . . 0.0 112.185 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.3 -38.05 87.9 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.79 0.836 . . . . 0.0 110.881 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -48.23 -52.63 20.21 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.267 1.027 . . . . 0.0 111.143 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.0 p -76.41 -61.91 1.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.201 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.69 -46.84 86.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.307 1.043 . . . . 0.0 112.787 -166.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -64.87 -33.27 75.61 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 123.229 0.33 . . . . 0.0 111.185 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.2 t -78.61 -23.32 45.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.568 0.347 . . . . 0.0 111.098 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -86.72 -12.3 48.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.684 0.794 . . . . 0.0 111.251 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.89 64.53 42.47 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.684 0.794 . . . . 0.0 109.156 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.13 4.34 7.15 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.814 2.343 . . . . 0.0 111.786 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 t -87.52 -34.58 18.57 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.498 HD13 HD21 ' A' ' 121' ' ' LEU . 25.7 tp -97.97 73.6 2.26 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 125.973 1.709 . . . . 0.0 110.878 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -57.36 124.28 18.35 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 12.4 m95 -89.33 139.77 30.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.591 1.156 . . . . 0.0 109.561 -170.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.658 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 96.3 mt -68.09 -44.98 75.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 169.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 79.0 mt -126.4 120.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.37 78.2 1.27 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -143.62 152.57 41.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.004 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -87.05 120.42 28.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.87 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.05 106.36 17.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 123.878 0.871 . . . . 0.0 109.558 -173.399 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.5 mt -122.33 151.7 40.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 152' ' ' LYS . 9.2 pt -139.19 142.84 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -124.94 145.29 49.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.591 0.71 . . . . 0.0 110.5 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.56 135.74 48.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.013 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 24' ' ' VAL . 16.6 tp -140.24 105.12 4.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.67 133.2 11.63 Favored Glycine 0 C--O 1.219 -0.783 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.658 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 7.8 tp60 -120.18 146.44 46.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.566 0.683 . . . . 0.0 111.35 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.566 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -62.12 138.17 58.36 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.581 0.551 . . . . 0.0 109.559 168.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--O 1.241 0.657 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.339 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 CA--C 1.549 0.911 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 tp -68.46 -21.39 64.63 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.383 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 m -86.46 -28.91 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 119.007 0.822 . . . . 0.0 109.434 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -74.83 -44.67 48.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.993 0.917 . . . . 0.0 110.001 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 28' ' ' ILE . 19.0 m -64.16 -37.04 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.6 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.02 67.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.16 -26.6 65.84 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.129 0.572 . . . . 0.0 109.728 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.721 ' HB3' HE21 ' A' ' 193' ' ' GLN . 24.0 mm-40 -88.74 -25.96 22.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.973 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 24' ' ' VAL . 47.9 mt -73.71 130.25 83.87 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.26 132.95 29.58 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.231 2.621 . . . . 0.0 112.835 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -74.58 27.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.96 -134.91 5.76 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -82.15 114.91 21.0 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.7 151.2 11.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 95' ' ' TRP . 66.9 tp -119.61 120.45 36.73 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 28.5 p -108.7 126.68 53.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.86 -172.42 1.3 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 123.599 0.76 . . . . 0.0 111.056 166.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.162 0 N-CA-C 113.769 0.267 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -61.98 -35.14 77.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.386 0.674 . . . . 0.0 112.049 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -56.15 -52.31 64.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.876 0.735 . . . . 0.0 111.099 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.51 -54.16 50.04 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.317 1.011 . . . . 0.0 111.8 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 6.2 p -67.89 -28.93 67.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.791 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 84.1 t80 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.446 0.698 . . . . 0.0 110.079 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 99' ' ' VAL . 50.9 mt -65.03 -35.85 82.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.829 0.852 . . . . 0.0 111.228 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.45 63.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.394 0.278 . . . . 0.0 111.247 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 76' ' ' VAL . 50.4 m -61.71 -23.05 65.88 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.355 0.662 . . . . 0.0 111.092 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.0 mt -78.23 12.39 1.92 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.988 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.51 66.59 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.475 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -103.41 152.98 20.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.252 0.526 . . . . 0.0 111.274 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -90.96 91.06 8.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.5 t -98.87 126.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.403 0.681 . . . . 0.0 109.985 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 m -99.77 111.69 24.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.738 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -96.68 139.53 32.61 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.814 0.446 . . . . 0.0 110.304 -172.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.0 t -118.28 150.09 20.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 164.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 27.8 t0 -157.99 144.57 17.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.288 0.495 . . . . 0.0 109.893 172.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.33 -20.47 66.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.073 0.858 . . . . 0.0 112.02 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 62' ' ' VAL . 1.9 m -108.92 140.32 42.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.158 0.983 . . . . 0.0 109.325 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 m -69.44 -29.23 66.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.784 0.434 . . . . 0.0 110.85 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 60' ' ' SER . 11.0 m -61.66 -35.25 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.829 0.706 . . . . 0.0 111.976 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.01 -35.37 35.01 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.53 0.519 . . . . 0.0 112.81 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -50.97 62.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.56 0.744 . . . . 0.0 110.435 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.13 76.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.158 0.983 . . . . 0.0 112.589 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -62.93 -43.81 97.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.429 0.692 . . . . 0.0 110.141 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -63.61 -46.02 87.67 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.28 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -67.24 -42.96 83.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.674 0.79 . . . . 0.0 110.782 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.49 -54.52 42.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.31 1.044 . . . . 0.0 111.627 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.513 HD23 ' SG ' ' A' ' 45' ' ' CYS . 30.5 tp -65.95 -28.82 69.19 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.923 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.78 -62.94 1.32 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.457 0.473 . . . . 0.0 111.062 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.62 -25.57 67.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.145 0.578 . . . . 0.0 111.274 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.79 -54.74 14.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.739 0.415 . . . . 0.0 109.904 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.28 -5.32 58.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.98 0.512 . . . . 0.0 112.083 -171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.58 34.15 40.64 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 121.923 -0.179 . . . . 0.0 113.064 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.0 m -125.21 170.46 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.633 1.173 . . . . 0.0 108.416 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -121.45 138.28 54.35 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mm -116.61 167.2 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -133.99 105.49 6.76 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 165.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.3 p -89.72 137.25 32.5 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.667 0.746 . . . . 0.0 111.576 -167.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 57' ' ' VAL . 58.8 t -125.05 135.0 65.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.324 1.849 . . . . 0.0 107.845 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -83.18 139.84 32.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 p -48.98 109.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.246 1.018 . . . . 0.0 113.144 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -136.58 93.7 2.91 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 90.8 mt -103.15 -35.25 8.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.141 0.577 . . . . 0.0 111.822 -170.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.09 -5.83 50.44 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.045 0.538 . . . . 0.0 112.117 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -116.23 -28.64 6.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.983 0.913 . . . . 0.0 111.174 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 47.3 t80 -157.79 156.09 30.93 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 125.166 1.387 . . . . 0.0 107.696 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.56 -70.58 0.17 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.407 1.458 . . . . 0.0 108.927 163.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.648 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.5 pt -139.5 118.77 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 0.0 110.268 -172.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.42 86.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.2 1.96 6.74 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.29 -47.87 69.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 165.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 -11.79 39.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.066 0.947 . . . . 0.0 111.962 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 34' ' ' LEU . 60.4 m95 -120.3 117.77 28.67 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.612 0.765 . . . . 0.0 110.119 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -58.46 -47.62 83.4 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.677 0.791 . . . . 0.0 111.366 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.97 156.28 18.11 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.924 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.3 mt -129.47 148.52 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 171.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 47' ' ' LEU . 4.3 p -135.27 143.12 37.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.759 1.224 . . . . 0.0 107.99 161.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.425 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 50.0 m -143.63 102.17 3.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.66 83.96 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 27.1 t80 -74.54 117.84 16.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.345 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.5 p -113.49 173.65 6.3 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -55.56 101.23 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.514 0.726 . . . . 0.0 110.721 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.16 139.81 42.37 Favored Pre-proline 0 C--O 1.247 0.961 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.61 144.9 24.16 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.838 2.359 . . . . 0.0 110.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -43.33 -34.61 1.27 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.713 1.205 . . . . 0.0 113.495 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 t -56.55 -64.25 0.93 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.45 1.1 . . . . 0.0 111.506 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.78 -30.74 65.87 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.728 0.411 . . . . 0.0 111.324 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -63.62 -62.4 1.69 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.682 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.49 -30.77 67.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -73.77 -33.95 64.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.178 0.591 . . . . 0.0 110.516 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.18 -48.48 62.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.855 0.722 . . . . 0.0 111.314 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -57.63 -44.31 99.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -166.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.41 -28.08 83.46 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 122.077 1.778 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -88.18 -12.38 44.05 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.026 0.931 . . . . 0.0 111.296 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 3.4 t -85.32 -33.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 165.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -66.07 -61.5 2.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.697 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.8 -47.78 16.04 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.83 -39.34 39.51 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 -166.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 28.4 tp -70.9 96.2 1.25 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.555 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 30.0 mmmt -67.0 130.13 93.93 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 27.5 Cg_exo -39.85 123.44 1.23 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.422 3.415 . . . . 0.0 114.547 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.99 14.78 2.98 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.704 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.88 150.47 17.04 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 167.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 20.4 m -109.84 131.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 123.264 0.626 . . . . 0.0 109.943 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.3 t80 -110.37 113.06 25.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.51 111.7 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.792 0.837 . . . . 0.0 109.865 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 156' ' ' LEU . 2.1 mp -129.18 149.5 50.96 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.302 0.641 . . . . 0.0 110.068 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 45.2 tt0 -135.67 103.64 5.5 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.803 0.689 . . . . 0.0 109.253 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.6 148.33 27.59 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 170.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.44 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.1 m-85 -111.04 168.28 9.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.609 0.763 . . . . 0.0 110.39 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 124.25 1.02 . . . . 0.0 111.861 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 132' ' ' PHE . 59.5 mt -81.72 108.17 10.32 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.718 ' HB2' HD11 ' A' ' 156' ' ' LEU . 65.3 Cg_endo -83.34 123.88 3.55 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.315 2.01 . . . . 0.0 111.79 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -86.65 159.09 19.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.141 0.976 . . . . 0.0 111.95 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 188' ' ' ILE . 71.7 mt -61.61 -36.63 81.27 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 166.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.23 -50.45 72.82 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.01 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 73.5 p -68.75 -62.33 1.43 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.299 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 151' ' ' PRO . 70.8 mt -61.84 -49.93 74.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.81 1.244 . . . . 0.0 112.952 -166.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.5 tt0 -58.47 -43.19 88.85 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 123.685 0.616 . . . . 0.0 111.426 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 t -73.13 -23.23 60.46 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.463 0.305 . . . . 0.0 111.594 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 155' ' ' THR . 53.9 mt-10 -80.86 -18.04 48.68 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.684 0.793 . . . . 0.0 111.399 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 97.0 mt -133.65 66.73 74.17 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.311 0.644 . . . . 0.0 110.507 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.35 2.97 7.89 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.783 2.322 . . . . 0.0 112.309 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.1 m -86.02 -35.23 20.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.4 tp -102.14 70.19 1.19 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.002 1.721 . . . . 0.0 110.663 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -64.98 136.88 57.32 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.664 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 19.3 m95 -96.98 136.92 36.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.512 0.725 . . . . 0.0 110.545 -163.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 46.2 mt -68.33 -30.02 68.9 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.634 0.584 . . . . 0.0 109.729 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 67.0 mt -132.01 125.09 54.29 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.38 66.38 0.7 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -128.97 143.71 50.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.655 -162.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -89.96 99.32 12.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.386 1.075 . . . . 0.0 109.535 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.7 mt -108.19 129.92 55.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.359 1.064 . . . . 0.0 111.56 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 123.113 0.565 . . . . 0.0 109.946 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.97 149.48 40.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 19.8 pt -132.54 117.24 30.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -98.55 144.58 27.72 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.375 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 48.6 mt -128.63 137.21 51.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.53 -1.213 . . . . 0.0 109.525 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.475 HD22 HG12 ' A' ' 24' ' ' VAL . 33.3 tp -135.11 105.08 6.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -90.92 138.14 14.21 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.721 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.1 tp-100 -143.52 157.43 44.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.299 0.64 . . . . 0.0 110.752 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 62.9 tttm -56.29 120.74 8.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.265 1.026 . . . . 0.0 109.207 172.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 N--CA 1.473 0.7 0 C-N-CA 122.58 0.352 . . . . 0.0 111.536 -173.791 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 CA--C 1.558 1.281 0 CA-C-O 121.296 0.57 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.98 -17.73 10.88 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.811 1.244 . . . . 0.0 112.747 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.55 -27.46 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.516 1.053 . . . . 0.0 109.398 -171.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 17.4 m -66.68 -52.69 41.9 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.473 0.709 . . . . 0.0 109.422 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 HD22 ' A' ' 191' ' ' LEU . 19.3 m -65.98 -37.09 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.9 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -58.68 -42.18 87.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.273 1.029 . . . . 0.0 112.25 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.51 -23.65 64.58 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.858 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.5 mm100 -83.91 -14.24 51.52 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.263 0.625 . . . . 0.0 111.366 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -82.89 128.94 63.7 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.275 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.15 140.05 41.82 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.122 2.548 . . . . 0.0 113.063 169.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.21 27.41 0.05 Allowed 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.42 -136.77 6.56 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-O 119.397 -0.669 . . . . 0.0 112.919 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -75.21 112.7 11.75 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -107.92 116.04 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.64 113.79 26.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 110.208 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 8.8 t -104.05 108.57 19.99 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 122.451 0.3 . . . . 0.0 111.531 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 90' ' ' ILE . 61.7 mt -81.26 123.41 28.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.646 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 1.359 0 O-C-N 125.153 1.533 . . . . 0.0 111.255 174.538 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtm105 -55.64 -26.69 45.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.786 1.234 . . . . 0.0 113.557 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.72 -54.63 32.51 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.351 0.661 . . . . 0.0 111.304 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.35 74.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.983 0.802 . . . . 0.0 110.808 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 26.5 m -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.906 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 89.0 t80 -66.14 -51.88 53.7 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.697 0.623 . . . . 0.0 109.6 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 99' ' ' VAL . 93.4 mt -61.38 -37.02 81.89 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.437 1.086 . . . . 0.0 110.901 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.71 66.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.312 0.645 . . . . 0.0 112.078 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.633 ' HA ' HG11 ' A' ' 76' ' ' VAL . 96.1 p -70.32 -2.78 14.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.2 mt -82.76 12.96 4.17 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.028 0.531 . . . . 0.0 110.501 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.44 32.82 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 119.846 -0.419 . . . . 0.0 113.925 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.8 158.87 35.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.352 0.576 . . . . 0.0 111.141 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.4 91.31 6.15 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.755 0.822 . . . . 0.0 108.98 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.95 110.45 23.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.993 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 79' ' ' THR . 47.4 p -84.88 105.48 15.69 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.073 173.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.0 129.2 46.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.245 0.618 . . . . 0.0 110.772 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.25 123.62 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.32 134.44 25.72 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.03 -2.45 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.66 1.184 . . . . 0.0 113.329 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 m -119.93 119.61 33.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.2 m -73.44 -24.95 60.31 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.306 0.642 . . . . 0.0 110.291 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.25 -35.88 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.776 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.01 -35.16 58.03 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.747 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.63 -49.71 69.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.494 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.611 0.764 . . . . 0.0 112.043 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -66.23 -46.28 77.75 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.874 0.87 . . . . 0.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.531 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -63.59 -40.92 98.17 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.99 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 36.6 ttpt -65.49 -45.05 85.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.462 1.105 . . . . 0.0 110.938 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 -51.55 68.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.105 0.962 . . . . 0.0 110.872 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.37 -30.59 70.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.172 0.92 . . . . 0.0 111.022 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -64.05 -61.37 2.31 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.505 0.503 . . . . 0.0 111.256 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.12 -24.39 65.01 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.341 0.656 . . . . 0.0 110.842 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.44 -35.24 75.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.932 0.893 . . . . 0.0 110.44 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.83 -10.41 45.47 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.39 0.676 . . . . 0.0 111.251 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.63 36.16 20.48 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 113.633 0.213 . . . . 0.0 113.633 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 49' ' ' SER . 19.4 m -132.32 174.58 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.373 1.069 . . . . 0.0 110.048 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.25 129.46 54.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.0 0.92 . . . . 0.0 111.814 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.1 mm -108.68 166.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 162.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 55' ' ' THR . 90.3 m -134.06 110.59 9.74 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 160.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.4 p -81.94 120.47 25.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.65 153.46 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.727 1.211 . . . . 0.0 109.693 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -85.81 103.59 14.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.6 p -46.9 99.92 0.02 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.55 1.14 . . . . 0.0 112.672 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -141.0 96.57 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 91.9 mt -103.79 -15.02 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.033 0.933 . . . . 0.0 112.424 -176.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -18.18 32.32 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.533 0.733 . . . . 0.0 112.651 -174.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.42 -10.9 3.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.759 0.823 . . . . 0.0 111.495 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.2 t80 -151.68 157.62 42.33 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -153.84 -57.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 117' ' ' VAL . 3.1 pt -151.81 134.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.0 109.322 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 93' ' ' ASP . 84.4 t -123.64 150.99 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.305 1.042 . . . . 0.0 108.215 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.27 -29.63 19.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.296 0.57 . . . . 0.0 110.27 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 91' ' ' VAL . 23.3 t70 -70.34 -51.66 28.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.262 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.34 -25.9 33.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.161 0.584 . . . . 0.0 112.362 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.425 ' HD1' ' H ' ' A' ' 91' ' ' VAL . 57.1 m95 -111.81 107.08 16.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.06 0.457 . . . . 0.0 110.865 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -56.88 12.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.165 1.386 . . . . 0.0 109.525 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.22 143.06 15.63 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.47 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.557 HD13 ' HB ' ' A' ' 90' ' ' ILE . 87.7 mt -124.9 127.26 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -123.12 102.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.308 1.052 . . . . 0.0 109.732 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.415 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 46.6 m -97.33 91.59 5.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.7 mm -72.37 150.36 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.869 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -17.92 105.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 127.258 2.223 . . . . 0.0 113.46 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 p -111.38 106.26 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.549 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -98.09 99.53 10.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.2 mt -114.81 146.07 35.29 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.735 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.583 ' HA ' HD13 ' A' ' 149' ' ' LEU . 35.8 Cg_exo -61.69 155.4 54.06 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.963 2.442 . . . . 0.0 110.715 167.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -46.3 -38.66 8.96 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.979 0.912 . . . . 0.0 112.752 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.8 m -56.0 -52.41 64.31 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 123.925 0.766 . . . . 0.0 111.986 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.96 -22.04 31.57 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.236 0.615 . . . . 0.0 111.039 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -76.08 -52.43 10.18 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.4 -14.23 62.85 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.746 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.2 -39.56 25.23 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 117' ' ' VAL . 64.2 tp -75.52 -60.25 2.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.033 0.533 . . . . 0.0 111.933 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -58.94 -43.72 97.99 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -164.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.8 -23.38 26.13 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 121.774 1.649 . . . . 0.0 112.04 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -86.17 -14.65 43.4 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.783 0.833 . . . . 0.0 110.16 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.598 ' HA ' HD11 ' A' ' 90' ' ' ILE . 28.9 t -75.27 -40.18 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 166.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.78 -54.16 50.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.109 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.2 -46.79 63.83 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.313 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.58 -57.27 3.92 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.376 0.511 . . . . 0.0 114.376 -172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' A' ' 90' ' ' ILE . 6.0 tt -74.6 138.28 42.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.553 0.741 . . . . 0.0 109.817 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -120.05 168.54 10.17 Favored Pre-proline 0 C--O 1.247 0.933 0 C-N-CA 124.622 1.169 . . . . 0.0 108.583 172.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.07 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 122.003 1.802 . . . . 0.0 112.042 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.72 -2.05 4.42 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.176 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -114.52 145.03 18.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 159.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.2 131.5 58.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.87 1.268 . . . . 0.0 109.447 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.2 t80 -106.37 111.71 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.24 107.82 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 91.3 mt -118.35 141.02 48.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.753 0.821 . . . . 0.0 110.669 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -127.15 101.43 6.51 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 164.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 179.6 53.19 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 164.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.495 ' H ' HD22 ' A' ' 150' ' ' LEU . 36.0 m-85 -130.16 169.37 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.116 0.566 . . . . 0.0 110.174 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 106' ' ' PRO . 23.9 mt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 132' ' ' PHE . 88.2 mt -72.88 115.35 39.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 123.307 0.379 . . . . 0.0 110.554 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 55.6 Cg_endo -93.79 114.11 0.23 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 122.647 2.231 . . . . 0.0 109.988 167.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -73.09 167.93 20.12 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.776 0.43 . . . . 0.0 111.761 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.634 HD21 ' HB ' ' A' ' 188' ' ' ILE . 67.8 mt -61.14 -30.58 70.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 0.0 110.9 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -56.8 -59.38 5.11 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.425 0.69 . . . . 0.0 110.73 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.1 p -65.57 -38.42 89.49 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.592 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.2 -43.68 23.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -173.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.477 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 29.6 tt0 -58.96 -40.02 83.47 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 120.927 0.394 . . . . 0.0 110.905 173.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -80.47 -13.3 59.23 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.438 0.695 . . . . 0.0 111.258 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -74.37 -31.77 62.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.464 0.706 . . . . 0.0 109.861 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 79.8 mt -134.08 74.25 68.55 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.99 -33.58 31.86 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.289 2.659 . . . . 0.0 113.407 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t -82.78 -35.43 26.53 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.5 tp -66.89 71.77 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.674 1.19 . . . . 0.0 111.799 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -51.8 120.93 5.78 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.797 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 55.3 m95 -87.94 119.7 28.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.508 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 79.8 mt -68.08 -33.76 75.15 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.846 0.458 . . . . 0.0 110.276 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.6 128.33 69.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.63 81.67 1.34 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -137.62 144.43 41.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.899 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.36 125.53 35.17 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.7 mt -105.75 107.12 17.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.119 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.422 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.7 mt -120.92 144.07 48.63 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 153' ' ' LEU . 27.3 pt -124.12 116.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.8 1.182 . . . . 0.0 109.944 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -100.04 146.74 26.4 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.692 0.758 . . . . 0.0 110.586 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 46.0 mt -137.07 141.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.073 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.542 HD22 HG12 ' A' ' 24' ' ' VAL . 40.9 tp -134.19 106.35 7.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 168.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.31 140.59 19.2 Favored Glycine 0 CA--C 1.505 -0.551 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.615 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 45.4 tp60 -123.75 148.37 46.68 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 193' ' ' GLN . 0.7 OUTLIER -57.11 115.92 2.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.371 161.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 167.932 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.654 0.264 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 24' ' ' VAL . 33.7 tp -67.62 -54.4 20.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.131 0.572 . . . . 0.0 111.208 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 m -47.39 -25.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 m -68.36 -49.07 62.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.862 0.865 . . . . 0.0 110.767 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.786 HG21 HD11 ' A' ' 128' ' ' ILE . 1.5 m -64.77 -36.48 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.032 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.54 66.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.1 -35.24 77.82 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.855 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -82.86 -18.25 41.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.143 0.977 . . . . 0.0 112.466 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 24' ' ' VAL . 74.1 mt -77.02 135.64 66.82 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.965 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.59 142.48 90.38 Favored 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.467 2.778 . . . . 0.0 112.331 171.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 28.2 pt20 -70.73 28.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.63 -141.87 6.76 Favored Glycine 0 N--CA 1.478 1.447 0 CA-C-N 118.769 0.713 . . . . 0.0 113.338 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 62.0 mttp -76.91 115.32 16.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 54' ' ' VAL . 21.0 mt -107.63 121.45 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 55' ' ' THR . 55.6 tp -90.69 111.62 23.04 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.02 0.528 . . . . 0.0 111.289 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 98.6 m -87.19 134.9 33.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.83 152.63 18.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.749 0.419 . . . . 0.0 110.469 167.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.953 0 O-C-N 124.685 1.241 . . . . 0.0 111.779 177.147 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -81.24 -26.38 35.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.257 1.023 . . . . 0.0 109.617 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' HG21 ' A' ' 101' ' ' ILE . 23.9 m120 -67.25 -35.08 78.8 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.943 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 56' ' ' ALA . . . -53.42 -57.55 10.23 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.418 1.087 . . . . 0.0 111.813 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.918 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 8.3 p -66.03 -34.13 77.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.976 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.96 -43.09 88.93 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.57 0.544 . . . . 0.0 111.29 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 99' ' ' VAL . 84.9 mt -67.35 -30.78 70.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.47 -36.71 74.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.724 0.41 . . . . 0.0 110.542 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -63.95 -14.63 55.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.207 1.003 . . . . 0.0 112.341 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.0 mt -85.26 17.19 3.17 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.934 0.894 . . . . 0.0 110.705 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 37.73 25.39 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 123.563 0.601 . . . . 0.0 114.436 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 25.2 m-85 -126.69 154.36 44.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.998 0.519 . . . . 0.0 111.318 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 33.5 mt-10 -89.6 86.9 6.84 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 33' ' ' ILE . 71.2 t -93.23 108.49 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.783 0.802 . . . . 0.0 110.376 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.8 t -83.69 108.71 16.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.957 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . . . -96.42 132.41 41.99 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.748 0.819 . . . . 0.0 111.359 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.29 120.51 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 22.4 t0 -136.27 134.91 38.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.238 0.472 . . . . 0.0 109.972 174.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -53.8 -24.03 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.771 1.628 . . . . 0.0 112.837 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 t -123.3 164.23 19.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 111.081 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.2 p -77.36 -18.35 57.46 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.096 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.51 -44.39 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.62 -34.01 40.91 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.275 0.359 . . . . 0.0 112.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 93.5 mt -69.02 -47.67 64.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.558 0.743 . . . . 0.0 111.61 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -54.31 -55.67 26.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.815 0.846 . . . . 0.0 111.855 171.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.35 -39.16 66.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.619 0.767 . . . . 0.0 110.842 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.918 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -59.98 -52.51 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.293 177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -69.01 -38.75 79.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 5.7 mm100 -62.51 -45.44 92.97 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.496 0.318 . . . . 0.0 111.395 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 45' ' ' CYS . 32.1 tp -70.92 -27.39 63.73 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.359 0.412 . . . . 0.0 110.785 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.15 -62.4 1.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 110.546 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.97 -30.21 70.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.586 0.754 . . . . 0.0 111.617 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.77 -54.58 25.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.06 0.544 . . . . 0.0 110.718 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.439 ' HE2' HD11 ' A' ' 70' ' ' LEU . 24.8 ttmm -83.87 -15.71 47.12 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.48 0.712 . . . . 0.0 111.727 -170.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.93 41.97 7.88 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 121.828 -0.225 . . . . 0.0 113.284 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.53 175.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.591 1.156 . . . . 0.0 109.109 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.14 140.69 51.65 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.031 0.378 . . . . 0.0 111.896 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.658 HG12 ' HB2' ' A' ' 71' ' ' ALA . 20.1 mm -115.56 160.75 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.004 1.322 . . . . 0.0 107.555 167.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.8 m -127.49 110.12 12.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 164.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.8 p -84.24 111.63 19.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.044 0.538 . . . . 0.0 109.822 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 157.25 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.177 1.391 . . . . 0.0 110.698 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.38 103.81 15.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.87 99.26 0.08 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.018 0.437 . . . . 0.0 111.618 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -142.64 91.54 2.32 Favored 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.57 -17.26 61.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.349 0.522 . . . . 0.0 110.839 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.34 -0.9 51.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.543 1.137 . . . . 0.0 112.295 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.04 -32.8 0.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -167.32 107.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.04 -63.4 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.483 1.113 . . . . 0.0 108.21 -171.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.624 ' HB ' HD13 ' A' ' 98' ' ' ILE . 29.8 pt -138.64 122.62 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.609 0.763 . . . . 0.0 110.8 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.44 87.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.719 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.95 -1.84 13.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.477 0.711 . . . . 0.0 112.744 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.86 -48.06 67.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.08 -24.41 30.37 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.923 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.481 ' CD2' HG21 ' A' ' 55' ' ' THR . 17.9 m95 -112.85 161.78 16.56 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.113 0.565 . . . . 0.0 109.682 -172.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.74 -58.1 2.85 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.82 16.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.257 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.624 HD13 ' HB ' ' A' ' 90' ' ' ILE . 80.6 mt -134.36 119.36 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 47' ' ' LEU . 11.6 p -109.11 133.27 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -125.96 90.9 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.547 HD13 HD12 ' A' ' 128' ' ' ILE . 12.2 mm -69.29 155.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.877 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -19.28 103.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 126.215 1.806 . . . . 0.0 113.501 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.28 114.55 11.61 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.271 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -97.76 100.24 11.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.9 mt -93.47 148.76 36.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.708 0.403 . . . . 0.0 110.279 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.57 156.71 55.29 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.156 1.904 . . . . 0.0 110.193 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.8 m -50.83 -33.0 21.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.033 0.933 . . . . 0.0 112.585 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -58.84 -52.99 63.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.899 0.88 . . . . 0.0 111.623 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.7 mt -83.42 -18.66 37.96 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.978 0.511 . . . . 0.0 111.283 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -63.71 -62.88 1.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -67.78 -10.52 53.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.617 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -77.84 -54.18 6.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.786 0.434 . . . . 0.0 109.926 166.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.3 tp -74.71 -49.85 19.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -165.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -67.25 -35.34 8.47 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.53 -33.68 96.85 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.194 1.929 . . . . 0.0 112.794 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 34.3 mmtp -72.64 -27.39 62.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.627 0.771 . . . . 0.0 110.894 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 127' ' ' PHE . 15.0 t -84.01 -34.75 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.727 0.411 . . . . 0.0 110.427 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.48 -61.76 2.35 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.94 -49.2 63.18 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.808 0.843 . . . . 0.0 113.247 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.27 24.07 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -164.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 125' ' ' GLY . 44.7 tp -70.82 104.37 2.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.463 0.632 . . . . 0.0 110.43 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.71 153.21 78.22 Favored Pre-proline 0 C--O 1.247 0.929 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -48.69 116.03 1.92 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.954 2.436 . . . . 0.0 113.277 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.86 12.23 2.46 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.318 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -102.24 146.67 16.99 Favored Glycine 0 N--CA 1.441 -0.975 0 O-C-N 122.539 -0.389 . . . . 0.0 112.437 163.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.6 m -116.64 130.88 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.825 0.85 . . . . 0.0 108.767 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -111.9 113.07 25.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.786 HD11 HG21 ' A' ' 24' ' ' VAL . 14.7 mt -107.62 108.93 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 49.8 mt -113.49 150.3 33.07 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.515 0.726 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.42 138.95 43.76 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 161.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.54 -176.44 14.37 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.405 ' HB2' HD21 ' A' ' 150' ' ' LEU . 53.3 m-85 -102.62 166.69 10.37 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.471 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 132' ' ' PHE . 95.1 mt -68.57 118.88 64.52 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 123.684 0.615 . . . . 0.0 112.194 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -94.71 98.28 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.916 2.411 . . . . 0.0 109.88 166.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 167.87 20.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.285 0.634 . . . . 0.0 111.335 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 188' ' ' ILE . 29.8 mt -67.07 -31.54 72.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.243 0.617 . . . . 0.0 110.984 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -55.49 -45.88 76.98 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.84 0.713 . . . . 0.0 111.058 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -84.26 -35.69 23.2 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.698 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 129' ' ' LEU . 40.8 mt -75.21 -47.24 29.16 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.464 0.706 . . . . 0.0 112.022 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.5 tt0 -60.68 -35.81 77.19 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.72 0.408 . . . . 0.0 111.154 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -71.86 -26.83 62.51 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 111.11 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.57 -15.0 44.05 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.247 1.019 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 78.0 mt -135.67 68.18 65.83 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.03 3.09 8.09 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 123.049 2.499 . . . . 0.0 112.226 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t -90.21 -36.36 14.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.407 1.083 . . . . 0.0 108.59 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.2 tp -94.75 72.32 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.35 1.46 . . . . 0.0 111.715 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -51.78 124.72 13.13 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.283 0.564 . . . . 0.0 110.172 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 24.9 m95 -93.66 132.88 37.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.665 1.186 . . . . 0.0 109.839 -170.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 85.9 mt -70.64 -35.99 73.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.415 0.686 . . . . 0.0 110.787 173.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.05 121.61 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.44 85.17 1.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.644 0.778 . . . . 0.0 109.165 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.52 149.06 29.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.941 0.401 . . . . 0.0 110.811 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.22 113.39 13.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.0 128.01 53.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.392 0.677 . . . . 0.0 109.508 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.644 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 65.8 mt -121.94 172.37 8.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.563 ' HB ' HD21 ' A' ' 153' ' ' LEU . 38.1 pt -135.6 144.9 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -137.17 154.17 50.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.761 0.791 . . . . 0.0 110.945 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 65.0 mt -139.12 146.25 40.44 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 27.6 tp -143.37 111.89 6.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -90.18 148.56 19.79 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.612 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 8.6 tp-100 -134.78 151.16 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.472 0.636 . . . . 0.0 111.242 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 17.1 pttp -55.99 136.26 52.08 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 167.04 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.5 t80 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' VAL . 41.6 tp -69.88 -51.71 30.96 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.837 0.455 . . . . 0.0 111.098 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 m -45.56 -29.51 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -72.43 -44.18 62.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.436 0.695 . . . . 0.0 110.564 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 28' ' ' ILE . 1.2 m -67.98 -33.75 63.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.004 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.15 73.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.554 1.141 . . . . 0.0 112.241 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -69.07 -23.95 64.1 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.281 0.632 . . . . 0.0 110.632 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.51 -14.29 25.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.63 0.772 . . . . 0.0 111.788 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 96.3 mt -83.93 125.77 72.08 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 18.3 Cg_exo -67.04 157.85 59.71 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.423 2.749 . . . . 0.0 112.848 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -72.54 28.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.4 -144.56 7.8 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 118.364 0.529 . . . . 0.0 113.716 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 31.1 mmmt -70.7 115.44 9.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.65 0.78 . . . . 0.0 109.666 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 50.2 mt -107.21 121.85 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 90' ' ' ILE . 55.3 tp -101.54 111.18 23.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HA ' HG13 ' A' ' 99' ' ' VAL . 51.1 t -102.61 110.12 21.96 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.445 0.698 . . . . 0.0 109.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.0 164.08 26.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.809 0.337 . . . . 0.0 111.695 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 C-N-CA 126.238 1.815 . . . . 0.0 114.814 -175.596 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.287 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -83.14 -52.95 6.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.819 1.248 . . . . 0.0 110.338 -174.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -61.32 -40.43 94.18 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.815 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.45 11.76 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.203 0.94 . . . . 0.0 111.524 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 70' ' ' LEU . 33.7 m -63.04 -33.78 76.17 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.782 0.833 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 79.4 t80 -63.34 -50.12 71.25 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.723 0.639 . . . . 0.0 110.218 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD13 HG11 ' A' ' 99' ' ' VAL . 63.9 mt -68.45 -29.48 68.13 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.579 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.44 -40.79 66.78 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.326 0.651 . . . . 0.0 112.006 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.727 ' HA ' HG11 ' A' ' 76' ' ' VAL . 58.1 p -72.2 -3.84 25.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.384 0.674 . . . . 0.0 112.762 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.2 mt -80.61 7.3 10.38 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 122.955 0.502 . . . . 0.0 110.735 165.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.68 24.35 39.17 Favored Glycine 0 C--N 1.361 1.939 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -126.04 162.4 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.059 0.929 . . . . 0.0 111.951 -172.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -88.94 91.45 8.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.24 1.016 . . . . 0.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.28 107.08 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.824 0.821 . . . . 0.0 110.727 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 m -87.27 108.89 19.15 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.188 1.395 . . . . 0.0 108.982 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.18 129.57 48.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.987 0.515 . . . . 0.0 109.643 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.8 t -111.94 118.52 57.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' H ' HD21 ' A' ' 64' ' ' LEU . 32.6 t70 -128.53 145.76 51.03 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.729 1.149 . . . . 0.0 110.621 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.02 -31.06 62.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.853 1.661 . . . . 0.0 113.211 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 m -116.13 144.1 44.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 0.0 110.252 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.6 p -68.65 -24.63 64.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.481 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.02 -33.94 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.497 0.719 . . . . 0.0 111.821 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 -30.82 67.62 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.371 0.419 . . . . 0.0 112.237 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 58' ' ' ASP . 81.5 mt -76.19 -42.31 46.75 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.983 0.913 . . . . 0.0 111.244 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.09 93.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.872 0.869 . . . . 0.0 111.93 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -67.02 -40.15 87.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.86 0.464 . . . . 0.0 110.755 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -56.95 -52.76 63.96 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 124.069 0.856 . . . . 0.0 110.406 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.0 -51.14 63.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 111.856 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.47 -47.45 81.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.918 0.887 . . . . 0.0 111.971 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.8 tp -64.52 -33.38 75.77 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.423 0.452 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.29 -51.03 49.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.413 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -66.52 -29.23 69.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.67 0.788 . . . . 0.0 110.257 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -63.18 -44.94 93.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.949 0.899 . . . . 0.0 110.276 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -85.05 -6.17 59.33 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.438 0.695 . . . . 0.0 111.569 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 40.07 12.32 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 120.391 -0.116 . . . . 0.0 113.226 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.2 m -139.64 174.22 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 124.452 1.101 . . . . 0.0 109.443 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -123.69 144.13 49.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.182 0.593 . . . . 0.0 112.316 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 mm -114.88 161.07 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 166.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.2 m -121.8 104.66 9.73 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 p -92.57 123.19 35.68 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.679 -0.638 . . . . 0.0 110.487 -167.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.1 t -115.61 141.07 34.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.192 1.397 . . . . 0.0 107.819 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -80.06 134.31 36.19 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.2 p -55.24 105.11 0.15 Allowed 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.146 0.978 . . . . 0.0 111.493 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.71 87.04 2.03 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.467 ' HB2' HD22 ' A' ' 109' ' ' LEU . 88.8 mt -94.24 -9.82 34.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.928 0.491 . . . . 0.0 110.537 -171.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.36 4.38 43.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.903 0.881 . . . . 0.0 110.319 170.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -130.96 -41.49 1.14 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.773 0.829 . . . . 0.0 110.812 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -156.76 121.72 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.234 1.014 . . . . 0.0 108.275 -169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.21 -69.6 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.652 -0.655 . . . . 0.0 109.626 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 117' ' ' VAL . 18.1 pt -149.88 131.27 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.899 0.879 . . . . 0.0 109.958 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.79 145.63 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.813 1.245 . . . . 0.0 109.171 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -88.41 -30.71 19.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.13 0.572 . . . . 0.0 110.743 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.95 -61.26 2.07 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.712 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.67 -29.27 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' NE1' HD22 ' A' ' 34' ' ' LEU . 37.3 m95 -113.63 144.69 42.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 109.871 -171.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 29' ' ' PRO . 15.8 tp10 -98.19 -46.3 5.89 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.479 1.112 . . . . 0.0 109.494 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -114.58 141.52 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.354 171.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 90' ' ' ILE . 63.7 mt -117.99 150.62 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 169.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG11 HD13 ' A' ' 47' ' ' LEU . 7.0 p -145.9 129.15 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 124.121 0.968 . . . . 0.0 109.01 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.3 m -129.57 94.2 3.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.548 HD13 HD12 ' A' ' 128' ' ' ILE . 22.1 mm -70.73 143.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -15.26 104.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.404 1.882 . . . . 0.0 114.834 -170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.506 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 45.6 t -100.64 115.78 31.0 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.006 -174.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -121.71 98.41 5.94 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 95.0 mt -108.79 155.75 40.14 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.386 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.02 143.33 83.54 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.589 2.193 . . . . 0.0 110.681 162.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.605 ' H ' HD22 ' A' ' 149' ' ' LEU . 41.4 m -50.14 -24.75 2.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.533 1.133 . . . . 0.0 113.288 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.3 m -56.39 -57.61 11.54 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.414 0.685 . . . . 0.0 110.336 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 85' ' ' LEU . 89.2 mt -79.71 -32.8 41.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.69 0.796 . . . . 0.0 110.032 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.561 ' HD3' ' HG3' ' A' ' 151' ' ' PRO . 8.4 tmm_? -74.02 -58.84 3.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.003 1.321 . . . . 0.0 109.959 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -68.55 -10.3 54.87 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.256 0.622 . . . . 0.0 112.373 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -88.5 -33.67 17.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 66.3 tp -67.86 -47.74 68.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.708 0.803 . . . . 0.0 111.514 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.49 -39.14 45.86 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.2 -32.08 92.46 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.919 165.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -81.24 -17.89 47.92 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.528 0.731 . . . . 0.0 111.249 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.537 ' HA ' HD11 ' A' ' 90' ' ' ILE . 9.5 t -83.96 -43.07 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 172.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.03 -48.9 78.22 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.27 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -79.08 -43.68 23.66 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.05 -20.4 16.3 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 116.711 1.444 . . . . 0.0 116.711 -164.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.511 HD12 HD12 ' A' ' 98' ' ' ILE . 16.7 tp -62.26 128.94 38.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.188 0.994 . . . . 0.0 110.025 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 16.7 tttp -70.65 142.39 88.64 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.94 109.05 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.347 1.365 . . . . 0.0 109.494 160.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.08 10.1 6.41 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.559 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.8 143.02 16.45 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 170.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.0 m -108.55 129.6 62.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 123.973 0.909 . . . . 0.0 109.466 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -112.5 112.19 23.55 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 101' ' ' ILE . 95.8 mt -110.25 113.97 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 109.304 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 190' ' ' LEU . 96.2 mt -124.34 114.91 20.16 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.34 107.96 4.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.29 1.036 . . . . 0.0 108.952 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.0 86.06 0.09 OUTLIER Glycine 0 N--CA 1.479 1.512 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.172 169.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.506 ' O ' HD23 ' A' ' 187' ' ' LEU . 95.3 m-85 -143.29 150.36 39.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.186 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.605 HD22 ' H ' ' A' ' 107' ' ' SER . 13.6 mt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 132' ' ' PHE . 41.1 mt -104.93 98.1 14.6 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.223 0.609 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.621 ' HG2' HD21 ' A' ' 156' ' ' LEU . 90.1 Cg_endo -84.0 126.58 3.89 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.871 165.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -72.82 173.13 9.59 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.749 0.819 . . . . 0.0 111.708 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.571 HD22 HD21 ' A' ' 190' ' ' LEU . 20.1 mt -55.95 -38.53 70.47 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.106 0.562 . . . . 0.0 112.212 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.02 -37.31 74.07 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.705 0.628 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.2 m -73.39 -51.95 15.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.219 0.608 . . . . 0.0 109.914 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.621 HD21 ' HG2' ' A' ' 151' ' ' PRO . 82.7 mt -65.7 -55.65 16.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.576 1.151 . . . . 0.0 112.008 -170.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.612 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.3 tt0 -59.03 -34.81 72.33 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 175.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.9 t -81.06 -13.25 58.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.144 0.429 . . . . 0.0 111.889 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -7.67 29.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.945 0.498 . . . . 0.0 110.315 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 89.2 mt -139.46 59.95 15.52 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.946 1.298 . . . . 0.0 108.079 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.55 -22.58 32.84 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.726 2.284 . . . . 0.0 113.745 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 p -81.83 -40.08 23.02 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.6 tp -70.8 68.5 0.42 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.814 1.246 . . . . 0.0 111.602 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -65.13 140.35 58.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.612 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 22.0 m95 -100.88 135.29 42.56 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.742 0.817 . . . . 0.0 109.349 -167.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.9 mt -72.03 -30.81 65.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.64 0.776 . . . . 0.0 110.44 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.9 mt -130.46 125.45 59.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.39 79.97 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -131.15 142.45 50.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.806 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -88.59 132.44 34.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.878 0.871 . . . . 0.0 109.955 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 34.2 mt -110.05 114.24 27.6 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 27.8 mt -104.27 158.04 16.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.519 ' HB ' HD21 ' A' ' 153' ' ' LEU . 3.7 pt -146.36 124.68 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.944 0.793 . . . . 0.0 110.473 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -93.27 145.56 24.35 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.986 0.914 . . . . 0.0 110.091 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 129' ' ' LEU . 54.9 mt -134.0 143.91 48.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 110.391 172.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.2 tp -142.96 108.29 5.02 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -92.98 146.43 18.1 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 126' ' ' VAL . 5.9 tp-100 -147.25 155.83 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.15 0.98 . . . . 0.0 109.683 174.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 193' ' ' GLN . 23.1 pttm -61.64 121.45 12.83 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.491 0.186 . . . . 0.0 111.32 -171.116 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 . . . . . 0 CA--C 1.553 1.067 0 CA-C-O 120.782 0.325 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tp -68.59 -43.53 76.3 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.736 0.814 . . . . 0.0 111.505 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.5 m -45.74 -35.32 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -74.36 -46.65 39.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.979 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.608 HG21 HD11 ' A' ' 128' ' ' ILE . 2.2 m -64.64 -37.14 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.082 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.36 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.313 1.045 . . . . 0.0 111.881 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -58.02 -38.97 77.18 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -82.4 -22.76 35.25 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 54.6 mt -75.59 129.31 82.08 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 118.238 0.472 . . . . 0.0 109.949 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.07 130.65 28.48 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.755 2.97 . . . . 0.0 112.296 166.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -77.62 27.71 0.17 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.306 1.443 . . . . 0.0 114.28 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.85 -133.5 5.3 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.498 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -78.0 113.51 15.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 28' ' ' ILE . 34.7 mt -114.24 130.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 95' ' ' TRP . 52.7 tp -100.09 114.27 27.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 53.6 t -101.48 109.73 21.61 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.29 0.636 . . . . 0.0 109.548 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.23 103.45 3.36 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 167.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.419 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.744 -172.408 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -48.79 -45.03 39.59 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.868 1.667 . . . . 0.0 111.217 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -64.75 -41.76 95.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.007 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.98 98.66 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.199 0.6 . . . . 0.0 110.92 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.421 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.9 m -60.46 -39.27 86.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.965 0.906 . . . . 0.0 112.696 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.7 t80 -64.92 -46.64 80.81 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.826 0.703 . . . . 0.0 110.199 177.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 99' ' ' VAL . 70.1 mt -67.62 -33.18 74.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.872 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.21 70.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.145 0.578 . . . . 0.0 111.804 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.745 ' HA ' HG11 ' A' ' 76' ' ' VAL . 93.2 p -72.06 -4.8 30.92 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 81.7 mt -83.84 11.14 8.05 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.265 168.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.09 19.15 78.9 Favored Glycine 0 C--N 1.366 2.218 0 CA-C-N 117.64 0.2 . . . . 0.0 113.174 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -106.44 133.1 51.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 109.257 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.79 90.71 2.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.574 0.702 . . . . 0.0 109.263 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -92.91 108.59 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.814 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.8 p -87.14 111.84 21.34 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.513 1.125 . . . . 0.0 108.607 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.72 126.98 53.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.268 0.627 . . . . 0.0 110.873 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 81' ' ' VAL . 10.9 t -101.69 114.72 41.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' H ' HD21 ' A' ' 64' ' ' LEU . 8.5 t70 -116.17 116.21 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.92 -10.67 2.62 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.678 0.791 . . . . 0.0 112.566 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -115.79 124.15 50.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.374 1.07 . . . . 0.0 108.595 169.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 m -72.06 -16.57 62.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.232 0.613 . . . . 0.0 111.568 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 31.5 m -62.97 -35.84 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.198 0.599 . . . . 0.0 111.508 170.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 -35.25 56.45 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 58' ' ' ASP . 99.2 mt -63.28 -42.65 99.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.085 0.954 . . . . 0.0 111.011 174.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.4 81.13 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.864 0.728 . . . . 0.0 111.756 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 30.3 mmmt -68.08 -45.03 74.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.04 0.536 . . . . 0.0 111.464 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.5 81.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.973 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -69.45 -42.3 75.12 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.144 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.45 -43.44 77.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.256 0.222 . . . . 0.0 110.939 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.38 -28.12 69.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.559 0.744 . . . . 0.0 110.609 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.08 -53.78 33.91 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.164 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.4 -35.28 75.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.817 0.847 . . . . 0.0 110.618 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -37.93 89.29 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.009 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -86.5 -0.32 55.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.94 0.896 . . . . 0.0 110.842 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.82 33.37 33.93 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-N 116.376 -0.375 . . . . 0.0 112.394 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.6 m -142.2 -177.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.887 1.275 . . . . 0.0 109.892 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 87.2 tttt -141.16 145.69 36.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.914 0.486 . . . . 0.0 111.587 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.8 mm -101.71 167.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 55' ' ' THR . 46.1 m -123.21 104.3 9.07 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -91.85 125.98 36.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.107 0.479 . . . . 0.0 111.253 -165.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 57' ' ' VAL . 84.8 t -101.06 124.01 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 109.401 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -97.85 89.3 4.54 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -145.25 -176.01 4.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.188 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -142.97 122.63 13.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -158.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.75 -8.03 39.3 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.773 0.671 . . . . 0.0 111.894 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.96 60.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.436 1.094 . . . . 0.0 112.459 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -130.45 -24.67 2.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.148 0.579 . . . . 0.0 112.084 -166.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -162.76 127.02 3.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.695 1.198 . . . . 0.0 108.168 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.34 -65.89 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.41 HG22 HD23 ' A' ' 34' ' ' LEU . 20.1 pt -140.42 127.88 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.361 0.664 . . . . 0.0 110.994 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 93' ' ' ASP . 46.8 t -115.55 148.96 17.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 124.546 1.138 . . . . 0.0 109.639 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -90.25 -35.71 15.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.149 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 91' ' ' VAL . 24.0 t70 -77.31 -44.33 30.0 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.645 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.03 44.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.483 ' CD1' HD22 ' A' ' 34' ' ' LEU . 11.6 m95 -123.26 134.13 54.12 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -169.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.39 -55.79 6.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.396 0.678 . . . . 0.0 109.971 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.63 164.44 12.19 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.109 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 121' ' ' LEU . 84.7 mt -134.45 145.44 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 47' ' ' LEU . 10.1 p -128.09 128.8 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 166.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -113.4 91.34 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.587 HD13 HD12 ' A' ' 128' ' ' ILE . 49.9 mm -68.56 136.13 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.104 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -14.03 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.413 2.321 . . . . 0.0 112.888 -171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 29.1 t -95.18 106.13 18.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 112.324 -2.216 . . . . 0.0 109.93 -169.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.45 99.73 9.8 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 75.7 mt -118.11 145.91 38.04 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.682 0.793 . . . . 0.0 110.585 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.63 158.15 58.12 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.693 2.262 . . . . 0.0 110.144 168.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 33.4 t -45.02 -30.58 1.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.822 1.649 . . . . 0.0 113.246 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 p -57.07 -58.27 8.9 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.2 1.0 . . . . 0.0 110.86 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 80.9 mt -83.29 -22.46 32.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.74 0.816 . . . . 0.0 110.236 -175.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 29.1 ttt180 -69.02 -65.13 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.129 1.372 . . . . 0.0 109.717 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -55.41 -29.64 58.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.113 0.565 . . . . 0.0 111.642 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.54 -42.35 64.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.864 0.466 . . . . 0.0 110.699 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 117' ' ' VAL . 51.2 tp -67.99 -44.99 75.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.47 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -61.2 -41.67 81.7 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -167.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.81 -28.03 75.65 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 122.016 1.811 . . . . 0.0 112.292 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -84.87 -14.88 46.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 0.0 110.971 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.695 ' HB ' HD21 ' A' ' 160' ' ' LEU . 4.7 t -86.51 -42.82 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.1 -56.17 24.12 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.511 0.324 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.5 -39.85 19.96 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.3 -25.7 25.52 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -166.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.617 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -66.24 117.65 8.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.803 0.802 . . . . 0.0 109.188 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 62.0 tttm -69.67 133.93 88.5 Favored Pre-proline 0 C--O 1.246 0.883 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.54 112.3 0.66 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.629 2.219 . . . . 0.0 111.143 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . 125.08 13.21 3.67 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.864 -173.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.617 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -100.48 139.85 14.62 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 168.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 32.7 m -109.08 138.88 34.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.762 0.825 . . . . 0.0 109.932 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.53 113.37 25.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.608 HD11 HG21 ' A' ' 24' ' ' VAL . 24.3 mt -107.88 108.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 79.7 mt -130.87 152.04 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.815 0.846 . . . . 0.0 111.315 -174.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 43.9 tt0 -140.61 104.05 4.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.51 167.16 54.79 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -131.08 167.62 18.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.494 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.41 1.484 . . . . 0.0 113.123 -176.172 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.8 mt -97.88 100.92 9.43 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.86 120.76 4.34 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.573 1.515 . . . . 0.0 110.245 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.419 ' HA ' HD11 ' A' ' 188' ' ' ILE . 32.6 mmtp -87.89 171.58 10.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.684 0.794 . . . . 0.0 111.775 -173.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD22 HD21 ' A' ' 190' ' ' LEU . 32.2 mt -59.23 -40.97 87.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -48.54 -50.9 30.11 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.74 1.216 . . . . 0.0 110.857 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 26.6 m -65.88 -62.36 1.54 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.701 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.429 HD13 HD13 ' A' ' 129' ' ' LEU . 25.2 mt -72.57 -46.56 53.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 112.707 -162.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.537 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.1 tt0 -53.4 -46.11 69.59 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 123.44 0.462 . . . . 0.0 111.025 171.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.3 t -70.77 -32.42 69.54 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.525 0.33 . . . . 0.0 111.841 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -85.7 -5.61 59.24 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.131 0.572 . . . . 0.0 111.951 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 117' ' ' VAL . 82.7 mt -140.51 74.68 28.04 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 -45.72 24.03 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.859 3.039 . . . . 0.0 113.156 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 m -84.85 -29.82 24.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.778 0.431 . . . . 0.0 110.499 -171.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.1 tp -70.21 68.54 0.34 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.054 0.942 . . . . 0.0 111.455 170.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -62.63 133.38 54.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 32.2 m95 -95.77 129.65 42.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.811 0.844 . . . . 0.0 109.401 -167.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.43 -33.73 76.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.67 0.788 . . . . 0.0 110.378 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 80.6 mt -132.7 121.93 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.23 84.57 1.13 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -150.42 148.66 29.03 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.08 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -86.35 116.48 24.54 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.089 0.956 . . . . 0.0 108.691 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.5 mt -110.68 125.06 53.06 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.351 1.06 . . . . 0.0 108.362 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 122.85 0.46 . . . . 0.0 110.004 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.64 149.53 32.71 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 22.1 pt -134.17 118.7 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.354 0.525 . . . . 0.0 110.062 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.68 138.6 31.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.834 0.349 . . . . 0.0 110.323 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 153' ' ' LEU . 49.5 mt -129.51 128.38 42.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.532 1.133 . . . . 0.0 109.41 173.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.7 tp -125.13 106.23 9.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.11 139.97 16.56 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 171.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -144.68 152.64 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 124' ' ' GLY . 19.5 pttm -57.64 155.19 10.23 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 123.75 0.656 . . . . 0.0 110.089 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.818 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -52.98 -72.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.534 1.133 . . . . 0.0 112.385 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -174.02 141.55 0.79 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.672 0.789 . . . . 0.0 109.092 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -118.99 125.12 48.65 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -77.11 132.62 38.95 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.472 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -74.93 102.95 4.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.9 p -73.7 75.06 1.55 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.623 0.769 . . . . 0.0 111.167 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -80.87 -26.46 36.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 0.0 110.52 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -75.25 92.48 2.74 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.402 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.8 160.67 27.27 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.09 92.31 1.61 Allowed 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.53 127.06 31.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -75.44 117.89 17.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.372 0.669 . . . . 0.0 111.375 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.59 85.5 0.27 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 124.103 0.877 . . . . 0.0 111.682 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -133.33 139.41 46.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.361 1.064 . . . . 0.0 109.06 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.77 121.39 77.39 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.892 -0.575 . . . . 0.0 109.452 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.06 121.96 10.29 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.026 2.484 . . . . 0.0 112.452 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 22' ' ' VAL . 40.2 t-20 -121.52 148.0 45.06 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.35 1.06 . . . . 0.0 109.209 -172.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.42 -79.52 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.473 0.709 . . . . 0.0 110.901 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.51 -48.37 27.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.467 0.707 . . . . 0.0 112.141 -172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.9 -15.03 58.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -165.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 18' ' ' ASN . 27.2 m -83.36 -24.6 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.726 0.694 . . . . 0.0 110.28 -176.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 89.7 p -70.0 -47.5 61.91 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.4 m -64.13 -41.29 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.365 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.43 74.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.173 0.989 . . . . 0.0 111.978 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -27.66 67.87 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.52 0.728 . . . . 0.0 109.338 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 23' ' ' SER . 75.5 mm-40 -82.88 -33.07 27.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.678 0.791 . . . . 0.0 110.971 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -73.06 131.09 83.96 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.34 84.11 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.768 2.312 . . . . 0.0 111.877 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.05 29.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.05 -134.24 5.42 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.396 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -89.63 110.48 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -172.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG22 HG12 ' A' ' 99' ' ' VAL . 36.6 mt -113.58 117.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.689 0.796 . . . . 0.0 110.63 -166.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 95' ' ' TRP . 48.3 tp -92.01 113.25 25.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.907 0.483 . . . . 0.0 111.033 -173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 56.8 m -92.64 137.74 32.1 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 90' ' ' ILE . 40.8 mt -89.41 161.84 16.08 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 170.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.34 124.32 5.62 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.831 1.332 . . . . 0.0 112.842 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.27 142.77 18.5 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.54 -27.2 60.77 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.578 0.549 . . . . 0.0 113.494 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -120.04 89.82 3.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 110.066 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.24 20.57 16.24 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.9 168.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -65.37 -31.62 72.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.464 1.106 . . . . 0.0 110.196 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.3 m-20 -62.51 -30.9 71.62 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.423 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.82 79.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.159 0.583 . . . . 0.0 110.871 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.49 -29.97 69.54 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.668 0.787 . . . . 0.0 112.098 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.22 -48.42 81.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.825 0.85 . . . . 0.0 109.5 172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 50' ' ' LEU . 78.6 mt -66.78 -31.45 72.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.896 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -38.2 77.0 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.275 0.63 . . . . 0.0 111.979 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 38.5 p -70.4 -9.47 56.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 47' ' ' LEU . 72.3 mt -81.27 6.92 12.71 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.481 . . . . 0.0 111.17 171.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 7.58 85.68 Favored Glycine 0 C--N 1.36 1.879 0 CA-C-N 117.681 0.218 . . . . 0.0 113.072 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -92.04 143.42 26.48 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.477 0.711 . . . . 0.0 109.325 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 44.1 mt-10 -84.59 96.81 9.29 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.4 t -96.87 128.29 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.004 0.522 . . . . 0.0 110.474 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.9 t -114.15 111.1 21.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.316 1.446 . . . . 0.0 108.714 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.98 136.1 43.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.018 0.527 . . . . 0.0 111.08 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.03 144.25 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -152.29 139.09 18.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 159.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.76 -13.11 62.18 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.681 0.613 . . . . 0.0 111.046 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -117.82 143.0 46.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.193 1.397 . . . . 0.0 109.741 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -73.89 -22.65 59.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.56 0.744 . . . . 0.0 111.219 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.33 -38.58 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.045 0.538 . . . . 0.0 111.814 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -40.05 40.04 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.369 0.418 . . . . 0.0 112.08 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 80' ' ' THR . 91.5 mt -65.6 -52.16 54.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.016 0.926 . . . . 0.0 111.947 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.86 75.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.926 0.89 . . . . 0.0 112.371 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -71.02 -42.03 70.09 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.34 0.656 . . . . 0.0 110.888 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.01 92.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.263 0.625 . . . . 0.0 110.548 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -75.02 -32.14 61.54 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 110.63 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -63.04 -51.1 68.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.57 0.748 . . . . 0.0 110.923 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 tp -65.25 -27.32 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.04 0.837 . . . . 0.0 110.56 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -60.15 -59.63 5.1 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 122.92 0.488 . . . . 0.0 110.597 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.19 -36.44 81.91 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.919 0.888 . . . . 0.0 110.693 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.54 -25.52 63.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.895 0.878 . . . . 0.0 111.666 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -100.33 -3.45 31.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.873 0.869 . . . . 0.0 111.073 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.33 28.27 56.06 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.014 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -132.58 165.53 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.057 0.943 . . . . 0.0 110.749 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -112.22 135.46 52.86 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.607 0.763 . . . . 0.0 111.247 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.628 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.0 mm -110.78 161.33 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 165.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -114.97 112.74 23.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 166.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 64' ' ' LEU . 85.5 m -84.15 110.73 18.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.973 0.909 . . . . 0.0 110.402 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.58 127.17 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 0.0 108.508 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -110.02 95.4 5.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -139.67 -175.15 4.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.657 1.183 . . . . 0.0 109.515 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -143.21 131.15 21.62 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -159.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 22.0 mt -73.28 -3.53 27.54 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.15 3.34 41.04 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.101 0.96 . . . . 0.0 112.845 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.4 -43.04 0.16 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.006 0.821 . . . . 0.0 112.34 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.54 112.63 4.29 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.76 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.45 -72.32 0.41 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -166.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG23 HD21 ' A' ' 36' ' ' LEU . 4.6 pt -137.72 111.0 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.534 1.134 . . . . 0.0 109.745 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 94' ' ' ALA . 47.3 t -124.84 88.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.2 -1.15 4.04 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.67 -48.18 14.12 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.457 0.703 . . . . 0.0 109.632 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -75.65 -35.97 60.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.562 0.745 . . . . 0.0 111.844 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CD1' HD22 ' A' ' 34' ' ' LEU . 57.6 m95 -104.16 174.74 5.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.984 0.914 . . . . 0.0 108.978 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -109.22 -45.78 3.68 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.878 0.37 . . . . 0.0 110.691 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.62 162.76 24.13 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.6 ' HB ' ' HA3' ' A' ' 125' ' ' GLY . 90.5 mt -137.2 145.35 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.593 0.757 . . . . 0.0 110.038 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.466 HG12 HG22 ' A' ' 33' ' ' ILE . 9.0 p -132.94 124.45 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.343 1.057 . . . . 0.0 108.21 165.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 m -120.13 94.98 4.57 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.05 134.17 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.525 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 1.5 p90 -18.78 111.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 126.739 2.016 . . . . 0.0 115.563 -168.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 25.8 p -66.94 106.65 1.98 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.267 -1.788 . . . . 0.0 111.588 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -96.18 97.6 9.66 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 85' ' ' LEU . 91.6 mt -139.54 138.97 21.09 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.37 0.668 . . . . 0.0 110.431 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.0 160.63 43.43 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.34 2.694 . . . . 0.0 110.874 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 t -46.44 -33.25 3.82 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.791 1.236 . . . . 0.0 113.47 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 36.4 m -55.52 -64.2 0.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.678 0.791 . . . . 0.0 111.623 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.14 -22.36 45.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.835 0.454 . . . . 0.0 110.527 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -69.66 -53.92 16.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.659 1.184 . . . . 0.0 110.1 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.07 -11.28 58.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 112.879 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 108' ' ' SER . 15.6 mm100 -81.92 -38.71 24.85 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.6 tp -76.54 -43.82 37.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -58.8 -44.57 99.12 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 119.457 1.026 . . . . 0.0 112.805 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.69 -28.42 86.35 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.37 2.046 . . . . 0.0 113.745 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.78 -28.01 60.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.204 0.602 . . . . 0.0 111.635 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.1 t -85.37 -27.38 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.848 0.832 . . . . 0.0 109.71 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -73.48 -63.86 1.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.388 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.7 -49.37 16.25 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.19 -39.15 32.58 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 114.069 0.387 . . . . 0.0 114.069 -169.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 30.1 tp -78.53 103.25 8.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.66 148.35 51.49 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 165.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.583 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 60.9 Cg_exo -43.24 127.24 5.3 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.152 3.235 . . . . 0.0 115.003 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 128.64 10.04 3.37 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.776 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -119.18 152.72 17.15 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 164.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.81 136.44 44.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 123.603 0.761 . . . . 0.0 109.861 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.0 113.04 26.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -103.83 107.99 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.4 mt -121.86 121.51 37.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.741 0.816 . . . . 0.0 110.362 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 36.5 tt0 -115.68 98.98 7.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 168.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.01 174.86 46.17 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.699 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.464 ' HB2' HD22 ' A' ' 150' ' ' LEU . 50.7 m-85 -127.87 160.84 30.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.46 157.58 67.39 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.22 0.608 . . . . 0.0 109.695 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.19 -11.18 28.82 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.405 2.07 . . . . 0.0 112.914 174.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.57 -8.52 58.24 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.819 0.847 . . . . 0.0 112.1 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -74.96 -56.57 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.489 HD21 HD21 ' A' ' 150' ' ' LEU . 12.6 mt -65.36 -23.8 67.08 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.21 -23.59 62.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.66 0.784 . . . . 0.0 111.44 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -61.54 -19.07 61.72 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.15 22.14 8.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.514 1.126 . . . . 0.0 110.133 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.686 HG21 HD13 ' A' ' 175' ' ' LEU . 20.6 p -80.71 -29.45 36.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.252 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.19 177.24 40.3 Favored Glycine 0 C--O 1.243 0.66 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.982 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA2' HD22 ' A' ' 137' ' ' LEU . . . 176.95 144.66 5.37 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.265 -0.741 . . . . 0.0 111.732 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.22 -42.76 5.32 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.614 2.209 . . . . 0.0 112.207 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -165.19 -46.76 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.765 0.826 . . . . 0.0 109.608 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.09 152.17 10.78 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.423 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.518 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -59.25 -8.38 1.62 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.893 1.277 . . . . 0.0 113.467 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.18 -43.53 82.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 0.0 110.64 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.1 mt -77.7 10.95 2.33 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.17 0.988 . . . . 0.0 112.904 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 44.0 mt -89.37 111.07 43.31 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.639 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.5 Cg_endo -79.98 108.71 2.27 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 122.017 1.812 . . . . 0.0 110.211 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.597 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 tttm -105.3 155.32 19.2 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.812 -0.555 . . . . 0.0 110.796 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.8 mt -50.51 -38.06 42.37 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.238 1.015 . . . . 0.0 111.937 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.51 -53.88 20.96 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 125.045 1.466 . . . . 0.0 109.776 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 35.3 m -71.94 -57.62 4.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.74 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.639 HD11 ' HB2' ' A' ' 151' ' ' PRO . 73.1 mt -62.21 -54.32 42.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.398 1.079 . . . . 0.0 112.309 -165.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.56 -35.67 81.73 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.645 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 t -61.36 -37.2 82.51 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.718 0.407 . . . . 0.0 111.829 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 155' ' ' THR . 23.4 mm-40 -83.72 -8.02 59.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.672 0.389 . . . . 0.0 111.31 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.5 mt -138.9 71.78 41.66 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.545 0.738 . . . . 0.0 110.125 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.29 -5.55 13.56 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.402 2.735 . . . . 0.0 111.761 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.5 p -89.71 -41.39 11.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.592 1.157 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 15.2 tp -90.62 71.67 6.8 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.623 1.569 . . . . 0.0 110.043 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -63.84 135.07 56.29 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.406 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 33.1 m95 -94.24 128.89 40.97 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.644 1.178 . . . . 0.0 109.999 -166.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.96 -34.25 77.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.543 0.737 . . . . 0.0 110.205 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 70.7 mt -126.14 125.9 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.17 76.87 1.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.052 0.941 . . . . 0.0 109.426 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.96 154.87 35.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.64 117.48 22.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.354 0.662 . . . . 0.0 109.743 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -111.94 130.31 55.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.203 0.601 . . . . 0.0 110.158 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -91.75 136.19 33.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.812 0.845 . . . . 0.0 110.541 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -132.7 131.94 41.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 108.923 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -79.85 130.62 35.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.009 0.524 . . . . 0.0 110.475 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 141' ' ' THR . 65.3 mt -82.31 153.32 25.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.598 0.759 . . . . 0.0 109.581 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -69.36 93.79 0.67 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.157 0.583 . . . . 0.0 110.881 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.57 173.89 10.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.667 0.787 . . . . 0.0 110.7 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.57 33.48 0.36 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -114.45 -54.15 2.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.935 0.894 . . . . 0.0 110.454 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -79.26 -17.67 54.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.939 0.896 . . . . 0.0 111.887 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 58.22 8.95 0.88 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.851 1.661 . . . . 0.0 113.053 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -142.77 18.65 1.99 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.433 1.093 . . . . 0.0 109.207 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.0 67.09 3.66 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.24 177.44 4.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.124 1.37 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.608 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -134.02 132.5 40.16 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -93.77 108.88 20.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.5 mt -122.21 165.87 15.49 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 152' ' ' LYS . 15.4 pt -138.58 141.3 37.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -127.73 143.81 51.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.206 0.527 . . . . 0.0 110.736 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 54.1 mt -135.08 129.0 33.29 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.597 1.559 . . . . 0.0 108.768 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 24' ' ' VAL . 30.2 tp -122.14 106.04 10.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.08 140.64 17.86 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 170.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.94 0.896 . . . . 0.0 110.48 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 80.4 tttt -55.9 123.52 14.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 123.742 0.651 . . . . 0.0 109.411 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 197' ' ' HIS . 19.4 mt -75.61 103.84 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.098 0.249 . . . . 0.0 110.347 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.59 -31.29 72.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.447 0.641 . . . . 0.0 109.966 165.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 195' ' ' LEU . 21.6 p80 -85.95 123.08 30.88 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.946 169.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -73.29 162.03 29.82 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -60.82 114.88 3.28 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -78.87 109.96 13.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.401 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -159.75 -179.05 7.51 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.916 0.886 . . . . 0.0 110.445 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.2 p80 . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.789 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.42 0.629 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -141.02 24.56 2.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.066 0.936 . . . . 0.0 108.894 172.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -92.03 -2.92 56.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.782 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -77.84 -49.09 14.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 0.0 109.584 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -143.56 93.13 2.44 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.77 0.828 . . . . 0.0 109.658 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -144.62 19.11 1.68 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.003 0.921 . . . . 0.0 109.238 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -75.97 -4.0 38.68 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.465 1.106 . . . . 0.0 112.834 -170.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.45 113.01 7.16 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.632 0.773 . . . . 0.0 110.84 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -90.64 -21.78 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.669 0.787 . . . . 0.0 111.31 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.68 -52.55 5.08 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.38 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -74.42 82.67 1.94 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.738 0.78 . . . . 0.0 110.453 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -165.61 -41.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.814 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 73.37 -46.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 126.026 1.73 . . . . 0.0 113.592 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.41 -32.65 57.9 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-O 121.171 0.317 . . . . 0.0 112.605 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.2 p -120.33 79.29 1.45 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 163.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.55 156.08 55.63 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.596 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -38.9 -41.6 1.79 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 124.571 3.514 . . . . 0.0 115.309 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.32 118.28 24.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.745 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -103.38 141.86 35.22 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.27 -21.36 62.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.963 0.505 . . . . 0.0 110.902 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.584 HD21 ' HG ' ' A' ' 47' ' ' LEU . 33.7 tp -58.81 -35.7 73.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.389 0.676 . . . . 0.0 111.809 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.37 -40.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.2 p -79.75 -51.45 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.258 0.551 . . . . 0.0 111.108 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 128' ' ' ILE . 26.5 m -63.41 -34.24 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.373 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.72 76.87 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.324 1.05 . . . . 0.0 111.987 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.06 -31.84 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.107 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HB3' HE21 ' A' ' 193' ' ' GLN . 29.8 mm-40 -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.848 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 24' ' ' VAL . 79.1 mt -69.79 128.21 92.05 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-O 119.003 -0.523 . . . . 0.0 109.735 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.35 115.04 1.54 Allowed 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.859 2.372 . . . . 0.0 111.369 164.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.47 32.67 0.13 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.809 1.644 . . . . 0.0 114.306 -166.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.94 -129.59 5.56 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-O 118.776 -1.014 . . . . 0.0 110.922 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -69.29 111.23 5.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.458 1.129 . . . . 0.0 109.897 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.03 119.5 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 89' ' ' ASP . 56.4 tp -98.24 121.06 39.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.901 0.481 . . . . 0.0 110.598 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -104.73 134.0 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.999 1.32 . . . . 0.0 109.422 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 66.1 mt -95.78 152.58 18.35 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.629 0.372 . . . . 0.0 110.9 171.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -78.04 -165.92 0.73 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.279 0.632 . . . . 0.0 111.711 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 64.22 22.62 12.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.34 1.056 . . . . 0.0 110.992 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.53 -31.2 0.1 Allowed Glycine 0 C--N 1.343 0.948 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.334 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 43' ' ' ASN . 67.7 tt0 -129.56 141.39 50.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.298 0.639 . . . . 0.0 111.465 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.07 -51.69 0.03 OUTLIER Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -65.31 -44.69 87.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 110.334 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 46.3 m-80 -65.73 -31.3 72.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.209 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.66 -58.35 8.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.651 0.78 . . . . 0.0 111.659 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.2 p -65.93 -27.34 68.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.961 0.504 . . . . 0.0 112.086 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 51.0 t80 -68.5 -36.9 79.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.889 0.476 . . . . 0.0 110.098 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 21' ' ' LEU . 55.6 mt -68.56 -32.29 72.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.327 0.651 . . . . 0.0 111.054 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.32 -33.87 61.2 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.47 0.308 . . . . 0.0 110.321 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -63.19 -19.2 64.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.149 0.98 . . . . 0.0 111.36 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 84.1 mt -82.07 14.23 2.95 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.89 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 33.7 58.31 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 123.295 0.474 . . . . 0.0 114.163 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -125.44 156.12 39.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.718 0.759 . . . . 0.0 110.628 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.53 97.51 7.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.481 0.712 . . . . 0.0 109.75 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -105.96 119.11 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.116 0.484 . . . . 0.0 111.501 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -84.97 112.3 20.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.32 120.48 40.32 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 81' ' ' VAL . 82.2 t -98.66 121.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.84 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 19.6 t70 -139.47 129.33 24.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -54.74 -26.92 37.22 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.782 1.233 . . . . 0.0 112.987 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.491 ' HB2' HG22 ' A' ' 62' ' ' VAL . 47.6 m -113.25 160.68 18.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.779 0.831 . . . . 0.0 111.386 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -69.81 -21.39 63.4 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.526 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 60' ' ' SER . 6.5 m -62.11 -43.8 98.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.183 0 C-N-CA 122.895 0.478 . . . . 0.0 111.992 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.28 -34.88 19.24 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 71.3 mt -67.66 -58.31 4.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.594 0.758 . . . . 0.0 111.773 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.46 70.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.321 0.649 . . . . 0.0 112.287 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.41 -42.3 71.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.883 0.473 . . . . 0.0 110.529 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.44 95.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.682 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -68.97 -34.97 76.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.559 1.144 . . . . 0.0 111.296 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -54.89 -48.51 72.91 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.087 0.955 . . . . 0.0 110.648 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.86 -29.25 64.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.057 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -58.54 -62.58 1.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.63 0.581 . . . . 0.0 111.069 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.21 -40.12 89.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.239 0.616 . . . . 0.0 111.665 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.95 -40.32 95.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.727 0.811 . . . . 0.0 111.55 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -103.92 -5.46 22.25 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.889 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 43.78 36.23 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.875 0.153 . . . . 0.0 113.206 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.76 172.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.316 1.047 . . . . 0.0 109.499 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.05 132.42 54.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.98 0.512 . . . . 0.0 111.497 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 71' ' ' ALA . 23.2 mm -114.42 155.76 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 166.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -121.46 108.21 13.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 165.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.7 t -86.62 113.49 22.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.209 0.603 . . . . 0.0 110.855 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 57' ' ' VAL . 24.7 t -120.79 139.19 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.307 1.043 . . . . 0.0 109.132 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.05 147.87 27.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 m -67.19 112.68 4.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.419 0.288 . . . . 0.0 111.338 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -144.01 89.06 2.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 165.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.42 -38.55 18.55 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.023 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.64 67.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.845 0.858 . . . . 0.0 112.194 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.22 -34.17 20.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.381 0.672 . . . . 0.0 111.499 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -166.74 117.27 0.92 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.348 0.659 . . . . 0.0 109.831 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -128.84 -64.59 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.9 pt -139.79 119.24 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.546 0.738 . . . . 0.0 110.279 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.97 86.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -69.25 2.19 3.11 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.03 -50.3 56.22 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.53 -22.17 47.7 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 34' ' ' LEU . 68.7 m95 -107.45 170.85 7.72 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 0.0 109.867 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -98.98 -56.98 2.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.336 0.589 . . . . 0.0 109.793 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.74 158.4 20.02 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.819 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.688 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 59.7 mt -122.73 153.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.57 136.1 35.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.937 1.295 . . . . 0.0 108.098 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 t -143.8 93.63 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 40' ' ' GLU . 26.2 mm -66.9 142.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.703 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 35.4 p90 -15.65 106.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.363 1.865 . . . . 0.0 115.417 -159.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.4 p -70.23 102.0 2.01 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.395 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -99.22 94.2 6.35 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.3 133.33 25.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.56 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -56.78 161.71 9.82 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.285 2.656 . . . . 0.0 112.36 169.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -40.94 -44.1 2.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.815 1.246 . . . . 0.0 112.85 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 m -54.12 -63.82 1.03 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.311 1.044 . . . . 0.0 112.179 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -75.55 -27.72 58.74 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.581 0.352 . . . . 0.0 111.066 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -65.27 -55.4 18.59 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.26 -35.35 26.61 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.608 1.163 . . . . 0.0 112.592 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.71 -17.07 39.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.962 0.505 . . . . 0.0 111.398 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 117' ' ' VAL . 58.6 tp -78.43 -38.42 41.4 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.904 0.482 . . . . 0.0 111.265 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -57.34 -41.13 89.3 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -29.99 84.69 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.967 1.778 . . . . 0.0 112.515 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -81.95 -26.86 33.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.541 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 113' ' ' LEU . 2.5 t -87.35 -24.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.257 0.551 . . . . 0.0 110.675 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -82.08 -65.45 1.01 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.85 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.55 -45.5 15.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.899 0.88 . . . . 0.0 112.853 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.83 -29.87 64.53 Favored Glycine 0 N--CA 1.479 1.523 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.909 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.73 146.16 50.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.205 0.602 . . . . 0.0 110.286 169.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 39.4 mmtm -129.47 158.21 73.99 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 108.063 170.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 194' ' ' LYS . 34.5 Cg_exo -40.18 110.87 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.392 2.728 . . . . 0.0 114.444 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.49 6.59 6.65 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.804 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.688 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -98.97 140.43 15.01 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 170.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 29.0 m -111.47 130.94 64.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.256 0.55 . . . . 0.0 110.3 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -110.03 107.4 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 24' ' ' VAL . 45.2 mt -110.4 107.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 156' ' ' LEU . 29.8 mt -125.73 116.42 21.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -167.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.703 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 45.5 tt0 -105.62 97.64 7.45 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.89 -177.46 46.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.974 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 150' ' ' LEU . 31.5 m-85 -138.21 159.05 43.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.942 0.897 . . . . 0.0 108.863 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.78 163.3 22.74 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 123.555 0.742 . . . . 0.0 110.31 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.677 ' HA ' HD22 ' A' ' 147' ' ' LEU . 71.7 Cg_exo -53.9 -16.3 8.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.476 2.784 . . . . 0.0 115.393 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.68 -22.84 59.82 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.071 0.548 . . . . 0.0 111.995 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -66.4 -56.49 10.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -162.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.488 HD21 HD21 ' A' ' 150' ' ' LEU . 26.3 mt -65.86 -21.5 66.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 123.279 0.362 . . . . 0.0 111.383 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -65.17 -22.56 66.93 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.176 0.59 . . . . 0.0 112.056 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -68.17 -6.05 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 52.33 22.14 1.93 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.575 1.55 . . . . 0.0 113.169 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.7 m -95.54 0.64 53.27 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.301 1.04 . . . . 0.0 109.091 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.83 145.6 5.07 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.143 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.66 81.69 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.573 ' HB2' HD12 ' A' ' 149' ' ' LEU . 22.5 Cg_exo -63.08 -26.01 73.31 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.724 2.283 . . . . 0.0 112.856 -173.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -174.24 -49.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.517 1.127 . . . . 0.0 108.405 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -171.58 162.37 6.43 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.475 0.71 . . . . 0.0 109.703 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -63.93 2.56 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.063 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.89 -36.7 80.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 144' ' ' PRO . 30.3 mt -76.09 3.62 10.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.525 0.73 . . . . 0.0 111.894 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 22.0 mt -90.88 103.24 6.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.98 109.02 2.81 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.617 2.211 . . . . 0.0 110.625 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' HD11 ' A' ' 188' ' ' ILE . 37.3 mtmm -108.0 162.71 13.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.275 0.63 . . . . 0.0 111.905 -168.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 188' ' ' ILE . 24.1 mt -60.15 -36.25 77.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.635 0.774 . . . . 0.0 109.899 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -48.53 -56.93 7.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.719 1.208 . . . . 0.0 110.79 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 57.2 m -71.73 -62.61 1.36 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.739 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 129' ' ' LEU . 24.3 mt -61.74 -55.48 29.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.696 1.198 . . . . 0.0 112.209 -166.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -59.7 -42.05 92.15 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.646 0.779 . . . . 0.0 111.9 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.1 t -63.76 -34.01 76.94 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 155' ' ' THR . 8.5 pt-20 -111.33 18.69 19.0 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.132 0.492 . . . . 0.0 111.251 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -139.74 63.23 25.55 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.108 0.963 . . . . 0.0 108.708 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.43 -8.87 15.01 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.62 2.214 . . . . 0.0 111.919 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.2 t -86.42 -33.09 20.55 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.6 tp -95.13 68.17 3.1 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 108.492 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.39 128.56 36.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 25.4 m95 -88.23 141.02 28.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 110.014 -163.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.34 -36.67 77.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.966 0.506 . . . . 0.0 109.843 170.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.5 mt -127.22 125.53 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.58 85.52 1.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.34 1.056 . . . . 0.0 108.658 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.09 149.59 28.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.565 0.346 . . . . 0.0 111.193 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.57 113.98 20.65 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.535 0.522 . . . . 0.0 109.633 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.9 mt -109.66 128.94 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 184' ' ' LYS . 41.6 tt0 -95.77 120.28 35.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -121.64 123.13 41.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.92 128.82 34.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.162 0.585 . . . . 0.0 111.134 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 185' ' ' ALA . 66.9 mt -76.72 169.45 18.28 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.949 0.899 . . . . 0.0 109.072 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -53.68 111.24 0.69 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.854 0.462 . . . . 0.0 109.981 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -116.67 150.68 37.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.131 0.572 . . . . 0.0 110.703 -173.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.57 36.68 0.14 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -142.09 -175.36 4.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.099 0.96 . . . . 0.0 110.626 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -90.29 1.49 56.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.552 0.741 . . . . 0.0 111.323 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -111.19 121.36 45.1 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.34 82.2 1.04 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.346 0.593 . . . . 0.0 110.639 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.86 94.49 0.36 Allowed Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.353 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.502 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 0.0 OUTLIER -111.05 -175.45 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.967 0.907 . . . . 0.0 109.869 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -126.02 130.25 50.79 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.29 109.35 20.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.46 154.01 30.07 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 152' ' ' LYS . 3.4 pt -136.14 116.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -97.86 138.1 35.72 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 34.5 mt -126.35 131.63 51.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.806 1.242 . . . . 0.0 108.1 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.515 HD22 HG12 ' A' ' 24' ' ' VAL . 40.1 tp -127.6 105.65 8.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 168.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.98 133.69 11.99 Favored Glycine 0 C--O 1.214 -1.133 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 27' ' ' GLN . 6.5 tp-100 -144.05 156.87 44.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.809 0.844 . . . . 0.0 109.304 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 123' ' ' PRO . 22.8 pttp -60.15 129.07 39.93 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.21 109.76 2.76 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.245 0.34 . . . . 0.0 110.581 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.95 160.83 14.04 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.652 0.381 . . . . 0.0 110.914 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 69.75 23.32 5.75 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.389 1.076 . . . . 0.0 109.477 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -138.75 88.31 2.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.183 0.993 . . . . 0.0 108.707 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -80.9 163.44 23.36 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.189 0.595 . . . . 0.0 110.555 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -76.54 132.28 39.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -148.48 114.34 5.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 108.996 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.015 0.926 . . . . 0.0 108.535 -176.198 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 mmt . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -150.88 116.62 5.49 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.041 0.936 . . . . 0.0 109.301 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.78 101.88 13.74 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.562 ' HG3' ' HD2' ' A' ' 6' ' ' PHE . 15.0 tp10 -68.85 84.76 0.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.826 0.85 . . . . 0.0 108.987 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 60.08 3.0 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.769 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.562 ' HD2' ' HG3' ' A' ' 4' ' ' GLU . 51.6 p90 -69.4 -17.67 63.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.19 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.0 t -52.72 -33.72 49.15 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.0 1.32 . . . . 0.0 111.255 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -118.68 91.76 3.64 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.3 m -61.38 -40.71 95.36 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.227 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -152.4 139.1 18.81 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -90.26 15.68 9.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.727 0.811 . . . . 0.0 112.462 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.06 142.99 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.818 0.447 . . . . 0.0 109.834 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.74 69.51 1.48 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.411 0.624 . . . . 0.0 110.231 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.9 91.47 0.6 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 165.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.681 HG22 ' HG3' ' A' ' 16' ' ' GLU . 20.0 m -72.39 -77.85 0.09 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.449 0.699 . . . . 0.0 111.387 -166.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.681 ' HG3' HG22 ' A' ' 15' ' ' THR . 44.5 mt-10 -126.86 106.99 22.48 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 123.398 0.679 . . . . 0.0 111.049 -170.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HA ' HG11 ' A' ' 22' ' ' VAL . 20.2 Cg_exo -66.29 135.03 38.36 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.121 2.547 . . . . 0.0 111.403 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.641 HD21 ' HB3' ' A' ' 21' ' ' LEU . 24.6 p-10 -130.88 -164.67 1.46 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.893 0.477 . . . . 0.0 109.838 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -43.25 -53.01 5.39 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.37 1.468 . . . . 0.0 114.381 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -172.44 -22.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.31 0.644 . . . . 0.0 110.494 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.641 ' HB3' HD21 ' A' ' 18' ' ' ASN . 33.2 tp -59.26 -31.88 69.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.538 0.735 . . . . 0.0 112.509 -174.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 17' ' ' PRO . 5.7 m -54.79 -38.05 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -68.12 -53.08 27.87 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.955 0.883 . . . . 0.0 110.425 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 128' ' ' ILE . 29.7 m -66.97 -29.27 45.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.546 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.91 72.94 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.249 1.02 . . . . 0.0 112.31 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.05 -35.57 79.02 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.021 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -95.2 -7.63 38.55 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' VAL . 57.9 mt -72.06 138.35 82.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.69 ' HG3' ' HD3' ' A' ' 194' ' ' LYS . 33.7 Cg_exo -59.87 131.83 41.77 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.084 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -70.78 30.37 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.02 -148.93 9.27 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -80.39 118.06 21.69 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -107.63 141.95 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.709 0.804 . . . . 0.0 110.197 -167.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 95' ' ' TRP . 33.0 tp -118.13 116.87 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.329 1.052 . . . . 0.0 109.127 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 26.5 p -107.21 111.93 24.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.277 0.489 . . . . 0.0 110.811 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -70.05 143.06 52.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.46 161.9 41.81 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.935 0.772 . . . . 0.0 110.041 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -115.58 -18.01 11.02 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.59 -9.21 0.03 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.943 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -137.9 122.7 18.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.596 1.159 . . . . 0.0 108.874 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . -97.2 39.4 2.8 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.379 0.425 . . . . 0.0 112.948 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 ttp-105 -70.75 -41.14 72.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.764 0.826 . . . . 0.0 109.891 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.43 -40.59 97.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.53 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.68 -57.27 13.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 111.575 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.651 ' SG ' HD23 ' A' ' 70' ' ' LEU . 20.1 p -61.67 -43.26 99.19 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.375 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -66.32 -46.18 77.75 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.256 0.348 . . . . 0.0 111.184 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' ' 21' ' ' LEU . 97.3 mt -67.05 -33.0 74.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.051 0.54 . . . . 0.0 110.874 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 -33.1 72.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.991 0.517 . . . . 0.0 110.873 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 63.9 m -75.43 -5.6 45.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.3 mt -88.59 13.15 12.77 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.245 0.618 . . . . 0.0 110.167 167.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.56 39.14 30.77 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.74 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -130.12 154.68 47.24 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.161 0.481 . . . . 0.0 111.888 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.19 89.18 7.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.575 0.75 . . . . 0.0 109.056 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.62 110.14 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.319 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 82.1 m -87.09 112.91 22.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.624 1.17 . . . . 0.0 109.79 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -92.31 125.82 37.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.707 0.803 . . . . 0.0 109.913 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' CG1' ' HA ' ' A' ' 83' ' ' SER . 5.6 t -105.37 116.45 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 167.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -135.74 133.93 38.51 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.4 -23.86 67.43 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.679 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.542 ' HB3' HG22 ' A' ' 62' ' ' VAL . 15.8 m -104.13 135.85 44.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.057 0.943 . . . . 0.0 109.814 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -73.11 -25.8 61.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 0.0 109.981 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 60' ' ' SER . 21.2 m -67.85 -36.6 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.258 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.98 -36.28 90.74 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.51 -48.23 70.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.402 1.081 . . . . 0.0 111.5 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.39 84.46 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.688 0.795 . . . . 0.0 112.47 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -77.45 -31.58 53.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.263 0.625 . . . . 0.0 111.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.69 -46.89 87.71 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 171.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.46 -40.95 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.169 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.4 -53.42 58.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.022 0.929 . . . . 0.0 110.823 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.651 HD23 ' SG ' ' A' ' 45' ' ' CYS . 19.3 tp -65.69 -28.47 69.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.642 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -54.46 17.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.734 0.414 . . . . 0.0 110.812 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -35.63 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.187 0.595 . . . . 0.0 110.769 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.66 -40.48 97.2 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.851 0.719 . . . . 0.0 110.356 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -91.02 -1.39 57.82 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.981 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.69 32.28 37.75 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 16.3 m -132.71 178.51 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.961 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -132.0 142.16 49.5 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.758 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.0 mm -110.61 170.06 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.97 1.308 . . . . 0.0 108.273 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 71.7 m -121.91 111.89 17.64 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 163.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t -86.08 109.96 19.2 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.592 0.757 . . . . 0.0 111.545 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.22 133.05 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.524 1.129 . . . . 0.0 108.955 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -85.41 132.42 34.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . 58.2 m -61.36 125.92 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -133.42 87.61 2.41 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.5 mt -91.1 -4.58 56.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.506 0.722 . . . . 0.0 110.674 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.39 3.54 54.25 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.825 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.39 -37.81 0.27 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -162.04 104.53 1.16 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -169.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.5 -65.15 0.99 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -174.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 98' ' ' ILE . 9.4 pt -136.32 115.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.479 0.712 . . . . 0.0 110.777 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 94' ' ' ALA . 61.4 t -128.07 94.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.83 -1.43 2.9 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.2 -51.27 9.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 168.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -70.55 -31.47 68.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.37 0.668 . . . . 0.0 111.861 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.488 ' CD1' HD22 ' A' ' 34' ' ' LEU . 24.5 m95 -116.94 145.08 43.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.778 0.831 . . . . 0.0 109.44 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.07 -33.06 44.92 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.178 0.513 . . . . 0.0 110.57 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -139.98 140.11 10.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.872 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 90' ' ' ILE . 82.1 mt -115.58 143.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' LEU . 7.7 p -135.8 134.58 51.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 164.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 m -136.89 113.77 10.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 128' ' ' ILE . 37.1 mm -76.34 144.51 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.735 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 2.9 p90 -20.31 109.36 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.124 1.77 . . . . 0.0 115.148 -173.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.415 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.7 t -80.36 113.48 18.58 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 112.896 -1.956 . . . . 0.0 110.313 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -120.19 98.08 5.9 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -122.1 150.72 57.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.91 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.68 159.53 53.27 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.91 2.407 . . . . 0.0 110.125 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.3 m -37.16 -45.0 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.157 1.783 . . . . 0.0 113.956 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.7 p -49.14 -63.08 1.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 O-C-N 124.675 1.234 . . . . 0.0 111.844 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.24 -22.28 28.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.392 0.677 . . . . 0.0 110.539 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -73.42 -62.93 1.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.129 0.972 . . . . 0.0 110.374 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.31 -15.17 56.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.451 0.7 . . . . 0.0 112.098 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.23 -41.65 27.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 117' ' ' VAL . 46.6 tp -74.86 -48.22 26.1 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.783 -170.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.449 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 34.7 m-85 -66.73 -40.56 32.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.56 -31.74 94.98 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 121.958 1.772 . . . . 0.0 112.281 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -82.65 -14.96 53.77 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.964 0.906 . . . . 0.0 110.057 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 113' ' ' LEU . 22.0 t -80.68 -36.46 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.506 ' HE1' ' HD2' ' A' ' 161' ' ' PRO . 33.0 t80 -57.8 -54.46 46.6 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -71.83 -47.01 56.07 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.806 0.842 . . . . 0.0 112.926 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.09 -45.94 10.99 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 114.276 0.47 . . . . 0.0 114.276 -170.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.1 tp -85.28 95.2 9.12 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -75.75 148.41 82.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 164.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.02 133.27 28.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.201 1.934 . . . . 0.0 110.125 168.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 128.87 -11.73 6.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -157.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.01 168.08 20.87 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 122.726 -0.279 . . . . 0.0 112.593 166.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.08 137.88 48.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.409 1.083 . . . . 0.0 109.45 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.98 113.33 23.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 24' ' ' VAL . 17.9 mt -106.95 109.62 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.934 0.893 . . . . 0.0 108.644 -171.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 156' ' ' LEU . 40.3 mt -125.85 114.1 18.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.995 0.518 . . . . 0.0 109.754 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.735 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 43.2 tt0 -103.47 98.95 8.76 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.91 -176.68 49.24 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.449 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.449 ' HB2' HD22 ' A' ' 150' ' ' LEU . 36.8 m-85 -132.79 158.61 42.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.215 1.006 . . . . 0.0 108.757 -176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.57 159.52 30.28 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 123.582 0.753 . . . . 0.0 110.553 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' HD22 ' A' ' 147' ' ' LEU . 73.3 Cg_exo -55.09 -18.43 17.4 Favored 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.85 3.034 . . . . 0.0 116.482 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -83.92 -5.82 59.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.869 -0.519 . . . . 0.0 112.179 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -73.85 -49.98 22.49 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.965 -0.46 . . . . 0.0 111.2 -169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.509 HD12 ' HG ' ' A' ' 147' ' ' LEU . 18.2 mt -69.86 -25.84 63.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -70.27 -23.55 62.9 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.305 1.042 . . . . 0.0 111.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.58 -7.5 15.19 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.129 0.572 . . . . 0.0 111.586 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 68.45 37.77 2.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.049 1.34 . . . . 0.0 109.23 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.8 p -79.04 -20.04 49.92 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.219 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' O ' HD22 ' A' ' 137' ' ' LEU . . . 127.6 122.88 2.56 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.769 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.41 95.42 1.15 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-O 118.821 -0.988 . . . . 0.0 111.539 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.55 -20.02 60.41 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.989 2.459 . . . . 0.0 112.541 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -159.6 -62.31 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -179.27 166.39 1.49 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.159 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.618 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -60.49 -1.85 0.42 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.706 1.602 . . . . 0.0 112.93 172.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -61.67 -40.16 93.95 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.36 1.464 . . . . 0.0 110.742 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.89 -1.7 23.55 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.618 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 20.9 mt -83.29 107.83 11.04 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -68.82 111.88 2.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.923 2.416 . . . . 0.0 111.239 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.13 151.89 20.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.276 0.63 . . . . 0.0 111.482 -169.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.504 HD21 ' HB ' ' A' ' 188' ' ' ILE . 60.5 mt -60.69 -39.37 88.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.166 0.586 . . . . 0.0 110.486 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.1 -51.39 58.02 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.389 1.076 . . . . 0.0 110.805 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.7 p -71.55 -55.18 8.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.671 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 129' ' ' LEU . 55.9 mt -73.51 -46.15 49.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.262 1.025 . . . . 0.0 113.52 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -64.42 -42.41 96.07 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 m -73.64 -21.94 60.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 19.7 tp10 -74.39 -22.25 59.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.635 0.774 . . . . 0.0 110.521 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.456 HD23 ' HD1' ' A' ' 118' ' ' TYR . 68.6 mt -140.22 65.56 28.69 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.535 0.734 . . . . 0.0 109.377 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.506 ' HD2' ' HE1' ' A' ' 118' ' ' TYR . 95.3 Cg_endo -81.42 2.49 8.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 123.068 2.512 . . . . 0.0 112.09 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 55.1 p -90.47 -33.84 15.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.367 1.067 . . . . 0.0 108.685 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.06 73.12 7.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.999 1.719 . . . . 0.0 111.178 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -50.06 114.15 1.03 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.476 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 35.4 m95 -84.88 128.99 34.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.786 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 84.8 mt -71.18 -36.61 72.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.429 0.692 . . . . 0.0 110.803 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 59.1 mt -125.25 120.74 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.02 70.98 0.95 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -148.23 146.51 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -170.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -73.97 112.42 10.07 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.272 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.9 mt -118.17 137.17 53.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 110.829 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -94.68 127.32 40.57 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.509 0.724 . . . . 0.0 110.005 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -109.25 123.01 48.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.662 0.785 . . . . 0.0 109.64 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -73.29 110.33 7.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.375 0.67 . . . . 0.0 110.792 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.74 167.84 20.1 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.981 0.912 . . . . 0.0 110.304 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -75.7 71.46 2.57 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.91 154.75 5.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.318 -164.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -168.58 34.94 0.2 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 120.268 -0.185 . . . . 0.0 112.838 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 91.89 0.12 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.235 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.3 t80 68.02 -76.1 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.669 1.588 . . . . 0.0 110.334 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -136.03 -16.5 1.68 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -70.77 90.6 0.79 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -147.39 13.21 1.4 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.94 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 184' ' ' LYS . 0.1 OUTLIER -133.4 176.27 8.68 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.892 0.877 . . . . 0.0 110.069 -174.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -125.75 132.05 52.41 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.98 106.01 15.31 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -127.28 171.94 11.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.657 0.783 . . . . 0.0 109.809 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.504 ' HB ' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -142.82 119.82 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.031 173.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -98.31 140.71 32.18 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 37.4 mt -129.23 133.35 47.49 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 108.453 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.47 HD22 HG12 ' A' ' 24' ' ' VAL . 46.3 tp -139.76 107.61 5.67 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.69 139.76 17.46 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 6.1 tp60 -116.72 146.79 42.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.001 0.9 . . . . 0.0 111.677 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.69 ' HD3' ' HG3' ' A' ' 29' ' ' PRO . 21.9 pttm -58.19 115.05 2.68 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.163 165.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.03 140.07 26.25 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 167.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -34.39 124.99 0.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.721 1.208 . . . . 0.0 113.228 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -72.53 80.02 1.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.204 1.002 . . . . 0.0 111.619 -176.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -93.47 -55.55 3.25 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.512 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -127.41 17.83 7.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.237 0.615 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -140.06 103.94 4.73 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 197' ' ' HIS . 32.2 m170 64.24 150.88 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.524 1.13 . . . . 0.0 111.845 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.245 1.018 . . . . 0.0 108.352 177.358 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mtp . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -87.02 70.74 10.3 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.919 0.866 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -110.93 161.01 16.27 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 -144.39 0.11 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.547 1.139 . . . . 0.0 109.172 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER 49.31 79.52 0.08 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.925 1.69 . . . . 0.0 112.338 -174.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -147.58 77.26 1.43 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -143.31 77.83 1.58 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -86.33 -13.55 46.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.669 0.788 . . . . 0.0 109.792 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -54.62 95.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.546 1.539 . . . . 0.0 112.178 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.53 94.15 4.98 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.055 0.931 . . . . 0.0 110.618 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -127.66 114.21 17.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.689 175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.22 25.05 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.963 0.887 . . . . 0.0 108.81 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -59.98 105.33 0.38 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.791 1.236 . . . . 0.0 112.05 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.75 44.64 1.46 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.48 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -70.97 149.48 46.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.892 0.877 . . . . 0.0 110.973 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -140.17 75.78 28.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.24 124.77 1.77 Allowed 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.661 2.241 . . . . 0.0 111.142 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.55 143.48 34.6 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 22' ' ' VAL . 15.3 t70 -156.66 173.18 17.33 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.892 0.877 . . . . 0.0 109.084 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -59.9 -29.51 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.727 0.811 . . . . 0.0 110.527 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 47' ' ' LEU . 18.2 tp -59.77 -33.97 72.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.848 1.259 . . . . 0.0 112.492 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 19' ' ' ASP . 11.0 m -52.54 -38.46 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -72.8 -44.72 61.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 0.0 110.938 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 128' ' ' ILE . 2.4 m -67.97 -33.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.044 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.27 77.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.485 1.114 . . . . 0.0 111.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.7 -33.87 73.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.191 0.596 . . . . 0.0 110.329 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -84.21 -22.52 30.85 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' VAL . 85.7 mt -76.98 131.67 72.63 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.91 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.39 143.93 71.83 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.788 2.326 . . . . 0.0 111.895 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -72.79 30.59 0.06 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.336 1.454 . . . . 0.0 114.371 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.76 177.95 17.35 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 96' ' ' GLU . 66.1 mttm -60.14 118.48 6.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.542 0.737 . . . . 0.0 110.845 -165.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.89 138.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -165.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 90' ' ' ILE . 59.9 tp -110.67 112.43 24.31 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.73 ' SG ' HG13 ' A' ' 54' ' ' VAL . 58.9 m -101.81 109.59 21.38 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 123.772 0.829 . . . . 0.0 110.412 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 89' ' ' ASP . 36.8 mt -76.69 127.31 32.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 165.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.2 86.58 2.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 103' ' ' CYS . 15.9 tp10 -106.02 73.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.094 0.949 . . . . 0.0 109.39 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.29 -40.56 1.27 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.487 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HG3' ' HG2' ' A' ' 42' ' ' ARG . 12.8 tp10 -159.91 133.95 7.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.245 0.618 . . . . 0.0 110.158 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.54 25.32 8.16 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.707 0.63 . . . . 0.0 113.7 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HG2' ' HG3' ' A' ' 40' ' ' GLU . 17.0 ptt180 -61.78 -38.21 87.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.445 0.698 . . . . 0.0 110.821 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -74.59 -33.61 62.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.182 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.05 66.61 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.297 0.639 . . . . 0.0 110.799 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.6 p -70.42 -28.44 65.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.2 t80 -66.88 -33.15 74.97 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' A' ' 21' ' ' LEU . 31.4 mt -64.59 -36.04 82.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.121 0.569 . . . . 0.0 111.164 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.56 69.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.661 0.267 . . . . 0.0 110.743 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.601 ' HA ' HG11 ' A' ' 76' ' ' VAL . 55.9 m -68.36 -10.86 57.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.531 0.732 . . . . 0.0 111.533 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 47' ' ' LEU . 65.7 mt -88.13 14.89 8.28 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.643 0.777 . . . . 0.0 110.846 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.16 36.97 44.05 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 123.146 0.403 . . . . 0.0 113.435 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.64 147.34 45.37 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.889 0.476 . . . . 0.0 112.101 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.9 90.64 4.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.902 0.881 . . . . 0.0 108.719 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.73 HG13 ' SG ' ' A' ' 35' ' ' CYS . 65.3 t -102.05 112.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.023 0.529 . . . . 0.0 111.969 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.2 m -85.3 104.88 15.54 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.68 120.95 41.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.268 0.627 . . . . 0.0 109.507 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 83' ' ' SER . 3.6 t -103.81 119.17 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -132.91 144.56 50.24 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.315 0.962 . . . . 0.0 111.32 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 3.0 pp0? -57.98 -18.27 22.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.526 1.53 . . . . 0.0 114.503 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 62' ' ' VAL . 77.5 p -131.2 139.2 49.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 110.409 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -76.83 -17.41 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.405 0.682 . . . . 0.0 110.163 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 60' ' ' SER . 20.1 m -73.5 -29.16 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.151 168.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.97 -28.99 57.77 Favored Glycine 0 C--N 1.359 1.827 0 O-C-N 123.524 0.515 . . . . 0.0 112.342 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.08 -39.97 68.59 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.666 0.787 . . . . 0.0 110.299 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.52 67.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.759 0.824 . . . . 0.0 111.15 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -70.66 -47.53 59.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.225 1.01 . . . . 0.0 109.011 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.56 95.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.119 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -69.83 -35.77 75.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.989 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.12 -46.3 82.77 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.914 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.65 -29.61 66.01 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.154 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -62.8 -62.27 1.84 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.879 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.11 -23.14 67.06 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.884 0.873 . . . . 0.0 112.028 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.93 -56.12 20.01 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -99.03 8.05 45.37 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.948 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.77 38.19 85.19 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 121.996 -0.44 . . . . 0.0 113.358 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.4 m -121.52 162.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.093 0.957 . . . . 0.0 109.282 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -106.05 129.32 54.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.151 0.58 . . . . 0.0 112.107 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 71' ' ' ALA . 16.2 mm -114.24 160.99 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 166.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -125.2 104.3 8.43 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 p -87.86 121.85 30.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.889 0.476 . . . . 0.0 110.744 -167.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.96 140.4 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 108.704 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -81.61 133.12 35.34 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 57' ' ' VAL . 37.7 t -65.55 114.86 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.47 0.481 . . . . 0.0 111.392 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -141.45 88.66 2.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.67 -10.77 50.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.143 0.577 . . . . 0.0 111.23 -166.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.04 -22.34 36.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.476 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.83 -37.66 10.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 110.896 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -171.95 135.54 0.83 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.157 1.383 . . . . 0.0 108.154 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' O ' HD21 ' A' ' 36' ' ' LEU . 1.8 p-10 -135.17 -73.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' A' ' 98' ' ' ILE . 3.7 pt -146.63 120.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.441 0.696 . . . . 0.0 110.774 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 94' ' ' ALA . 44.2 t -130.34 93.27 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.897 0.479 . . . . 0.0 109.968 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.0 23.76 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.34 -44.03 59.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.409 0.684 . . . . 0.0 109.229 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.406 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -77.34 -34.42 55.22 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.32 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.538 ' NE1' HD22 ' A' ' 34' ' ' LEU . 74.5 m95 -109.05 149.71 28.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.218 0.607 . . . . 0.0 111.379 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' N ' ' A' ' 32' ' ' LYS . 45.1 mt-10 -91.74 3.69 54.51 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.835 0.854 . . . . 0.0 111.112 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.33 151.44 16.49 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.1 mt -128.6 149.12 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.903 0.881 . . . . 0.0 108.853 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -147.66 144.24 19.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 162.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 127' ' ' PHE . 47.4 m -133.24 100.37 4.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.9 mm -70.09 138.96 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.739 1.216 . . . . 0.0 108.705 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -18.18 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.533 1.933 . . . . 0.0 114.723 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 26.3 p -82.45 106.32 14.23 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.619 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -96.42 97.37 9.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.5 mt -124.67 145.7 50.34 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.709 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.17 152.44 71.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.858 2.372 . . . . 0.0 109.926 167.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.4 m -44.18 -40.0 4.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.769 1.227 . . . . 0.0 113.168 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 34.6 m -51.39 -60.81 2.72 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 124.454 1.096 . . . . 0.0 111.002 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.97 -24.15 38.25 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.864 0.466 . . . . 0.0 111.424 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 114' ' ' TYR . 29.2 ttp180 -75.8 -48.67 20.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -68.35 -10.37 54.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.582 0.753 . . . . 0.0 112.81 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 108' ' ' SER . 30.1 mm-40 -88.0 -26.97 22.35 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.014 0.37 . . . . 0.0 110.144 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 117' ' ' VAL . 57.6 tp -78.03 -52.87 8.11 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.867 -174.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 110' ' ' ARG . 29.1 m-85 -66.39 -38.04 18.89 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 24.2 Cg_endo -61.54 -29.43 84.6 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.958 1.772 . . . . 0.0 112.514 167.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -81.57 -22.97 37.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.216 1.007 . . . . 0.0 109.799 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.533 HG22 HD11 ' A' ' 90' ' ' ILE . 28.6 t -78.18 -39.65 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.886 0.874 . . . . 0.0 109.211 170.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.59 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 13.3 t80 -54.09 -58.61 6.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.817 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.36 -49.54 66.57 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.742 0.817 . . . . 0.0 113.036 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.5 -40.48 32.59 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -165.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 34.1 tp -81.21 115.58 20.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.739 0.815 . . . . 0.0 109.56 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.55 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 9.0 mmpt? -103.71 159.39 29.46 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.362 1.065 . . . . 0.0 109.363 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.97 113.35 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.623 0 C-N-CA 123.458 2.772 . . . . 0.0 113.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.556 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.94 14.01 2.6 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.733 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.609 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.21 150.46 17.17 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 162.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 31.8 m -110.62 133.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.373 0 C-N-CA 123.039 0.535 . . . . 0.0 109.57 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 100' ' ' SER . 0.8 OUTLIER -105.79 112.74 25.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 24' ' ' VAL . 50.3 mt -107.01 107.55 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 96.9 mt -121.41 123.26 41.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -106.02 99.31 8.91 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.622 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -79.97 173.87 55.03 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.102 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.3 157.04 46.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.46 163.54 24.26 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.185 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.715 ' HA ' HD22 ' A' ' 147' ' ' LEU . 20.7 Cg_endo -61.01 -4.28 3.62 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.847 2.364 . . . . 0.0 115.569 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.4 -12.06 52.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.926 0.49 . . . . 0.0 111.758 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -69.28 -56.94 6.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.602 -167.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 150' ' ' LEU . 15.2 mt -62.97 -21.3 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.345 0.403 . . . . 0.0 111.187 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.4 -32.85 74.02 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.186 0.994 . . . . 0.0 112.186 172.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.93 7.06 13.12 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.958 0.903 . . . . 0.0 112.411 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 137' ' ' LEU . 66.0 t30 -68.98 153.88 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.167 0.587 . . . . 0.0 112.46 -164.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -79.24 -0.25 31.38 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.285 1.034 . . . . 0.0 111.624 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.43 179.05 28.39 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.969 0.319 . . . . 0.0 112.322 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -121.31 94.59 0.54 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.941 -0.921 . . . . 0.0 111.196 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.47 -124.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.024 2.483 . . . . 0.0 111.14 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -129.21 -38.45 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.174 0.897 . . . . 0.0 110.573 178.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -168.96 153.86 5.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.487 0.715 . . . . 0.0 109.185 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.715 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -60.52 -3.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.201 1.4 . . . . 0.0 113.591 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.81 -39.65 81.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.957 0.903 . . . . 0.0 109.838 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.8 mt -82.71 12.82 4.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.888 0.475 . . . . 0.0 111.937 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 137' ' ' LEU . 25.7 mt -90.88 105.45 12.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.622 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 24.6 Cg_exo -63.56 112.96 1.92 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.123 2.548 . . . . 0.0 112.479 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -95.02 145.83 24.68 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.909 0.884 . . . . 0.0 111.279 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 HD21 ' A' ' 190' ' ' LEU . 41.2 mt -61.03 -51.32 69.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.164 0.586 . . . . 0.0 110.69 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.97 -35.7 47.17 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.533 0.733 . . . . 0.0 112.164 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 m -76.56 -45.87 28.7 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.29 1.036 . . . . 0.0 110.719 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' PRO . 83.2 mt -82.3 -46.49 13.58 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.094 0.958 . . . . 0.0 112.877 -170.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.7 -39.93 62.47 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.515 . . . . 0.0 111.261 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t -70.89 -33.92 71.06 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -96.47 -7.41 34.85 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 118' ' ' TYR . 72.4 mt -139.66 62.69 24.1 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.247 0.619 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.59 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 57.3 Cg_endo -81.62 -3.21 11.82 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.138 2.559 . . . . 0.0 113.082 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.5 p -88.46 -30.13 19.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.893 0.877 . . . . 0.0 109.105 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 tp -93.22 75.7 4.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.825 1.65 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -44.5 111.87 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 0.0 111.194 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.457 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 54.4 m95 -85.0 129.43 34.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD11 ' HG2' ' A' ' 193' ' ' GLN . 71.8 mt -76.97 -35.66 57.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.572 0.349 . . . . 0.0 110.467 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.85 123.63 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.71 85.55 1.04 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.11 0.964 . . . . 0.0 108.933 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.09 151.09 35.06 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 188' ' ' ILE . 13.5 t30 -79.16 103.73 9.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.472 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.07 125.25 50.77 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 109.306 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.85 142.44 27.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -145.14 132.84 21.01 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -74.86 139.03 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.437 0.695 . . . . 0.0 109.992 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.0 mt -79.23 169.59 17.91 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.793 1.237 . . . . 0.0 110.14 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.09 -52.33 65.72 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 171.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -172.24 111.61 0.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.112 -1.404 . . . . 0.0 107.592 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 -0.23 3.84 Favored Glycine 0 N--CA 1.475 1.27 0 CA-C-O 119.968 -0.351 . . . . 0.0 113.889 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -159.67 -167.35 1.98 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.352 0.661 . . . . 0.0 110.824 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -118.66 -36.49 3.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.891 0.876 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -77.69 -54.79 5.96 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -166.83 116.0 0.87 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -75.44 79.56 1.07 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -99.3 167.64 10.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.291 1.036 . . . . 0.0 110.117 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -150.49 132.47 15.19 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -91.36 125.3 36.07 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.92 165.02 18.11 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.43 ' HB ' HD21 ' A' ' 153' ' ' LEU . 6.3 pt -140.88 116.26 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -102.49 145.57 29.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.584 0.707 . . . . 0.0 110.395 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.471 HD21 HD22 ' A' ' 153' ' ' LEU . 35.7 mt -131.36 135.62 47.38 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.498 -174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 24' ' ' VAL . 43.5 tp -135.46 105.71 6.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.54 139.76 16.81 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HG2' HD11 ' A' ' 166' ' ' LEU . 5.6 tp60 -136.87 154.28 50.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.879 0.84 . . . . 0.0 111.489 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 22.1 ptmt -55.35 142.83 30.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.2 mt -70.12 99.49 1.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.5 36.76 2.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.561 1.172 . . . . 0.0 108.698 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -167.95 162.5 13.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.227 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -78.67 149.31 32.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.562 . . . . 0.0 111.094 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -65.43 95.55 0.21 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.326 0.651 . . . . 0.0 109.274 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -144.22 62.61 1.34 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.612 1.196 . . . . 0.0 109.222 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -112.32 23.44 13.64 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.527 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 125.83 1.652 . . . . 0.0 107.256 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -158.77 140.17 13.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.688 0.795 . . . . 0.0 109.018 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -75.98 89.04 2.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.177 0.989 . . . . 0.0 109.819 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -87.77 44.81 1.22 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.071 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.18 101.35 13.09 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -151.27 146.61 26.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.605 0.762 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m -149.9 -65.32 0.21 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.362 1.065 . . . . 0.0 108.335 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 49.93 71.51 0.4 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.019 1.328 . . . . 0.0 111.329 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -149.06 73.45 1.21 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.13 157.21 18.9 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.888 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -158.72 159.78 35.63 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.318 0.58 . . . . 0.0 111.919 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.89 157.7 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.978 1.311 . . . . 0.0 107.487 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -149.18 135.63 19.36 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -165.41 46.03 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.586 0.554 . . . . 0.0 112.879 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.6 t -154.67 14.67 0.43 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.136 0.975 . . . . 0.0 110.472 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.85 95.53 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 125.527 1.531 . . . . 0.0 109.618 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.88 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.915 2.41 . . . . 0.0 114.402 -168.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -96.57 14.98 22.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.412 0.685 . . . . 0.0 109.861 166.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.09 155.27 39.92 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.861 1.664 . . . . 0.0 111.676 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.47 -43.48 26.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.096 0.959 . . . . 0.0 110.799 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 ' ND2' ' A' ' 43' ' ' ASN . 21.3 tp -59.74 -44.77 93.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.606 0.763 . . . . 0.0 111.559 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 m -43.56 -34.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -50.84 19.5 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.57 0.623 . . . . 0.0 110.329 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 128' ' ' ILE . 1.4 m -59.41 -33.08 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.734 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.8 74.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 0.0 111.776 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.3 -26.75 68.62 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.922 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -89.71 -19.87 24.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.959 0.903 . . . . 0.0 111.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 66.7 mt -80.1 135.98 54.23 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 122.972 0.509 . . . . 0.0 109.833 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -58.92 133.27 52.56 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.974 2.45 . . . . 0.0 111.864 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.59 27.17 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.69 -131.76 4.57 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.767 0.712 . . . . 0.0 111.828 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 67.5 mttm -77.15 113.19 14.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.074 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 99' ' ' VAL . 21.1 mt -111.68 120.54 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 109.144 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' THR . 36.2 tp -93.4 113.19 25.29 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.632 0.373 . . . . 0.0 110.576 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 54.0 t -108.77 107.66 18.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.17 165.39 9.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.76 0.424 . . . . 0.0 111.519 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -57.87 -25.9 61.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.253 0.549 . . . . 0.0 110.429 170.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -68.52 82.33 0.27 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 161.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 101' ' ' ILE . . . 173.67 -156.81 24.72 Favored Glycine 0 C--O 1.241 0.55 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.551 -170.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -148.86 140.36 23.41 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.8 -51.56 52.68 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.56 0.538 . . . . 0.0 113.821 -171.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -69.96 -28.92 65.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.121 0.569 . . . . 0.0 110.792 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' HD22 ' A' ' 21' ' ' LEU . 24.9 t-20 -64.91 -43.64 92.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.228 1.011 . . . . 0.0 110.363 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.83 -47.05 70.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.708 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.9 m -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.662 . . . . 0.0 112.459 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.3 t80 -68.66 -39.29 80.73 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.058 0.543 . . . . 0.0 109.716 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.27 -34.32 77.17 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.078 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.55 71.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.96 0.504 . . . . 0.0 111.147 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG11 ' A' ' 76' ' ' VAL . 34.7 t -70.28 -11.28 60.8 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 111.781 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 79.1 mt -85.1 5.84 28.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.76 0.424 . . . . 0.0 110.384 170.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.04 27.95 47.55 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 123.173 0.416 . . . . 0.0 113.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -113.62 151.4 31.78 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.27 0.535 . . . . 0.0 109.697 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 40.9 mt-10 -85.36 87.61 7.41 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.25 104.89 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.297 0.57 . . . . 0.0 109.904 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.1 t -85.54 111.09 19.7 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.834 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.49 121.2 44.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.932 0.493 . . . . 0.0 109.873 -172.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 3.7 t -89.31 134.54 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 t70 -152.83 129.23 10.61 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -62.69 -28.38 69.9 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.238 1.015 . . . . 0.0 112.831 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.444 ' OG ' HG22 ' A' ' 62' ' ' VAL . 10.2 t -102.6 123.8 46.98 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -72.38 -19.79 61.56 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.168 0.587 . . . . 0.0 111.042 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' OG ' ' A' ' 60' ' ' SER . 18.9 m -66.65 -32.74 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 122.819 0.448 . . . . 0.0 110.685 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.51 -39.84 55.55 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.897 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 80' ' ' THR . 94.5 mt -62.52 -48.52 79.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 110.983 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -57.6 -46.63 83.8 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -69.96 -38.03 75.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.249 0.62 . . . . 0.0 110.641 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.386 0.612 . . . . 0.0 110.541 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -74.05 -29.65 62.01 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.703 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 69.8 mt-30 -61.91 -45.5 93.46 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.13 0.572 . . . . 0.0 110.168 171.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.52 -26.72 64.66 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 123.882 0.739 . . . . 0.0 110.568 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.44 -62.07 1.92 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.185 173.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.24 -37.69 81.17 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.123 0.569 . . . . 0.0 111.036 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.42 -45.86 92.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.608 0.763 . . . . 0.0 110.56 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -97.65 8.65 44.28 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.971 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 37.53 77.45 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-N 116.617 -0.265 . . . . 0.0 113.701 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -130.42 -177.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.914 1.286 . . . . 0.0 109.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -131.18 136.04 47.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.746 HG12 ' HB2' ' A' ' 71' ' ' ALA . 25.7 mm -104.87 165.41 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 42.4 m -125.89 104.58 8.39 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 166.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.461 ' HB ' HD22 ' A' ' 64' ' ' LEU . 45.2 p -88.09 124.43 33.77 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.07 -0.394 . . . . 0.0 111.056 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 24.1 t -118.86 138.32 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.923 1.289 . . . . 0.0 108.555 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -86.42 128.28 34.93 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.779 0.718 . . . . 0.0 110.168 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 57' ' ' VAL . 47.3 m -63.19 125.21 23.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -143.31 91.4 2.26 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 28.8 mt -82.01 -8.32 59.66 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.566 0.621 . . . . 0.0 111.642 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.16 11.03 31.5 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.571 1.148 . . . . 0.0 110.681 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -143.65 -44.57 0.28 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.302 0.641 . . . . 0.0 111.553 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -166.91 109.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.23 1.412 . . . . 0.0 107.622 -170.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -125.71 -71.8 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.266 0.626 . . . . 0.0 109.531 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 98' ' ' ILE . 27.6 pt -133.94 121.28 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.386 0.674 . . . . 0.0 110.763 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.55 84.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.674 0.79 . . . . 0.0 109.31 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.66 0.34 10.93 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.824 0.45 . . . . 0.0 111.835 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.57 -47.58 46.97 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.475 1.11 . . . . 0.0 108.696 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.72 65.34 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.503 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -107.49 -166.06 1.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.83 -30.14 3.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.388 0.675 . . . . 0.0 110.568 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.36 166.66 29.08 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 90' ' ' ILE . 62.6 mt -137.55 141.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 9.8 p -129.4 131.96 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.2 m -143.19 119.82 11.1 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.81 -0.556 . . . . 0.0 109.628 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 11.8 mm -88.93 148.27 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.697 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 37.1 p90 -16.08 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 126.505 1.922 . . . . 0.0 115.416 -163.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.434 ' SG ' HD21 ' A' ' 129' ' ' LEU . 27.1 p -85.46 107.01 17.22 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.658 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -108.92 96.67 6.48 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 68.9 mt -120.41 148.8 48.44 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.144 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 153.93 28.25 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.095 2.53 . . . . 0.0 111.344 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.9 t -49.0 -32.16 8.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.105 0.962 . . . . 0.0 112.076 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 33.7 p -58.56 -60.8 3.23 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.455 1.102 . . . . 0.0 111.968 172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.35 -21.59 55.93 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.527 -174.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -69.99 -52.77 21.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 108.689 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -64.84 -11.78 41.11 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.178 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 108' ' ' SER . 16.2 mm100 -91.65 -38.44 12.44 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.106 -0.371 . . . . 0.0 110.805 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.9 tp -73.23 -50.34 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.748 0.419 . . . . 0.0 111.744 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 156' ' ' LEU . 39.6 m-85 -68.13 -35.88 8.18 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -54.17 -32.12 68.81 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.017 1.812 . . . . 0.0 113.64 163.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 32.4 mmtp -78.01 -30.71 50.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.462 0.705 . . . . 0.0 110.586 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.553 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.3 t -78.43 -25.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-O 121.626 0.726 . . . . 0.0 109.643 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -75.66 -64.07 1.16 Allowed 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.893 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -82.07 -50.41 9.11 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.88 51.72 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 116.754 -0.203 . . . . 0.0 113.191 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 125' ' ' GLY . 39.6 tp -69.75 100.42 1.5 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 122.896 0.478 . . . . 0.0 109.735 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.655 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 mtpp -66.74 149.3 98.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 165.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -42.52 119.21 1.32 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 124.041 3.161 . . . . 0.0 114.93 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.22 12.98 3.33 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.699 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -96.76 141.25 15.51 Favored Glycine 0 C--O 1.241 0.551 0 O-C-N 122.053 -0.675 . . . . 0.0 111.531 165.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 28.1 m -109.16 130.88 61.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.852 0.861 . . . . 0.0 108.903 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.95 111.98 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 24' ' ' VAL . 64.9 mt -103.53 107.91 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 17.1 mt -121.85 114.58 21.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.568 0.747 . . . . 0.0 109.528 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.697 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 28.5 tt0 -105.71 99.38 8.98 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -83.82 170.38 47.77 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.211 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.475 ' HB2' HD22 ' A' ' 150' ' ' LEU . 57.2 m-85 -133.17 159.12 41.09 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 108.863 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . . . -91.43 166.62 17.74 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.058 0.943 . . . . 0.0 110.126 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.687 ' HA ' HD22 ' A' ' 147' ' ' LEU . 32.3 Cg_endo -61.31 -6.06 6.17 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 123.167 2.578 . . . . 0.0 114.439 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 21.6 pt-20 -82.97 -7.99 59.61 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.709 0.803 . . . . 0.0 111.914 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -68.52 -61.5 1.8 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 0.0 111.733 -172.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.451 HD12 ' HG ' ' A' ' 147' ' ' LEU . 16.3 mt -68.75 -17.71 64.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 123.608 0.567 . . . . 0.0 110.231 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -64.57 -46.58 82.14 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.326 0.65 . . . . 0.0 110.509 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -56.31 -53.22 59.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.358 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -154.7 152.27 29.73 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.6 t -80.27 41.51 0.53 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 124.316 1.047 . . . . 0.0 112.087 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.47 48.36 2.19 Favored Glycine 0 C--N 1.363 2.081 0 C-N-CA 123.605 0.622 . . . . 0.0 113.108 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.66 137.72 11.43 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 118.8 -1.0 . . . . 0.0 110.646 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.91 -10.51 29.07 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.682 2.255 . . . . 0.0 113.577 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -171.41 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.367 1.334 0 CA-C-N 118.18 0.445 . . . . 0.0 110.386 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.13 158.84 22.36 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 109.696 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -56.44 -9.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.77 1.628 . . . . 0.0 113.257 173.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.01 -33.74 72.41 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.198 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -83.76 1.21 43.94 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.192 0.997 . . . . 0.0 112.038 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 132' ' ' PHE . 71.0 mt -78.92 112.02 24.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 156' ' ' LEU . 23.5 Cg_exo -64.74 105.3 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.386 2.724 . . . . 0.0 112.588 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HA ' HD11 ' A' ' 188' ' ' ILE . 21.9 ttmm -98.34 146.75 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.802 0.728 . . . . 0.0 111.504 -170.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.1 mt -61.11 -48.91 79.46 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -50.84 -47.51 60.22 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.168 0.917 . . . . 0.0 110.673 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.6 m -66.51 -61.94 1.72 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.68 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 151' ' ' PRO . 22.1 mt -73.52 -42.15 62.11 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.331 0.652 . . . . 0.0 112.355 -165.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -62.19 -34.89 77.3 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.604 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 96.1 p -81.21 -22.23 38.98 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.555 0.216 . . . . 0.0 111.027 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.49 -16.83 57.09 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.042 0.537 . . . . 0.0 110.425 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 117' ' ' VAL . 86.3 mt -143.5 64.02 13.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.167 0.987 . . . . 0.0 109.026 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.63 -9.97 15.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.021 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.8 t -88.34 -30.1 19.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 109.317 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.2 tp -88.21 70.86 9.24 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.583 1.153 . . . . 0.0 109.286 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -52.7 127.34 22.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.468 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.44 ' HZ2' ' HB2' ' A' ' 160' ' ' LEU . 42.1 m95 -92.08 126.76 37.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.664 1.186 . . . . 0.0 109.446 -171.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.28 -32.96 74.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.387 0.675 . . . . 0.0 110.086 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 79.8 mt -126.23 124.85 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.22 82.67 1.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.051 0.94 . . . . 0.0 108.573 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -149.89 151.56 33.64 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.67 114.15 26.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.591 1.156 . . . . 0.0 109.997 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.25 136.79 52.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.807 0.443 . . . . 0.0 110.613 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.96 125.87 34.34 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.039 0.535 . . . . 0.0 110.535 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.591 ' HB2' HD11 ' A' ' 187' ' ' LEU . 30.8 ttm180 -92.99 131.9 37.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.041 0.536 . . . . 0.0 110.101 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -83.8 98.36 9.67 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.401 HD23 ' HG2' ' A' ' 173' ' ' ARG . 81.0 mt -65.53 155.77 34.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.941 0.896 . . . . 0.0 111.228 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.81 -45.55 94.01 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.358 0.663 . . . . 0.0 111.014 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.93 146.67 28.34 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.178 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -89.46 139.32 15.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.913 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -75.47 -77.03 0.13 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -94.72 -55.87 2.97 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -117.97 -71.2 0.75 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -107.73 171.2 7.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.292 0.637 . . . . 0.0 109.603 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -103.38 121.08 6.98 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -107.92 156.47 19.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.836 0.854 . . . . 0.0 109.673 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -147.51 133.07 18.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.67 118.28 23.76 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 173' ' ' ARG . 34.8 mt -113.1 157.95 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' LYS . 11.6 pt -138.25 116.19 12.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -95.39 138.57 32.89 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 110.871 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 51.5 mt -128.35 131.73 48.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.119 1.368 . . . . 0.0 108.02 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.1 tp -126.34 110.21 13.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.22 135.76 13.78 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -142.48 149.76 39.63 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 147.16 52.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.943 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.64 153.84 43.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.388 0.675 . . . . 0.0 111.498 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 199' ' ' HIS . 33.7 tt0 66.56 16.53 10.43 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.806 1.242 . . . . 0.0 112.044 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -58.04 -43.96 87.11 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.131 0.572 . . . . 0.0 112.374 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -90.58 -31.05 16.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.786 0.435 . . . . 0.0 111.071 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.498 ' HB3' ' HG3' ' A' ' 196' ' ' GLU . 32.9 t-80 -63.08 -50.97 68.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.981 0.513 . . . . 0.0 110.733 -176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -84.01 151.99 24.68 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 165.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -84.37 125.69 32.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.991 0.516 . . . . 0.0 109.961 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.598 0.759 . . . . 0.0 109.795 177.894 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.34 -73.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.833 0.453 . . . . 0.0 111.325 -171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -152.83 93.72 1.79 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -94.12 117.63 30.38 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -145.11 120.67 10.4 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -134.15 145.44 49.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.388 0.675 . . . . 0.0 109.497 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.5 p -158.32 159.84 36.34 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.986 0.914 . . . . 0.0 109.811 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -154.56 122.72 5.98 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.698 0.799 . . . . 0.0 109.699 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -93.44 85.58 4.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.733 0.813 . . . . 0.0 110.09 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.23 162.35 14.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.32 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -138.01 142.23 40.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.67 0.788 . . . . 0.0 109.627 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 18.26 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.557 0.743 . . . . 0.0 110.047 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 76.1 t80 -64.5 140.07 58.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.947 0.499 . . . . 0.0 111.138 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.16 41.67 0.03 OUTLIER Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.411 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -161.41 157.57 25.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.209 0.504 . . . . 0.0 111.208 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -163.32 84.87 1.37 Allowed Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.17 162.69 34.7 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.762 2.975 . . . . 0.0 114.419 -164.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' HG11 ' A' ' 22' ' ' VAL . 26.6 p-10 -107.28 148.85 28.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.469 0.708 . . . . 0.0 110.178 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 22' ' ' VAL . 21.8 t70 -170.78 -179.63 2.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.731 0.812 . . . . 0.0 109.067 -170.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -58.94 -28.68 66.49 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.238 0.615 . . . . 0.0 109.849 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.16 -43.16 87.25 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.92 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 19' ' ' ASP . 5.0 m -52.45 -36.25 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 m -72.54 -50.47 25.45 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.141 0.577 . . . . 0.0 110.465 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.548 HG12 HD22 ' A' ' 191' ' ' LEU . 7.0 m -66.35 -33.54 64.17 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.41 83.66 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.359 1.464 . . . . 0.0 112.199 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.42 -31.82 73.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.926 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -88.18 -18.65 28.26 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 112.117 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' VAL . 60.5 mt -70.39 137.47 86.38 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.825 0.85 . . . . 0.0 111.061 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.79 128.25 29.54 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.745 2.963 . . . . 0.0 112.46 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -76.59 29.6 0.13 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.61 -134.85 4.92 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.881 -0.399 . . . . 0.0 112.243 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 60.8 mttm -84.93 112.73 20.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.526 0.731 . . . . 0.0 109.587 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG22 HG12 ' A' ' 99' ' ' VAL . 3.0 mt -116.13 126.75 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -171.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 90' ' ' ILE . 35.4 tp -96.74 117.68 31.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.445 0.298 . . . . 0.0 110.954 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 44.0 t -100.08 121.44 41.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.691 0.796 . . . . 0.0 110.257 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 89' ' ' ASP . 23.1 mt -101.56 118.98 38.05 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.561 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 49.37 85.01 0.03 OUTLIER 'General case' 0 C--N 1.361 1.067 0 O-C-N 125.448 1.717 . . . . 0.0 112.297 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.1 pt-20 -93.68 -3.66 51.99 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.68 3.77 Favored Glycine 0 C--N 1.345 1.031 0 C-N-CA 123.612 0.625 . . . . 0.0 112.124 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.35 151.95 36.74 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.672 1.189 . . . . 0.0 108.135 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.0 1.84 9.74 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -55.08 -32.48 61.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.978 1.711 . . . . 0.0 112.552 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -76.4 -54.98 5.97 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.095 0.558 . . . . 0.0 111.04 -173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.85 39.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 0.0 111.935 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB2' HD23 ' A' ' 70' ' ' LEU . 30.0 p -63.86 -34.8 78.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.323 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.3 t80 -68.33 -50.43 53.41 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.414 0.446 . . . . 0.0 110.398 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 99.3 mt -65.41 -37.38 86.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.688 0.617 . . . . 0.0 110.366 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.29 65.1 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.79 0.436 . . . . 0.0 111.592 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 76' ' ' VAL . 41.8 t -66.36 -13.35 60.48 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.992 0.917 . . . . 0.0 110.933 172.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 31.8 mt -90.75 6.92 42.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.541 0.737 . . . . 0.0 111.18 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.49 23.44 58.42 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -100.14 147.56 25.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.66 0.784 . . . . 0.0 110.603 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 41.7 mt-10 -86.79 88.27 7.64 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 37.4 t -94.79 106.6 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.07 0.462 . . . . 0.0 111.336 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.489 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.6 p -86.99 103.47 15.38 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . . . -106.06 132.17 52.46 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.967 0.907 . . . . 0.0 111.219 -169.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.1 t -116.54 120.02 63.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.05 147.3 43.95 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.06 -27.43 67.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.571 0.749 . . . . 0.0 112.35 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.589 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.7 m -106.79 125.43 50.99 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.057 0.543 . . . . 0.0 110.325 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 m -70.78 -23.72 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.633 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' SER . 29.3 m -63.0 -32.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.545 0.738 . . . . 0.0 111.63 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.14 -47.65 29.45 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.95 -51.38 59.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.902 0.881 . . . . 0.0 111.764 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.07 -44.93 75.26 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.178 0.991 . . . . 0.0 113.371 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -72.42 -27.12 62.14 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.006 0.191 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.15 95.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.611 0.365 . . . . 0.0 110.129 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.2 mtpm? -69.24 -36.24 76.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.303 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.58 -46.49 86.81 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 16.6 tp -70.21 -22.01 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 123.468 0.48 . . . . 0.0 110.895 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -59.35 -59.71 5.03 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.25 -37.23 86.73 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.831 0.348 . . . . 0.0 111.394 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 70' ' ' LEU . 44.9 tt0 -60.26 -35.49 75.62 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.739 1.216 . . . . 0.0 111.808 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.26 -20.31 14.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.816 0.447 . . . . 0.0 112.152 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.94 49.23 7.16 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 122.116 -0.365 . . . . 0.0 113.305 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.9 m -123.77 -179.29 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 125.342 1.457 . . . . 0.0 108.515 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.82 137.64 53.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.7 0.4 . . . . 0.0 111.831 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 71' ' ' ALA . 11.6 mm -112.92 169.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 55' ' ' THR . 58.8 m -139.77 105.15 5.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 163.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -93.91 130.97 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.544 0.687 . . . . 0.0 111.407 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 57' ' ' VAL . 41.8 t -116.12 143.29 26.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.682 1.593 . . . . 0.0 107.503 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -79.95 141.4 36.05 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 p -58.49 101.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.03 0.831 . . . . 0.0 111.188 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -141.18 92.8 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 80.8 mt -97.68 -21.7 16.87 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.63 0.372 . . . . 0.0 111.775 -170.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.31 -3.46 57.5 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.299 0.639 . . . . 0.0 111.756 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -125.32 -15.87 6.08 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.577 0.751 . . . . 0.0 111.632 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 60.4 t80 -165.15 147.91 8.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.915 1.286 . . . . 0.0 108.211 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.461 ' O ' HD21 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -140.23 -72.71 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.604 1.093 . . . . 0.0 109.054 173.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 117' ' ' VAL . 10.8 pt -145.72 129.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.58 0.752 . . . . 0.0 111.163 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 94' ' ' ALA . 25.4 t -135.1 94.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.523 0.729 . . . . 0.0 109.07 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.75 -3.05 10.83 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.539 0.736 . . . . 0.0 112.361 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.54 -41.8 17.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.266 0.627 . . . . 0.0 110.452 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -73.02 -34.29 66.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.085 0.554 . . . . 0.0 111.71 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' NE1' HD22 ' A' ' 34' ' ' LEU . 31.8 m95 -107.53 172.63 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.42 -57.67 2.87 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -116.82 168.38 12.77 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.501 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 90' ' ' ILE . 92.1 mt -134.92 131.16 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.562 0.745 . . . . 0.0 108.996 172.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -116.05 104.95 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -101.78 96.29 6.97 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 128' ' ' ILE . 34.4 mm -75.44 149.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.015 0.926 . . . . 0.0 110.277 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -17.66 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.092 2.157 . . . . 0.0 113.31 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 50.7 t -95.58 127.1 41.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.287 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -128.95 98.73 5.04 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 109' ' ' LEU . 97.1 mt -124.77 138.95 32.26 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.235 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.64 160.61 20.24 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.721 2.281 . . . . 0.0 111.724 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 38.1 m -53.05 -21.91 5.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.36 1.064 . . . . 0.0 113.812 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -63.29 -59.08 5.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.308 0.643 . . . . 0.0 111.432 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.498 ' HB3' HD13 ' A' ' 105' ' ' LEU . 29.5 mt -80.29 -21.13 42.95 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.532 0.333 . . . . 0.0 110.597 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 15.8 ttm180 -69.44 -55.77 9.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.467 0.707 . . . . 0.0 110.147 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -52.66 -28.7 22.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.467 1.107 . . . . 0.0 111.965 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -78.16 -47.61 17.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.9 tp -75.41 -56.75 4.4 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.12 -165.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.448 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 82.9 m-85 -67.87 -38.21 13.84 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 42.8 Cg_endo -66.45 -24.07 49.9 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 121.7 1.6 . . . . 0.0 112.321 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -84.64 -15.85 44.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 0.0 109.828 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.572 ' HA ' HD11 ' A' ' 90' ' ' ILE . 29.9 t -78.07 -36.84 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.335 0.588 . . . . 0.0 109.463 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -58.16 -58.1 9.94 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.645 170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -64.63 -37.52 87.86 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.52 -50.05 3.27 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.991 0.357 . . . . 0.0 113.991 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.519 HD13 HD12 ' A' ' 98' ' ' ILE . 55.4 tp -101.54 99.0 9.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.636 1.174 . . . . 0.0 110.753 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.44 172.74 8.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 163.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' A' ' 195' ' ' LEU . 39.8 Cg_exo -38.71 130.92 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.276 1.984 . . . . 0.0 110.808 158.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 131.72 -24.19 4.13 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -158.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -133.64 166.93 23.75 Favored Glycine 0 N--CA 1.467 0.701 0 O-C-N 121.953 -0.733 . . . . 0.0 113.691 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 18.3 m -108.13 135.57 46.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.599 1.16 . . . . 0.0 109.584 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.15 117.21 31.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 24' ' ' VAL . 24.1 mt -112.3 107.93 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.199 1.0 . . . . 0.0 109.439 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 156' ' ' LEU . 84.6 mt -126.64 139.41 53.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.353 0.661 . . . . 0.0 110.985 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -127.0 101.97 6.78 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.92 173.4 43.19 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.455 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -132.61 170.77 14.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.407 1.083 . . . . 0.0 108.748 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.43 172.32 6.09 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.67 1.03 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.056 0 C-N-CA 121.922 1.748 . . . . 0.0 114.686 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -38.96 29.35 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 58.6 tp60 -76.79 -44.73 31.57 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.292 0.496 . . . . 0.0 110.27 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 9.5 mt -65.99 -11.63 49.26 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-N 118.993 0.815 . . . . 0.0 113.091 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -76.05 -19.18 58.83 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 122.72 0.408 . . . . 0.0 109.928 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -90.44 -44.85 9.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.909 0.884 . . . . 0.0 108.892 172.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 137' ' ' LEU . 3.6 m-20 -63.4 124.58 21.65 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.289 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.3 m -104.94 -8.9 18.3 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.286 0.634 . . . . 0.0 109.69 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.5 -132.71 1.42 Allowed Glycine 0 C--N 1.357 1.705 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.88 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.73 -169.79 20.95 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.998 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.2 -167.78 0.42 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.446 2.764 . . . . 0.0 113.106 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.7 mttp 107.99 -1.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 127.934 2.494 . . . . 0.0 109.935 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.552 ' HB2' HD21 ' A' ' 137' ' ' LEU . 39.0 m-20 -110.5 -90.89 0.47 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.775 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 6.8 mp -100.24 10.42 41.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.271 0.628 . . . . 0.0 112.567 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.72 -27.07 68.05 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.482 1.134 . . . . 0.0 108.633 157.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.8 mt -88.89 27.28 1.36 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.125 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 147' ' ' LEU . 83.6 mt -71.98 115.9 42.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 169.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 156' ' ' LEU . 72.0 Cg_endo -91.15 108.59 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.544 2.163 . . . . 0.0 109.55 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 10.6 mtmp? -96.37 161.39 13.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.712 0.405 . . . . 0.0 111.76 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 188' ' ' ILE . 59.9 mt -56.45 -34.57 66.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.199 1.0 . . . . 0.0 112.551 -170.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.03 -48.72 77.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.243 1.017 . . . . 0.0 109.542 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.1 m -66.02 -49.71 66.78 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.335 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 129' ' ' LEU . 68.3 mt -77.64 -50.74 11.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.917 0.887 . . . . 0.0 112.616 -165.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.5 -36.14 79.66 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.759 0.424 . . . . 0.0 111.033 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.0 t -74.24 -26.98 60.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.908 0.483 . . . . 0.0 111.47 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 10.2 tp10 -76.82 -21.83 54.5 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.305 0.642 . . . . 0.0 110.392 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.58 69.26 72.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.006 0.922 . . . . 0.0 109.11 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.65 0.36 9.42 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.37 2.713 . . . . 0.0 112.389 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.4 t -92.28 -41.91 10.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.8 tp -83.9 72.03 10.44 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.071 1.748 . . . . 0.0 109.745 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 195' ' ' LEU . 27.6 t-20 -57.11 124.34 18.4 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.78 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.551 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 25.5 m95 -89.11 130.46 35.55 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.284 1.434 . . . . 0.0 109.985 -169.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.09 -37.82 75.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.122 0.569 . . . . 0.0 110.313 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.93 121.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.84 76.51 1.0 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -145.78 153.12 40.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -91.33 122.18 33.72 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.821 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.0 mt -102.81 131.58 49.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.81 128.88 34.82 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.684 0.394 . . . . 0.0 110.606 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -100.29 125.82 46.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -80.38 102.7 9.76 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 177' ' ' GLU . 59.2 mt -74.34 132.79 42.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.617 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.3 5.84 13.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.831 0.852 . . . . 0.0 111.899 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 175' ' ' LEU . 15.0 mm-40 -58.87 -54.59 45.39 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.922 0.889 . . . . 0.0 110.631 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.15 48.01 79.38 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.95 10.0 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.028 0.931 . . . . 0.0 112.374 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.1 t80 75.45 -66.2 0.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.181 1.792 . . . . 0.0 110.964 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -75.08 -14.85 60.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.691 0.797 . . . . 0.0 110.949 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.23 139.97 20.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.503 0.721 . . . . 0.0 109.505 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.75 -3.49 0.95 Allowed Glycine 0 C--N 1.344 1.026 0 O-C-N 123.677 0.611 . . . . 0.0 112.874 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.88 -176.47 3.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.512 0.656 . . . . 0.0 111.875 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.76 133.03 17.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 109.3 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -84.73 110.36 18.72 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.88 133.69 53.92 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 153' ' ' LEU . 36.7 pt -123.8 118.78 55.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 118.766 0.712 . . . . 0.0 109.554 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.39 141.42 34.29 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.16 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 153' ' ' LEU . 46.9 mt -129.37 139.78 51.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.657 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.548 HD22 HG12 ' A' ' 24' ' ' VAL . 42.6 tp -145.41 106.17 4.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 168.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.64 146.2 21.41 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -130.0 152.0 49.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.104 0.952 . . . . 0.0 112.236 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.74 112.4 3.69 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.682 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.528 ' H ' ' HB3' ' A' ' 123' ' ' PRO . 3.4 mt -67.45 143.62 56.14 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 138.36 57.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -70.8 84.39 0.65 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.954 0.883 . . . . 0.0 110.908 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -105.66 153.9 21.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 113.867 -1.515 . . . . 0.0 107.735 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -85.69 75.5 10.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 0.0 111.139 -173.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -91.41 87.27 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -98.15 174.54 6.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.239 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 69.9 m80 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.451 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -88.76 69.85 8.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.527 0.68 . . . . 0.0 110.937 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -173.28 19.08 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.817 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.27 110.67 3.13 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.718 0.807 . . . . 0.0 109.582 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -146.07 60.92 1.25 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.324 1.059 . . . . 0.0 108.958 -170.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -61.94 128.98 38.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.833 -167.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m 62.73 18.92 11.04 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.526 1.13 . . . . 0.0 112.422 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.341 0.0 OUTLIER 51.03 -59.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 128.191 2.596 . . . . 0.0 116.078 -175.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t 68.44 13.79 9.03 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.674 1.19 . . . . 0.0 111.303 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -96.32 92.59 6.41 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.379 1.072 . . . . 0.0 108.817 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -75.33 82.7 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.449 0.7 . . . . 0.0 110.283 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.7 m -84.24 161.77 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.076 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -128.72 143.78 51.01 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.662 0.785 . . . . 0.0 109.661 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.01 -115.76 0.65 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 171.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -111.36 139.76 46.51 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 117.384 0.592 . . . . 0.0 110.623 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.11 126.43 92.75 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.991 0.917 . . . . 0.0 110.163 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.41 162.55 35.92 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.335 2.69 . . . . 0.0 114.138 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -92.17 84.07 5.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.836 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.59 -92.82 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.931 1.292 . . . . 0.0 113.635 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -78.25 -19.48 53.63 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.206 1.003 . . . . 0.0 110.847 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 47' ' ' LEU . 25.3 tp -60.47 -18.05 48.96 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.203 1.001 . . . . 0.0 113.147 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -76.7 -34.86 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.699 0.681 . . . . 0.0 110.589 -168.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p -69.74 -47.94 61.2 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.9 0.88 . . . . 0.0 109.799 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 191' ' ' LEU . 21.6 m -68.43 -41.07 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.31 72.2 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.634 0.773 . . . . 0.0 112.335 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -73.67 -22.21 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.123 0.569 . . . . 0.0 110.497 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -90.21 -18.92 24.83 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.354 0.662 . . . . 0.0 110.379 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 24' ' ' VAL . 70.1 mt -72.3 129.04 88.04 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.118 0.567 . . . . 0.0 110.097 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.83 153.05 69.06 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.564 2.176 . . . . 0.0 112.41 172.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 51.4 tt0 -68.46 31.1 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.058 1.743 . . . . 0.0 114.654 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -118.64 -156.97 10.31 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.084 -1.01 . . . . 0.0 112.794 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -87.88 121.47 30.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.562 0.745 . . . . 0.0 109.045 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 54' ' ' VAL . 4.3 mt -111.77 148.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.649 0.78 . . . . 0.0 109.592 -168.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD22 ' NE1' ' A' ' 95' ' ' TRP . 49.4 tp -106.92 117.28 33.63 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.163 0.438 . . . . 0.0 110.198 171.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 51.1 t -102.98 114.75 29.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.983 0.913 . . . . 0.0 110.072 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.2 mt -81.29 141.29 34.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.75 153.0 37.57 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.614 0.766 . . . . 0.0 110.448 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.57 11.05 8.53 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.555 1.142 . . . . 0.0 109.206 173.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.4 -175.17 30.06 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.536 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -63.19 99.85 0.2 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.004 0.522 . . . . 0.0 111.11 -177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.04 73.97 2.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.465 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -69.66 -31.48 69.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.122 0.569 . . . . 0.0 110.061 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.33 -41.95 98.98 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.522 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.66 87.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.758 0.823 . . . . 0.0 111.454 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.86 -34.94 75.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.678 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.57 -32.74 66.27 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.285 0.365 . . . . 0.0 110.484 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 99' ' ' VAL . 74.3 mt -67.02 -31.6 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.54 72.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.196 0.598 . . . . 0.0 111.253 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.591 ' HA ' HG11 ' A' ' 76' ' ' VAL . 20.1 m -71.99 -4.39 28.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.711 0.804 . . . . 0.0 112.491 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.28 12.49 15.91 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.332 0.653 . . . . 0.0 110.218 168.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.85 56.27 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 114.163 0.425 . . . . 0.0 114.163 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 11.8 m-85 -114.1 152.24 31.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.79 91.81 8.78 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 33' ' ' ILE . 92.4 t -91.16 111.94 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.254 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 40.4 p -84.22 106.64 16.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 108.314 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.9 129.43 46.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.126 0.571 . . . . 0.0 109.935 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG22 ' HB ' ' A' ' 81' ' ' VAL . 8.4 t -111.39 120.21 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' H ' HD21 ' A' ' 64' ' ' LEU . 41.8 t0 -129.7 137.42 50.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 75.8 mt-30 -60.41 -25.84 66.23 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.626 1.204 . . . . 0.0 112.238 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.6 m -97.95 116.18 29.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.465 ' HA ' HD12 ' A' ' 64' ' ' LEU . 60.5 p -66.29 -30.69 71.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.607 0.718 . . . . 0.0 109.954 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 60' ' ' SER . 26.7 m -61.76 -35.95 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.674 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.95 -32.86 60.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.587 0.554 . . . . 0.0 112.062 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 61' ' ' SER . 86.5 mt -62.58 -43.57 98.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.792 0.837 . . . . 0.0 110.742 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.28 94.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.256 0.623 . . . . 0.0 111.708 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -70.19 -30.99 68.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.127 0.571 . . . . 0.0 111.166 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 -44.52 90.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.562 0.745 . . . . 0.0 111.036 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.35 -35.18 68.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.684 0.794 . . . . 0.0 110.995 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.08 -47.63 84.55 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.603 0.761 . . . . 0.0 110.246 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.38 -28.46 67.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.826 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.99 -61.52 2.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.276 0.63 . . . . 0.0 111.075 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.66 -29.01 70.0 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.116 0.566 . . . . 0.0 111.005 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -65.1 -43.62 91.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.149 0.58 . . . . 0.0 110.143 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -93.64 -2.73 53.64 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.07 34.48 55.38 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.7 -0.227 . . . . 0.0 113.232 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.5 m -127.45 175.34 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.122 0.969 . . . . 0.0 110.09 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.56 131.66 56.01 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.011 0.924 . . . . 0.0 111.103 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.826 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.8 mm -110.75 164.39 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 161.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 88.8 m -131.88 104.59 6.95 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 p -86.87 121.6 29.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.859 0.463 . . . . 0.0 110.273 -168.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 57' ' ' VAL . 59.6 t -108.62 136.98 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 108.427 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -79.76 128.6 33.62 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 59' ' ' GLN . 80.4 p -59.63 120.21 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.871 0.732 . . . . 0.0 112.326 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.31 85.16 1.95 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 161.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.577 ' HB2' HD22 ' A' ' 109' ' ' LEU . 74.4 mt -84.87 -24.86 28.35 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.233 0.613 . . . . 0.0 110.608 -168.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 -7.67 32.26 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.062 0.945 . . . . 0.0 111.864 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -132.64 -23.43 2.06 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.564 0.746 . . . . 0.0 111.819 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 81' ' ' VAL . 38.4 t80 -162.32 116.88 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.286 1.034 . . . . 0.0 109.666 -171.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -125.36 -60.11 1.35 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' HB ' HD13 ' A' ' 98' ' ' ILE . 34.4 pt -139.99 131.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 118.803 0.729 . . . . 0.0 111.757 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.91 89.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.225 1.01 . . . . 0.0 109.648 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.639 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -70.73 1.01 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.22 -44.27 68.94 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.63 -32.94 64.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.709 0.803 . . . . 0.0 112.566 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.494 ' NE1' HD22 ' A' ' 34' ' ' LEU . 12.7 m95 -109.05 162.69 14.0 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.054 0.542 . . . . 0.0 110.091 -170.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 12.3 tp10 -76.21 -56.86 4.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.35 171.97 17.33 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 90' ' ' ILE . 74.3 mt -135.89 127.59 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 47' ' ' LEU . 7.8 p -114.55 125.11 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -124.39 93.37 3.89 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.547 HD13 HD12 ' A' ' 128' ' ' ILE . 35.5 mm -65.34 138.79 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -18.47 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.012 1.725 . . . . 0.0 114.098 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 t -78.44 111.01 14.03 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.849 -171.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -107.81 98.14 7.77 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.42 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 71.3 mt -124.97 140.47 35.92 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.9 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 160.62 45.97 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.921 2.414 . . . . 0.0 110.871 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 m -43.36 -42.41 4.59 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.844 1.258 . . . . 0.0 113.778 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -53.57 -55.42 25.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.143 0.977 . . . . 0.0 112.226 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 85' ' ' LEU . 98.8 mt -83.18 -24.89 32.26 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.214 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -77.54 -52.57 8.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.054 0.942 . . . . 0.0 109.841 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.07 -22.42 66.85 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 0.0 112.277 170.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -75.76 -35.26 60.22 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.41 0.684 . . . . 0.0 109.611 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.4 tp -65.78 -52.17 53.07 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.592 0.757 . . . . 0.0 111.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -58.44 -44.15 98.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -166.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.28 -31.59 81.95 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.713 1.609 . . . . 0.0 112.003 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -81.94 -15.11 54.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.2 0.6 . . . . 0.0 110.91 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 12.0 t -84.0 -42.87 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -59.26 -59.68 5.08 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.08 -48.33 44.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.821 0.849 . . . . 0.0 113.095 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.58 -35.23 17.33 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -165.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.8 tp -77.99 95.18 4.76 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.89 0.845 . . . . 0.0 110.351 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.639 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -75.04 150.74 85.91 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.986 168.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -42.74 117.72 0.97 Allowed 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 124.667 3.578 . . . . 0.0 115.341 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.47 12.46 3.77 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.137 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.68 137.75 13.79 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.3 m -105.85 129.55 58.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.73 0.812 . . . . 0.0 110.458 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.65 112.94 25.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 101' ' ' ILE . 46.6 mt -105.26 109.26 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.59 HD13 HD13 ' A' ' 156' ' ' LEU . 55.7 mt -123.59 134.38 53.82 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -117.57 102.33 9.08 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.532 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -72.37 140.54 29.7 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.914 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 150' ' ' LEU . 69.5 m-85 -111.23 164.02 13.32 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.122 0.487 . . . . 0.0 111.297 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.87 166.72 32.29 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.006 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.569 ' HA ' HD22 ' A' ' 147' ' ' LEU . 49.1 Cg_endo -64.62 -0.68 3.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.495 2.13 . . . . 0.0 112.872 172.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -82.21 -7.85 59.63 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.383 1.473 . . . . 0.0 111.654 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.5 -63.49 1.14 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.726 0.41 . . . . 0.0 111.139 -166.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.542 ' HB3' ' HA2' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -88.66 -9.62 51.44 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.493 0.317 . . . . 0.0 110.655 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -62.72 -50.7 70.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -73.66 -17.67 61.12 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 0.0 110.848 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.4 t30 67.32 27.44 8.24 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.314 1.445 . . . . 0.0 110.307 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -85.66 -2.38 58.13 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.802 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.93 82.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 137' ' ' LEU . . . -109.9 106.19 2.12 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.836 -0.98 . . . . 0.0 112.253 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.41 -75.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.082 1.854 . . . . 0.0 111.257 173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -137.96 -44.82 0.52 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.233 1.013 . . . . 0.0 109.343 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' C ' HD11 ' A' ' 137' ' ' LEU . 28.3 t70 -156.73 152.4 26.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.67 0.788 . . . . 0.0 109.172 -174.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.1 mt -57.53 -9.72 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.36 1.464 . . . . 0.0 113.05 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.25 -36.75 68.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.463 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -83.96 4.13 31.07 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.891 0.876 . . . . 0.0 111.731 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 132' ' ' PHE . 62.5 mt -81.73 112.9 38.42 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 167.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.678 ' HB3' HD11 ' A' ' 156' ' ' LEU . 17.0 Cg_exo -69.35 137.73 37.35 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.292 2.661 . . . . 0.0 113.416 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.519 ' HA ' HD11 ' A' ' 188' ' ' ILE . 44.7 mmtm -118.4 148.36 42.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.514 0.726 . . . . 0.0 112.234 171.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 190' ' ' LEU . 39.9 mt -60.92 -42.33 97.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.295 1.038 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -51.78 -45.12 63.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.085 0.865 . . . . 0.0 111.256 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.9 m -77.79 -46.29 22.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.871 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.678 HD11 ' HB3' ' A' ' 151' ' ' PRO . 89.4 mt -76.5 -46.29 27.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.833 0.853 . . . . 0.0 113.28 -170.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.536 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 62.2 tt0 -54.47 -46.0 73.29 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 110.688 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 t -73.03 -22.89 60.56 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.928 0.491 . . . . 0.0 111.769 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -73.51 -30.97 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.42 0.688 . . . . 0.0 110.84 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.1 mt -131.61 75.76 76.04 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.69 -11.74 24.17 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.08 2.52 . . . . 0.0 111.549 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -87.51 -39.44 15.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.937 1.295 . . . . 0.0 108.69 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 21.3 tp -91.52 72.95 5.99 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.075 1.35 . . . . 0.0 110.064 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.23 132.93 55.23 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.536 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 23.4 m95 -94.82 132.33 39.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.509 0.724 . . . . 0.0 109.283 -168.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.84 -30.78 71.05 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.282 0.633 . . . . 0.0 110.337 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.08 127.92 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -146.15 63.42 1.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -108.6 139.17 43.75 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.797 -164.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -96.46 105.91 18.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.078 0.951 . . . . 0.0 109.498 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 47.0 mt -97.18 119.34 35.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.555 0.742 . . . . 0.0 110.902 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.13 121.58 21.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 185' ' ' ALA . 9.1 ttt180 -91.02 142.83 27.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.971 0.509 . . . . 0.0 110.529 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 183' ' ' GLY . 95.3 m-20 -101.69 99.72 10.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.828 0.851 . . . . 0.0 109.171 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 185' ' ' ALA . 46.5 mt -78.01 109.52 12.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.021 0.928 . . . . 0.0 110.395 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -67.23 140.23 57.4 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.05 44.49 5.85 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.544 1.152 . . . . 0.0 110.388 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 129.55 49.1 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.611 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.07 59.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.701 1.2 . . . . 0.0 112.586 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.71 28.77 8.23 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 0.0 109.201 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 8.6 m170 55.88 40.99 30.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 0.0 109.904 -165.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -67.55 -63.49 1.05 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.419 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 174' ' ' ASN . . . 63.45 11.61 41.89 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.445 -0.798 . . . . 0.0 114.553 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.8 147.44 50.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 117.845 0.823 . . . . 0.0 112.061 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . . . -156.42 157.25 35.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.437 1.495 . . . . 0.0 108.536 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.06 121.14 41.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.389 . . . . 0.0 109.956 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 73.0 mt -117.65 166.11 12.79 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 152' ' ' LYS . 10.2 pt -149.28 149.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.029 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -129.7 150.53 50.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 111.117 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 153' ' ' LEU . 61.6 mt -130.85 135.2 47.5 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.269 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 24' ' ' VAL . 34.4 tp -129.79 104.68 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 167.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -89.21 128.62 9.26 Favored Glycine 0 C--O 1.208 -1.48 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -142.38 156.19 45.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.747 0.819 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -59.71 127.43 31.93 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.428 0.455 . . . . 0.0 109.978 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.8 mt -76.83 96.34 4.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.751 -0.643 . . . . 0.0 110.031 -171.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 45.63 125.32 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.175 1.916 . . . . 0.0 116.175 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -59.85 -27.68 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.208 0.528 . . . . 0.0 110.386 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -112.44 85.23 2.11 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 167.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -49.27 -60.15 3.07 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.936 1.295 . . . . 0.0 112.519 -168.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -80.2 117.09 20.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -59.35 -22.43 61.3 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.063 0.945 . . . . 0.0 111.996 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 79.6 t60 . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 124.861 1.264 . . . . 0.0 110.886 174.163 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -78.77 140.9 38.18 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -171.8 66.91 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.721 1.208 . . . . 0.0 108.339 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.86 74.81 8.97 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.796 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -110.34 100.97 9.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.99 128.79 17.3 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -149.34 122.26 8.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.126 0.57 . . . . 0.0 110.114 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -129.75 92.47 3.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.012 0.925 . . . . 0.0 108.608 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -140.06 39.56 1.95 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.534 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.02 42.15 1.07 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.043 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -74.19 107.82 6.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 109.233 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.56 117.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.857 0.863 . . . . 0.0 110.476 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.58 120.02 20.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.262 0.625 . . . . 0.0 109.362 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.02 92.91 0.1 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -154.59 147.24 24.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.736 0.815 . . . . 0.0 109.721 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -109.54 102.9 51.49 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 46' ' ' PHE . 30.0 Cg_endo -91.12 -173.08 0.53 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.261 2.641 . . . . 0.0 114.323 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -88.63 143.37 26.98 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.731 165.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 22' ' ' VAL . 6.2 p-10 -70.59 -26.39 63.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.073 0.549 . . . . 0.0 112.228 -171.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -83.31 -23.25 32.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HA ' HG22 ' A' ' 24' ' ' VAL . 56.0 tp -74.17 -41.7 61.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.346 0.659 . . . . 0.0 111.413 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 19' ' ' ASP . 15.6 m -45.76 -41.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 p -80.5 -51.22 9.05 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.073 0.549 . . . . 0.0 111.091 -174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 128' ' ' ILE . 16.7 m -59.52 -35.53 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.933 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -59.17 -39.53 82.79 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 124.476 1.11 . . . . 0.0 111.734 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.21 -27.95 69.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.636 0.775 . . . . 0.0 110.719 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 87.7 mm-40 -90.17 -7.66 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.691 0.796 . . . . 0.0 112.634 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' VAL . 68.0 mt -87.41 136.26 33.52 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.895 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.01 134.68 43.21 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.778 2.985 . . . . 0.0 113.752 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -77.61 27.89 0.16 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.99 -134.67 5.52 Favored Glycine 0 N--CA 1.475 1.258 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.874 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.98 112.35 18.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.202 0.501 . . . . 0.0 109.734 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG22 HG12 ' A' ' 99' ' ' VAL . 18.6 mt -115.04 129.46 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -170.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 89' ' ' ASP . 66.1 tp -94.37 114.44 26.49 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.716 0.406 . . . . 0.0 110.836 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 36.2 t -94.35 140.13 30.19 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -90.91 173.71 7.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.777 0.322 . . . . 0.0 111.554 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -57.64 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.653 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -91.84 -21.39 20.66 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 109.603 173.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.23 90.58 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.73 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -95.25 -49.37 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.117 0.567 . . . . 0.0 110.041 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.79 -28.38 5.46 Favored Glycine 0 CA--C 1.54 1.641 0 O-C-N 123.812 0.695 . . . . 0.0 112.875 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -70.65 -35.7 73.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.98 1.312 . . . . 0.0 111.68 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -64.28 -50.18 68.92 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.597 0.56 . . . . 0.0 110.824 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.75 -50.04 69.38 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.208 0.942 . . . . 0.0 111.508 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.717 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 73.5 m -55.93 -49.02 74.64 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.09 0.956 . . . . 0.0 113.513 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 41.4 t80 -58.16 -43.17 87.25 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.703 0.627 . . . . 0.0 111.011 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.444 HD13 HG11 ' A' ' 99' ' ' VAL . 60.9 mt -67.92 -32.61 73.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.778 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.06 -33.6 65.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.92 0.488 . . . . 0.0 111.448 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.592 ' HA ' HG11 ' A' ' 76' ' ' VAL . 19.3 m -65.47 -15.3 62.51 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.06 0.944 . . . . 0.0 111.738 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.1 mt -82.7 3.11 30.44 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.553 0.741 . . . . 0.0 110.831 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.92 16.81 62.55 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-O 119.798 -0.446 . . . . 0.0 113.928 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -103.09 155.11 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.695 0.748 . . . . 0.0 110.881 -173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.1 87.69 6.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.533 0.733 . . . . 0.0 109.207 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.88 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HA ' ' A' ' 34' ' ' LEU . 3.3 t -86.01 106.74 17.39 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.928 0.891 . . . . 0.0 109.287 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.56 131.32 53.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.469 0.708 . . . . 0.0 110.438 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -95.46 146.68 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 29.9 t0 -150.14 135.34 17.95 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -73.11 -11.1 60.42 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.825 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.3 t -113.65 164.48 13.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.033 0.933 . . . . 0.0 109.268 169.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -78.2 -26.57 47.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.991 0.516 . . . . 0.0 112.187 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.8 m -56.87 -43.95 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.83 -34.71 62.22 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.203 0.314 . . . . 0.0 112.474 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 94.3 mt -67.86 -59.46 3.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.702 0.801 . . . . 0.0 111.322 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.46 73.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.109 0.964 . . . . 0.0 112.934 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.24 -45.58 92.68 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.839 0.855 . . . . 0.0 110.416 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.717 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -64.11 -46.51 83.89 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.92 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -71.76 -35.22 70.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.231 1.012 . . . . 0.0 111.02 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.43 -61.23 2.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.397 0.679 . . . . 0.0 111.152 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.37 -22.6 66.25 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.567 0.542 . . . . 0.0 111.17 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.6 -63.63 1.05 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.984 174.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.93 -30.59 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.04 0.536 . . . . 0.0 110.824 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.39 -31.51 71.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.255 1.022 . . . . 0.0 111.474 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -102.25 1.69 36.15 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.116 0.566 . . . . 0.0 111.417 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.48 67.76 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 122.355 -0.216 . . . . 0.0 113.233 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.7 m -124.08 -179.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 108.182 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.78 131.92 36.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.749 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.7 mm -106.96 166.88 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 166.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -129.42 105.75 8.31 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.3 p -85.69 119.83 26.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.092 0.557 . . . . 0.0 110.924 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.9 124.18 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.044 1.337 . . . . 0.0 109.264 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -100.24 91.7 4.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -142.57 -177.6 5.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.237 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -146.33 136.91 24.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -162.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 14.2 mt -76.19 -8.46 57.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 123.543 0.527 . . . . 0.0 112.389 -166.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -94.77 -0.32 54.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.834 0.454 . . . . 0.0 112.144 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -123.42 -44.17 2.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.824 0.449 . . . . 0.0 110.685 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -169.46 124.52 0.83 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.514 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -134.96 -72.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.059 0.944 . . . . 0.0 109.308 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' HB ' HD13 ' A' ' 98' ' ' ILE . 10.7 pt -129.55 122.74 56.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 C-N-CA 123.199 0.599 . . . . 0.0 111.616 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.92 94.64 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.698 1.199 . . . . 0.0 108.816 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.25 -0.52 2.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -73.49 -48.05 36.45 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.883 0.473 . . . . 0.0 110.291 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.05 61.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.11 0.564 . . . . 0.0 112.259 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.498 ' CD1' HD22 ' A' ' 34' ' ' LEU . 13.7 m95 -113.17 139.08 49.06 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.009 0.524 . . . . 0.0 109.847 -170.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.97 -40.12 79.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.33 174.65 29.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.025 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.546 HD13 ' HB ' ' A' ' 90' ' ' ILE . 64.3 mt -132.12 140.56 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 6.2 p -124.84 108.48 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.749 0.82 . . . . 0.0 109.1 167.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.493 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 42.7 m -108.89 89.49 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 32.1 mm -70.59 149.83 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.943 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -17.66 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 127.394 2.278 . . . . 0.0 112.61 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.8 p -99.78 104.78 16.5 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.848 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -96.57 98.07 9.91 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.61 147.83 40.61 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.916 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 149' ' ' LEU . 46.8 Cg_exo -59.05 149.28 80.78 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.282 1.988 . . . . 0.0 110.099 160.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 11.7 t -57.78 -22.72 48.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.421 0.688 . . . . 0.0 112.187 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t -52.87 -55.82 20.39 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.566 0.746 . . . . 0.0 111.363 168.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.9 mt -81.0 -27.47 35.87 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.472 0.709 . . . . 0.0 110.824 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 151' ' ' PRO . 11.3 ttp180 -68.48 -56.27 8.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.966 0.906 . . . . 0.0 110.334 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -37.52 63.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.45 1.1 . . . . 0.0 111.328 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 6.2 tp-100 -70.38 -31.9 69.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.107 0.563 . . . . 0.0 110.22 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 117' ' ' VAL . 45.6 tp -76.46 -33.84 58.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.945 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -55.1 -47.33 98.77 Favored Pre-proline 0 CA--C 1.569 1.695 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.79 -29.67 90.5 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.247 1.965 . . . . 0.0 112.672 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -75.26 -31.73 60.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.735 0.814 . . . . 0.0 111.142 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 1.6 t -88.37 -27.23 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.363 0.601 . . . . 0.0 110.735 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.61 -64.61 1.15 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.29 -49.76 10.35 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.69 -33.58 63.36 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 113.711 0.245 . . . . 0.0 113.711 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.5 tp -78.69 131.22 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.297 0.57 . . . . 0.0 109.791 171.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -114.82 161.71 27.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.797 1.239 . . . . 0.0 107.988 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -36.4 114.72 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 124.305 3.337 . . . . 0.0 115.529 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.52 -0.85 5.97 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.678 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -100.3 148.62 18.45 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 166.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.92 131.7 65.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 C-N-CA 124.493 1.117 . . . . 0.0 109.103 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.7 t80 -109.33 109.13 19.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.569 HD13 HG21 ' A' ' 24' ' ' VAL . 43.8 mt -111.34 108.07 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.298 1.039 . . . . 0.0 108.608 -170.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 95.1 mt -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.774 0.83 . . . . 0.0 111.144 -172.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.4 101.78 4.93 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.8 118.39 6.06 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 187' ' ' LEU . 27.1 m-85 -78.83 169.4 18.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.415 1.086 . . . . 0.0 109.873 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.15 133.87 39.96 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.584 . . . . 0.0 111.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.83 -17.56 44.21 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.621 2.881 . . . . 0.0 112.337 174.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 138' ' ' GLN . 34.4 tt0 -54.35 -31.02 53.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.825 1.25 . . . . 0.0 111.484 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.718 ' HB3' HD22 ' A' ' 147' ' ' LEU . 61.1 tp60 -60.08 -58.55 8.05 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 123.639 0.587 . . . . 0.0 110.757 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 14.9 mt -57.75 -35.54 70.85 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.245 0.545 . . . . 0.0 111.5 172.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 135' ' ' GLU . 31.8 tt0 -71.54 -15.51 62.29 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.933 -170.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -55.91 -43.62 77.47 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 123.003 0.521 . . . . 0.0 110.901 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -103.72 169.75 8.33 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -79.12 2.86 19.36 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.29 133.25 1.55 Allowed Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.791 -0.524 . . . . 0.0 111.791 174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.61 64.32 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.222 -0.765 . . . . 0.0 111.553 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.14 -169.53 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.332 2.688 . . . . 0.0 112.389 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 tptm 90.37 1.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.812 1.245 . . . . 0.0 109.777 171.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -131.32 -90.77 0.43 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 136' ' ' GLN . 4.8 mp -80.65 22.88 0.55 Allowed 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.42 ' N ' HD11 ' A' ' 137' ' ' LEU . 31.3 t70 -85.08 -29.44 24.88 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 164.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 106' ' ' PRO . 13.9 mt -84.69 24.41 1.03 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.045 2.138 . . . . 0.0 111.931 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.626 HD11 ' HB3' ' A' ' 147' ' ' LEU . 95.7 mt -74.99 113.25 22.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 123.351 0.407 . . . . 0.0 110.481 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.65 ' HB3' HH11 ' A' ' 110' ' ' ARG . 93.4 Cg_endo -87.01 129.55 2.9 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.258 1.972 . . . . 0.0 111.405 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -81.36 164.37 22.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.718 0.807 . . . . 0.0 111.54 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 188' ' ' ILE . 81.1 mt -60.62 -41.47 94.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.155 0.582 . . . . 0.0 110.478 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.51 -39.49 67.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.398 0.679 . . . . 0.0 111.471 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.4 p -81.48 -53.6 6.14 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.486 0.314 . . . . 0.0 110.732 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -61.63 -50.59 71.92 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.576 1.15 . . . . 0.0 111.93 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -65.48 -30.81 71.63 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.787 0.835 . . . . 0.0 111.702 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.6 t -73.19 -29.43 62.82 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 122.812 0.445 . . . . 0.0 111.08 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 -10.66 58.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.087 0.555 . . . . 0.0 111.021 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 96.5 mt -141.34 71.03 27.06 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.459 0.704 . . . . 0.0 109.559 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.59 7.38 4.69 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.065 2.51 . . . . 0.0 111.298 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.0 t -90.71 -41.17 11.44 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.4 tp -91.82 71.18 5.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.024 1.33 . . . . 0.0 110.626 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB3' HD22 ' A' ' 195' ' ' LEU . 4.0 t-20 -59.89 129.77 43.47 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 28.9 m95 -95.54 141.37 29.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.014 0.926 . . . . 0.0 110.765 -164.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.15 -36.81 72.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.172 0.589 . . . . 0.0 110.345 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 68.1 mt -126.88 125.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.24 84.26 1.13 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.664 0.785 . . . . 0.0 109.916 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -155.92 155.59 33.11 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.485 0.314 . . . . 0.0 111.475 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.08 110.98 13.52 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.55 130.37 47.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.275 0.63 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 146.09 24.07 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -133.75 138.99 46.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.49 0.716 . . . . 0.0 109.666 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.46 117.1 18.59 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.133 0.573 . . . . 0.0 110.552 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.64 170.4 9.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.835 0.854 . . . . 0.0 110.373 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.81 106.52 0.5 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.38 119.97 20.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.13 0.572 . . . . 0.0 109.791 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -66.32 -67.48 1.99 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.24 -72.86 0.03 OUTLIER 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.463 0.705 . . . . 0.0 109.963 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -86.7 -38.26 17.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.147 0.579 . . . . 0.0 110.076 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -71.95 126.2 29.14 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -65.72 140.03 58.42 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.35 1.031 . . . . 0.0 110.638 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -85.21 63.04 4.42 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.861 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.12 161.75 28.51 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.84 0.856 . . . . 0.0 111.28 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.78 134.37 38.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.429 1.091 . . . . 0.0 109.061 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.18 100.38 12.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 132' ' ' PHE . 56.4 mt -116.71 163.86 15.49 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 153' ' ' LEU . 44.4 pt -135.93 139.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -132.69 151.28 52.01 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.976 0.893 . . . . 0.0 111.365 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 165' ' ' TRP . 64.5 mt -136.29 138.26 41.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 113.329 -1.76 . . . . 0.0 108.791 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.514 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -129.71 107.52 9.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 168.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.03 139.84 17.26 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 8.3 tp-100 -140.32 153.02 46.3 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.438 0.695 . . . . 0.0 109.693 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.543 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 18.1 pttp -58.17 128.43 37.09 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.806 0.691 . . . . 0.0 109.254 170.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 164' ' ' ASN . 4.5 mt -69.6 111.05 5.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -50.04 70.69 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.872 0.733 . . . . 0.0 109.493 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -107.73 112.33 24.95 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -77.43 76.49 3.97 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -79.39 121.9 25.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.481 -170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -139.48 96.83 3.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 64.88 101.27 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.439 1.496 . . . . 0.0 110.262 -169.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.702 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -85.81 170.33 12.51 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.243 0.617 . . . . 0.0 110.057 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -144.67 144.75 31.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.73 0.412 . . . . 0.0 110.196 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.6 71.42 7.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -87.94 150.6 23.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.042 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -163.11 127.51 2.97 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.1 m -129.67 105.07 7.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 108.922 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.05 179.12 4.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.231 0.612 . . . . 0.0 111.512 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -137.55 127.6 25.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.094 0.558 . . . . 0.0 110.341 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.21 100.86 6.91 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.981 0.912 . . . . 0.0 109.784 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -151.41 95.27 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.4 m -91.91 137.31 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.114 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -163.76 147.08 9.98 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 0.0 109.51 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.76 89.08 0.11 Allowed Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 t -62.39 123.54 18.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.534 0.734 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.05 98.79 40.49 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 124.059 0.944 . . . . 0.0 108.583 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.52 112.4 3.45 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.384 2.056 . . . . 0.0 109.934 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -51.96 116.97 2.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.187 0.995 . . . . 0.0 111.056 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 22' ' ' VAL . 32.3 t70 -155.88 173.74 16.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.954 0.502 . . . . 0.0 110.867 -167.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 24' ' ' VAL . 43.4 t80 -63.99 -41.04 97.64 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.509 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 24' ' ' VAL . 37.4 tp -62.22 -47.51 84.11 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.806 0.842 . . . . 0.0 112.065 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 19' ' ' ASP . 5.9 m -54.81 -33.67 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -70.39 -50.95 33.42 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.621 0.768 . . . . 0.0 110.903 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 128' ' ' ILE . 2.7 m -64.46 -30.13 49.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.558 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -59.49 -38.17 80.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.625 1.17 . . . . 0.0 111.243 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -70.13 -29.07 65.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.383 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -87.93 -7.23 57.43 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.632 0.773 . . . . 0.0 112.41 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 24' ' ' VAL . 89.9 mt -82.51 123.45 78.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -52.34 133.49 48.32 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.175 2.583 . . . . 0.0 113.131 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.1 31.0 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 126.928 2.091 . . . . 0.0 116.138 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.4 -154.34 10.95 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.663 -0.52 . . . . 0.0 112.483 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.09 120.65 19.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.128 0.571 . . . . 0.0 110.572 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 mt -109.07 135.88 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 0.0 110.07 -167.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 55' ' ' THR . 67.9 tp -110.4 118.26 35.8 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.002 0.521 . . . . 0.0 109.714 171.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 42.3 t -96.58 130.86 43.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.227 1.011 . . . . 0.0 109.462 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -95.1 117.56 30.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 164.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.9 163.72 13.59 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.55 0.691 . . . . 0.0 111.012 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.71 21.53 3.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.879 -175.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.19 134.9 7.43 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 76.37 -47.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.851 1.661 . . . . 0.0 112.988 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 32.63 84.84 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 113.341 0.096 . . . . 0.0 113.341 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -60.6 -34.37 74.11 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.679 0.752 . . . . 0.0 109.903 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.0 p30 -56.15 -48.08 76.97 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.163 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.3 93.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.748 0.819 . . . . 0.0 111.324 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 14.4 m -61.79 -42.27 98.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.668 0.787 . . . . 0.0 112.465 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -64.61 -44.74 89.6 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.791 0.682 . . . . 0.0 109.876 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 43' ' ' ASN . 81.2 mt -67.51 -32.7 73.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 -34.39 67.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.174 0.59 . . . . 0.0 111.59 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.749 ' HA ' HG11 ' A' ' 76' ' ' VAL . 28.4 t -68.71 -9.93 53.39 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.831 0.852 . . . . 0.0 111.7 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 25' ' ' ALA . 85.4 mt -78.54 6.73 7.99 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.329 0.652 . . . . 0.0 111.105 170.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.52 27.69 26.6 Favored Glycine 0 C--N 1.359 1.808 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.962 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -130.52 163.05 27.9 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.492 0.646 . . . . 0.0 111.016 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.97 93.06 6.39 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.61 112.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.7 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 34' ' ' LEU . 57.6 m -86.09 108.84 18.46 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.053 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.4 130.14 47.55 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.957 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.6 116.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' H ' HD21 ' A' ' 64' ' ' LEU . 14.0 t0 -123.17 124.87 44.01 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.08 -25.71 46.58 Favored 'General case' 0 CA--C 1.562 1.41 0 O-C-N 124.593 1.183 . . . . 0.0 111.678 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -112.31 121.64 45.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.404 1.082 . . . . 0.0 108.786 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' HD12 ' A' ' 64' ' ' LEU . 34.8 p -69.03 -15.28 63.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 112.406 -173.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.5 m -56.48 -44.25 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.434 0.459 . . . . 0.0 110.82 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.86 -30.08 66.36 Favored Glycine 0 C--N 1.358 1.792 0 O-C-N 123.654 0.596 . . . . 0.0 113.036 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 91.1 mt -64.85 -45.96 83.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.749 0.82 . . . . 0.0 110.695 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -62.6 -39.42 93.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.593 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 73.4 mmtt -64.98 -43.44 92.59 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.715 0.406 . . . . 0.0 109.914 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.571 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -57.62 -40.68 79.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.6 -36.42 73.52 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.68 0.792 . . . . 0.0 111.488 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 77.3 mt-30 -57.6 -58.27 9.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.594 0.757 . . . . 0.0 111.718 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 38.2 tp -67.41 -24.94 65.71 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.213 -176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.35 7.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.481 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.39 -27.82 68.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.832 0.453 . . . . 0.0 111.108 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.35 -44.42 92.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.279 1.032 . . . . 0.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 6.19 46.48 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.659 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.52 39.28 50.35 Favored Glycine 0 C--N 1.356 1.65 0 N-CA-C 113.936 0.334 . . . . 0.0 113.936 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.7 m -136.31 175.45 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.117 0.967 . . . . 0.0 109.524 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -129.52 142.67 50.71 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.025 0.44 . . . . 0.0 112.131 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 45' ' ' CYS . 17.7 mm -105.53 169.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.13 1.372 . . . . 0.0 107.43 170.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 m -121.47 105.87 10.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 164.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' LEU . 70.0 p -93.05 111.16 22.7 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 110.655 -165.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.64 124.81 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.6 1.16 . . . . 0.0 110.082 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -100.51 95.28 6.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -144.34 -174.66 4.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.848 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -144.87 127.52 16.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -158.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 105' ' ' LEU . 26.5 mt -68.81 -6.06 24.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.151 0.58 . . . . 0.0 112.542 -172.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -96.9 9.98 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.267 1.027 . . . . 0.0 112.6 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.9 -46.44 0.27 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.207 0.603 . . . . 0.0 110.379 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -155.37 122.87 5.59 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.983 1.713 . . . . 0.0 106.594 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 1.9 p-10 -135.39 -71.8 0.47 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 117' ' ' VAL . 14.5 pt -143.25 123.01 9.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.497 0.719 . . . . 0.0 109.904 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.92 84.91 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.18 -5.97 15.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.91 -39.27 93.79 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.562 0.745 . . . . 0.0 109.111 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.99 -20.46 24.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.029 0.932 . . . . 0.0 111.9 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD22 ' A' ' 34' ' ' LEU . 51.9 m95 -121.7 114.08 20.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 0.0 109.946 -170.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.2 -43.83 81.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.584 0.754 . . . . 0.0 110.337 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.16 151.3 18.24 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.042 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 121' ' ' LEU . 73.1 mt -132.07 148.17 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.4 p -135.49 120.79 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.246 1.018 . . . . 0.0 108.417 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.4 m -108.69 93.23 4.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.639 HD13 HD12 ' A' ' 128' ' ' ILE . 23.3 mm -70.44 140.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.829 0.852 . . . . 0.0 109.512 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -14.0 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.03 2.132 . . . . 0.0 113.691 -171.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.77 107.1 19.46 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.25 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -105.5 101.15 10.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 85' ' ' LEU . 82.4 mt -121.35 138.8 28.63 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.47 163.53 35.92 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.158 2.572 . . . . 0.0 110.717 171.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -35.98 -43.46 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 126.105 1.762 . . . . 0.0 114.875 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 p -57.0 -56.49 21.1 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.641 0.776 . . . . 0.0 110.957 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 94.1 mt -84.39 -22.85 30.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.768 0.827 . . . . 0.0 110.555 -172.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -73.51 -61.26 1.89 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.956 0.903 . . . . 0.0 109.656 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.82 -9.62 15.82 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.226 0.611 . . . . 0.0 112.159 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 24.6 tp60 -87.43 -37.77 16.71 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.673 0.389 . . . . 0.0 110.748 170.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 117' ' ' VAL . 62.7 tp -85.56 -61.27 1.8 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 77.6 m-85 -68.48 -39.57 16.09 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -160.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 45.9 Cg_endo -66.35 -23.96 50.78 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 121.908 1.738 . . . . 0.0 111.894 170.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -83.12 -19.74 36.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.955 0.902 . . . . 0.0 109.286 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 127' ' ' PHE . 39.1 t -77.0 -38.81 28.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -49.67 -57.83 6.46 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.5 -46.81 62.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.093 0.957 . . . . 0.0 113.004 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.04 -37.65 28.5 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -166.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -77.1 109.62 11.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 109.109 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -79.79 163.83 56.36 Favored Pre-proline 0 C--O 1.247 0.931 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.98 115.41 0.87 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.72 2.28 . . . . 0.0 113.542 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.571 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.6 12.87 2.92 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.943 172.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -107.91 148.91 16.71 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 117.482 0.641 . . . . 0.0 112.508 166.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.4 139.5 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.126 0.97 . . . . 0.0 109.024 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.49 121.07 41.6 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 24' ' ' VAL . 55.1 mt -110.91 109.04 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.758 0.823 . . . . 0.0 109.201 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 156' ' ' LEU . 47.5 mt -125.8 144.0 50.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.933 0.893 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -132.23 102.5 5.8 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.94 -173.37 46.58 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.566 ' HB2' HD22 ' A' ' 150' ' ' LEU . 71.5 m-85 -135.31 158.98 43.0 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.0 161.91 56.41 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.594 0.758 . . . . 0.0 111.648 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.03 -24.05 71.61 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.159 2.572 . . . . 0.0 113.431 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.39 -14.25 57.38 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.516 -0.766 . . . . 0.0 113.053 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 132' ' ' PHE . 60.8 tp60 -70.91 -60.66 2.11 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 3.7 mt -75.32 -8.6 57.09 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.127 0.489 . . . . 0.0 110.071 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.65 -17.01 61.2 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.563 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -61.17 -54.62 42.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -170.54 -162.07 0.27 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -75.72 3.48 9.69 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.843 1.202 . . . . 0.0 112.191 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.18 98.7 0.06 OUTLIER Glycine 0 C--N 1.358 1.78 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 171.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.73 -170.99 39.26 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -166.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.96 -57.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.91 2.407 . . . . 0.0 111.04 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -157.42 -44.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.727 1.211 . . . . 0.0 109.594 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -167.92 152.3 6.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.586 0.755 . . . . 0.0 109.509 -166.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 1.0 OUTLIER -61.09 -6.79 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.91 -36.85 78.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.065 0.46 . . . . 0.0 110.346 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.37 12.04 1.36 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.02 0.928 . . . . 0.0 113.048 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 132' ' ' PHE . 48.1 mt -88.38 110.59 37.56 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.599 ' HB2' HD11 ' A' ' 156' ' ' LEU . 5.1 Cg_exo -76.41 104.28 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.581 2.187 . . . . 0.0 109.387 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 mtpt -94.93 160.24 14.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.171 0.588 . . . . 0.0 111.287 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 HD21 ' A' ' 190' ' ' LEU . 71.9 mt -53.26 -37.57 62.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.911 0.884 . . . . 0.0 110.929 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.06 -54.36 20.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.057 1.343 . . . . 0.0 111.74 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -76.24 -45.93 30.53 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.306 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 129' ' ' LEU . 82.7 mt -71.38 -49.73 39.17 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.714 0.806 . . . . 0.0 112.411 -168.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -58.75 -37.69 76.8 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 0.0 111.637 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.0 t -76.62 -17.58 59.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.294 0.238 . . . . 0.0 111.421 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.99 -5.54 55.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.644 0.378 . . . . 0.0 110.619 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 39.3 mt -145.71 59.1 5.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.488 1.115 . . . . 0.0 108.532 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.04 -26.34 21.7 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.06 2.507 . . . . 0.0 112.731 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -90.24 -14.41 33.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.485 0.714 . . . . 0.0 110.209 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 17.7 tp -89.75 69.28 7.64 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.596 1.158 . . . . 0.0 108.628 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.568 ' HB3' HD21 ' A' ' 195' ' ' LEU . 28.2 t30 -61.93 124.62 21.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -88.68 143.53 26.87 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.429 1.091 . . . . 0.0 109.594 -165.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.14 -39.07 72.18 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.172 0.589 . . . . 0.0 109.976 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 75.6 mt -129.14 119.08 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.73 86.05 1.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.747 0.819 . . . . 0.0 109.328 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -160.19 157.96 29.25 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 188' ' ' ILE . 26.0 p-10 -75.35 104.93 6.12 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 mt -102.04 135.44 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 159.02 18.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.651 0.263 . . . . 0.0 110.753 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -141.88 134.78 28.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.32 114.85 7.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.671 0.788 . . . . 0.0 110.5 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 59.6 mt -82.43 167.44 18.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.465 0.706 . . . . 0.0 109.601 168.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.14 -19.9 19.03 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 160.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -76.66 124.64 27.95 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.032 0.933 . . . . 0.0 110.709 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 182' ' ' GLN . . . -87.5 67.52 3.26 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.43 -148.38 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.214 1.006 . . . . 0.0 110.867 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -51.58 -43.09 62.32 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.584 0.754 . . . . 0.0 109.393 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -104.26 120.28 40.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 178' ' ' GLY . 35.8 tt0 -67.66 103.56 1.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.561 0.745 . . . . 0.0 110.968 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.09 18.61 62.74 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.435 -0.802 . . . . 0.0 114.517 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -130.9 146.97 52.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.427 0.691 . . . . 0.0 109.419 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.52 140.58 44.87 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.841 0.856 . . . . 0.0 110.137 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.48 114.8 28.69 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.5 mt -126.56 174.88 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 152' ' ' LYS . 23.8 pt -139.23 139.05 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -127.22 149.94 49.76 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.783 0.802 . . . . 0.0 110.804 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 67.7 mt -133.57 136.53 45.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.395 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.478 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -137.25 108.26 6.73 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.7 147.39 22.02 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -142.55 150.88 40.99 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.551 0.74 . . . . 0.0 110.127 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 13.1 ptmm? -59.96 143.08 52.57 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 164' ' ' ASN . 9.8 mt -88.56 161.44 16.95 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' HB2' ' NZ ' ' A' ' 194' ' ' LYS . 22.5 tt0 -157.29 55.32 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.283 1.04 . . . . 0.0 109.895 173.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -143.5 38.69 1.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -65.66 170.46 5.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.329 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 67.49 81.19 0.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.163 1.385 . . . . 0.0 111.208 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -103.22 174.47 5.85 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 165.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -80.01 151.32 30.04 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.737 0.415 . . . . 0.0 110.848 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 36.9 m80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.856 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -62.13 127.04 29.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.055 0.542 . . . . 0.0 110.693 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.68 143.98 25.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.622 0.769 . . . . 0.0 112.098 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -140.11 80.65 1.77 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.044 1.338 . . . . 0.0 108.54 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -73.12 137.69 45.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.575 0.75 . . . . 0.0 109.866 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.4 137.98 24.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.252 0.621 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -150.67 107.62 3.56 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -78.71 86.85 4.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.457 0.703 . . . . 0.0 110.675 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -82.89 69.62 9.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.008 0.908 . . . . 0.0 109.265 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.6 7.74 19.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.397 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.09 136.34 34.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.976 0.91 . . . . 0.0 109.379 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.87 64.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.926 0.869 . . . . 0.0 109.03 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -87.3 71.88 9.92 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.095 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.0 24.22 0.08 OUTLIER Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.239 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.9 p -70.77 101.84 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.68 0.792 . . . . 0.0 110.082 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.79 123.92 66.66 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.571 0.748 . . . . 0.0 110.028 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.34 -168.24 0.42 Allowed 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.862 2.375 . . . . 0.0 111.478 166.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -113.31 121.75 45.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.64 0.776 . . . . 0.0 110.125 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -176.95 -177.84 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.579 1.152 . . . . 0.0 108.519 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.86 -34.99 20.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 165.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.627 HD21 ' HG ' ' A' ' 47' ' ' LEU . 24.3 tp -62.78 -47.01 85.33 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.553 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -45.68 -33.78 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -68.76 -51.5 40.53 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.34 0.656 . . . . 0.0 110.135 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 128' ' ' ILE . 2.5 m -62.4 -32.9 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.466 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.75 74.53 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.519 1.128 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.58 -21.53 61.13 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.306 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.705 ' HB3' HE21 ' A' ' 193' ' ' GLN . 84.1 mm-40 -84.1 -23.4 30.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.392 0.677 . . . . 0.0 111.207 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 24' ' ' VAL . 63.2 mt -82.23 135.22 47.72 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -52.99 145.61 40.63 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.82 2.347 . . . . 0.0 112.043 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -65.5 29.81 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -115.6 -167.39 15.12 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 118.999 0.818 . . . . 0.0 111.818 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -73.36 127.7 33.4 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.852 0.358 . . . . 0.0 110.309 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.492 HG22 HG12 ' A' ' 99' ' ' VAL . 5.2 mt -113.77 135.93 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.439 -168.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.515 HD22 ' CD1' ' A' ' 95' ' ' TRP . 54.2 tp -98.76 119.99 38.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 6.8 p -110.83 118.64 36.68 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.768 0.827 . . . . 0.0 109.983 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 90' ' ' ILE . 58.2 mt -78.27 135.98 37.66 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 168.91 23.66 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 108.808 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 10.76 0.97 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.965 0.506 . . . . 0.0 111.652 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.39 -31.85 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 C-N-CA 121.944 -0.169 . . . . 0.0 113.276 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.89 151.75 20.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.996 0.918 . . . . 0.0 110.171 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.17 65.26 0.31 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 113.366 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -69.68 -42.64 73.87 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.526 0.73 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD13 ' A' ' 21' ' ' LEU . 92.5 m-20 -73.07 -32.76 65.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.203 0.601 . . . . 0.0 110.367 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -58.01 -51.8 68.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.668 0.787 . . . . 0.0 110.569 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 31.0 m -65.9 -32.89 74.65 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.575 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 38.2 t80 -67.81 -32.14 72.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.627 ' HG ' HD21 ' A' ' 21' ' ' LEU . 37.0 mt -65.84 -33.53 76.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.309 0.644 . . . . 0.0 110.531 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.29 70.65 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.862 0.363 . . . . 0.0 110.896 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.63 ' HA ' HG11 ' A' ' 76' ' ' VAL . 35.6 t -65.75 -18.23 65.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.654 0.782 . . . . 0.0 111.579 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 47' ' ' LEU . 55.9 mt -89.15 18.93 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.914 0.885 . . . . 0.0 110.794 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.88 19.61 78.68 Favored Glycine 0 C--N 1.362 1.974 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -104.06 148.42 26.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.092 0.557 . . . . 0.0 109.941 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -88.56 88.98 7.8 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.8 t -94.59 109.94 22.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.611 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 79' ' ' THR . 69.6 p -84.31 112.62 20.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.312 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.594 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -106.43 111.65 24.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.834 0.854 . . . . 0.0 111.047 -172.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.49 HG23 HD11 ' A' ' 34' ' ' LEU . 22.3 t -81.24 126.82 39.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.35 119.58 11.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.46 -18.18 65.12 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.617 0.573 . . . . 0.0 111.957 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.1 m -97.45 130.39 44.56 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.7 p -65.59 -27.71 68.61 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 18.4 m -63.27 -41.0 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.3 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.54 -40.81 94.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.647 0.592 . . . . 0.0 112.328 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.5 -42.16 83.3 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.537 0.735 . . . . 0.0 111.287 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.22 90.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.782 0.833 . . . . 0.0 112.328 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 2.8 mmmp? -65.85 -41.97 91.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.845 0.458 . . . . 0.0 110.134 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -61.0 -55.4 33.29 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.607 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.37 -23.41 50.81 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.69 -44.52 96.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' A' ' 45' ' ' CYS . 35.2 tp -69.11 -24.25 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.651 0.594 . . . . 0.0 111.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.14 -51.63 68.25 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.484 0.659 . . . . 0.0 109.434 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -72.58 -30.29 64.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.005 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.22 -53.62 10.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.598 0.759 . . . . 0.0 110.804 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.36 -1.4 55.95 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.5 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 38.77 78.43 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.846 -0.161 . . . . 0.0 113.299 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -112.97 173.99 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.734 0.814 . . . . 0.0 109.849 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -111.65 121.1 44.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.15 0.58 . . . . 0.0 111.152 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.2 mm -107.26 163.41 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 164.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 55' ' ' THR . 29.7 m -133.59 106.13 7.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p -87.04 112.85 22.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.436 0.694 . . . . 0.0 111.083 -166.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.13 126.41 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.013 1.325 . . . . 0.0 109.303 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -104.77 92.34 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -134.21 -176.83 4.33 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -141.14 110.1 6.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.734 -1.121 . . . . 0.0 107.999 -158.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 105' ' ' LEU . 17.7 mt -65.87 -7.69 17.84 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.507 1.123 . . . . 0.0 111.733 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.97 -41.91 83.93 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.325 1.05 . . . . 0.0 112.218 172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -151.67 12.36 0.61 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.27 110.24 1.58 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.438 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -138.26 -73.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.493 HG23 HD11 ' A' ' 36' ' ' LEU . 17.7 pt -119.72 117.79 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.49 87.05 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.405 0.682 . . . . 0.0 109.537 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.57 -30.04 4.89 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.231 1.413 . . . . 0.0 114.153 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.51 -46.11 80.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.431 0.692 . . . . 0.0 109.272 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.35 -25.71 51.33 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.515 ' CD1' HD22 ' A' ' 34' ' ' LEU . 47.9 m95 -117.5 166.32 12.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -169.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 11.3 tp10 -94.07 -74.63 0.53 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.855 0.862 . . . . 0.0 109.836 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.87 162.11 17.46 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.495 HD12 HD12 ' A' ' 121' ' ' LEU . 54.1 mt -128.7 147.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 33' ' ' ILE . 7.2 p -139.24 141.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.893 1.277 . . . . 0.0 107.87 167.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . 50.5 m -136.97 92.31 2.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 128' ' ' ILE . 40.7 mm -62.28 133.51 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 129' ' ' LEU . 14.6 p90 -20.93 102.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.123 2.139 . . . . 0.0 114.148 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 71.0 m -77.95 103.42 7.88 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.058 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -91.09 96.94 10.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 85' ' ' LEU . 86.8 mt -125.65 142.33 41.7 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.201 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.01 159.88 36.48 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.534 2.156 . . . . 0.0 110.707 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.3 p -41.87 -43.14 2.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.5 1.52 . . . . 0.0 113.668 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -55.77 -50.93 69.1 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.209 0.943 . . . . 0.0 112.172 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.92 -33.94 33.74 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.284 0.634 . . . . 0.0 111.714 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.42 -43.63 31.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.583 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.44 -35.0 18.1 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.693 0.797 . . . . 0.0 111.967 165.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -79.47 -33.03 42.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.64 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 117' ' ' VAL . 48.1 tp -71.21 -48.61 50.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.891 0.476 . . . . 0.0 111.581 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -60.93 -42.77 88.67 Favored Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -167.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.43 -25.45 48.61 Favored 'Trans proline' 0 C--N 1.396 3.076 0 CA-C-N 121.364 1.523 . . . . 0.0 111.984 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -81.7 -21.17 38.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 122.995 0.518 . . . . 0.0 110.357 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 113' ' ' LEU . 19.3 t -85.03 -35.74 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 42.4 t80 -48.9 -61.6 1.96 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.125 0.97 . . . . 0.0 112.256 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.425 ' HG3' ' HD1' ' A' ' 118' ' ' TYR . 47.9 mt-30 -95.46 -22.3 17.77 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 172.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.21 -23.86 53.49 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD12 HD12 ' A' ' 98' ' ' ILE . 39.7 tp -61.05 124.89 21.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.394 0.678 . . . . 0.0 110.884 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -67.11 133.11 93.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.65 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.596 2.197 . . . . 0.0 112.297 168.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.16 14.76 8.17 Favored Glycine 0 C--O 1.248 1.005 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.433 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -95.87 135.56 12.39 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.5 m -109.4 130.4 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.002 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.17 111.59 24.08 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 24' ' ' VAL . 58.1 mt -106.98 108.27 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 102' ' ' PHE . 69.8 mt -124.25 117.49 24.68 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.423 0.689 . . . . 0.0 109.381 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -99.55 98.71 9.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.61 169.16 53.26 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.905 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.439 ' HD1' HD22 ' A' ' 187' ' ' LEU . 7.7 m-85 -133.06 156.02 48.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.0 171.75 4.15 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.898 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.652 ' HA ' HD22 ' A' ' 147' ' ' LEU . 90.7 Cg_exo -45.27 -21.29 0.64 Allowed 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 124.169 3.246 . . . . 0.0 116.247 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -76.54 -6.67 52.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.915 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.409 ' O ' HG22 ' A' ' 141' ' ' THR . 61.4 tp60 -76.34 -63.61 1.29 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -173.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.89 -11.92 59.88 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.404 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -63.62 -39.74 95.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.173 0.989 . . . . 0.0 111.78 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.72 11.85 8.3 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.237 0.615 . . . . 0.0 111.085 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.5 p30 42.84 43.93 3.66 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.358 1.863 . . . . 0.0 113.485 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 136' ' ' GLN . 15.1 t -89.48 3.22 53.07 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.003 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.46 159.08 20.84 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.35 74.77 0.08 OUTLIER Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.04 -19.12 45.91 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.973 2.449 . . . . 0.0 112.559 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -163.12 -60.27 0.04 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.915 0.886 . . . . 0.0 108.764 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -177.2 166.08 2.33 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.288 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.692 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -60.64 -2.29 0.5 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.977 1.311 . . . . 0.0 112.435 173.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.71 -33.33 72.73 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.905 1.282 . . . . 0.0 111.34 168.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.5 1.79 44.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.478 0.711 . . . . 0.0 112.685 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.692 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 29.0 mt -86.89 102.81 3.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.882 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.1 Cg_endo -75.69 123.68 7.66 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.858 2.372 . . . . 0.0 112.618 -168.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -102.78 151.37 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.795 0.838 . . . . 0.0 111.839 -168.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 190' ' ' LEU . 32.5 mt -61.0 -54.39 45.58 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.692 . . . . 0.0 111.829 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -52.51 -39.54 61.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.93 0.892 . . . . 0.0 111.181 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 29.3 m -74.7 -57.12 4.12 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 151' ' ' PRO . 88.8 mt -63.92 -46.43 84.8 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.251 1.021 . . . . 0.0 112.631 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.602 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.5 tt0 -53.38 -35.57 60.48 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 111.837 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.5 t -84.44 -20.88 31.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.694 . . . . 0.0 112.062 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 155' ' ' THR . 41.6 mm-40 -79.53 -16.53 55.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.608 . . . . 0.0 110.875 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 82.1 mt -142.12 66.53 20.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.768 0.827 . . . . 0.0 109.461 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.591 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 13.8 Cg_exo -72.24 -3.84 14.08 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 123.115 2.543 . . . . 0.0 112.635 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 p -85.62 -33.87 21.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.8 tp -99.59 70.49 1.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.361 1.464 . . . . 0.0 111.257 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.402 ' HB3' HD22 ' A' ' 195' ' ' LEU . 26.5 t-20 -53.03 126.96 22.32 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.602 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 17.4 m95 -91.08 133.26 35.47 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.81 -35.56 77.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.985 0.514 . . . . 0.0 109.7 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 78.1 mt -126.45 123.04 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.22 69.69 1.01 Allowed 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -129.48 145.93 51.38 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.327 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -92.17 112.1 23.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.436 1.094 . . . . 0.0 109.493 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.8 mt -117.25 125.42 51.1 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.456 0.702 . . . . 0.0 110.316 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -88.5 124.9 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -90.16 125.45 35.46 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -80.28 96.9 6.77 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 37.8 mt -68.67 145.83 53.53 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.915 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -78.91 2.39 20.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.003 0.521 . . . . 0.0 110.63 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -49.51 -38.1 29.11 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.48 -82.96 0.33 Allowed Glycine 0 N--CA 1.476 1.321 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.592 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 63.94 163.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.072 1.349 . . . . 0.0 113.402 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -67.3 -48.98 66.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.65 0.78 . . . . 0.0 112.358 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -88.03 -59.77 2.15 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.03 138.47 1.71 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.288 0.993 . . . . 0.0 109.138 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.61 98.32 0.94 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -132.17 170.43 15.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.83 0.824 . . . . 0.0 111.508 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -157.28 131.2 8.19 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.186 -1.825 . . . . 0.0 106.486 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.72 130.38 35.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.439 HD22 ' HD1' ' A' ' 132' ' ' PHE . 52.1 mt -135.36 173.65 11.48 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 151' ' ' PRO . 9.8 pt -145.88 135.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.931 0.892 . . . . 0.0 109.257 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.4 142.25 33.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.664 0.386 . . . . 0.0 110.442 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 153' ' ' LEU . 39.5 mt -129.36 131.42 46.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.7 1.2 . . . . 0.0 109.069 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.86 105.74 7.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.07 138.16 15.24 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.705 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.0 tp-100 -142.55 149.7 39.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.587 0.693 . . . . 0.0 110.219 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -66.34 138.93 57.96 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 164' ' ' ASN . 5.6 mt -61.25 101.34 0.16 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.557 1.161 . . . . 0.0 109.169 -171.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 65.93 80.92 0.21 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.06 1.344 . . . . 0.0 110.724 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -81.65 -29.01 33.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.532 0.733 . . . . 0.0 112.241 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -138.1 37.45 2.33 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.478 0.656 . . . . 0.0 109.458 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.56 70.15 7.22 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.035 0.921 . . . . 0.0 109.32 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -155.78 -178.2 7.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.72 1.608 . . . . 0.0 107.799 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -74.6 124.19 26.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.747 0.419 . . . . 0.0 110.878 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 . . . . . 0 N--CA 1.481 1.109 0 C-N-CA 123.094 0.558 . . . . 0.0 109.853 172.254 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -123.41 35.15 4.92 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.417 0.687 . . . . 0.0 110.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.19 29.61 6.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.198 0.599 . . . . 0.0 110.934 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.38 101.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.52 0.728 . . . . 0.0 110.22 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -143.2 87.92 1.99 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.509 0.724 . . . . 0.0 109.963 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -160.57 119.2 2.59 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.92 0.888 . . . . 0.0 108.801 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 85.83 1.5 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -71.0 92.16 0.92 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.157 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 p -78.34 109.49 12.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.805 0.842 . . . . 0.0 110.989 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.65 141.23 26.64 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.301 0.64 . . . . 0.0 111.193 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -172.07 127.85 0.59 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.748 1.219 . . . . 0.0 108.092 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.47 135.65 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 0.0 110.724 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.24 150.09 9.07 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.008 1.323 . . . . 0.0 108.07 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.59 90.74 0.08 OUTLIER Glycine 0 C--O 1.239 0.451 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -135.57 158.42 44.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.765 0.826 . . . . 0.0 108.85 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.42 160.77 66.65 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 109.628 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.38 17.6 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 123.402 2.734 . . . . 0.0 114.727 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -138.36 44.3 2.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.343 1.068 . . . . 0.0 109.047 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.58 84.71 0.86 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.319 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -177.4 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.69 1.596 . . . . 0.0 106.721 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.474 HD21 ' HG ' ' A' ' 47' ' ' LEU . 37.5 tp -62.95 -36.54 83.78 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.763 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 m -44.13 -36.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.239 1.016 . . . . 0.0 113.584 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 m -74.89 -52.43 11.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.521 0.729 . . . . 0.0 110.84 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 128' ' ' ILE . 2.1 m -62.3 -37.06 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.588 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.0 83.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.314 1.446 . . . . 0.0 112.057 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.99 -28.05 68.59 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.813 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.18 -14.6 28.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.211 0.605 . . . . 0.0 112.194 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 76.1 mt -77.71 130.58 73.12 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.72 140.71 46.14 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.266 2.644 . . . . 0.0 112.65 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.45 28.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.66 -147.12 8.66 Favored Glycine 0 N--CA 1.468 0.777 0 CA-C-N 118.455 0.571 . . . . 0.0 112.905 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -80.43 119.34 23.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -110.27 139.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.218 1.007 . . . . 0.0 108.555 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 26.1 tp -115.42 128.65 56.19 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.968 0.804 . . . . 0.0 111.498 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 32.7 m -94.05 138.0 32.62 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.051 0.94 . . . . 0.0 110.239 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.6 108.95 17.08 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.986 0.514 . . . . 0.0 111.152 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 43.45 63.91 1.4 Allowed 'General case' 0 N--CA 1.485 1.282 0 O-C-N 125.482 1.738 . . . . 0.0 112.501 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.81 -58.43 3.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.44 0.638 . . . . 0.0 111.086 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.39 100.39 2.49 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 78.11 4.4 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.069 1.348 . . . . 0.0 113.9 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.6 19.24 41.14 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -62.13 -49.09 77.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.336 1.054 . . . . 0.0 111.297 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.455 HD22 HG21 ' A' ' 101' ' ' ILE . 93.5 m-20 -77.69 -32.78 53.23 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.804 -172.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.43 77.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.577 0.751 . . . . 0.0 110.101 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -68.85 -30.47 69.01 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.526 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 21' ' ' LEU . 57.4 t80 -62.93 -43.53 98.55 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HG ' HD21 ' A' ' 21' ' ' LEU . 89.4 mt -70.36 -30.78 67.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.85 76.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.88 0.472 . . . . 0.0 111.197 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 23.6 p -75.85 -2.44 30.08 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.303 0.641 . . . . 0.0 111.985 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 94.4 mt -86.32 14.97 5.75 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.314 0.646 . . . . 0.0 110.427 164.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.29 47.31 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 123.223 0.44 . . . . 0.0 113.523 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -125.29 157.03 37.66 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.337 0.589 . . . . 0.0 111.065 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.76 88.57 5.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.12 116.57 36.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.237 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 27.1 m -84.95 112.78 20.89 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 124.761 1.224 . . . . 0.0 107.977 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.27 133.85 46.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 111.174 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 81' ' ' VAL . 15.1 t -115.66 120.1 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.64 143.8 50.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.05 -20.98 66.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.506 0.722 . . . . 0.0 111.263 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 62' ' ' VAL . 46.1 m -111.75 124.52 52.51 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.716 1.206 . . . . 0.0 109.003 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.5 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.907 0.883 . . . . 0.0 110.062 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 60' ' ' SER . 19.1 m -66.26 -26.35 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.67 -35.1 33.06 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.157 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.3 -44.79 82.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.031 0.933 . . . . 0.0 110.449 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.26 91.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.924 0.889 . . . . 0.0 111.528 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -66.81 -40.28 87.99 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.295 0.638 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.08 88.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.294 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -70.02 -36.87 75.41 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.431 1.092 . . . . 0.0 111.476 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -61.08 -52.15 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.23 -28.77 69.96 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.984 0.803 . . . . 0.0 110.715 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.32 -62.24 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.981 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -65.77 -26.24 67.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 111.559 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.52 -46.28 90.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.162 0.985 . . . . 0.0 109.786 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -98.81 -0.71 41.99 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.553 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.85 51.23 8.03 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.366 0.506 . . . . 0.0 114.366 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.2 m -138.42 176.29 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.932 0.893 . . . . 0.0 110.618 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -114.74 140.88 48.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.832 0.853 . . . . 0.0 111.937 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.5 157.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 85.6 m -119.12 103.23 9.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 t -94.62 114.89 26.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.278 0.561 . . . . 0.0 110.535 -163.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 57' ' ' VAL . 61.7 t -109.92 139.69 32.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.683 1.193 . . . . 0.0 108.883 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -78.87 132.26 36.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.639 0.775 . . . . 0.0 109.902 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 p -63.61 106.07 0.89 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 111.515 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -144.21 89.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 165.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -78.87 -16.36 57.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.804 0.442 . . . . 0.0 111.047 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.22 -27.3 62.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.565 0.746 . . . . 0.0 111.333 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -104.52 -37.12 7.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.262 0.625 . . . . 0.0 111.654 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -161.34 126.25 3.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.378 1.071 . . . . 0.0 108.323 -170.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.01 -70.55 0.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 117' ' ' VAL . 2.9 pt -143.5 118.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.582 0.753 . . . . 0.0 109.778 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.879 0.872 . . . . 0.0 109.685 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 122' ' ' LYS . . . -44.88 -26.67 0.43 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 -44.42 71.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.991 0.516 . . . . 0.0 110.761 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.68 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -140.89 -165.32 1.92 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.223 0.609 . . . . 0.0 111.25 -171.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -118.01 -37.16 3.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.752 0.821 . . . . 0.0 112.42 -169.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.36 172.21 23.94 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 122.369 -0.207 . . . . 0.0 112.862 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.536 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 42.6 mt -134.35 145.83 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.881 0.873 . . . . 0.0 109.233 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -127.3 105.09 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 159.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.9 t -104.19 88.03 2.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 43' ' ' ASN . 34.4 mm -71.58 146.16 11.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.656 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -17.54 99.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 126.563 2.414 . . . . 0.0 112.261 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.558 ' SG ' HD21 ' A' ' 129' ' ' LEU . 28.8 p -99.15 104.83 16.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.158 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -96.67 96.71 8.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.4 mt -112.19 139.27 22.28 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.717 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 105' ' ' LEU . 11.7 Cg_exo -71.19 162.03 43.87 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.937 2.425 . . . . 0.0 110.981 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 149' ' ' LEU . 14.0 m -34.98 -42.56 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.199 1.8 . . . . 0.0 115.368 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.3 m -70.61 -46.52 63.22 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.241 0.338 . . . . 0.0 110.692 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.52 -35.72 34.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.632 0.373 . . . . 0.0 110.427 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -69.14 -62.73 1.26 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.679 0.792 . . . . 0.0 109.945 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -51.87 -34.06 39.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.918 0.887 . . . . 0.0 113.135 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.64 -32.58 47.36 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 117' ' ' VAL . 55.9 tp -71.92 -39.27 69.6 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.457 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -62.86 -38.86 47.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.94 -30.89 67.35 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.819 1.679 . . . . 0.0 111.792 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.08 -15.71 56.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.787 0.835 . . . . 0.0 110.209 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.616 ' HA ' HD11 ' A' ' 90' ' ' ILE . 22.3 t -83.84 -40.92 16.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -57.8 -52.39 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -69.95 -42.7 72.88 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.3 -39.86 14.65 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 25.8 tp -69.78 111.84 5.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.916 0.886 . . . . 0.0 110.61 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 19.4 ptmt -85.42 157.95 58.11 Favored Pre-proline 0 C--O 1.247 0.948 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.106 167.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.588 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 83.1 Cg_exo -50.8 112.29 0.73 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.343 2.029 . . . . 0.0 112.291 168.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 126.61 12.73 3.27 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.319 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.78 147.53 16.37 Favored Glycine 0 C--O 1.246 0.862 0 O-C-N 122.545 -0.385 . . . . 0.0 112.303 168.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 35.1 m -109.44 131.57 59.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 123.548 0.739 . . . . 0.0 110.076 177.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.93 112.54 24.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 24' ' ' VAL . 59.6 mt -115.44 112.26 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.132 0.973 . . . . 0.0 109.543 -171.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' SG ' ' A' ' 103' ' ' CYS . 96.5 mt -133.33 153.42 51.6 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 37.7 tt0 -132.49 100.76 5.08 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 164.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 151' ' ' PRO . . . -80.23 166.58 49.96 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.779 175.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.413 ' HB2' HD22 ' A' ' 150' ' ' LEU . 58.0 m-85 -127.29 157.43 39.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 109.383 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -89.35 164.59 29.5 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.571 ' HA ' HD22 ' A' ' 147' ' ' LEU . 38.5 Cg_exo -61.01 -0.83 1.36 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.96 2.44 . . . . 0.0 114.248 173.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.02 -19.62 47.25 Favored 'General case' 0 CA--C 1.571 1.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.625 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.52 -63.18 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 113.126 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.571 HD12 ' HG ' ' A' ' 147' ' ' LEU . 15.5 mt -71.01 -11.49 61.0 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -73.46 -40.86 63.83 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.185 0.994 . . . . 0.0 111.136 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -68.69 -58.03 4.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.155 0.502 . . . . 0.0 110.189 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -127.93 134.36 49.32 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -84.99 40.18 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.819 0.847 . . . . 0.0 111.76 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.37 53.93 2.76 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 121.61 0.561 . . . . 0.0 111.926 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.23 125.65 7.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 118.46 -1.189 . . . . 0.0 111.83 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.76 -35.1 90.49 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.445 2.097 . . . . 0.0 110.671 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -169.92 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.076 1.35 . . . . 0.0 108.638 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -169.71 158.83 7.78 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.281 -173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.571 ' HG ' HD12 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -61.32 -7.25 2.74 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.326 1.45 . . . . 0.0 112.847 175.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.5 -37.31 83.21 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.377 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 107' ' ' SER . 71.8 mt -83.88 8.61 14.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.514 0.726 . . . . 0.0 112.261 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 132' ' ' PHE . 56.3 mt -85.63 108.52 16.76 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.511 ' HB2' HD11 ' A' ' 156' ' ' LEU . 12.2 Cg_exo -70.22 122.63 9.18 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.977 2.451 . . . . 0.0 112.53 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -96.61 150.11 21.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.1 0.96 . . . . 0.0 111.282 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.583 HD22 HD21 ' A' ' 190' ' ' LEU . 37.9 mt -57.55 -36.87 72.2 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 122.987 0.515 . . . . 0.0 109.696 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -50.9 -51.37 52.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.534 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -69.75 -48.84 57.88 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.55 -58.73 3.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.396 1.078 . . . . 0.0 112.516 -166.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.27 -31.28 72.35 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.455 0.702 . . . . 0.0 112.091 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.0 t -84.54 -13.85 50.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.065 0.393 . . . . 0.0 111.519 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.85 -45.35 10.94 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.675 0.75 . . . . 0.0 109.317 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.9 mt -104.85 78.89 0.4 Allowed Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.702 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.37 -4.06 7.63 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 123.002 2.468 . . . . 0.0 111.367 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -85.52 -28.62 24.83 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.49 1.116 . . . . 0.0 108.115 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.83 70.81 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.78 1.632 . . . . 0.0 109.015 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 195' ' ' LEU . 6.8 t30 -60.46 121.42 12.05 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.425 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 16.7 m95 -87.85 141.51 28.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.516 1.126 . . . . 0.0 108.998 -167.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.4 mt -73.42 -35.72 65.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.077 0.551 . . . . 0.0 109.809 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 82.2 mt -126.11 118.09 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.81 76.5 1.07 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -141.3 143.03 33.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.11 112.23 20.49 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.473 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.4 mt -103.86 131.27 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.409 1.083 . . . . 0.0 108.884 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.74 122.99 37.91 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -120.23 131.6 55.02 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -77.72 133.02 38.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.446 0.699 . . . . 0.0 109.635 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 183' ' ' GLY . 17.4 mt -105.68 170.33 7.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.253 1.421 . . . . 0.0 108.788 -174.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.32 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.323 0.649 . . . . 0.0 111.062 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 183' ' ' GLY . 10.2 tp10 -162.18 157.74 23.55 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.44 1.096 . . . . 0.0 109.382 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.43 154.39 48.1 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.461 0.476 . . . . 0.0 112.802 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.7 70.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 112.855 -172.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -66.1 -27.81 68.34 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.121 0.569 . . . . 0.0 112.048 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -101.3 -61.17 1.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.883 0.473 . . . . 0.0 110.924 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 47.6 mt-30 64.08 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.891 1.276 . . . . 0.0 109.85 -167.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.66 99.27 0.52 Allowed Glycine 0 C--O 1.208 -1.531 0 O-C-N 123.645 0.591 . . . . 0.0 112.966 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 182' ' ' GLN . 53.9 mttp -87.76 147.91 24.97 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -149.42 132.86 16.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.03 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -79.03 109.64 13.52 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.0 mt -122.16 144.03 49.2 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 13.4 pt -133.02 116.61 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.15 0.432 . . . . 0.0 110.025 -170.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.61 137.77 36.76 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.067 0.46 . . . . 0.0 109.779 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 153' ' ' LEU . 62.9 mt -125.98 146.0 50.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.388 1.075 . . . . 0.0 110.343 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 23.7 tp -149.88 106.15 3.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -88.48 142.36 17.22 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -142.65 156.76 45.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.649 0.725 . . . . 0.0 111.04 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 68.2 tttt -55.34 135.26 50.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.322 1.449 . . . . 0.0 110.368 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 164' ' ' ASN . 3.5 mt -86.17 125.04 33.23 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 164.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.491 ' HA ' ' HE2' ' A' ' 194' ' ' LYS . 9.2 tp10 -58.15 107.83 0.53 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.511 0.672 . . . . 0.0 110.21 -171.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -93.58 46.15 1.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.923 1.289 . . . . 0.0 109.128 -166.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . 0.254 28.8 p-80 41.72 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.505 1.922 . . . . 0.0 113.372 -168.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -129.1 159.58 35.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.716 1.207 . . . . 0.0 109.209 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -67.33 -2.96 6.87 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.938 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 63.92 32.24 13.32 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.788 1.235 . . . . 0.0 111.836 165.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 . . . . . 0 C--O 1.252 1.189 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.351 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -143.94 135.73 26.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.427 1.091 . . . . 0.0 108.408 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -100.01 100.96 11.91 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.77 0.795 . . . . 0.0 110.778 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -98.61 165.88 11.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.661 0.785 . . . . 0.0 109.923 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.48 73.19 8.53 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -73.63 132.45 42.78 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 p -66.98 101.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.944 0.898 . . . . 0.0 111.03 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.79 119.07 4.16 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.002 0.921 . . . . 0.0 109.945 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.5 t -84.63 67.88 10.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.458 0.703 . . . . 0.0 112.115 -164.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.31 72.05 8.13 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 38.8 t80 -69.99 125.29 26.32 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.46 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.46 136.51 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -66.01 93.51 0.2 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.043 0.537 . . . . 0.0 111.028 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.34 53.06 0.75 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.421 HG23 HD22 ' A' ' 50' ' ' LEU . 85.2 m -112.75 99.16 7.7 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.149 0.98 . . . . 0.0 109.326 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' H ' ' HZ ' ' A' ' 46' ' ' PHE . 5.1 tp10 -147.32 70.55 11.81 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.48 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.42 -74.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.928 2.418 . . . . 0.0 111.472 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 54.72 76.0 0.27 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.665 1.186 . . . . 0.0 111.941 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -167.76 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.764 0.425 . . . . 0.0 111.639 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.1 t80 174.24 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.976 1.31 . . . . 0.0 107.65 -165.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.61 -17.91 57.14 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.695 1.198 . . . . 0.0 112.443 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.69 -37.92 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -71.84 -41.15 68.48 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.031 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.4 m -66.8 -43.5 89.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -57.27 -38.41 73.86 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.18 0.992 . . . . 0.0 112.253 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -69.61 -21.32 63.59 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.626 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -91.1 -21.86 21.0 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.41 0.684 . . . . 0.0 110.54 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 92.3 mt -74.09 134.2 77.77 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 123.532 0.733 . . . . 0.0 110.51 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.66 136.42 49.68 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.36 2.707 . . . . 0.0 112.111 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.44 28.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.7 -132.81 4.98 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -84.33 112.41 20.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HG12 ' A' ' 99' ' ' VAL . 8.9 mt -111.59 119.11 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.691 0.796 . . . . 0.0 109.197 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 90' ' ' ILE . 28.7 tp -89.95 108.0 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.667 0.212 . . . . 0.0 110.743 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 49.3 t -94.92 110.39 22.29 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.265 0.626 . . . . 0.0 110.689 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.2 mt -79.02 126.35 30.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 154.96 38.57 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.791 0.682 . . . . 0.0 109.816 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.25 32.74 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.23 -76.28 0.02 OUTLIER Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.504 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -80.9 -60.46 2.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.901 0.481 . . . . 0.0 111.351 -167.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 -51.43 4.37 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.881 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -49.78 -38.32 33.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.417 1.487 . . . . 0.0 112.2 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.422 ' ND2' HG13 ' A' ' 101' ' ' ILE . 29.1 p-10 -64.2 -41.0 97.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.0 72.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.51 0.724 . . . . 0.0 110.719 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 9.9 m -59.55 -38.89 82.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.627 0.771 . . . . 0.0 111.099 173.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' HZ ' ' H ' ' A' ' 16' ' ' GLU . 73.0 t80 -73.2 -33.5 65.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.592 0.757 . . . . 0.0 110.906 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HG11 ' A' ' 99' ' ' VAL . 50.6 mt -64.03 -32.36 73.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 110.421 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.17 -31.24 58.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.879 0.472 . . . . 0.0 110.763 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 m -68.37 -6.09 22.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.809 0.844 . . . . 0.0 111.835 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD22 HG23 ' A' ' 15' ' ' THR . 38.8 mt -83.89 12.38 6.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.596 0.758 . . . . 0.0 110.646 168.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 34.72 25.44 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 123.285 0.469 . . . . 0.0 113.985 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.4 162.16 26.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.882 0.473 . . . . 0.0 111.387 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -92.99 91.07 7.2 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 165.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 33' ' ' ILE . 85.7 t -88.4 112.12 23.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.2 t -83.3 104.4 13.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.28 134.75 42.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.985 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.3 t -113.71 118.22 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -133.68 142.48 48.03 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -54.31 -32.2 55.98 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.191 0.997 . . . . 0.0 112.364 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' HG22 ' A' ' 62' ' ' VAL . 9.1 t -109.03 130.33 55.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.631 0.772 . . . . 0.0 110.005 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 t -74.98 -16.86 60.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.929 0.892 . . . . 0.0 110.991 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.461 HG22 ' OG ' ' A' ' 60' ' ' SER . 9.6 m -63.85 -32.98 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.544 0.337 . . . . 0.0 110.511 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.42 -33.21 56.75 Favored Glycine 0 C--N 1.351 1.382 0 O-C-N 123.538 0.523 . . . . 0.0 112.646 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.09 -48.03 59.38 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.779 0.832 . . . . 0.0 110.413 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.55 86.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.712 0.805 . . . . 0.0 112.047 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -63.35 -39.41 94.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.861 0.864 . . . . 0.0 110.748 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -60.92 -46.71 89.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.942 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -71.08 -37.14 72.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.635 0.774 . . . . 0.0 111.652 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.63 -55.72 31.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.93 0.892 . . . . 0.0 109.849 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.2 tp -66.61 -25.19 66.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.221 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.09 -52.09 52.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.973 0.509 . . . . 0.0 110.495 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.85 -33.83 73.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.026 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.6 -48.22 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.545 0.528 . . . . 0.0 110.723 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 ttmp? -87.68 -13.5 42.4 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.96 44.83 13.04 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 121.054 0.252 . . . . 0.0 112.674 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 172.83 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.394 1.078 . . . . 0.0 108.124 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -121.77 141.26 51.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.706 0.403 . . . . 0.0 110.896 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.8 mm -109.24 165.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 45.0 m -131.13 104.02 6.84 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 164.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.2 p -86.74 114.33 23.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.884 0.474 . . . . 0.0 111.108 -168.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' HB ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -104.63 139.01 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.746 1.218 . . . . 0.0 108.108 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -78.9 136.35 37.26 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 p -50.47 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.5 1.12 . . . . 0.0 111.838 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 6.6 m-20 -134.65 91.1 2.73 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 65.7 mt -100.46 -6.71 25.15 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.691 0.758 . . . . 0.0 110.68 -170.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.27 3.44 29.98 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.189 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 32.2 t70 -139.64 -46.38 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -168.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -163.86 100.5 0.88 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.634 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -132.84 -58.28 0.92 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.522 0.729 . . . . 0.0 109.343 -164.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 34' ' ' LEU . 4.7 pt -134.35 110.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 123.039 0.535 . . . . 0.0 111.028 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 t -129.2 84.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.559 0.744 . . . . 0.0 109.346 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.529 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.65 -1.02 14.61 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.897 0.479 . . . . 0.0 112.176 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -76.16 -45.95 30.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.98 61.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.614 0.766 . . . . 0.0 112.57 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.508 ' CD1' HD22 ' A' ' 34' ' ' LEU . 44.8 m95 -113.79 -177.71 3.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.254 0.622 . . . . 0.0 110.486 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -92.49 -55.83 3.25 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.69 0.796 . . . . 0.0 109.994 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.77 173.84 21.34 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.521 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.8 mt -132.68 139.3 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 47' ' ' LEU . 7.5 p -124.06 106.94 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.64 0.734 . . . . 0.0 109.233 165.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.2 m -103.82 94.11 5.25 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.449 HD13 HD12 ' A' ' 128' ' ' ILE . 41.6 mm -68.52 141.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.359 1.063 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 8.2 p90 -21.63 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 126.032 1.733 . . . . 0.0 113.85 -172.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.494 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 35.8 t -94.53 109.56 21.44 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.615 -168.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -108.52 98.69 8.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.494 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 62.5 mt -114.62 145.53 34.06 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.809 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.73 150.55 69.79 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.833 2.355 . . . . 0.0 110.269 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.6 t -44.9 -33.88 2.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.771 1.228 . . . . 0.0 113.324 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.0 m -59.4 -59.81 4.85 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.312 0.645 . . . . 0.0 111.399 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.66 -24.41 53.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.992 0.517 . . . . 0.0 110.537 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.84 -54.62 14.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.416 1.086 . . . . 0.0 109.57 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -55.75 -28.67 57.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.387 1.075 . . . . 0.0 112.436 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.65 -22.95 24.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.842 0.457 . . . . 0.0 111.078 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.5 tp -71.9 -45.42 61.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.133 0.573 . . . . 0.0 111.172 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -58.58 -41.52 89.48 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -52.79 -38.05 77.22 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 122.449 2.099 . . . . 0.0 112.811 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.55 -23.61 56.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.391 0.677 . . . . 0.0 111.595 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 t -85.46 -28.08 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.362 0.601 . . . . 0.0 110.142 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -75.04 -61.09 2.01 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.291 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -76.99 -47.36 20.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.501 1.12 . . . . 0.0 113.584 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.62 -36.72 22.22 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 114.14 0.416 . . . . 0.0 114.14 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.2 tp -75.36 108.5 8.18 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 1.2 mptm? -82.59 159.53 63.73 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.529 168.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -41.29 113.05 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.305 2.67 . . . . 0.0 113.813 166.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 14.22 3.24 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.235 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -112.32 144.43 17.8 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 121.766 -0.843 . . . . 0.0 111.146 165.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 33.9 m -107.59 132.16 55.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.834 0.854 . . . . 0.0 109.96 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.56 112.79 25.95 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.449 HD12 HD13 ' A' ' 101' ' ' ILE . 57.9 mt -104.21 109.43 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 156' ' ' LEU . 51.7 mt -124.59 120.71 32.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 110.088 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 37.8 tt0 -112.28 102.6 10.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.57 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.65 169.08 40.5 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.668 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.635 ' HD1' HD22 ' A' ' 187' ' ' LEU . 57.1 m-85 -137.73 165.97 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.78 0.832 . . . . 0.0 109.445 -172.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.572 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -76.91 164.15 60.98 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.833 0.853 . . . . 0.0 110.072 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.564 ' HA ' HD22 ' A' ' 147' ' ' LEU . 38.1 Cg_endo -63.88 -2.3 4.37 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.237 1.958 . . . . 0.0 113.03 169.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.9 -6.75 59.34 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.506 1.122 . . . . 0.0 111.846 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -63.68 -59.93 3.96 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.209 -0.307 . . . . 0.0 111.177 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.47 HD12 ' HG ' ' A' ' 147' ' ' LEU . 14.5 mt -73.07 -12.3 60.86 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.363 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -68.59 -29.03 67.47 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -61.16 -30.05 70.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 61.08 42.39 12.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.001 1.321 . . . . 0.0 110.004 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 76.1 p -109.19 -6.58 15.52 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.94 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.18 153.6 14.93 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.75 98.8 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.222 -0.765 . . . . 0.0 111.848 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.22 -36.4 36.56 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.721 2.28 . . . . 0.0 112.1 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -168.14 -55.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.201 1.0 . . . . 0.0 108.718 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -162.64 159.24 24.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.343 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.5 OUTLIER -61.04 -3.18 0.74 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.52 1.528 . . . . 0.0 112.903 175.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.3 -38.0 79.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.91 0.884 . . . . 0.0 109.746 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 105' ' ' LEU . 24.0 mt -87.61 9.46 21.2 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.158 -173.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 79.3 mt -81.24 106.02 5.04 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.57 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 15.3 Cg_exo -68.29 110.77 2.32 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 123.203 2.602 . . . . 0.0 112.651 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -95.51 147.67 23.3 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.926 0.891 . . . . 0.0 111.311 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.6 mt -59.84 -45.26 92.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.52 0.6 . . . . 0.0 110.428 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.63 -46.77 77.37 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.261 0.976 . . . . 0.0 110.942 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.7 p -71.95 -53.73 12.15 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 129' ' ' LEU . 40.6 mt -70.01 -51.29 33.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.533 1.133 . . . . 0.0 113.274 -169.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 30.0 tt0 -59.98 -35.06 74.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.679 0.392 . . . . 0.0 111.38 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.7 t -78.04 -28.1 48.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.703 0.401 . . . . 0.0 110.864 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -78.39 -24.15 46.46 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.885 . . . . 0.0 110.768 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.7 mt -131.84 73.27 78.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -82.71 -9.18 11.12 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.252 2.634 . . . . 0.0 112.606 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -91.84 -29.86 16.5 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp -88.4 72.44 8.91 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.624 1.17 . . . . 0.0 110.29 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -53.6 125.69 19.07 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.108 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.406 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 41.9 m95 -91.76 125.12 36.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.541 1.137 . . . . 0.0 108.899 -172.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.96 -34.13 75.98 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.089 0.556 . . . . 0.0 109.983 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 72.7 mt -127.54 122.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.63 76.26 1.01 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -145.98 145.76 30.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 -172.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -74.97 115.54 14.7 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.493 0.717 . . . . 0.0 110.432 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.1 mt -107.84 114.56 28.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 45.7 mt-10 -91.83 127.33 37.25 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.082 0.553 . . . . 0.0 111.1 -171.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -101.57 134.5 44.6 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.342 0.657 . . . . 0.0 110.784 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -64.34 108.31 1.57 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.105 0.962 . . . . 0.0 111.655 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 185' ' ' ALA . 46.7 mt -92.87 167.87 11.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.583 0.753 . . . . 0.0 111.73 177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -149.83 41.69 0.85 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.0 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -33.3 66.49 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.902 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.87 47.39 83.44 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.284 0.365 . . . . 0.0 113.398 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -127.54 -69.91 0.72 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.193 0.597 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -167.12 -35.71 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 0.0 109.832 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -58.82 147.64 32.83 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.905 . . . . 0.0 111.66 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -58.44 156.27 10.63 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.739 0.816 . . . . 0.0 111.604 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.7 17.88 2.54 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.8 178.47 6.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 110.508 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -126.41 134.24 51.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.484 0.713 . . . . 0.0 109.795 -170.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -78.89 99.74 6.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.635 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.3 mt -127.61 160.68 30.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 16.3 pt -140.39 142.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -129.42 150.13 50.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.555 0.693 . . . . 0.0 111.147 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 40.7 mt -132.25 140.7 48.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.608 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 34.2 tp -134.03 104.16 6.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.94 136.54 14.07 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.34 155.58 44.48 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.462 0.705 . . . . 0.0 109.883 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -57.1 144.95 32.62 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.476 0.71 . . . . 0.0 110.36 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.59 138.26 54.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 57.22 72.23 0.53 Allowed 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -75.09 70.03 2.03 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 122.165 0.983 . . . . 0.0 108.665 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -164.5 131.68 3.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.977 1.711 . . . . 0.0 107.404 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -70.81 125.56 27.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -73.44 131.73 42.15 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 111.063 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -128.59 129.43 45.92 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 61.2 t60 . . . . . 0 C--O 1.25 1.118 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.285 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -136.21 43.95 2.47 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.307 1.051 . . . . 0.0 108.396 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -62.78 116.67 5.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.42 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.66 104.08 13.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.841 0.857 . . . . 0.0 110.217 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 53.63 0.79 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.388 0.675 . . . . 0.0 109.282 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -81.25 98.17 7.98 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.197 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -152.29 139.85 19.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -133.57 104.57 6.44 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.912 0.885 . . . . 0.0 108.712 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -92.09 98.33 11.48 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -166.64 125.87 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.934 0.493 . . . . 0.0 110.105 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -157.87 150.39 22.56 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.014 0.526 . . . . 0.0 110.883 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -167.05 122.4 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.051 0.94 . . . . 0.0 109.801 170.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -162.29 142.95 10.19 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.823 0.849 . . . . 0.0 109.029 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.27 173.23 32.83 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 123.439 0.462 . . . . 0.0 112.409 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -123.99 68.38 1.05 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.318 1.047 . . . . 0.0 109.164 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.71 126.46 92.2 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.502 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.98 121.17 8.77 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.182 2.588 . . . . 0.0 112.562 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.28 151.31 26.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.458 0.703 . . . . 0.0 110.517 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -168.07 175.66 6.52 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -52.42 -25.29 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.633 1.173 . . . . 0.0 111.169 165.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -57.69 -19.68 28.73 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.902 1.281 . . . . 0.0 112.838 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.73 -27.8 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 118.973 0.806 . . . . 0.0 108.897 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -72.32 -43.14 64.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.361 1.064 . . . . 0.0 110.615 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.6 m -68.84 -37.47 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.309 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -26.2 68.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.907 0.883 . . . . 0.0 112.63 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -70.34 -28.31 65.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.688 0.795 . . . . 0.0 109.572 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -84.75 -24.08 28.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.783 0.833 . . . . 0.0 111.393 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 33' ' ' ILE . 63.7 mt -72.85 131.42 84.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.263 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -64.72 144.33 83.56 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.817 2.345 . . . . 0.0 112.003 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -69.14 27.49 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' HA3' ' HG3' ' A' ' 96' ' ' GLU . . . -116.61 -140.95 6.94 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 119.065 0.848 . . . . 0.0 112.832 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 41.5 mtpt -83.63 118.48 23.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.378 0.671 . . . . 0.0 109.682 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.571 HD13 HG21 ' A' ' 28' ' ' ILE . 9.7 mt -115.43 131.92 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.409 HD22 ' NE1' ' A' ' 95' ' ' TRP . 33.0 tp -97.89 113.85 25.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.8 t -95.34 133.82 38.83 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.881 0.872 . . . . 0.0 108.68 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -101.53 159.06 15.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.566 0.346 . . . . 0.0 111.053 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.77 113.82 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 125.023 1.452 . . . . 0.0 113.061 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 -33.14 3.76 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.191 0.996 . . . . 0.0 111.235 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.47 -65.67 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -121.91 121.15 36.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.789 0.836 . . . . 0.0 108.889 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.8 -0.24 2.74 Favored Glycine 0 CA--C 1.548 2.133 0 N-CA-C 114.288 0.475 . . . . 0.0 114.288 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.667 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 51.1 mtp180 -56.43 -34.92 67.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.37 1.068 . . . . 0.0 111.787 168.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.66 -45.25 89.76 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.901 0.88 . . . . 0.0 110.293 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.7 75.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.331 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 42' ' ' ARG . 22.7 p -73.8 -19.78 60.66 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.363 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.61 -50.15 53.72 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.98 -30.55 69.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.399 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.05 0.54 . . . . 0.0 111.956 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.646 ' HA ' HG11 ' A' ' 76' ' ' VAL . 87.7 p -73.56 -3.85 30.39 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.836 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.02 12.08 3.6 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.758 0.823 . . . . 0.0 111.219 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.02 15.97 60.17 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 123.173 0.416 . . . . 0.0 113.932 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.86 157.93 20.8 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.788 0.835 . . . . 0.0 109.869 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 45.1 mt-10 -97.34 90.83 5.22 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 33' ' ' ILE . 61.9 t -94.84 110.97 24.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.596 0.712 . . . . 0.0 110.06 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -86.18 114.82 23.32 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.528 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.53 144.65 29.27 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 123.877 0.871 . . . . 0.0 111.268 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -119.89 117.25 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 165.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.64 148.17 51.51 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.229 0.922 . . . . 0.0 111.195 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -56.1 -34.18 65.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.129 1.772 . . . . 0.0 112.473 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.3 p -123.72 140.42 53.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.085 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -73.54 -15.75 61.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.086 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.2 m -63.84 -38.59 82.74 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -41.18 55.31 Favored Glycine 0 C--N 1.357 1.725 0 O-C-N 123.551 0.532 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.45 -41.67 98.91 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.518 0.727 . . . . 0.0 110.435 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.03 76.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.016 0.926 . . . . 0.0 112.532 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 75.0 mmtt -62.61 -39.37 93.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.603 0.361 . . . . 0.0 110.357 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -62.5 -51.34 67.81 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.593 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -71.21 -32.48 68.88 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.305 0.642 . . . . 0.0 111.849 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -58.41 -48.88 79.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.2 0.6 . . . . 0.0 110.703 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.8 tp -68.63 -25.88 65.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 123.269 0.355 . . . . 0.0 110.64 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.79 -59.29 5.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.023 0.529 . . . . 0.0 110.897 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -58.33 -48.33 80.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.81 0.844 . . . . 0.0 111.839 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 -41.96 88.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.82 0.848 . . . . 0.0 111.191 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -105.56 -12.06 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.137 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.31 44.39 22.45 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 121.907 -0.187 . . . . 0.0 113.509 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -124.55 160.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -104.77 126.4 51.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.674 0.79 . . . . 0.0 110.775 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.643 HG21 ' HB1' ' A' ' 67' ' ' ALA . 5.1 mm -117.84 164.89 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -133.98 108.04 8.15 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 p -94.5 125.92 39.45 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.942 0.497 . . . . 0.0 111.303 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.35 140.74 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.359 1.464 . . . . 0.0 107.882 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -82.98 144.17 30.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -62.8 102.9 0.38 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.714 0.806 . . . . 0.0 112.903 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -142.27 89.63 2.18 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.93 -8.39 51.89 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.39 0.676 . . . . 0.0 111.792 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.79 -16.64 50.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.901 0.881 . . . . 0.0 110.763 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.55 -38.42 4.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.416 0.687 . . . . 0.0 110.544 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -151.02 130.16 12.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.667 1.187 . . . . 0.0 107.91 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.98 -75.32 0.51 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 pt -143.27 119.45 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.026 0.93 . . . . 0.0 109.473 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.31 79.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 0.0 108.955 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -74.98 0.33 16.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.354 0.662 . . . . 0.0 112.089 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.79 -40.32 83.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 167.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.09 57.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.409 ' NE1' HD22 ' A' ' 34' ' ' LEU . 23.7 m95 -113.4 176.77 4.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.256 0.622 . . . . 0.0 111.211 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 52.2 mm-40 -90.18 -51.73 5.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.022 0.929 . . . . 0.0 109.883 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.88 178.56 21.12 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 121' ' ' LEU . 69.4 mt -131.59 145.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.85 0.86 . . . . 0.0 108.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 8.3 p -130.87 133.61 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 166.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 m -142.41 95.76 2.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' HD1' ' A' ' 102' ' ' PHE . 8.7 mm -74.3 153.78 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HD1' HG22 ' A' ' 101' ' ' ILE . 20.5 p90 -16.02 103.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.202 1.801 . . . . 0.0 115.004 -163.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.4 t -75.41 105.49 6.46 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.984 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -105.13 97.66 7.48 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -125.33 145.76 51.93 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.541 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -56.13 150.7 46.8 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.022 2.481 . . . . 0.0 110.666 163.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.3 t -48.53 -37.82 18.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.652 1.181 . . . . 0.0 112.006 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -53.57 -57.01 12.26 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.905 0.753 . . . . 0.0 111.113 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.71 -24.99 56.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.894 0.478 . . . . 0.0 110.636 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -75.44 -53.91 7.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.737 0.815 . . . . 0.0 110.637 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -60.41 -28.18 68.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.957 0.503 . . . . 0.0 111.723 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -75.74 -30.37 59.2 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 60.5 tp -74.56 -36.54 63.09 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.839 0.712 . . . . 0.0 111.888 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -54.87 -49.69 90.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.41 -24.92 70.96 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.05 1.833 . . . . 0.0 112.186 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.1 -29.59 61.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.011 0.524 . . . . 0.0 111.142 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' LEU . 5.0 t -85.75 -26.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.153 0.581 . . . . 0.0 110.064 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -69.95 -61.69 1.68 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.41 -49.74 38.85 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.92 -18.11 51.88 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 115.122 0.809 . . . . 0.0 115.122 -163.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 98' ' ' ILE . 13.3 tp -76.52 102.41 6.04 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.661 0.73 . . . . 0.0 109.076 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -75.86 145.44 77.91 Favored Pre-proline 0 C--O 1.247 0.951 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -44.19 111.93 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.059 2.506 . . . . 0.0 113.242 174.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.24 11.64 5.6 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.105 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.09 140.61 15.15 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 19.3 m -109.84 129.47 64.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -110.2 108.8 19.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -116.13 113.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.901 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 102' ' ' PHE . 3.6 mp -130.06 147.42 51.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.041 0.448 . . . . 0.0 111.13 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.94 98.47 6.5 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 165.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.85 -179.79 52.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.721 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.6 m-85 -137.9 158.4 44.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.429 -173.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.39 169.14 8.12 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.642 0.777 . . . . 0.0 110.45 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.624 ' HA ' HD22 ' A' ' 147' ' ' LEU . 36.9 Cg_exo -41.63 -26.16 0.38 Allowed 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 124.628 3.552 . . . . 0.0 115.972 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.48 -19.26 62.95 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.559 0.744 . . . . 0.0 112.839 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -67.68 -53.44 27.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.093 0.406 . . . . 0.0 111.832 -165.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.434 HD12 ' HG ' ' A' ' 147' ' ' LEU . 7.7 mt -82.87 -16.86 45.93 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.348 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.75 -45.41 86.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.576 0.751 . . . . 0.0 109.228 170.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.38 -26.28 60.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.8 t30 61.87 39.52 13.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.098 1.359 . . . . 0.0 110.11 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -96.17 37.13 1.26 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.072 0.949 . . . . 0.0 110.183 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 144.5 9.72 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA3' HD22 ' A' ' 137' ' ' LEU . . . 169.33 145.43 4.63 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.724 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HB2' HD12 ' A' ' 149' ' ' LEU . 16.3 Cg_exo -70.22 -59.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.219 2.612 . . . . 0.0 112.389 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -158.14 -32.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.695 0.398 . . . . 0.0 111.625 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -158.37 153.61 25.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 1.4 mt -57.09 -13.47 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.865 1.666 . . . . 0.0 113.567 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.24 -38.24 85.93 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.078 172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 144' ' ' PRO . 56.0 mt -90.25 13.79 14.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.41 0.684 . . . . 0.0 112.306 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 53.1 mt -78.99 112.58 28.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 166.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HB2' HD11 ' A' ' 156' ' ' LEU . 60.4 Cg_endo -71.71 93.63 0.69 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.26 1.973 . . . . 0.0 111.274 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.573 ' HA ' HD11 ' A' ' 188' ' ' ILE . 42.9 mtmt -96.78 156.06 16.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.608 -166.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 188' ' ' ILE . 35.3 mt -61.69 -49.85 74.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.345 0.658 . . . . 0.0 110.333 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.19 -40.33 73.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.887 0.742 . . . . 0.0 110.977 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.1 m -65.65 -64.27 0.9 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.696 174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 151' ' ' PRO . 83.5 mt -72.58 -45.16 60.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.704 0.802 . . . . 0.0 112.481 -164.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 64.0 tt0 -57.84 -42.02 83.55 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.04 0.536 . . . . 0.0 111.877 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -76.83 -26.23 54.11 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -84.66 -12.76 53.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.929 0.892 . . . . 0.0 111.25 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 70.0 mt -134.57 71.6 70.88 Favored Pre-proline 0 N--CA 1.475 0.792 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.56 -3.31 13.21 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.198 2.599 . . . . 0.0 111.002 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.5 t -83.86 -42.26 16.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.677 1.191 . . . . 0.0 107.912 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.6 tp -95.11 71.76 3.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.863 1.265 . . . . 0.0 110.487 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.31 127.86 32.96 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.58 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 36.8 m95 -91.5 137.83 32.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 0.0 109.226 -167.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.81 -32.24 63.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.761 0.424 . . . . 0.0 110.83 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 83.0 mt -132.81 128.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.87 77.63 0.96 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.91 1.284 . . . . 0.0 107.771 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.36 133.42 36.77 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 -169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.69 113.5 18.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.343 0.657 . . . . 0.0 110.773 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.3 mt -108.39 135.67 49.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.605 0.762 . . . . 0.0 109.981 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.92 123.6 36.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.524 ' HB3' ' HB3' ' A' ' 185' ' ' ALA . 37.5 ttt180 -98.64 122.7 42.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -85.53 98.01 10.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.4 144.6 49.74 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.485 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.86 153.44 41.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 164.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 66.38 77.78 0.28 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.897 0.879 . . . . 0.0 109.585 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.23 78.53 0.04 OUTLIER Glycine 0 C--N 1.344 0.972 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.738 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 105.8 4.12 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.353 0.661 . . . . 0.0 110.44 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 51.3 t80 73.25 -78.5 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.161 1.384 . . . . 0.0 110.769 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.21 124.5 25.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.902 0.881 . . . . 0.0 111.05 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 59.26 18.8 6.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.673 1.589 . . . . 0.0 112.768 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -99.39 15.54 60.0 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -97.37 163.29 12.95 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.95 0.9 . . . . 0.0 111.218 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . . . -131.06 130.39 43.17 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.436 ' HB2' ' HE2' ' A' ' 184' ' ' LYS . . . -89.77 104.29 16.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.89 163.67 19.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.632 0.773 . . . . 0.0 109.122 -169.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 152' ' ' LYS . 7.6 pt -143.82 125.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -97.72 141.55 30.6 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.941 -0.475 . . . . 0.0 111.061 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 37.6 mt -127.57 130.13 48.54 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.387 1.475 . . . . 0.0 108.997 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.419 HD22 HG12 ' A' ' 24' ' ' VAL . 29.9 tp -125.64 105.08 8.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -93.23 131.35 10.73 Favored Glycine 0 C--O 1.212 -1.221 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 173.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -141.51 156.55 45.72 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 108.859 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -54.49 153.86 5.26 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.975 0.91 . . . . 0.0 110.957 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.96 165.97 16.71 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.78 0.432 . . . . 0.0 110.22 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -167.57 115.86 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -64.92 88.93 0.07 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.084 0.945 . . . . 0.0 108.507 170.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -123.41 145.01 49.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.048 -167.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -73.93 74.11 1.65 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.626 . . . . 0.0 109.407 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -78.65 152.15 31.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.556 -171.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -68.56 138.3 55.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.661 -173.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--O 1.255 1.392 0 C-N-CA 124.03 0.932 . . . . 0.0 108.523 173.22 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -87.53 76.16 9.01 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.179 0.591 . . . . 0.0 109.516 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -149.34 101.71 3.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.638 0.775 . . . . 0.0 109.691 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -94.58 96.34 9.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.451 0.701 . . . . 0.0 109.528 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 97.22 8.99 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -125.22 98.37 5.62 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -144.62 80.69 1.64 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.517 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -86.16 125.77 33.75 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.858 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.4 p -62.25 123.49 18.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.962 0.905 . . . . 0.0 110.96 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 21.8 13.28 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.786 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 1.4 p90 -52.02 145.26 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.136 1.374 . . . . 0.0 112.296 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.89 134.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.874 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.15 101.26 7.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.281 0.632 . . . . 0.0 110.02 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.99 74.8 1.58 Allowed Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.846 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -139.55 153.17 47.38 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.095 0.958 . . . . 0.0 108.971 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -158.58 108.12 1.64 Allowed Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 119.105 -0.474 . . . . 0.0 109.747 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.29 161.84 32.67 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.879 2.386 . . . . 0.0 112.357 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -132.62 -8.08 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.727 0.811 . . . . 0.0 111.74 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -106.3 -156.92 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.405 0.682 . . . . 0.0 109.47 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.44 -25.09 67.78 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 118.564 0.62 . . . . 0.0 111.747 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 25' ' ' ALA . 14.1 tp -60.2 -22.52 63.07 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.77 0.828 . . . . 0.0 112.286 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 m -40.48 -56.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 124.489 1.116 . . . . 0.0 113.853 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 p -74.93 -50.62 16.18 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 110.681 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.2 m -66.93 -41.4 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.364 -171.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -60.9 -37.26 81.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.918 0.887 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -68.63 -26.78 65.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 12.7 mm100 -92.86 -13.26 29.25 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 24' ' ' VAL . 73.7 mt -77.68 134.43 65.34 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.237 0.615 . . . . 0.0 110.87 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.77 132.38 47.55 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.326 2.684 . . . . 0.0 111.894 171.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -74.23 29.51 0.08 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.88 -145.68 9.54 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 12.3 mmmm -85.63 118.7 25.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -170.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mt -114.15 134.29 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.8 0.84 . . . . 0.0 110.04 -165.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.511 HD22 ' NE1' ' A' ' 95' ' ' TRP . 50.8 tp -106.92 127.01 53.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.243 0.617 . . . . 0.0 110.607 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 36.1 m -98.89 137.47 37.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.578 0.751 . . . . 0.0 110.16 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 89' ' ' ASP . 15.7 mt -114.58 116.05 28.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.181 0.593 . . . . 0.0 110.928 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . 46.98 78.65 0.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 125.38 1.675 . . . . 0.0 113.657 165.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.3 -77.06 0.26 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.41 -68.39 0.26 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.24 -36.05 4.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.126 0.97 . . . . 0.0 109.759 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 44.79 7.57 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.355 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -69.37 -35.45 75.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.481 0.658 . . . . 0.0 109.469 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -80.8 -31.51 35.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.813 1.245 . . . . 0.0 110.426 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.24 82.73 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.936 0.772 . . . . 0.0 109.682 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 55.9 m -58.62 -43.18 89.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.462 171.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.4 -31.55 68.81 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.4 0.437 . . . . 0.0 111.096 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.14 -37.02 85.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.953 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.24 73.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.767 0.427 . . . . 0.0 111.227 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 11.7 m -65.99 -15.77 63.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.951 0.9 . . . . 0.0 112.155 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.79 8.72 5.0 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.039 0.535 . . . . 0.0 110.767 172.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.09 8.66 61.4 Favored Glycine 0 C--N 1.362 1.996 0 CA-C-O 119.69 -0.506 . . . . 0.0 114.326 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -105.65 152.37 23.21 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.428 0.614 . . . . 0.0 110.129 -172.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 35.5 mt-10 -94.89 90.8 6.14 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.2 t -88.86 118.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.354 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.1 p -86.04 113.0 21.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -112.3 122.35 47.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.862 0.465 . . . . 0.0 111.196 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.6 t -99.25 144.19 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 163.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t70 -124.77 178.19 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -87.24 -27.02 23.2 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.719 0.808 . . . . 0.0 109.851 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.4 m -119.43 135.97 54.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.954 -1.476 . . . . 0.0 110.559 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -68.64 -22.51 64.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.153 0.981 . . . . 0.0 110.689 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 60' ' ' SER . 17.7 m -64.84 -34.37 69.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.62 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -36.43 73.68 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.24 -43.13 78.59 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.016 0.927 . . . . 0.0 110.835 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -66.75 -37.06 83.89 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.299 0.239 . . . . 0.0 110.813 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -59.83 -48.49 81.47 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.877 0.736 . . . . 0.0 110.631 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.45 -44.8 74.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.006 0.922 . . . . 0.0 111.237 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.95 -50.87 71.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.337 1.055 . . . . 0.0 111.507 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 15.0 tp -69.61 -23.74 63.56 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.991 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -68.26 -51.27 46.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.728 173.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.17 -36.11 80.85 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.702 0.801 . . . . 0.0 111.191 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -59.07 -54.55 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.995 0.809 . . . . 0.0 110.511 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -85.18 -6.43 59.28 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.15 -169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.17 39.18 58.51 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 120.877 0.154 . . . . 0.0 112.892 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -127.66 167.41 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.568 1.147 . . . . 0.0 109.279 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -115.78 135.4 54.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.457 0.703 . . . . 0.0 112.265 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.7 mm -111.41 168.48 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 163.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 60.9 m -132.95 105.59 7.18 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 163.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.4 p -88.27 121.17 30.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.267 0.627 . . . . 0.0 110.119 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.683 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.6 t -103.13 137.52 31.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -77.32 135.52 38.4 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.93 0.395 . . . . 0.0 110.321 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -43.63 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.909 1.684 . . . . 0.0 112.233 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -145.32 97.47 3.0 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 84.3 mt -102.1 -8.59 21.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.024 0.53 . . . . 0.0 111.193 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -17.31 43.57 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.305 0.642 . . . . 0.0 112.093 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -137.34 -3.2 1.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.711 0.404 . . . . 0.0 112.046 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 87.3 t80 -156.49 143.87 19.08 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' O ' HD21 ' A' ' 36' ' ' LEU . 7.5 p-10 -150.79 -70.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 36' ' ' LEU . 13.5 pt -142.68 125.55 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.404 0.682 . . . . 0.0 109.538 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 t -130.56 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -72.51 0.23 10.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.248 0.619 . . . . 0.0 112.374 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.85 -34.09 77.15 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.444 0.697 . . . . 0.0 109.235 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.61 -18.81 22.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.316 1.046 . . . . 0.0 112.452 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.511 ' NE1' HD22 ' A' ' 34' ' ' LEU . 24.3 m95 -118.69 134.51 55.07 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.821 0.448 . . . . 0.0 110.856 -171.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -73.58 -28.56 61.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.451 0.7 . . . . 0.0 111.137 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.09 163.67 28.64 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.668 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 92' ' ' ALA . 75.5 mt -133.9 155.59 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.22 142.89 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.533 1.133 . . . . 0.0 109.225 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -143.62 103.99 4.15 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 128' ' ' ILE . 17.7 mm -75.31 145.72 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -16.16 102.83 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.843 2.057 . . . . 0.0 113.891 -171.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 24.4 p -119.77 149.76 41.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.879 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -145.16 101.58 3.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.016 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.24 147.37 33.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.347 0.659 . . . . 0.0 111.114 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.19 162.15 37.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.965 2.443 . . . . 0.0 110.767 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.2 t -39.12 -39.42 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.094 1.758 . . . . 0.0 114.274 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -64.01 -53.17 54.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.026 0.53 . . . . 0.0 111.591 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.9 -22.16 31.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.222 0.609 . . . . 0.0 110.714 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.421 HH22 ' HB3' ' A' ' 151' ' ' PRO . 75.2 ttt180 -77.88 -55.3 5.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 0.0 109.827 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -60.88 -22.12 63.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.035 0.534 . . . . 0.0 112.289 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.64 -33.84 53.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.7 tp -77.88 -52.7 8.45 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.613 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -56.15 -51.96 76.62 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -168.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.28 -23.35 62.13 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 121.807 1.681 . . . . 0.0 112.109 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -86.99 -25.5 24.24 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.262 1.025 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 10.9 t -80.9 -37.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.363 -0.836 . . . . 0.0 109.403 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.36 -62.12 2.12 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -74.63 -36.64 62.9 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.36 -34.1 7.25 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -166.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 40.2 tp -69.42 104.32 2.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.593 0.697 . . . . 0.0 109.954 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.07 141.19 88.91 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 164.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.47 125.5 12.46 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.753 2.302 . . . . 0.0 112.326 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 129.31 -2.51 6.2 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.711 -177.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -95.03 139.68 14.63 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 165.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.6 m -108.53 129.76 62.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 123.302 0.641 . . . . 0.0 109.555 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 110.97 22.71 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 101' ' ' ILE . 77.4 mt -106.77 106.77 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 85.7 mt -129.23 153.68 47.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.16 0.984 . . . . 0.0 110.193 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.08 106.73 4.86 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.91 134.67 23.77 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.669 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.7 m-85 -89.61 160.04 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.004 0.522 . . . . 0.0 110.95 -172.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.94 152.39 94.99 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.064 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.611 ' HA ' HD22 ' A' ' 147' ' ' LEU . 30.7 Cg_endo -64.1 -17.36 59.49 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 C-N-CA 121.814 1.676 . . . . 0.0 111.122 162.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -73.83 -25.19 59.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.321 1.048 . . . . 0.0 111.287 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -64.06 -61.61 2.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.729 0.412 . . . . 0.0 111.799 -165.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.6 mt -79.21 -16.43 56.55 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -60.43 -35.25 75.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.183 0.993 . . . . 0.0 110.492 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -74.25 15.6 0.31 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.922 0.889 . . . . 0.0 112.846 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 65.74 35.77 6.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.402 1.081 . . . . 0.0 111.245 172.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.1 p -80.39 -24.45 39.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.649 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.18 64.39 3.28 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.772 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.2 -159.85 1.05 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HB2' HD12 ' A' ' 149' ' ' LEU . 25.7 Cg_endo -58.17 -25.48 71.85 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.75 2.966 . . . . 0.0 114.254 -170.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -173.13 -48.35 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.468 0.707 . . . . 0.0 109.187 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.55 157.87 2.15 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.403 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.5 mt -58.63 -9.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.923 1.289 . . . . 0.0 113.228 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.38 -40.02 92.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.765 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 144' ' ' PRO . 17.3 mt -80.91 17.76 1.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 132' ' ' PHE . 25.6 mt -99.71 103.26 20.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HB3' HH22 ' A' ' 110' ' ' ARG . 89.7 Cg_endo -81.22 129.33 6.72 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.611 2.208 . . . . 0.0 112.417 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -92.54 165.58 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.013 0.925 . . . . 0.0 112.173 -177.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 188' ' ' ILE . 75.6 mt -56.81 -40.48 76.05 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.942 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.9 -43.57 59.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 0.0 111.037 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 32.5 m -78.41 -54.57 6.04 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.128 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.4 HD13 HD13 ' A' ' 129' ' ' LEU . 85.9 mt -72.03 -46.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.051 0.94 . . . . 0.0 112.577 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -60.31 -44.05 95.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.657 0.783 . . . . 0.0 109.784 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.9 t -72.3 -21.41 61.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.819 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -76.9 -23.52 52.55 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.247 0.619 . . . . 0.0 110.542 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 76.3 mt -130.3 75.21 79.51 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.38 -19.48 17.03 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.196 2.598 . . . . 0.0 113.355 -172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -87.87 -42.09 12.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 28.8 tp -69.03 71.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.549 172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.03 131.29 45.87 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -91.29 135.62 33.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.591 1.156 . . . . 0.0 109.317 -169.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.479 HD11 ' HG2' ' A' ' 193' ' ' GLN . 79.1 mt -72.39 -30.01 64.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.064 0.546 . . . . 0.0 110.13 171.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.9 mt -131.04 120.85 48.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 73.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -143.77 152.31 41.09 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.13 0.491 . . . . 0.0 111.982 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -77.94 105.08 8.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.924 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.21 123.75 50.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.549 0.74 . . . . 0.0 109.595 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -86.34 122.7 30.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -98.04 125.06 42.83 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.52 98.31 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.6 mt -50.53 120.26 4.5 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.131 1.372 . . . . 0.0 110.556 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 108.95 1.9 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.737 0.648 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.19 -55.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.668 0.787 . . . . 0.0 109.202 -173.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.76 52.54 14.77 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.892 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -168.9 1.7 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.085 0.954 . . . . 0.0 111.338 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.62 0.724 . . . . 0.0 109.543 174.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -87.64 159.08 18.69 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.477 169.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.35 -25.43 67.15 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.632 0.373 . . . . 0.0 111.926 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.33 70.83 0.99 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 124.251 0.97 . . . . 0.0 111.48 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -111.88 176.05 5.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.954 0.902 . . . . 0.0 110.794 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -157.59 132.67 8.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.647 0.779 . . . . 0.0 109.006 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.67 108.82 16.33 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 77.0 mt -117.67 167.66 11.14 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.531 ' HB ' HD21 ' A' ' 153' ' ' LEU . 8.2 pt -142.68 118.62 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.32 145.18 28.45 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 38.3 mt -131.47 131.18 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.889 1.276 . . . . 0.0 109.723 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.09 106.13 6.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.03 139.46 16.95 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.553 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 7.9 tp-100 -136.11 157.54 46.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.445 ' HB2' ' N ' ' A' ' 124' ' ' GLY . 59.6 tttp -56.02 120.13 6.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.961 165.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.56 135.33 54.96 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -150.48 166.0 31.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.02 -8.03 45.8 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.134 0.574 . . . . 0.0 111.854 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -67.99 101.12 1.06 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -85.98 141.87 29.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.325 0.65 . . . . 0.0 109.638 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -83.51 -49.39 9.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -146.95 -167.57 2.81 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.715 1.206 . . . . 0.0 109.636 174.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 62.0 t60 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 124.984 1.314 . . . . 0.0 110.057 178.168 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -162.92 141.29 8.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.755 0.822 . . . . 0.0 109.279 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.28 122.35 33.11 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.745 0.818 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -65.71 101.21 0.6 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -77.38 95.91 4.53 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.733 0.778 . . . . 0.0 111.116 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -61.77 -21.7 64.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.07 0.948 . . . . 0.0 112.309 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -66.53 100.7 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -158.48 151.51 22.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 m -70.09 92.66 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.126 0.57 . . . . 0.0 111.108 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -69.67 -15.46 63.18 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.538 0.735 . . . . 0.0 110.553 172.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -54.59 -19.61 6.32 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.168 1.387 . . . . 0.0 113.199 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.28 97.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -66.4 -59.36 3.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.357 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.46 74.49 0.49 Allowed Glycine 0 C--N 1.35 1.358 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -166.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -42.54 110.95 0.2 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.518 1.527 . . . . 0.0 112.999 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.8 99.41 5.7 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.601 1.16 . . . . 0.0 109.059 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.573 ' HD2' ' HE2' ' A' ' 46' ' ' PHE . 77.5 Cg_endo -78.9 -179.26 5.3 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.992 2.461 . . . . 0.0 113.477 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -80.8 65.67 6.03 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.033 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -88.77 153.71 20.86 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -58.58 -30.68 67.36 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.954 0.502 . . . . 0.0 110.934 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' HG ' ' A' ' 47' ' ' LEU . 20.1 tp -61.81 -33.31 73.89 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.566 1.146 . . . . 0.0 113.077 -174.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -45.9 -40.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -75.87 -46.65 29.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.749 . . . . 0.0 109.85 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -63.23 -35.59 72.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.549 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.9 81.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.397 1.079 . . . . 0.0 111.781 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.87 -29.01 70.43 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.448 172.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.604 ' HB3' HE22 ' A' ' 193' ' ' GLN . 27.1 mm-40 -89.75 -21.37 22.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.451 1.1 . . . . 0.0 112.557 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 24' ' ' VAL . 77.1 mt -79.08 136.13 57.82 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-O 119.301 -0.38 . . . . 0.0 110.307 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.35 133.96 20.09 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 123.776 2.984 . . . . 0.0 113.537 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.18 27.99 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.16 -139.26 6.15 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 118.716 0.689 . . . . 0.0 112.619 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 40.9 ttmt -86.55 114.89 23.66 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 28' ' ' ILE . 11.9 mt -110.64 126.83 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 90' ' ' ILE . 54.2 tp -89.97 114.05 25.82 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 m -88.9 135.22 33.65 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.14 152.29 20.03 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.725 0.41 . . . . 0.0 110.186 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . -30.84 104.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 125.671 1.857 . . . . 0.0 114.219 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 7.3 pt-20 -103.75 -157.15 0.6 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.975 0.91 . . . . 0.0 109.659 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.21 -65.1 2.16 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.541 -0.299 . . . . 0.0 112.721 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 -19.7 10.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -162.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 21.11 59.37 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -72.32 -52.25 17.04 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.421 1.088 . . . . 0.0 110.249 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 101' ' ' ILE . 40.2 m-80 -76.07 -29.19 57.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.649 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.43 -57.84 11.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.67 0.788 . . . . 0.0 111.189 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.782 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 25.5 p -69.57 -26.98 64.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.362 0.665 . . . . 0.0 112.341 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 21' ' ' LEU . 38.2 t80 -60.14 -45.55 92.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.454 0.702 . . . . 0.0 109.465 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.681 ' HG ' HD21 ' A' ' 21' ' ' LEU . 68.9 mt -65.45 -32.63 74.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.863 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.56 74.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.394 0.278 . . . . 0.0 111.515 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.594 ' HA ' HG11 ' A' ' 76' ' ' VAL . 81.3 p -71.62 -6.6 42.14 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 123.245 0.34 . . . . 0.0 111.214 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' LEU . 50.0 mt -90.04 11.97 19.08 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.727 0.811 . . . . 0.0 111.124 168.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.63 21.31 66.75 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.549 0.58 . . . . 0.0 114.549 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.59 141.2 36.84 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.943 0.872 . . . . 0.0 110.917 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 45.6 mt-10 -77.47 88.53 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -90.63 107.31 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.592 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 34' ' ' LEU . 5.5 t -85.22 103.64 14.36 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.71 131.93 45.38 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.623 -169.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 81' ' ' VAL . 38.5 t -110.61 134.33 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 20.5 t70 -145.85 140.58 27.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 pt20 -68.52 -20.78 64.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.591 0.756 . . . . 0.0 111.661 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 m -112.9 141.49 46.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.959 0.904 . . . . 0.0 109.406 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.9 p -72.13 -15.95 61.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.646 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.38 -32.97 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.824 0.449 . . . . 0.0 111.113 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.17 -36.72 23.63 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.621 0.575 . . . . 0.0 113.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.72 -52.03 14.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.625 0.77 . . . . 0.0 111.25 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.38 -36.71 69.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.683 0.793 . . . . 0.0 112.302 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -64.3 -45.83 86.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.106 0.562 . . . . 0.0 110.572 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.782 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -58.69 -47.91 82.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 124.03 0.831 . . . . 0.0 110.59 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.82 -31.83 71.1 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.504 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -63.55 -51.93 63.3 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.365 0.666 . . . . 0.0 112.474 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 27.8 tp -67.97 -23.27 65.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.314 0.384 . . . . 0.0 110.49 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' A' ' 76' ' ' VAL . . . -61.45 -57.74 10.99 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 122.874 0.47 . . . . 0.0 110.187 172.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.21 -30.55 71.03 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.887 0.875 . . . . 0.0 112.247 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.02 -53.42 26.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.121 0.569 . . . . 0.0 111.257 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -98.04 1.72 48.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.616 0.367 . . . . 0.0 111.437 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.56 43.2 69.65 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 122.321 -0.237 . . . . 0.0 113.484 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 49' ' ' SER . 27.7 m -118.55 169.85 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.579 1.152 . . . . 0.0 109.478 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -112.15 128.7 56.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.891 0.476 . . . . 0.0 111.983 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.8 163.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.637 1.575 . . . . 0.0 107.573 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.5 m -136.53 105.18 5.81 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.0 p -87.34 121.44 29.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.287 -168.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 57' ' ' VAL . 47.5 t -114.59 135.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.261 1.425 . . . . 0.0 108.834 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.11 130.64 35.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 59' ' ' GLN . 32.5 t -69.21 118.04 11.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.891 0.476 . . . . 0.0 111.961 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -142.99 86.79 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 167.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.1 mt -78.19 -20.93 50.91 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.13 -13.46 61.19 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 112.187 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.57 -29.39 4.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.285 0.634 . . . . 0.0 111.518 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -159.03 125.41 4.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.524 1.13 . . . . 0.0 108.313 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -70.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.519 HG22 HD23 ' A' ' 34' ' ' LEU . 7.3 pt -140.2 119.22 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.134 0.974 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -130.8 98.33 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.91 0.884 . . . . 0.0 108.722 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.29 -9.53 5.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.85 -52.83 21.58 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.196 0.598 . . . . 0.0 110.812 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.62 -29.34 66.82 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -169.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CZ3' HG12 ' A' ' 98' ' ' ILE . 11.1 p-90 -133.62 176.28 8.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.673 0.789 . . . . 0.0 110.938 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.15 -90.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.301 0.64 . . . . 0.0 111.229 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.87 172.13 41.89 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 118.448 0.567 . . . . 0.0 113.509 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 121' ' ' LEU . 5.9 mt -123.09 150.86 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.55 0.74 . . . . 0.0 109.025 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.408 HG12 HG22 ' A' ' 33' ' ' ILE . 14.1 p -144.46 134.53 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 163.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -133.02 99.2 4.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 30.4 mm -74.88 154.75 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.258 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -18.42 104.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.067 2.147 . . . . 0.0 113.592 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.05 148.96 44.06 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.63 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.419 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 6.3 p-80 -147.16 101.64 3.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.09 143.29 26.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.544 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.2 158.57 47.68 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.652 2.234 . . . . 0.0 110.732 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 t -45.59 -36.41 4.69 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.38 1.472 . . . . 0.0 113.737 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 p -56.28 -58.81 6.37 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.355 1.062 . . . . 0.0 111.997 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.25 -19.09 37.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.859 0.864 . . . . 0.0 111.07 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -77.94 -47.25 19.06 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.647 0.779 . . . . 0.0 109.438 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -52.79 -34.49 53.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.903 0.881 . . . . 0.0 111.783 164.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -75.67 -44.27 43.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 117' ' ' VAL . 49.2 tp -92.19 -55.56 3.38 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.67 -40.02 6.24 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 119.623 1.101 . . . . 0.0 112.479 -161.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.37 -28.92 87.71 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 122.281 1.987 . . . . 0.0 112.044 166.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 5.5 tppp? -77.42 -24.77 50.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.396 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 113' ' ' LEU . 41.6 t -72.13 -34.18 49.23 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.364 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -53.93 -62.39 1.69 Allowed 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.69 -33.66 35.24 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.22 57.28 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 98' ' ' ILE . 26.8 tp -60.7 128.37 36.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.882 0.473 . . . . 0.0 110.604 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 148.56 34.68 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.74 113.28 1.76 Allowed 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.74 1.626 . . . . 0.0 111.201 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 128.31 6.15 4.88 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.017 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -101.53 143.59 16.14 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 164.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.2 m -110.78 130.67 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.566 0.746 . . . . 0.0 109.16 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CE2' HD11 ' A' ' 129' ' ' LEU . 8.8 t80 -106.61 112.55 25.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 24' ' ' VAL . 55.6 mt -115.43 109.01 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.995 0.918 . . . . 0.0 110.25 -168.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 127' ' ' PHE . 89.0 mt -128.96 133.91 47.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.354 0.662 . . . . 0.0 110.073 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -113.09 98.84 7.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.522 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -88.92 -174.49 46.78 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.721 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.408 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.6 m-85 -138.56 159.54 41.84 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.08 0.952 . . . . 0.0 108.565 -177.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.28 162.96 22.95 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.743 0.817 . . . . 0.0 110.454 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -59.45 -12.77 18.08 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.22 2.614 . . . . 0.0 114.347 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.21 -11.86 59.88 Favored 'General case' 0 CA--C 1.563 1.452 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.46 -57.71 4.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.368 0.667 . . . . 0.0 112.459 -167.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.472 HD22 ' H ' ' A' ' 143' ' ' GLY . 12.4 mt -75.42 -13.45 60.39 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -69.15 -23.98 64.02 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.657 0.783 . . . . 0.0 110.336 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -80.27 9.9 5.18 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.749 0.82 . . . . 0.0 112.722 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 64.98 33.99 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -77.55 -27.56 51.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.917 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.32 58.97 7.82 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.614 0.571 . . . . 0.0 112.075 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.472 ' H ' HD22 ' A' ' 137' ' ' LEU . . . -63.9 -170.46 1.83 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 114.521 0.568 . . . . 0.0 114.521 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.05 -36.83 77.81 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.876 3.05 . . . . 0.0 114.453 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -163.53 -54.47 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.364 0.666 . . . . 0.0 109.384 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -160.37 156.66 26.56 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.964 -167.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.661 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -58.17 -8.54 1.12 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.141 1.377 . . . . 0.0 113.536 179.097 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.35 -35.11 79.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.049 0.94 . . . . 0.0 110.707 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.9 mt -88.58 13.37 12.27 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.078 0.951 . . . . 0.0 112.053 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.661 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 36.4 mt -89.75 103.85 7.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -67.74 103.58 0.86 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.079 2.52 . . . . 0.0 111.729 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 188' ' ' ILE . 16.4 ptpt -100.43 152.4 20.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.284 0.493 . . . . 0.0 112.185 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.3 -38.05 87.9 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.79 0.836 . . . . 0.0 110.881 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -48.23 -52.63 20.21 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.267 1.027 . . . . 0.0 111.143 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.0 p -76.41 -61.91 1.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.201 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.69 -46.84 86.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.307 1.043 . . . . 0.0 112.787 -166.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -64.87 -33.27 75.61 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 123.229 0.33 . . . . 0.0 111.185 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.2 t -78.61 -23.32 45.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.568 0.347 . . . . 0.0 111.098 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -86.72 -12.3 48.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.684 0.794 . . . . 0.0 111.251 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.89 64.53 42.47 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.684 0.794 . . . . 0.0 109.156 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.13 4.34 7.15 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.814 2.343 . . . . 0.0 111.786 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 t -87.52 -34.58 18.57 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.498 HD13 HD21 ' A' ' 121' ' ' LEU . 25.7 tp -97.97 73.6 2.26 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 125.973 1.709 . . . . 0.0 110.878 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -57.36 124.28 18.35 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 12.4 m95 -89.33 139.77 30.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.591 1.156 . . . . 0.0 109.561 -170.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.658 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 96.3 mt -68.09 -44.98 75.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 169.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 79.0 mt -126.4 120.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.37 78.2 1.27 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -143.62 152.57 41.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.004 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -87.05 120.42 28.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.87 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.05 106.36 17.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -85.88 123.51 31.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.878 0.871 . . . . 0.0 109.558 -173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -96.13 130.26 43.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.673 1.189 . . . . 0.0 110.486 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -81.0 106.41 12.97 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.76 160.15 22.36 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.0 125.44 44.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.73 177.24 11.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.362 0.665 . . . . 0.0 109.852 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.07 59.17 0.55 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -149.91 -170.57 3.68 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 109.941 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -92.78 9.81 33.54 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.35 0.66 . . . . 0.0 110.892 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.25 148.95 39.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.154 0.982 . . . . 0.0 110.071 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -63.01 94.85 0.07 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.8 34.77 2.94 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.887 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -109.64 -177.31 3.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.238 1.015 . . . . 0.0 109.155 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -147.82 131.12 16.54 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.25 111.54 22.37 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.5 mt -122.33 151.7 40.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 152' ' ' LYS . 9.2 pt -139.19 142.84 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -124.94 145.29 49.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.591 0.71 . . . . 0.0 110.5 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.56 135.74 48.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.013 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 24' ' ' VAL . 16.6 tp -140.24 105.12 4.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.67 133.2 11.63 Favored Glycine 0 C--O 1.219 -0.783 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.658 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 7.8 tp60 -120.18 146.44 46.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.566 0.683 . . . . 0.0 111.35 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.566 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -62.12 138.17 58.36 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.581 0.551 . . . . 0.0 109.559 168.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.1 mt -72.99 146.24 46.12 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.81 -3.49 6.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.607 0.763 . . . . 0.0 112.152 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -51.22 -36.77 43.29 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.946 1.299 . . . . 0.0 111.028 165.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -93.35 133.69 36.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.44 0.696 . . . . 0.0 110.085 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -69.23 147.07 51.77 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.753 0.658 . . . . 0.0 110.478 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -84.08 -49.76 8.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.9 t60 58.35 78.22 0.26 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.274 1.43 . . . . 0.0 110.219 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 CA--C 1.549 0.913 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 179.21 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.925 0.393 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -93.5 154.22 18.02 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.547 0.739 . . . . 0.0 109.92 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -94.53 147.17 23.55 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.184 0.594 . . . . 0.0 110.758 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.13 118.37 29.61 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.759 0.824 . . . . 0.0 109.395 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -68.12 106.77 2.5 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.607 0.763 . . . . 0.0 109.759 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.55 117.93 19.47 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.4 t -67.08 152.95 44.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.992 0.917 . . . . 0.0 110.586 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -114.19 142.61 46.03 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.1 t -150.65 85.77 1.38 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.024 0.53 . . . . 0.0 109.745 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.21 95.55 4.73 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.659 0.783 . . . . 0.0 109.197 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -80.43 67.71 6.37 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.13 113.21 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -163.86 89.7 0.58 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.89 78.1 0.36 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -139.53 105.1 5.1 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.267 0.627 . . . . 0.0 110.43 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -151.81 71.91 8.02 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.933 0.893 . . . . 0.0 109.021 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' O ' HG21 ' A' ' 22' ' ' VAL . 1.6 Cg_endo -84.24 161.17 13.27 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.009 2.473 . . . . 0.0 110.616 172.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.84 78.61 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.728 0.775 . . . . 0.0 109.535 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.682 ' HB2' HG13 ' A' ' 22' ' ' VAL . 12.2 m-20 -124.63 163.17 22.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.188 0.995 . . . . 0.0 109.789 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.15 -34.54 78.28 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 tp -68.46 -21.39 64.63 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.383 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' ' 19' ' ' ASP . 11.2 m -86.46 -28.91 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 119.007 0.822 . . . . 0.0 109.434 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -74.83 -44.67 48.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.993 0.917 . . . . 0.0 110.001 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 28' ' ' ILE . 19.0 m -64.16 -37.04 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.6 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.02 67.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.16 -26.6 65.84 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.129 0.572 . . . . 0.0 109.728 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.721 ' HB3' HE21 ' A' ' 193' ' ' GLN . 24.0 mm-40 -88.74 -25.96 22.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.973 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 24' ' ' VAL . 47.9 mt -73.71 130.25 83.87 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.26 132.95 29.58 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.231 2.621 . . . . 0.0 112.835 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -74.58 27.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.96 -134.91 5.76 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -82.15 114.91 21.0 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.7 151.2 11.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 95' ' ' TRP . 66.9 tp -119.61 120.45 36.73 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 28.5 p -108.7 126.68 53.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.86 -172.42 1.3 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . -48.84 88.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.599 0.76 . . . . 0.0 111.056 166.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.0 154.69 40.55 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.375 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -24.42 54.16 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 123.591 0.557 . . . . 0.0 113.105 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 42' ' ' ARG . 43.7 tt0 -150.43 145.86 26.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.23 1.012 . . . . 0.0 109.247 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.5 -22.92 66.27 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.214 0.435 . . . . 0.0 113.769 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.529 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 70.8 mtt180 -61.98 -35.14 77.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.386 0.674 . . . . 0.0 112.049 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -56.15 -52.31 64.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.876 0.735 . . . . 0.0 111.099 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.51 -54.16 50.04 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.317 1.011 . . . . 0.0 111.8 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 6.2 p -67.89 -28.93 67.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.791 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 84.1 t80 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.446 0.698 . . . . 0.0 110.079 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 99' ' ' VAL . 50.9 mt -65.03 -35.85 82.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.829 0.852 . . . . 0.0 111.228 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.45 63.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.394 0.278 . . . . 0.0 111.247 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 76' ' ' VAL . 50.4 m -61.71 -23.05 65.88 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.355 0.662 . . . . 0.0 111.092 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.0 mt -78.23 12.39 1.92 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.988 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.51 66.59 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.475 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -103.41 152.98 20.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.252 0.526 . . . . 0.0 111.274 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -90.96 91.06 8.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.5 t -98.87 126.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.403 0.681 . . . . 0.0 109.985 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 m -99.77 111.69 24.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.738 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -96.68 139.53 32.61 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.814 0.446 . . . . 0.0 110.304 -172.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.0 t -118.28 150.09 20.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 164.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 27.8 t0 -157.99 144.57 17.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.288 0.495 . . . . 0.0 109.893 172.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.33 -20.47 66.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.073 0.858 . . . . 0.0 112.02 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 62' ' ' VAL . 1.9 m -108.92 140.32 42.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.158 0.983 . . . . 0.0 109.325 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 m -69.44 -29.23 66.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.784 0.434 . . . . 0.0 110.85 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 60' ' ' SER . 11.0 m -61.66 -35.25 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.829 0.706 . . . . 0.0 111.976 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.01 -35.37 35.01 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.53 0.519 . . . . 0.0 112.81 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -50.97 62.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.56 0.744 . . . . 0.0 110.435 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.13 76.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.158 0.983 . . . . 0.0 112.589 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -62.93 -43.81 97.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.429 0.692 . . . . 0.0 110.141 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -63.61 -46.02 87.67 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.28 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -67.24 -42.96 83.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.674 0.79 . . . . 0.0 110.782 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.49 -54.52 42.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.31 1.044 . . . . 0.0 111.627 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.513 HD23 ' SG ' ' A' ' 45' ' ' CYS . 30.5 tp -65.95 -28.82 69.19 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.923 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.78 -62.94 1.32 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.457 0.473 . . . . 0.0 111.062 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.62 -25.57 67.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.145 0.578 . . . . 0.0 111.274 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.79 -54.74 14.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.739 0.415 . . . . 0.0 109.904 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.28 -5.32 58.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.98 0.512 . . . . 0.0 112.083 -171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.58 34.15 40.64 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 121.923 -0.179 . . . . 0.0 113.064 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.0 m -125.21 170.46 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.633 1.173 . . . . 0.0 108.416 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -121.45 138.28 54.35 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mm -116.61 167.2 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -133.99 105.49 6.76 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 165.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.3 p -89.72 137.25 32.5 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.667 0.746 . . . . 0.0 111.576 -167.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 57' ' ' VAL . 58.8 t -125.05 135.0 65.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.324 1.849 . . . . 0.0 107.845 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -83.18 139.84 32.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 p -48.98 109.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.246 1.018 . . . . 0.0 113.144 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -136.58 93.7 2.91 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 90.8 mt -103.15 -35.25 8.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.141 0.577 . . . . 0.0 111.822 -170.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.09 -5.83 50.44 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.045 0.538 . . . . 0.0 112.117 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -116.23 -28.64 6.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.983 0.913 . . . . 0.0 111.174 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 47.3 t80 -157.79 156.09 30.93 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 125.166 1.387 . . . . 0.0 107.696 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.56 -70.58 0.17 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.407 1.458 . . . . 0.0 108.927 163.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.648 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.5 pt -139.5 118.77 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 0.0 110.268 -172.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.42 86.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.2 1.96 6.74 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.29 -47.87 69.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 165.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 -11.79 39.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.066 0.947 . . . . 0.0 111.962 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 34' ' ' LEU . 60.4 m95 -120.3 117.77 28.67 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.612 0.765 . . . . 0.0 110.119 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -58.46 -47.62 83.4 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.677 0.791 . . . . 0.0 111.366 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.97 156.28 18.11 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.924 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.3 mt -129.47 148.52 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 171.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 47' ' ' LEU . 4.3 p -135.27 143.12 37.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.759 1.224 . . . . 0.0 107.99 161.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.425 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 50.0 m -143.63 102.17 3.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.66 83.96 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 27.1 t80 -74.54 117.84 16.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.345 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.5 p -113.49 173.65 6.3 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -55.56 101.23 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.514 0.726 . . . . 0.0 110.721 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.16 139.81 42.37 Favored Pre-proline 0 C--O 1.247 0.961 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.61 144.9 24.16 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.838 2.359 . . . . 0.0 110.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -43.33 -34.61 1.27 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.713 1.205 . . . . 0.0 113.495 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 t -56.55 -64.25 0.93 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.45 1.1 . . . . 0.0 111.506 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.78 -30.74 65.87 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.728 0.411 . . . . 0.0 111.324 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -63.62 -62.4 1.69 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.682 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.49 -30.77 67.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -73.77 -33.95 64.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.178 0.591 . . . . 0.0 110.516 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.18 -48.48 62.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.855 0.722 . . . . 0.0 111.314 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -57.63 -44.31 99.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -166.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.41 -28.08 83.46 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 122.077 1.778 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -88.18 -12.38 44.05 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.026 0.931 . . . . 0.0 111.296 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 3.4 t -85.32 -33.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 165.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -66.07 -61.5 2.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.697 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.8 -47.78 16.04 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.83 -39.34 39.51 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 -166.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 28.4 tp -70.9 96.2 1.25 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.555 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 30.0 mmmt -67.0 130.13 93.93 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 27.5 Cg_exo -39.85 123.44 1.23 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.422 3.415 . . . . 0.0 114.547 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.99 14.78 2.98 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.704 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.88 150.47 17.04 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 167.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 20.4 m -109.84 131.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 123.264 0.626 . . . . 0.0 109.943 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.3 t80 -110.37 113.06 25.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.51 111.7 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.792 0.837 . . . . 0.0 109.865 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 156' ' ' LEU . 2.1 mp -129.18 149.5 50.96 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.302 0.641 . . . . 0.0 110.068 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 45.2 tt0 -135.67 103.64 5.5 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.803 0.689 . . . . 0.0 109.253 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.6 148.33 27.59 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 170.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.44 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.1 m-85 -111.04 168.28 9.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.609 0.763 . . . . 0.0 110.39 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -76.35 164.07 62.2 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.25 1.02 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.742 ' HA ' HD22 ' A' ' 147' ' ' LEU . 83.5 Cg_exo -50.29 -21.84 7.61 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.398 2.732 . . . . 0.0 113.715 165.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.01 -24.76 62.44 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.752 1.221 . . . . 0.0 112.092 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -71.27 -57.72 4.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -163.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.418 ' HG ' ' HG ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -61.36 -37.09 82.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.543 0.737 . . . . 0.0 110.273 177.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -60.0 -43.33 95.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.66 1.225 . . . . 0.0 110.842 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -78.36 -21.34 49.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.439 0.696 . . . . 0.0 110.409 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.71 20.76 12.39 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.369 1.468 . . . . 0.0 111.057 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.5 p -88.13 8.43 26.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.17 0.988 . . . . 0.0 111.908 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.87 52.66 0.02 OUTLIER Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.31 3.7 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.121 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -71.75 -71.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.7 2.267 . . . . 0.0 112.907 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -128.04 -52.21 1.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.908 0.883 . . . . 0.0 109.517 -173.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.82 150.92 25.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.099 0.959 . . . . 0.0 108.551 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.742 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.1 mt -52.4 -9.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.18 1.792 . . . . 0.0 113.812 173.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.46 -39.25 79.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.129 0.571 . . . . 0.0 110.206 171.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.69 1.65 22.21 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 123.41 0.684 . . . . 0.0 112.491 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 59.5 mt -81.72 108.17 10.32 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.718 ' HB2' HD11 ' A' ' 156' ' ' LEU . 65.3 Cg_endo -83.34 123.88 3.55 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.315 2.01 . . . . 0.0 111.79 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -86.65 159.09 19.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.141 0.976 . . . . 0.0 111.95 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 188' ' ' ILE . 71.7 mt -61.61 -36.63 81.27 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 166.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.23 -50.45 72.82 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.01 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 73.5 p -68.75 -62.33 1.43 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.299 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 151' ' ' PRO . 70.8 mt -61.84 -49.93 74.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.81 1.244 . . . . 0.0 112.952 -166.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.5 tt0 -58.47 -43.19 88.85 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 123.685 0.616 . . . . 0.0 111.426 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 t -73.13 -23.23 60.46 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.463 0.305 . . . . 0.0 111.594 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 155' ' ' THR . 53.9 mt-10 -80.86 -18.04 48.68 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.684 0.793 . . . . 0.0 111.399 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 97.0 mt -133.65 66.73 74.17 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.311 0.644 . . . . 0.0 110.507 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.35 2.97 7.89 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.783 2.322 . . . . 0.0 112.309 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.1 m -86.02 -35.23 20.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.4 tp -102.14 70.19 1.19 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.002 1.721 . . . . 0.0 110.663 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -64.98 136.88 57.32 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.664 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 19.3 m95 -96.98 136.92 36.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.512 0.725 . . . . 0.0 110.545 -163.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 46.2 mt -68.33 -30.02 68.9 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.634 0.584 . . . . 0.0 109.729 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 67.0 mt -132.01 125.09 54.29 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.38 66.38 0.7 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -128.97 143.71 50.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.655 -162.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -89.96 99.32 12.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.386 1.075 . . . . 0.0 109.535 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.7 mt -108.19 129.92 55.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.359 1.064 . . . . 0.0 111.56 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 131.14 41.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.113 0.565 . . . . 0.0 109.946 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 184' ' ' LYS . 21.4 ttt180 -107.63 131.94 53.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.98 0.912 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -71.93 104.53 3.53 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.696 0.623 . . . . 0.0 111.709 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 185' ' ' ALA . 17.4 mt -83.66 169.23 15.54 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.594 165.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.36 141.83 58.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.469 0.308 . . . . 0.0 110.672 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 182' ' ' GLN . 35.5 tt0 -94.59 143.73 26.19 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.444 0.698 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.48 -64.42 0.01 OUTLIER Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.58 -172.36 3.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.909 0.884 . . . . 0.0 110.156 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -53.39 -33.22 52.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.192 0.597 . . . . 0.0 110.569 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -59.66 93.7 0.02 OUTLIER 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.737 -1.12 . . . . 0.0 107.991 167.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.589 ' HA ' ' HG3' ' A' ' 177' ' ' GLU . 9.4 pt20 -70.69 3.15 3.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.781 0.832 . . . . 0.0 112.907 -174.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.22 61.22 1.2 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.078 167.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -127.03 172.03 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.336 0.589 . . . . 0.0 110.177 158.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -145.3 132.36 20.35 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.193 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -74.99 107.31 6.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.058 0.849 . . . . 0.0 108.959 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.97 149.48 40.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 19.8 pt -132.54 117.24 30.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -98.55 144.58 27.72 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.375 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 48.6 mt -128.63 137.21 51.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.53 -1.213 . . . . 0.0 109.525 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.475 HD22 HG12 ' A' ' 24' ' ' VAL . 33.3 tp -135.11 105.08 6.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -90.92 138.14 14.21 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.721 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.1 tp-100 -143.52 157.43 44.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.299 0.64 . . . . 0.0 110.752 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 62.9 tttm -56.29 120.74 8.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.265 1.026 . . . . 0.0 109.207 172.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.99 116.14 10.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.58 0.352 . . . . 0.0 111.536 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.51 132.87 12.79 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.732 0.645 . . . . 0.0 109.835 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.64 32.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.673 1.189 . . . . 0.0 107.98 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' HIS . . . . . 0.504 ' O ' ' HB3' ' A' ' 201' ' ' HIS . 34.1 t60 68.35 114.71 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.693 1.597 . . . . 0.0 109.056 -166.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.02 150.86 40.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.035 0.534 . . . . 0.0 109.795 174.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 15.3 m170 70.77 11.35 7.16 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.818 1.247 . . . . 0.0 111.749 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 198' ' ' HIS . 16.5 t-80 -109.66 110.51 21.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.564 1.145 . . . . 0.0 107.975 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.646 0.778 . . . . 0.0 109.084 -179.168 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.075 0.464 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -159.12 156.21 28.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.682 0.793 . . . . 0.0 110.099 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . 8.0 p-10 -160.58 142.66 12.65 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.476 1.11 . . . . 0.0 108.686 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.45 125.06 9.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 111.876 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -133.67 155.7 49.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.278 1.431 . . . . 0.0 107.544 165.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -156.14 127.65 7.21 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 111.38 23.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.561 0.745 . . . . 0.0 109.437 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -87.56 152.59 22.08 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.711 0.804 . . . . 0.0 108.854 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 t -145.91 98.3 3.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -84.4 83.42 8.0 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.12 0.568 . . . . 0.0 109.513 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -61.44 125.22 22.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.335 1.054 . . . . 0.0 111.532 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.27 111.95 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.715 0.806 . . . . 0.0 109.33 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -93.13 108.5 20.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.262 1.025 . . . . 0.0 109.34 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.54 105.49 2.83 Favored Glycine 0 N--CA 1.467 0.761 0 O-C-N 123.624 0.577 . . . . 0.0 111.963 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -90.24 79.92 6.31 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.294 0.568 . . . . 0.0 110.302 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -93.16 114.84 63.89 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.416 0.687 . . . . 0.0 110.546 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.01 -177.31 3.56 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.745 2.297 . . . . 0.0 111.906 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.45 139.59 16.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.089 0.956 . . . . 0.0 108.987 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -162.07 177.49 9.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.217 0.607 . . . . 0.0 109.768 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.3 -23.51 65.75 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.486 1.114 . . . . 0.0 110.245 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.98 -17.73 10.88 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.811 1.244 . . . . 0.0 112.747 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.55 -27.46 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.516 1.053 . . . . 0.0 109.398 -171.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 17.4 m -66.68 -52.69 41.9 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.473 0.709 . . . . 0.0 109.422 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 HD22 ' A' ' 191' ' ' LEU . 19.3 m -65.98 -37.09 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.9 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -58.68 -42.18 87.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.273 1.029 . . . . 0.0 112.25 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.51 -23.65 64.58 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.858 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.5 mm100 -83.91 -14.24 51.52 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.263 0.625 . . . . 0.0 111.366 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -82.89 128.94 63.7 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.275 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.15 140.05 41.82 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.122 2.548 . . . . 0.0 113.063 169.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.21 27.41 0.05 Allowed 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.42 -136.77 6.56 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-O 119.397 -0.669 . . . . 0.0 112.919 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -75.21 112.7 11.75 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -107.92 116.04 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.64 113.79 26.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 110.208 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 8.8 t -104.05 108.57 19.99 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 122.451 0.3 . . . . 0.0 111.531 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 90' ' ' ILE . 61.7 mt -81.26 123.41 28.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.646 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 45.85 68.82 0.53 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 125.153 1.533 . . . . 0.0 111.255 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.567 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -68.87 169.11 12.14 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.156 -169.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.45 68.83 3.48 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.75 -174.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 60.79 74.4 0.45 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.561 1.144 . . . . 0.0 113.5 166.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.2 -73.81 0.54 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtm105 -55.64 -26.69 45.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.786 1.234 . . . . 0.0 113.557 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.72 -54.63 32.51 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.351 0.661 . . . . 0.0 111.304 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.35 74.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.983 0.802 . . . . 0.0 110.808 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 26.5 m -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.906 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 89.0 t80 -66.14 -51.88 53.7 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.697 0.623 . . . . 0.0 109.6 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 99' ' ' VAL . 93.4 mt -61.38 -37.02 81.89 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.437 1.086 . . . . 0.0 110.901 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.71 66.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.312 0.645 . . . . 0.0 112.078 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.633 ' HA ' HG11 ' A' ' 76' ' ' VAL . 96.1 p -70.32 -2.78 14.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.2 mt -82.76 12.96 4.17 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.028 0.531 . . . . 0.0 110.501 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.44 32.82 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 119.846 -0.419 . . . . 0.0 113.925 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.8 158.87 35.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.352 0.576 . . . . 0.0 111.141 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.4 91.31 6.15 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.755 0.822 . . . . 0.0 108.98 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.95 110.45 23.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.993 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 79' ' ' THR . 47.4 p -84.88 105.48 15.69 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.073 173.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.0 129.2 46.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.245 0.618 . . . . 0.0 110.772 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.25 123.62 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.32 134.44 25.72 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.03 -2.45 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.66 1.184 . . . . 0.0 113.329 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 m -119.93 119.61 33.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.2 m -73.44 -24.95 60.31 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.306 0.642 . . . . 0.0 110.291 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.25 -35.88 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.776 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.01 -35.16 58.03 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.747 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.63 -49.71 69.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.494 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.611 0.764 . . . . 0.0 112.043 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -66.23 -46.28 77.75 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.874 0.87 . . . . 0.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.531 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -63.59 -40.92 98.17 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.99 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 36.6 ttpt -65.49 -45.05 85.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.462 1.105 . . . . 0.0 110.938 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 -51.55 68.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.105 0.962 . . . . 0.0 110.872 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.37 -30.59 70.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.172 0.92 . . . . 0.0 111.022 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -64.05 -61.37 2.31 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.505 0.503 . . . . 0.0 111.256 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.12 -24.39 65.01 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.341 0.656 . . . . 0.0 110.842 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.44 -35.24 75.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.932 0.893 . . . . 0.0 110.44 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.83 -10.41 45.47 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.39 0.676 . . . . 0.0 111.251 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.63 36.16 20.48 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 113.633 0.213 . . . . 0.0 113.633 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 49' ' ' SER . 19.4 m -132.32 174.58 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.373 1.069 . . . . 0.0 110.048 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.25 129.46 54.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.0 0.92 . . . . 0.0 111.814 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.1 mm -108.68 166.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 162.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 55' ' ' THR . 90.3 m -134.06 110.59 9.74 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 160.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.4 p -81.94 120.47 25.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.65 153.46 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.727 1.211 . . . . 0.0 109.693 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -85.81 103.59 14.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.6 p -46.9 99.92 0.02 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.55 1.14 . . . . 0.0 112.672 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -141.0 96.57 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 91.9 mt -103.79 -15.02 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.033 0.933 . . . . 0.0 112.424 -176.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -18.18 32.32 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.533 0.733 . . . . 0.0 112.651 -174.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.42 -10.9 3.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.759 0.823 . . . . 0.0 111.495 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.2 t80 -151.68 157.62 42.33 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -153.84 -57.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 117' ' ' VAL . 3.1 pt -151.81 134.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.0 109.322 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 93' ' ' ASP . 84.4 t -123.64 150.99 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.305 1.042 . . . . 0.0 108.215 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.27 -29.63 19.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.296 0.57 . . . . 0.0 110.27 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 91' ' ' VAL . 23.3 t70 -70.34 -51.66 28.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.262 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.34 -25.9 33.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.161 0.584 . . . . 0.0 112.362 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.425 ' HD1' ' H ' ' A' ' 91' ' ' VAL . 57.1 m95 -111.81 107.08 16.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.06 0.457 . . . . 0.0 110.865 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -56.88 12.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.165 1.386 . . . . 0.0 109.525 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.22 143.06 15.63 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.47 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.557 HD13 ' HB ' ' A' ' 90' ' ' ILE . 87.7 mt -124.9 127.26 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -123.12 102.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.308 1.052 . . . . 0.0 109.732 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.415 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 46.6 m -97.33 91.59 5.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.7 mm -72.37 150.36 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.869 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -17.92 105.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 127.258 2.223 . . . . 0.0 113.46 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 p -111.38 106.26 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.549 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -98.09 99.53 10.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.2 mt -114.81 146.07 35.29 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.735 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.583 ' HA ' HD13 ' A' ' 149' ' ' LEU . 35.8 Cg_exo -61.69 155.4 54.06 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.963 2.442 . . . . 0.0 110.715 167.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -46.3 -38.66 8.96 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.979 0.912 . . . . 0.0 112.752 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.8 m -56.0 -52.41 64.31 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 123.925 0.766 . . . . 0.0 111.986 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.96 -22.04 31.57 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.236 0.615 . . . . 0.0 111.039 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -76.08 -52.43 10.18 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.4 -14.23 62.85 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.746 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.2 -39.56 25.23 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 117' ' ' VAL . 64.2 tp -75.52 -60.25 2.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.033 0.533 . . . . 0.0 111.933 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -58.94 -43.72 97.99 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -164.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.8 -23.38 26.13 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 121.774 1.649 . . . . 0.0 112.04 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -86.17 -14.65 43.4 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.783 0.833 . . . . 0.0 110.16 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.598 ' HA ' HD11 ' A' ' 90' ' ' ILE . 28.9 t -75.27 -40.18 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 166.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.78 -54.16 50.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.109 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.2 -46.79 63.83 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.313 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.58 -57.27 3.92 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.376 0.511 . . . . 0.0 114.376 -172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' A' ' 90' ' ' ILE . 6.0 tt -74.6 138.28 42.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.553 0.741 . . . . 0.0 109.817 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -120.05 168.54 10.17 Favored Pre-proline 0 C--O 1.247 0.933 0 C-N-CA 124.622 1.169 . . . . 0.0 108.583 172.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.07 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 122.003 1.802 . . . . 0.0 112.042 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.72 -2.05 4.42 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.176 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -114.52 145.03 18.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 159.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.2 131.5 58.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.87 1.268 . . . . 0.0 109.447 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.2 t80 -106.37 111.71 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.24 107.82 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 91.3 mt -118.35 141.02 48.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.753 0.821 . . . . 0.0 110.669 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -127.15 101.43 6.51 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 164.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 179.6 53.19 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 164.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.495 ' H ' HD22 ' A' ' 150' ' ' LEU . 36.0 m-85 -130.16 169.37 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -100.9 154.31 37.23 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.116 0.566 . . . . 0.0 110.174 172.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.08 -6.77 5.38 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.409 2.74 . . . . 0.0 114.023 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -25.59 7.94 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.099 0.96 . . . . 0.0 112.535 171.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.564 ' HB3' HD22 ' A' ' 147' ' ' LEU . 56.4 tp60 -78.42 -50.75 11.14 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 118.797 -0.62 . . . . 0.0 110.388 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.712 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 32.3 mt -61.38 -13.24 18.33 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 119.136 0.88 . . . . 0.0 112.797 171.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.68 -33.73 76.29 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.03 -50.1 5.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.624 0.77 . . . . 0.0 109.939 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.48 86.88 2.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 p -82.05 -25.37 34.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.871 -166.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -114.44 65.92 0.28 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.682 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.78 59.24 0.51 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.567 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.74 144.18 34.77 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.296 1.997 . . . . 0.0 109.396 170.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 84.44 22.87 0.11 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.86 1.264 . . . . 0.0 108.707 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -119.13 -74.46 0.61 Allowed 'General case' 0 C--N 1.347 0.496 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.712 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 5.7 mp -104.6 6.52 34.58 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.913 -0.492 . . . . 0.0 111.916 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.29 -31.15 67.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.349 -1.469 . . . . 0.0 109.97 161.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 106' ' ' PRO . 23.9 mt -92.34 25.37 2.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.451 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 147' ' ' LEU . 88.2 mt -72.88 115.35 39.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 123.307 0.379 . . . . 0.0 110.554 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 55.6 Cg_endo -93.79 114.11 0.23 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 122.647 2.231 . . . . 0.0 109.988 167.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -73.09 167.93 20.12 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.776 0.43 . . . . 0.0 111.761 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.634 HD21 ' HB ' ' A' ' 188' ' ' ILE . 67.8 mt -61.14 -30.58 70.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 0.0 110.9 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -56.8 -59.38 5.11 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.425 0.69 . . . . 0.0 110.73 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.1 p -65.57 -38.42 89.49 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.592 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.2 -43.68 23.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -173.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.477 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 29.6 tt0 -58.96 -40.02 83.47 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 120.927 0.394 . . . . 0.0 110.905 173.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -80.47 -13.3 59.23 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.438 0.695 . . . . 0.0 111.258 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -74.37 -31.77 62.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.464 0.706 . . . . 0.0 109.861 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 79.8 mt -134.08 74.25 68.55 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.99 -33.58 31.86 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.289 2.659 . . . . 0.0 113.407 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t -82.78 -35.43 26.53 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.5 tp -66.89 71.77 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.674 1.19 . . . . 0.0 111.799 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -51.8 120.93 5.78 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.797 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 55.3 m95 -87.94 119.7 28.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.508 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 79.8 mt -68.08 -33.76 75.15 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.846 0.458 . . . . 0.0 110.276 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.6 128.33 69.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.63 81.67 1.34 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -137.62 144.43 41.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.899 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.36 125.53 35.17 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.7 mt -105.75 107.12 17.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.8 119.33 28.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -98.81 129.6 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 110.109 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -73.38 104.03 4.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.001 0.92 . . . . 0.0 110.469 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 185' ' ' ALA . 13.5 mt -75.03 108.53 7.82 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 33.5 t70 61.31 94.59 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.295 1.038 . . . . 0.0 110.506 -170.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.65 30.37 4.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.796 0.838 . . . . 0.0 110.413 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.91 -67.45 2.19 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.758 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.47 -52.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.016 0.526 . . . . 0.0 111.862 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -98.74 -36.52 9.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -164.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -63.09 -68.55 0.33 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 118.13 0.423 . . . . 0.0 110.433 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 58.59 18.32 5.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.421 1.088 . . . . 0.0 112.105 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.52 34.69 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -123.16 -172.59 2.53 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 0.0 110.877 -172.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -166.9 131.52 2.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -83.5 138.71 33.31 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.422 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.7 mt -120.92 144.07 48.63 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 153' ' ' LEU . 27.3 pt -124.12 116.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.8 1.182 . . . . 0.0 109.944 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -100.04 146.74 26.4 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.692 0.758 . . . . 0.0 110.586 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 46.0 mt -137.07 141.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.073 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.542 HD22 HG12 ' A' ' 24' ' ' VAL . 40.9 tp -134.19 106.35 7.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 168.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.31 140.59 19.2 Favored Glycine 0 CA--C 1.505 -0.551 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.615 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 45.4 tp60 -123.75 148.37 46.68 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 193' ' ' GLN . 0.7 OUTLIER -57.11 115.92 2.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.371 161.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.3 mt -61.22 116.13 4.35 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 167.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -58.66 132.55 54.17 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.023 0.827 . . . . 0.0 109.777 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.59 83.17 0.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 124.058 0.849 . . . . 0.0 109.313 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -82.58 78.63 9.18 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.39 1.076 . . . . 0.0 109.461 -177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -77.27 109.89 11.53 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.764 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -145.87 176.43 9.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.288 0.635 . . . . 0.0 110.359 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -73.09 87.76 1.4 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.407 0.683 . . . . 0.0 109.775 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 . . . . . 0 C--O 1.245 0.849 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 171.703 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -79.76 157.17 27.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.6 99.67 7.44 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.539 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -90.17 69.14 7.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -157.11 145.15 19.27 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.104 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -138.23 157.67 45.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.673 0.789 . . . . 0.0 111.061 -173.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 p -91.86 103.21 15.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.998 0.919 . . . . 0.0 108.877 171.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -67.55 115.95 7.72 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.141 0.576 . . . . 0.0 109.94 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 t -123.24 30.49 6.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 110.262 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.5 105.01 2.48 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.422 0.689 . . . . 0.0 109.73 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -91.67 159.65 15.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.387 0.675 . . . . 0.0 110.127 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.63 116.37 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -109.21 139.06 44.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.091 0.556 . . . . 0.0 110.444 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.06 148.51 5.94 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.587 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -172.03 112.37 0.3 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.547 1.939 . . . . 0.0 107.579 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -120.79 73.73 24.54 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.192 0.597 . . . . 0.0 110.83 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.03 124.75 0.94 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.819 2.346 . . . . 0.0 110.961 167.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -68.91 110.6 4.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.162 0.585 . . . . 0.0 109.907 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 22' ' ' VAL . 22.3 t70 -142.13 170.69 15.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.596 0.758 . . . . 0.0 110.302 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.85 -34.19 77.58 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.983 0.913 . . . . 0.0 110.773 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 24' ' ' VAL . 33.7 tp -67.62 -54.4 20.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.131 0.572 . . . . 0.0 111.208 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 19' ' ' ASP . 14.4 m -47.39 -25.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 m -68.36 -49.07 62.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.862 0.865 . . . . 0.0 110.767 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.786 HG21 HD11 ' A' ' 128' ' ' ILE . 1.5 m -64.77 -36.48 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.032 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.54 66.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.1 -35.24 77.82 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.855 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -82.86 -18.25 41.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.143 0.977 . . . . 0.0 112.466 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 24' ' ' VAL . 74.1 mt -77.02 135.64 66.82 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.965 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.59 142.48 90.38 Favored 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.467 2.778 . . . . 0.0 112.331 171.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 28.2 pt20 -70.73 28.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.63 -141.87 6.76 Favored Glycine 0 N--CA 1.478 1.447 0 CA-C-N 118.769 0.713 . . . . 0.0 113.338 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 62.0 mttp -76.91 115.32 16.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 54' ' ' VAL . 21.0 mt -107.63 121.45 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 55' ' ' THR . 55.6 tp -90.69 111.62 23.04 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.02 0.528 . . . . 0.0 111.289 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 98.6 m -87.19 134.9 33.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.83 152.63 18.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.749 0.419 . . . . 0.0 110.469 167.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.47 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.685 1.241 . . . . 0.0 111.779 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.08 -165.92 1.46 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.423 1.089 . . . . 0.0 109.858 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.26 -56.68 20.32 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.239 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -135.67 129.13 32.27 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.926 0.89 . . . . 0.0 109.397 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.76 36.86 2.47 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.43 0.538 . . . . 0.0 114.152 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -81.24 -26.38 35.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.257 1.023 . . . . 0.0 109.617 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' HG21 ' A' ' 101' ' ' ILE . 23.9 m120 -67.25 -35.08 78.8 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.943 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 56' ' ' ALA . . . -53.42 -57.55 10.23 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.418 1.087 . . . . 0.0 111.813 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.918 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 8.3 p -66.03 -34.13 77.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.976 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.96 -43.09 88.93 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.57 0.544 . . . . 0.0 111.29 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 99' ' ' VAL . 84.9 mt -67.35 -30.78 70.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.47 -36.71 74.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.724 0.41 . . . . 0.0 110.542 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -63.95 -14.63 55.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.207 1.003 . . . . 0.0 112.341 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.0 mt -85.26 17.19 3.17 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.934 0.894 . . . . 0.0 110.705 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 37.73 25.39 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 123.563 0.601 . . . . 0.0 114.436 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 25.2 m-85 -126.69 154.36 44.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.998 0.519 . . . . 0.0 111.318 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 33.5 mt-10 -89.6 86.9 6.84 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 33' ' ' ILE . 71.2 t -93.23 108.49 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.783 0.802 . . . . 0.0 110.376 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.8 t -83.69 108.71 16.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.957 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . . . -96.42 132.41 41.99 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.748 0.819 . . . . 0.0 111.359 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.29 120.51 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 22.4 t0 -136.27 134.91 38.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.238 0.472 . . . . 0.0 109.972 174.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -53.8 -24.03 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.771 1.628 . . . . 0.0 112.837 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 t -123.3 164.23 19.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 111.081 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.2 p -77.36 -18.35 57.46 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.096 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.51 -44.39 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.62 -34.01 40.91 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.275 0.359 . . . . 0.0 112.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 93.5 mt -69.02 -47.67 64.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.558 0.743 . . . . 0.0 111.61 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -54.31 -55.67 26.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.815 0.846 . . . . 0.0 111.855 171.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.35 -39.16 66.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.619 0.767 . . . . 0.0 110.842 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.918 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -59.98 -52.51 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.293 177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -69.01 -38.75 79.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 5.7 mm100 -62.51 -45.44 92.97 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.496 0.318 . . . . 0.0 111.395 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 45' ' ' CYS . 32.1 tp -70.92 -27.39 63.73 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.359 0.412 . . . . 0.0 110.785 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.15 -62.4 1.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 110.546 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.97 -30.21 70.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.586 0.754 . . . . 0.0 111.617 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.77 -54.58 25.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.06 0.544 . . . . 0.0 110.718 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' HE2' HD11 ' A' ' 70' ' ' LEU . 24.8 ttmm -83.87 -15.71 47.12 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.48 0.712 . . . . 0.0 111.727 -170.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.93 41.97 7.88 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 121.828 -0.225 . . . . 0.0 113.284 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.53 175.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.591 1.156 . . . . 0.0 109.109 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.14 140.69 51.65 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.031 0.378 . . . . 0.0 111.896 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.658 HG12 ' HB2' ' A' ' 71' ' ' ALA . 20.1 mm -115.56 160.75 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.004 1.322 . . . . 0.0 107.555 167.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.8 m -127.49 110.12 12.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 164.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.8 p -84.24 111.63 19.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.044 0.538 . . . . 0.0 109.822 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 157.25 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.177 1.391 . . . . 0.0 110.698 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.38 103.81 15.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.87 99.26 0.08 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.018 0.437 . . . . 0.0 111.618 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -142.64 91.54 2.32 Favored 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.57 -17.26 61.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.349 0.522 . . . . 0.0 110.839 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.34 -0.9 51.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.543 1.137 . . . . 0.0 112.295 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.04 -32.8 0.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -167.32 107.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.04 -63.4 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.483 1.113 . . . . 0.0 108.21 -171.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.624 ' HB ' HD13 ' A' ' 98' ' ' ILE . 29.8 pt -138.64 122.62 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.609 0.763 . . . . 0.0 110.8 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.44 87.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.719 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.95 -1.84 13.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.477 0.711 . . . . 0.0 112.744 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.86 -48.06 67.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.08 -24.41 30.37 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.923 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.481 ' CD2' HG21 ' A' ' 55' ' ' THR . 17.9 m95 -112.85 161.78 16.56 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.113 0.565 . . . . 0.0 109.682 -172.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.74 -58.1 2.85 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.82 16.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.257 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.624 HD13 ' HB ' ' A' ' 90' ' ' ILE . 80.6 mt -134.36 119.36 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 47' ' ' LEU . 11.6 p -109.11 133.27 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -125.96 90.9 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.547 HD13 HD12 ' A' ' 128' ' ' ILE . 12.2 mm -69.29 155.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.877 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -19.28 103.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 126.215 1.806 . . . . 0.0 113.501 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.28 114.55 11.61 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.271 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -97.76 100.24 11.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.9 mt -93.47 148.76 36.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.708 0.403 . . . . 0.0 110.279 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.57 156.71 55.29 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.156 1.904 . . . . 0.0 110.193 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.8 m -50.83 -33.0 21.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.033 0.933 . . . . 0.0 112.585 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -58.84 -52.99 63.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.899 0.88 . . . . 0.0 111.623 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.7 mt -83.42 -18.66 37.96 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.978 0.511 . . . . 0.0 111.283 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -63.71 -62.88 1.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -67.78 -10.52 53.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.617 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -77.84 -54.18 6.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.786 0.434 . . . . 0.0 109.926 166.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.3 tp -74.71 -49.85 19.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -165.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -67.25 -35.34 8.47 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.53 -33.68 96.85 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.194 1.929 . . . . 0.0 112.794 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 34.3 mmtp -72.64 -27.39 62.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.627 0.771 . . . . 0.0 110.894 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 127' ' ' PHE . 15.0 t -84.01 -34.75 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.727 0.411 . . . . 0.0 110.427 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.48 -61.76 2.35 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.94 -49.2 63.18 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.808 0.843 . . . . 0.0 113.247 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.27 24.07 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -164.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 125' ' ' GLY . 44.7 tp -70.82 104.37 2.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.463 0.632 . . . . 0.0 110.43 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.71 153.21 78.22 Favored Pre-proline 0 C--O 1.247 0.929 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -48.69 116.03 1.92 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.954 2.436 . . . . 0.0 113.277 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.86 12.23 2.46 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.318 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -102.24 146.67 16.99 Favored Glycine 0 N--CA 1.441 -0.975 0 O-C-N 122.539 -0.389 . . . . 0.0 112.437 163.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.6 m -116.64 130.88 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.825 0.85 . . . . 0.0 108.767 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -111.9 113.07 25.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.786 HD11 HG21 ' A' ' 24' ' ' VAL . 14.7 mt -107.62 108.93 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 49.8 mt -113.49 150.3 33.07 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.515 0.726 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.42 138.95 43.76 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 161.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.54 -176.44 14.37 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.405 ' HB2' HD21 ' A' ' 150' ' ' LEU . 53.3 m-85 -102.62 166.69 10.37 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 134' ' ' PRO . . . -116.2 169.26 7.28 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 133' ' ' ALA . 37.0 Cg_endo -63.78 60.76 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.635 2.224 . . . . 0.0 112.915 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.678 ' HG3' ' H ' ' A' ' 186' ' ' ALA . 2.7 tm-20 -97.12 -63.98 1.08 Allowed 'General case' 0 C--N 1.349 0.575 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.451 ' HB3' HD22 ' A' ' 147' ' ' LEU . 53.7 tp60 -65.64 -49.17 69.67 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.963 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.721 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 7.3 mt -66.59 -10.15 42.66 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 118.748 0.704 . . . . 0.0 111.394 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -80.06 -46.45 16.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.824 0.45 . . . . 0.0 110.51 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -84.56 -15.58 45.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -113.28 152.08 30.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 m -80.95 -27.76 35.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.72 116.96 0.77 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.46 69.04 0.41 Allowed Glycine 0 CA--C 1.535 1.337 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.29 130.37 12.92 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.562 2.175 . . . . 0.0 110.594 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.557 ' H ' ' HB3' ' A' ' 148' ' ' ASP . 94.4 mttt 86.56 15.19 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.453 1.501 . . . . 0.0 110.855 172.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -110.41 -89.66 0.49 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.721 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 4.2 mp -96.62 27.0 4.09 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 118.514 0.597 . . . . 0.0 110.614 168.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.557 ' HB3' ' H ' ' A' ' 145' ' ' LYS . 23.6 t70 -87.07 -34.61 19.09 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.24 25.16 0.62 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.497 1.919 . . . . 0.0 113.096 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 147' ' ' LEU . 95.1 mt -68.57 118.88 64.52 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 123.684 0.615 . . . . 0.0 112.194 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -94.71 98.28 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.916 2.411 . . . . 0.0 109.88 166.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 167.87 20.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.285 0.634 . . . . 0.0 111.335 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 188' ' ' ILE . 29.8 mt -67.07 -31.54 72.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.243 0.617 . . . . 0.0 110.984 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -55.49 -45.88 76.98 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.84 0.713 . . . . 0.0 111.058 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -84.26 -35.69 23.2 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.698 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 129' ' ' LEU . 40.8 mt -75.21 -47.24 29.16 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.464 0.706 . . . . 0.0 112.022 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.5 tt0 -60.68 -35.81 77.19 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.72 0.408 . . . . 0.0 111.154 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -71.86 -26.83 62.51 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 111.11 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.57 -15.0 44.05 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.247 1.019 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 78.0 mt -135.67 68.18 65.83 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.03 3.09 8.09 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 123.049 2.499 . . . . 0.0 112.226 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t -90.21 -36.36 14.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.407 1.083 . . . . 0.0 108.59 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.2 tp -94.75 72.32 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.35 1.46 . . . . 0.0 111.715 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -51.78 124.72 13.13 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.283 0.564 . . . . 0.0 110.172 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 24.9 m95 -93.66 132.88 37.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.665 1.186 . . . . 0.0 109.839 -170.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 85.9 mt -70.64 -35.99 73.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.415 0.686 . . . . 0.0 110.787 173.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.05 121.61 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.44 85.17 1.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.644 0.778 . . . . 0.0 109.165 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.52 149.06 29.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.941 0.401 . . . . 0.0 110.811 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.22 113.39 13.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.0 128.01 53.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.392 0.677 . . . . 0.0 109.508 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 9.5 pt-20 -92.23 120.37 32.73 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -96.64 125.17 40.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.096 0.558 . . . . 0.0 109.987 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -72.37 121.02 18.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.813 0.845 . . . . 0.0 111.023 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.25 159.22 15.72 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.322 1.049 . . . . 0.0 110.785 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -54.08 137.76 39.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.788 1.235 . . . . 0.0 112.404 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.82 90.08 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.969 0.907 . . . . 0.0 110.159 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.2 43.19 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.807 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -147.41 148.39 31.25 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.592 0.757 . . . . 0.0 109.999 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -65.45 -39.91 92.6 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -62.64 117.84 6.81 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.076 0.951 . . . . 0.0 108.612 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -59.34 149.98 27.48 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.907 0.483 . . . . 0.0 110.562 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.79 74.78 0.76 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 124.167 0.917 . . . . 0.0 115.253 -168.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -152.49 164.47 37.5 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.55 0.74 . . . . 0.0 110.698 162.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -143.64 129.23 19.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.014 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.678 ' H ' ' HG3' ' A' ' 135' ' ' GLU . . . -76.38 108.65 9.48 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 65.8 mt -121.94 172.37 8.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.563 ' HB ' HD21 ' A' ' 153' ' ' LEU . 38.1 pt -135.6 144.9 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -137.17 154.17 50.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.761 0.791 . . . . 0.0 110.945 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 65.0 mt -139.12 146.25 40.44 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 27.6 tp -143.37 111.89 6.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -90.18 148.56 19.79 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.612 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 8.6 tp-100 -134.78 151.16 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.472 0.636 . . . . 0.0 111.242 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 17.1 pttp -55.99 136.26 52.08 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.64 116.84 10.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 167.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 200' ' ' HIS . 2.6 tp10 -66.22 92.67 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 123.86 0.725 . . . . 0.0 110.217 -171.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -89.45 52.53 2.37 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.176 0.988 . . . . 0.0 110.154 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -176.84 -169.57 0.27 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.262 2.225 . . . . 0.0 106.596 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -61.63 147.02 47.13 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.923 0.783 . . . . 0.0 109.831 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 196' ' ' GLU . 19.4 p-80 -56.12 154.17 8.11 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.531 0.732 . . . . 0.0 112.3 -172.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -54.52 107.83 0.32 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.899 0.749 . . . . 0.0 110.277 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.1 p80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.18 176.407 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -81.69 81.97 7.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.599 0.759 . . . . 0.0 110.486 -171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.87 88.49 7.7 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -132.51 141.97 49.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.36 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -166.92 102.75 0.55 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -127.56 120.78 28.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.666 0.786 . . . . 0.0 109.563 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.7 t -152.64 97.98 2.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.301 0.64 . . . . 0.0 110.576 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -100.98 89.86 3.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.301 1.04 . . . . 0.0 109.636 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 p -84.39 93.53 8.29 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.13 144.31 27.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.533 0.733 . . . . 0.0 111.333 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -165.35 131.69 2.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.763 0.825 . . . . 0.0 109.354 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 m -86.44 86.76 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 122.186 0.993 . . . . 0.0 110.923 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -144.96 117.51 8.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.324 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.53 47.91 0.28 Allowed Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.118 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 p -81.19 148.68 29.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.719 0.807 . . . . 0.0 110.282 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -151.88 67.39 7.13 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.098 0.559 . . . . 0.0 109.696 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 22' ' ' VAL . 77.5 Cg_endo -99.21 124.3 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.928 2.419 . . . . 0.0 112.382 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -103.64 86.46 2.63 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.433 0.635 . . . . 0.0 109.752 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.83 161.16 42.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.597 1.159 . . . . 0.0 108.445 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.23 -54.3 35.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.471 0.708 . . . . 0.0 111.535 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' VAL . 41.6 tp -69.88 -51.71 30.96 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.837 0.455 . . . . 0.0 111.098 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 17' ' ' PRO . 11.3 m -45.56 -29.51 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -72.43 -44.18 62.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.436 0.695 . . . . 0.0 110.564 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 28' ' ' ILE . 1.2 m -67.98 -33.75 63.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.004 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.15 73.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.554 1.141 . . . . 0.0 112.241 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -69.07 -23.95 64.1 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.281 0.632 . . . . 0.0 110.632 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.51 -14.29 25.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.63 0.772 . . . . 0.0 111.788 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 96.3 mt -83.93 125.77 72.08 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 18.3 Cg_exo -67.04 157.85 59.71 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.423 2.749 . . . . 0.0 112.848 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -72.54 28.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.4 -144.56 7.8 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 118.364 0.529 . . . . 0.0 113.716 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 31.1 mmmt -70.7 115.44 9.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.65 0.78 . . . . 0.0 109.666 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 50.2 mt -107.21 121.85 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 90' ' ' ILE . 55.3 tp -101.54 111.18 23.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HA ' HG13 ' A' ' 99' ' ' VAL . 51.1 t -102.61 110.12 21.96 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.445 0.698 . . . . 0.0 109.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.0 164.08 26.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.809 0.337 . . . . 0.0 111.695 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -37.51 118.31 0.63 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.238 1.815 . . . . 0.0 114.814 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.673 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -124.36 -18.44 5.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.14 0.976 . . . . 0.0 110.837 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.69 -37.29 3.52 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.37 -44.78 20.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 0.0 112.439 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.97 85.84 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.398 -162.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -83.14 -52.95 6.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.819 1.248 . . . . 0.0 110.338 -174.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 24.9 m-80 -61.32 -40.43 94.18 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.815 -174.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.45 11.76 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.203 0.94 . . . . 0.0 111.524 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 70' ' ' LEU . 33.7 m -63.04 -33.78 76.17 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.782 0.833 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 79.4 t80 -63.34 -50.12 71.25 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.723 0.639 . . . . 0.0 110.218 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD13 HG11 ' A' ' 99' ' ' VAL . 63.9 mt -68.45 -29.48 68.13 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.579 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.44 -40.79 66.78 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.326 0.651 . . . . 0.0 112.006 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.727 ' HA ' HG11 ' A' ' 76' ' ' VAL . 58.1 p -72.2 -3.84 25.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.384 0.674 . . . . 0.0 112.762 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.2 mt -80.61 7.3 10.38 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 122.955 0.502 . . . . 0.0 110.735 165.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.68 24.35 39.17 Favored Glycine 0 C--N 1.361 1.939 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -126.04 162.4 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.059 0.929 . . . . 0.0 111.951 -172.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -88.94 91.45 8.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.24 1.016 . . . . 0.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.28 107.08 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.824 0.821 . . . . 0.0 110.727 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 m -87.27 108.89 19.15 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.188 1.395 . . . . 0.0 108.982 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.18 129.57 48.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.987 0.515 . . . . 0.0 109.643 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.8 t -111.94 118.52 57.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' H ' HD21 ' A' ' 64' ' ' LEU . 32.6 t70 -128.53 145.76 51.03 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.729 1.149 . . . . 0.0 110.621 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.02 -31.06 62.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.853 1.661 . . . . 0.0 113.211 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 m -116.13 144.1 44.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 0.0 110.252 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.6 p -68.65 -24.63 64.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.481 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.02 -33.94 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.497 0.719 . . . . 0.0 111.821 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 -30.82 67.62 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.371 0.419 . . . . 0.0 112.237 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 58' ' ' ASP . 81.5 mt -76.19 -42.31 46.75 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.983 0.913 . . . . 0.0 111.244 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.09 93.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.872 0.869 . . . . 0.0 111.93 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -67.02 -40.15 87.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.86 0.464 . . . . 0.0 110.755 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -56.95 -52.76 63.96 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 124.069 0.856 . . . . 0.0 110.406 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.0 -51.14 63.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 111.856 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.47 -47.45 81.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.918 0.887 . . . . 0.0 111.971 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.8 tp -64.52 -33.38 75.77 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.423 0.452 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.29 -51.03 49.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.413 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -66.52 -29.23 69.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.67 0.788 . . . . 0.0 110.257 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -63.18 -44.94 93.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.949 0.899 . . . . 0.0 110.276 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -85.05 -6.17 59.33 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.438 0.695 . . . . 0.0 111.569 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 40.07 12.32 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 120.391 -0.116 . . . . 0.0 113.226 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.2 m -139.64 174.22 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 124.452 1.101 . . . . 0.0 109.443 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -123.69 144.13 49.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.182 0.593 . . . . 0.0 112.316 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 mm -114.88 161.07 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 166.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.2 m -121.8 104.66 9.73 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 p -92.57 123.19 35.68 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.679 -0.638 . . . . 0.0 110.487 -167.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.1 t -115.61 141.07 34.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.192 1.397 . . . . 0.0 107.819 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -80.06 134.31 36.19 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.2 p -55.24 105.11 0.15 Allowed 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.146 0.978 . . . . 0.0 111.493 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.71 87.04 2.03 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.467 ' HB2' HD22 ' A' ' 109' ' ' LEU . 88.8 mt -94.24 -9.82 34.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.928 0.491 . . . . 0.0 110.537 -171.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.36 4.38 43.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.903 0.881 . . . . 0.0 110.319 170.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -130.96 -41.49 1.14 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.773 0.829 . . . . 0.0 110.812 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -156.76 121.72 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.234 1.014 . . . . 0.0 108.275 -169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.21 -69.6 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.652 -0.655 . . . . 0.0 109.626 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 117' ' ' VAL . 18.1 pt -149.88 131.27 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.899 0.879 . . . . 0.0 109.958 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.79 145.63 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.813 1.245 . . . . 0.0 109.171 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -88.41 -30.71 19.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.13 0.572 . . . . 0.0 110.743 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.95 -61.26 2.07 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.712 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.67 -29.27 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' NE1' HD22 ' A' ' 34' ' ' LEU . 37.3 m95 -113.63 144.69 42.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 109.871 -171.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 29' ' ' PRO . 15.8 tp10 -98.19 -46.3 5.89 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.479 1.112 . . . . 0.0 109.494 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -114.58 141.52 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.354 171.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 90' ' ' ILE . 63.7 mt -117.99 150.62 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 169.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG11 HD13 ' A' ' 47' ' ' LEU . 7.0 p -145.9 129.15 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 124.121 0.968 . . . . 0.0 109.01 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.3 m -129.57 94.2 3.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.673 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 22.1 mm -70.73 143.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -15.26 104.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.404 1.882 . . . . 0.0 114.834 -170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.506 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 45.6 t -100.64 115.78 31.0 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.006 -174.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -121.71 98.41 5.94 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 95.0 mt -108.79 155.75 40.14 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.386 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.02 143.33 83.54 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.589 2.193 . . . . 0.0 110.681 162.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.605 ' H ' HD22 ' A' ' 149' ' ' LEU . 41.4 m -50.14 -24.75 2.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.533 1.133 . . . . 0.0 113.288 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.3 m -56.39 -57.61 11.54 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.414 0.685 . . . . 0.0 110.336 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 85' ' ' LEU . 89.2 mt -79.71 -32.8 41.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.69 0.796 . . . . 0.0 110.032 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.561 ' HD3' ' HG3' ' A' ' 151' ' ' PRO . 8.4 tmm_? -74.02 -58.84 3.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.003 1.321 . . . . 0.0 109.959 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -68.55 -10.3 54.87 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.256 0.622 . . . . 0.0 112.373 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -88.5 -33.67 17.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 66.3 tp -67.86 -47.74 68.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.708 0.803 . . . . 0.0 111.514 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.49 -39.14 45.86 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.2 -32.08 92.46 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.919 165.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -81.24 -17.89 47.92 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.528 0.731 . . . . 0.0 111.249 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.537 ' HA ' HD11 ' A' ' 90' ' ' ILE . 9.5 t -83.96 -43.07 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 172.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.03 -48.9 78.22 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.27 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -79.08 -43.68 23.66 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.05 -20.4 16.3 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 116.711 1.444 . . . . 0.0 116.711 -164.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.511 HD12 HD12 ' A' ' 98' ' ' ILE . 16.7 tp -62.26 128.94 38.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.188 0.994 . . . . 0.0 110.025 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 16.7 tttp -70.65 142.39 88.64 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.94 109.05 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.347 1.365 . . . . 0.0 109.494 160.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.08 10.1 6.41 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.559 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.8 143.02 16.45 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 170.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.0 m -108.55 129.6 62.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 123.973 0.909 . . . . 0.0 109.466 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -112.5 112.19 23.55 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 101' ' ' ILE . 95.8 mt -110.25 113.97 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 109.304 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 190' ' ' LEU . 96.2 mt -124.34 114.91 20.16 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.34 107.96 4.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.29 1.036 . . . . 0.0 108.952 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.0 86.06 0.09 OUTLIER Glycine 0 N--CA 1.479 1.512 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.172 169.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.506 ' O ' HD23 ' A' ' 187' ' ' LEU . 95.3 m-85 -143.29 150.36 39.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 136' ' ' GLN . . . -175.51 167.65 1.73 Allowed Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.74 -46.24 9.34 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 121.392 1.395 . . . . 0.0 110.572 165.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -3.88 57.58 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -176.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 133' ' ' ALA . 26.2 tp60 -45.95 -63.58 0.94 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -170.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.546 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 9.9 mt -82.49 -15.22 53.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.587 0.755 . . . . 0.0 111.57 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.56 -20.13 62.94 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.531 0.732 . . . . 0.0 111.296 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 141' ' ' THR . 6.7 m-30 -53.66 -34.96 60.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.869 1.268 . . . . 0.0 112.503 172.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.3 t30 71.45 -0.81 2.99 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.159 1.383 . . . . 0.0 111.834 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.437 HG22 ' HB3' ' A' ' 139' ' ' TYR . 12.0 t -112.61 -8.93 13.79 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.26 1.024 . . . . 0.0 109.95 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -143.94 74.53 0.32 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.523 ' HA2' HD22 ' A' ' 137' ' ' LEU . . . 177.4 117.47 0.52 Allowed Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.282 -1.288 . . . . 0.0 111.524 -173.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.5 -20.32 65.81 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.7 2.267 . . . . 0.0 114.548 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' A' ' 149' ' ' LEU . 11.7 ptmm? -168.22 -38.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.929 0.786 . . . . 0.0 111.43 170.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.517 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 31.8 t70 178.79 151.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.39 0.676 . . . . 0.0 110.3 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HG ' ' HB2' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -52.62 -6.95 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 126.411 1.884 . . . . 0.0 115.786 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.94 -30.42 58.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.398 0.679 . . . . 0.0 111.224 168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.637 HD11 ' HG2' ' A' ' 145' ' ' LYS . 13.6 mt -79.53 8.49 6.28 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.766 1.226 . . . . 0.0 112.449 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 132' ' ' PHE . 41.1 mt -104.93 98.1 14.6 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.223 0.609 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.621 ' HG2' HD21 ' A' ' 156' ' ' LEU . 90.1 Cg_endo -84.0 126.58 3.89 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.871 165.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -72.82 173.13 9.59 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.749 0.819 . . . . 0.0 111.708 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.571 HD22 HD21 ' A' ' 190' ' ' LEU . 20.1 mt -55.95 -38.53 70.47 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.106 0.562 . . . . 0.0 112.212 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.02 -37.31 74.07 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.705 0.628 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.2 m -73.39 -51.95 15.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.219 0.608 . . . . 0.0 109.914 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.621 HD21 ' HG2' ' A' ' 151' ' ' PRO . 82.7 mt -65.7 -55.65 16.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.576 1.151 . . . . 0.0 112.008 -170.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.612 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.3 tt0 -59.03 -34.81 72.33 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 175.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.9 t -81.06 -13.25 58.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.144 0.429 . . . . 0.0 111.889 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -7.67 29.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.945 0.498 . . . . 0.0 110.315 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 89.2 mt -139.46 59.95 15.52 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.946 1.298 . . . . 0.0 108.079 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.55 -22.58 32.84 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.726 2.284 . . . . 0.0 113.745 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 p -81.83 -40.08 23.02 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.6 tp -70.8 68.5 0.42 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.814 1.246 . . . . 0.0 111.602 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -65.13 140.35 58.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.612 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 22.0 m95 -100.88 135.29 42.56 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.742 0.817 . . . . 0.0 109.349 -167.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.9 mt -72.03 -30.81 65.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.64 0.776 . . . . 0.0 110.44 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.9 mt -130.46 125.45 59.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.39 79.97 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -131.15 142.45 50.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.806 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -88.59 132.44 34.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.878 0.871 . . . . 0.0 109.955 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 34.2 mt -110.05 114.24 27.6 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.1 121.06 15.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.703 ' HB3' ' HB3' ' A' ' 185' ' ' ALA . 52.5 ttt180 -90.2 121.53 32.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.33 99.87 12.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.24 141.16 28.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.611 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.35 122.67 22.41 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.926 0.766 . . . . 0.0 109.708 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.62 139.62 58.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.404 0.682 . . . . 0.0 110.272 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.62 -49.83 0.09 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.82 -39.65 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.07 170.78 11.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.614 1.165 . . . . 0.0 109.54 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -64.66 -30.12 71.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.73 0.812 . . . . 0.0 109.6 168.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -104.57 177.58 4.81 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 124.602 1.161 . . . . 0.0 110.354 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.52 113.81 0.3 Allowed Glycine 0 C--N 1.334 0.471 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -159.66 178.52 9.75 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . . . -155.71 173.91 16.06 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -130.22 114.78 16.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 27.8 mt -104.27 158.04 16.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.519 ' HB ' HD21 ' A' ' 153' ' ' LEU . 3.7 pt -146.36 124.68 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.944 0.793 . . . . 0.0 110.473 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -93.27 145.56 24.35 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.986 0.914 . . . . 0.0 110.091 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 129' ' ' LEU . 54.9 mt -134.0 143.91 48.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 110.391 172.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.2 tp -142.96 108.29 5.02 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -92.98 146.43 18.1 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 126' ' ' VAL . 5.9 tp-100 -147.25 155.83 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.15 0.98 . . . . 0.0 109.683 174.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.581 ' HD2' ' HB3' ' A' ' 197' ' ' HIS . 23.1 pttm -61.64 121.45 12.83 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.26 97.7 0.2 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.491 0.186 . . . . 0.0 111.32 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 29.33 37.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.754 2.022 . . . . 0.0 115.884 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 194' ' ' LYS . 10.3 t-80 -64.57 107.58 1.44 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -40.05 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 125.702 1.877 . . . . 0.0 113.088 -158.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -125.64 154.47 42.27 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.837 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -48.7 126.81 12.58 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 124.48 1.113 . . . . 0.0 109.502 162.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -50.72 -31.34 16.3 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.462 1.105 . . . . 0.0 111.99 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 C--O 1.257 1.497 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.723 172.915 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -156.34 52.27 0.53 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.66 85.64 3.31 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.086 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -94.85 26.32 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 mtt85 -81.44 34.04 0.37 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.544 1.138 . . . . 0.0 112.054 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -74.85 84.85 2.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.5 p -106.49 23.9 13.45 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.518 1.127 . . . . 0.0 109.706 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -73.01 92.54 1.67 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.378 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 p -160.94 147.93 15.26 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.854 -172.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -154.86 130.74 10.09 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -135.89 68.97 1.43 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.477 0.711 . . . . 0.0 109.847 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.95 98.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.87 116.17 23.17 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.13 175.29 44.29 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.191 0.307 . . . . 0.0 112.877 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.607 HG23 ' HD3' ' A' ' 17' ' ' PRO . 8.8 t -170.03 -31.86 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.827 1.251 . . . . 0.0 109.319 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 55.39 78.48 0.38 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.522 1.529 . . . . 0.0 112.433 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD3' HG23 ' A' ' 15' ' ' THR . 74.0 Cg_endo -72.81 151.09 50.88 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.902 1.734 . . . . 0.0 110.519 163.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -73.2 83.12 1.34 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.283 0.633 . . . . 0.0 109.782 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -142.48 177.59 8.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.063 0.945 . . . . 0.0 111.696 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -88.51 -30.2 19.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.737 1.215 . . . . 0.0 110.156 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tp -68.59 -43.53 76.3 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.736 0.814 . . . . 0.0 111.505 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.5 m -45.74 -35.32 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -74.36 -46.65 39.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.979 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.608 HG21 HD11 ' A' ' 128' ' ' ILE . 2.2 m -64.64 -37.14 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.082 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.36 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.313 1.045 . . . . 0.0 111.881 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -58.02 -38.97 77.18 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -82.4 -22.76 35.25 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 54.6 mt -75.59 129.31 82.08 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 118.238 0.472 . . . . 0.0 109.949 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.07 130.65 28.48 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.755 2.97 . . . . 0.0 112.296 166.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -77.62 27.71 0.17 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.306 1.443 . . . . 0.0 114.28 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.85 -133.5 5.3 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.498 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -78.0 113.51 15.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 28' ' ' ILE . 34.7 mt -114.24 130.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 95' ' ' TRP . 52.7 tp -100.09 114.27 27.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 53.6 t -101.48 109.73 21.61 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.29 0.636 . . . . 0.0 109.548 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.23 103.45 3.36 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 167.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.49 111.38 22.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.744 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -139.11 -54.8 0.59 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.312 1.045 . . . . 0.0 108.232 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.13 -77.95 0.17 Allowed Glycine 0 C--N 1.353 1.512 0 O-C-N 123.956 0.785 . . . . 0.0 112.638 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 46.0 mt-10 -138.67 128.95 25.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.609 0.763 . . . . 0.0 110.343 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.13 -17.48 77.3 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 31.5 ttt180 -48.79 -45.03 39.59 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.868 1.667 . . . . 0.0 111.217 167.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.546 HD22 HD12 ' A' ' 101' ' ' ILE . 2.7 m-20 -64.75 -41.76 95.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.007 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.98 98.66 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.199 0.6 . . . . 0.0 110.92 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.421 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.9 m -60.46 -39.27 86.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.965 0.906 . . . . 0.0 112.696 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.7 t80 -64.92 -46.64 80.81 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.826 0.703 . . . . 0.0 110.199 177.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 99' ' ' VAL . 70.1 mt -67.62 -33.18 74.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.872 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.21 70.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.145 0.578 . . . . 0.0 111.804 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.745 ' HA ' HG11 ' A' ' 76' ' ' VAL . 93.2 p -72.06 -4.8 30.92 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 81.7 mt -83.84 11.14 8.05 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.265 168.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.09 19.15 78.9 Favored Glycine 0 C--N 1.366 2.218 0 CA-C-N 117.64 0.2 . . . . 0.0 113.174 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -106.44 133.1 51.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 109.257 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.79 90.71 2.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.574 0.702 . . . . 0.0 109.263 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -92.91 108.59 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.814 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.8 p -87.14 111.84 21.34 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.513 1.125 . . . . 0.0 108.607 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.72 126.98 53.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.268 0.627 . . . . 0.0 110.873 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 81' ' ' VAL . 10.9 t -101.69 114.72 41.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' H ' HD21 ' A' ' 64' ' ' LEU . 8.5 t70 -116.17 116.21 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.92 -10.67 2.62 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.678 0.791 . . . . 0.0 112.566 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -115.79 124.15 50.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.374 1.07 . . . . 0.0 108.595 169.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 m -72.06 -16.57 62.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.232 0.613 . . . . 0.0 111.568 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 31.5 m -62.97 -35.84 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.198 0.599 . . . . 0.0 111.508 170.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 -35.25 56.45 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 58' ' ' ASP . 99.2 mt -63.28 -42.65 99.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.085 0.954 . . . . 0.0 111.011 174.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.4 81.13 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.864 0.728 . . . . 0.0 111.756 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 30.3 mmmt -68.08 -45.03 74.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.04 0.536 . . . . 0.0 111.464 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.5 81.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.973 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -69.45 -42.3 75.12 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.144 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.45 -43.44 77.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.256 0.222 . . . . 0.0 110.939 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.38 -28.12 69.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.559 0.744 . . . . 0.0 110.609 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.08 -53.78 33.91 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.164 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.4 -35.28 75.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.817 0.847 . . . . 0.0 110.618 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -37.93 89.29 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.009 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -86.5 -0.32 55.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.94 0.896 . . . . 0.0 110.842 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.82 33.37 33.93 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-N 116.376 -0.375 . . . . 0.0 112.394 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.6 m -142.2 -177.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.887 1.275 . . . . 0.0 109.892 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 87.2 tttt -141.16 145.69 36.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.914 0.486 . . . . 0.0 111.587 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.8 mm -101.71 167.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 55' ' ' THR . 46.1 m -123.21 104.3 9.07 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -91.85 125.98 36.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.107 0.479 . . . . 0.0 111.253 -165.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 57' ' ' VAL . 84.8 t -101.06 124.01 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 109.401 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -97.85 89.3 4.54 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -145.25 -176.01 4.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.188 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -142.97 122.63 13.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -158.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.75 -8.03 39.3 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.773 0.671 . . . . 0.0 111.894 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.96 60.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.436 1.094 . . . . 0.0 112.459 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -130.45 -24.67 2.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.148 0.579 . . . . 0.0 112.084 -166.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -162.76 127.02 3.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.695 1.198 . . . . 0.0 108.168 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.34 -65.89 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.41 HG22 HD23 ' A' ' 34' ' ' LEU . 20.1 pt -140.42 127.88 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.361 0.664 . . . . 0.0 110.994 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 93' ' ' ASP . 46.8 t -115.55 148.96 17.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 124.546 1.138 . . . . 0.0 109.639 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -90.25 -35.71 15.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.149 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 91' ' ' VAL . 24.0 t70 -77.31 -44.33 30.0 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.645 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.03 44.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.483 ' CD1' HD22 ' A' ' 34' ' ' LEU . 11.6 m95 -123.26 134.13 54.12 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -169.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.39 -55.79 6.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.396 0.678 . . . . 0.0 109.971 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.63 164.44 12.19 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.109 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 121' ' ' LEU . 84.7 mt -134.45 145.44 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 47' ' ' LEU . 10.1 p -128.09 128.8 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 166.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -113.4 91.34 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.587 HD13 HD12 ' A' ' 128' ' ' ILE . 49.9 mm -68.56 136.13 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.104 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -14.03 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.413 2.321 . . . . 0.0 112.888 -171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 29.1 t -95.18 106.13 18.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 112.324 -2.216 . . . . 0.0 109.93 -169.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.45 99.73 9.8 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 75.7 mt -118.11 145.91 38.04 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.682 0.793 . . . . 0.0 110.585 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.63 158.15 58.12 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.693 2.262 . . . . 0.0 110.144 168.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 33.4 t -45.02 -30.58 1.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.822 1.649 . . . . 0.0 113.246 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 p -57.07 -58.27 8.9 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.2 1.0 . . . . 0.0 110.86 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 80.9 mt -83.29 -22.46 32.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.74 0.816 . . . . 0.0 110.236 -175.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 29.1 ttt180 -69.02 -65.13 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.129 1.372 . . . . 0.0 109.717 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -55.41 -29.64 58.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.113 0.565 . . . . 0.0 111.642 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.54 -42.35 64.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.864 0.466 . . . . 0.0 110.699 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 117' ' ' VAL . 51.2 tp -67.99 -44.99 75.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.47 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -61.2 -41.67 81.7 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -167.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.81 -28.03 75.65 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 122.016 1.811 . . . . 0.0 112.292 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -84.87 -14.88 46.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 0.0 110.971 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.695 ' HB ' HD21 ' A' ' 160' ' ' LEU . 4.7 t -86.51 -42.82 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.1 -56.17 24.12 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.511 0.324 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.5 -39.85 19.96 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.3 -25.7 25.52 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -166.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.617 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -66.24 117.65 8.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.803 0.802 . . . . 0.0 109.188 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 62.0 tttm -69.67 133.93 88.5 Favored Pre-proline 0 C--O 1.246 0.883 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.54 112.3 0.66 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.629 2.219 . . . . 0.0 111.143 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . 125.08 13.21 3.67 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.864 -173.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.617 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -100.48 139.85 14.62 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 168.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 32.7 m -109.08 138.88 34.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.762 0.825 . . . . 0.0 109.932 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.53 113.37 25.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.608 HD11 HG21 ' A' ' 24' ' ' VAL . 24.3 mt -107.88 108.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 79.7 mt -130.87 152.04 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.815 0.846 . . . . 0.0 111.315 -174.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 43.9 tt0 -140.61 104.05 4.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.51 167.16 54.79 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -131.08 167.62 18.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.494 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.584 ' HB2' ' H ' ' A' ' 186' ' ' ALA . . . -59.4 155.09 39.36 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.41 1.484 . . . . 0.0 113.123 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -56.6 -25.16 57.83 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.933 2.422 . . . . 0.0 113.579 166.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.07 -30.06 68.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.302 1.041 . . . . 0.0 113.586 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.674 ' HG3' HD23 ' A' ' 137' ' ' LEU . 54.6 tp60 -54.57 -62.97 1.31 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -161.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 136' ' ' GLN . 7.0 mt -90.41 -10.33 44.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.038 0.835 . . . . 0.0 110.643 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -49.98 -24.17 2.43 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.925 1.69 . . . . 0.0 114.929 -164.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -52.91 -33.55 50.96 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.684 1.194 . . . . 0.0 110.809 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -115.48 148.5 39.38 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.5 m -134.81 -3.58 2.55 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.083 0.553 . . . . 0.0 110.84 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.06 -95.63 0.13 Allowed Glycine 0 C--N 1.356 1.661 0 CA-C-N 116.789 -0.187 . . . . 0.0 112.658 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.39 -157.76 32.7 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-O 118.202 -1.332 . . . . 0.0 111.192 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -41.55 137.09 2.72 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.56 2.84 . . . . 0.0 112.828 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.487 ' HA ' HD13 ' A' ' 137' ' ' LEU . 52.8 mtmt 76.55 66.44 0.05 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.73 1.612 . . . . 0.0 108.144 -154.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -149.78 15.0 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.18 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 137' ' ' LEU . 0.5 OUTLIER 62.93 -1.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 126.098 1.759 . . . . 0.0 115.744 -175.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.59 -24.37 60.06 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.985 0.421 . . . . 0.0 109.945 171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.18 -7.36 51.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.947 0.899 . . . . 0.0 112.762 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 45.8 mt -97.88 100.92 9.43 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.86 120.76 4.34 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.573 1.515 . . . . 0.0 110.245 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.419 ' HA ' HD11 ' A' ' 188' ' ' ILE . 32.6 mmtp -87.89 171.58 10.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.684 0.794 . . . . 0.0 111.775 -173.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD22 HD21 ' A' ' 190' ' ' LEU . 32.2 mt -59.23 -40.97 87.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -48.54 -50.9 30.11 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.74 1.216 . . . . 0.0 110.857 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 26.6 m -65.88 -62.36 1.54 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.701 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.429 HD13 HD13 ' A' ' 129' ' ' LEU . 25.2 mt -72.57 -46.56 53.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 112.707 -162.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.537 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.1 tt0 -53.4 -46.11 69.59 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 123.44 0.462 . . . . 0.0 111.025 171.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.3 t -70.77 -32.42 69.54 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.525 0.33 . . . . 0.0 111.841 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -85.7 -5.61 59.24 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.131 0.572 . . . . 0.0 111.951 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 117' ' ' VAL . 82.7 mt -140.51 74.68 28.04 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 -45.72 24.03 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.859 3.039 . . . . 0.0 113.156 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 m -84.85 -29.82 24.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.778 0.431 . . . . 0.0 110.499 -171.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.1 tp -70.21 68.54 0.34 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.054 0.942 . . . . 0.0 111.455 170.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -62.63 133.38 54.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 32.2 m95 -95.77 129.65 42.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.811 0.844 . . . . 0.0 109.401 -167.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.43 -33.73 76.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.67 0.788 . . . . 0.0 110.378 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 80.6 mt -132.7 121.93 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.23 84.57 1.13 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -150.42 148.66 29.03 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.08 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -86.35 116.48 24.54 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.089 0.956 . . . . 0.0 108.691 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.5 mt -110.68 125.06 53.06 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.351 1.06 . . . . 0.0 108.362 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.34 124.07 35.26 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 122.85 0.46 . . . . 0.0 110.004 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -94.03 139.68 30.65 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.168 0.587 . . . . 0.0 110.146 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.34 98.91 11.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 109.664 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.22 169.59 17.16 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.116 0.966 . . . . 0.0 109.186 169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.63 120.2 13.04 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.61 146.97 53.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.71 -45.38 0.15 Allowed Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.79 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.52 96.41 0.37 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 0.0 110.333 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 26.0 t80 59.93 47.8 9.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.664 1.186 . . . . 0.0 109.398 -172.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 69.03 3.29 3.97 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.37 1.468 . . . . 0.0 113.116 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.56 155.69 50.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.86 0.464 . . . . 0.0 111.32 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.36 69.3 0.52 Allowed Glycine 0 C--O 1.219 -0.835 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -93.44 157.02 16.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.972 0.909 . . . . 0.0 111.032 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.08 130.1 23.27 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.584 ' H ' ' HB2' ' A' ' 133' ' ' ALA . . . -89.13 103.85 16.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.64 149.53 32.71 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 22.1 pt -134.17 118.7 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.354 0.525 . . . . 0.0 110.062 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.68 138.6 31.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.834 0.349 . . . . 0.0 110.323 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 153' ' ' LEU . 49.5 mt -129.51 128.38 42.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.532 1.133 . . . . 0.0 109.41 173.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.7 tp -125.13 106.23 9.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.11 139.97 16.56 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 171.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -144.68 152.64 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HE2' ' HB3' ' A' ' 196' ' ' GLU . 19.5 pttm -57.64 155.19 10.23 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 123.75 0.656 . . . . 0.0 110.089 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 mt -79.7 130.92 35.77 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.583 ' HB3' ' HE2' ' A' ' 194' ' ' LYS . 0.9 OUTLIER -120.07 48.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 122.54 1.162 . . . . 0.0 108.826 174.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -77.05 75.28 3.62 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.199 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 55.53 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 112.393 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 196' ' ' GLU . 11.3 m-70 -91.97 176.99 6.31 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.423 0.63 . . . . 0.0 111.204 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -65.5 -22.97 66.78 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.858 167.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -62.17 105.89 0.66 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.409 0.683 . . . . 0.0 109.716 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 CA--C 1.551 0.996 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.285 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.9 -15.03 58.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -165.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.36 -24.6 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.726 0.694 . . . . 0.0 110.28 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 89.7 p -70.0 -47.5 61.91 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.4 m -64.13 -41.29 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.365 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.43 74.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.173 0.989 . . . . 0.0 111.978 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -27.66 67.87 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.52 0.728 . . . . 0.0 109.338 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 23' ' ' SER . 75.5 mm-40 -82.88 -33.07 27.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.678 0.791 . . . . 0.0 110.971 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -73.06 131.09 83.96 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.34 84.11 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.768 2.312 . . . . 0.0 111.877 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.05 29.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.05 -134.24 5.42 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.396 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -89.63 110.48 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -172.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG22 HG12 ' A' ' 99' ' ' VAL . 36.6 mt -113.58 117.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.689 0.796 . . . . 0.0 110.63 -166.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 95' ' ' TRP . 48.3 tp -92.01 113.25 25.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.907 0.483 . . . . 0.0 111.033 -173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 56.8 m -92.64 137.74 32.1 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 90' ' ' ILE . 40.8 mt -89.41 161.84 16.08 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 170.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 O-C-N 124.831 1.332 . . . . 0.0 112.842 175.329 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -65.37 -31.62 72.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.464 1.106 . . . . 0.0 110.196 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.3 m-20 -62.51 -30.9 71.62 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.423 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.82 79.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.159 0.583 . . . . 0.0 110.871 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.49 -29.97 69.54 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.668 0.787 . . . . 0.0 112.098 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.22 -48.42 81.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.825 0.85 . . . . 0.0 109.5 172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 50' ' ' LEU . 78.6 mt -66.78 -31.45 72.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.896 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -38.2 77.0 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.275 0.63 . . . . 0.0 111.979 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 38.5 p -70.4 -9.47 56.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 47' ' ' LEU . 72.3 mt -81.27 6.92 12.71 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.481 . . . . 0.0 111.17 171.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 7.58 85.68 Favored Glycine 0 C--N 1.36 1.879 0 CA-C-N 117.681 0.218 . . . . 0.0 113.072 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -92.04 143.42 26.48 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.477 0.711 . . . . 0.0 109.325 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 44.1 mt-10 -84.59 96.81 9.29 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.4 t -96.87 128.29 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.004 0.522 . . . . 0.0 110.474 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.9 t -114.15 111.1 21.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.316 1.446 . . . . 0.0 108.714 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.98 136.1 43.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.018 0.527 . . . . 0.0 111.08 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.03 144.25 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -152.29 139.09 18.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 159.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.76 -13.11 62.18 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.681 0.613 . . . . 0.0 111.046 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -117.82 143.0 46.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.193 1.397 . . . . 0.0 109.741 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -73.89 -22.65 59.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.56 0.744 . . . . 0.0 111.219 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.33 -38.58 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.045 0.538 . . . . 0.0 111.814 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -40.05 40.04 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.369 0.418 . . . . 0.0 112.08 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 80' ' ' THR . 91.5 mt -65.6 -52.16 54.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.016 0.926 . . . . 0.0 111.947 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.86 75.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.926 0.89 . . . . 0.0 112.371 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -71.02 -42.03 70.09 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.34 0.656 . . . . 0.0 110.888 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.01 92.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.263 0.625 . . . . 0.0 110.548 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -75.02 -32.14 61.54 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 110.63 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -63.04 -51.1 68.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.57 0.748 . . . . 0.0 110.923 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 tp -65.25 -27.32 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.04 0.837 . . . . 0.0 110.56 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -60.15 -59.63 5.1 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 122.92 0.488 . . . . 0.0 110.597 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.19 -36.44 81.91 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.919 0.888 . . . . 0.0 110.693 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.54 -25.52 63.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.895 0.878 . . . . 0.0 111.666 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -100.33 -3.45 31.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.873 0.869 . . . . 0.0 111.073 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.33 28.27 56.06 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.014 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -132.58 165.53 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.057 0.943 . . . . 0.0 110.749 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -112.22 135.46 52.86 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.607 0.763 . . . . 0.0 111.247 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.628 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.0 mm -110.78 161.33 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 165.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -114.97 112.74 23.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 166.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 64' ' ' LEU . 85.5 m -84.15 110.73 18.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.973 0.909 . . . . 0.0 110.402 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.58 127.17 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 0.0 108.508 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -110.02 95.4 5.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -139.67 -175.15 4.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.657 1.183 . . . . 0.0 109.515 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -143.21 131.15 21.62 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -159.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 22.0 mt -73.28 -3.53 27.54 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.15 3.34 41.04 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.101 0.96 . . . . 0.0 112.845 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.4 -43.04 0.16 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.006 0.821 . . . . 0.0 112.34 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.54 112.63 4.29 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.76 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.45 -72.32 0.41 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -166.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG23 HD21 ' A' ' 36' ' ' LEU . 4.6 pt -137.72 111.0 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.534 1.134 . . . . 0.0 109.745 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 94' ' ' ALA . 47.3 t -124.84 88.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.2 -1.15 4.04 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.67 -48.18 14.12 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.457 0.703 . . . . 0.0 109.632 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -75.65 -35.97 60.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.562 0.745 . . . . 0.0 111.844 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CD1' HD22 ' A' ' 34' ' ' LEU . 57.6 m95 -104.16 174.74 5.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.984 0.914 . . . . 0.0 108.978 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -109.22 -45.78 3.68 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.878 0.37 . . . . 0.0 110.691 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.62 162.76 24.13 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.6 ' HB ' ' HA3' ' A' ' 125' ' ' GLY . 90.5 mt -137.2 145.35 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.593 0.757 . . . . 0.0 110.038 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.466 HG12 HG22 ' A' ' 33' ' ' ILE . 9.0 p -132.94 124.45 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.343 1.057 . . . . 0.0 108.21 165.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 m -120.13 94.98 4.57 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.05 134.17 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.525 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 1.5 p90 -18.78 111.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 126.739 2.016 . . . . 0.0 115.563 -168.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 25.8 p -66.94 106.65 1.98 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.267 -1.788 . . . . 0.0 111.588 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -96.18 97.6 9.66 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 85' ' ' LEU . 91.6 mt -139.54 138.97 21.09 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.37 0.668 . . . . 0.0 110.431 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.0 160.63 43.43 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.34 2.694 . . . . 0.0 110.874 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 t -46.44 -33.25 3.82 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.791 1.236 . . . . 0.0 113.47 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 36.4 m -55.52 -64.2 0.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.678 0.791 . . . . 0.0 111.623 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.14 -22.36 45.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.835 0.454 . . . . 0.0 110.527 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -69.66 -53.92 16.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.659 1.184 . . . . 0.0 110.1 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.07 -11.28 58.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 112.879 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 108' ' ' SER . 15.6 mm100 -81.92 -38.71 24.85 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.6 tp -76.54 -43.82 37.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -58.8 -44.57 99.12 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 119.457 1.026 . . . . 0.0 112.805 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.69 -28.42 86.35 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.37 2.046 . . . . 0.0 113.745 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.78 -28.01 60.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.204 0.602 . . . . 0.0 111.635 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.1 t -85.37 -27.38 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.848 0.832 . . . . 0.0 109.71 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -73.48 -63.86 1.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.388 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -76.7 -49.37 16.25 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.19 -39.15 32.58 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 114.069 0.387 . . . . 0.0 114.069 -169.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 30.1 tp -78.53 103.25 8.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.66 148.35 51.49 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 165.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.583 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 60.9 Cg_exo -43.24 127.24 5.3 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.152 3.235 . . . . 0.0 115.003 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 128.64 10.04 3.37 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.776 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -119.18 152.72 17.15 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 164.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.81 136.44 44.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 123.603 0.761 . . . . 0.0 109.861 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.0 113.04 26.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -103.83 107.99 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.4 mt -121.86 121.51 37.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.741 0.816 . . . . 0.0 110.362 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 36.5 tt0 -115.68 98.98 7.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 168.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.01 174.86 46.17 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.699 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.464 ' HB2' HD22 ' A' ' 150' ' ' LEU . 50.7 m-85 -127.87 160.84 30.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 123.22 0.608 . . . . 0.0 109.695 176.557 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 132' ' ' PHE . 44.0 mt -89.37 111.07 43.31 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.639 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.5 Cg_endo -79.98 108.71 2.27 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 122.017 1.812 . . . . 0.0 110.211 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.597 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 tttm -105.3 155.32 19.2 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.812 -0.555 . . . . 0.0 110.796 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.8 mt -50.51 -38.06 42.37 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.238 1.015 . . . . 0.0 111.937 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.51 -53.88 20.96 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 125.045 1.466 . . . . 0.0 109.776 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 35.3 m -71.94 -57.62 4.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.74 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.639 HD11 ' HB2' ' A' ' 151' ' ' PRO . 73.1 mt -62.21 -54.32 42.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.398 1.079 . . . . 0.0 112.309 -165.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.56 -35.67 81.73 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.645 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 t -61.36 -37.2 82.51 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.718 0.407 . . . . 0.0 111.829 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 155' ' ' THR . 23.4 mm-40 -83.72 -8.02 59.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.672 0.389 . . . . 0.0 111.31 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.5 mt -138.9 71.78 41.66 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.545 0.738 . . . . 0.0 110.125 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.29 -5.55 13.56 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.402 2.735 . . . . 0.0 111.761 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.5 p -89.71 -41.39 11.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.592 1.157 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 15.2 tp -90.62 71.67 6.8 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.623 1.569 . . . . 0.0 110.043 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -63.84 135.07 56.29 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.406 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 33.1 m95 -94.24 128.89 40.97 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.644 1.178 . . . . 0.0 109.999 -166.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.96 -34.25 77.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.543 0.737 . . . . 0.0 110.205 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 70.7 mt -126.14 125.9 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.17 76.87 1.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.052 0.941 . . . . 0.0 109.426 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.96 154.87 35.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.64 117.48 22.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.354 0.662 . . . . 0.0 109.743 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -111.94 130.31 55.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.203 0.601 . . . . 0.0 110.158 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.812 0.845 . . . . 0.0 110.541 -178.407 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.5 mt -122.21 165.87 15.49 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 152' ' ' LYS . 15.4 pt -138.58 141.3 37.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.73 143.81 51.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.206 0.527 . . . . 0.0 110.736 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 54.1 mt -135.08 129.0 33.29 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.597 1.559 . . . . 0.0 108.768 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 24' ' ' VAL . 30.2 tp -122.14 106.04 10.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.08 140.64 17.86 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 170.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.94 0.896 . . . . 0.0 110.48 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 80.4 tttt -55.9 123.52 14.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 123.742 0.651 . . . . 0.0 109.411 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 CA--C 1.543 0.676 0 O-C-N 123.098 0.249 . . . . 0.0 110.347 179.219 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.5 t80 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.506 0.193 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.584 HD21 ' HG ' ' A' ' 47' ' ' LEU . 33.7 tp -58.81 -35.7 73.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.389 0.676 . . . . 0.0 111.809 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.37 -40.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.2 p -79.75 -51.45 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.258 0.551 . . . . 0.0 111.108 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 128' ' ' ILE . 26.5 m -63.41 -34.24 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.373 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.72 76.87 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.324 1.05 . . . . 0.0 111.987 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.06 -31.84 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.107 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HB3' HE21 ' A' ' 193' ' ' GLN . 29.8 mm-40 -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.848 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 24' ' ' VAL . 79.1 mt -69.79 128.21 92.05 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-O 119.003 -0.523 . . . . 0.0 109.735 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.35 115.04 1.54 Allowed 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.859 2.372 . . . . 0.0 111.369 164.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.47 32.67 0.13 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.809 1.644 . . . . 0.0 114.306 -166.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.94 -129.59 5.56 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-O 118.776 -1.014 . . . . 0.0 110.922 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -69.29 111.23 5.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.458 1.129 . . . . 0.0 109.897 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.03 119.5 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 89' ' ' ASP . 56.4 tp -98.24 121.06 39.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.901 0.481 . . . . 0.0 110.598 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -104.73 134.0 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.999 1.32 . . . . 0.0 109.422 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.78 152.58 18.35 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.629 0.372 . . . . 0.0 110.9 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 123.279 0.632 . . . . 0.0 111.711 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -65.31 -44.69 87.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 110.334 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -65.73 -31.3 72.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.209 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.66 -58.35 8.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.651 0.78 . . . . 0.0 111.659 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.2 p -65.93 -27.34 68.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.961 0.504 . . . . 0.0 112.086 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 51.0 t80 -68.5 -36.9 79.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.889 0.476 . . . . 0.0 110.098 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 21' ' ' LEU . 55.6 mt -68.56 -32.29 72.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.327 0.651 . . . . 0.0 111.054 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.32 -33.87 61.2 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.47 0.308 . . . . 0.0 110.321 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -63.19 -19.2 64.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.149 0.98 . . . . 0.0 111.36 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 84.1 mt -82.07 14.23 2.95 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.89 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 33.7 58.31 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 123.295 0.474 . . . . 0.0 114.163 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -125.44 156.12 39.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.718 0.759 . . . . 0.0 110.628 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.53 97.51 7.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.481 0.712 . . . . 0.0 109.75 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -105.96 119.11 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.116 0.484 . . . . 0.0 111.501 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -84.97 112.3 20.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.32 120.48 40.32 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 81' ' ' VAL . 82.2 t -98.66 121.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.84 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 19.6 t70 -139.47 129.33 24.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -54.74 -26.92 37.22 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.782 1.233 . . . . 0.0 112.987 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.491 ' HB2' HG22 ' A' ' 62' ' ' VAL . 47.6 m -113.25 160.68 18.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.779 0.831 . . . . 0.0 111.386 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -69.81 -21.39 63.4 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.526 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 60' ' ' SER . 6.5 m -62.11 -43.8 98.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.183 0 C-N-CA 122.895 0.478 . . . . 0.0 111.992 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.28 -34.88 19.24 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 71.3 mt -67.66 -58.31 4.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.594 0.758 . . . . 0.0 111.773 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.46 70.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.321 0.649 . . . . 0.0 112.287 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.41 -42.3 71.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.883 0.473 . . . . 0.0 110.529 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.44 95.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.682 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -68.97 -34.97 76.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.559 1.144 . . . . 0.0 111.296 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -54.89 -48.51 72.91 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.087 0.955 . . . . 0.0 110.648 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.86 -29.25 64.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.057 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -58.54 -62.58 1.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.63 0.581 . . . . 0.0 111.069 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.21 -40.12 89.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.239 0.616 . . . . 0.0 111.665 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.95 -40.32 95.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.727 0.811 . . . . 0.0 111.55 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -103.92 -5.46 22.25 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.889 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 43.78 36.23 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.875 0.153 . . . . 0.0 113.206 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.76 172.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.316 1.047 . . . . 0.0 109.499 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.05 132.42 54.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.98 0.512 . . . . 0.0 111.497 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 71' ' ' ALA . 23.2 mm -114.42 155.76 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 166.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -121.46 108.21 13.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 165.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.7 t -86.62 113.49 22.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.209 0.603 . . . . 0.0 110.855 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 57' ' ' VAL . 24.7 t -120.79 139.19 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.307 1.043 . . . . 0.0 109.132 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.05 147.87 27.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 m -67.19 112.68 4.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.419 0.288 . . . . 0.0 111.338 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -144.01 89.06 2.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 165.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.42 -38.55 18.55 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.023 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.64 67.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.845 0.858 . . . . 0.0 112.194 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.22 -34.17 20.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.381 0.672 . . . . 0.0 111.499 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -166.74 117.27 0.92 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.348 0.659 . . . . 0.0 109.831 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -128.84 -64.59 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.9 pt -139.79 119.24 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.546 0.738 . . . . 0.0 110.279 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.97 86.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -69.25 2.19 3.11 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.03 -50.3 56.22 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.53 -22.17 47.7 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 34' ' ' LEU . 68.7 m95 -107.45 170.85 7.72 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 0.0 109.867 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -98.98 -56.98 2.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.336 0.589 . . . . 0.0 109.793 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.74 158.4 20.02 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.819 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.688 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 59.7 mt -122.73 153.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.57 136.1 35.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.937 1.295 . . . . 0.0 108.098 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 t -143.8 93.63 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.2 mm -66.9 142.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.703 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 35.4 p90 -15.65 106.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.363 1.865 . . . . 0.0 115.417 -159.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.4 p -70.23 102.0 2.01 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.395 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -99.22 94.2 6.35 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.3 133.33 25.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.56 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -56.78 161.71 9.82 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.285 2.656 . . . . 0.0 112.36 169.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -40.94 -44.1 2.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.815 1.246 . . . . 0.0 112.85 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 m -54.12 -63.82 1.03 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.311 1.044 . . . . 0.0 112.179 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -75.55 -27.72 58.74 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.581 0.352 . . . . 0.0 111.066 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -65.27 -55.4 18.59 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.26 -35.35 26.61 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.608 1.163 . . . . 0.0 112.592 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.71 -17.07 39.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.962 0.505 . . . . 0.0 111.398 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 117' ' ' VAL . 58.6 tp -78.43 -38.42 41.4 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.904 0.482 . . . . 0.0 111.265 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -57.34 -41.13 89.3 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -29.99 84.69 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.967 1.778 . . . . 0.0 112.515 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -81.95 -26.86 33.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.541 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 113' ' ' LEU . 2.5 t -87.35 -24.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.257 0.551 . . . . 0.0 110.675 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -82.08 -65.45 1.01 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.85 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.55 -45.5 15.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.899 0.88 . . . . 0.0 112.853 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.83 -29.87 64.53 Favored Glycine 0 N--CA 1.479 1.523 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.909 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.73 146.16 50.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.205 0.602 . . . . 0.0 110.286 169.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 39.4 mmtm -129.47 158.21 73.99 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 108.063 170.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 194' ' ' LYS . 34.5 Cg_exo -40.18 110.87 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.392 2.728 . . . . 0.0 114.444 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.49 6.59 6.65 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.804 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.688 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -98.97 140.43 15.01 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 170.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 29.0 m -111.47 130.94 64.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.256 0.55 . . . . 0.0 110.3 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -110.03 107.4 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 24' ' ' VAL . 45.2 mt -110.4 107.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 156' ' ' LEU . 29.8 mt -125.73 116.42 21.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -167.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.703 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 45.5 tt0 -105.62 97.64 7.45 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.89 -177.46 46.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.974 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 150' ' ' LEU . 31.5 m-85 -138.21 159.05 43.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.942 0.897 . . . . 0.0 108.863 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 123.555 0.742 . . . . 0.0 110.31 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 132' ' ' PHE . 22.0 mt -90.88 103.24 6.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.98 109.02 2.81 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.617 2.211 . . . . 0.0 110.625 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' HD11 ' A' ' 188' ' ' ILE . 37.3 mtmm -108.0 162.71 13.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.275 0.63 . . . . 0.0 111.905 -168.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 188' ' ' ILE . 24.1 mt -60.15 -36.25 77.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.635 0.774 . . . . 0.0 109.899 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -48.53 -56.93 7.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.719 1.208 . . . . 0.0 110.79 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 57.2 m -71.73 -62.61 1.36 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.739 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 129' ' ' LEU . 24.3 mt -61.74 -55.48 29.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.696 1.198 . . . . 0.0 112.209 -166.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -59.7 -42.05 92.15 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.646 0.779 . . . . 0.0 111.9 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.1 t -63.76 -34.01 76.94 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 155' ' ' THR . 8.5 pt-20 -111.33 18.69 19.0 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.132 0.492 . . . . 0.0 111.251 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -139.74 63.23 25.55 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.108 0.963 . . . . 0.0 108.708 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.43 -8.87 15.01 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.62 2.214 . . . . 0.0 111.919 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.2 t -86.42 -33.09 20.55 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.6 tp -95.13 68.17 3.1 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 108.492 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.39 128.56 36.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 25.4 m95 -88.23 141.02 28.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 110.014 -163.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.34 -36.67 77.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.966 0.506 . . . . 0.0 109.843 170.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.5 mt -127.22 125.53 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.58 85.52 1.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.34 1.056 . . . . 0.0 108.658 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.09 149.59 28.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.565 0.346 . . . . 0.0 111.193 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.57 113.98 20.65 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.535 0.522 . . . . 0.0 109.633 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.9 mt -109.66 128.94 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.196 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.46 154.01 30.07 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 152' ' ' LYS . 3.4 pt -136.14 116.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -97.86 138.1 35.72 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 34.5 mt -126.35 131.63 51.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.806 1.242 . . . . 0.0 108.1 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.515 HD22 HG12 ' A' ' 24' ' ' VAL . 40.1 tp -127.6 105.65 8.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 168.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.98 133.69 11.99 Favored Glycine 0 C--O 1.214 -1.133 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 27' ' ' GLN . 6.5 tp-100 -144.05 156.87 44.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.809 0.844 . . . . 0.0 109.304 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 123' ' ' PRO . 22.8 pttp -60.15 129.07 39.93 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 CA--C 1.54 0.586 0 O-C-N 123.245 0.34 . . . . 0.0 110.581 -177.815 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.477 HD21 ' HG ' ' A' ' 47' ' ' LEU . 33.2 tp -59.26 -31.88 69.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.538 0.735 . . . . 0.0 112.509 -174.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 m -54.79 -38.05 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -68.12 -53.08 27.87 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.955 0.883 . . . . 0.0 110.425 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 128' ' ' ILE . 29.7 m -66.97 -29.27 45.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.546 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.91 72.94 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.249 1.02 . . . . 0.0 112.31 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.05 -35.57 79.02 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.021 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -95.2 -7.63 38.55 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' VAL . 57.9 mt -72.06 138.35 82.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.69 ' HG3' ' HD3' ' A' ' 194' ' ' LYS . 33.7 Cg_exo -59.87 131.83 41.77 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.084 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -70.78 30.37 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.02 -148.93 9.27 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -80.39 118.06 21.69 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -107.63 141.95 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.709 0.804 . . . . 0.0 110.197 -167.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 95' ' ' TRP . 33.0 tp -118.13 116.87 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.329 1.052 . . . . 0.0 109.127 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 26.5 p -107.21 111.93 24.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.277 0.489 . . . . 0.0 110.811 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -70.05 143.06 52.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 O-C-N 123.935 0.772 . . . . 0.0 110.041 -179.32 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.195 0 N-CA-C 112.948 -0.061 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 ttp-105 -70.75 -41.14 72.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.764 0.826 . . . . 0.0 109.891 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.43 -40.59 97.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.53 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.68 -57.27 13.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 111.575 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.651 ' SG ' HD23 ' A' ' 70' ' ' LEU . 20.1 p -61.67 -43.26 99.19 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.375 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -66.32 -46.18 77.75 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.256 0.348 . . . . 0.0 111.184 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' ' 21' ' ' LEU . 97.3 mt -67.05 -33.0 74.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.051 0.54 . . . . 0.0 110.874 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 -33.1 72.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.991 0.517 . . . . 0.0 110.873 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 63.9 m -75.43 -5.6 45.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.3 mt -88.59 13.15 12.77 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.245 0.618 . . . . 0.0 110.167 167.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.56 39.14 30.77 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.74 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -130.12 154.68 47.24 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.161 0.481 . . . . 0.0 111.888 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.19 89.18 7.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.575 0.75 . . . . 0.0 109.056 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.62 110.14 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.319 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 82.1 m -87.09 112.91 22.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.624 1.17 . . . . 0.0 109.79 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -92.31 125.82 37.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.707 0.803 . . . . 0.0 109.913 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' CG1' ' HA ' ' A' ' 83' ' ' SER . 5.6 t -105.37 116.45 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 167.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -135.74 133.93 38.51 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.4 -23.86 67.43 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.679 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.542 ' HB3' HG22 ' A' ' 62' ' ' VAL . 15.8 m -104.13 135.85 44.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.057 0.943 . . . . 0.0 109.814 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -73.11 -25.8 61.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 0.0 109.981 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 60' ' ' SER . 21.2 m -67.85 -36.6 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.258 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.98 -36.28 90.74 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.51 -48.23 70.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.402 1.081 . . . . 0.0 111.5 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.39 84.46 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.688 0.795 . . . . 0.0 112.47 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -77.45 -31.58 53.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.263 0.625 . . . . 0.0 111.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.69 -46.89 87.71 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 171.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.46 -40.95 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.169 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -58.4 -53.42 58.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.022 0.929 . . . . 0.0 110.823 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.651 HD23 ' SG ' ' A' ' 45' ' ' CYS . 19.3 tp -65.69 -28.47 69.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.642 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -54.46 17.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.734 0.414 . . . . 0.0 110.812 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -35.63 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.187 0.595 . . . . 0.0 110.769 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.66 -40.48 97.2 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.851 0.719 . . . . 0.0 110.356 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -91.02 -1.39 57.82 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.981 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.69 32.28 37.75 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 16.3 m -132.71 178.51 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.961 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -132.0 142.16 49.5 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.758 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.0 mm -110.61 170.06 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.97 1.308 . . . . 0.0 108.273 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 71.7 m -121.91 111.89 17.64 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 163.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t -86.08 109.96 19.2 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.592 0.757 . . . . 0.0 111.545 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.22 133.05 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.524 1.129 . . . . 0.0 108.955 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -85.41 132.42 34.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . 58.2 m -61.36 125.92 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -133.42 87.61 2.41 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.5 mt -91.1 -4.58 56.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.506 0.722 . . . . 0.0 110.674 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.39 3.54 54.25 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.825 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.39 -37.81 0.27 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -162.04 104.53 1.16 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -169.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.5 -65.15 0.99 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -174.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 98' ' ' ILE . 9.4 pt -136.32 115.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.479 0.712 . . . . 0.0 110.777 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 94' ' ' ALA . 61.4 t -128.07 94.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.83 -1.43 2.9 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.2 -51.27 9.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 168.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -70.55 -31.47 68.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.37 0.668 . . . . 0.0 111.861 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.488 ' CD1' HD22 ' A' ' 34' ' ' LEU . 24.5 m95 -116.94 145.08 43.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.778 0.831 . . . . 0.0 109.44 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.07 -33.06 44.92 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.178 0.513 . . . . 0.0 110.57 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -139.98 140.11 10.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.872 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 90' ' ' ILE . 82.1 mt -115.58 143.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' LEU . 7.7 p -135.8 134.58 51.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 164.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 m -136.89 113.77 10.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 128' ' ' ILE . 37.1 mm -76.34 144.51 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.735 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 2.9 p90 -20.31 109.36 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.124 1.77 . . . . 0.0 115.148 -173.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.415 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.7 t -80.36 113.48 18.58 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 112.896 -1.956 . . . . 0.0 110.313 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -120.19 98.08 5.9 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -122.1 150.72 57.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.91 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.68 159.53 53.27 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.91 2.407 . . . . 0.0 110.125 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.3 m -37.16 -45.0 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.157 1.783 . . . . 0.0 113.956 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.7 p -49.14 -63.08 1.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 O-C-N 124.675 1.234 . . . . 0.0 111.844 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.24 -22.28 28.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.392 0.677 . . . . 0.0 110.539 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -73.42 -62.93 1.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.129 0.972 . . . . 0.0 110.374 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.31 -15.17 56.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.451 0.7 . . . . 0.0 112.098 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.23 -41.65 27.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 117' ' ' VAL . 46.6 tp -74.86 -48.22 26.1 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.783 -170.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.449 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 34.7 m-85 -66.73 -40.56 32.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.56 -31.74 94.98 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 121.958 1.772 . . . . 0.0 112.281 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -82.65 -14.96 53.77 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.964 0.906 . . . . 0.0 110.057 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 113' ' ' LEU . 22.0 t -80.68 -36.46 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.506 ' HE1' ' HD2' ' A' ' 161' ' ' PRO . 33.0 t80 -57.8 -54.46 46.6 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -71.83 -47.01 56.07 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.806 0.842 . . . . 0.0 112.926 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.09 -45.94 10.99 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 114.276 0.47 . . . . 0.0 114.276 -170.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.1 tp -85.28 95.2 9.12 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -75.75 148.41 82.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 164.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.02 133.27 28.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.201 1.934 . . . . 0.0 110.125 168.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 128.87 -11.73 6.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -157.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.01 168.08 20.87 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 122.726 -0.279 . . . . 0.0 112.593 166.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.08 137.88 48.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.409 1.083 . . . . 0.0 109.45 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.98 113.33 23.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 24' ' ' VAL . 17.9 mt -106.95 109.62 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.934 0.893 . . . . 0.0 108.644 -171.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 156' ' ' LEU . 40.3 mt -125.85 114.1 18.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.995 0.518 . . . . 0.0 109.754 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.735 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 43.2 tt0 -103.47 98.95 8.76 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.91 -176.68 49.24 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.449 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.449 ' HB2' HD22 ' A' ' 150' ' ' LEU . 36.8 m-85 -132.79 158.61 42.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.215 1.006 . . . . 0.0 108.757 -176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.582 0.753 . . . . 0.0 110.553 179.434 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 132' ' ' PHE . 20.9 mt -83.29 107.83 11.04 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -68.82 111.88 2.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.923 2.416 . . . . 0.0 111.239 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.13 151.89 20.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.276 0.63 . . . . 0.0 111.482 -169.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.504 HD21 ' HB ' ' A' ' 188' ' ' ILE . 60.5 mt -60.69 -39.37 88.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.166 0.586 . . . . 0.0 110.486 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.1 -51.39 58.02 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.389 1.076 . . . . 0.0 110.805 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.7 p -71.55 -55.18 8.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.671 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 129' ' ' LEU . 55.9 mt -73.51 -46.15 49.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.262 1.025 . . . . 0.0 113.52 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -42.41 96.07 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 m -73.64 -21.94 60.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 19.7 tp10 -74.39 -22.25 59.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.635 0.774 . . . . 0.0 110.521 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.456 HD23 ' HD1' ' A' ' 118' ' ' TYR . 68.6 mt -140.22 65.56 28.69 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.535 0.734 . . . . 0.0 109.377 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.506 ' HD2' ' HE1' ' A' ' 118' ' ' TYR . 95.3 Cg_endo -81.42 2.49 8.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 123.068 2.512 . . . . 0.0 112.09 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 55.1 p -90.47 -33.84 15.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.367 1.067 . . . . 0.0 108.685 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.06 73.12 7.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.999 1.719 . . . . 0.0 111.178 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -50.06 114.15 1.03 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.476 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 35.4 m95 -84.88 128.99 34.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.786 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 84.8 mt -71.18 -36.61 72.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.429 0.692 . . . . 0.0 110.803 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 59.1 mt -125.25 120.74 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.02 70.98 0.95 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -148.23 146.51 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -170.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -73.97 112.42 10.07 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.272 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.9 mt -118.17 137.17 53.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 110.829 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 123.509 0.724 . . . . 0.0 110.005 176.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.564 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -127.28 171.94 11.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.657 0.783 . . . . 0.0 109.809 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.504 ' HB ' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -142.82 119.82 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.031 173.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -98.31 140.71 32.18 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 37.4 mt -129.23 133.35 47.49 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 108.453 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.47 HD22 HG12 ' A' ' 24' ' ' VAL . 46.3 tp -139.76 107.61 5.67 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.69 139.76 17.46 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 6.1 tp60 -116.72 146.79 42.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.001 0.9 . . . . 0.0 111.677 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.69 ' HD3' ' HG3' ' A' ' 29' ' ' PRO . 21.9 pttm -58.19 115.05 2.68 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.163 165.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 167.813 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.416 0.627 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 47' ' ' LEU . 18.2 tp -59.77 -33.97 72.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.848 1.259 . . . . 0.0 112.492 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.0 m -52.54 -38.46 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -72.8 -44.72 61.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 0.0 110.938 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 128' ' ' ILE . 2.4 m -67.97 -33.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.044 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.27 77.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.485 1.114 . . . . 0.0 111.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.7 -33.87 73.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.191 0.596 . . . . 0.0 110.329 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -84.21 -22.52 30.85 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' VAL . 85.7 mt -76.98 131.67 72.63 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.91 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.39 143.93 71.83 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.788 2.326 . . . . 0.0 111.895 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -72.79 30.59 0.06 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.336 1.454 . . . . 0.0 114.371 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.76 177.95 17.35 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 96' ' ' GLU . 66.1 mttm -60.14 118.48 6.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.542 0.737 . . . . 0.0 110.845 -165.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.89 138.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -165.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 90' ' ' ILE . 59.9 tp -110.67 112.43 24.31 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.73 ' SG ' HG13 ' A' ' 54' ' ' VAL . 58.9 m -101.81 109.59 21.38 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 123.772 0.829 . . . . 0.0 110.412 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 89' ' ' ASP . 36.8 mt -76.69 127.31 32.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 165.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -177.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.862 0 CA-C-O 120.014 -0.325 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -61.78 -38.21 87.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.445 0.698 . . . . 0.0 110.821 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.59 -33.61 62.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.182 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.05 66.61 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.297 0.639 . . . . 0.0 110.799 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.6 p -70.42 -28.44 65.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.2 t80 -66.88 -33.15 74.97 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' A' ' 21' ' ' LEU . 31.4 mt -64.59 -36.04 82.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.121 0.569 . . . . 0.0 111.164 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.56 69.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.661 0.267 . . . . 0.0 110.743 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.601 ' HA ' HG11 ' A' ' 76' ' ' VAL . 55.9 m -68.36 -10.86 57.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.531 0.732 . . . . 0.0 111.533 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 47' ' ' LEU . 65.7 mt -88.13 14.89 8.28 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.643 0.777 . . . . 0.0 110.846 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.16 36.97 44.05 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 123.146 0.403 . . . . 0.0 113.435 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.64 147.34 45.37 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.889 0.476 . . . . 0.0 112.101 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.9 90.64 4.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.902 0.881 . . . . 0.0 108.719 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.73 HG13 ' SG ' ' A' ' 35' ' ' CYS . 65.3 t -102.05 112.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.023 0.529 . . . . 0.0 111.969 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.2 m -85.3 104.88 15.54 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.68 120.95 41.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.268 0.627 . . . . 0.0 109.507 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 83' ' ' SER . 3.6 t -103.81 119.17 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -132.91 144.56 50.24 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.315 0.962 . . . . 0.0 111.32 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 3.0 pp0? -57.98 -18.27 22.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.526 1.53 . . . . 0.0 114.503 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 62' ' ' VAL . 77.5 p -131.2 139.2 49.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 110.409 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -76.83 -17.41 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.405 0.682 . . . . 0.0 110.163 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 60' ' ' SER . 20.1 m -73.5 -29.16 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.151 168.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.97 -28.99 57.77 Favored Glycine 0 C--N 1.359 1.827 0 O-C-N 123.524 0.515 . . . . 0.0 112.342 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.08 -39.97 68.59 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.666 0.787 . . . . 0.0 110.299 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.52 67.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.759 0.824 . . . . 0.0 111.15 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -70.66 -47.53 59.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.225 1.01 . . . . 0.0 109.011 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.56 95.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.119 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -69.83 -35.77 75.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.989 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.12 -46.3 82.77 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.914 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.65 -29.61 66.01 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.154 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -62.8 -62.27 1.84 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.879 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.11 -23.14 67.06 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.884 0.873 . . . . 0.0 112.028 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.93 -56.12 20.01 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -99.03 8.05 45.37 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.948 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.77 38.19 85.19 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 121.996 -0.44 . . . . 0.0 113.358 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.4 m -121.52 162.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.093 0.957 . . . . 0.0 109.282 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -106.05 129.32 54.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.151 0.58 . . . . 0.0 112.107 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 71' ' ' ALA . 16.2 mm -114.24 160.99 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 166.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -125.2 104.3 8.43 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 p -87.86 121.85 30.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.889 0.476 . . . . 0.0 110.744 -167.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.96 140.4 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 108.704 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -81.61 133.12 35.34 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 57' ' ' VAL . 37.7 t -65.55 114.86 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.47 0.481 . . . . 0.0 111.392 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -141.45 88.66 2.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.67 -10.77 50.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.143 0.577 . . . . 0.0 111.23 -166.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.04 -22.34 36.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.476 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.83 -37.66 10.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 110.896 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -171.95 135.54 0.83 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.157 1.383 . . . . 0.0 108.154 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' O ' HD21 ' A' ' 36' ' ' LEU . 1.8 p-10 -135.17 -73.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' A' ' 98' ' ' ILE . 3.7 pt -146.63 120.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.441 0.696 . . . . 0.0 110.774 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 94' ' ' ALA . 44.2 t -130.34 93.27 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.897 0.479 . . . . 0.0 109.968 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.0 23.76 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.34 -44.03 59.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.409 0.684 . . . . 0.0 109.229 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.406 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -77.34 -34.42 55.22 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.32 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.538 ' NE1' HD22 ' A' ' 34' ' ' LEU . 74.5 m95 -109.05 149.71 28.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.218 0.607 . . . . 0.0 111.379 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' N ' ' A' ' 32' ' ' LYS . 45.1 mt-10 -91.74 3.69 54.51 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.835 0.854 . . . . 0.0 111.112 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.33 151.44 16.49 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.1 mt -128.6 149.12 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.903 0.881 . . . . 0.0 108.853 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -147.66 144.24 19.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 162.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 127' ' ' PHE . 47.4 m -133.24 100.37 4.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.9 mm -70.09 138.96 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.739 1.216 . . . . 0.0 108.705 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -18.18 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.533 1.933 . . . . 0.0 114.723 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.45 106.32 14.23 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.619 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -96.42 97.37 9.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.5 mt -124.67 145.7 50.34 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.709 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.17 152.44 71.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.858 2.372 . . . . 0.0 109.926 167.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.4 m -44.18 -40.0 4.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.769 1.227 . . . . 0.0 113.168 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 34.6 m -51.39 -60.81 2.72 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 124.454 1.096 . . . . 0.0 111.002 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.97 -24.15 38.25 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.864 0.466 . . . . 0.0 111.424 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 114' ' ' TYR . 29.2 ttp180 -75.8 -48.67 20.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -68.35 -10.37 54.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.582 0.753 . . . . 0.0 112.81 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 108' ' ' SER . 30.1 mm-40 -88.0 -26.97 22.35 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.014 0.37 . . . . 0.0 110.144 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 117' ' ' VAL . 57.6 tp -78.03 -52.87 8.11 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.867 -174.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 110' ' ' ARG . 29.1 m-85 -66.39 -38.04 18.89 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 24.2 Cg_endo -61.54 -29.43 84.6 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.958 1.772 . . . . 0.0 112.514 167.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -81.57 -22.97 37.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.216 1.007 . . . . 0.0 109.799 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.533 HG22 HD11 ' A' ' 90' ' ' ILE . 28.6 t -78.18 -39.65 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.886 0.874 . . . . 0.0 109.211 170.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.59 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 13.3 t80 -54.09 -58.61 6.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.817 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.36 -49.54 66.57 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.742 0.817 . . . . 0.0 113.036 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.5 -40.48 32.59 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -165.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 34.1 tp -81.21 115.58 20.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.739 0.815 . . . . 0.0 109.56 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.55 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 9.0 mmpt? -103.71 159.39 29.46 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.362 1.065 . . . . 0.0 109.363 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.97 113.35 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.623 0 C-N-CA 123.458 2.772 . . . . 0.0 113.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.556 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.94 14.01 2.6 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.733 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.609 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.21 150.46 17.17 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 162.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 31.8 m -110.62 133.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.373 0 C-N-CA 123.039 0.535 . . . . 0.0 109.57 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 100' ' ' SER . 0.8 OUTLIER -105.79 112.74 25.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 24' ' ' VAL . 50.3 mt -107.01 107.55 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 96.9 mt -121.41 123.26 41.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -106.02 99.31 8.91 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.622 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -79.97 173.87 55.03 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.102 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.3 157.04 46.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.185 -179.711 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.7 mt -90.88 105.45 12.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.622 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 24.6 Cg_exo -63.56 112.96 1.92 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.123 2.548 . . . . 0.0 112.479 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -95.02 145.83 24.68 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.909 0.884 . . . . 0.0 111.279 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 HD21 ' A' ' 190' ' ' LEU . 41.2 mt -61.03 -51.32 69.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.164 0.586 . . . . 0.0 110.69 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.97 -35.7 47.17 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.533 0.733 . . . . 0.0 112.164 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 m -76.56 -45.87 28.7 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.29 1.036 . . . . 0.0 110.719 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' PRO . 83.2 mt -82.3 -46.49 13.58 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.094 0.958 . . . . 0.0 112.877 -170.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.7 -39.93 62.47 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.515 . . . . 0.0 111.261 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t -70.89 -33.92 71.06 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -96.47 -7.41 34.85 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 118' ' ' TYR . 72.4 mt -139.66 62.69 24.1 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.247 0.619 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.59 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 57.3 Cg_endo -81.62 -3.21 11.82 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.138 2.559 . . . . 0.0 113.082 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.5 p -88.46 -30.13 19.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.893 0.877 . . . . 0.0 109.105 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 tp -93.22 75.7 4.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.825 1.65 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -44.5 111.87 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 0.0 111.194 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.457 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 54.4 m95 -85.0 129.43 34.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD11 ' HG2' ' A' ' 193' ' ' GLN . 71.8 mt -76.97 -35.66 57.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.572 0.349 . . . . 0.0 110.467 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.85 123.63 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.71 85.55 1.04 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.11 0.964 . . . . 0.0 108.933 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.09 151.09 35.06 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 188' ' ' ILE . 24.3 t-20 -79.16 103.73 9.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.472 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.07 125.25 50.77 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 109.306 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.02 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.656 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.92 165.02 18.11 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.43 ' HB ' HD21 ' A' ' 153' ' ' LEU . 6.3 pt -140.88 116.26 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -102.49 145.57 29.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.584 0.707 . . . . 0.0 110.395 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.471 HD21 HD22 ' A' ' 153' ' ' LEU . 35.7 mt -131.36 135.62 47.38 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.498 -174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 24' ' ' VAL . 43.5 tp -135.46 105.71 6.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.54 139.76 16.81 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HG2' HD11 ' A' ' 166' ' ' LEU . 5.6 tp60 -136.87 154.28 50.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.879 0.84 . . . . 0.0 111.489 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 22.1 ptmt -55.35 142.83 30.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.046 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 t80 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.313 0.101 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 ' ND2' ' A' ' 43' ' ' ASN . 21.3 tp -59.74 -44.77 93.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.606 0.763 . . . . 0.0 111.559 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 m -43.56 -34.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -50.84 19.5 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.57 0.623 . . . . 0.0 110.329 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 128' ' ' ILE . 1.4 m -59.41 -33.08 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.734 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.8 74.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 0.0 111.776 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.3 -26.75 68.62 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.922 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -89.71 -19.87 24.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.959 0.903 . . . . 0.0 111.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 66.7 mt -80.1 135.98 54.23 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 122.972 0.509 . . . . 0.0 109.833 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -58.92 133.27 52.56 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.974 2.45 . . . . 0.0 111.864 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.59 27.17 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.69 -131.76 4.57 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.767 0.712 . . . . 0.0 111.828 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 67.5 mttm -77.15 113.19 14.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.074 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 99' ' ' VAL . 21.1 mt -111.68 120.54 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 109.144 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' THR . 36.2 tp -93.4 113.19 25.29 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.632 0.373 . . . . 0.0 110.576 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 54.0 t -108.77 107.66 18.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.17 165.39 9.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.76 0.424 . . . . 0.0 111.519 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.253 0.549 . . . . 0.0 110.429 170.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 113.821 0.288 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -69.96 -28.92 65.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.121 0.569 . . . . 0.0 110.792 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' HD22 ' A' ' 21' ' ' LEU . 24.9 t-20 -64.91 -43.64 92.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.228 1.011 . . . . 0.0 110.363 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.83 -47.05 70.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.708 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.9 m -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.662 . . . . 0.0 112.459 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.3 t80 -68.66 -39.29 80.73 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.058 0.543 . . . . 0.0 109.716 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.27 -34.32 77.17 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.078 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.55 71.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.96 0.504 . . . . 0.0 111.147 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG11 ' A' ' 76' ' ' VAL . 34.7 t -70.28 -11.28 60.8 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 111.781 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 79.1 mt -85.1 5.84 28.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.76 0.424 . . . . 0.0 110.384 170.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.04 27.95 47.55 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 123.173 0.416 . . . . 0.0 113.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -113.62 151.4 31.78 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.27 0.535 . . . . 0.0 109.697 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 40.9 mt-10 -85.36 87.61 7.41 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.25 104.89 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.297 0.57 . . . . 0.0 109.904 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.1 t -85.54 111.09 19.7 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.834 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.49 121.2 44.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.932 0.493 . . . . 0.0 109.873 -172.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 3.7 t -89.31 134.54 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 t70 -152.83 129.23 10.61 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -62.69 -28.38 69.9 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.238 1.015 . . . . 0.0 112.831 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.444 ' OG ' HG22 ' A' ' 62' ' ' VAL . 10.2 t -102.6 123.8 46.98 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -72.38 -19.79 61.56 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.168 0.587 . . . . 0.0 111.042 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' OG ' ' A' ' 60' ' ' SER . 18.9 m -66.65 -32.74 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 122.819 0.448 . . . . 0.0 110.685 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.51 -39.84 55.55 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.897 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 80' ' ' THR . 94.5 mt -62.52 -48.52 79.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 110.983 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -57.6 -46.63 83.8 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -69.96 -38.03 75.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.249 0.62 . . . . 0.0 110.641 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.386 0.612 . . . . 0.0 110.541 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -74.05 -29.65 62.01 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.703 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 69.8 mt-30 -61.91 -45.5 93.46 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.13 0.572 . . . . 0.0 110.168 171.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.52 -26.72 64.66 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 123.882 0.739 . . . . 0.0 110.568 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.44 -62.07 1.92 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.185 173.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.24 -37.69 81.17 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.123 0.569 . . . . 0.0 111.036 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.42 -45.86 92.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.608 0.763 . . . . 0.0 110.56 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -97.65 8.65 44.28 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.971 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 37.53 77.45 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-N 116.617 -0.265 . . . . 0.0 113.701 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -130.42 -177.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.914 1.286 . . . . 0.0 109.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -131.18 136.04 47.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.746 HG12 ' HB2' ' A' ' 71' ' ' ALA . 25.7 mm -104.87 165.41 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 42.4 m -125.89 104.58 8.39 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 166.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.461 ' HB ' HD22 ' A' ' 64' ' ' LEU . 45.2 p -88.09 124.43 33.77 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.07 -0.394 . . . . 0.0 111.056 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 24.1 t -118.86 138.32 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.923 1.289 . . . . 0.0 108.555 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -86.42 128.28 34.93 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.779 0.718 . . . . 0.0 110.168 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 57' ' ' VAL . 47.3 m -63.19 125.21 23.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -143.31 91.4 2.26 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 28.8 mt -82.01 -8.32 59.66 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.566 0.621 . . . . 0.0 111.642 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.16 11.03 31.5 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.571 1.148 . . . . 0.0 110.681 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -143.65 -44.57 0.28 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.302 0.641 . . . . 0.0 111.553 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -166.91 109.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.23 1.412 . . . . 0.0 107.622 -170.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -125.71 -71.8 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.266 0.626 . . . . 0.0 109.531 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 98' ' ' ILE . 27.6 pt -133.94 121.28 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.386 0.674 . . . . 0.0 110.763 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.55 84.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.674 0.79 . . . . 0.0 109.31 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.66 0.34 10.93 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.824 0.45 . . . . 0.0 111.835 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.57 -47.58 46.97 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.475 1.11 . . . . 0.0 108.696 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.72 65.34 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.503 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -107.49 -166.06 1.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.83 -30.14 3.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.388 0.675 . . . . 0.0 110.568 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.36 166.66 29.08 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 90' ' ' ILE . 62.6 mt -137.55 141.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 9.8 p -129.4 131.96 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.2 m -143.19 119.82 11.1 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.81 -0.556 . . . . 0.0 109.628 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.8 mm -88.93 148.27 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.697 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 37.1 p90 -16.08 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 126.505 1.922 . . . . 0.0 115.416 -163.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.434 ' SG ' HD21 ' A' ' 129' ' ' LEU . 27.1 p -85.46 107.01 17.22 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.658 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -108.92 96.67 6.48 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 68.9 mt -120.41 148.8 48.44 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.144 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 153.93 28.25 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.095 2.53 . . . . 0.0 111.344 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.9 t -49.0 -32.16 8.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.105 0.962 . . . . 0.0 112.076 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 33.7 p -58.56 -60.8 3.23 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.455 1.102 . . . . 0.0 111.968 172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.35 -21.59 55.93 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.527 -174.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -69.99 -52.77 21.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 108.689 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -64.84 -11.78 41.11 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.178 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 108' ' ' SER . 16.2 mm100 -91.65 -38.44 12.44 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.106 -0.371 . . . . 0.0 110.805 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.9 tp -73.23 -50.34 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.748 0.419 . . . . 0.0 111.744 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 156' ' ' LEU . 39.6 m-85 -68.13 -35.88 8.18 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -54.17 -32.12 68.81 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.017 1.812 . . . . 0.0 113.64 163.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 32.4 mmtp -78.01 -30.71 50.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.462 0.705 . . . . 0.0 110.586 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.553 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.3 t -78.43 -25.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-O 121.626 0.726 . . . . 0.0 109.643 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -75.66 -64.07 1.16 Allowed 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.893 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -82.07 -50.41 9.11 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.88 51.72 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 116.754 -0.203 . . . . 0.0 113.191 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 125' ' ' GLY . 39.6 tp -69.75 100.42 1.5 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 122.896 0.478 . . . . 0.0 109.735 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.655 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 mtpp -66.74 149.3 98.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 165.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -42.52 119.21 1.32 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 124.041 3.161 . . . . 0.0 114.93 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.22 12.98 3.33 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.699 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -96.76 141.25 15.51 Favored Glycine 0 C--O 1.241 0.551 0 O-C-N 122.053 -0.675 . . . . 0.0 111.531 165.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 28.1 m -109.16 130.88 61.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.852 0.861 . . . . 0.0 108.903 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.95 111.98 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 24' ' ' VAL . 64.9 mt -103.53 107.91 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 17.1 mt -121.85 114.58 21.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.568 0.747 . . . . 0.0 109.528 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.697 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 28.5 tt0 -105.71 99.38 8.98 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -83.82 170.38 47.77 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.211 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.475 ' HB2' HD22 ' A' ' 150' ' ' LEU . 57.2 m-85 -133.17 159.12 41.09 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 108.863 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.075 0 C-N-CA 124.058 0.943 . . . . 0.0 110.126 -178.113 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 132' ' ' PHE . 71.0 mt -78.92 112.02 24.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 156' ' ' LEU . 23.5 Cg_exo -64.74 105.3 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.386 2.724 . . . . 0.0 112.588 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HA ' HD11 ' A' ' 188' ' ' ILE . 21.9 ttmm -98.34 146.75 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.802 0.728 . . . . 0.0 111.504 -170.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.1 mt -61.11 -48.91 79.46 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -50.84 -47.51 60.22 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.168 0.917 . . . . 0.0 110.673 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.6 m -66.51 -61.94 1.72 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.68 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 151' ' ' PRO . 22.1 mt -73.52 -42.15 62.11 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.331 0.652 . . . . 0.0 112.355 -165.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -62.19 -34.89 77.3 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.604 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 96.1 p -81.21 -22.23 38.98 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.555 0.216 . . . . 0.0 111.027 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.49 -16.83 57.09 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.042 0.537 . . . . 0.0 110.425 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 117' ' ' VAL . 86.3 mt -143.5 64.02 13.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.167 0.987 . . . . 0.0 109.026 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.63 -9.97 15.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.021 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.8 t -88.34 -30.1 19.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 109.317 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.2 tp -88.21 70.86 9.24 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.583 1.153 . . . . 0.0 109.286 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -52.7 127.34 22.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.468 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.44 ' HZ2' ' HB2' ' A' ' 160' ' ' LEU . 42.1 m95 -92.08 126.76 37.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.664 1.186 . . . . 0.0 109.446 -171.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.28 -32.96 74.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.387 0.675 . . . . 0.0 110.086 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 79.8 mt -126.23 124.85 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.22 82.67 1.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.051 0.94 . . . . 0.0 108.573 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -149.89 151.56 33.64 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.67 114.15 26.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.591 1.156 . . . . 0.0 109.997 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.25 136.79 52.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.807 0.443 . . . . 0.0 110.613 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 123.039 0.535 . . . . 0.0 110.535 177.64 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.671 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 34.8 mt -113.1 157.95 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' LYS . 11.6 pt -138.25 116.19 12.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -95.39 138.57 32.89 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 110.871 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 51.5 mt -128.35 131.73 48.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.119 1.368 . . . . 0.0 108.02 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.1 tp -126.34 110.21 13.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.22 135.76 13.78 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -142.48 149.76 39.63 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 147.16 52.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.943 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 123.388 0.675 . . . . 0.0 111.498 -179.116 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.001 0.429 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.16 -43.16 87.25 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.92 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 5.0 m -52.45 -36.25 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 m -72.54 -50.47 25.45 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.141 0.577 . . . . 0.0 110.465 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.548 HG12 HD22 ' A' ' 191' ' ' LEU . 7.0 m -66.35 -33.54 64.17 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.41 83.66 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.359 1.464 . . . . 0.0 112.199 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.42 -31.82 73.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.926 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -88.18 -18.65 28.26 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 112.117 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' VAL . 60.5 mt -70.39 137.47 86.38 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.825 0.85 . . . . 0.0 111.061 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.79 128.25 29.54 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.745 2.963 . . . . 0.0 112.46 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -76.59 29.6 0.13 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.61 -134.85 4.92 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.881 -0.399 . . . . 0.0 112.243 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 60.8 mttm -84.93 112.73 20.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.526 0.731 . . . . 0.0 109.587 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG22 HG12 ' A' ' 99' ' ' VAL . 3.0 mt -116.13 126.75 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -171.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 90' ' ' ILE . 35.4 tp -96.74 117.68 31.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.445 0.298 . . . . 0.0 110.954 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.0 t -100.08 121.44 41.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.691 0.796 . . . . 0.0 110.257 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 89' ' ' ASP . 23.1 mt -101.56 118.98 38.05 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.561 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 125.448 1.717 . . . . 0.0 112.297 172.092 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -55.08 -32.48 61.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.978 1.711 . . . . 0.0 112.552 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -76.4 -54.98 5.97 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.095 0.558 . . . . 0.0 111.04 -173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.85 39.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 0.0 111.935 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB2' HD23 ' A' ' 70' ' ' LEU . 30.0 p -63.86 -34.8 78.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.323 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.3 t80 -68.33 -50.43 53.41 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.414 0.446 . . . . 0.0 110.398 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 99.3 mt -65.41 -37.38 86.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.688 0.617 . . . . 0.0 110.366 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.29 65.1 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.79 0.436 . . . . 0.0 111.592 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 76' ' ' VAL . 41.8 t -66.36 -13.35 60.48 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.992 0.917 . . . . 0.0 110.933 172.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 31.8 mt -90.75 6.92 42.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.541 0.737 . . . . 0.0 111.18 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.49 23.44 58.42 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -100.14 147.56 25.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.66 0.784 . . . . 0.0 110.603 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 41.7 mt-10 -86.79 88.27 7.64 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 37.4 t -94.79 106.6 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.07 0.462 . . . . 0.0 111.336 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.489 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.6 p -86.99 103.47 15.38 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . . . -106.06 132.17 52.46 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.967 0.907 . . . . 0.0 111.219 -169.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.1 t -116.54 120.02 63.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.05 147.3 43.95 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.06 -27.43 67.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.571 0.749 . . . . 0.0 112.35 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.589 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.7 m -106.79 125.43 50.99 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.057 0.543 . . . . 0.0 110.325 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 m -70.78 -23.72 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.633 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' SER . 29.3 m -63.0 -32.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.545 0.738 . . . . 0.0 111.63 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.14 -47.65 29.45 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.95 -51.38 59.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.902 0.881 . . . . 0.0 111.764 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.07 -44.93 75.26 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.178 0.991 . . . . 0.0 113.371 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -72.42 -27.12 62.14 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.006 0.191 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.15 95.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.611 0.365 . . . . 0.0 110.129 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.2 mtpm? -69.24 -36.24 76.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.303 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.58 -46.49 86.81 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 16.6 tp -70.21 -22.01 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 123.468 0.48 . . . . 0.0 110.895 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -59.35 -59.71 5.03 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.25 -37.23 86.73 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.831 0.348 . . . . 0.0 111.394 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 70' ' ' LEU . 44.9 tt0 -60.26 -35.49 75.62 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.739 1.216 . . . . 0.0 111.808 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.26 -20.31 14.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.816 0.447 . . . . 0.0 112.152 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.94 49.23 7.16 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 122.116 -0.365 . . . . 0.0 113.305 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.9 m -123.77 -179.29 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 125.342 1.457 . . . . 0.0 108.515 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.82 137.64 53.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.7 0.4 . . . . 0.0 111.831 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 71' ' ' ALA . 11.6 mm -112.92 169.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 55' ' ' THR . 58.8 m -139.77 105.15 5.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 163.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -93.91 130.97 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.544 0.687 . . . . 0.0 111.407 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 57' ' ' VAL . 41.8 t -116.12 143.29 26.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.682 1.593 . . . . 0.0 107.503 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -79.95 141.4 36.05 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 p -58.49 101.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.03 0.831 . . . . 0.0 111.188 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -141.18 92.8 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 80.8 mt -97.68 -21.7 16.87 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.63 0.372 . . . . 0.0 111.775 -170.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.31 -3.46 57.5 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.299 0.639 . . . . 0.0 111.756 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -125.32 -15.87 6.08 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.577 0.751 . . . . 0.0 111.632 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 60.4 t80 -165.15 147.91 8.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.915 1.286 . . . . 0.0 108.211 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.461 ' O ' HD21 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -140.23 -72.71 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.604 1.093 . . . . 0.0 109.054 173.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 117' ' ' VAL . 10.8 pt -145.72 129.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.58 0.752 . . . . 0.0 111.163 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 94' ' ' ALA . 25.4 t -135.1 94.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.523 0.729 . . . . 0.0 109.07 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.75 -3.05 10.83 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.539 0.736 . . . . 0.0 112.361 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.54 -41.8 17.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.266 0.627 . . . . 0.0 110.452 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -73.02 -34.29 66.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.085 0.554 . . . . 0.0 111.71 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' NE1' HD22 ' A' ' 34' ' ' LEU . 31.8 m95 -107.53 172.63 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.42 -57.67 2.87 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -116.82 168.38 12.77 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.501 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 90' ' ' ILE . 92.1 mt -134.92 131.16 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.562 0.745 . . . . 0.0 108.996 172.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -116.05 104.95 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -101.78 96.29 6.97 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 128' ' ' ILE . 34.4 mm -75.44 149.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.015 0.926 . . . . 0.0 110.277 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -17.66 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.092 2.157 . . . . 0.0 113.31 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 50.7 t -95.58 127.1 41.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.287 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -128.95 98.73 5.04 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 109' ' ' LEU . 97.1 mt -124.77 138.95 32.26 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.235 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.64 160.61 20.24 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.721 2.281 . . . . 0.0 111.724 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 38.1 m -53.05 -21.91 5.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.36 1.064 . . . . 0.0 113.812 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -63.29 -59.08 5.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.308 0.643 . . . . 0.0 111.432 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.498 ' HB3' HD13 ' A' ' 105' ' ' LEU . 29.5 mt -80.29 -21.13 42.95 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.532 0.333 . . . . 0.0 110.597 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 15.8 ttm180 -69.44 -55.77 9.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.467 0.707 . . . . 0.0 110.147 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -28.7 22.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.467 1.107 . . . . 0.0 111.965 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -78.16 -47.61 17.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.9 tp -75.41 -56.75 4.4 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.12 -165.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.448 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 82.9 m-85 -67.87 -38.21 13.84 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 42.8 Cg_endo -66.45 -24.07 49.9 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 121.7 1.6 . . . . 0.0 112.321 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -84.64 -15.85 44.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 0.0 109.828 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.572 ' HA ' HD11 ' A' ' 90' ' ' ILE . 29.9 t -78.07 -36.84 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.335 0.588 . . . . 0.0 109.463 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -58.16 -58.1 9.94 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.645 170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -64.63 -37.52 87.86 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.52 -50.05 3.27 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.991 0.357 . . . . 0.0 113.991 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.519 HD13 HD12 ' A' ' 98' ' ' ILE . 55.4 tp -101.54 99.0 9.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.636 1.174 . . . . 0.0 110.753 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.44 172.74 8.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 163.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' A' ' 195' ' ' LEU . 39.8 Cg_exo -38.71 130.92 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.276 1.984 . . . . 0.0 110.808 158.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.574 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 131.72 -24.19 4.13 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -158.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -133.64 166.93 23.75 Favored Glycine 0 N--CA 1.467 0.701 0 O-C-N 121.953 -0.733 . . . . 0.0 113.691 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 18.3 m -108.13 135.57 46.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.599 1.16 . . . . 0.0 109.584 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.15 117.21 31.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 24' ' ' VAL . 24.1 mt -112.3 107.93 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.199 1.0 . . . . 0.0 109.439 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 156' ' ' LEU . 84.6 mt -126.64 139.41 53.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.353 0.661 . . . . 0.0 110.985 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -127.0 101.97 6.78 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.92 173.4 43.19 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.455 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -132.61 170.77 14.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.407 1.083 . . . . 0.0 108.748 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.003 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.8 mt . . . . . 0 CA--C 1.551 0.995 0 N-CA-C 111.125 0.046 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.98 115.9 42.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 156' ' ' LEU . 72.0 Cg_endo -91.15 108.59 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.544 2.163 . . . . 0.0 109.55 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 10.6 mtmp? -96.37 161.39 13.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.712 0.405 . . . . 0.0 111.76 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 188' ' ' ILE . 59.9 mt -56.45 -34.57 66.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.199 1.0 . . . . 0.0 112.551 -170.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.03 -48.72 77.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.243 1.017 . . . . 0.0 109.542 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.1 m -66.02 -49.71 66.78 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.335 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 129' ' ' LEU . 68.3 mt -77.64 -50.74 11.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.917 0.887 . . . . 0.0 112.616 -165.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.5 -36.14 79.66 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.759 0.424 . . . . 0.0 111.033 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.0 t -74.24 -26.98 60.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.908 0.483 . . . . 0.0 111.47 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 10.2 tp10 -76.82 -21.83 54.5 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.305 0.642 . . . . 0.0 110.392 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.58 69.26 72.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.006 0.922 . . . . 0.0 109.11 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.65 0.36 9.42 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.37 2.713 . . . . 0.0 112.389 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.4 t -92.28 -41.91 10.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.8 tp -83.9 72.03 10.44 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.071 1.748 . . . . 0.0 109.745 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 195' ' ' LEU . 27.6 t-20 -57.11 124.34 18.4 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.78 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.551 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 25.5 m95 -89.11 130.46 35.55 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.284 1.434 . . . . 0.0 109.985 -169.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.09 -37.82 75.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.122 0.569 . . . . 0.0 110.313 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.93 121.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.84 76.51 1.0 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -145.78 153.12 40.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -91.33 122.18 33.72 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.821 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.0 mt -102.81 131.58 49.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 122.684 0.394 . . . . 0.0 110.606 179.774 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.88 133.69 53.92 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 153' ' ' LEU . 36.7 pt -123.8 118.78 55.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 118.766 0.712 . . . . 0.0 109.554 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.39 141.42 34.29 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.16 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 153' ' ' LEU . 46.9 mt -129.37 139.78 51.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.657 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.548 HD22 HG12 ' A' ' 24' ' ' VAL . 42.6 tp -145.41 106.17 4.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 168.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.64 146.2 21.41 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -130.0 152.0 49.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.104 0.952 . . . . 0.0 112.236 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.74 112.4 3.69 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.682 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.528 ' H ' ' HB3' ' A' ' 123' ' ' PRO . 3.4 mt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.0 t80 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.998 0.428 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 47' ' ' LEU . 25.3 tp -60.47 -18.05 48.96 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.203 1.001 . . . . 0.0 113.147 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -76.7 -34.86 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.699 0.681 . . . . 0.0 110.589 -168.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p -69.74 -47.94 61.2 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.9 0.88 . . . . 0.0 109.799 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 191' ' ' LEU . 21.6 m -68.43 -41.07 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.31 72.2 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.634 0.773 . . . . 0.0 112.335 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -73.67 -22.21 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.123 0.569 . . . . 0.0 110.497 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -90.21 -18.92 24.83 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.354 0.662 . . . . 0.0 110.379 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 24' ' ' VAL . 70.1 mt -72.3 129.04 88.04 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.118 0.567 . . . . 0.0 110.097 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.83 153.05 69.06 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.564 2.176 . . . . 0.0 112.41 172.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 51.4 tt0 -68.46 31.1 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.058 1.743 . . . . 0.0 114.654 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -118.64 -156.97 10.31 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.084 -1.01 . . . . 0.0 112.794 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -87.88 121.47 30.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.562 0.745 . . . . 0.0 109.045 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 54' ' ' VAL . 4.3 mt -111.77 148.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.649 0.78 . . . . 0.0 109.592 -168.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD22 ' NE1' ' A' ' 95' ' ' TRP . 49.4 tp -106.92 117.28 33.63 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.163 0.438 . . . . 0.0 110.198 171.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 51.1 t -102.98 114.75 29.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.983 0.913 . . . . 0.0 110.072 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.2 mt -81.29 141.29 34.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 123.614 0.766 . . . . 0.0 110.448 177.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -69.66 -31.48 69.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.122 0.569 . . . . 0.0 110.061 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.432 HD21 HD13 ' A' ' 21' ' ' LEU . 17.4 t-20 -62.33 -41.95 98.98 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.66 87.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.758 0.823 . . . . 0.0 111.454 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.86 -34.94 75.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.678 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.57 -32.74 66.27 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.285 0.365 . . . . 0.0 110.484 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 99' ' ' VAL . 74.3 mt -67.02 -31.6 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.54 72.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.196 0.598 . . . . 0.0 111.253 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.591 ' HA ' HG11 ' A' ' 76' ' ' VAL . 20.1 m -71.99 -4.39 28.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.711 0.804 . . . . 0.0 112.491 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.28 12.49 15.91 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.332 0.653 . . . . 0.0 110.218 168.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.85 56.27 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 114.163 0.425 . . . . 0.0 114.163 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 11.8 m-85 -114.1 152.24 31.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.79 91.81 8.78 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 33' ' ' ILE . 92.4 t -91.16 111.94 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.254 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 40.4 p -84.22 106.64 16.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 108.314 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.9 129.43 46.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.126 0.571 . . . . 0.0 109.935 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG22 ' HB ' ' A' ' 81' ' ' VAL . 8.4 t -111.39 120.21 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' H ' HD21 ' A' ' 64' ' ' LEU . 41.8 t0 -129.7 137.42 50.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 23.3 mt-30 -60.41 -25.84 66.23 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.626 1.204 . . . . 0.0 112.238 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.6 m -97.95 116.18 29.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.465 ' HA ' HD12 ' A' ' 64' ' ' LEU . 60.5 p -66.29 -30.69 71.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.607 0.718 . . . . 0.0 109.954 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 60' ' ' SER . 26.7 m -61.76 -35.95 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.674 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.95 -32.86 60.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.587 0.554 . . . . 0.0 112.062 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 61' ' ' SER . 86.5 mt -62.58 -43.57 98.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.792 0.837 . . . . 0.0 110.742 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.28 94.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.256 0.623 . . . . 0.0 111.708 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -70.19 -30.99 68.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.127 0.571 . . . . 0.0 111.166 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 -44.52 90.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.562 0.745 . . . . 0.0 111.036 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.35 -35.18 68.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.684 0.794 . . . . 0.0 110.995 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.08 -47.63 84.55 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.603 0.761 . . . . 0.0 110.246 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.38 -28.46 67.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.826 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.99 -61.52 2.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.276 0.63 . . . . 0.0 111.075 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.66 -29.01 70.0 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.116 0.566 . . . . 0.0 111.005 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -65.1 -43.62 91.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.149 0.58 . . . . 0.0 110.143 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -93.64 -2.73 53.64 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.07 34.48 55.38 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.7 -0.227 . . . . 0.0 113.232 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.5 m -127.45 175.34 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.122 0.969 . . . . 0.0 110.09 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.56 131.66 56.01 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.011 0.924 . . . . 0.0 111.103 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.826 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.8 mm -110.75 164.39 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 161.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 88.8 m -131.88 104.59 6.95 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 p -86.87 121.6 29.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.859 0.463 . . . . 0.0 110.273 -168.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 57' ' ' VAL . 59.6 t -108.62 136.98 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 108.427 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -79.76 128.6 33.62 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 59' ' ' GLN . 80.4 p -59.63 120.21 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.871 0.732 . . . . 0.0 112.326 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.31 85.16 1.95 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 161.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.577 ' HB2' HD22 ' A' ' 109' ' ' LEU . 74.4 mt -84.87 -24.86 28.35 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.233 0.613 . . . . 0.0 110.608 -168.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 -7.67 32.26 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.062 0.945 . . . . 0.0 111.864 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -132.64 -23.43 2.06 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.564 0.746 . . . . 0.0 111.819 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 81' ' ' VAL . 38.4 t80 -162.32 116.88 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.286 1.034 . . . . 0.0 109.666 -171.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -125.36 -60.11 1.35 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' HB ' HD13 ' A' ' 98' ' ' ILE . 34.4 pt -139.99 131.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 118.803 0.729 . . . . 0.0 111.757 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.91 89.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.225 1.01 . . . . 0.0 109.648 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.639 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -70.73 1.01 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.22 -44.27 68.94 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.63 -32.94 64.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.709 0.803 . . . . 0.0 112.566 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.494 ' NE1' HD22 ' A' ' 34' ' ' LEU . 12.7 m95 -109.05 162.69 14.0 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.054 0.542 . . . . 0.0 110.091 -170.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 12.3 tp10 -76.21 -56.86 4.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.35 171.97 17.33 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 90' ' ' ILE . 74.3 mt -135.89 127.59 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 47' ' ' LEU . 7.8 p -114.55 125.11 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -124.39 93.37 3.89 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.547 HD13 HD12 ' A' ' 128' ' ' ILE . 35.5 mm -65.34 138.79 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -18.47 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.012 1.725 . . . . 0.0 114.098 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 t -78.44 111.01 14.03 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.849 -171.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -107.81 98.14 7.77 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.42 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 71.3 mt -124.97 140.47 35.92 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.9 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 160.62 45.97 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.921 2.414 . . . . 0.0 110.871 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 m -43.36 -42.41 4.59 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.844 1.258 . . . . 0.0 113.778 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -53.57 -55.42 25.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.143 0.977 . . . . 0.0 112.226 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 85' ' ' LEU . 98.8 mt -83.18 -24.89 32.26 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.214 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -77.54 -52.57 8.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.054 0.942 . . . . 0.0 109.841 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.07 -22.42 66.85 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 0.0 112.277 170.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -75.76 -35.26 60.22 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.41 0.684 . . . . 0.0 109.611 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.4 tp -65.78 -52.17 53.07 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.592 0.757 . . . . 0.0 111.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -58.44 -44.15 98.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -166.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.28 -31.59 81.95 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.713 1.609 . . . . 0.0 112.003 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -81.94 -15.11 54.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.2 0.6 . . . . 0.0 110.91 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 12.0 t -84.0 -42.87 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -59.26 -59.68 5.08 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.08 -48.33 44.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.821 0.849 . . . . 0.0 113.095 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.58 -35.23 17.33 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -165.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.8 tp -77.99 95.18 4.76 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.89 0.845 . . . . 0.0 110.351 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.639 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -75.04 150.74 85.91 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.986 168.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -42.74 117.72 0.97 Allowed 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 124.667 3.578 . . . . 0.0 115.341 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.47 12.46 3.77 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.137 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.68 137.75 13.79 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.3 m -105.85 129.55 58.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.73 0.812 . . . . 0.0 110.458 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.65 112.94 25.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 101' ' ' ILE . 46.6 mt -105.26 109.26 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.59 HD13 HD13 ' A' ' 156' ' ' LEU . 55.7 mt -123.59 134.38 53.82 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -117.57 102.33 9.08 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.532 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -72.37 140.54 29.7 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.914 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 150' ' ' LEU . 69.5 m-85 -111.23 164.02 13.32 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.122 0.487 . . . . 0.0 111.297 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.006 -178.829 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 132' ' ' PHE . 62.5 mt -81.73 112.9 38.42 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 167.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.678 ' HB3' HD11 ' A' ' 156' ' ' LEU . 17.0 Cg_exo -69.35 137.73 37.35 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.292 2.661 . . . . 0.0 113.416 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.519 ' HA ' HD11 ' A' ' 188' ' ' ILE . 44.7 mmtm -118.4 148.36 42.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.514 0.726 . . . . 0.0 112.234 171.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 190' ' ' LEU . 39.9 mt -60.92 -42.33 97.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.295 1.038 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -51.78 -45.12 63.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.085 0.865 . . . . 0.0 111.256 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.9 m -77.79 -46.29 22.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.871 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.678 HD11 ' HB3' ' A' ' 151' ' ' PRO . 89.4 mt -76.5 -46.29 27.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.833 0.853 . . . . 0.0 113.28 -170.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.536 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.1 tt0 -54.47 -46.0 73.29 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 110.688 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 t -73.03 -22.89 60.56 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.928 0.491 . . . . 0.0 111.769 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -73.51 -30.97 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.42 0.688 . . . . 0.0 110.84 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.1 mt -131.61 75.76 76.04 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.69 -11.74 24.17 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.08 2.52 . . . . 0.0 111.549 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -87.51 -39.44 15.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.937 1.295 . . . . 0.0 108.69 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 21.3 tp -91.52 72.95 5.99 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.075 1.35 . . . . 0.0 110.064 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.23 132.93 55.23 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.536 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 23.4 m95 -94.82 132.33 39.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.509 0.724 . . . . 0.0 109.283 -168.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.84 -30.78 71.05 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.282 0.633 . . . . 0.0 110.337 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.08 127.92 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -146.15 63.42 1.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -108.6 139.17 43.75 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.797 -164.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -96.46 105.91 18.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.078 0.951 . . . . 0.0 109.498 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 47.0 mt -97.18 119.34 35.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.555 0.742 . . . . 0.0 110.902 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 168.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.389 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 73.0 mt -117.65 166.11 12.79 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 152' ' ' LYS . 10.2 pt -149.28 149.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.029 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -129.7 150.53 50.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 111.117 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 153' ' ' LEU . 61.6 mt -130.85 135.2 47.5 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.269 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 24' ' ' VAL . 34.4 tp -129.79 104.68 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 167.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -89.21 128.62 9.26 Favored Glycine 0 C--O 1.208 -1.48 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -142.38 156.19 45.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.747 0.819 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -59.71 127.43 31.93 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.428 0.455 . . . . 0.0 109.978 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 118.751 -0.643 . . . . 0.0 110.031 -171.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.9 t80 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HA ' HG22 ' A' ' 24' ' ' VAL . 56.0 tp -74.17 -41.7 61.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.346 0.659 . . . . 0.0 111.413 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -45.76 -41.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 p -80.5 -51.22 9.05 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.073 0.549 . . . . 0.0 111.091 -174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 128' ' ' ILE . 16.7 m -59.52 -35.53 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.933 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -59.17 -39.53 82.79 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 124.476 1.11 . . . . 0.0 111.734 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.21 -27.95 69.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.636 0.775 . . . . 0.0 110.719 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 87.7 mm-40 -90.17 -7.66 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.691 0.796 . . . . 0.0 112.634 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' VAL . 68.0 mt -87.41 136.26 33.52 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.895 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.01 134.68 43.21 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.778 2.985 . . . . 0.0 113.752 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -77.61 27.89 0.16 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.99 -134.67 5.52 Favored Glycine 0 N--CA 1.475 1.258 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.874 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.98 112.35 18.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.202 0.501 . . . . 0.0 109.734 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG22 HG12 ' A' ' 99' ' ' VAL . 18.6 mt -115.04 129.46 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -170.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 89' ' ' ASP . 66.1 tp -94.37 114.44 26.49 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.716 0.406 . . . . 0.0 110.836 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 36.2 t -94.35 140.13 30.19 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -90.91 173.71 7.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.777 0.322 . . . . 0.0 111.554 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.653 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.641 0 CA-C-O 120.8 0.111 . . . . 0.0 112.875 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -70.65 -35.7 73.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.98 1.312 . . . . 0.0 111.68 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -64.28 -50.18 68.92 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.597 0.56 . . . . 0.0 110.824 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.75 -50.04 69.38 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.208 0.942 . . . . 0.0 111.508 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.717 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 73.5 m -55.93 -49.02 74.64 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.09 0.956 . . . . 0.0 113.513 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 41.4 t80 -58.16 -43.17 87.25 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.703 0.627 . . . . 0.0 111.011 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.444 HD13 HG11 ' A' ' 99' ' ' VAL . 60.9 mt -67.92 -32.61 73.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.778 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.06 -33.6 65.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.92 0.488 . . . . 0.0 111.448 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.592 ' HA ' HG11 ' A' ' 76' ' ' VAL . 19.3 m -65.47 -15.3 62.51 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.06 0.944 . . . . 0.0 111.738 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.1 mt -82.7 3.11 30.44 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.553 0.741 . . . . 0.0 110.831 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.92 16.81 62.55 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-O 119.798 -0.446 . . . . 0.0 113.928 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -103.09 155.11 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.695 0.748 . . . . 0.0 110.881 -173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.1 87.69 6.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.533 0.733 . . . . 0.0 109.207 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.88 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HA ' ' A' ' 34' ' ' LEU . 3.3 t -86.01 106.74 17.39 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.928 0.891 . . . . 0.0 109.287 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.56 131.32 53.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.469 0.708 . . . . 0.0 110.438 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -95.46 146.68 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 29.9 t0 -150.14 135.34 17.95 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.11 -11.1 60.42 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.825 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.3 t -113.65 164.48 13.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.033 0.933 . . . . 0.0 109.268 169.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -78.2 -26.57 47.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.991 0.516 . . . . 0.0 112.187 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.8 m -56.87 -43.95 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.83 -34.71 62.22 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.203 0.314 . . . . 0.0 112.474 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 94.3 mt -67.86 -59.46 3.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.702 0.801 . . . . 0.0 111.322 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.46 73.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.109 0.964 . . . . 0.0 112.934 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.24 -45.58 92.68 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.839 0.855 . . . . 0.0 110.416 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.717 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -64.11 -46.51 83.89 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.92 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -71.76 -35.22 70.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.231 1.012 . . . . 0.0 111.02 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.43 -61.23 2.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.397 0.679 . . . . 0.0 111.152 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.37 -22.6 66.25 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.567 0.542 . . . . 0.0 111.17 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.6 -63.63 1.05 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.984 174.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.93 -30.59 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.04 0.536 . . . . 0.0 110.824 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.39 -31.51 71.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.255 1.022 . . . . 0.0 111.474 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -102.25 1.69 36.15 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.116 0.566 . . . . 0.0 111.417 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.48 67.76 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 122.355 -0.216 . . . . 0.0 113.233 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.7 m -124.08 -179.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 108.182 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.78 131.92 36.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.749 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.7 mm -106.96 166.88 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 166.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -129.42 105.75 8.31 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.3 p -85.69 119.83 26.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.092 0.557 . . . . 0.0 110.924 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.9 124.18 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.044 1.337 . . . . 0.0 109.264 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -100.24 91.7 4.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -142.57 -177.6 5.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.237 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -146.33 136.91 24.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -162.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 14.2 mt -76.19 -8.46 57.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 123.543 0.527 . . . . 0.0 112.389 -166.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -94.77 -0.32 54.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.834 0.454 . . . . 0.0 112.144 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -123.42 -44.17 2.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.824 0.449 . . . . 0.0 110.685 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -169.46 124.52 0.83 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.514 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -134.96 -72.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.059 0.944 . . . . 0.0 109.308 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' HB ' HD13 ' A' ' 98' ' ' ILE . 10.7 pt -129.55 122.74 56.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 C-N-CA 123.199 0.599 . . . . 0.0 111.616 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.92 94.64 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.698 1.199 . . . . 0.0 108.816 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.25 -0.52 2.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -73.49 -48.05 36.45 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.883 0.473 . . . . 0.0 110.291 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.05 61.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.11 0.564 . . . . 0.0 112.259 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.498 ' CD1' HD22 ' A' ' 34' ' ' LEU . 13.7 m95 -113.17 139.08 49.06 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.009 0.524 . . . . 0.0 109.847 -170.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.97 -40.12 79.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.33 174.65 29.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.025 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.546 HD13 ' HB ' ' A' ' 90' ' ' ILE . 64.3 mt -132.12 140.56 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 6.2 p -124.84 108.48 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.749 0.82 . . . . 0.0 109.1 167.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.493 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 42.7 m -108.89 89.49 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.59 149.83 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.943 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -17.66 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 127.394 2.278 . . . . 0.0 112.61 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.8 p -99.78 104.78 16.5 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.848 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -96.57 98.07 9.91 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.61 147.83 40.61 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.916 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 149' ' ' LEU . 46.8 Cg_exo -59.05 149.28 80.78 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.282 1.988 . . . . 0.0 110.099 160.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 11.7 t -57.78 -22.72 48.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.421 0.688 . . . . 0.0 112.187 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t -52.87 -55.82 20.39 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.566 0.746 . . . . 0.0 111.363 168.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.9 mt -81.0 -27.47 35.87 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.472 0.709 . . . . 0.0 110.824 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 151' ' ' PRO . 11.3 ttp180 -68.48 -56.27 8.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.966 0.906 . . . . 0.0 110.334 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -37.52 63.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.45 1.1 . . . . 0.0 111.328 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 6.2 tp-100 -70.38 -31.9 69.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.107 0.563 . . . . 0.0 110.22 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 117' ' ' VAL . 45.6 tp -76.46 -33.84 58.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.945 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -55.1 -47.33 98.77 Favored Pre-proline 0 CA--C 1.569 1.695 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.79 -29.67 90.5 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.247 1.965 . . . . 0.0 112.672 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -75.26 -31.73 60.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.735 0.814 . . . . 0.0 111.142 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 1.6 t -88.37 -27.23 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.363 0.601 . . . . 0.0 110.735 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.61 -64.61 1.15 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.29 -49.76 10.35 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.69 -33.58 63.36 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 113.711 0.245 . . . . 0.0 113.711 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.5 tp -78.69 131.22 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.297 0.57 . . . . 0.0 109.791 171.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -114.82 161.71 27.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.797 1.239 . . . . 0.0 107.988 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -36.4 114.72 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 124.305 3.337 . . . . 0.0 115.529 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.543 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.52 -0.85 5.97 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.678 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -100.3 148.62 18.45 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 166.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.92 131.7 65.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 C-N-CA 124.493 1.117 . . . . 0.0 109.103 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.7 t80 -109.33 109.13 19.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.569 HD13 HG21 ' A' ' 24' ' ' VAL . 43.8 mt -111.34 108.07 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.298 1.039 . . . . 0.0 108.608 -170.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 95.1 mt -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.774 0.83 . . . . 0.0 111.144 -172.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.4 101.78 4.93 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.8 118.39 6.06 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 187' ' ' LEU . 27.1 m-85 -78.83 169.4 18.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.415 1.086 . . . . 0.0 109.873 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.584 . . . . 0.0 111.537 -175.625 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 106' ' ' PRO . 13.9 mt . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 132' ' ' PHE . 95.7 mt -74.99 113.25 22.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 123.351 0.407 . . . . 0.0 110.481 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.65 ' HB3' HH11 ' A' ' 110' ' ' ARG . 93.4 Cg_endo -87.01 129.55 2.9 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.258 1.972 . . . . 0.0 111.405 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -81.36 164.37 22.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.718 0.807 . . . . 0.0 111.54 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 188' ' ' ILE . 81.1 mt -60.62 -41.47 94.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.155 0.582 . . . . 0.0 110.478 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.51 -39.49 67.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.398 0.679 . . . . 0.0 111.471 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.4 p -81.48 -53.6 6.14 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.486 0.314 . . . . 0.0 110.732 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -61.63 -50.59 71.92 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.576 1.15 . . . . 0.0 111.93 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -65.48 -30.81 71.63 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.787 0.835 . . . . 0.0 111.702 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.6 t -73.19 -29.43 62.82 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 122.812 0.445 . . . . 0.0 111.08 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 -10.66 58.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.087 0.555 . . . . 0.0 111.021 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 96.5 mt -141.34 71.03 27.06 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.459 0.704 . . . . 0.0 109.559 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.59 7.38 4.69 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.065 2.51 . . . . 0.0 111.298 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.0 t -90.71 -41.17 11.44 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.4 tp -91.82 71.18 5.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.024 1.33 . . . . 0.0 110.626 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB3' HD22 ' A' ' 195' ' ' LEU . 4.0 t-20 -59.89 129.77 43.47 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 28.9 m95 -95.54 141.37 29.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.014 0.926 . . . . 0.0 110.765 -164.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.15 -36.81 72.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.172 0.589 . . . . 0.0 110.345 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 68.1 mt -126.88 125.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.24 84.26 1.13 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.664 0.785 . . . . 0.0 109.916 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -155.92 155.59 33.11 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.485 0.314 . . . . 0.0 111.475 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.08 110.98 13.52 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.55 130.37 47.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.275 0.63 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.361 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 132' ' ' PHE . 56.4 mt -116.71 163.86 15.49 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 153' ' ' LEU . 44.4 pt -135.93 139.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -132.69 151.28 52.01 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.976 0.893 . . . . 0.0 111.365 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 165' ' ' TRP . 64.5 mt -136.29 138.26 41.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 113.329 -1.76 . . . . 0.0 108.791 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.514 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -129.71 107.52 9.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 168.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.03 139.84 17.26 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 8.3 tp-100 -140.32 153.02 46.3 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.438 0.695 . . . . 0.0 109.693 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.543 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 18.1 pttp -58.17 128.43 37.09 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.806 0.691 . . . . 0.0 109.254 170.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 164' ' ' ASN . 4.5 mt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 24' ' ' VAL . 43.4 t80 . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 24' ' ' VAL . 37.4 tp -62.22 -47.51 84.11 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.806 0.842 . . . . 0.0 112.065 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.81 -33.67 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -70.39 -50.95 33.42 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.621 0.768 . . . . 0.0 110.903 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 128' ' ' ILE . 2.7 m -64.46 -30.13 49.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.558 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -59.49 -38.17 80.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.625 1.17 . . . . 0.0 111.243 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -70.13 -29.07 65.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.383 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -87.93 -7.23 57.43 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.632 0.773 . . . . 0.0 112.41 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 24' ' ' VAL . 89.9 mt -82.51 123.45 78.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -52.34 133.49 48.32 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.175 2.583 . . . . 0.0 113.131 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -67.1 31.0 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 126.928 2.091 . . . . 0.0 116.138 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.4 -154.34 10.95 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.663 -0.52 . . . . 0.0 112.483 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.09 120.65 19.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.128 0.571 . . . . 0.0 110.572 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 mt -109.07 135.88 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 0.0 110.07 -167.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 55' ' ' THR . 67.9 tp -110.4 118.26 35.8 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.002 0.521 . . . . 0.0 109.714 171.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 42.3 t -96.58 130.86 43.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.227 1.011 . . . . 0.0 109.462 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -95.1 117.56 30.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 164.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.55 0.691 . . . . 0.0 111.012 -169.727 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 113.341 0.096 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -60.6 -34.37 74.11 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.679 0.752 . . . . 0.0 109.903 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.0 p30 -56.15 -48.08 76.97 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.163 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.3 93.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.748 0.819 . . . . 0.0 111.324 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 14.4 m -61.79 -42.27 98.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.668 0.787 . . . . 0.0 112.465 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -64.61 -44.74 89.6 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.791 0.682 . . . . 0.0 109.876 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 43' ' ' ASN . 81.2 mt -67.51 -32.7 73.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 -34.39 67.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.174 0.59 . . . . 0.0 111.59 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.749 ' HA ' HG11 ' A' ' 76' ' ' VAL . 28.4 t -68.71 -9.93 53.39 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.831 0.852 . . . . 0.0 111.7 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 25' ' ' ALA . 85.4 mt -78.54 6.73 7.99 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.329 0.652 . . . . 0.0 111.105 170.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.52 27.69 26.6 Favored Glycine 0 C--N 1.359 1.808 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.962 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -130.52 163.05 27.9 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.492 0.646 . . . . 0.0 111.016 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.97 93.06 6.39 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.61 112.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.7 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 34' ' ' LEU . 57.6 m -86.09 108.84 18.46 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.053 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.4 130.14 47.55 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.957 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.6 116.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' H ' HD21 ' A' ' 64' ' ' LEU . 14.0 t0 -123.17 124.87 44.01 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.08 -25.71 46.58 Favored 'General case' 0 CA--C 1.562 1.41 0 O-C-N 124.593 1.183 . . . . 0.0 111.678 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -112.31 121.64 45.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.404 1.082 . . . . 0.0 108.786 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' HD12 ' A' ' 64' ' ' LEU . 34.8 p -69.03 -15.28 63.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 112.406 -173.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.5 m -56.48 -44.25 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.434 0.459 . . . . 0.0 110.82 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.86 -30.08 66.36 Favored Glycine 0 C--N 1.358 1.792 0 O-C-N 123.654 0.596 . . . . 0.0 113.036 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 91.1 mt -64.85 -45.96 83.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.749 0.82 . . . . 0.0 110.695 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -62.6 -39.42 93.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.593 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 73.4 mmtt -64.98 -43.44 92.59 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.715 0.406 . . . . 0.0 109.914 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.571 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -57.62 -40.68 79.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.6 -36.42 73.52 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.68 0.792 . . . . 0.0 111.488 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 26.4 mt-30 -57.6 -58.27 9.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.594 0.757 . . . . 0.0 111.718 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 38.2 tp -67.41 -24.94 65.71 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.213 -176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.35 7.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.481 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.39 -27.82 68.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.832 0.453 . . . . 0.0 111.108 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.35 -44.42 92.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.279 1.032 . . . . 0.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 6.19 46.48 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.659 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.52 39.28 50.35 Favored Glycine 0 C--N 1.356 1.65 0 N-CA-C 113.936 0.334 . . . . 0.0 113.936 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.7 m -136.31 175.45 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.117 0.967 . . . . 0.0 109.524 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -129.52 142.67 50.71 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.025 0.44 . . . . 0.0 112.131 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 45' ' ' CYS . 17.7 mm -105.53 169.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.13 1.372 . . . . 0.0 107.43 170.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 m -121.47 105.87 10.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 164.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' LEU . 70.0 p -93.05 111.16 22.7 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 110.655 -165.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.64 124.81 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.6 1.16 . . . . 0.0 110.082 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.51 95.28 6.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -144.34 -174.66 4.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.848 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -144.87 127.52 16.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -158.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 105' ' ' LEU . 26.5 mt -68.81 -6.06 24.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.151 0.58 . . . . 0.0 112.542 -172.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -96.9 9.98 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.267 1.027 . . . . 0.0 112.6 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.9 -46.44 0.27 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.207 0.603 . . . . 0.0 110.379 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -155.37 122.87 5.59 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.983 1.713 . . . . 0.0 106.594 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 1.9 p-10 -135.39 -71.8 0.47 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 117' ' ' VAL . 14.5 pt -143.25 123.01 9.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.497 0.719 . . . . 0.0 109.904 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.92 84.91 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.18 -5.97 15.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.91 -39.27 93.79 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.562 0.745 . . . . 0.0 109.111 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.99 -20.46 24.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.029 0.932 . . . . 0.0 111.9 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD22 ' A' ' 34' ' ' LEU . 51.9 m95 -121.7 114.08 20.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 0.0 109.946 -170.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.2 -43.83 81.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.584 0.754 . . . . 0.0 110.337 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.16 151.3 18.24 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.042 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 121' ' ' LEU . 73.1 mt -132.07 148.17 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.4 p -135.49 120.79 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.246 1.018 . . . . 0.0 108.417 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.4 m -108.69 93.23 4.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.639 HD13 HD12 ' A' ' 128' ' ' ILE . 23.3 mm -70.44 140.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.829 0.852 . . . . 0.0 109.512 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -14.0 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.03 2.132 . . . . 0.0 113.691 -171.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.77 107.1 19.46 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.25 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -105.5 101.15 10.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 85' ' ' LEU . 82.4 mt -121.35 138.8 28.63 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.47 163.53 35.92 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.158 2.572 . . . . 0.0 110.717 171.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -35.98 -43.46 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 126.105 1.762 . . . . 0.0 114.875 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 p -57.0 -56.49 21.1 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.641 0.776 . . . . 0.0 110.957 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 94.1 mt -84.39 -22.85 30.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.768 0.827 . . . . 0.0 110.555 -172.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -73.51 -61.26 1.89 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.956 0.903 . . . . 0.0 109.656 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.82 -9.62 15.82 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.226 0.611 . . . . 0.0 112.159 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 24.6 tp60 -87.43 -37.77 16.71 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.673 0.389 . . . . 0.0 110.748 170.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 117' ' ' VAL . 62.7 tp -85.56 -61.27 1.8 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 77.6 m-85 -68.48 -39.57 16.09 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -160.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 45.9 Cg_endo -66.35 -23.96 50.78 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 121.908 1.738 . . . . 0.0 111.894 170.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -83.12 -19.74 36.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.955 0.902 . . . . 0.0 109.286 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 127' ' ' PHE . 39.1 t -77.0 -38.81 28.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -49.67 -57.83 6.46 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.5 -46.81 62.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.093 0.957 . . . . 0.0 113.004 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.04 -37.65 28.5 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -166.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -77.1 109.62 11.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 109.109 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -79.79 163.83 56.36 Favored Pre-proline 0 C--O 1.247 0.931 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.98 115.41 0.87 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.72 2.28 . . . . 0.0 113.542 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.571 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.6 12.87 2.92 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.943 172.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -107.91 148.91 16.71 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 117.482 0.641 . . . . 0.0 112.508 166.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.4 139.5 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.126 0.97 . . . . 0.0 109.024 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.49 121.07 41.6 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 24' ' ' VAL . 55.1 mt -110.91 109.04 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.758 0.823 . . . . 0.0 109.201 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 156' ' ' LEU . 47.5 mt -125.8 144.0 50.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.933 0.893 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -132.23 102.5 5.8 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.94 -173.37 46.58 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.566 ' HB2' HD22 ' A' ' 150' ' ' LEU . 71.5 m-85 -135.31 158.98 43.0 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 123.594 0.758 . . . . 0.0 111.648 -178.442 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.555 1.146 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 132' ' ' PHE . 48.1 mt -88.38 110.59 37.56 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.599 ' HB2' HD11 ' A' ' 156' ' ' LEU . 5.1 Cg_exo -76.41 104.28 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.581 2.187 . . . . 0.0 109.387 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 mtpt -94.93 160.24 14.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.171 0.588 . . . . 0.0 111.287 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 HD21 ' A' ' 190' ' ' LEU . 71.9 mt -53.26 -37.57 62.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.911 0.884 . . . . 0.0 110.929 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.06 -54.36 20.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.057 1.343 . . . . 0.0 111.74 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -76.24 -45.93 30.53 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.306 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 129' ' ' LEU . 82.7 mt -71.38 -49.73 39.17 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.714 0.806 . . . . 0.0 112.411 -168.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -58.75 -37.69 76.8 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 0.0 111.637 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.0 t -76.62 -17.58 59.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.294 0.238 . . . . 0.0 111.421 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.99 -5.54 55.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.644 0.378 . . . . 0.0 110.619 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 39.3 mt -145.71 59.1 5.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.488 1.115 . . . . 0.0 108.532 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.04 -26.34 21.7 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.06 2.507 . . . . 0.0 112.731 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -90.24 -14.41 33.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.485 0.714 . . . . 0.0 110.209 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 17.7 tp -89.75 69.28 7.64 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.596 1.158 . . . . 0.0 108.628 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.568 ' HB3' HD21 ' A' ' 195' ' ' LEU . 28.2 t30 -61.93 124.62 21.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -88.68 143.53 26.87 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.429 1.091 . . . . 0.0 109.594 -165.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.14 -39.07 72.18 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.172 0.589 . . . . 0.0 109.976 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 75.6 mt -129.14 119.08 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.73 86.05 1.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.747 0.819 . . . . 0.0 109.328 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -160.19 157.96 29.25 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 188' ' ' ILE . 26.0 p-10 -75.35 104.93 6.12 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 mt -102.04 135.44 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.651 0.263 . . . . 0.0 110.753 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.5 mt -126.56 174.88 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 152' ' ' LYS . 23.8 pt -139.23 139.05 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -127.22 149.94 49.76 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.783 0.802 . . . . 0.0 110.804 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 67.7 mt -133.57 136.53 45.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.395 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.478 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -137.25 108.26 6.73 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.7 147.39 22.02 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -142.55 150.88 40.99 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.551 0.74 . . . . 0.0 110.127 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 13.1 ptmm? -59.96 143.08 52.57 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 164' ' ' ASN . 9.8 mt . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.627 HD21 ' HG ' ' A' ' 47' ' ' LEU . 24.3 tp -62.78 -47.01 85.33 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.553 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -45.68 -33.78 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -68.76 -51.5 40.53 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.34 0.656 . . . . 0.0 110.135 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 128' ' ' ILE . 2.5 m -62.4 -32.9 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.466 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.75 74.53 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.519 1.128 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.58 -21.53 61.13 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.306 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.705 ' HB3' HE21 ' A' ' 193' ' ' GLN . 84.1 mm-40 -84.1 -23.4 30.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.392 0.677 . . . . 0.0 111.207 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 24' ' ' VAL . 63.2 mt -82.23 135.22 47.72 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -52.99 145.61 40.63 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.82 2.347 . . . . 0.0 112.043 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -65.5 29.81 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -115.6 -167.39 15.12 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 118.999 0.818 . . . . 0.0 111.818 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -73.36 127.7 33.4 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.852 0.358 . . . . 0.0 110.309 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.492 HG22 HG12 ' A' ' 99' ' ' VAL . 5.2 mt -113.77 135.93 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.439 -168.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.515 HD22 ' CD1' ' A' ' 95' ' ' TRP . 54.2 tp -98.76 119.99 38.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 6.8 p -110.83 118.64 36.68 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.768 0.827 . . . . 0.0 109.983 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 90' ' ' ILE . 58.2 mt -78.27 135.98 37.66 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 108.808 174.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 CA-C-O 120.404 -0.109 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -69.68 -42.64 73.87 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.526 0.73 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD13 ' A' ' 21' ' ' LEU . 14.3 m120 -73.07 -32.76 65.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.203 0.601 . . . . 0.0 110.367 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -58.01 -51.8 68.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.668 0.787 . . . . 0.0 110.569 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 31.0 m -65.9 -32.89 74.65 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.575 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 38.2 t80 -67.81 -32.14 72.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.627 ' HG ' HD21 ' A' ' 21' ' ' LEU . 37.0 mt -65.84 -33.53 76.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.309 0.644 . . . . 0.0 110.531 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.29 70.65 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.862 0.363 . . . . 0.0 110.896 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.63 ' HA ' HG11 ' A' ' 76' ' ' VAL . 35.6 t -65.75 -18.23 65.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.654 0.782 . . . . 0.0 111.579 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 47' ' ' LEU . 55.9 mt -89.15 18.93 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.914 0.885 . . . . 0.0 110.794 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.88 19.61 78.68 Favored Glycine 0 C--N 1.362 1.974 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -104.06 148.42 26.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.092 0.557 . . . . 0.0 109.941 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -88.56 88.98 7.8 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.8 t -94.59 109.94 22.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.611 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 79' ' ' THR . 69.6 p -84.31 112.62 20.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.312 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.594 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -106.43 111.65 24.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.834 0.854 . . . . 0.0 111.047 -172.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.49 HG23 HD11 ' A' ' 34' ' ' LEU . 22.3 t -81.24 126.82 39.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.35 119.58 11.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.46 -18.18 65.12 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.617 0.573 . . . . 0.0 111.957 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.1 m -97.45 130.39 44.56 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.7 p -65.59 -27.71 68.61 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 18.4 m -63.27 -41.0 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.3 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.54 -40.81 94.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.647 0.592 . . . . 0.0 112.328 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.5 -42.16 83.3 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.537 0.735 . . . . 0.0 111.287 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.22 90.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.782 0.833 . . . . 0.0 112.328 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 2.8 mmmp? -65.85 -41.97 91.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.845 0.458 . . . . 0.0 110.134 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -61.0 -55.4 33.29 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.607 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.37 -23.41 50.81 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.69 -44.52 96.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' A' ' 45' ' ' CYS . 35.2 tp -69.11 -24.25 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.651 0.594 . . . . 0.0 111.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.14 -51.63 68.25 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.484 0.659 . . . . 0.0 109.434 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -72.58 -30.29 64.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.005 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.22 -53.62 10.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.598 0.759 . . . . 0.0 110.804 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.36 -1.4 55.95 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.5 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 38.77 78.43 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.846 -0.161 . . . . 0.0 113.299 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -112.97 173.99 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.734 0.814 . . . . 0.0 109.849 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -111.65 121.1 44.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.15 0.58 . . . . 0.0 111.152 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.2 mm -107.26 163.41 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 164.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 55' ' ' THR . 29.7 m -133.59 106.13 7.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p -87.04 112.85 22.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.436 0.694 . . . . 0.0 111.083 -166.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.13 126.41 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.013 1.325 . . . . 0.0 109.303 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -104.77 92.34 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -134.21 -176.83 4.33 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -141.14 110.1 6.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.734 -1.121 . . . . 0.0 107.999 -158.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 105' ' ' LEU . 17.7 mt -65.87 -7.69 17.84 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.507 1.123 . . . . 0.0 111.733 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.649 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -57.97 -41.91 83.93 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.325 1.05 . . . . 0.0 112.218 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -151.67 12.36 0.61 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.27 110.24 1.58 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.438 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -138.26 -73.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.493 HG23 HD11 ' A' ' 36' ' ' LEU . 17.7 pt -119.72 117.79 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.49 87.05 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.405 0.682 . . . . 0.0 109.537 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.57 -30.04 4.89 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.231 1.413 . . . . 0.0 114.153 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.51 -46.11 80.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.431 0.692 . . . . 0.0 109.272 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.35 -25.71 51.33 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.515 ' CD1' HD22 ' A' ' 34' ' ' LEU . 47.9 m95 -117.5 166.32 12.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -169.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 11.3 tp10 -94.07 -74.63 0.53 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.855 0.862 . . . . 0.0 109.836 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.87 162.11 17.46 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.495 HD12 HD12 ' A' ' 121' ' ' LEU . 54.1 mt -128.7 147.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 33' ' ' ILE . 7.2 p -139.24 141.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.893 1.277 . . . . 0.0 107.87 167.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . 50.5 m -136.97 92.31 2.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 128' ' ' ILE . 40.7 mm -62.28 133.51 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 129' ' ' LEU . 14.6 p90 -20.93 102.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.123 2.139 . . . . 0.0 114.148 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 71.0 m -77.95 103.42 7.88 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.058 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -91.09 96.94 10.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 85' ' ' LEU . 86.8 mt -125.65 142.33 41.7 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.201 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.01 159.88 36.48 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.534 2.156 . . . . 0.0 110.707 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.3 p -41.87 -43.14 2.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.5 1.52 . . . . 0.0 113.668 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -55.77 -50.93 69.1 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.209 0.943 . . . . 0.0 112.172 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.92 -33.94 33.74 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.284 0.634 . . . . 0.0 111.714 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.42 -43.63 31.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.583 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.44 -35.0 18.1 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.693 0.797 . . . . 0.0 111.967 165.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.649 HE22 ' HA ' ' A' ' 86' ' ' ALA . 24.9 tt0 -79.47 -33.03 42.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.64 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 117' ' ' VAL . 48.1 tp -71.21 -48.61 50.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.891 0.476 . . . . 0.0 111.581 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -60.93 -42.77 88.67 Favored Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -167.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.43 -25.45 48.61 Favored 'Trans proline' 0 C--N 1.396 3.076 0 CA-C-N 121.364 1.523 . . . . 0.0 111.984 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -81.7 -21.17 38.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 122.995 0.518 . . . . 0.0 110.357 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 113' ' ' LEU . 19.3 t -85.03 -35.74 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 42.4 t80 -48.9 -61.6 1.96 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.125 0.97 . . . . 0.0 112.256 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.425 ' HG3' ' HD1' ' A' ' 118' ' ' TYR . 47.9 mt-30 -95.46 -22.3 17.77 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 172.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.21 -23.86 53.49 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD12 HD12 ' A' ' 98' ' ' ILE . 39.7 tp -61.05 124.89 21.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.394 0.678 . . . . 0.0 110.884 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -67.11 133.11 93.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.65 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.596 2.197 . . . . 0.0 112.297 168.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.16 14.76 8.17 Favored Glycine 0 C--O 1.248 1.005 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.433 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -95.87 135.56 12.39 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.5 m -109.4 130.4 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.002 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.17 111.59 24.08 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 24' ' ' VAL . 58.1 mt -106.98 108.27 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 102' ' ' PHE . 69.8 mt -124.25 117.49 24.68 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.423 0.689 . . . . 0.0 109.381 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -99.55 98.71 9.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.61 169.16 53.26 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.905 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.439 ' HD1' HD22 ' A' ' 187' ' ' LEU . 7.7 m-85 -133.06 156.02 48.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.898 -179.257 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.0 mt -86.89 102.81 3.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.882 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.1 Cg_endo -75.69 123.68 7.66 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.858 2.372 . . . . 0.0 112.618 -168.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -102.78 151.37 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.795 0.838 . . . . 0.0 111.839 -168.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 190' ' ' LEU . 32.5 mt -61.0 -54.39 45.58 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.692 . . . . 0.0 111.829 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -52.51 -39.54 61.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.93 0.892 . . . . 0.0 111.181 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 29.3 m -74.7 -57.12 4.12 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 151' ' ' PRO . 88.8 mt -63.92 -46.43 84.8 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.251 1.021 . . . . 0.0 112.631 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.602 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.5 tt0 -53.38 -35.57 60.48 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 111.837 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.5 t -84.44 -20.88 31.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.694 . . . . 0.0 112.062 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 155' ' ' THR . 41.6 mm-40 -79.53 -16.53 55.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.608 . . . . 0.0 110.875 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 82.1 mt -142.12 66.53 20.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.768 0.827 . . . . 0.0 109.461 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.591 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 13.8 Cg_exo -72.24 -3.84 14.08 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 123.115 2.543 . . . . 0.0 112.635 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 p -85.62 -33.87 21.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.8 tp -99.59 70.49 1.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.361 1.464 . . . . 0.0 111.257 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.402 ' HB3' HD22 ' A' ' 195' ' ' LEU . 26.5 t-20 -53.03 126.96 22.32 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.602 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 17.4 m95 -91.08 133.26 35.47 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.81 -35.56 77.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.985 0.514 . . . . 0.0 109.7 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 78.1 mt -126.45 123.04 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.22 69.69 1.01 Allowed 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -129.48 145.93 51.38 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.327 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -92.17 112.1 23.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.436 1.094 . . . . 0.0 109.493 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.8 mt -117.25 125.42 51.1 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.456 0.702 . . . . 0.0 110.316 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.439 HD22 ' HD1' ' A' ' 132' ' ' PHE . 52.1 mt -135.36 173.65 11.48 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 151' ' ' PRO . 9.8 pt -145.88 135.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.931 0.892 . . . . 0.0 109.257 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.4 142.25 33.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.664 0.386 . . . . 0.0 110.442 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 153' ' ' LEU . 39.5 mt -129.36 131.42 46.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.7 1.2 . . . . 0.0 109.069 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.86 105.74 7.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.07 138.16 15.24 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.705 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.0 tp-100 -142.55 149.7 39.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.587 0.693 . . . . 0.0 110.219 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -66.34 138.93 57.96 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 164' ' ' ASN . 5.6 mt . . . . . 0 N--CA 1.475 0.791 0 O-C-N 124.557 1.161 . . . . 0.0 109.169 -171.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.474 HD21 ' HG ' ' A' ' 47' ' ' LEU . 37.5 tp -62.95 -36.54 83.78 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.763 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 m -44.13 -36.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.239 1.016 . . . . 0.0 113.584 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 m -74.89 -52.43 11.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.521 0.729 . . . . 0.0 110.84 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 128' ' ' ILE . 2.1 m -62.3 -37.06 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.588 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.0 83.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.314 1.446 . . . . 0.0 112.057 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.99 -28.05 68.59 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.813 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.18 -14.6 28.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.211 0.605 . . . . 0.0 112.194 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 76.1 mt -77.71 130.58 73.12 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.72 140.71 46.14 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.266 2.644 . . . . 0.0 112.65 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.45 28.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.66 -147.12 8.66 Favored Glycine 0 N--CA 1.468 0.777 0 CA-C-N 118.455 0.571 . . . . 0.0 112.905 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -80.43 119.34 23.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -110.27 139.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.218 1.007 . . . . 0.0 108.555 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 26.1 tp -115.42 128.65 56.19 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.968 0.804 . . . . 0.0 111.498 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 32.7 m -94.05 138.0 32.62 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.051 0.94 . . . . 0.0 110.239 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.6 108.95 17.08 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.986 0.514 . . . . 0.0 111.152 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 O-C-N 125.482 1.738 . . . . 0.0 112.501 168.545 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -62.13 -49.09 77.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.336 1.054 . . . . 0.0 111.297 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.455 HD22 HG21 ' A' ' 101' ' ' ILE . 93.5 m-20 -77.69 -32.78 53.23 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.804 -172.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.43 77.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.577 0.751 . . . . 0.0 110.101 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -68.85 -30.47 69.01 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.526 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 21' ' ' LEU . 57.4 t80 -62.93 -43.53 98.55 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HG ' HD21 ' A' ' 21' ' ' LEU . 89.4 mt -70.36 -30.78 67.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.85 76.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.88 0.472 . . . . 0.0 111.197 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 23.6 p -75.85 -2.44 30.08 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.303 0.641 . . . . 0.0 111.985 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 94.4 mt -86.32 14.97 5.75 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.314 0.646 . . . . 0.0 110.427 164.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.29 47.31 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 123.223 0.44 . . . . 0.0 113.523 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -125.29 157.03 37.66 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.337 0.589 . . . . 0.0 111.065 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.76 88.57 5.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.12 116.57 36.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.237 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 27.1 m -84.95 112.78 20.89 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 124.761 1.224 . . . . 0.0 107.977 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.27 133.85 46.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 111.174 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 81' ' ' VAL . 15.1 t -115.66 120.1 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.64 143.8 50.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.05 -20.98 66.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.506 0.722 . . . . 0.0 111.263 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 62' ' ' VAL . 46.1 m -111.75 124.52 52.51 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.716 1.206 . . . . 0.0 109.003 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.5 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.907 0.883 . . . . 0.0 110.062 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 60' ' ' SER . 19.1 m -66.26 -26.35 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.67 -35.1 33.06 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.157 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.3 -44.79 82.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.031 0.933 . . . . 0.0 110.449 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.26 91.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.924 0.889 . . . . 0.0 111.528 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -66.81 -40.28 87.99 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.295 0.638 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.08 88.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.294 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -70.02 -36.87 75.41 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.431 1.092 . . . . 0.0 111.476 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -61.08 -52.15 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.23 -28.77 69.96 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.984 0.803 . . . . 0.0 110.715 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.32 -62.24 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.981 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -65.77 -26.24 67.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 111.559 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.52 -46.28 90.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.162 0.985 . . . . 0.0 109.786 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -98.81 -0.71 41.99 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.553 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.85 51.23 8.03 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.366 0.506 . . . . 0.0 114.366 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.2 m -138.42 176.29 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.932 0.893 . . . . 0.0 110.618 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -114.74 140.88 48.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.832 0.853 . . . . 0.0 111.937 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.5 157.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 85.6 m -119.12 103.23 9.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 t -94.62 114.89 26.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.278 0.561 . . . . 0.0 110.535 -163.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 57' ' ' VAL . 61.7 t -109.92 139.69 32.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.683 1.193 . . . . 0.0 108.883 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -78.87 132.26 36.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.639 0.775 . . . . 0.0 109.902 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 p -63.61 106.07 0.89 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 111.515 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -144.21 89.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 165.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -78.87 -16.36 57.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.804 0.442 . . . . 0.0 111.047 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . . . -72.22 -27.3 62.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.565 0.746 . . . . 0.0 111.333 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -104.52 -37.12 7.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.262 0.625 . . . . 0.0 111.654 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -161.34 126.25 3.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.378 1.071 . . . . 0.0 108.323 -170.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.01 -70.55 0.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 117' ' ' VAL . 2.9 pt -143.5 118.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.582 0.753 . . . . 0.0 109.778 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.879 0.872 . . . . 0.0 109.685 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 122' ' ' LYS . . . -44.88 -26.67 0.43 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 -44.42 71.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.991 0.516 . . . . 0.0 110.761 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.68 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -140.89 -165.32 1.92 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.223 0.609 . . . . 0.0 111.25 -171.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -118.01 -37.16 3.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.752 0.821 . . . . 0.0 112.42 -169.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.36 172.21 23.94 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 122.369 -0.207 . . . . 0.0 112.862 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.536 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 42.6 mt -134.35 145.83 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.881 0.873 . . . . 0.0 109.233 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -127.3 105.09 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 159.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.9 t -104.19 88.03 2.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 43' ' ' ASN . 34.4 mm -71.58 146.16 11.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.656 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -17.54 99.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 126.563 2.414 . . . . 0.0 112.261 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.558 ' SG ' HD21 ' A' ' 129' ' ' LEU . 28.8 p -99.15 104.83 16.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.158 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -96.67 96.71 8.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.4 mt -112.19 139.27 22.28 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.717 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 105' ' ' LEU . 11.7 Cg_exo -71.19 162.03 43.87 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.937 2.425 . . . . 0.0 110.981 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 149' ' ' LEU . 14.0 m -34.98 -42.56 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.199 1.8 . . . . 0.0 115.368 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.3 m -70.61 -46.52 63.22 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.241 0.338 . . . . 0.0 110.692 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.52 -35.72 34.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.632 0.373 . . . . 0.0 110.427 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -69.14 -62.73 1.26 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.679 0.792 . . . . 0.0 109.945 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -51.87 -34.06 39.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.918 0.887 . . . . 0.0 113.135 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 53.8 tt0 -78.64 -32.58 47.36 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 117' ' ' VAL . 55.9 tp -71.92 -39.27 69.6 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.457 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -62.86 -38.86 47.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.94 -30.89 67.35 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.819 1.679 . . . . 0.0 111.792 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.08 -15.71 56.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.787 0.835 . . . . 0.0 110.209 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.616 ' HA ' HD11 ' A' ' 90' ' ' ILE . 22.3 t -83.84 -40.92 16.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -57.8 -52.39 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -69.95 -42.7 72.88 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.3 -39.86 14.65 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 25.8 tp -69.78 111.84 5.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.916 0.886 . . . . 0.0 110.61 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 19.4 ptmt -85.42 157.95 58.11 Favored Pre-proline 0 C--O 1.247 0.948 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.106 167.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.588 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 83.1 Cg_exo -50.8 112.29 0.73 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.343 2.029 . . . . 0.0 112.291 168.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 126.61 12.73 3.27 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.319 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.78 147.53 16.37 Favored Glycine 0 C--O 1.246 0.862 0 O-C-N 122.545 -0.385 . . . . 0.0 112.303 168.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 35.1 m -109.44 131.57 59.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 123.548 0.739 . . . . 0.0 110.076 177.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.93 112.54 24.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 24' ' ' VAL . 59.6 mt -115.44 112.26 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.132 0.973 . . . . 0.0 109.543 -171.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' SG ' ' A' ' 103' ' ' CYS . 96.5 mt -133.33 153.42 51.6 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 37.7 tt0 -132.49 100.76 5.08 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 164.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 151' ' ' PRO . . . -80.23 166.58 49.96 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.779 175.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.413 ' HB2' HD22 ' A' ' 150' ' ' LEU . 58.0 m-85 -127.29 157.43 39.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 109.383 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.479 0.98 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 107' ' ' SER . 71.8 mt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 132' ' ' PHE . 56.3 mt -85.63 108.52 16.76 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.511 ' HB2' HD11 ' A' ' 156' ' ' LEU . 12.2 Cg_exo -70.22 122.63 9.18 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.977 2.451 . . . . 0.0 112.53 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -96.61 150.11 21.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.1 0.96 . . . . 0.0 111.282 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.583 HD22 HD21 ' A' ' 190' ' ' LEU . 37.9 mt -57.55 -36.87 72.2 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 122.987 0.515 . . . . 0.0 109.696 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -50.9 -51.37 52.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.534 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -69.75 -48.84 57.88 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.55 -58.73 3.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.396 1.078 . . . . 0.0 112.516 -166.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.27 -31.28 72.35 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.455 0.702 . . . . 0.0 112.091 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.0 t -84.54 -13.85 50.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.065 0.393 . . . . 0.0 111.519 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.85 -45.35 10.94 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.675 0.75 . . . . 0.0 109.317 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.9 mt -104.85 78.89 0.4 Allowed Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.702 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.37 -4.06 7.63 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 123.002 2.468 . . . . 0.0 111.367 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -85.52 -28.62 24.83 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.49 1.116 . . . . 0.0 108.115 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.83 70.81 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.78 1.632 . . . . 0.0 109.015 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 195' ' ' LEU . 6.8 t30 -60.46 121.42 12.05 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.425 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 16.7 m95 -87.85 141.51 28.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.516 1.126 . . . . 0.0 108.998 -167.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.4 mt -73.42 -35.72 65.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.077 0.551 . . . . 0.0 109.809 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 82.2 mt -126.11 118.09 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.81 76.5 1.07 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -141.3 143.03 33.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.11 112.23 20.49 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.473 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.4 mt -103.86 131.27 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.409 1.083 . . . . 0.0 108.884 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 C--O 1.238 0.462 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 175.067 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 C--O 1.237 0.429 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.0 mt -122.16 144.03 49.2 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 13.4 pt -133.02 116.61 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.15 0.432 . . . . 0.0 110.025 -170.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.61 137.77 36.76 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.067 0.46 . . . . 0.0 109.779 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 153' ' ' LEU . 62.9 mt -125.98 146.0 50.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.388 1.075 . . . . 0.0 110.343 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 23.7 tp -149.88 106.15 3.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -88.48 142.36 17.22 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -142.65 156.76 45.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.649 0.725 . . . . 0.0 111.04 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 68.2 tttt -55.34 135.26 50.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.322 1.449 . . . . 0.0 110.368 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 164' ' ' ASN . 3.5 mt . . . . . 0 C--O 1.245 0.84 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 164.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.61 -17.91 57.14 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.695 1.198 . . . . 0.0 112.443 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.69 -37.92 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -71.84 -41.15 68.48 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.031 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.4 m -66.8 -43.5 89.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -57.27 -38.41 73.86 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.18 0.992 . . . . 0.0 112.253 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.61 -21.32 63.59 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.626 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -91.1 -21.86 21.0 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.41 0.684 . . . . 0.0 110.54 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 92.3 mt -74.09 134.2 77.77 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 123.532 0.733 . . . . 0.0 110.51 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.66 136.42 49.68 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.36 2.707 . . . . 0.0 112.111 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.44 28.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.7 -132.81 4.98 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -84.33 112.41 20.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HG12 ' A' ' 99' ' ' VAL . 8.9 mt -111.59 119.11 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.691 0.796 . . . . 0.0 109.197 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 90' ' ' ILE . 28.7 tp -89.95 108.0 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.667 0.212 . . . . 0.0 110.743 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 49.3 t -94.92 110.39 22.29 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.265 0.626 . . . . 0.0 110.689 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.2 mt -79.02 126.35 30.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.458 0 O-C-N 123.791 0.682 . . . . 0.0 109.816 -177.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -49.78 -38.32 33.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.417 1.487 . . . . 0.0 112.2 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.422 ' ND2' HG13 ' A' ' 101' ' ' ILE . 29.1 p-10 -64.2 -41.0 97.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.0 72.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.51 0.724 . . . . 0.0 110.719 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 9.9 m -59.55 -38.89 82.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.627 0.771 . . . . 0.0 111.099 173.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -73.2 -33.5 65.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.592 0.757 . . . . 0.0 110.906 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HG11 ' A' ' 99' ' ' VAL . 50.6 mt -64.03 -32.36 73.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 110.421 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.17 -31.24 58.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.879 0.472 . . . . 0.0 110.763 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 m -68.37 -6.09 22.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.809 0.844 . . . . 0.0 111.835 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.8 mt -83.89 12.38 6.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.596 0.758 . . . . 0.0 110.646 168.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 34.72 25.44 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 123.285 0.469 . . . . 0.0 113.985 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.4 162.16 26.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.882 0.473 . . . . 0.0 111.387 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -92.99 91.07 7.2 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 165.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 33' ' ' ILE . 85.7 t -88.4 112.12 23.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.2 t -83.3 104.4 13.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.28 134.75 42.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.985 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.501 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.3 t -113.71 118.22 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -133.68 142.48 48.03 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -54.31 -32.2 55.98 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.191 0.997 . . . . 0.0 112.364 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' HG22 ' A' ' 62' ' ' VAL . 9.1 t -109.03 130.33 55.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.631 0.772 . . . . 0.0 110.005 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 t -74.98 -16.86 60.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.929 0.892 . . . . 0.0 110.991 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.461 HG22 ' OG ' ' A' ' 60' ' ' SER . 9.6 m -63.85 -32.98 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.544 0.337 . . . . 0.0 110.511 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.42 -33.21 56.75 Favored Glycine 0 C--N 1.351 1.382 0 O-C-N 123.538 0.523 . . . . 0.0 112.646 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.09 -48.03 59.38 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.779 0.832 . . . . 0.0 110.413 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.55 86.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.712 0.805 . . . . 0.0 112.047 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -63.35 -39.41 94.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.861 0.864 . . . . 0.0 110.748 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -60.92 -46.71 89.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.942 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -71.08 -37.14 72.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.635 0.774 . . . . 0.0 111.652 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.63 -55.72 31.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.93 0.892 . . . . 0.0 109.849 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.2 tp -66.61 -25.19 66.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.221 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.09 -52.09 52.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.973 0.509 . . . . 0.0 110.495 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.85 -33.83 73.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.026 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.6 -48.22 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.545 0.528 . . . . 0.0 110.723 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 74' ' ' LYS . 2.0 ttmp? -87.68 -13.5 42.4 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.96 44.83 13.04 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 121.054 0.252 . . . . 0.0 112.674 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 172.83 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.394 1.078 . . . . 0.0 108.124 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -121.77 141.26 51.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.706 0.403 . . . . 0.0 110.896 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.8 mm -109.24 165.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 45.0 m -131.13 104.02 6.84 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 164.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.2 p -86.74 114.33 23.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.884 0.474 . . . . 0.0 111.108 -168.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' HB ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -104.63 139.01 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.746 1.218 . . . . 0.0 108.108 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -78.9 136.35 37.26 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 p -50.47 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.5 1.12 . . . . 0.0 111.838 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 6.6 m-20 -134.65 91.1 2.73 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 65.7 mt -100.46 -6.71 25.15 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.691 0.758 . . . . 0.0 110.68 -170.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.27 3.44 29.98 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.189 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 32.2 t70 -139.64 -46.38 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -168.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -163.86 100.5 0.88 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.634 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -132.84 -58.28 0.92 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.522 0.729 . . . . 0.0 109.343 -164.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 34' ' ' LEU . 4.7 pt -134.35 110.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 123.039 0.535 . . . . 0.0 111.028 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 t -129.2 84.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.559 0.744 . . . . 0.0 109.346 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.529 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.65 -1.02 14.61 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.897 0.479 . . . . 0.0 112.176 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -76.16 -45.95 30.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.98 61.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.614 0.766 . . . . 0.0 112.57 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.508 ' CD1' HD22 ' A' ' 34' ' ' LEU . 44.8 m95 -113.79 -177.71 3.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.254 0.622 . . . . 0.0 110.486 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -92.49 -55.83 3.25 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.69 0.796 . . . . 0.0 109.994 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.77 173.84 21.34 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.521 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.8 mt -132.68 139.3 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 47' ' ' LEU . 7.5 p -124.06 106.94 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.64 0.734 . . . . 0.0 109.233 165.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.2 m -103.82 94.11 5.25 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.449 HD13 HD12 ' A' ' 128' ' ' ILE . 41.6 mm -68.52 141.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.359 1.063 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 8.2 p90 -21.63 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 126.032 1.733 . . . . 0.0 113.85 -172.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.494 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 35.8 t -94.53 109.56 21.44 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.615 -168.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -108.52 98.69 8.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.494 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 62.5 mt -114.62 145.53 34.06 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.809 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.73 150.55 69.79 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.833 2.355 . . . . 0.0 110.269 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.6 t -44.9 -33.88 2.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.771 1.228 . . . . 0.0 113.324 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.0 m -59.4 -59.81 4.85 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.312 0.645 . . . . 0.0 111.399 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.66 -24.41 53.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.992 0.517 . . . . 0.0 110.537 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.84 -54.62 14.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.416 1.086 . . . . 0.0 109.57 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -55.75 -28.67 57.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.387 1.075 . . . . 0.0 112.436 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.65 -22.95 24.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.842 0.457 . . . . 0.0 111.078 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.5 tp -71.9 -45.42 61.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.133 0.573 . . . . 0.0 111.172 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -58.58 -41.52 89.48 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -52.79 -38.05 77.22 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 122.449 2.099 . . . . 0.0 112.811 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.55 -23.61 56.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.391 0.677 . . . . 0.0 111.595 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 t -85.46 -28.08 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.362 0.601 . . . . 0.0 110.142 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -75.04 -61.09 2.01 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.291 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -76.99 -47.36 20.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.501 1.12 . . . . 0.0 113.584 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.62 -36.72 22.22 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 114.14 0.416 . . . . 0.0 114.14 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.2 tp -75.36 108.5 8.18 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 1.2 mptm? -82.59 159.53 63.73 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.529 168.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -41.29 113.05 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.305 2.67 . . . . 0.0 113.813 166.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 14.22 3.24 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.235 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -112.32 144.43 17.8 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 121.766 -0.843 . . . . 0.0 111.146 165.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 33.9 m -107.59 132.16 55.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.834 0.854 . . . . 0.0 109.96 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.56 112.79 25.95 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.449 HD12 HD13 ' A' ' 101' ' ' ILE . 57.9 mt -104.21 109.43 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 156' ' ' LEU . 51.7 mt -124.59 120.71 32.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 110.088 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 37.8 tt0 -112.28 102.6 10.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.57 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.65 169.08 40.5 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.668 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.635 ' HD1' HD22 ' A' ' 187' ' ' LEU . 57.1 m-85 -137.73 165.97 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.78 0.832 . . . . 0.0 109.445 -172.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.572 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 123.833 0.853 . . . . 0.0 110.072 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 105' ' ' LEU . 24.0 mt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.742 0.306 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.24 106.02 5.04 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 166.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.57 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 15.3 Cg_exo -68.29 110.77 2.32 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 123.203 2.602 . . . . 0.0 112.651 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -95.51 147.67 23.3 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.926 0.891 . . . . 0.0 111.311 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.6 mt -59.84 -45.26 92.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.52 0.6 . . . . 0.0 110.428 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.63 -46.77 77.37 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.261 0.976 . . . . 0.0 110.942 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.7 p -71.95 -53.73 12.15 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 129' ' ' LEU . 40.6 mt -70.01 -51.29 33.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.533 1.133 . . . . 0.0 113.274 -169.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 30.0 tt0 -59.98 -35.06 74.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.679 0.392 . . . . 0.0 111.38 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.7 t -78.04 -28.1 48.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.703 0.401 . . . . 0.0 110.864 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -78.39 -24.15 46.46 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.885 . . . . 0.0 110.768 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.7 mt -131.84 73.27 78.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -82.71 -9.18 11.12 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.252 2.634 . . . . 0.0 112.606 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -91.84 -29.86 16.5 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp -88.4 72.44 8.91 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.624 1.17 . . . . 0.0 110.29 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -53.6 125.69 19.07 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.108 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.406 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 41.9 m95 -91.76 125.12 36.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.541 1.137 . . . . 0.0 108.899 -172.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.96 -34.13 75.98 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.089 0.556 . . . . 0.0 109.983 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 72.7 mt -127.54 122.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.63 76.26 1.01 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -145.98 145.76 30.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 -172.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.548 ' H ' HD22 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -74.97 115.54 14.7 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.493 0.717 . . . . 0.0 110.432 174.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.1 mt -107.84 114.56 28.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.082 0.553 . . . . 0.0 111.1 -171.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.635 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.3 mt -127.61 160.68 30.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 16.3 pt -140.39 142.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -129.42 150.13 50.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.555 0.693 . . . . 0.0 111.147 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 40.7 mt -132.25 140.7 48.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.608 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 34.2 tp -134.03 104.16 6.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.94 136.54 14.07 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.34 155.58 44.48 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.462 0.705 . . . . 0.0 109.883 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -57.1 144.95 32.62 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.476 0.71 . . . . 0.0 110.36 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--O 1.245 0.83 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.005 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.018 0.437 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -57.69 -19.68 28.73 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.902 1.281 . . . . 0.0 112.838 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.73 -27.8 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 118.973 0.806 . . . . 0.0 108.897 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -72.32 -43.14 64.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.361 1.064 . . . . 0.0 110.615 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.6 m -68.84 -37.47 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.309 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -26.2 68.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.907 0.883 . . . . 0.0 112.63 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -70.34 -28.31 65.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.688 0.795 . . . . 0.0 109.572 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -84.75 -24.08 28.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.783 0.833 . . . . 0.0 111.393 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 33' ' ' ILE . 63.7 mt -72.85 131.42 84.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.263 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -64.72 144.33 83.56 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.817 2.345 . . . . 0.0 112.003 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -69.14 27.49 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.526 ' HA3' ' HG3' ' A' ' 96' ' ' GLU . . . -116.61 -140.95 6.94 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 119.065 0.848 . . . . 0.0 112.832 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 41.5 mtpt -83.63 118.48 23.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.378 0.671 . . . . 0.0 109.682 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.571 HD13 HG21 ' A' ' 28' ' ' ILE . 9.7 mt -115.43 131.92 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.409 HD22 ' NE1' ' A' ' 95' ' ' TRP . 33.0 tp -97.89 113.85 25.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.8 t -95.34 133.82 38.83 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.881 0.872 . . . . 0.0 108.68 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -101.53 159.06 15.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.566 0.346 . . . . 0.0 111.053 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 O-C-N 125.023 1.452 . . . . 0.0 113.061 178.9 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.133 0 N-CA-C 114.288 0.475 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.667 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 51.1 mtp180 -56.43 -34.92 67.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.37 1.068 . . . . 0.0 111.787 168.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.66 -45.25 89.76 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.901 0.88 . . . . 0.0 110.293 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.7 75.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.331 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 42' ' ' ARG . 22.7 p -73.8 -19.78 60.66 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.363 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.61 -50.15 53.72 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.98 -30.55 69.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.399 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.05 0.54 . . . . 0.0 111.956 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.646 ' HA ' HG11 ' A' ' 76' ' ' VAL . 87.7 p -73.56 -3.85 30.39 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.836 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.02 12.08 3.6 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.758 0.823 . . . . 0.0 111.219 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.02 15.97 60.17 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 123.173 0.416 . . . . 0.0 113.932 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.86 157.93 20.8 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.788 0.835 . . . . 0.0 109.869 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 45.1 mt-10 -97.34 90.83 5.22 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 33' ' ' ILE . 61.9 t -94.84 110.97 24.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.596 0.712 . . . . 0.0 110.06 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -86.18 114.82 23.32 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.528 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.53 144.65 29.27 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 123.877 0.871 . . . . 0.0 111.268 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -119.89 117.25 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 165.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.64 148.17 51.51 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.229 0.922 . . . . 0.0 111.195 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -56.1 -34.18 65.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.129 1.772 . . . . 0.0 112.473 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.3 p -123.72 140.42 53.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.085 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -73.54 -15.75 61.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.086 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.2 m -63.84 -38.59 82.74 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -41.18 55.31 Favored Glycine 0 C--N 1.357 1.725 0 O-C-N 123.551 0.532 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.45 -41.67 98.91 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.518 0.727 . . . . 0.0 110.435 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.03 76.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.016 0.926 . . . . 0.0 112.532 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 75.0 mmtt -62.61 -39.37 93.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.603 0.361 . . . . 0.0 110.357 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -62.5 -51.34 67.81 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.593 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -71.21 -32.48 68.88 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.305 0.642 . . . . 0.0 111.849 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -58.41 -48.88 79.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.2 0.6 . . . . 0.0 110.703 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.8 tp -68.63 -25.88 65.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 123.269 0.355 . . . . 0.0 110.64 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.79 -59.29 5.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.023 0.529 . . . . 0.0 110.897 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -58.33 -48.33 80.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.81 0.844 . . . . 0.0 111.839 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 -41.96 88.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.82 0.848 . . . . 0.0 111.191 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -105.56 -12.06 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.137 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.31 44.39 22.45 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 121.907 -0.187 . . . . 0.0 113.509 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -124.55 160.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -104.77 126.4 51.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.674 0.79 . . . . 0.0 110.775 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.643 HG21 ' HB1' ' A' ' 67' ' ' ALA . 5.1 mm -117.84 164.89 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -133.98 108.04 8.15 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 p -94.5 125.92 39.45 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.942 0.497 . . . . 0.0 111.303 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.35 140.74 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.359 1.464 . . . . 0.0 107.882 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -82.98 144.17 30.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -62.8 102.9 0.38 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.714 0.806 . . . . 0.0 112.903 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -142.27 89.63 2.18 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.93 -8.39 51.89 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.39 0.676 . . . . 0.0 111.792 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.79 -16.64 50.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.901 0.881 . . . . 0.0 110.763 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.55 -38.42 4.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.416 0.687 . . . . 0.0 110.544 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -151.02 130.16 12.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.667 1.187 . . . . 0.0 107.91 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.98 -75.32 0.51 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 pt -143.27 119.45 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.026 0.93 . . . . 0.0 109.473 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.31 79.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 0.0 108.955 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -74.98 0.33 16.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.354 0.662 . . . . 0.0 112.089 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.79 -40.32 83.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 167.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.09 57.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.409 ' NE1' HD22 ' A' ' 34' ' ' LEU . 23.7 m95 -113.4 176.77 4.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.256 0.622 . . . . 0.0 111.211 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 52.2 mm-40 -90.18 -51.73 5.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.022 0.929 . . . . 0.0 109.883 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.88 178.56 21.12 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 121' ' ' LEU . 69.4 mt -131.59 145.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.85 0.86 . . . . 0.0 108.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 8.3 p -130.87 133.61 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 166.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 m -142.41 95.76 2.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' HD1' ' A' ' 102' ' ' PHE . 8.7 mm -74.3 153.78 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HD1' HG22 ' A' ' 101' ' ' ILE . 20.5 p90 -16.02 103.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.202 1.801 . . . . 0.0 115.004 -163.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.4 t -75.41 105.49 6.46 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.984 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -105.13 97.66 7.48 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -125.33 145.76 51.93 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.541 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -56.13 150.7 46.8 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.022 2.481 . . . . 0.0 110.666 163.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.3 t -48.53 -37.82 18.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.652 1.181 . . . . 0.0 112.006 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -53.57 -57.01 12.26 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.905 0.753 . . . . 0.0 111.113 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.71 -24.99 56.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.894 0.478 . . . . 0.0 110.636 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -75.44 -53.91 7.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.737 0.815 . . . . 0.0 110.637 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -60.41 -28.18 68.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.957 0.503 . . . . 0.0 111.723 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -75.74 -30.37 59.2 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 60.5 tp -74.56 -36.54 63.09 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.839 0.712 . . . . 0.0 111.888 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -54.87 -49.69 90.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.41 -24.92 70.96 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.05 1.833 . . . . 0.0 112.186 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.1 -29.59 61.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.011 0.524 . . . . 0.0 111.142 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' LEU . 5.0 t -85.75 -26.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.153 0.581 . . . . 0.0 110.064 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -69.95 -61.69 1.68 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.41 -49.74 38.85 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.92 -18.11 51.88 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 115.122 0.809 . . . . 0.0 115.122 -163.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 98' ' ' ILE . 13.3 tp -76.52 102.41 6.04 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.661 0.73 . . . . 0.0 109.076 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -75.86 145.44 77.91 Favored Pre-proline 0 C--O 1.247 0.951 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -44.19 111.93 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.059 2.506 . . . . 0.0 113.242 174.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.24 11.64 5.6 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.105 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.09 140.61 15.15 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 19.3 m -109.84 129.47 64.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -110.2 108.8 19.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -116.13 113.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.901 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 102' ' ' PHE . 3.6 mp -130.06 147.42 51.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.041 0.448 . . . . 0.0 111.13 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.94 98.47 6.5 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 165.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.85 -179.79 52.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.721 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.6 m-85 -137.9 158.4 44.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.429 -173.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 123.642 0.777 . . . . 0.0 110.45 178.822 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 132' ' ' PHE . 53.1 mt -78.99 112.58 28.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 166.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HB2' HD11 ' A' ' 156' ' ' LEU . 60.4 Cg_endo -71.71 93.63 0.69 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.26 1.973 . . . . 0.0 111.274 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.573 ' HA ' HD11 ' A' ' 188' ' ' ILE . 42.9 mtmt -96.78 156.06 16.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.608 -166.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 188' ' ' ILE . 35.3 mt -61.69 -49.85 74.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.345 0.658 . . . . 0.0 110.333 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.19 -40.33 73.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.887 0.742 . . . . 0.0 110.977 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.1 m -65.65 -64.27 0.9 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.696 174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 151' ' ' PRO . 83.5 mt -72.58 -45.16 60.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.704 0.802 . . . . 0.0 112.481 -164.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 64.0 tt0 -57.84 -42.02 83.55 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.04 0.536 . . . . 0.0 111.877 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -76.83 -26.23 54.11 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -84.66 -12.76 53.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.929 0.892 . . . . 0.0 111.25 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 70.0 mt -134.57 71.6 70.88 Favored Pre-proline 0 N--CA 1.475 0.792 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.56 -3.31 13.21 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.198 2.599 . . . . 0.0 111.002 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.5 t -83.86 -42.26 16.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.677 1.191 . . . . 0.0 107.912 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.6 tp -95.11 71.76 3.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.863 1.265 . . . . 0.0 110.487 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.31 127.86 32.96 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.58 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 36.8 m95 -91.5 137.83 32.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 0.0 109.226 -167.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.81 -32.24 63.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.761 0.424 . . . . 0.0 110.83 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 83.0 mt -132.81 128.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.87 77.63 0.96 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.91 1.284 . . . . 0.0 107.771 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.36 133.42 36.77 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 -169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -80.69 113.5 18.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.343 0.657 . . . . 0.0 110.773 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.3 mt -108.39 135.67 49.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.605 0.762 . . . . 0.0 109.981 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.549 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.89 163.67 19.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.632 0.773 . . . . 0.0 109.122 -169.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 152' ' ' LYS . 7.6 pt -143.82 125.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -97.72 141.55 30.6 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.941 -0.475 . . . . 0.0 111.061 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 37.6 mt -127.57 130.13 48.54 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.387 1.475 . . . . 0.0 108.997 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.419 HD22 HG12 ' A' ' 24' ' ' VAL . 29.9 tp -125.64 105.08 8.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -93.23 131.35 10.73 Favored Glycine 0 C--O 1.212 -1.221 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 173.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.614 ' HA ' HE21 ' A' ' 193' ' ' GLN . 0.0 OUTLIER -141.51 156.55 45.72 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 108.859 176.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -54.49 153.86 5.26 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.975 0.91 . . . . 0.0 110.957 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.245 0.835 0 C-N-CA 122.78 0.432 . . . . 0.0 110.22 175.808 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 t80 . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.449 HD22 HD22 ' A' ' 43' ' ' ASN . 14.1 tp -60.2 -22.52 63.07 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.77 0.828 . . . . 0.0 112.286 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 m -40.48 -56.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 124.489 1.116 . . . . 0.0 113.853 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 p -74.93 -50.62 16.18 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 110.681 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.2 m -66.93 -41.4 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.364 -171.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -60.9 -37.26 81.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.918 0.887 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -68.63 -26.78 65.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 193' ' ' GLN . 12.7 mm100 -92.86 -13.26 29.25 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 24' ' ' VAL . 73.7 mt -77.68 134.43 65.34 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.237 0.615 . . . . 0.0 110.87 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.77 132.38 47.55 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.326 2.684 . . . . 0.0 111.894 171.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -74.23 29.51 0.08 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.88 -145.68 9.54 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 12.3 mmmm -85.63 118.7 25.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -170.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mt -114.15 134.29 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.8 0.84 . . . . 0.0 110.04 -165.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.511 HD22 ' NE1' ' A' ' 95' ' ' TRP . 50.8 tp -106.92 127.01 53.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.243 0.617 . . . . 0.0 110.607 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 36.1 m -98.89 137.47 37.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.578 0.751 . . . . 0.0 110.16 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 89' ' ' ASP . 15.7 mt -114.58 116.05 28.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.181 0.593 . . . . 0.0 110.928 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.195 0 O-C-N 125.38 1.675 . . . . 0.0 113.657 165.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 114.355 0.502 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -69.37 -35.45 75.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.481 0.658 . . . . 0.0 109.469 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.449 HD22 HD22 ' A' ' 21' ' ' LEU . 26.3 m120 -80.8 -31.51 35.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.813 1.245 . . . . 0.0 110.426 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.24 82.73 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.936 0.772 . . . . 0.0 109.682 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 55.9 m -58.62 -43.18 89.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.462 171.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.4 -31.55 68.81 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.4 0.437 . . . . 0.0 111.096 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.14 -37.02 85.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.953 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.24 73.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.767 0.427 . . . . 0.0 111.227 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 11.7 m -65.99 -15.77 63.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.951 0.9 . . . . 0.0 112.155 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.79 8.72 5.0 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.039 0.535 . . . . 0.0 110.767 172.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.09 8.66 61.4 Favored Glycine 0 C--N 1.362 1.996 0 CA-C-O 119.69 -0.506 . . . . 0.0 114.326 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -105.65 152.37 23.21 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.428 0.614 . . . . 0.0 110.129 -172.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 35.5 mt-10 -94.89 90.8 6.14 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.2 t -88.86 118.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.354 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.1 p -86.04 113.0 21.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -112.3 122.35 47.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.862 0.465 . . . . 0.0 111.196 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.6 t -99.25 144.19 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 163.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t70 -124.77 178.19 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -87.24 -27.02 23.2 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.719 0.808 . . . . 0.0 109.851 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.4 m -119.43 135.97 54.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.954 -1.476 . . . . 0.0 110.559 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -68.64 -22.51 64.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.153 0.981 . . . . 0.0 110.689 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 60' ' ' SER . 17.7 m -64.84 -34.37 69.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.62 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -36.43 73.68 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.24 -43.13 78.59 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.016 0.927 . . . . 0.0 110.835 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -66.75 -37.06 83.89 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.299 0.239 . . . . 0.0 110.813 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -59.83 -48.49 81.47 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.877 0.736 . . . . 0.0 110.631 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.45 -44.8 74.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.006 0.922 . . . . 0.0 111.237 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.95 -50.87 71.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.337 1.055 . . . . 0.0 111.507 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 15.0 tp -69.61 -23.74 63.56 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.991 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -68.26 -51.27 46.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.728 173.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.17 -36.11 80.85 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.702 0.801 . . . . 0.0 111.191 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -59.07 -54.55 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.995 0.809 . . . . 0.0 110.511 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -85.18 -6.43 59.28 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.15 -169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.17 39.18 58.51 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 120.877 0.154 . . . . 0.0 112.892 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -127.66 167.41 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.568 1.147 . . . . 0.0 109.279 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -115.78 135.4 54.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.457 0.703 . . . . 0.0 112.265 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.7 mm -111.41 168.48 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 163.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 60.9 m -132.95 105.59 7.18 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 163.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.4 p -88.27 121.17 30.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.267 0.627 . . . . 0.0 110.119 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.683 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.6 t -103.13 137.52 31.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -77.32 135.52 38.4 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.93 0.395 . . . . 0.0 110.321 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -43.63 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.909 1.684 . . . . 0.0 112.233 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -145.32 97.47 3.0 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 84.3 mt -102.1 -8.59 21.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.024 0.53 . . . . 0.0 111.193 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -17.31 43.57 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.305 0.642 . . . . 0.0 112.093 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -137.34 -3.2 1.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.711 0.404 . . . . 0.0 112.046 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 87.3 t80 -156.49 143.87 19.08 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' O ' HD21 ' A' ' 36' ' ' LEU . 7.5 p-10 -150.79 -70.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 36' ' ' LEU . 13.5 pt -142.68 125.55 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.404 0.682 . . . . 0.0 109.538 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 t -130.56 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -72.51 0.23 10.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.248 0.619 . . . . 0.0 112.374 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.85 -34.09 77.15 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.444 0.697 . . . . 0.0 109.235 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.61 -18.81 22.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.316 1.046 . . . . 0.0 112.452 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.511 ' NE1' HD22 ' A' ' 34' ' ' LEU . 24.3 m95 -118.69 134.51 55.07 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.821 0.448 . . . . 0.0 110.856 -171.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -73.58 -28.56 61.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.451 0.7 . . . . 0.0 111.137 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.09 163.67 28.64 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.668 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 92' ' ' ALA . 75.5 mt -133.9 155.59 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.22 142.89 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.533 1.133 . . . . 0.0 109.225 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -143.62 103.99 4.15 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 128' ' ' ILE . 17.7 mm -75.31 145.72 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -16.16 102.83 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.843 2.057 . . . . 0.0 113.891 -171.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 24.4 p -119.77 149.76 41.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.879 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -145.16 101.58 3.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.016 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.24 147.37 33.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.347 0.659 . . . . 0.0 111.114 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.19 162.15 37.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.965 2.443 . . . . 0.0 110.767 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.2 t -39.12 -39.42 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.094 1.758 . . . . 0.0 114.274 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -64.01 -53.17 54.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.026 0.53 . . . . 0.0 111.591 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.9 -22.16 31.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.222 0.609 . . . . 0.0 110.714 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.421 HH22 ' HB3' ' A' ' 151' ' ' PRO . 75.2 ttt180 -77.88 -55.3 5.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 0.0 109.827 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -60.88 -22.12 63.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.035 0.534 . . . . 0.0 112.289 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.64 -33.84 53.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.7 tp -77.88 -52.7 8.45 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.613 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -56.15 -51.96 76.62 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -168.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.28 -23.35 62.13 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 121.807 1.681 . . . . 0.0 112.109 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -86.99 -25.5 24.24 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.262 1.025 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 10.9 t -80.9 -37.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.363 -0.836 . . . . 0.0 109.403 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.36 -62.12 2.12 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -74.63 -36.64 62.9 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.36 -34.1 7.25 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -166.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 40.2 tp -69.42 104.32 2.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.593 0.697 . . . . 0.0 109.954 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.07 141.19 88.91 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 164.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.47 125.5 12.46 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.753 2.302 . . . . 0.0 112.326 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 129.31 -2.51 6.2 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.711 -177.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -95.03 139.68 14.63 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 165.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.6 m -108.53 129.76 62.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 123.302 0.641 . . . . 0.0 109.555 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 110.97 22.71 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 101' ' ' ILE . 77.4 mt -106.77 106.77 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 85.7 mt -129.23 153.68 47.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.16 0.984 . . . . 0.0 110.193 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.08 106.73 4.86 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.91 134.67 23.77 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.669 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.7 m-85 -89.61 160.04 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.004 0.522 . . . . 0.0 110.95 -172.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.064 -176.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 132' ' ' PHE . 25.6 mt -99.71 103.26 20.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HB3' HH22 ' A' ' 110' ' ' ARG . 89.7 Cg_endo -81.22 129.33 6.72 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.611 2.208 . . . . 0.0 112.417 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -92.54 165.58 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.013 0.925 . . . . 0.0 112.173 -177.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 188' ' ' ILE . 75.6 mt -56.81 -40.48 76.05 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.942 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.9 -43.57 59.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 0.0 111.037 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 32.5 m -78.41 -54.57 6.04 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.128 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.4 HD13 HD13 ' A' ' 129' ' ' LEU . 85.9 mt -72.03 -46.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.051 0.94 . . . . 0.0 112.577 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -60.31 -44.05 95.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.657 0.783 . . . . 0.0 109.784 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.9 t -72.3 -21.41 61.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.819 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -76.9 -23.52 52.55 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.247 0.619 . . . . 0.0 110.542 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 76.3 mt -130.3 75.21 79.51 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.38 -19.48 17.03 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.196 2.598 . . . . 0.0 113.355 -172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -87.87 -42.09 12.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 28.8 tp -69.03 71.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.549 172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.03 131.29 45.87 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -91.29 135.62 33.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.591 1.156 . . . . 0.0 109.317 -169.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.479 HD11 ' HG2' ' A' ' 193' ' ' GLN . 79.1 mt -72.39 -30.01 64.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.064 0.546 . . . . 0.0 110.13 171.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.9 mt -131.04 120.85 48.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 73.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -143.77 152.31 41.09 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.13 0.491 . . . . 0.0 111.982 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -77.94 105.08 8.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.924 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.21 123.75 50.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.549 0.74 . . . . 0.0 109.595 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.276 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 77.0 mt -117.67 167.66 11.14 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.531 ' HB ' HD21 ' A' ' 153' ' ' LEU . 8.2 pt -142.68 118.62 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.32 145.18 28.45 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 38.3 mt -131.47 131.18 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.889 1.276 . . . . 0.0 109.723 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.09 106.13 6.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.03 139.46 16.95 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.516 HE21 ' H ' ' A' ' 194' ' ' LYS . 32.7 tp60 -136.11 157.54 46.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.516 ' H ' HE21 ' A' ' 193' ' ' GLN . 59.6 tttp -56.02 120.13 6.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.961 165.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.373 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' HG ' ' A' ' 47' ' ' LEU . 20.1 tp -61.81 -33.31 73.89 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.566 1.146 . . . . 0.0 113.077 -174.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -45.9 -40.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -75.87 -46.65 29.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.749 . . . . 0.0 109.85 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -63.23 -35.59 72.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.549 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.9 81.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.397 1.079 . . . . 0.0 111.781 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.87 -29.01 70.43 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.448 172.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.604 ' HB3' HE22 ' A' ' 193' ' ' GLN . 27.1 mm-40 -89.75 -21.37 22.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.451 1.1 . . . . 0.0 112.557 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 24' ' ' VAL . 77.1 mt -79.08 136.13 57.82 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-O 119.301 -0.38 . . . . 0.0 110.307 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.35 133.96 20.09 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 123.776 2.984 . . . . 0.0 113.537 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.18 27.99 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.16 -139.26 6.15 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 118.716 0.689 . . . . 0.0 112.619 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 40.9 ttmt -86.55 114.89 23.66 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 28' ' ' ILE . 11.9 mt -110.64 126.83 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 90' ' ' ILE . 54.2 tp -89.97 114.05 25.82 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 m -88.9 135.22 33.65 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.14 152.29 20.03 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.725 0.41 . . . . 0.0 110.186 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.413 0 O-C-N 125.671 1.857 . . . . 0.0 114.219 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.018 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -72.32 -52.25 17.04 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.421 1.088 . . . . 0.0 110.249 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 101' ' ' ILE . 18.7 m120 -76.07 -29.19 57.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.649 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.43 -57.84 11.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.67 0.788 . . . . 0.0 111.189 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.782 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 25.5 p -69.57 -26.98 64.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.362 0.665 . . . . 0.0 112.341 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 21' ' ' LEU . 38.2 t80 -60.14 -45.55 92.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.454 0.702 . . . . 0.0 109.465 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.681 ' HG ' HD21 ' A' ' 21' ' ' LEU . 68.9 mt -65.45 -32.63 74.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.863 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.56 74.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.394 0.278 . . . . 0.0 111.515 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.594 ' HA ' HG11 ' A' ' 76' ' ' VAL . 81.3 p -71.62 -6.6 42.14 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 123.245 0.34 . . . . 0.0 111.214 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' LEU . 50.0 mt -90.04 11.97 19.08 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.727 0.811 . . . . 0.0 111.124 168.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.63 21.31 66.75 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.549 0.58 . . . . 0.0 114.549 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.59 141.2 36.84 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.943 0.872 . . . . 0.0 110.917 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 45.6 mt-10 -77.47 88.53 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -90.63 107.31 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.592 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 34' ' ' LEU . 5.5 t -85.22 103.64 14.36 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.71 131.93 45.38 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.623 -169.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 81' ' ' VAL . 38.5 t -110.61 134.33 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 20.5 t70 -145.85 140.58 27.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 pt20 -68.52 -20.78 64.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.591 0.756 . . . . 0.0 111.661 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 m -112.9 141.49 46.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.959 0.904 . . . . 0.0 109.406 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.9 p -72.13 -15.95 61.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.646 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.38 -32.97 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.824 0.449 . . . . 0.0 111.113 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.17 -36.72 23.63 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.621 0.575 . . . . 0.0 113.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.72 -52.03 14.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.625 0.77 . . . . 0.0 111.25 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.38 -36.71 69.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.683 0.793 . . . . 0.0 112.302 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -64.3 -45.83 86.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.106 0.562 . . . . 0.0 110.572 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.782 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -58.69 -47.91 82.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 124.03 0.831 . . . . 0.0 110.59 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.82 -31.83 71.1 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.504 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HA ' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -63.55 -51.93 63.3 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.365 0.666 . . . . 0.0 112.474 176.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 27.8 tp -67.97 -23.27 65.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.314 0.384 . . . . 0.0 110.49 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' A' ' 76' ' ' VAL . . . -61.45 -57.74 10.99 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 122.874 0.47 . . . . 0.0 110.187 172.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.21 -30.55 71.03 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.887 0.875 . . . . 0.0 112.247 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.02 -53.42 26.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.121 0.569 . . . . 0.0 111.257 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -98.04 1.72 48.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.616 0.367 . . . . 0.0 111.437 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.56 43.2 69.65 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 122.321 -0.237 . . . . 0.0 113.484 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 49' ' ' SER . 27.7 m -118.55 169.85 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.579 1.152 . . . . 0.0 109.478 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -112.15 128.7 56.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.891 0.476 . . . . 0.0 111.983 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.8 163.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.637 1.575 . . . . 0.0 107.573 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.5 m -136.53 105.18 5.81 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.0 p -87.34 121.44 29.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.287 -168.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 57' ' ' VAL . 47.5 t -114.59 135.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.261 1.425 . . . . 0.0 108.834 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.11 130.64 35.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 59' ' ' GLN . 32.5 t -69.21 118.04 11.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.891 0.476 . . . . 0.0 111.961 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -142.99 86.79 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 167.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.1 mt -78.19 -20.93 50.91 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.13 -13.46 61.19 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 112.187 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.57 -29.39 4.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.285 0.634 . . . . 0.0 111.518 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -159.03 125.41 4.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.524 1.13 . . . . 0.0 108.313 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -70.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.519 HG22 HD23 ' A' ' 34' ' ' LEU . 7.3 pt -140.2 119.22 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.134 0.974 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -130.8 98.33 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.91 0.884 . . . . 0.0 108.722 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.29 -9.53 5.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.85 -52.83 21.58 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.196 0.598 . . . . 0.0 110.812 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.62 -29.34 66.82 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -169.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CZ3' HG12 ' A' ' 98' ' ' ILE . 11.1 p-90 -133.62 176.28 8.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.673 0.789 . . . . 0.0 110.938 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.15 -90.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.301 0.64 . . . . 0.0 111.229 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.87 172.13 41.89 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 118.448 0.567 . . . . 0.0 113.509 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 121' ' ' LEU . 5.9 mt -123.09 150.86 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.55 0.74 . . . . 0.0 109.025 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.408 HG12 HG22 ' A' ' 33' ' ' ILE . 14.1 p -144.46 134.53 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 163.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -133.02 99.2 4.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 43' ' ' ASN . 30.4 mm -74.88 154.75 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.258 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -18.42 104.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.067 2.147 . . . . 0.0 113.592 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.05 148.96 44.06 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.63 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.419 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 6.3 p-80 -147.16 101.64 3.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.09 143.29 26.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.544 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.2 158.57 47.68 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.652 2.234 . . . . 0.0 110.732 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 t -45.59 -36.41 4.69 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.38 1.472 . . . . 0.0 113.737 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 p -56.28 -58.81 6.37 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.355 1.062 . . . . 0.0 111.997 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.25 -19.09 37.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.859 0.864 . . . . 0.0 111.07 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -77.94 -47.25 19.06 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.647 0.779 . . . . 0.0 109.438 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -52.79 -34.49 53.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.903 0.881 . . . . 0.0 111.783 164.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -75.67 -44.27 43.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 117' ' ' VAL . 49.2 tp -92.19 -55.56 3.38 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.67 -40.02 6.24 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 119.623 1.101 . . . . 0.0 112.479 -161.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.37 -28.92 87.71 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 122.281 1.987 . . . . 0.0 112.044 166.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 5.5 tppp? -77.42 -24.77 50.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.396 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 113' ' ' LEU . 41.6 t -72.13 -34.18 49.23 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.364 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -53.93 -62.39 1.69 Allowed 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.69 -33.66 35.24 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.22 57.28 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 98' ' ' ILE . 26.8 tp -60.7 128.37 36.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.882 0.473 . . . . 0.0 110.604 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 148.56 34.68 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.74 113.28 1.76 Allowed 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.74 1.626 . . . . 0.0 111.201 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.566 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 128.31 6.15 4.88 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.017 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -101.53 143.59 16.14 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 164.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.2 m -110.78 130.67 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.566 0.746 . . . . 0.0 109.16 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CE2' HD11 ' A' ' 129' ' ' LEU . 8.8 t80 -106.61 112.55 25.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 24' ' ' VAL . 55.6 mt -115.43 109.01 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.995 0.918 . . . . 0.0 110.25 -168.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 127' ' ' PHE . 89.0 mt -128.96 133.91 47.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.354 0.662 . . . . 0.0 110.073 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -113.09 98.84 7.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.522 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -88.92 -174.49 46.78 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.721 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.408 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.6 m-85 -138.56 159.54 41.84 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.08 0.952 . . . . 0.0 108.565 -177.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 123.743 0.817 . . . . 0.0 110.454 178.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 132' ' ' PHE . 36.4 mt -89.75 103.85 7.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -67.74 103.58 0.86 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.079 2.52 . . . . 0.0 111.729 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 188' ' ' ILE . 16.4 ptpt -100.43 152.4 20.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.284 0.493 . . . . 0.0 112.185 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.3 -38.05 87.9 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.79 0.836 . . . . 0.0 110.881 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -48.23 -52.63 20.21 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.267 1.027 . . . . 0.0 111.143 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.0 p -76.41 -61.91 1.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.201 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.69 -46.84 86.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.307 1.043 . . . . 0.0 112.787 -166.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -64.87 -33.27 75.61 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 123.229 0.33 . . . . 0.0 111.185 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.2 t -78.61 -23.32 45.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.568 0.347 . . . . 0.0 111.098 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -86.72 -12.3 48.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.684 0.794 . . . . 0.0 111.251 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.89 64.53 42.47 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.684 0.794 . . . . 0.0 109.156 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.13 4.34 7.15 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.814 2.343 . . . . 0.0 111.786 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 t -87.52 -34.58 18.57 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.498 HD13 HD21 ' A' ' 121' ' ' LEU . 25.7 tp -97.97 73.6 2.26 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 125.973 1.709 . . . . 0.0 110.878 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -57.36 124.28 18.35 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 12.4 m95 -89.33 139.77 30.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.591 1.156 . . . . 0.0 109.561 -170.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.658 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 96.3 mt -68.09 -44.98 75.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 169.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 79.0 mt -126.4 120.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.37 78.2 1.27 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -143.62 152.57 41.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.004 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.626 ' H ' HD22 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -87.05 120.42 28.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.87 173.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.05 106.36 17.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 123.878 0.871 . . . . 0.0 109.558 -173.399 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.5 mt -122.33 151.7 40.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 152' ' ' LYS . 9.2 pt -139.19 142.84 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -124.94 145.29 49.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.591 0.71 . . . . 0.0 110.5 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.56 135.74 48.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.013 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 24' ' ' VAL . 16.6 tp -140.24 105.12 4.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.67 133.2 11.63 Favored Glycine 0 C--O 1.219 -0.783 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.658 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 7.8 tp60 -120.18 146.44 46.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.566 0.683 . . . . 0.0 111.35 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.566 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -62.12 138.17 58.36 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.581 0.551 . . . . 0.0 109.559 168.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--O 1.241 0.657 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.339 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 CA--C 1.549 0.911 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 tp -68.46 -21.39 64.63 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.383 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 m -86.46 -28.91 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 119.007 0.822 . . . . 0.0 109.434 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -74.83 -44.67 48.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.993 0.917 . . . . 0.0 110.001 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 28' ' ' ILE . 19.0 m -64.16 -37.04 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.6 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.02 67.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.16 -26.6 65.84 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.129 0.572 . . . . 0.0 109.728 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.721 ' HB3' HE21 ' A' ' 193' ' ' GLN . 24.0 mm-40 -88.74 -25.96 22.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.973 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 24' ' ' VAL . 47.9 mt -73.71 130.25 83.87 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.26 132.95 29.58 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.231 2.621 . . . . 0.0 112.835 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -74.58 27.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.96 -134.91 5.76 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -82.15 114.91 21.0 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.7 151.2 11.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 95' ' ' TRP . 66.9 tp -119.61 120.45 36.73 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 28.5 p -108.7 126.68 53.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.86 -172.42 1.3 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 123.599 0.76 . . . . 0.0 111.056 166.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.162 0 N-CA-C 113.769 0.267 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -61.98 -35.14 77.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.386 0.674 . . . . 0.0 112.049 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -56.15 -52.31 64.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.876 0.735 . . . . 0.0 111.099 -173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.51 -54.16 50.04 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.317 1.011 . . . . 0.0 111.8 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 6.2 p -67.89 -28.93 67.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.791 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 84.1 t80 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.446 0.698 . . . . 0.0 110.079 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 99' ' ' VAL . 50.9 mt -65.03 -35.85 82.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.829 0.852 . . . . 0.0 111.228 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.45 63.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.394 0.278 . . . . 0.0 111.247 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 76' ' ' VAL . 50.4 m -61.71 -23.05 65.88 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.355 0.662 . . . . 0.0 111.092 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.0 mt -78.23 12.39 1.92 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.988 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.51 66.59 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.475 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -103.41 152.98 20.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.252 0.526 . . . . 0.0 111.274 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -90.96 91.06 8.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.5 t -98.87 126.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.403 0.681 . . . . 0.0 109.985 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 m -99.77 111.69 24.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.738 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -96.68 139.53 32.61 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.814 0.446 . . . . 0.0 110.304 -172.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.0 t -118.28 150.09 20.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 164.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 27.8 t0 -157.99 144.57 17.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.288 0.495 . . . . 0.0 109.893 172.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.33 -20.47 66.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.073 0.858 . . . . 0.0 112.02 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 62' ' ' VAL . 1.9 m -108.92 140.32 42.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.158 0.983 . . . . 0.0 109.325 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 m -69.44 -29.23 66.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.784 0.434 . . . . 0.0 110.85 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 60' ' ' SER . 11.0 m -61.66 -35.25 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.829 0.706 . . . . 0.0 111.976 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.01 -35.37 35.01 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.53 0.519 . . . . 0.0 112.81 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -50.97 62.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.56 0.744 . . . . 0.0 110.435 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.13 76.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.158 0.983 . . . . 0.0 112.589 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -62.93 -43.81 97.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.429 0.692 . . . . 0.0 110.141 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -63.61 -46.02 87.67 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.28 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -67.24 -42.96 83.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.674 0.79 . . . . 0.0 110.782 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.49 -54.52 42.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.31 1.044 . . . . 0.0 111.627 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.513 HD23 ' SG ' ' A' ' 45' ' ' CYS . 30.5 tp -65.95 -28.82 69.19 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.923 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.78 -62.94 1.32 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.457 0.473 . . . . 0.0 111.062 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.62 -25.57 67.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.145 0.578 . . . . 0.0 111.274 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.79 -54.74 14.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.739 0.415 . . . . 0.0 109.904 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.28 -5.32 58.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.98 0.512 . . . . 0.0 112.083 -171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.58 34.15 40.64 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 121.923 -0.179 . . . . 0.0 113.064 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.0 m -125.21 170.46 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.633 1.173 . . . . 0.0 108.416 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -121.45 138.28 54.35 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mm -116.61 167.2 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -133.99 105.49 6.76 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 165.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.3 p -89.72 137.25 32.5 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.667 0.746 . . . . 0.0 111.576 -167.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 57' ' ' VAL . 58.8 t -125.05 135.0 65.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.324 1.849 . . . . 0.0 107.845 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -83.18 139.84 32.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 p -48.98 109.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.246 1.018 . . . . 0.0 113.144 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -136.58 93.7 2.91 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 90.8 mt -103.15 -35.25 8.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.141 0.577 . . . . 0.0 111.822 -170.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.09 -5.83 50.44 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.045 0.538 . . . . 0.0 112.117 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -116.23 -28.64 6.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.983 0.913 . . . . 0.0 111.174 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 47.3 t80 -157.79 156.09 30.93 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 125.166 1.387 . . . . 0.0 107.696 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.56 -70.58 0.17 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.407 1.458 . . . . 0.0 108.927 163.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.648 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.5 pt -139.5 118.77 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 0.0 110.268 -172.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.42 86.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.2 1.96 6.74 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.29 -47.87 69.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 165.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 -11.79 39.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.066 0.947 . . . . 0.0 111.962 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 34' ' ' LEU . 60.4 m95 -120.3 117.77 28.67 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.612 0.765 . . . . 0.0 110.119 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -58.46 -47.62 83.4 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.677 0.791 . . . . 0.0 111.366 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.97 156.28 18.11 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.924 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.3 mt -129.47 148.52 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 171.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 47' ' ' LEU . 4.3 p -135.27 143.12 37.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.759 1.224 . . . . 0.0 107.99 161.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.425 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 50.0 m -143.63 102.17 3.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.66 83.96 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 27.1 t80 -74.54 117.84 16.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.345 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.5 p -113.49 173.65 6.3 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -55.56 101.23 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.514 0.726 . . . . 0.0 110.721 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.16 139.81 42.37 Favored Pre-proline 0 C--O 1.247 0.961 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.61 144.9 24.16 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.838 2.359 . . . . 0.0 110.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -43.33 -34.61 1.27 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.713 1.205 . . . . 0.0 113.495 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 t -56.55 -64.25 0.93 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.45 1.1 . . . . 0.0 111.506 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.78 -30.74 65.87 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.728 0.411 . . . . 0.0 111.324 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -63.62 -62.4 1.69 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.682 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.49 -30.77 67.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.77 -33.95 64.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.178 0.591 . . . . 0.0 110.516 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.18 -48.48 62.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.855 0.722 . . . . 0.0 111.314 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -57.63 -44.31 99.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -166.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.41 -28.08 83.46 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 122.077 1.778 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -88.18 -12.38 44.05 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.026 0.931 . . . . 0.0 111.296 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 3.4 t -85.32 -33.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 165.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -66.07 -61.5 2.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.697 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.8 -47.78 16.04 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.83 -39.34 39.51 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 -166.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 28.4 tp -70.9 96.2 1.25 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.555 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 30.0 mmmt -67.0 130.13 93.93 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 27.5 Cg_exo -39.85 123.44 1.23 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.422 3.415 . . . . 0.0 114.547 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.99 14.78 2.98 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.704 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.88 150.47 17.04 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 167.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 20.4 m -109.84 131.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 123.264 0.626 . . . . 0.0 109.943 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.3 t80 -110.37 113.06 25.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.51 111.7 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.792 0.837 . . . . 0.0 109.865 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 156' ' ' LEU . 2.1 mp -129.18 149.5 50.96 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.302 0.641 . . . . 0.0 110.068 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 45.2 tt0 -135.67 103.64 5.5 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.803 0.689 . . . . 0.0 109.253 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.6 148.33 27.59 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 170.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.44 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.1 m-85 -111.04 168.28 9.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.609 0.763 . . . . 0.0 110.39 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 124.25 1.02 . . . . 0.0 111.861 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 132' ' ' PHE . 59.5 mt -81.72 108.17 10.32 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.718 ' HB2' HD11 ' A' ' 156' ' ' LEU . 65.3 Cg_endo -83.34 123.88 3.55 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.315 2.01 . . . . 0.0 111.79 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -86.65 159.09 19.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.141 0.976 . . . . 0.0 111.95 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 188' ' ' ILE . 71.7 mt -61.61 -36.63 81.27 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 166.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.23 -50.45 72.82 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.01 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 73.5 p -68.75 -62.33 1.43 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.299 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 151' ' ' PRO . 70.8 mt -61.84 -49.93 74.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.81 1.244 . . . . 0.0 112.952 -166.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.5 tt0 -58.47 -43.19 88.85 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 123.685 0.616 . . . . 0.0 111.426 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 t -73.13 -23.23 60.46 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.463 0.305 . . . . 0.0 111.594 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 155' ' ' THR . 53.9 mt-10 -80.86 -18.04 48.68 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.684 0.793 . . . . 0.0 111.399 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 97.0 mt -133.65 66.73 74.17 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.311 0.644 . . . . 0.0 110.507 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.35 2.97 7.89 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.783 2.322 . . . . 0.0 112.309 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.1 m -86.02 -35.23 20.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.4 tp -102.14 70.19 1.19 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.002 1.721 . . . . 0.0 110.663 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -64.98 136.88 57.32 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.664 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 19.3 m95 -96.98 136.92 36.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.512 0.725 . . . . 0.0 110.545 -163.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 46.2 mt -68.33 -30.02 68.9 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.634 0.584 . . . . 0.0 109.729 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 67.0 mt -132.01 125.09 54.29 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.38 66.38 0.7 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -128.97 143.71 50.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.655 -162.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -89.96 99.32 12.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.386 1.075 . . . . 0.0 109.535 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.7 mt -108.19 129.92 55.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.359 1.064 . . . . 0.0 111.56 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 123.113 0.565 . . . . 0.0 109.946 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.97 149.48 40.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 19.8 pt -132.54 117.24 30.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -98.55 144.58 27.72 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.375 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 48.6 mt -128.63 137.21 51.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.53 -1.213 . . . . 0.0 109.525 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.475 HD22 HG12 ' A' ' 24' ' ' VAL . 33.3 tp -135.11 105.08 6.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -90.92 138.14 14.21 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.721 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.1 tp-100 -143.52 157.43 44.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.299 0.64 . . . . 0.0 110.752 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 62.9 tttm -56.29 120.74 8.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.265 1.026 . . . . 0.0 109.207 172.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 N--CA 1.473 0.7 0 C-N-CA 122.58 0.352 . . . . 0.0 111.536 -173.791 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 CA--C 1.558 1.281 0 CA-C-O 121.296 0.57 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.98 -17.73 10.88 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.811 1.244 . . . . 0.0 112.747 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.55 -27.46 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.516 1.053 . . . . 0.0 109.398 -171.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 17.4 m -66.68 -52.69 41.9 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.473 0.709 . . . . 0.0 109.422 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 HD22 ' A' ' 191' ' ' LEU . 19.3 m -65.98 -37.09 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.9 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -58.68 -42.18 87.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.273 1.029 . . . . 0.0 112.25 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.51 -23.65 64.58 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.858 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.756 ' HB3' HE22 ' A' ' 193' ' ' GLN . 12.5 mm100 -83.91 -14.24 51.52 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.263 0.625 . . . . 0.0 111.366 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -82.89 128.94 63.7 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.275 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.15 140.05 41.82 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.122 2.548 . . . . 0.0 113.063 169.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.21 27.41 0.05 Allowed 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.42 -136.77 6.56 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-O 119.397 -0.669 . . . . 0.0 112.919 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -75.21 112.7 11.75 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -107.92 116.04 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.64 113.79 26.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 110.208 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 8.8 t -104.05 108.57 19.99 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 122.451 0.3 . . . . 0.0 111.531 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 90' ' ' ILE . 61.7 mt -81.26 123.41 28.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.646 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 1.359 0 O-C-N 125.153 1.533 . . . . 0.0 111.255 174.538 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtm105 -55.64 -26.69 45.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.786 1.234 . . . . 0.0 113.557 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -63.72 -54.63 32.51 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.351 0.661 . . . . 0.0 111.304 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.35 74.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.983 0.802 . . . . 0.0 110.808 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 26.5 m -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.906 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 89.0 t80 -66.14 -51.88 53.7 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.697 0.623 . . . . 0.0 109.6 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 99' ' ' VAL . 93.4 mt -61.38 -37.02 81.89 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.437 1.086 . . . . 0.0 110.901 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.71 66.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.312 0.645 . . . . 0.0 112.078 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.633 ' HA ' HG11 ' A' ' 76' ' ' VAL . 96.1 p -70.32 -2.78 14.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.2 mt -82.76 12.96 4.17 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.028 0.531 . . . . 0.0 110.501 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.44 32.82 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 119.846 -0.419 . . . . 0.0 113.925 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.8 158.87 35.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.352 0.576 . . . . 0.0 111.141 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.4 91.31 6.15 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.755 0.822 . . . . 0.0 108.98 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.95 110.45 23.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.993 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 79' ' ' THR . 47.4 p -84.88 105.48 15.69 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.073 173.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.0 129.2 46.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.245 0.618 . . . . 0.0 110.772 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.25 123.62 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.32 134.44 25.72 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.03 -2.45 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.66 1.184 . . . . 0.0 113.329 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 m -119.93 119.61 33.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.2 m -73.44 -24.95 60.31 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.306 0.642 . . . . 0.0 110.291 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.25 -35.88 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.776 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.01 -35.16 58.03 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.747 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.63 -49.71 69.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.494 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.611 0.764 . . . . 0.0 112.043 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -66.23 -46.28 77.75 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.874 0.87 . . . . 0.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.531 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -63.59 -40.92 98.17 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.99 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 36.6 ttpt -65.49 -45.05 85.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.462 1.105 . . . . 0.0 110.938 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 -51.55 68.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.105 0.962 . . . . 0.0 110.872 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.37 -30.59 70.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.172 0.92 . . . . 0.0 111.022 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -64.05 -61.37 2.31 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.505 0.503 . . . . 0.0 111.256 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.12 -24.39 65.01 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.341 0.656 . . . . 0.0 110.842 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.44 -35.24 75.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.932 0.893 . . . . 0.0 110.44 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.83 -10.41 45.47 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.39 0.676 . . . . 0.0 111.251 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.63 36.16 20.48 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 113.633 0.213 . . . . 0.0 113.633 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 49' ' ' SER . 19.4 m -132.32 174.58 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.373 1.069 . . . . 0.0 110.048 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.25 129.46 54.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.0 0.92 . . . . 0.0 111.814 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.1 mm -108.68 166.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 162.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 55' ' ' THR . 90.3 m -134.06 110.59 9.74 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 160.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.4 p -81.94 120.47 25.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.65 153.46 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.727 1.211 . . . . 0.0 109.693 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -85.81 103.59 14.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.6 p -46.9 99.92 0.02 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.55 1.14 . . . . 0.0 112.672 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -141.0 96.57 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 91.9 mt -103.79 -15.02 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.033 0.933 . . . . 0.0 112.424 -176.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -18.18 32.32 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.533 0.733 . . . . 0.0 112.651 -174.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.42 -10.9 3.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.759 0.823 . . . . 0.0 111.495 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.2 t80 -151.68 157.62 42.33 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -153.84 -57.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 117' ' ' VAL . 3.1 pt -151.81 134.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.0 109.322 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 93' ' ' ASP . 84.4 t -123.64 150.99 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.305 1.042 . . . . 0.0 108.215 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.27 -29.63 19.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.296 0.57 . . . . 0.0 110.27 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 91' ' ' VAL . 23.3 t70 -70.34 -51.66 28.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.262 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.34 -25.9 33.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.161 0.584 . . . . 0.0 112.362 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.425 ' HD1' ' H ' ' A' ' 91' ' ' VAL . 57.1 m95 -111.81 107.08 16.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.06 0.457 . . . . 0.0 110.865 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -56.88 12.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.165 1.386 . . . . 0.0 109.525 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.22 143.06 15.63 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.47 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.557 HD13 ' HB ' ' A' ' 90' ' ' ILE . 87.7 mt -124.9 127.26 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -123.12 102.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.308 1.052 . . . . 0.0 109.732 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.415 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 46.6 m -97.33 91.59 5.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.7 mm -72.37 150.36 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.869 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -17.92 105.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 127.258 2.223 . . . . 0.0 113.46 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 p -111.38 106.26 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.549 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -98.09 99.53 10.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.2 mt -114.81 146.07 35.29 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.735 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.583 ' HA ' HD13 ' A' ' 149' ' ' LEU . 35.8 Cg_exo -61.69 155.4 54.06 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.963 2.442 . . . . 0.0 110.715 167.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -46.3 -38.66 8.96 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.979 0.912 . . . . 0.0 112.752 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.8 m -56.0 -52.41 64.31 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 123.925 0.766 . . . . 0.0 111.986 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.96 -22.04 31.57 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.236 0.615 . . . . 0.0 111.039 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -76.08 -52.43 10.18 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.4 -14.23 62.85 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.746 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.2 -39.56 25.23 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 117' ' ' VAL . 64.2 tp -75.52 -60.25 2.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.033 0.533 . . . . 0.0 111.933 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -58.94 -43.72 97.99 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -164.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.8 -23.38 26.13 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 121.774 1.649 . . . . 0.0 112.04 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -86.17 -14.65 43.4 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.783 0.833 . . . . 0.0 110.16 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.598 ' HA ' HD11 ' A' ' 90' ' ' ILE . 28.9 t -75.27 -40.18 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 166.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.78 -54.16 50.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.109 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.2 -46.79 63.83 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.313 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.58 -57.27 3.92 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.376 0.511 . . . . 0.0 114.376 -172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' A' ' 90' ' ' ILE . 6.0 tt -74.6 138.28 42.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.553 0.741 . . . . 0.0 109.817 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -120.05 168.54 10.17 Favored Pre-proline 0 C--O 1.247 0.933 0 C-N-CA 124.622 1.169 . . . . 0.0 108.583 172.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.07 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 122.003 1.802 . . . . 0.0 112.042 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.72 -2.05 4.42 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.176 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -114.52 145.03 18.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 159.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.2 131.5 58.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.87 1.268 . . . . 0.0 109.447 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.2 t80 -106.37 111.71 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.24 107.82 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 91.3 mt -118.35 141.02 48.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.753 0.821 . . . . 0.0 110.669 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -127.15 101.43 6.51 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 164.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 179.6 53.19 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 164.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.495 ' H ' HD22 ' A' ' 150' ' ' LEU . 36.0 m-85 -130.16 169.37 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.116 0.566 . . . . 0.0 110.174 172.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 106' ' ' PRO . 23.9 mt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 132' ' ' PHE . 88.2 mt -72.88 115.35 39.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 123.307 0.379 . . . . 0.0 110.554 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 55.6 Cg_endo -93.79 114.11 0.23 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 122.647 2.231 . . . . 0.0 109.988 167.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -73.09 167.93 20.12 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.776 0.43 . . . . 0.0 111.761 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.634 HD21 ' HB ' ' A' ' 188' ' ' ILE . 67.8 mt -61.14 -30.58 70.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 0.0 110.9 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -56.8 -59.38 5.11 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.425 0.69 . . . . 0.0 110.73 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.1 p -65.57 -38.42 89.49 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.592 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.2 -43.68 23.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -173.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.477 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 29.6 tt0 -58.96 -40.02 83.47 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 120.927 0.394 . . . . 0.0 110.905 173.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -80.47 -13.3 59.23 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.438 0.695 . . . . 0.0 111.258 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -74.37 -31.77 62.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.464 0.706 . . . . 0.0 109.861 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 79.8 mt -134.08 74.25 68.55 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.99 -33.58 31.86 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.289 2.659 . . . . 0.0 113.407 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t -82.78 -35.43 26.53 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.5 tp -66.89 71.77 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.674 1.19 . . . . 0.0 111.799 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -51.8 120.93 5.78 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.797 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 55.3 m95 -87.94 119.7 28.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.508 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 79.8 mt -68.08 -33.76 75.15 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.846 0.458 . . . . 0.0 110.276 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.6 128.33 69.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.63 81.67 1.34 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -137.62 144.43 41.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.899 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.36 125.53 35.17 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.7 mt -105.75 107.12 17.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.119 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.422 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.7 mt -120.92 144.07 48.63 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 153' ' ' LEU . 27.3 pt -124.12 116.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.8 1.182 . . . . 0.0 109.944 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -100.04 146.74 26.4 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.692 0.758 . . . . 0.0 110.586 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 46.0 mt -137.07 141.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.073 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.542 HD22 HG12 ' A' ' 24' ' ' VAL . 40.9 tp -134.19 106.35 7.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 168.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.31 140.59 19.2 Favored Glycine 0 CA--C 1.505 -0.551 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.756 HE22 ' HB3' ' A' ' 27' ' ' GLN . 7.4 tp-100 -123.75 148.37 46.68 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 193' ' ' GLN . 0.7 OUTLIER -57.11 115.92 2.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.371 161.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.241 0.625 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 167.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 120.654 0.264 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 24' ' ' VAL . 33.7 tp -67.62 -54.4 20.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.131 0.572 . . . . 0.0 111.208 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 m -47.39 -25.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 m -68.36 -49.07 62.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.862 0.865 . . . . 0.0 110.767 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.786 HG21 HD11 ' A' ' 128' ' ' ILE . 1.5 m -64.77 -36.48 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.032 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.54 66.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.1 -35.24 77.82 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.855 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -82.86 -18.25 41.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.143 0.977 . . . . 0.0 112.466 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 24' ' ' VAL . 74.1 mt -77.02 135.64 66.82 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.965 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.59 142.48 90.38 Favored 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.467 2.778 . . . . 0.0 112.331 171.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 28.2 pt20 -70.73 28.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.63 -141.87 6.76 Favored Glycine 0 N--CA 1.478 1.447 0 CA-C-N 118.769 0.713 . . . . 0.0 113.338 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 62.0 mttp -76.91 115.32 16.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 54' ' ' VAL . 21.0 mt -107.63 121.45 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 55' ' ' THR . 55.6 tp -90.69 111.62 23.04 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.02 0.528 . . . . 0.0 111.289 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 98.6 m -87.19 134.9 33.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.83 152.63 18.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.749 0.419 . . . . 0.0 110.469 167.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.953 0 O-C-N 124.685 1.241 . . . . 0.0 111.779 177.147 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -81.24 -26.38 35.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.257 1.023 . . . . 0.0 109.617 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.56 ' ND2' HG21 ' A' ' 101' ' ' ILE . 79.8 m-20 -67.25 -35.08 78.8 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.943 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 56' ' ' ALA . . . -53.42 -57.55 10.23 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.418 1.087 . . . . 0.0 111.813 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.918 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 8.3 p -66.03 -34.13 77.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.976 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.96 -43.09 88.93 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.57 0.544 . . . . 0.0 111.29 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 99' ' ' VAL . 84.9 mt -67.35 -30.78 70.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.47 -36.71 74.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.724 0.41 . . . . 0.0 110.542 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -63.95 -14.63 55.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.207 1.003 . . . . 0.0 112.341 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.0 mt -85.26 17.19 3.17 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.934 0.894 . . . . 0.0 110.705 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 37.73 25.39 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 123.563 0.601 . . . . 0.0 114.436 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 25.2 m-85 -126.69 154.36 44.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.998 0.519 . . . . 0.0 111.318 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 33.5 mt-10 -89.6 86.9 6.84 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 33' ' ' ILE . 71.2 t -93.23 108.49 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.783 0.802 . . . . 0.0 110.376 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.8 t -83.69 108.71 16.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.957 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . . . -96.42 132.41 41.99 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.748 0.819 . . . . 0.0 111.359 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.29 120.51 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 22.4 t0 -136.27 134.91 38.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.238 0.472 . . . . 0.0 109.972 174.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -53.8 -24.03 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.771 1.628 . . . . 0.0 112.837 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 t -123.3 164.23 19.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 111.081 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.2 p -77.36 -18.35 57.46 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.096 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.51 -44.39 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.62 -34.01 40.91 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.275 0.359 . . . . 0.0 112.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 93.5 mt -69.02 -47.67 64.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.558 0.743 . . . . 0.0 111.61 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -54.31 -55.67 26.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.815 0.846 . . . . 0.0 111.855 171.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.35 -39.16 66.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.619 0.767 . . . . 0.0 110.842 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.918 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -59.98 -52.51 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.293 177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -69.01 -38.75 79.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 5.7 mm100 -62.51 -45.44 92.97 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.496 0.318 . . . . 0.0 111.395 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 45' ' ' CYS . 32.1 tp -70.92 -27.39 63.73 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.359 0.412 . . . . 0.0 110.785 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.15 -62.4 1.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 110.546 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.97 -30.21 70.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.586 0.754 . . . . 0.0 111.617 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.77 -54.58 25.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.06 0.544 . . . . 0.0 110.718 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.439 ' HE2' HD11 ' A' ' 70' ' ' LEU . 24.8 ttmm -83.87 -15.71 47.12 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.48 0.712 . . . . 0.0 111.727 -170.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.93 41.97 7.88 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 121.828 -0.225 . . . . 0.0 113.284 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.53 175.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.591 1.156 . . . . 0.0 109.109 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.14 140.69 51.65 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.031 0.378 . . . . 0.0 111.896 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.658 HG12 ' HB2' ' A' ' 71' ' ' ALA . 20.1 mm -115.56 160.75 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.004 1.322 . . . . 0.0 107.555 167.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.8 m -127.49 110.12 12.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 164.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.8 p -84.24 111.63 19.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.044 0.538 . . . . 0.0 109.822 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 157.25 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.177 1.391 . . . . 0.0 110.698 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.38 103.81 15.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.87 99.26 0.08 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.018 0.437 . . . . 0.0 111.618 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -142.64 91.54 2.32 Favored 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.57 -17.26 61.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.349 0.522 . . . . 0.0 110.839 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.34 -0.9 51.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.543 1.137 . . . . 0.0 112.295 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.04 -32.8 0.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -167.32 107.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.04 -63.4 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.483 1.113 . . . . 0.0 108.21 -171.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.624 ' HB ' HD13 ' A' ' 98' ' ' ILE . 29.8 pt -138.64 122.62 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.609 0.763 . . . . 0.0 110.8 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.44 87.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.719 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.95 -1.84 13.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.477 0.711 . . . . 0.0 112.744 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.86 -48.06 67.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.08 -24.41 30.37 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.923 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.481 ' CD2' HG21 ' A' ' 55' ' ' THR . 17.9 m95 -112.85 161.78 16.56 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.113 0.565 . . . . 0.0 109.682 -172.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.74 -58.1 2.85 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.82 16.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.257 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.624 HD13 ' HB ' ' A' ' 90' ' ' ILE . 80.6 mt -134.36 119.36 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 47' ' ' LEU . 11.6 p -109.11 133.27 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -125.96 90.9 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.56 HG21 ' ND2' ' A' ' 43' ' ' ASN . 12.2 mm -69.29 155.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.877 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -19.28 103.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 126.215 1.806 . . . . 0.0 113.501 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.28 114.55 11.61 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.271 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -97.76 100.24 11.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.9 mt -93.47 148.76 36.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.708 0.403 . . . . 0.0 110.279 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.57 156.71 55.29 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.156 1.904 . . . . 0.0 110.193 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.8 m -50.83 -33.0 21.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.033 0.933 . . . . 0.0 112.585 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -58.84 -52.99 63.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.899 0.88 . . . . 0.0 111.623 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.7 mt -83.42 -18.66 37.96 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.978 0.511 . . . . 0.0 111.283 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -63.71 -62.88 1.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -67.78 -10.52 53.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.617 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -77.84 -54.18 6.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.786 0.434 . . . . 0.0 109.926 166.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.3 tp -74.71 -49.85 19.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -165.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -67.25 -35.34 8.47 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.53 -33.68 96.85 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.194 1.929 . . . . 0.0 112.794 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 34.3 mmtp -72.64 -27.39 62.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.627 0.771 . . . . 0.0 110.894 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 127' ' ' PHE . 15.0 t -84.01 -34.75 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.727 0.411 . . . . 0.0 110.427 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.48 -61.76 2.35 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.94 -49.2 63.18 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.808 0.843 . . . . 0.0 113.247 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.27 24.07 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -164.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 125' ' ' GLY . 44.7 tp -70.82 104.37 2.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.463 0.632 . . . . 0.0 110.43 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.71 153.21 78.22 Favored Pre-proline 0 C--O 1.247 0.929 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -48.69 116.03 1.92 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.954 2.436 . . . . 0.0 113.277 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.86 12.23 2.46 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.318 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -102.24 146.67 16.99 Favored Glycine 0 N--CA 1.441 -0.975 0 O-C-N 122.539 -0.389 . . . . 0.0 112.437 163.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.6 m -116.64 130.88 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.825 0.85 . . . . 0.0 108.767 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -111.9 113.07 25.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.786 HD11 HG21 ' A' ' 24' ' ' VAL . 14.7 mt -107.62 108.93 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 49.8 mt -113.49 150.3 33.07 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.515 0.726 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.42 138.95 43.76 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 161.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.54 -176.44 14.37 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.405 ' HB2' HD21 ' A' ' 150' ' ' LEU . 53.3 m-85 -102.62 166.69 10.37 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.471 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 132' ' ' PHE . 95.1 mt -68.57 118.88 64.52 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 123.684 0.615 . . . . 0.0 112.194 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -94.71 98.28 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.916 2.411 . . . . 0.0 109.88 166.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 167.87 20.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.285 0.634 . . . . 0.0 111.335 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 188' ' ' ILE . 29.8 mt -67.07 -31.54 72.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.243 0.617 . . . . 0.0 110.984 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -55.49 -45.88 76.98 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.84 0.713 . . . . 0.0 111.058 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -84.26 -35.69 23.2 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.698 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 129' ' ' LEU . 40.8 mt -75.21 -47.24 29.16 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.464 0.706 . . . . 0.0 112.022 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.5 tt0 -60.68 -35.81 77.19 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.72 0.408 . . . . 0.0 111.154 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -71.86 -26.83 62.51 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 111.11 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.57 -15.0 44.05 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.247 1.019 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 78.0 mt -135.67 68.18 65.83 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.03 3.09 8.09 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 123.049 2.499 . . . . 0.0 112.226 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t -90.21 -36.36 14.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.407 1.083 . . . . 0.0 108.59 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.2 tp -94.75 72.32 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.35 1.46 . . . . 0.0 111.715 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -51.78 124.72 13.13 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.283 0.564 . . . . 0.0 110.172 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 24.9 m95 -93.66 132.88 37.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.665 1.186 . . . . 0.0 109.839 -170.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 85.9 mt -70.64 -35.99 73.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.415 0.686 . . . . 0.0 110.787 173.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.05 121.61 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.44 85.17 1.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.644 0.778 . . . . 0.0 109.165 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.52 149.06 29.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.941 0.401 . . . . 0.0 110.811 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.22 113.39 13.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.0 128.01 53.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.392 0.677 . . . . 0.0 109.508 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.644 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 65.8 mt -121.94 172.37 8.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.563 ' HB ' HD21 ' A' ' 153' ' ' LEU . 38.1 pt -135.6 144.9 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -137.17 154.17 50.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.761 0.791 . . . . 0.0 110.945 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 65.0 mt -139.12 146.25 40.44 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 27.6 tp -143.37 111.89 6.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -90.18 148.56 19.79 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.612 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 8.6 tp-100 -134.78 151.16 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.472 0.636 . . . . 0.0 111.242 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 17.1 pttp -55.99 136.26 52.08 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 167.04 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.5 t80 . . . . . 0 CA--C 1.553 1.077 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' VAL . 41.6 tp -69.88 -51.71 30.96 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.837 0.455 . . . . 0.0 111.098 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 m -45.56 -29.51 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -72.43 -44.18 62.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.436 0.695 . . . . 0.0 110.564 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 28' ' ' ILE . 1.2 m -67.98 -33.75 63.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.004 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.15 73.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.554 1.141 . . . . 0.0 112.241 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -69.07 -23.95 64.1 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.281 0.632 . . . . 0.0 110.632 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.51 -14.29 25.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.63 0.772 . . . . 0.0 111.788 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 96.3 mt -83.93 125.77 72.08 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 18.3 Cg_exo -67.04 157.85 59.71 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.423 2.749 . . . . 0.0 112.848 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -72.54 28.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.4 -144.56 7.8 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 118.364 0.529 . . . . 0.0 113.716 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 31.1 mmmt -70.7 115.44 9.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.65 0.78 . . . . 0.0 109.666 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 50.2 mt -107.21 121.85 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 90' ' ' ILE . 55.3 tp -101.54 111.18 23.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HA ' HG13 ' A' ' 99' ' ' VAL . 51.1 t -102.61 110.12 21.96 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.445 0.698 . . . . 0.0 109.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.0 164.08 26.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.809 0.337 . . . . 0.0 111.695 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 C-N-CA 126.238 1.815 . . . . 0.0 114.814 -175.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.287 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -83.14 -52.95 6.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.819 1.248 . . . . 0.0 110.338 -174.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -61.32 -40.43 94.18 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.815 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.45 11.76 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.203 0.94 . . . . 0.0 111.524 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 70' ' ' LEU . 33.7 m -63.04 -33.78 76.17 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.782 0.833 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 79.4 t80 -63.34 -50.12 71.25 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.723 0.639 . . . . 0.0 110.218 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD13 HG11 ' A' ' 99' ' ' VAL . 63.9 mt -68.45 -29.48 68.13 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.579 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.44 -40.79 66.78 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.326 0.651 . . . . 0.0 112.006 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.727 ' HA ' HG11 ' A' ' 76' ' ' VAL . 58.1 p -72.2 -3.84 25.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.384 0.674 . . . . 0.0 112.762 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.2 mt -80.61 7.3 10.38 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 122.955 0.502 . . . . 0.0 110.735 165.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.68 24.35 39.17 Favored Glycine 0 C--N 1.361 1.939 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -126.04 162.4 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.059 0.929 . . . . 0.0 111.951 -172.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -88.94 91.45 8.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.24 1.016 . . . . 0.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.28 107.08 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.824 0.821 . . . . 0.0 110.727 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 m -87.27 108.89 19.15 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.188 1.395 . . . . 0.0 108.982 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.18 129.57 48.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.987 0.515 . . . . 0.0 109.643 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.8 t -111.94 118.52 57.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' H ' HD21 ' A' ' 64' ' ' LEU . 32.6 t70 -128.53 145.76 51.03 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.729 1.149 . . . . 0.0 110.621 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.02 -31.06 62.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.853 1.661 . . . . 0.0 113.211 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 m -116.13 144.1 44.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 0.0 110.252 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.6 p -68.65 -24.63 64.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.481 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.02 -33.94 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.497 0.719 . . . . 0.0 111.821 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 -30.82 67.62 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.371 0.419 . . . . 0.0 112.237 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 58' ' ' ASP . 81.5 mt -76.19 -42.31 46.75 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.983 0.913 . . . . 0.0 111.244 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.09 93.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.872 0.869 . . . . 0.0 111.93 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -67.02 -40.15 87.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.86 0.464 . . . . 0.0 110.755 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -56.95 -52.76 63.96 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 124.069 0.856 . . . . 0.0 110.406 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.0 -51.14 63.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 111.856 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.47 -47.45 81.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.918 0.887 . . . . 0.0 111.971 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.8 tp -64.52 -33.38 75.77 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.423 0.452 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.29 -51.03 49.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.413 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -66.52 -29.23 69.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.67 0.788 . . . . 0.0 110.257 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -63.18 -44.94 93.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.949 0.899 . . . . 0.0 110.276 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -85.05 -6.17 59.33 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.438 0.695 . . . . 0.0 111.569 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 40.07 12.32 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 120.391 -0.116 . . . . 0.0 113.226 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.2 m -139.64 174.22 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 124.452 1.101 . . . . 0.0 109.443 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -123.69 144.13 49.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.182 0.593 . . . . 0.0 112.316 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 mm -114.88 161.07 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 166.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.2 m -121.8 104.66 9.73 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 p -92.57 123.19 35.68 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.679 -0.638 . . . . 0.0 110.487 -167.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.1 t -115.61 141.07 34.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.192 1.397 . . . . 0.0 107.819 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -80.06 134.31 36.19 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.2 p -55.24 105.11 0.15 Allowed 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.146 0.978 . . . . 0.0 111.493 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.71 87.04 2.03 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.467 ' HB2' HD22 ' A' ' 109' ' ' LEU . 88.8 mt -94.24 -9.82 34.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.928 0.491 . . . . 0.0 110.537 -171.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.36 4.38 43.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.903 0.881 . . . . 0.0 110.319 170.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -130.96 -41.49 1.14 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.773 0.829 . . . . 0.0 110.812 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -156.76 121.72 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.234 1.014 . . . . 0.0 108.275 -169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.21 -69.6 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.652 -0.655 . . . . 0.0 109.626 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 117' ' ' VAL . 18.1 pt -149.88 131.27 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.899 0.879 . . . . 0.0 109.958 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.79 145.63 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.813 1.245 . . . . 0.0 109.171 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -88.41 -30.71 19.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.13 0.572 . . . . 0.0 110.743 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.95 -61.26 2.07 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.712 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.67 -29.27 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' NE1' HD22 ' A' ' 34' ' ' LEU . 37.3 m95 -113.63 144.69 42.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 109.871 -171.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 29' ' ' PRO . 15.8 tp10 -98.19 -46.3 5.89 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.479 1.112 . . . . 0.0 109.494 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -114.58 141.52 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.354 171.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 90' ' ' ILE . 63.7 mt -117.99 150.62 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 169.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG11 HD13 ' A' ' 47' ' ' LEU . 7.0 p -145.9 129.15 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 124.121 0.968 . . . . 0.0 109.01 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.3 m -129.57 94.2 3.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.548 HD13 HD12 ' A' ' 128' ' ' ILE . 22.1 mm -70.73 143.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -15.26 104.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.404 1.882 . . . . 0.0 114.834 -170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.506 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 45.6 t -100.64 115.78 31.0 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.006 -174.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -121.71 98.41 5.94 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 95.0 mt -108.79 155.75 40.14 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.386 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.02 143.33 83.54 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.589 2.193 . . . . 0.0 110.681 162.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.605 ' H ' HD22 ' A' ' 149' ' ' LEU . 41.4 m -50.14 -24.75 2.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.533 1.133 . . . . 0.0 113.288 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.3 m -56.39 -57.61 11.54 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.414 0.685 . . . . 0.0 110.336 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 85' ' ' LEU . 89.2 mt -79.71 -32.8 41.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.69 0.796 . . . . 0.0 110.032 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.561 ' HD3' ' HG3' ' A' ' 151' ' ' PRO . 8.4 tmm_? -74.02 -58.84 3.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.003 1.321 . . . . 0.0 109.959 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -68.55 -10.3 54.87 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.256 0.622 . . . . 0.0 112.373 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -88.5 -33.67 17.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 66.3 tp -67.86 -47.74 68.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.708 0.803 . . . . 0.0 111.514 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.49 -39.14 45.86 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.2 -32.08 92.46 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.919 165.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -81.24 -17.89 47.92 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.528 0.731 . . . . 0.0 111.249 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.537 ' HA ' HD11 ' A' ' 90' ' ' ILE . 9.5 t -83.96 -43.07 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 172.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.03 -48.9 78.22 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.27 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -79.08 -43.68 23.66 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.05 -20.4 16.3 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 116.711 1.444 . . . . 0.0 116.711 -164.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.511 HD12 HD12 ' A' ' 98' ' ' ILE . 16.7 tp -62.26 128.94 38.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.188 0.994 . . . . 0.0 110.025 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 16.7 tttp -70.65 142.39 88.64 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.94 109.05 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.347 1.365 . . . . 0.0 109.494 160.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.08 10.1 6.41 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.559 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.8 143.02 16.45 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 170.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.0 m -108.55 129.6 62.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 123.973 0.909 . . . . 0.0 109.466 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -112.5 112.19 23.55 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 101' ' ' ILE . 95.8 mt -110.25 113.97 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 109.304 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 190' ' ' LEU . 96.2 mt -124.34 114.91 20.16 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.34 107.96 4.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.29 1.036 . . . . 0.0 108.952 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.0 86.06 0.09 OUTLIER Glycine 0 N--CA 1.479 1.512 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.172 169.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.506 ' O ' HD23 ' A' ' 187' ' ' LEU . 95.3 m-85 -143.29 150.36 39.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.186 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.605 HD22 ' H ' ' A' ' 107' ' ' SER . 13.6 mt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 132' ' ' PHE . 41.1 mt -104.93 98.1 14.6 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.223 0.609 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.621 ' HG2' HD21 ' A' ' 156' ' ' LEU . 90.1 Cg_endo -84.0 126.58 3.89 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.871 165.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -72.82 173.13 9.59 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.749 0.819 . . . . 0.0 111.708 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.571 HD22 HD21 ' A' ' 190' ' ' LEU . 20.1 mt -55.95 -38.53 70.47 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.106 0.562 . . . . 0.0 112.212 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.02 -37.31 74.07 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.705 0.628 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.2 m -73.39 -51.95 15.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.219 0.608 . . . . 0.0 109.914 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.621 HD21 ' HG2' ' A' ' 151' ' ' PRO . 82.7 mt -65.7 -55.65 16.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.576 1.151 . . . . 0.0 112.008 -170.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.612 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.3 tt0 -59.03 -34.81 72.33 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 175.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.9 t -81.06 -13.25 58.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.144 0.429 . . . . 0.0 111.889 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -7.67 29.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.945 0.498 . . . . 0.0 110.315 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 89.2 mt -139.46 59.95 15.52 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.946 1.298 . . . . 0.0 108.079 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.55 -22.58 32.84 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.726 2.284 . . . . 0.0 113.745 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 p -81.83 -40.08 23.02 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.6 tp -70.8 68.5 0.42 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.814 1.246 . . . . 0.0 111.602 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -65.13 140.35 58.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.612 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 22.0 m95 -100.88 135.29 42.56 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.742 0.817 . . . . 0.0 109.349 -167.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.9 mt -72.03 -30.81 65.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.64 0.776 . . . . 0.0 110.44 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.9 mt -130.46 125.45 59.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.39 79.97 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -131.15 142.45 50.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.806 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -88.59 132.44 34.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.878 0.871 . . . . 0.0 109.955 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 34.2 mt -110.05 114.24 27.6 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 27.8 mt -104.27 158.04 16.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.519 ' HB ' HD21 ' A' ' 153' ' ' LEU . 3.7 pt -146.36 124.68 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.944 0.793 . . . . 0.0 110.473 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -93.27 145.56 24.35 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.986 0.914 . . . . 0.0 110.091 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 129' ' ' LEU . 54.9 mt -134.0 143.91 48.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 110.391 172.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.2 tp -142.96 108.29 5.02 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -92.98 146.43 18.1 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 126' ' ' VAL . 5.9 tp-100 -147.25 155.83 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.15 0.98 . . . . 0.0 109.683 174.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 193' ' ' GLN . 23.1 pttm -61.64 121.45 12.83 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.491 0.186 . . . . 0.0 111.32 -171.116 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 . . . . . 0 CA--C 1.553 1.067 0 CA-C-O 120.782 0.325 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tp -68.59 -43.53 76.3 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.736 0.814 . . . . 0.0 111.505 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.5 m -45.74 -35.32 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -74.36 -46.65 39.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.979 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.608 HG21 HD11 ' A' ' 128' ' ' ILE . 2.2 m -64.64 -37.14 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.082 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.36 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.313 1.045 . . . . 0.0 111.881 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -58.02 -38.97 77.18 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -82.4 -22.76 35.25 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 54.6 mt -75.59 129.31 82.08 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 118.238 0.472 . . . . 0.0 109.949 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.07 130.65 28.48 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.755 2.97 . . . . 0.0 112.296 166.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -77.62 27.71 0.17 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.306 1.443 . . . . 0.0 114.28 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.85 -133.5 5.3 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.498 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -78.0 113.51 15.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 28' ' ' ILE . 34.7 mt -114.24 130.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 95' ' ' TRP . 52.7 tp -100.09 114.27 27.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 53.6 t -101.48 109.73 21.61 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.29 0.636 . . . . 0.0 109.548 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.23 103.45 3.36 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 167.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.419 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.744 -172.408 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -48.79 -45.03 39.59 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.868 1.667 . . . . 0.0 111.217 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.546 HD22 HD12 ' A' ' 101' ' ' ILE . 2.7 m-20 -64.75 -41.76 95.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.007 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.98 98.66 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.199 0.6 . . . . 0.0 110.92 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.421 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.9 m -60.46 -39.27 86.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.965 0.906 . . . . 0.0 112.696 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.7 t80 -64.92 -46.64 80.81 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.826 0.703 . . . . 0.0 110.199 177.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 99' ' ' VAL . 70.1 mt -67.62 -33.18 74.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.872 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.21 70.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.145 0.578 . . . . 0.0 111.804 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.745 ' HA ' HG11 ' A' ' 76' ' ' VAL . 93.2 p -72.06 -4.8 30.92 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 81.7 mt -83.84 11.14 8.05 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.265 168.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.09 19.15 78.9 Favored Glycine 0 C--N 1.366 2.218 0 CA-C-N 117.64 0.2 . . . . 0.0 113.174 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -106.44 133.1 51.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 109.257 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.79 90.71 2.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.574 0.702 . . . . 0.0 109.263 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -92.91 108.59 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.814 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.8 p -87.14 111.84 21.34 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.513 1.125 . . . . 0.0 108.607 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.72 126.98 53.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.268 0.627 . . . . 0.0 110.873 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 81' ' ' VAL . 10.9 t -101.69 114.72 41.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' H ' HD21 ' A' ' 64' ' ' LEU . 8.5 t70 -116.17 116.21 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.92 -10.67 2.62 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.678 0.791 . . . . 0.0 112.566 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -115.79 124.15 50.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.374 1.07 . . . . 0.0 108.595 169.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 m -72.06 -16.57 62.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.232 0.613 . . . . 0.0 111.568 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 31.5 m -62.97 -35.84 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.198 0.599 . . . . 0.0 111.508 170.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 -35.25 56.45 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 58' ' ' ASP . 99.2 mt -63.28 -42.65 99.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.085 0.954 . . . . 0.0 111.011 174.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.4 81.13 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.864 0.728 . . . . 0.0 111.756 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 30.3 mmmt -68.08 -45.03 74.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.04 0.536 . . . . 0.0 111.464 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.5 81.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.973 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -69.45 -42.3 75.12 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.144 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.45 -43.44 77.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.256 0.222 . . . . 0.0 110.939 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.38 -28.12 69.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.559 0.744 . . . . 0.0 110.609 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.08 -53.78 33.91 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.164 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.4 -35.28 75.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.817 0.847 . . . . 0.0 110.618 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -37.93 89.29 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.009 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -86.5 -0.32 55.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.94 0.896 . . . . 0.0 110.842 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.82 33.37 33.93 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-N 116.376 -0.375 . . . . 0.0 112.394 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.6 m -142.2 -177.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.887 1.275 . . . . 0.0 109.892 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 87.2 tttt -141.16 145.69 36.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.914 0.486 . . . . 0.0 111.587 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.8 mm -101.71 167.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 55' ' ' THR . 46.1 m -123.21 104.3 9.07 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -91.85 125.98 36.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.107 0.479 . . . . 0.0 111.253 -165.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 57' ' ' VAL . 84.8 t -101.06 124.01 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 109.401 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -97.85 89.3 4.54 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -145.25 -176.01 4.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.188 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -142.97 122.63 13.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -158.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.75 -8.03 39.3 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.773 0.671 . . . . 0.0 111.894 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.96 60.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.436 1.094 . . . . 0.0 112.459 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -130.45 -24.67 2.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.148 0.579 . . . . 0.0 112.084 -166.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -162.76 127.02 3.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.695 1.198 . . . . 0.0 108.168 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.34 -65.89 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.41 HG22 HD23 ' A' ' 34' ' ' LEU . 20.1 pt -140.42 127.88 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.361 0.664 . . . . 0.0 110.994 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 93' ' ' ASP . 46.8 t -115.55 148.96 17.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 124.546 1.138 . . . . 0.0 109.639 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -90.25 -35.71 15.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.149 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 91' ' ' VAL . 24.0 t70 -77.31 -44.33 30.0 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.645 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.03 44.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.483 ' CD1' HD22 ' A' ' 34' ' ' LEU . 11.6 m95 -123.26 134.13 54.12 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -169.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.39 -55.79 6.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.396 0.678 . . . . 0.0 109.971 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.63 164.44 12.19 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.109 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 121' ' ' LEU . 84.7 mt -134.45 145.44 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 47' ' ' LEU . 10.1 p -128.09 128.8 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 166.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -113.4 91.34 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.587 HD13 HD12 ' A' ' 128' ' ' ILE . 49.9 mm -68.56 136.13 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.104 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -14.03 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.413 2.321 . . . . 0.0 112.888 -171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 29.1 t -95.18 106.13 18.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 112.324 -2.216 . . . . 0.0 109.93 -169.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.45 99.73 9.8 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 75.7 mt -118.11 145.91 38.04 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.682 0.793 . . . . 0.0 110.585 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.63 158.15 58.12 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.693 2.262 . . . . 0.0 110.144 168.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 33.4 t -45.02 -30.58 1.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.822 1.649 . . . . 0.0 113.246 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 p -57.07 -58.27 8.9 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.2 1.0 . . . . 0.0 110.86 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 80.9 mt -83.29 -22.46 32.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.74 0.816 . . . . 0.0 110.236 -175.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 29.1 ttt180 -69.02 -65.13 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.129 1.372 . . . . 0.0 109.717 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -55.41 -29.64 58.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.113 0.565 . . . . 0.0 111.642 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.54 -42.35 64.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.864 0.466 . . . . 0.0 110.699 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 117' ' ' VAL . 51.2 tp -67.99 -44.99 75.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.47 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -61.2 -41.67 81.7 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -167.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.81 -28.03 75.65 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 122.016 1.811 . . . . 0.0 112.292 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -84.87 -14.88 46.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 0.0 110.971 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.695 ' HB ' HD21 ' A' ' 160' ' ' LEU . 4.7 t -86.51 -42.82 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.1 -56.17 24.12 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.511 0.324 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.5 -39.85 19.96 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.3 -25.7 25.52 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -166.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.617 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -66.24 117.65 8.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.803 0.802 . . . . 0.0 109.188 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 62.0 tttm -69.67 133.93 88.5 Favored Pre-proline 0 C--O 1.246 0.883 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.54 112.3 0.66 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.629 2.219 . . . . 0.0 111.143 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . 125.08 13.21 3.67 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.864 -173.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.617 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -100.48 139.85 14.62 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 168.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 32.7 m -109.08 138.88 34.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.762 0.825 . . . . 0.0 109.932 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.53 113.37 25.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.608 HD11 HG21 ' A' ' 24' ' ' VAL . 24.3 mt -107.88 108.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 79.7 mt -130.87 152.04 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.815 0.846 . . . . 0.0 111.315 -174.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 43.9 tt0 -140.61 104.05 4.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.51 167.16 54.79 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -131.08 167.62 18.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.494 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.41 1.484 . . . . 0.0 113.123 -176.172 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.8 mt -97.88 100.92 9.43 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.86 120.76 4.34 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.573 1.515 . . . . 0.0 110.245 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.419 ' HA ' HD11 ' A' ' 188' ' ' ILE . 32.6 mmtp -87.89 171.58 10.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.684 0.794 . . . . 0.0 111.775 -173.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD22 HD21 ' A' ' 190' ' ' LEU . 32.2 mt -59.23 -40.97 87.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -48.54 -50.9 30.11 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.74 1.216 . . . . 0.0 110.857 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 26.6 m -65.88 -62.36 1.54 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.701 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.429 HD13 HD13 ' A' ' 129' ' ' LEU . 25.2 mt -72.57 -46.56 53.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 112.707 -162.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.537 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.1 tt0 -53.4 -46.11 69.59 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 123.44 0.462 . . . . 0.0 111.025 171.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.3 t -70.77 -32.42 69.54 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.525 0.33 . . . . 0.0 111.841 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -85.7 -5.61 59.24 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.131 0.572 . . . . 0.0 111.951 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 117' ' ' VAL . 82.7 mt -140.51 74.68 28.04 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 -45.72 24.03 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.859 3.039 . . . . 0.0 113.156 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 m -84.85 -29.82 24.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.778 0.431 . . . . 0.0 110.499 -171.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.1 tp -70.21 68.54 0.34 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.054 0.942 . . . . 0.0 111.455 170.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -62.63 133.38 54.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 32.2 m95 -95.77 129.65 42.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.811 0.844 . . . . 0.0 109.401 -167.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.43 -33.73 76.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.67 0.788 . . . . 0.0 110.378 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 80.6 mt -132.7 121.93 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.23 84.57 1.13 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -150.42 148.66 29.03 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.08 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -86.35 116.48 24.54 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.089 0.956 . . . . 0.0 108.691 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.5 mt -110.68 125.06 53.06 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.351 1.06 . . . . 0.0 108.362 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 122.85 0.46 . . . . 0.0 110.004 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.64 149.53 32.71 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 22.1 pt -134.17 118.7 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.354 0.525 . . . . 0.0 110.062 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.68 138.6 31.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.834 0.349 . . . . 0.0 110.323 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 153' ' ' LEU . 49.5 mt -129.51 128.38 42.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.532 1.133 . . . . 0.0 109.41 173.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.7 tp -125.13 106.23 9.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.11 139.97 16.56 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 171.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -144.68 152.64 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.467 ' HB3' ' H ' ' A' ' 124' ' ' GLY . 19.5 pttm -57.64 155.19 10.23 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 123.75 0.656 . . . . 0.0 110.089 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -52.98 -72.42 0.05 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.534 1.133 . . . . 0.0 112.385 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -174.02 141.55 0.79 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.672 0.789 . . . . 0.0 109.092 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -118.99 125.12 48.65 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -77.11 132.62 38.95 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.472 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -74.93 102.95 4.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.9 p -73.7 75.06 1.55 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.623 0.769 . . . . 0.0 111.167 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -80.87 -26.46 36.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 0.0 110.52 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -75.25 92.48 2.74 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.402 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.8 160.67 27.27 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.09 92.31 1.61 Allowed 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -70.53 127.06 31.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -75.44 117.89 17.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.372 0.669 . . . . 0.0 111.375 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.59 85.5 0.27 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 124.103 0.877 . . . . 0.0 111.682 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -133.33 139.41 46.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.361 1.064 . . . . 0.0 109.06 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.77 121.39 77.39 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.892 -0.575 . . . . 0.0 109.452 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.06 121.96 10.29 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 123.026 2.484 . . . . 0.0 112.452 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.408 ' HB3' HG13 ' A' ' 22' ' ' VAL . 40.2 t-20 -121.52 148.0 45.06 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.35 1.06 . . . . 0.0 109.209 -172.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.42 -79.52 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.473 0.709 . . . . 0.0 110.901 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -74.51 -48.37 27.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.467 0.707 . . . . 0.0 112.141 -172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.5 tp -63.9 -15.03 58.08 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -165.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 18' ' ' ASN . 27.2 m -83.36 -24.6 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.726 0.694 . . . . 0.0 110.28 -176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 89.7 p -70.0 -47.5 61.91 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.4 m -64.13 -41.29 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.365 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.43 74.85 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.173 0.989 . . . . 0.0 111.978 175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -27.66 67.87 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.52 0.728 . . . . 0.0 109.338 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 23' ' ' SER . 75.5 mm-40 -82.88 -33.07 27.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.678 0.791 . . . . 0.0 110.971 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -73.06 131.09 83.96 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.34 84.11 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.768 2.312 . . . . 0.0 111.877 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.05 29.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.05 -134.24 5.42 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.396 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -89.63 110.48 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -172.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG22 HG12 ' A' ' 99' ' ' VAL . 36.6 mt -113.58 117.77 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.689 0.796 . . . . 0.0 110.63 -166.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 95' ' ' TRP . 48.3 tp -92.01 113.25 25.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.907 0.483 . . . . 0.0 111.033 -173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 56.8 m -92.64 137.74 32.1 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 90' ' ' ILE . 40.8 mt -89.41 161.84 16.08 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 170.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.34 124.32 5.62 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.831 1.332 . . . . 0.0 112.842 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.27 142.77 18.5 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.54 -27.2 60.77 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 123.578 0.549 . . . . 0.0 113.494 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -120.04 89.82 3.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.949 0.9 . . . . 0.0 110.066 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.24 20.57 16.24 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.9 168.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -65.37 -31.62 72.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.464 1.106 . . . . 0.0 110.196 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 2.3 m-20 -62.51 -30.9 71.62 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.423 176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.82 79.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.159 0.583 . . . . 0.0 110.871 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.49 -29.97 69.54 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.668 0.787 . . . . 0.0 112.098 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.22 -48.42 81.8 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.825 0.85 . . . . 0.0 109.5 172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.536 ' HA ' HD12 ' A' ' 50' ' ' LEU . 78.6 mt -66.78 -31.45 72.1 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.896 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -38.2 77.0 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.275 0.63 . . . . 0.0 111.979 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 38.5 p -70.4 -9.47 56.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 47' ' ' LEU . 72.3 mt -81.27 6.92 12.71 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.481 . . . . 0.0 111.17 171.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 7.58 85.68 Favored Glycine 0 C--N 1.36 1.879 0 CA-C-N 117.681 0.218 . . . . 0.0 113.072 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -92.04 143.42 26.48 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.477 0.711 . . . . 0.0 109.325 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 44.1 mt-10 -84.59 96.81 9.29 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.4 t -96.87 128.29 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.004 0.522 . . . . 0.0 110.474 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.9 t -114.15 111.1 21.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.316 1.446 . . . . 0.0 108.714 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.98 136.1 43.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.018 0.527 . . . . 0.0 111.08 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.03 144.25 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -152.29 139.09 18.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 159.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.76 -13.11 62.18 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.681 0.613 . . . . 0.0 111.046 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.9 m -117.82 143.0 46.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.193 1.397 . . . . 0.0 109.741 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -73.89 -22.65 59.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.56 0.744 . . . . 0.0 111.219 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.33 -38.58 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.045 0.538 . . . . 0.0 111.814 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.53 -40.05 40.04 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.369 0.418 . . . . 0.0 112.08 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 80' ' ' THR . 91.5 mt -65.6 -52.16 54.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.016 0.926 . . . . 0.0 111.947 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 -34.86 75.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.926 0.89 . . . . 0.0 112.371 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -71.02 -42.03 70.09 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.34 0.656 . . . . 0.0 110.888 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.01 92.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.263 0.625 . . . . 0.0 110.548 176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -75.02 -32.14 61.54 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 110.63 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -63.04 -51.1 68.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.57 0.748 . . . . 0.0 110.923 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.7 tp -65.25 -27.32 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.04 0.837 . . . . 0.0 110.56 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -60.15 -59.63 5.1 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 122.92 0.488 . . . . 0.0 110.597 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.19 -36.44 81.91 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.919 0.888 . . . . 0.0 110.693 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.54 -25.52 63.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.895 0.878 . . . . 0.0 111.666 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -100.33 -3.45 31.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.873 0.869 . . . . 0.0 111.073 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.33 28.27 56.06 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.014 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -132.58 165.53 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.057 0.943 . . . . 0.0 110.749 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -112.22 135.46 52.86 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.607 0.763 . . . . 0.0 111.247 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.628 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.0 mm -110.78 161.33 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 165.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.7 m -114.97 112.74 23.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 166.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 64' ' ' LEU . 85.5 m -84.15 110.73 18.74 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.973 0.909 . . . . 0.0 110.402 -169.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.58 127.17 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 0.0 108.508 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -110.02 95.4 5.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -139.67 -175.15 4.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.657 1.183 . . . . 0.0 109.515 -173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -143.21 131.15 21.62 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -159.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 22.0 mt -73.28 -3.53 27.54 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -169.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.15 3.34 41.04 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.101 0.96 . . . . 0.0 112.845 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.4 -43.04 0.16 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.006 0.821 . . . . 0.0 112.34 -171.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -151.54 112.63 4.29 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.76 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -138.45 -72.32 0.41 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -166.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG23 HD21 ' A' ' 36' ' ' LEU . 4.6 pt -137.72 111.0 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.534 1.134 . . . . 0.0 109.745 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 94' ' ' ALA . 47.3 t -124.84 88.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.2 -1.15 4.04 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -79.67 -48.18 14.12 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.457 0.703 . . . . 0.0 109.632 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.433 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -75.65 -35.97 60.28 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.562 0.745 . . . . 0.0 111.844 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CD1' HD22 ' A' ' 34' ' ' LEU . 57.6 m95 -104.16 174.74 5.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.984 0.914 . . . . 0.0 108.978 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -109.22 -45.78 3.68 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.878 0.37 . . . . 0.0 110.691 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.62 162.76 24.13 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.6 ' HB ' ' HA3' ' A' ' 125' ' ' GLY . 90.5 mt -137.2 145.35 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.593 0.757 . . . . 0.0 110.038 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.466 HG12 HG22 ' A' ' 33' ' ' ILE . 9.0 p -132.94 124.45 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.343 1.057 . . . . 0.0 108.21 165.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 m -120.13 94.98 4.57 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.05 134.17 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.525 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 1.5 p90 -18.78 111.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 126.739 2.016 . . . . 0.0 115.563 -168.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 25.8 p -66.94 106.65 1.98 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 113.267 -1.788 . . . . 0.0 111.588 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -96.18 97.6 9.66 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 85' ' ' LEU . 91.6 mt -139.54 138.97 21.09 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.37 0.668 . . . . 0.0 110.431 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.0 160.63 43.43 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.34 2.694 . . . . 0.0 110.874 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.8 t -46.44 -33.25 3.82 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.791 1.236 . . . . 0.0 113.47 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 36.4 m -55.52 -64.2 0.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.678 0.791 . . . . 0.0 111.623 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 93.9 mt -79.14 -22.36 45.2 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.835 0.454 . . . . 0.0 110.527 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -69.66 -53.92 16.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.659 1.184 . . . . 0.0 110.1 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.07 -11.28 58.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 112.879 173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 108' ' ' SER . 15.6 mm100 -81.92 -38.71 24.85 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 117' ' ' VAL . 52.6 tp -76.54 -43.82 37.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -168.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -58.8 -44.57 99.12 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-N 119.457 1.026 . . . . 0.0 112.805 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.69 -28.42 86.35 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.37 2.046 . . . . 0.0 113.745 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.78 -28.01 60.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.204 0.602 . . . . 0.0 111.635 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.1 t -85.37 -27.38 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.848 0.832 . . . . 0.0 109.71 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -73.48 -63.86 1.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.388 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -76.7 -49.37 16.25 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.19 -39.15 32.58 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 114.069 0.387 . . . . 0.0 114.069 -169.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 30.1 tp -78.53 103.25 8.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.66 148.35 51.49 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 165.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.583 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 60.9 Cg_exo -43.24 127.24 5.3 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.152 3.235 . . . . 0.0 115.003 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 128.64 10.04 3.37 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.776 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -119.18 152.72 17.15 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 164.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.81 136.44 44.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 123.603 0.761 . . . . 0.0 109.861 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.0 113.04 26.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -103.83 107.99 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 29.4 mt -121.86 121.51 37.31 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.741 0.816 . . . . 0.0 110.362 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 36.5 tt0 -115.68 98.98 7.0 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 168.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.01 174.86 46.17 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.699 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.464 ' HB2' HD22 ' A' ' 150' ' ' LEU . 50.7 m-85 -127.87 160.84 30.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.46 157.58 67.39 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.22 0.608 . . . . 0.0 109.695 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.19 -11.18 28.82 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.405 2.07 . . . . 0.0 112.914 174.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.57 -8.52 58.24 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.819 0.847 . . . . 0.0 112.1 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -74.96 -56.57 4.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -168.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.489 HD21 HD21 ' A' ' 150' ' ' LEU . 12.6 mt -65.36 -23.8 67.08 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.21 -23.59 62.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.66 0.784 . . . . 0.0 111.44 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -61.54 -19.07 61.72 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.7 t30 68.15 22.14 8.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.514 1.126 . . . . 0.0 110.133 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.686 HG21 HD13 ' A' ' 175' ' ' LEU . 20.6 p -80.71 -29.45 36.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.252 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.19 177.24 40.3 Favored Glycine 0 C--O 1.243 0.66 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.982 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA2' HD22 ' A' ' 137' ' ' LEU . . . 176.95 144.66 5.37 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 119.265 -0.741 . . . . 0.0 111.732 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.22 -42.76 5.32 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.614 2.209 . . . . 0.0 112.207 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -165.19 -46.76 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.765 0.826 . . . . 0.0 109.608 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -165.09 152.17 10.78 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.423 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.518 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -59.25 -8.38 1.62 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.893 1.277 . . . . 0.0 113.467 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.18 -43.53 82.73 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 0.0 110.64 169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.1 mt -77.7 10.95 2.33 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.17 0.988 . . . . 0.0 112.904 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 44.0 mt -89.37 111.07 43.31 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.639 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.5 Cg_endo -79.98 108.71 2.27 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 122.017 1.812 . . . . 0.0 110.211 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.597 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 tttm -105.3 155.32 19.2 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.812 -0.555 . . . . 0.0 110.796 -173.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.8 mt -50.51 -38.06 42.37 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.238 1.015 . . . . 0.0 111.937 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -49.51 -53.88 20.96 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 125.045 1.466 . . . . 0.0 109.776 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 35.3 m -71.94 -57.62 4.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.74 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.639 HD11 ' HB2' ' A' ' 151' ' ' PRO . 73.1 mt -62.21 -54.32 42.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.398 1.079 . . . . 0.0 112.309 -165.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.56 -35.67 81.73 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.645 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 t -61.36 -37.2 82.51 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.718 0.407 . . . . 0.0 111.829 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 155' ' ' THR . 23.4 mm-40 -83.72 -8.02 59.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.672 0.389 . . . . 0.0 111.31 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.5 mt -138.9 71.78 41.66 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.545 0.738 . . . . 0.0 110.125 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.29 -5.55 13.56 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.402 2.735 . . . . 0.0 111.761 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.5 p -89.71 -41.39 11.94 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.592 1.157 . . . . 0.0 108.576 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 15.2 tp -90.62 71.67 6.8 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 125.623 1.569 . . . . 0.0 110.043 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -63.84 135.07 56.29 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.406 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 33.1 m95 -94.24 128.89 40.97 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.644 1.178 . . . . 0.0 109.999 -166.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.96 -34.25 77.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.543 0.737 . . . . 0.0 110.205 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 70.7 mt -126.14 125.9 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.17 76.87 1.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.052 0.941 . . . . 0.0 109.426 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.96 154.87 35.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.64 117.48 22.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.354 0.662 . . . . 0.0 109.743 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 68.6 mt -111.94 130.31 55.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.203 0.601 . . . . 0.0 110.158 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -91.75 136.19 33.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.812 0.845 . . . . 0.0 110.541 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -132.7 131.94 41.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 108.923 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -79.85 130.62 35.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.009 0.524 . . . . 0.0 110.475 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 141' ' ' THR . 65.3 mt -82.31 153.32 25.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.598 0.759 . . . . 0.0 109.581 176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -69.36 93.79 0.67 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.157 0.583 . . . . 0.0 110.881 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.57 173.89 10.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.667 0.787 . . . . 0.0 110.7 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.57 33.48 0.36 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -114.45 -54.15 2.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.935 0.894 . . . . 0.0 110.454 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -79.26 -17.67 54.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.939 0.896 . . . . 0.0 111.887 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 58.22 8.95 0.88 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.851 1.661 . . . . 0.0 113.053 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -142.77 18.65 1.99 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.433 1.093 . . . . 0.0 109.207 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.0 67.09 3.66 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -111.24 177.44 4.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.124 1.37 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.608 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -134.02 132.5 40.16 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -93.77 108.88 20.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.5 mt -122.21 165.87 15.49 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' A' ' 152' ' ' LYS . 15.4 pt -138.58 141.3 37.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -127.73 143.81 51.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.206 0.527 . . . . 0.0 110.736 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 54.1 mt -135.08 129.0 33.29 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.597 1.559 . . . . 0.0 108.768 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 24' ' ' VAL . 30.2 tp -122.14 106.04 10.8 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.08 140.64 17.86 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 170.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.94 0.896 . . . . 0.0 110.48 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 80.4 tttt -55.9 123.52 14.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 123.742 0.651 . . . . 0.0 109.411 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 197' ' ' HIS . 19.4 mt -75.61 103.84 5.9 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.098 0.249 . . . . 0.0 110.347 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -65.59 -31.29 72.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.447 0.641 . . . . 0.0 109.966 165.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 195' ' ' LEU . 21.6 p80 -85.95 123.08 30.88 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.946 169.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -73.29 162.03 29.82 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -60.82 114.88 3.28 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -78.87 109.96 13.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.401 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -159.75 -179.05 7.51 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.916 0.886 . . . . 0.0 110.445 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.2 p80 . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.42 0.629 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -141.02 24.56 2.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 122.066 0.936 . . . . 0.0 108.894 172.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -92.03 -2.92 56.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.782 -170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -77.84 -49.09 14.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 0.0 109.584 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -143.56 93.13 2.44 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.77 0.828 . . . . 0.0 109.658 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -144.62 19.11 1.68 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.003 0.921 . . . . 0.0 109.238 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -75.97 -4.0 38.68 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.465 1.106 . . . . 0.0 112.834 -170.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.45 113.01 7.16 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.632 0.773 . . . . 0.0 110.84 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 m -90.64 -21.78 21.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.669 0.787 . . . . 0.0 111.31 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.68 -52.55 5.08 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.38 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -74.42 82.67 1.94 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.738 0.78 . . . . 0.0 110.453 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -165.61 -41.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.814 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 73.37 -46.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 126.026 1.73 . . . . 0.0 113.592 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.41 -32.65 57.9 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-O 121.171 0.317 . . . . 0.0 112.605 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.2 p -120.33 79.29 1.45 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 163.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.55 156.08 55.63 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.596 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -38.9 -41.6 1.79 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 124.571 3.514 . . . . 0.0 115.309 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.32 118.28 24.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.745 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -103.38 141.86 35.22 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -70.27 -21.36 62.97 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.963 0.505 . . . . 0.0 110.902 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.584 HD21 ' HG ' ' A' ' 47' ' ' LEU . 33.7 tp -58.81 -35.7 73.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.389 0.676 . . . . 0.0 111.809 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.37 -40.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 76.2 p -79.75 -51.45 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.258 0.551 . . . . 0.0 111.108 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 128' ' ' ILE . 26.5 m -63.41 -34.24 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.373 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -34.72 76.87 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.324 1.05 . . . . 0.0 111.987 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.06 -31.84 72.29 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.107 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HB3' HE21 ' A' ' 193' ' ' GLN . 29.8 mm-40 -85.46 -25.59 26.82 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.848 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 24' ' ' VAL . 79.1 mt -69.79 128.21 92.05 Favored Pre-proline 0 N--CA 1.488 1.428 0 CA-C-O 119.003 -0.523 . . . . 0.0 109.735 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.35 115.04 1.54 Allowed 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.859 2.372 . . . . 0.0 111.369 164.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.47 32.67 0.13 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.809 1.644 . . . . 0.0 114.306 -166.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.94 -129.59 5.56 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-O 118.776 -1.014 . . . . 0.0 110.922 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -69.29 111.23 5.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.458 1.129 . . . . 0.0 109.897 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.03 119.5 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 89' ' ' ASP . 56.4 tp -98.24 121.06 39.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.901 0.481 . . . . 0.0 110.598 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -104.73 134.0 48.62 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.999 1.32 . . . . 0.0 109.422 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 66.1 mt -95.78 152.58 18.35 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.629 0.372 . . . . 0.0 110.9 171.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -78.04 -165.92 0.73 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.279 0.632 . . . . 0.0 111.711 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 64.22 22.62 12.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.34 1.056 . . . . 0.0 110.992 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.53 -31.2 0.1 Allowed Glycine 0 C--N 1.343 0.948 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.334 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 43' ' ' ASN . 67.7 tt0 -129.56 141.39 50.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.298 0.639 . . . . 0.0 111.465 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.07 -51.69 0.03 OUTLIER Glycine 0 C--N 1.343 0.958 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -65.31 -44.69 87.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.742 0.817 . . . . 0.0 110.334 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' ' HG3' ' A' ' 40' ' ' GLU . 19.6 m120 -65.73 -31.3 72.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.209 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.66 -58.35 8.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.651 0.78 . . . . 0.0 111.659 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.2 p -65.93 -27.34 68.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.961 0.504 . . . . 0.0 112.086 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 51.0 t80 -68.5 -36.9 79.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.889 0.476 . . . . 0.0 110.098 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 21' ' ' LEU . 55.6 mt -68.56 -32.29 72.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.327 0.651 . . . . 0.0 111.054 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.32 -33.87 61.2 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.47 0.308 . . . . 0.0 110.321 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -63.19 -19.2 64.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.149 0.98 . . . . 0.0 111.36 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 84.1 mt -82.07 14.23 2.95 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.89 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 33.7 58.31 Favored Glycine 0 C--N 1.358 1.752 0 C-N-CA 123.295 0.474 . . . . 0.0 114.163 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -125.44 156.12 39.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.718 0.759 . . . . 0.0 110.628 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.53 97.51 7.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.481 0.712 . . . . 0.0 109.75 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -105.96 119.11 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.116 0.484 . . . . 0.0 111.501 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.9 m -84.97 112.3 20.47 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.32 120.48 40.32 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 81' ' ' VAL . 82.2 t -98.66 121.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.84 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 19.6 t70 -139.47 129.33 24.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -54.74 -26.92 37.22 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.782 1.233 . . . . 0.0 112.987 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.491 ' HB2' HG22 ' A' ' 62' ' ' VAL . 47.6 m -113.25 160.68 18.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.779 0.831 . . . . 0.0 111.386 -176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -69.81 -21.39 63.4 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.526 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 60' ' ' SER . 6.5 m -62.11 -43.8 98.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.183 0 C-N-CA 122.895 0.478 . . . . 0.0 111.992 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.28 -34.88 19.24 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 71.3 mt -67.66 -58.31 4.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.594 0.758 . . . . 0.0 111.773 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.46 70.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.321 0.649 . . . . 0.0 112.287 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -70.41 -42.3 71.81 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.883 0.473 . . . . 0.0 110.529 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.44 95.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.682 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -68.97 -34.97 76.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.559 1.144 . . . . 0.0 111.296 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -54.89 -48.51 72.91 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.087 0.955 . . . . 0.0 110.648 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.86 -29.25 64.19 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.057 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -58.54 -62.58 1.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.63 0.581 . . . . 0.0 111.069 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.21 -40.12 89.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.239 0.616 . . . . 0.0 111.665 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.95 -40.32 95.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.727 0.811 . . . . 0.0 111.55 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -103.92 -5.46 22.25 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.889 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.44 43.78 36.23 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.875 0.153 . . . . 0.0 113.206 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.76 172.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.316 1.047 . . . . 0.0 109.499 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.05 132.42 54.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.98 0.512 . . . . 0.0 111.497 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.537 HG12 ' HB2' ' A' ' 71' ' ' ALA . 23.2 mm -114.42 155.76 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 166.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -121.46 108.21 13.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 165.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.7 t -86.62 113.49 22.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.209 0.603 . . . . 0.0 110.855 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 57' ' ' VAL . 24.7 t -120.79 139.19 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.307 1.043 . . . . 0.0 109.132 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -84.05 147.87 27.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 172.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 m -67.19 112.68 4.61 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.419 0.288 . . . . 0.0 111.338 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -144.01 89.06 2.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 165.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.6 mt -85.42 -38.55 18.55 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.023 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.64 67.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.845 0.858 . . . . 0.0 112.194 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -86.22 -34.17 20.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.381 0.672 . . . . 0.0 111.499 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -166.74 117.27 0.92 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.348 0.659 . . . . 0.0 109.831 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -128.84 -64.59 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.9 pt -139.79 119.24 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.546 0.738 . . . . 0.0 110.279 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.97 86.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -69.25 2.19 3.11 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.03 -50.3 56.22 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.53 -22.17 47.7 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 34' ' ' LEU . 68.7 m95 -107.45 170.85 7.72 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 0.0 109.867 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -98.98 -56.98 2.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.336 0.589 . . . . 0.0 109.793 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.74 158.4 20.02 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.819 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.688 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 59.7 mt -122.73 153.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.57 136.1 35.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.937 1.295 . . . . 0.0 108.098 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 t -143.8 93.63 2.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 40' ' ' GLU . 26.2 mm -66.9 142.71 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.703 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 35.4 p90 -15.65 106.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.363 1.865 . . . . 0.0 115.417 -159.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.4 p -70.23 102.0 2.01 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.395 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -99.22 94.2 6.35 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.5 mt -128.3 133.33 25.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.56 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -56.78 161.71 9.82 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.285 2.656 . . . . 0.0 112.36 169.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.7 m -40.94 -44.1 2.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.815 1.246 . . . . 0.0 112.85 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.3 m -54.12 -63.82 1.03 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.311 1.044 . . . . 0.0 112.179 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -75.55 -27.72 58.74 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.581 0.352 . . . . 0.0 111.066 -172.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -65.27 -55.4 18.59 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.26 -35.35 26.61 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.608 1.163 . . . . 0.0 112.592 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -84.71 -17.07 39.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.962 0.505 . . . . 0.0 111.398 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 117' ' ' VAL . 58.6 tp -78.43 -38.42 41.4 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.904 0.482 . . . . 0.0 111.265 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -57.34 -41.13 89.3 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -29.99 84.69 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.967 1.778 . . . . 0.0 112.515 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -81.95 -26.86 33.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.541 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 113' ' ' LEU . 2.5 t -87.35 -24.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.257 0.551 . . . . 0.0 110.675 176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -82.08 -65.45 1.01 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.85 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.55 -45.5 15.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.899 0.88 . . . . 0.0 112.853 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.83 -29.87 64.53 Favored Glycine 0 N--CA 1.479 1.523 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.909 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.73 146.16 50.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.205 0.602 . . . . 0.0 110.286 169.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 39.4 mmtm -129.47 158.21 73.99 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.08 1.352 . . . . 0.0 108.063 170.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 194' ' ' LYS . 34.5 Cg_exo -40.18 110.87 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.392 2.728 . . . . 0.0 114.444 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.49 6.59 6.65 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.804 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.688 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -98.97 140.43 15.01 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 170.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 29.0 m -111.47 130.94 64.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.256 0.55 . . . . 0.0 110.3 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -110.03 107.4 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.578 HD13 HG21 ' A' ' 24' ' ' VAL . 45.2 mt -110.4 107.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -169.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 156' ' ' LEU . 29.8 mt -125.73 116.42 21.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -167.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.703 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 45.5 tt0 -105.62 97.64 7.45 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.89 -177.46 46.45 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.974 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.431 ' HB2' HD13 ' A' ' 150' ' ' LEU . 31.5 m-85 -138.21 159.05 43.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.942 0.897 . . . . 0.0 108.863 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.78 163.3 22.74 Favored Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 123.555 0.742 . . . . 0.0 110.31 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.677 ' HA ' HD22 ' A' ' 147' ' ' LEU . 71.7 Cg_exo -53.9 -16.3 8.61 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.476 2.784 . . . . 0.0 115.393 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.68 -22.84 59.82 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.071 0.548 . . . . 0.0 111.995 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -66.4 -56.49 10.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -162.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.488 HD21 HD21 ' A' ' 150' ' ' LEU . 26.3 mt -65.86 -21.5 66.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 123.279 0.362 . . . . 0.0 111.383 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -65.17 -22.56 66.93 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.176 0.59 . . . . 0.0 112.056 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -68.17 -6.05 21.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 52.33 22.14 1.93 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.575 1.55 . . . . 0.0 113.169 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.7 m -95.54 0.64 53.27 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.301 1.04 . . . . 0.0 109.091 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.83 145.6 5.07 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.143 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.66 81.69 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.573 ' HB2' HD12 ' A' ' 149' ' ' LEU . 22.5 Cg_exo -63.08 -26.01 73.31 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.724 2.283 . . . . 0.0 112.856 -173.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -174.24 -49.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.517 1.127 . . . . 0.0 108.405 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -171.58 162.37 6.43 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.475 0.71 . . . . 0.0 109.703 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -63.93 2.56 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -176.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.89 -36.7 80.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 144' ' ' PRO . 30.3 mt -76.09 3.62 10.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.525 0.73 . . . . 0.0 111.894 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 22.0 mt -90.88 103.24 6.64 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.98 109.02 2.81 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.617 2.211 . . . . 0.0 110.625 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' HD11 ' A' ' 188' ' ' ILE . 37.3 mtmm -108.0 162.71 13.79 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.275 0.63 . . . . 0.0 111.905 -168.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 188' ' ' ILE . 24.1 mt -60.15 -36.25 77.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.635 0.774 . . . . 0.0 109.899 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -48.53 -56.93 7.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.719 1.208 . . . . 0.0 110.79 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 57.2 m -71.73 -62.61 1.36 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.739 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 129' ' ' LEU . 24.3 mt -61.74 -55.48 29.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.696 1.198 . . . . 0.0 112.209 -166.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -59.7 -42.05 92.15 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.646 0.779 . . . . 0.0 111.9 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.1 t -63.76 -34.01 76.94 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 155' ' ' THR . 8.5 pt-20 -111.33 18.69 19.0 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.132 0.492 . . . . 0.0 111.251 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -139.74 63.23 25.55 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.108 0.963 . . . . 0.0 108.708 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.43 -8.87 15.01 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.62 2.214 . . . . 0.0 111.919 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.2 t -86.42 -33.09 20.55 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.6 tp -95.13 68.17 3.1 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.21 1.004 . . . . 0.0 108.492 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.39 128.56 36.29 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.433 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 25.4 m95 -88.23 141.02 28.89 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 110.014 -163.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.34 -36.67 77.15 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.966 0.506 . . . . 0.0 109.843 170.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.5 mt -127.22 125.53 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.58 85.52 1.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.34 1.056 . . . . 0.0 108.658 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -153.09 149.59 28.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.565 0.346 . . . . 0.0 111.193 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.57 113.98 20.65 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.535 0.522 . . . . 0.0 109.633 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.9 mt -109.66 128.94 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 184' ' ' LYS . 41.6 tt0 -95.77 120.28 35.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -121.64 123.13 41.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -77.92 128.82 34.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.162 0.585 . . . . 0.0 111.134 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 185' ' ' ALA . 66.9 mt -76.72 169.45 18.28 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.949 0.899 . . . . 0.0 109.072 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -53.68 111.24 0.69 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.854 0.462 . . . . 0.0 109.981 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -116.67 150.68 37.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.131 0.572 . . . . 0.0 110.703 -173.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -172.57 36.68 0.14 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.693 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -142.09 -175.36 4.39 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.099 0.96 . . . . 0.0 110.626 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -90.29 1.49 56.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.552 0.741 . . . . 0.0 111.323 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -111.19 121.36 45.1 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.34 82.2 1.04 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.346 0.593 . . . . 0.0 110.639 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -68.86 94.49 0.36 Allowed Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.353 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.502 ' HD2' ' H ' ' A' ' 184' ' ' LYS . 0.0 OUTLIER -111.05 -175.45 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.967 0.907 . . . . 0.0 109.869 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -126.02 130.25 50.79 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.29 109.35 20.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.8 mt -115.46 154.01 30.07 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -173.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 152' ' ' LYS . 3.4 pt -136.14 116.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -97.86 138.1 35.72 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 34.5 mt -126.35 131.63 51.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.806 1.242 . . . . 0.0 108.1 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.515 HD22 HG12 ' A' ' 24' ' ' VAL . 40.1 tp -127.6 105.65 8.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 168.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.98 133.69 11.99 Favored Glycine 0 C--O 1.214 -1.133 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 27' ' ' GLN . 6.5 tp-100 -144.05 156.87 44.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.809 0.844 . . . . 0.0 109.304 177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 123' ' ' PRO . 22.8 pttp -60.15 129.07 39.93 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.9 mt -66.21 109.76 2.76 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.245 0.34 . . . . 0.0 110.581 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.95 160.83 14.04 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.652 0.381 . . . . 0.0 110.914 170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 69.75 23.32 5.75 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.389 1.076 . . . . 0.0 109.477 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -138.75 88.31 2.28 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.183 0.993 . . . . 0.0 108.707 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -80.9 163.44 23.36 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.189 0.595 . . . . 0.0 110.555 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -76.54 132.28 39.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -148.48 114.34 5.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 108.996 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.015 0.926 . . . . 0.0 108.535 -176.198 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 mmt . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -150.88 116.62 5.49 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.041 0.936 . . . . 0.0 109.301 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.78 101.88 13.74 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.562 ' HG3' ' HD2' ' A' ' 6' ' ' PHE . 15.0 tp10 -68.85 84.76 0.32 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.826 0.85 . . . . 0.0 108.987 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 60.08 3.0 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.769 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.562 ' HD2' ' HG3' ' A' ' 4' ' ' GLU . 51.6 p90 -69.4 -17.67 63.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.19 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.0 t -52.72 -33.72 49.15 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.0 1.32 . . . . 0.0 111.255 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -118.68 91.76 3.64 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.3 m -61.38 -40.71 95.36 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.227 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -152.4 139.1 18.81 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -90.26 15.68 9.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.727 0.811 . . . . 0.0 112.462 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.06 142.99 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.818 0.447 . . . . 0.0 109.834 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -131.74 69.51 1.48 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.411 0.624 . . . . 0.0 110.231 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.9 91.47 0.6 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 165.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.681 HG22 ' HG3' ' A' ' 16' ' ' GLU . 20.0 m -72.39 -77.85 0.09 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.449 0.699 . . . . 0.0 111.387 -166.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.681 ' HG3' HG22 ' A' ' 15' ' ' THR . 44.5 mt-10 -126.86 106.99 22.48 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 123.398 0.679 . . . . 0.0 111.049 -170.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HA ' HG11 ' A' ' 22' ' ' VAL . 20.2 Cg_exo -66.29 135.03 38.36 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.121 2.547 . . . . 0.0 111.403 172.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.641 HD21 ' HB3' ' A' ' 21' ' ' LEU . 24.6 p-10 -130.88 -164.67 1.46 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.893 0.477 . . . . 0.0 109.838 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -43.25 -53.01 5.39 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.37 1.468 . . . . 0.0 114.381 -177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -172.44 -22.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.31 0.644 . . . . 0.0 110.494 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.641 ' HB3' HD21 ' A' ' 18' ' ' ASN . 33.2 tp -59.26 -31.88 69.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.538 0.735 . . . . 0.0 112.509 -174.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 17' ' ' PRO . 5.7 m -54.79 -38.05 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -68.12 -53.08 27.87 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.955 0.883 . . . . 0.0 110.425 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 128' ' ' ILE . 29.7 m -66.97 -29.27 45.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.546 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.91 72.94 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.249 1.02 . . . . 0.0 112.31 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.05 -35.57 79.02 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.021 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -95.2 -7.63 38.55 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' VAL . 57.9 mt -72.06 138.35 82.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.69 ' HG3' ' HD3' ' A' ' 194' ' ' LYS . 33.7 Cg_exo -59.87 131.83 41.77 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.836 2.357 . . . . 0.0 112.084 174.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -70.78 30.37 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.02 -148.93 9.27 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -80.39 118.06 21.69 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -107.63 141.95 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.709 0.804 . . . . 0.0 110.197 -167.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 95' ' ' TRP . 33.0 tp -118.13 116.87 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.329 1.052 . . . . 0.0 109.127 170.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 26.5 p -107.21 111.93 24.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.277 0.489 . . . . 0.0 110.811 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.5 mt -70.05 143.06 52.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.46 161.9 41.81 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.935 0.772 . . . . 0.0 110.041 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -115.58 -18.01 11.02 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 174.59 -9.21 0.03 OUTLIER Glycine 0 CA--C 1.522 0.528 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.943 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -137.9 122.7 18.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.596 1.159 . . . . 0.0 108.874 -173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 67' ' ' ALA . . . -97.2 39.4 2.8 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.379 0.425 . . . . 0.0 112.948 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 ttp-105 -70.75 -41.14 72.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.764 0.826 . . . . 0.0 109.891 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.43 -40.59 97.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.53 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.68 -57.27 13.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.798 0.839 . . . . 0.0 111.575 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.651 ' SG ' HD23 ' A' ' 70' ' ' LEU . 20.1 p -61.67 -43.26 99.19 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.375 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -66.32 -46.18 77.75 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.256 0.348 . . . . 0.0 111.184 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' HG ' HD21 ' A' ' 21' ' ' LEU . 97.3 mt -67.05 -33.0 74.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.051 0.54 . . . . 0.0 110.874 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.1 -33.1 72.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.991 0.517 . . . . 0.0 110.873 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 63.9 m -75.43 -5.6 45.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.3 mt -88.59 13.15 12.77 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.245 0.618 . . . . 0.0 110.167 167.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.56 39.14 30.77 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.74 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -130.12 154.68 47.24 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.161 0.481 . . . . 0.0 111.888 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.19 89.18 7.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.575 0.75 . . . . 0.0 109.056 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.7 t -100.62 110.14 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.319 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 82.1 m -87.09 112.91 22.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.624 1.17 . . . . 0.0 109.79 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -92.31 125.82 37.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.707 0.803 . . . . 0.0 109.913 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' CG1' ' HA ' ' A' ' 83' ' ' SER . 5.6 t -105.37 116.45 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 167.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -135.74 133.93 38.51 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -64.4 -23.86 67.43 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.679 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.542 ' HB3' HG22 ' A' ' 62' ' ' VAL . 15.8 m -104.13 135.85 44.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.057 0.943 . . . . 0.0 109.814 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -73.11 -25.8 61.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 0.0 109.981 175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 60' ' ' SER . 21.2 m -67.85 -36.6 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.258 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.98 -36.28 90.74 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.51 -48.23 70.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.402 1.081 . . . . 0.0 111.5 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.39 84.46 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.688 0.795 . . . . 0.0 112.47 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -77.45 -31.58 53.91 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.263 0.625 . . . . 0.0 111.312 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . -59.69 -46.89 87.71 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 171.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -71.46 -40.95 69.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.169 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -58.4 -53.42 58.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.022 0.929 . . . . 0.0 110.823 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.651 HD23 ' SG ' ' A' ' 45' ' ' CYS . 19.3 tp -65.69 -28.47 69.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.642 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.32 -54.46 17.29 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.734 0.414 . . . . 0.0 110.812 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -35.63 78.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.187 0.595 . . . . 0.0 110.769 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -62.66 -40.48 97.2 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.851 0.719 . . . . 0.0 110.356 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -91.02 -1.39 57.82 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.981 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.69 32.28 37.75 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 16.3 m -132.71 178.51 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.985 0.914 . . . . 0.0 109.961 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -132.0 142.16 49.5 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.758 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.0 mm -110.61 170.06 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.97 1.308 . . . . 0.0 108.273 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 71.7 m -121.91 111.89 17.64 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 163.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 t -86.08 109.96 19.2 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.592 0.757 . . . . 0.0 111.545 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.22 133.05 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.524 1.129 . . . . 0.0 108.955 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -85.41 132.42 34.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' CG1' ' A' ' 57' ' ' VAL . 58.2 m -61.36 125.92 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -133.42 87.61 2.41 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.5 mt -91.1 -4.58 56.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.506 0.722 . . . . 0.0 110.674 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.39 3.54 54.25 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.825 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.39 -37.81 0.27 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -162.04 104.53 1.16 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -169.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.5 -65.15 0.99 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -174.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 98' ' ' ILE . 9.4 pt -136.32 115.03 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.479 0.712 . . . . 0.0 110.777 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 94' ' ' ALA . 61.4 t -128.07 94.37 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.83 -1.43 2.9 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -80.2 -51.27 9.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 168.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -70.55 -31.47 68.53 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.37 0.668 . . . . 0.0 111.861 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.488 ' CD1' HD22 ' A' ' 34' ' ' LEU . 24.5 m95 -116.94 145.08 43.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.778 0.831 . . . . 0.0 109.44 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -79.07 -33.06 44.92 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.178 0.513 . . . . 0.0 110.57 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -139.98 140.11 10.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.872 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 90' ' ' ILE . 82.1 mt -115.58 143.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' LEU . 7.7 p -135.8 134.58 51.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 164.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 m -136.89 113.77 10.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 128' ' ' ILE . 37.1 mm -76.34 144.51 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.735 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 2.9 p90 -20.31 109.36 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.124 1.77 . . . . 0.0 115.148 -173.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.415 ' SG ' HD23 ' A' ' 113' ' ' LEU . 40.7 t -80.36 113.48 18.58 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 112.896 -1.956 . . . . 0.0 110.313 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -120.19 98.08 5.9 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -122.1 150.72 57.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.91 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.68 159.53 53.27 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.91 2.407 . . . . 0.0 110.125 168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.3 m -37.16 -45.0 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.157 1.783 . . . . 0.0 113.956 -173.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.7 p -49.14 -63.08 1.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 O-C-N 124.675 1.234 . . . . 0.0 111.844 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.24 -22.28 28.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.392 0.677 . . . . 0.0 110.539 -173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -73.42 -62.93 1.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.129 0.972 . . . . 0.0 110.374 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.31 -15.17 56.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.451 0.7 . . . . 0.0 112.098 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.23 -41.65 27.78 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 117' ' ' VAL . 46.6 tp -74.86 -48.22 26.1 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.783 -170.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.449 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 34.7 m-85 -66.73 -40.56 32.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -165.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.56 -31.74 94.98 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 121.958 1.772 . . . . 0.0 112.281 167.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -82.65 -14.96 53.77 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.964 0.906 . . . . 0.0 110.057 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 113' ' ' LEU . 22.0 t -80.68 -36.46 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 170.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.506 ' HE1' ' HD2' ' A' ' 161' ' ' PRO . 33.0 t80 -57.8 -54.46 46.6 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 175.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -71.83 -47.01 56.07 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.806 0.842 . . . . 0.0 112.926 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.09 -45.94 10.99 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 114.276 0.47 . . . . 0.0 114.276 -170.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.1 tp -85.28 95.2 9.12 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -75.75 148.41 82.27 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 164.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -49.02 133.27 28.48 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.201 1.934 . . . . 0.0 110.125 168.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 128.87 -11.73 6.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -157.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.01 168.08 20.87 Favored Glycine 0 C--N 1.344 1.012 0 O-C-N 122.726 -0.279 . . . . 0.0 112.593 166.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.08 137.88 48.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.409 1.083 . . . . 0.0 109.45 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.98 113.33 23.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 24' ' ' VAL . 17.9 mt -106.95 109.62 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.934 0.893 . . . . 0.0 108.644 -171.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 156' ' ' LEU . 40.3 mt -125.85 114.1 18.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.995 0.518 . . . . 0.0 109.754 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.735 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 43.2 tt0 -103.47 98.95 8.76 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.498 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.91 -176.68 49.24 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.449 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.449 ' HB2' HD22 ' A' ' 150' ' ' LEU . 36.8 m-85 -132.79 158.61 42.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.215 1.006 . . . . 0.0 108.757 -176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.57 159.52 30.28 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 123.582 0.753 . . . . 0.0 110.553 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HA ' HD22 ' A' ' 147' ' ' LEU . 73.3 Cg_exo -55.09 -18.43 17.4 Favored 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.85 3.034 . . . . 0.0 116.482 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -83.92 -5.82 59.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.869 -0.519 . . . . 0.0 112.179 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -73.85 -49.98 22.49 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.965 -0.46 . . . . 0.0 111.2 -169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.509 HD12 ' HG ' ' A' ' 147' ' ' LEU . 18.2 mt -69.86 -25.84 63.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -70.27 -23.55 62.9 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.305 1.042 . . . . 0.0 111.411 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -65.58 -7.5 15.19 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.129 0.572 . . . . 0.0 111.586 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 68.45 37.77 2.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.049 1.34 . . . . 0.0 109.23 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.8 p -79.04 -20.04 49.92 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.219 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.402 ' O ' HD22 ' A' ' 137' ' ' LEU . . . 127.6 122.88 2.56 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.769 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.41 95.42 1.15 Allowed Glycine 0 N--CA 1.467 0.741 0 CA-C-O 118.821 -0.988 . . . . 0.0 111.539 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.55 -20.02 60.41 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.989 2.459 . . . . 0.0 112.541 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -159.6 -62.31 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -179.27 166.39 1.49 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.159 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.618 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.9 OUTLIER -60.49 -1.85 0.42 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.706 1.602 . . . . 0.0 112.93 172.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -61.67 -40.16 93.95 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.36 1.464 . . . . 0.0 110.742 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.89 -1.7 23.55 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.618 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 20.9 mt -83.29 107.83 11.04 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -68.82 111.88 2.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.923 2.416 . . . . 0.0 111.239 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -99.13 151.89 20.47 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.276 0.63 . . . . 0.0 111.482 -169.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.504 HD21 ' HB ' ' A' ' 188' ' ' ILE . 60.5 mt -60.69 -39.37 88.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.166 0.586 . . . . 0.0 110.486 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.1 -51.39 58.02 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.389 1.076 . . . . 0.0 110.805 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.7 p -71.55 -55.18 8.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.671 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.638 HD13 HD13 ' A' ' 129' ' ' LEU . 55.9 mt -73.51 -46.15 49.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.262 1.025 . . . . 0.0 113.52 -167.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -42.41 96.07 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 m -73.64 -21.94 60.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 19.7 tp10 -74.39 -22.25 59.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.635 0.774 . . . . 0.0 110.521 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.456 HD23 ' HD1' ' A' ' 118' ' ' TYR . 68.6 mt -140.22 65.56 28.69 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 123.535 0.734 . . . . 0.0 109.377 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.506 ' HD2' ' HE1' ' A' ' 118' ' ' TYR . 95.3 Cg_endo -81.42 2.49 8.52 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 123.068 2.512 . . . . 0.0 112.09 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 55.1 p -90.47 -33.84 15.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.367 1.067 . . . . 0.0 108.685 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 tp -90.06 73.12 7.33 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.999 1.719 . . . . 0.0 111.178 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -50.06 114.15 1.03 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.476 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.549 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 35.4 m95 -84.88 128.99 34.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.786 -174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.538 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 84.8 mt -71.18 -36.61 72.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.429 0.692 . . . . 0.0 110.803 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 59.1 mt -125.25 120.74 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -152.02 70.98 0.95 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -148.23 146.51 28.69 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -170.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -73.97 112.42 10.07 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.272 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 66.9 mt -118.17 137.17 53.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 110.829 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -94.68 127.32 40.57 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.509 0.724 . . . . 0.0 110.005 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -109.25 123.01 48.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.662 0.785 . . . . 0.0 109.64 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -73.29 110.33 7.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.375 0.67 . . . . 0.0 110.792 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.74 167.84 20.1 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.981 0.912 . . . . 0.0 110.304 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -75.7 71.46 2.57 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.91 154.75 5.36 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.318 -164.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -168.58 34.94 0.2 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 120.268 -0.185 . . . . 0.0 112.838 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 91.89 0.12 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.88 0.872 . . . . 0.0 111.235 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.3 t80 68.02 -76.1 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.669 1.588 . . . . 0.0 110.334 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -136.03 -16.5 1.68 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.214 1.006 . . . . 0.0 110.43 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -70.77 90.6 0.79 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -147.39 13.21 1.4 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.94 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 184' ' ' LYS . 0.1 OUTLIER -133.4 176.27 8.68 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.892 0.877 . . . . 0.0 110.069 -174.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -125.75 132.05 52.41 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.98 106.01 15.31 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 68.6 mt -127.28 171.94 11.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.657 0.783 . . . . 0.0 109.809 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.504 ' HB ' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -142.82 119.82 6.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.031 173.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -98.31 140.71 32.18 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 37.4 mt -129.23 133.35 47.49 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 108.453 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.47 HD22 HG12 ' A' ' 24' ' ' VAL . 46.3 tp -139.76 107.61 5.67 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.69 139.76 17.46 Favored Glycine 0 C--O 1.225 -0.433 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 6.1 tp60 -116.72 146.79 42.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.001 0.9 . . . . 0.0 111.677 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.69 ' HD3' ' HG3' ' A' ' 29' ' ' PRO . 21.9 pttm -58.19 115.05 2.68 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.163 165.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.9 mt -53.03 140.07 26.25 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 167.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -34.39 124.99 0.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.721 1.208 . . . . 0.0 113.228 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -72.53 80.02 1.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.204 1.002 . . . . 0.0 111.619 -176.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -93.47 -55.55 3.25 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.512 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -127.41 17.83 7.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.237 0.615 . . . . 0.0 111.458 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -140.06 103.94 4.73 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 197' ' ' HIS . 32.2 m170 64.24 150.88 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.524 1.13 . . . . 0.0 111.845 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.245 1.018 . . . . 0.0 108.352 177.358 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mtp . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -87.02 70.74 10.3 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.919 0.866 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -110.93 161.01 16.27 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.968 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.35 -144.39 0.11 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.547 1.139 . . . . 0.0 109.172 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER 49.31 79.52 0.08 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.925 1.69 . . . . 0.0 112.338 -174.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -147.58 77.26 1.43 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m -143.31 77.83 1.58 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -86.33 -13.55 46.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.669 0.788 . . . . 0.0 109.792 169.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -54.62 95.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.546 1.539 . . . . 0.0 112.178 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.53 94.15 4.98 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.055 0.931 . . . . 0.0 110.618 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -127.66 114.21 17.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.689 175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.22 25.05 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 121.963 0.887 . . . . 0.0 108.81 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -59.98 105.33 0.38 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.791 1.236 . . . . 0.0 112.05 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.75 44.64 1.46 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.48 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.4 p -70.97 149.48 46.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.892 0.877 . . . . 0.0 110.973 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -140.17 75.78 28.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.24 124.77 1.77 Allowed 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.661 2.241 . . . . 0.0 111.142 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -106.55 143.48 34.6 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 22' ' ' VAL . 15.3 t70 -156.66 173.18 17.33 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.892 0.877 . . . . 0.0 109.084 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -59.9 -29.51 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.727 0.811 . . . . 0.0 110.527 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 47' ' ' LEU . 18.2 tp -59.77 -33.97 72.39 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.848 1.259 . . . . 0.0 112.492 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 19' ' ' ASP . 11.0 m -52.54 -38.46 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -72.8 -44.72 61.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 0.0 110.938 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 128' ' ' ILE . 2.4 m -67.97 -33.5 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.044 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.27 77.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.485 1.114 . . . . 0.0 111.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.7 -33.87 73.52 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.191 0.596 . . . . 0.0 110.329 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -84.21 -22.52 30.85 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' VAL . 85.7 mt -76.98 131.67 72.63 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 122.834 0.454 . . . . 0.0 110.91 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.39 143.93 71.83 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.788 2.326 . . . . 0.0 111.895 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -72.79 30.59 0.06 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.336 1.454 . . . . 0.0 114.371 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.76 177.95 17.35 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 96' ' ' GLU . 66.1 mttm -60.14 118.48 6.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.542 0.737 . . . . 0.0 110.845 -165.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.89 138.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -165.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 90' ' ' ILE . 59.9 tp -110.67 112.43 24.31 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.73 ' SG ' HG13 ' A' ' 54' ' ' VAL . 58.9 m -101.81 109.59 21.38 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 123.772 0.829 . . . . 0.0 110.412 -176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 89' ' ' ASP . 36.8 mt -76.69 127.31 32.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 165.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.2 86.58 2.45 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 103' ' ' CYS . 15.9 tp10 -106.02 73.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.094 0.949 . . . . 0.0 109.39 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.29 -40.56 1.27 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 113.937 -1.483 . . . . 0.0 111.487 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HG3' ' HG2' ' A' ' 42' ' ' ARG . 12.8 tp10 -159.91 133.95 7.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.245 0.618 . . . . 0.0 110.158 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.54 25.32 8.16 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.707 0.63 . . . . 0.0 113.7 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HG2' ' HG3' ' A' ' 40' ' ' GLU . 17.0 ptt180 -61.78 -38.21 87.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.445 0.698 . . . . 0.0 110.821 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -74.59 -33.61 62.68 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.182 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.05 66.61 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.297 0.639 . . . . 0.0 110.799 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.6 p -70.42 -28.44 65.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.2 t80 -66.88 -33.15 74.97 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' HD21 ' A' ' 21' ' ' LEU . 31.4 mt -64.59 -36.04 82.94 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.121 0.569 . . . . 0.0 111.164 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.56 69.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.661 0.267 . . . . 0.0 110.743 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.601 ' HA ' HG11 ' A' ' 76' ' ' VAL . 55.9 m -68.36 -10.86 57.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.531 0.732 . . . . 0.0 111.533 174.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.536 HD12 HD23 ' A' ' 47' ' ' LEU . 65.7 mt -88.13 14.89 8.28 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.643 0.777 . . . . 0.0 110.846 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.16 36.97 44.05 Favored Glycine 0 C--N 1.354 1.542 0 C-N-CA 123.146 0.403 . . . . 0.0 113.435 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.64 147.34 45.37 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.889 0.476 . . . . 0.0 112.101 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.9 90.64 4.73 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.902 0.881 . . . . 0.0 108.719 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.73 HG13 ' SG ' ' A' ' 35' ' ' CYS . 65.3 t -102.05 112.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.023 0.529 . . . . 0.0 111.969 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.2 m -85.3 104.88 15.54 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.68 120.95 41.14 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.268 0.627 . . . . 0.0 109.507 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 83' ' ' SER . 3.6 t -103.81 119.17 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -132.91 144.56 50.24 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.315 0.962 . . . . 0.0 111.32 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 3.0 pp0? -57.98 -18.27 22.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.526 1.53 . . . . 0.0 114.503 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 62' ' ' VAL . 77.5 p -131.2 139.2 49.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.479 0.712 . . . . 0.0 110.409 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.9 p -76.83 -17.41 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.405 0.682 . . . . 0.0 110.163 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 60' ' ' SER . 20.1 m -73.5 -29.16 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.151 168.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.97 -28.99 57.77 Favored Glycine 0 C--N 1.359 1.827 0 O-C-N 123.524 0.515 . . . . 0.0 112.342 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.08 -39.97 68.59 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.666 0.787 . . . . 0.0 110.299 171.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.52 67.15 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.759 0.824 . . . . 0.0 111.15 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -70.66 -47.53 59.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.225 1.01 . . . . 0.0 109.011 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.56 95.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.119 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -69.83 -35.77 75.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.989 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.12 -46.3 82.77 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.728 0.811 . . . . 0.0 110.914 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.65 -29.61 66.01 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.154 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -62.8 -62.27 1.84 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.879 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.11 -23.14 67.06 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.884 0.873 . . . . 0.0 112.028 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.93 -56.12 20.01 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -99.03 8.05 45.37 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.948 -171.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.77 38.19 85.19 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 121.996 -0.44 . . . . 0.0 113.358 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.4 m -121.52 162.3 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.093 0.957 . . . . 0.0 109.282 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -106.05 129.32 54.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.151 0.58 . . . . 0.0 112.107 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 71' ' ' ALA . 16.2 mm -114.24 160.99 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 166.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.8 m -125.2 104.3 8.43 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 p -87.86 121.85 30.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.889 0.476 . . . . 0.0 110.744 -167.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.96 140.4 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 108.704 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -81.61 133.12 35.34 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 57' ' ' VAL . 37.7 t -65.55 114.86 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.47 0.481 . . . . 0.0 111.392 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -141.45 88.66 2.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.67 -10.77 50.31 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.143 0.577 . . . . 0.0 111.23 -166.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.04 -22.34 36.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.476 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.83 -37.66 10.17 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 110.896 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -171.95 135.54 0.83 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.157 1.383 . . . . 0.0 108.154 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' O ' HD21 ' A' ' 36' ' ' LEU . 1.8 p-10 -135.17 -73.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' A' ' 98' ' ' ILE . 3.7 pt -146.63 120.84 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.441 0.696 . . . . 0.0 110.774 -175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 94' ' ' ALA . 44.2 t -130.34 93.27 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.897 0.479 . . . . 0.0 109.968 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.0 23.76 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.34 -44.03 59.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.409 0.684 . . . . 0.0 109.229 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.406 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -77.34 -34.42 55.22 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.32 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.538 ' NE1' HD22 ' A' ' 34' ' ' LEU . 74.5 m95 -109.05 149.71 28.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.218 0.607 . . . . 0.0 111.379 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HB2' ' N ' ' A' ' 32' ' ' LYS . 45.1 mt-10 -91.74 3.69 54.51 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.835 0.854 . . . . 0.0 111.112 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.33 151.44 16.49 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.645 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.1 mt -128.6 149.12 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.903 0.881 . . . . 0.0 108.853 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -147.66 144.24 19.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 162.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 127' ' ' PHE . 47.4 m -133.24 100.37 4.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.9 mm -70.09 138.96 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.739 1.216 . . . . 0.0 108.705 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -18.18 106.12 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.533 1.933 . . . . 0.0 114.723 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 26.3 p -82.45 106.32 14.23 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.619 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -96.42 97.37 9.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.5 mt -124.67 145.7 50.34 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.709 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.17 152.44 71.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.858 2.372 . . . . 0.0 109.926 167.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.4 m -44.18 -40.0 4.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.769 1.227 . . . . 0.0 113.168 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 34.6 m -51.39 -60.81 2.72 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 124.454 1.096 . . . . 0.0 111.002 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.97 -24.15 38.25 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.864 0.466 . . . . 0.0 111.424 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 114' ' ' TYR . 29.2 ttp180 -75.8 -48.67 20.71 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -68.35 -10.37 54.49 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.582 0.753 . . . . 0.0 112.81 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 108' ' ' SER . 30.1 mm-40 -88.0 -26.97 22.35 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.014 0.37 . . . . 0.0 110.144 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 117' ' ' VAL . 57.6 tp -78.03 -52.87 8.11 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.867 -174.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 110' ' ' ARG . 29.1 m-85 -66.39 -38.04 18.89 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 24.2 Cg_endo -61.54 -29.43 84.6 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.958 1.772 . . . . 0.0 112.514 167.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -81.57 -22.97 37.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.216 1.007 . . . . 0.0 109.799 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.533 HG22 HD11 ' A' ' 90' ' ' ILE . 28.6 t -78.18 -39.65 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.886 0.874 . . . . 0.0 109.211 170.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.59 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 13.3 t80 -54.09 -58.61 6.7 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.817 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.36 -49.54 66.57 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.742 0.817 . . . . 0.0 113.036 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.5 -40.48 32.59 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -165.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 34.1 tp -81.21 115.58 20.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.739 0.815 . . . . 0.0 109.56 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.55 ' HA ' ' HE2' ' A' ' 122' ' ' LYS . 9.0 mmpt? -103.71 159.39 29.46 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.362 1.065 . . . . 0.0 109.363 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.97 113.35 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.623 0 C-N-CA 123.458 2.772 . . . . 0.0 113.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.556 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.94 14.01 2.6 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.733 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.609 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.21 150.46 17.17 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 162.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 31.8 m -110.62 133.85 54.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.373 0 C-N-CA 123.039 0.535 . . . . 0.0 109.57 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 100' ' ' SER . 0.8 OUTLIER -105.79 112.74 25.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 24' ' ' VAL . 50.3 mt -107.01 107.55 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 96.9 mt -121.41 123.26 41.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -106.02 99.31 8.91 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.622 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -79.97 173.87 55.03 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.102 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -139.3 157.04 46.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.46 163.54 24.26 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.185 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.715 ' HA ' HD22 ' A' ' 147' ' ' LEU . 20.7 Cg_endo -61.01 -4.28 3.62 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.847 2.364 . . . . 0.0 115.569 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.4 -12.06 52.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.926 0.49 . . . . 0.0 111.758 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -69.28 -56.94 6.09 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.602 -167.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 150' ' ' LEU . 15.2 mt -62.97 -21.3 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 123.345 0.403 . . . . 0.0 111.187 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.4 -32.85 74.02 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.186 0.994 . . . . 0.0 112.186 172.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.93 7.06 13.12 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.958 0.903 . . . . 0.0 112.411 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 137' ' ' LEU . 66.0 t30 -68.98 153.88 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.167 0.587 . . . . 0.0 112.46 -164.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -79.24 -0.25 31.38 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.285 1.034 . . . . 0.0 111.624 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -151.43 179.05 28.39 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.969 0.319 . . . . 0.0 112.322 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -121.31 94.59 0.54 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.941 -0.921 . . . . 0.0 111.196 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.47 -124.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.024 2.483 . . . . 0.0 111.14 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -129.21 -38.45 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.174 0.897 . . . . 0.0 110.573 178.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -168.96 153.86 5.89 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.487 0.715 . . . . 0.0 109.185 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.715 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -60.52 -3.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.201 1.4 . . . . 0.0 113.591 176.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.81 -39.65 81.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.957 0.903 . . . . 0.0 109.838 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.8 mt -82.71 12.82 4.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.888 0.475 . . . . 0.0 111.937 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 137' ' ' LEU . 25.7 mt -90.88 105.45 12.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.622 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 24.6 Cg_exo -63.56 112.96 1.92 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.123 2.548 . . . . 0.0 112.479 -176.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -95.02 145.83 24.68 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.909 0.884 . . . . 0.0 111.279 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 HD21 ' A' ' 190' ' ' LEU . 41.2 mt -61.03 -51.32 69.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.164 0.586 . . . . 0.0 110.69 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.97 -35.7 47.17 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.533 0.733 . . . . 0.0 112.164 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 m -76.56 -45.87 28.7 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.29 1.036 . . . . 0.0 110.719 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 151' ' ' PRO . 83.2 mt -82.3 -46.49 13.58 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.094 0.958 . . . . 0.0 112.877 -170.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.7 -39.93 62.47 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.515 . . . . 0.0 111.261 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.2 t -70.89 -33.92 71.06 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -96.47 -7.41 34.85 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 118' ' ' TYR . 72.4 mt -139.66 62.69 24.1 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.247 0.619 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.59 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 57.3 Cg_endo -81.62 -3.21 11.82 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.138 2.559 . . . . 0.0 113.082 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.5 p -88.46 -30.13 19.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.893 0.877 . . . . 0.0 109.105 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 tp -93.22 75.7 4.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.825 1.65 . . . . 0.0 111.145 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -44.5 111.87 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 0.0 111.194 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.457 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 54.4 m95 -85.0 129.43 34.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD11 ' HG2' ' A' ' 193' ' ' GLN . 71.8 mt -76.97 -35.66 57.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.572 0.349 . . . . 0.0 110.467 173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.85 123.63 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.71 85.55 1.04 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.11 0.964 . . . . 0.0 108.933 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -148.09 151.09 35.06 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.406 ' HA ' HG22 ' A' ' 188' ' ' ILE . 24.3 t-20 -79.16 103.73 9.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.472 175.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.07 125.25 50.77 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.876 1.271 . . . . 0.0 109.306 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.85 142.44 27.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -145.14 132.84 21.01 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -74.86 139.03 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.437 0.695 . . . . 0.0 109.992 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.0 mt -79.23 169.59 17.91 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.793 1.237 . . . . 0.0 110.14 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.09 -52.33 65.72 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 171.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -172.24 111.61 0.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.112 -1.404 . . . . 0.0 107.592 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 -0.23 3.84 Favored Glycine 0 N--CA 1.475 1.27 0 CA-C-O 119.968 -0.351 . . . . 0.0 113.889 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -159.67 -167.35 1.98 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.352 0.661 . . . . 0.0 110.824 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -118.66 -36.49 3.47 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.891 0.876 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -77.69 -54.79 5.96 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -166.83 116.0 0.87 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.933 0.893 . . . . 0.0 109.248 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -75.44 79.56 1.07 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -99.3 167.64 10.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.291 1.036 . . . . 0.0 110.117 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -150.49 132.47 15.19 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -91.36 125.3 36.07 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -123.92 165.02 18.11 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.43 ' HB ' HD21 ' A' ' 153' ' ' LEU . 6.3 pt -140.88 116.26 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -102.49 145.57 29.38 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.584 0.707 . . . . 0.0 110.395 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.471 HD21 HD22 ' A' ' 153' ' ' LEU . 35.7 mt -131.36 135.62 47.38 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.498 -174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.453 HD22 HG12 ' A' ' 24' ' ' VAL . 43.5 tp -135.46 105.71 6.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.54 139.76 16.81 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.411 ' HG2' HD11 ' A' ' 166' ' ' LEU . 5.6 tp60 -136.87 154.28 50.53 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.879 0.84 . . . . 0.0 111.489 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 22.1 ptmt -55.35 142.83 30.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.2 mt -70.12 99.49 1.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.5 36.76 2.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.561 1.172 . . . . 0.0 108.698 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -167.95 162.5 13.45 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.643 -1.617 . . . . 0.0 108.227 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -78.67 149.31 32.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.562 . . . . 0.0 111.094 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -65.43 95.55 0.21 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 123.326 0.651 . . . . 0.0 109.274 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -144.22 62.61 1.34 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.612 1.196 . . . . 0.0 109.222 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -112.32 23.44 13.64 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 113.836 -1.529 . . . . 0.0 108.527 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 125.83 1.652 . . . . 0.0 107.256 -179.857 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -158.77 140.17 13.27 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.688 0.795 . . . . 0.0 109.018 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -75.98 89.04 2.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.177 0.989 . . . . 0.0 109.819 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -87.77 44.81 1.22 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.071 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -95.18 101.35 13.09 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -151.27 146.61 26.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.605 0.762 . . . . 0.0 110.15 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m -149.9 -65.32 0.21 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.362 1.065 . . . . 0.0 108.335 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 49.93 71.51 0.4 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.019 1.328 . . . . 0.0 111.329 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -149.06 73.45 1.21 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.13 157.21 18.9 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.888 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -158.72 159.78 35.63 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.318 0.58 . . . . 0.0 111.919 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.89 157.7 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.978 1.311 . . . . 0.0 107.487 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -149.18 135.63 19.36 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -165.41 46.03 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.586 0.554 . . . . 0.0 112.879 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.6 t -154.67 14.67 0.43 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.136 0.975 . . . . 0.0 110.472 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.85 95.53 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 125.527 1.531 . . . . 0.0 109.618 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.88 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.915 2.41 . . . . 0.0 114.402 -168.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -96.57 14.98 22.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.412 0.685 . . . . 0.0 109.861 166.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.09 155.27 39.92 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.861 1.664 . . . . 0.0 111.676 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.47 -43.48 26.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.096 0.959 . . . . 0.0 110.799 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 ' ND2' ' A' ' 43' ' ' ASN . 21.3 tp -59.74 -44.77 93.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.606 0.763 . . . . 0.0 111.559 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.8 m -43.56 -34.64 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p -73.47 -50.84 19.5 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.57 0.623 . . . . 0.0 110.329 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 128' ' ' ILE . 1.4 m -59.41 -33.08 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.734 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.35 -36.8 74.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 0.0 111.776 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.3 -26.75 68.62 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.922 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -89.71 -19.87 24.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.959 0.903 . . . . 0.0 111.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 66.7 mt -80.1 135.98 54.23 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 122.972 0.509 . . . . 0.0 109.833 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -58.92 133.27 52.56 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.974 2.45 . . . . 0.0 111.864 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.59 27.17 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.69 -131.76 4.57 Favored Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.767 0.712 . . . . 0.0 111.828 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 67.5 mttm -77.15 113.19 14.62 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.972 0.386 . . . . 0.0 110.074 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 99' ' ' VAL . 21.1 mt -111.68 120.54 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.703 0.801 . . . . 0.0 109.144 -176.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' THR . 36.2 tp -93.4 113.19 25.29 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.632 0.373 . . . . 0.0 110.576 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 54.0 t -108.77 107.66 18.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.17 165.39 9.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.76 0.424 . . . . 0.0 111.519 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -57.87 -25.9 61.37 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.253 0.549 . . . . 0.0 110.429 170.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -68.52 82.33 0.27 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 161.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 101' ' ' ILE . . . 173.67 -156.81 24.72 Favored Glycine 0 C--O 1.241 0.55 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.551 -170.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -148.86 140.36 23.41 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.8 -51.56 52.68 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.56 0.538 . . . . 0.0 113.821 -171.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -69.96 -28.92 65.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.121 0.569 . . . . 0.0 110.792 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' ND2' HD22 ' A' ' 21' ' ' LEU . 24.9 t-20 -64.91 -43.64 92.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.228 1.011 . . . . 0.0 110.363 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.83 -47.05 70.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.708 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.9 m -65.91 -24.67 66.88 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.662 . . . . 0.0 112.459 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.3 t80 -68.66 -39.29 80.73 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.058 0.543 . . . . 0.0 109.716 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.27 -34.32 77.17 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.078 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.55 71.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.96 0.504 . . . . 0.0 111.147 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG11 ' A' ' 76' ' ' VAL . 34.7 t -70.28 -11.28 60.8 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.531 0.732 . . . . 0.0 111.781 174.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 79.1 mt -85.1 5.84 28.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.76 0.424 . . . . 0.0 110.384 170.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.04 27.95 47.55 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 123.173 0.416 . . . . 0.0 113.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -113.62 151.4 31.78 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.27 0.535 . . . . 0.0 109.697 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 40.9 mt-10 -85.36 87.61 7.41 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.25 104.89 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.297 0.57 . . . . 0.0 109.904 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.469 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.1 t -85.54 111.09 19.7 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.834 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.49 121.2 44.14 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.932 0.493 . . . . 0.0 109.873 -172.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 3.7 t -89.31 134.54 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 t70 -152.83 129.23 10.61 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -62.69 -28.38 69.9 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.238 1.015 . . . . 0.0 112.831 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.444 ' OG ' HG22 ' A' ' 62' ' ' VAL . 10.2 t -102.6 123.8 46.98 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -72.38 -19.79 61.56 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.168 0.587 . . . . 0.0 111.042 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' OG ' ' A' ' 60' ' ' SER . 18.9 m -66.65 -32.74 59.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 122.819 0.448 . . . . 0.0 110.685 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.51 -39.84 55.55 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.897 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 80' ' ' THR . 94.5 mt -62.52 -48.52 79.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 110.983 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -57.6 -46.63 83.8 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -69.96 -38.03 75.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.249 0.62 . . . . 0.0 110.641 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.386 0.612 . . . . 0.0 110.541 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -74.05 -29.65 62.01 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.703 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 69.8 mt-30 -61.91 -45.5 93.46 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.13 0.572 . . . . 0.0 110.168 171.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.8 tp -69.52 -26.72 64.66 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 123.882 0.739 . . . . 0.0 110.568 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.44 -62.07 1.92 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.185 173.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -60.24 -37.69 81.17 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.123 0.569 . . . . 0.0 111.036 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -60.42 -45.86 92.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.608 0.763 . . . . 0.0 110.56 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -97.65 8.65 44.28 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.971 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 37.53 77.45 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-N 116.617 -0.265 . . . . 0.0 113.701 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 49' ' ' SER . 29.4 m -130.42 -177.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.914 1.286 . . . . 0.0 109.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -131.18 136.04 47.95 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.746 HG12 ' HB2' ' A' ' 71' ' ' ALA . 25.7 mm -104.87 165.41 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 42.4 m -125.89 104.58 8.39 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 166.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.461 ' HB ' HD22 ' A' ' 64' ' ' LEU . 45.2 p -88.09 124.43 33.77 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.07 -0.394 . . . . 0.0 111.056 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 24.1 t -118.86 138.32 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.923 1.289 . . . . 0.0 108.555 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -86.42 128.28 34.93 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.779 0.718 . . . . 0.0 110.168 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' HG12 ' A' ' 57' ' ' VAL . 47.3 m -63.19 125.21 23.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -143.31 91.4 2.26 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 165.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 28.8 mt -82.01 -8.32 59.66 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.566 0.621 . . . . 0.0 111.642 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.16 11.03 31.5 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.571 1.148 . . . . 0.0 110.681 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -143.65 -44.57 0.28 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.302 0.641 . . . . 0.0 111.553 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -166.91 109.95 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.23 1.412 . . . . 0.0 107.622 -170.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -125.71 -71.8 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.266 0.626 . . . . 0.0 109.531 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 98' ' ' ILE . 27.6 pt -133.94 121.28 38.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.386 0.674 . . . . 0.0 110.763 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.55 84.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.674 0.79 . . . . 0.0 109.31 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.66 0.34 10.93 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.824 0.45 . . . . 0.0 111.835 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.57 -47.58 46.97 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.475 1.11 . . . . 0.0 108.696 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.72 65.34 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.503 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -107.49 -166.06 1.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -125.83 -30.14 3.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.388 0.675 . . . . 0.0 110.568 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.36 166.66 29.08 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 90' ' ' ILE . 62.6 mt -137.55 141.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 9.8 p -129.4 131.96 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 170.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.2 m -143.19 119.82 11.1 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.81 -0.556 . . . . 0.0 109.628 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 11.8 mm -88.93 148.27 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.266 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.697 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 37.1 p90 -16.08 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 126.505 1.922 . . . . 0.0 115.416 -163.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.434 ' SG ' HD21 ' A' ' 129' ' ' LEU . 27.1 p -85.46 107.01 17.22 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.658 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -108.92 96.67 6.48 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 68.9 mt -120.41 148.8 48.44 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.144 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 153.93 28.25 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.095 2.53 . . . . 0.0 111.344 171.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.9 t -49.0 -32.16 8.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.105 0.962 . . . . 0.0 112.076 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 112' ' ' GLN . 33.7 p -58.56 -60.8 3.23 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.455 1.102 . . . . 0.0 111.968 172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.35 -21.59 55.93 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.114 0.566 . . . . 0.0 110.527 -174.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -69.99 -52.77 21.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.749 1.219 . . . . 0.0 108.689 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -64.84 -11.78 41.11 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.178 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 108' ' ' SER . 16.2 mm100 -91.65 -38.44 12.44 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.106 -0.371 . . . . 0.0 110.805 170.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.9 tp -73.23 -50.34 22.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.748 0.419 . . . . 0.0 111.744 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.476 ' CZ ' HD22 ' A' ' 156' ' ' LEU . 39.6 m-85 -68.13 -35.88 8.18 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -54.17 -32.12 68.81 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.017 1.812 . . . . 0.0 113.64 163.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 32.4 mmtp -78.01 -30.71 50.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.462 0.705 . . . . 0.0 110.586 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.553 ' HB ' HD21 ' A' ' 160' ' ' LEU . 3.3 t -78.43 -25.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-O 121.626 0.726 . . . . 0.0 109.643 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -75.66 -64.07 1.16 Allowed 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.893 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -82.07 -50.41 9.11 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.88 51.72 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 116.754 -0.203 . . . . 0.0 113.191 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 125' ' ' GLY . 39.6 tp -69.75 100.42 1.5 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 122.896 0.478 . . . . 0.0 109.735 171.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.655 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 mtpp -66.74 149.3 98.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.027 165.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -42.52 119.21 1.32 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 124.041 3.161 . . . . 0.0 114.93 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.22 12.98 3.33 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.699 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -96.76 141.25 15.51 Favored Glycine 0 C--O 1.241 0.551 0 O-C-N 122.053 -0.675 . . . . 0.0 111.531 165.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 28.1 m -109.16 130.88 61.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.852 0.861 . . . . 0.0 108.903 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.95 111.98 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 24' ' ' VAL . 64.9 mt -103.53 107.91 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 17.1 mt -121.85 114.58 21.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.568 0.747 . . . . 0.0 109.528 -175.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.697 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 28.5 tt0 -105.71 99.38 8.98 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 170.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -83.82 170.38 47.77 Favored Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.211 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.475 ' HB2' HD22 ' A' ' 150' ' ' LEU . 57.2 m-85 -133.17 159.12 41.09 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.946 0.898 . . . . 0.0 108.863 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 135' ' ' GLU . . . -91.43 166.62 17.74 Favored Pre-proline 0 N--CA 1.481 1.075 0 C-N-CA 124.058 0.943 . . . . 0.0 110.126 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.687 ' HA ' HD22 ' A' ' 147' ' ' LEU . 32.3 Cg_endo -61.31 -6.06 6.17 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 123.167 2.578 . . . . 0.0 114.439 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HG2' ' HB3' ' A' ' 133' ' ' ALA . 21.6 pt-20 -82.97 -7.99 59.61 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.709 0.803 . . . . 0.0 111.914 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -68.52 -61.5 1.8 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.185 0.594 . . . . 0.0 111.733 -172.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.451 HD12 ' HG ' ' A' ' 147' ' ' LEU . 16.3 mt -68.75 -17.71 64.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 123.608 0.567 . . . . 0.0 110.231 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -64.57 -46.58 82.14 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.326 0.65 . . . . 0.0 110.509 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -56.31 -53.22 59.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 123.694 0.621 . . . . 0.0 110.358 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -154.7 152.27 29.73 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.6 t -80.27 41.51 0.53 Allowed 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 124.316 1.047 . . . . 0.0 112.087 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.47 48.36 2.19 Favored Glycine 0 C--N 1.363 2.081 0 C-N-CA 123.605 0.622 . . . . 0.0 113.108 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -122.66 137.72 11.43 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 118.8 -1.0 . . . . 0.0 110.646 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.91 -10.51 29.07 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.682 2.255 . . . . 0.0 113.577 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -171.41 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.367 1.334 0 CA-C-N 118.18 0.445 . . . . 0.0 110.386 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -163.13 158.84 22.36 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.279 0.562 . . . . 0.0 109.696 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -56.44 -9.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 125.77 1.628 . . . . 0.0 113.257 173.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -60.01 -33.74 72.41 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.198 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -83.76 1.21 43.94 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.192 0.997 . . . . 0.0 112.038 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 132' ' ' PHE . 71.0 mt -78.92 112.02 24.23 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 156' ' ' LEU . 23.5 Cg_exo -64.74 105.3 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.386 2.724 . . . . 0.0 112.588 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.484 ' HA ' HD11 ' A' ' 188' ' ' ILE . 21.9 ttmm -98.34 146.75 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.802 0.728 . . . . 0.0 111.504 -170.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 188' ' ' ILE . 31.1 mt -61.11 -48.91 79.46 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.36 0.527 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -50.84 -47.51 60.22 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.168 0.917 . . . . 0.0 110.673 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 52.6 m -66.51 -61.94 1.72 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.68 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 151' ' ' PRO . 22.1 mt -73.52 -42.15 62.11 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.331 0.652 . . . . 0.0 112.355 -165.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -62.19 -34.89 77.3 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.604 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 96.1 p -81.21 -22.23 38.98 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.555 0.216 . . . . 0.0 111.027 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.49 -16.83 57.09 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.042 0.537 . . . . 0.0 110.425 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' A' ' 117' ' ' VAL . 86.3 mt -143.5 64.02 13.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.167 0.987 . . . . 0.0 109.026 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -78.63 -9.97 15.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.515 2.143 . . . . 0.0 112.021 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.8 t -88.34 -30.1 19.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 109.317 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.2 tp -88.21 70.86 9.24 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.583 1.153 . . . . 0.0 109.286 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -52.7 127.34 22.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.468 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.44 ' HZ2' ' HB2' ' A' ' 160' ' ' LEU . 42.1 m95 -92.08 126.76 37.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.664 1.186 . . . . 0.0 109.446 -171.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.28 -32.96 74.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.387 0.675 . . . . 0.0 110.086 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 79.8 mt -126.23 124.85 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.22 82.67 1.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.051 0.94 . . . . 0.0 108.573 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -149.89 151.56 33.64 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.458 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.67 114.15 26.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.591 1.156 . . . . 0.0 109.997 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.25 136.79 52.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.807 0.443 . . . . 0.0 110.613 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.96 125.87 34.34 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.039 0.535 . . . . 0.0 110.535 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.591 ' HB2' HD11 ' A' ' 187' ' ' LEU . 30.8 ttm180 -92.99 131.9 37.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.041 0.536 . . . . 0.0 110.101 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -83.8 98.36 9.67 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.401 HD23 ' HG2' ' A' ' 173' ' ' ARG . 81.0 mt -65.53 155.77 34.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.941 0.896 . . . . 0.0 111.228 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.81 -45.55 94.01 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.358 0.663 . . . . 0.0 111.014 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.93 146.67 28.34 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.178 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -89.46 139.32 15.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.913 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -75.47 -77.03 0.13 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -94.72 -55.87 2.97 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -117.97 -71.2 0.75 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -107.73 171.2 7.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.292 0.637 . . . . 0.0 109.603 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -103.38 121.08 6.98 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -107.92 156.47 19.15 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.836 0.854 . . . . 0.0 109.673 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -147.51 133.07 18.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.67 118.28 23.76 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 173' ' ' ARG . 34.8 mt -113.1 157.95 20.98 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' LYS . 11.6 pt -138.25 116.19 12.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -95.39 138.57 32.89 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 110.871 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 51.5 mt -128.35 131.73 48.58 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.119 1.368 . . . . 0.0 108.02 174.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.1 tp -126.34 110.21 13.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -85.22 135.76 13.78 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -142.48 149.76 39.63 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 147.16 52.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.943 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 mt -68.64 153.84 43.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.388 0.675 . . . . 0.0 111.498 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 199' ' ' HIS . 33.7 tt0 66.56 16.53 10.43 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.806 1.242 . . . . 0.0 112.044 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -58.04 -43.96 87.11 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.131 0.572 . . . . 0.0 112.374 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -90.58 -31.05 16.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.786 0.435 . . . . 0.0 111.071 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.498 ' HB3' ' HG3' ' A' ' 196' ' ' GLU . 32.9 t-80 -63.08 -50.97 68.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.981 0.513 . . . . 0.0 110.733 -176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -84.01 151.99 24.68 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 165.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -84.37 125.69 32.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.991 0.516 . . . . 0.0 109.961 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.598 0.759 . . . . 0.0 109.795 177.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.34 -73.01 0.59 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.833 0.453 . . . . 0.0 111.325 -171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -152.83 93.72 1.79 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -94.12 117.63 30.38 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -145.11 120.67 10.4 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -134.15 145.44 49.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.388 0.675 . . . . 0.0 109.497 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.5 p -158.32 159.84 36.34 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.986 0.914 . . . . 0.0 109.811 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -154.56 122.72 5.98 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.698 0.799 . . . . 0.0 109.699 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 m -93.44 85.58 4.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.733 0.813 . . . . 0.0 110.09 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.23 162.35 14.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.32 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -138.01 142.23 40.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.67 0.788 . . . . 0.0 109.627 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 18.26 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 123.557 0.743 . . . . 0.0 110.047 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 76.1 t80 -64.5 140.07 58.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.947 0.499 . . . . 0.0 111.138 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.16 41.67 0.03 OUTLIER Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.411 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.9 t -161.41 157.57 25.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.209 0.504 . . . . 0.0 111.208 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -163.32 84.87 1.37 Allowed Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.17 162.69 34.7 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.762 2.975 . . . . 0.0 114.419 -164.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' HG11 ' A' ' 22' ' ' VAL . 26.6 p-10 -107.28 148.85 28.46 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.469 0.708 . . . . 0.0 110.178 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 22' ' ' VAL . 21.8 t70 -170.78 -179.63 2.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.731 0.812 . . . . 0.0 109.067 -170.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -58.94 -28.68 66.49 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.238 0.615 . . . . 0.0 109.849 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.1 tp -58.16 -43.16 87.25 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.92 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 19' ' ' ASP . 5.0 m -52.45 -36.25 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 m -72.54 -50.47 25.45 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.141 0.577 . . . . 0.0 110.465 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.548 HG12 HD22 ' A' ' 191' ' ' LEU . 7.0 m -66.35 -33.54 64.17 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.106 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.41 83.66 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.359 1.464 . . . . 0.0 112.199 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -63.42 -31.82 73.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.926 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -88.18 -18.65 28.26 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.867 0.867 . . . . 0.0 112.117 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' VAL . 60.5 mt -70.39 137.47 86.38 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.825 0.85 . . . . 0.0 111.061 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.79 128.25 29.54 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.745 2.963 . . . . 0.0 112.46 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -76.59 29.6 0.13 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -119.61 -134.85 4.92 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.881 -0.399 . . . . 0.0 112.243 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 60.8 mttm -84.93 112.73 20.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.526 0.731 . . . . 0.0 109.587 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG22 HG12 ' A' ' 99' ' ' VAL . 3.0 mt -116.13 126.75 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -171.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 90' ' ' ILE . 35.4 tp -96.74 117.68 31.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.445 0.298 . . . . 0.0 110.954 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 44.0 t -100.08 121.44 41.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.691 0.796 . . . . 0.0 110.257 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 89' ' ' ASP . 23.1 mt -101.56 118.98 38.05 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.561 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 49.37 85.01 0.03 OUTLIER 'General case' 0 C--N 1.361 1.067 0 O-C-N 125.448 1.717 . . . . 0.0 112.297 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.1 pt-20 -93.68 -3.66 51.99 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.25 -65.68 3.77 Favored Glycine 0 C--N 1.345 1.031 0 C-N-CA 123.612 0.625 . . . . 0.0 112.124 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.35 151.95 36.74 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.672 1.189 . . . . 0.0 108.135 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.0 1.84 9.74 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -55.08 -32.48 61.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.978 1.711 . . . . 0.0 112.552 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -76.4 -54.98 5.97 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.095 0.558 . . . . 0.0 111.04 -173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.85 39.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 0.0 111.935 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB2' HD23 ' A' ' 70' ' ' LEU . 30.0 p -63.86 -34.8 78.76 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.323 -178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.3 t80 -68.33 -50.43 53.41 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.414 0.446 . . . . 0.0 110.398 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 54' ' ' VAL . 99.3 mt -65.41 -37.38 86.78 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.688 0.617 . . . . 0.0 110.366 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.29 65.1 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.79 0.436 . . . . 0.0 111.592 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.456 ' HA ' HG11 ' A' ' 76' ' ' VAL . 41.8 t -66.36 -13.35 60.48 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.992 0.917 . . . . 0.0 110.933 172.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 31.8 mt -90.75 6.92 42.17 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.541 0.737 . . . . 0.0 111.18 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.49 23.44 58.42 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.202 0.441 . . . . 0.0 114.202 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -100.14 147.56 25.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.66 0.784 . . . . 0.0 110.603 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 41.7 mt-10 -86.79 88.27 7.64 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 47' ' ' LEU . 37.4 t -94.79 106.6 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.07 0.462 . . . . 0.0 111.336 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.489 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.6 p -86.99 103.47 15.38 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . . . -106.06 132.17 52.46 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.967 0.907 . . . . 0.0 111.219 -169.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.1 t -116.54 120.02 63.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -138.05 147.3 43.95 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.06 -27.43 67.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.571 0.749 . . . . 0.0 112.35 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.589 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.7 m -106.79 125.43 50.99 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.057 0.543 . . . . 0.0 110.325 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 m -70.78 -23.72 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.633 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 60' ' ' SER . 29.3 m -63.0 -32.54 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.545 0.738 . . . . 0.0 111.63 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.14 -47.65 29.45 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.95 -51.38 59.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.902 0.881 . . . . 0.0 111.764 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.07 -44.93 75.26 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.178 0.991 . . . . 0.0 113.371 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -72.42 -27.12 62.14 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.006 0.191 . . . . 0.0 111.214 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.15 95.94 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 122.611 0.365 . . . . 0.0 110.129 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 8.2 mtpm? -69.24 -36.24 76.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.303 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -58.58 -46.49 86.81 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.653 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . 16.6 tp -70.21 -22.01 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 123.468 0.48 . . . . 0.0 110.895 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -59.35 -59.71 5.03 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 171.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.25 -37.23 86.73 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 120.831 0.348 . . . . 0.0 111.394 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 70' ' ' LEU . 44.9 tt0 -60.26 -35.49 75.62 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.739 1.216 . . . . 0.0 111.808 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.26 -20.31 14.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.816 0.447 . . . . 0.0 112.152 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.94 49.23 7.16 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 122.116 -0.365 . . . . 0.0 113.305 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.9 m -123.77 -179.29 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 125.342 1.457 . . . . 0.0 108.515 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -126.82 137.64 53.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.7 0.4 . . . . 0.0 111.831 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 71' ' ' ALA . 11.6 mm -112.92 169.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 55' ' ' THR . 58.8 m -139.77 105.15 5.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 163.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -93.91 130.97 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.544 0.687 . . . . 0.0 111.407 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 57' ' ' VAL . 41.8 t -116.12 143.29 26.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.682 1.593 . . . . 0.0 107.503 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -79.95 141.4 36.05 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.1 p -58.49 101.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 124.03 0.831 . . . . 0.0 111.188 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -141.18 92.8 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 80.8 mt -97.68 -21.7 16.87 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.63 0.372 . . . . 0.0 111.775 -170.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.31 -3.46 57.5 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.299 0.639 . . . . 0.0 111.756 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -125.32 -15.87 6.08 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.577 0.751 . . . . 0.0 111.632 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 60.4 t80 -165.15 147.91 8.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.915 1.286 . . . . 0.0 108.211 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.461 ' O ' HD21 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -140.23 -72.71 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.604 1.093 . . . . 0.0 109.054 173.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 117' ' ' VAL . 10.8 pt -145.72 129.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.58 0.752 . . . . 0.0 111.163 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 94' ' ' ALA . 25.4 t -135.1 94.14 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.523 0.729 . . . . 0.0 109.07 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.75 -3.05 10.83 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.539 0.736 . . . . 0.0 112.361 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -83.54 -41.8 17.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.266 0.627 . . . . 0.0 110.452 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -73.02 -34.29 66.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.085 0.554 . . . . 0.0 111.71 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' NE1' HD22 ' A' ' 34' ' ' LEU . 31.8 m95 -107.53 172.63 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.42 -57.67 2.87 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 124' ' ' GLY . . . -116.82 168.38 12.77 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.501 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' HB ' ' A' ' 90' ' ' ILE . 92.1 mt -134.92 131.16 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.562 0.745 . . . . 0.0 108.996 172.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -116.05 104.95 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.1 m -101.78 96.29 6.97 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 HD12 ' A' ' 128' ' ' ILE . 34.4 mm -75.44 149.89 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.015 0.926 . . . . 0.0 110.277 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -17.66 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 127.092 2.157 . . . . 0.0 113.31 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 50.7 t -95.58 127.1 41.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.287 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -128.95 98.73 5.04 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 109' ' ' LEU . 97.1 mt -124.77 138.95 32.26 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.235 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -59.64 160.61 20.24 Favored 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.721 2.281 . . . . 0.0 111.724 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.405 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 38.1 m -53.05 -21.91 5.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.36 1.064 . . . . 0.0 113.812 -172.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t -63.29 -59.08 5.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.308 0.643 . . . . 0.0 111.432 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.498 ' HB3' HD13 ' A' ' 105' ' ' LEU . 29.5 mt -80.29 -21.13 42.95 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.532 0.333 . . . . 0.0 110.597 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 15.8 ttm180 -69.44 -55.77 9.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.467 0.707 . . . . 0.0 110.147 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -28.7 22.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.467 1.107 . . . . 0.0 111.965 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -78.16 -47.61 17.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.9 tp -75.41 -56.75 4.4 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.12 -165.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.448 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 82.9 m-85 -67.87 -38.21 13.84 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -162.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 42.8 Cg_endo -66.45 -24.07 49.9 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 121.7 1.6 . . . . 0.0 112.321 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -84.64 -15.85 44.04 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.678 0.791 . . . . 0.0 109.828 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.572 ' HA ' HD11 ' A' ' 90' ' ' ILE . 29.9 t -78.07 -36.84 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.335 0.588 . . . . 0.0 109.463 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -58.16 -58.1 9.94 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.645 170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -64.63 -37.52 87.86 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.52 -50.05 3.27 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.991 0.357 . . . . 0.0 113.991 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.519 HD13 HD12 ' A' ' 98' ' ' ILE . 55.4 tp -101.54 99.0 9.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.636 1.174 . . . . 0.0 110.753 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.44 172.74 8.13 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 163.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.528 ' HB3' ' H ' ' A' ' 195' ' ' LEU . 39.8 Cg_exo -38.71 130.92 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.276 1.984 . . . . 0.0 110.808 158.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.574 ' O ' ' HA2' ' A' ' 97' ' ' GLY . . . 131.72 -24.19 4.13 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -158.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -133.64 166.93 23.75 Favored Glycine 0 N--CA 1.467 0.701 0 O-C-N 121.953 -0.733 . . . . 0.0 113.691 168.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 18.3 m -108.13 135.57 46.42 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 C-N-CA 124.599 1.16 . . . . 0.0 109.584 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.15 117.21 31.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 24' ' ' VAL . 24.1 mt -112.3 107.93 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.199 1.0 . . . . 0.0 109.439 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 156' ' ' LEU . 84.6 mt -126.64 139.41 53.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.353 0.661 . . . . 0.0 110.985 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -127.0 101.97 6.78 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.92 173.4 43.19 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.455 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -132.61 170.77 14.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.407 1.083 . . . . 0.0 108.748 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.43 172.32 6.09 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.67 1.03 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.056 0 C-N-CA 121.922 1.748 . . . . 0.0 114.686 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.3 -38.96 29.35 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 58.6 tp60 -76.79 -44.73 31.57 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.292 0.496 . . . . 0.0 110.27 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.775 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 9.5 mt -65.99 -11.63 49.26 Favored 'General case' 0 N--CA 1.507 2.413 0 CA-C-N 118.993 0.815 . . . . 0.0 113.091 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -76.05 -19.18 58.83 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 122.72 0.408 . . . . 0.0 109.928 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -90.44 -44.85 9.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.909 0.884 . . . . 0.0 108.892 172.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 137' ' ' LEU . 3.6 m-20 -63.4 124.58 21.65 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.289 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.3 m -104.94 -8.9 18.3 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.286 0.634 . . . . 0.0 109.69 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.5 -132.71 1.42 Allowed Glycine 0 C--N 1.357 1.705 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.88 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.73 -169.79 20.95 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.998 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.2 -167.78 0.42 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.446 2.764 . . . . 0.0 113.106 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.7 mttp 107.99 -1.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 127.934 2.494 . . . . 0.0 109.935 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.552 ' HB2' HD21 ' A' ' 137' ' ' LEU . 39.0 m-20 -110.5 -90.89 0.47 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.775 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 6.8 mp -100.24 10.42 41.27 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.271 0.628 . . . . 0.0 112.567 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.72 -27.07 68.05 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.482 1.134 . . . . 0.0 108.633 157.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.8 mt -88.89 27.28 1.36 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 112.876 -1.965 . . . . 0.0 111.125 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 147' ' ' LEU . 83.6 mt -71.98 115.9 42.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 169.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 156' ' ' LEU . 72.0 Cg_endo -91.15 108.59 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.544 2.163 . . . . 0.0 109.55 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 10.6 mtmp? -96.37 161.39 13.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.712 0.405 . . . . 0.0 111.76 -175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.49 HD21 ' HB ' ' A' ' 188' ' ' ILE . 59.9 mt -56.45 -34.57 66.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.199 1.0 . . . . 0.0 112.551 -170.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.03 -48.72 77.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.243 1.017 . . . . 0.0 109.542 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.1 m -66.02 -49.71 66.78 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.335 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 129' ' ' LEU . 68.3 mt -77.64 -50.74 11.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.917 0.887 . . . . 0.0 112.616 -165.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -61.5 -36.14 79.66 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.759 0.424 . . . . 0.0 111.033 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.0 t -74.24 -26.98 60.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.908 0.483 . . . . 0.0 111.47 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 114' ' ' TYR . 10.2 tp10 -76.82 -21.83 54.5 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.305 0.642 . . . . 0.0 110.392 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.58 69.26 72.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.006 0.922 . . . . 0.0 109.11 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.65 0.36 9.42 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.37 2.713 . . . . 0.0 112.389 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.4 t -92.28 -41.91 10.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.015 0.926 . . . . 0.0 108.666 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.8 tp -83.9 72.03 10.44 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.071 1.748 . . . . 0.0 109.745 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 195' ' ' LEU . 27.6 t-20 -57.11 124.34 18.4 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.78 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.551 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 25.5 m95 -89.11 130.46 35.55 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.284 1.434 . . . . 0.0 109.985 -169.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.09 -37.82 75.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.122 0.569 . . . . 0.0 110.313 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 73.9 mt -126.93 121.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.84 76.51 1.0 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -145.78 153.12 40.57 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -91.33 122.18 33.72 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.821 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.0 mt -102.81 131.58 49.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.81 128.88 34.82 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.684 0.394 . . . . 0.0 110.606 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -100.29 125.82 46.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -80.38 102.7 9.76 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 177' ' ' GLU . 59.2 mt -74.34 132.79 42.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.617 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.3 5.84 13.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.831 0.852 . . . . 0.0 111.899 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.515 ' HG2' ' HB3' ' A' ' 175' ' ' LEU . 15.0 mm-40 -58.87 -54.59 45.39 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.922 0.889 . . . . 0.0 110.631 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.15 48.01 79.38 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.95 10.0 5.71 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.028 0.931 . . . . 0.0 112.374 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 37.1 t80 75.45 -66.2 0.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.181 1.792 . . . . 0.0 110.964 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -75.08 -14.85 60.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.691 0.797 . . . . 0.0 110.949 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.23 139.97 20.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.503 0.721 . . . . 0.0 109.505 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.75 -3.49 0.95 Allowed Glycine 0 C--N 1.344 1.026 0 O-C-N 123.677 0.611 . . . . 0.0 112.874 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.88 -176.47 3.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.512 0.656 . . . . 0.0 111.875 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -148.76 133.03 17.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 109.3 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -84.73 110.36 18.72 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.88 133.69 53.92 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.49 ' HB ' HD21 ' A' ' 153' ' ' LEU . 36.7 pt -123.8 118.78 55.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 118.766 0.712 . . . . 0.0 109.554 -169.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.39 141.42 34.29 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.16 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 153' ' ' LEU . 46.9 mt -129.37 139.78 51.58 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.473 1.109 . . . . 0.0 109.657 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.548 HD22 HG12 ' A' ' 24' ' ' VAL . 42.6 tp -145.41 106.17 4.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 168.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -85.64 146.2 21.41 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -130.0 152.0 49.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.104 0.952 . . . . 0.0 112.236 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.74 112.4 3.69 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.682 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.528 ' H ' ' HB3' ' A' ' 123' ' ' PRO . 3.4 mt -67.45 143.62 56.14 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.88 138.36 57.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 172.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -70.8 84.39 0.65 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.954 0.883 . . . . 0.0 110.908 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -105.66 153.9 21.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 113.867 -1.515 . . . . 0.0 107.735 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -85.69 75.5 10.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 0.0 111.139 -173.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -91.41 87.27 6.37 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 170.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -98.15 174.54 6.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.239 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 69.9 m80 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.451 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -88.76 69.85 8.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.527 0.68 . . . . 0.0 110.937 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -173.28 19.08 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.817 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.27 110.67 3.13 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 123.718 0.807 . . . . 0.0 109.582 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -146.07 60.92 1.25 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.324 1.059 . . . . 0.0 108.958 -170.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -61.94 128.98 38.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.833 -167.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 m 62.73 18.92 11.04 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.526 1.13 . . . . 0.0 112.422 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.341 0.0 OUTLIER 51.03 -59.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 128.191 2.596 . . . . 0.0 116.078 -175.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t 68.44 13.79 9.03 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.674 1.19 . . . . 0.0 111.303 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -96.32 92.59 6.41 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.379 1.072 . . . . 0.0 108.817 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -75.33 82.7 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.449 0.7 . . . . 0.0 110.283 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.7 m -84.24 161.77 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.076 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -128.72 143.78 51.01 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.662 0.785 . . . . 0.0 109.661 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.01 -115.76 0.65 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 171.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -111.36 139.76 46.51 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 117.384 0.592 . . . . 0.0 110.623 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -69.11 126.43 92.75 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.991 0.917 . . . . 0.0 110.163 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.41 162.55 35.92 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.335 2.69 . . . . 0.0 114.138 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -92.17 84.07 5.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.836 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.59 -92.82 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.931 1.292 . . . . 0.0 113.635 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -78.25 -19.48 53.63 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.206 1.003 . . . . 0.0 110.847 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 47' ' ' LEU . 25.3 tp -60.47 -18.05 48.96 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.203 1.001 . . . . 0.0 113.147 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -76.7 -34.86 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.699 0.681 . . . . 0.0 110.589 -168.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p -69.74 -47.94 61.2 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.9 0.88 . . . . 0.0 109.799 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 191' ' ' LEU . 21.6 m -68.43 -41.07 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.718 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.31 72.2 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.634 0.773 . . . . 0.0 112.335 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -73.67 -22.21 60.02 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.123 0.569 . . . . 0.0 110.497 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -90.21 -18.92 24.83 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.354 0.662 . . . . 0.0 110.379 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 24' ' ' VAL . 70.1 mt -72.3 129.04 88.04 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.118 0.567 . . . . 0.0 110.097 174.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.83 153.05 69.06 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.564 2.176 . . . . 0.0 112.41 172.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 51.4 tt0 -68.46 31.1 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.058 1.743 . . . . 0.0 114.654 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -118.64 -156.97 10.31 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.084 -1.01 . . . . 0.0 112.794 -177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -87.88 121.47 30.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.562 0.745 . . . . 0.0 109.045 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 54' ' ' VAL . 4.3 mt -111.77 148.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.649 0.78 . . . . 0.0 109.592 -168.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD22 ' NE1' ' A' ' 95' ' ' TRP . 49.4 tp -106.92 117.28 33.63 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.163 0.438 . . . . 0.0 110.198 171.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 51.1 t -102.98 114.75 29.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.983 0.913 . . . . 0.0 110.072 177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.2 mt -81.29 141.29 34.22 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.75 153.0 37.57 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.614 0.766 . . . . 0.0 110.448 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.57 11.05 8.53 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.555 1.142 . . . . 0.0 109.206 173.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -159.4 -175.17 30.06 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.536 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -63.19 99.85 0.2 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.004 0.522 . . . . 0.0 111.11 -177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.04 73.97 2.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.465 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -69.66 -31.48 69.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.122 0.569 . . . . 0.0 110.061 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.432 HD21 HD13 ' A' ' 21' ' ' LEU . 17.4 t-20 -62.33 -41.95 98.98 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.522 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.66 87.76 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.758 0.823 . . . . 0.0 111.454 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.8 m -60.86 -34.94 75.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.678 174.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -72.57 -32.74 66.27 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.285 0.365 . . . . 0.0 110.484 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.575 HD13 HG11 ' A' ' 99' ' ' VAL . 74.3 mt -67.02 -31.6 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.54 72.21 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.196 0.598 . . . . 0.0 111.253 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.591 ' HA ' HG11 ' A' ' 76' ' ' VAL . 20.1 m -71.99 -4.39 28.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.711 0.804 . . . . 0.0 112.491 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.3 mt -89.28 12.49 15.91 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.332 0.653 . . . . 0.0 110.218 168.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.85 56.27 Favored Glycine 0 C--N 1.357 1.746 0 N-CA-C 114.163 0.425 . . . . 0.0 114.163 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 11.8 m-85 -114.1 152.24 31.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -89.79 91.81 8.78 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 33' ' ' ILE . 92.4 t -91.16 111.94 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.254 -176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 40.4 p -84.22 106.64 16.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.255 1.022 . . . . 0.0 108.314 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.9 129.43 46.75 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.126 0.571 . . . . 0.0 109.935 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG22 ' HB ' ' A' ' 81' ' ' VAL . 8.4 t -111.39 120.21 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' H ' HD21 ' A' ' 64' ' ' LEU . 41.8 t0 -129.7 137.42 50.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 23.3 mt-30 -60.41 -25.84 66.23 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.626 1.204 . . . . 0.0 112.238 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.6 m -97.95 116.18 29.66 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.465 ' HA ' HD12 ' A' ' 64' ' ' LEU . 60.5 p -66.29 -30.69 71.17 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.607 0.718 . . . . 0.0 109.954 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 60' ' ' SER . 26.7 m -61.76 -35.95 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.674 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.95 -32.86 60.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.587 0.554 . . . . 0.0 112.062 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 61' ' ' SER . 86.5 mt -62.58 -43.57 98.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.792 0.837 . . . . 0.0 110.742 173.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.28 94.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.256 0.623 . . . . 0.0 111.708 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -70.19 -30.99 68.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.127 0.571 . . . . 0.0 111.166 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.59 -44.52 90.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.562 0.745 . . . . 0.0 111.036 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.35 -35.18 68.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.684 0.794 . . . . 0.0 110.995 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.08 -47.63 84.55 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.603 0.761 . . . . 0.0 110.246 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.38 -28.46 67.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.826 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.99 -61.52 2.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.276 0.63 . . . . 0.0 111.075 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.66 -29.01 70.0 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.116 0.566 . . . . 0.0 111.005 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -65.1 -43.62 91.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.149 0.58 . . . . 0.0 110.143 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -93.64 -2.73 53.64 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.07 34.48 55.38 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.7 -0.227 . . . . 0.0 113.232 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.5 m -127.45 175.34 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.122 0.969 . . . . 0.0 110.09 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -113.56 131.66 56.01 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.011 0.924 . . . . 0.0 111.103 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.826 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.8 mm -110.75 164.39 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 161.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 88.8 m -131.88 104.59 6.95 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.8 p -86.87 121.6 29.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.859 0.463 . . . . 0.0 110.273 -168.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' HG22 ' A' ' 57' ' ' VAL . 59.6 t -108.62 136.98 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 108.427 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -79.76 128.6 33.62 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 59' ' ' GLN . 80.4 p -59.63 120.21 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.871 0.732 . . . . 0.0 112.326 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.31 85.16 1.95 Allowed 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 161.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.577 ' HB2' HD22 ' A' ' 109' ' ' LEU . 74.4 mt -84.87 -24.86 28.35 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.233 0.613 . . . . 0.0 110.608 -168.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.2 -7.67 32.26 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.062 0.945 . . . . 0.0 111.864 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -132.64 -23.43 2.06 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.564 0.746 . . . . 0.0 111.819 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 81' ' ' VAL . 38.4 t80 -162.32 116.88 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.286 1.034 . . . . 0.0 109.666 -171.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -125.36 -60.11 1.35 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' HB ' HD13 ' A' ' 98' ' ' ILE . 34.4 pt -139.99 131.42 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 118.803 0.729 . . . . 0.0 111.757 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.91 89.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.225 1.01 . . . . 0.0 109.648 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.639 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -70.73 1.01 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.22 -44.27 68.94 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.63 -32.94 64.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.709 0.803 . . . . 0.0 112.566 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.494 ' NE1' HD22 ' A' ' 34' ' ' LEU . 12.7 m95 -109.05 162.69 14.0 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.054 0.542 . . . . 0.0 110.091 -170.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 12.3 tp10 -76.21 -56.86 4.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 171.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.35 171.97 17.33 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 90' ' ' ILE . 74.3 mt -135.89 127.59 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 47' ' ' LEU . 7.8 p -114.55 125.11 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 170.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -124.39 93.37 3.89 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.547 HD13 HD12 ' A' ' 128' ' ' ILE . 35.5 mm -65.34 138.79 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -18.47 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.012 1.725 . . . . 0.0 114.098 -169.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 44.6 t -78.44 111.01 14.03 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.849 -171.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -107.81 98.14 7.77 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.42 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 71.3 mt -124.97 140.47 35.92 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.9 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.86 160.62 45.97 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.921 2.414 . . . . 0.0 110.871 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 m -43.36 -42.41 4.59 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.844 1.258 . . . . 0.0 113.778 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 m -53.57 -55.42 25.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.143 0.977 . . . . 0.0 112.226 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 ' HB2' ' A' ' 85' ' ' LEU . 98.8 mt -83.18 -24.89 32.26 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.404 0.682 . . . . 0.0 111.214 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -77.54 -52.57 8.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.054 0.942 . . . . 0.0 109.841 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.07 -22.42 66.85 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 0.0 112.277 170.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -75.76 -35.26 60.22 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.41 0.684 . . . . 0.0 109.611 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.4 tp -65.78 -52.17 53.07 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.592 0.757 . . . . 0.0 111.052 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -58.44 -44.15 98.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -166.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.28 -31.59 81.95 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.713 1.609 . . . . 0.0 112.003 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -81.94 -15.11 54.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.2 0.6 . . . . 0.0 110.91 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 12.0 t -84.0 -42.87 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -59.26 -59.68 5.08 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.494 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.08 -48.33 44.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.821 0.849 . . . . 0.0 113.095 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.58 -35.23 17.33 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -165.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.8 tp -77.99 95.18 4.76 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.89 0.845 . . . . 0.0 110.351 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.639 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -75.04 150.74 85.91 Favored Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.986 168.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -42.74 117.72 0.97 Allowed 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 124.667 3.578 . . . . 0.0 115.341 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.47 12.46 3.77 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.137 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.68 137.75 13.79 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.3 m -105.85 129.55 58.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.73 0.812 . . . . 0.0 110.458 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.65 112.94 25.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 101' ' ' ILE . 46.6 mt -105.26 109.26 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.59 HD13 HD13 ' A' ' 156' ' ' LEU . 55.7 mt -123.59 134.38 53.82 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.815 0.846 . . . . 0.0 109.741 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -117.57 102.33 9.08 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.532 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -72.37 140.54 29.7 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.914 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 150' ' ' LEU . 69.5 m-85 -111.23 164.02 13.32 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.122 0.487 . . . . 0.0 111.297 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.87 166.72 32.29 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.006 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.569 ' HA ' HD22 ' A' ' 147' ' ' LEU . 49.1 Cg_endo -64.62 -0.68 3.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.495 2.13 . . . . 0.0 112.872 172.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -82.21 -7.85 59.63 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.383 1.473 . . . . 0.0 111.654 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.555 HE21 ' HA3' ' A' ' 142' ' ' GLY . 53.5 tp60 -72.5 -63.49 1.14 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.726 0.41 . . . . 0.0 111.139 -166.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.542 ' HB3' ' HA2' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -88.66 -9.62 51.44 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.493 0.317 . . . . 0.0 110.655 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -62.72 -50.7 70.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -73.66 -17.67 61.12 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 0.0 110.848 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 61.4 t30 67.32 27.44 8.24 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.314 1.445 . . . . 0.0 110.307 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -85.66 -2.38 58.13 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.802 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.555 ' HA3' HE21 ' A' ' 136' ' ' GLN . . . -176.93 82.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 137' ' ' LEU . . . -109.9 106.19 2.12 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 118.836 -0.98 . . . . 0.0 112.253 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.41 -75.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.082 1.854 . . . . 0.0 111.257 173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -137.96 -44.82 0.52 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.233 1.013 . . . . 0.0 109.343 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' C ' HD11 ' A' ' 137' ' ' LEU . 28.3 t70 -156.73 152.4 26.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.67 0.788 . . . . 0.0 109.172 -174.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.1 mt -57.53 -9.72 1.22 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.36 1.464 . . . . 0.0 113.05 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.25 -36.75 68.9 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.463 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.8 mt -83.96 4.13 31.07 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.891 0.876 . . . . 0.0 111.731 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 132' ' ' PHE . 62.5 mt -81.73 112.9 38.42 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 167.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.678 ' HB3' HD11 ' A' ' 156' ' ' LEU . 17.0 Cg_exo -69.35 137.73 37.35 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.292 2.661 . . . . 0.0 113.416 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.519 ' HA ' HD11 ' A' ' 188' ' ' ILE . 44.7 mmtm -118.4 148.36 42.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.514 0.726 . . . . 0.0 112.234 171.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 190' ' ' LEU . 39.9 mt -60.92 -42.33 97.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.295 1.038 . . . . 0.0 110.436 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -51.78 -45.12 63.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.085 0.865 . . . . 0.0 111.256 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.9 m -77.79 -46.29 22.03 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.871 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.678 HD11 ' HB3' ' A' ' 151' ' ' PRO . 89.4 mt -76.5 -46.29 27.29 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.833 0.853 . . . . 0.0 113.28 -170.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.536 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.1 tt0 -54.47 -46.0 73.29 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.773 0.429 . . . . 0.0 110.688 171.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 t -73.03 -22.89 60.56 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.928 0.491 . . . . 0.0 111.769 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -73.51 -30.97 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.42 0.688 . . . . 0.0 110.84 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 87.1 mt -131.61 75.76 76.04 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.69 -11.74 24.17 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.08 2.52 . . . . 0.0 111.549 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.8 p -87.51 -39.44 15.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.937 1.295 . . . . 0.0 108.69 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 21.3 tp -91.52 72.95 5.99 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.075 1.35 . . . . 0.0 110.064 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.23 132.93 55.23 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.536 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 23.4 m95 -94.82 132.33 39.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.509 0.724 . . . . 0.0 109.283 -168.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.84 -30.78 71.05 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.282 0.633 . . . . 0.0 110.337 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.08 127.92 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -146.15 63.42 1.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -108.6 139.17 43.75 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.797 -164.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -96.46 105.91 18.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.078 0.951 . . . . 0.0 109.498 -174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 47.0 mt -97.18 119.34 35.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.555 0.742 . . . . 0.0 110.902 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.13 121.58 21.39 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' A' ' 185' ' ' ALA . 9.1 ttt180 -91.02 142.83 27.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.971 0.509 . . . . 0.0 110.529 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 183' ' ' GLY . 95.3 m-20 -101.69 99.72 10.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.828 0.851 . . . . 0.0 109.171 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 185' ' ' ALA . 46.5 mt -78.01 109.52 12.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.021 0.928 . . . . 0.0 110.395 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -67.23 140.23 57.4 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.05 44.49 5.85 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.544 1.152 . . . . 0.0 110.388 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 129.55 49.1 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.611 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.07 59.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.701 1.2 . . . . 0.0 112.586 -172.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.71 28.77 8.23 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 0.0 109.201 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 8.6 m170 55.88 40.99 30.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.091 0.956 . . . . 0.0 109.904 -165.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -67.55 -63.49 1.05 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.419 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 174' ' ' ASN . . . 63.45 11.61 41.89 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.445 -0.798 . . . . 0.0 114.553 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.8 147.44 50.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 117.845 0.823 . . . . 0.0 112.061 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . . . -156.42 157.25 35.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.437 1.495 . . . . 0.0 108.536 177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.06 121.14 41.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.389 . . . . 0.0 109.956 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 73.0 mt -117.65 166.11 12.79 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 152' ' ' LYS . 10.2 pt -149.28 149.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.029 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -129.7 150.53 50.98 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.535 0.683 . . . . 0.0 111.117 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 153' ' ' LEU . 61.6 mt -130.85 135.2 47.5 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 113.842 -1.526 . . . . 0.0 109.269 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 24' ' ' VAL . 34.4 tp -129.79 104.68 7.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 167.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -89.21 128.62 9.26 Favored Glycine 0 C--O 1.208 -1.48 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -142.38 156.19 45.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.747 0.819 . . . . 0.0 109.663 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -59.71 127.43 31.93 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.428 0.455 . . . . 0.0 109.978 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.8 mt -76.83 96.34 4.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.751 -0.643 . . . . 0.0 110.031 -171.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 45.63 125.32 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.175 1.916 . . . . 0.0 116.175 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -59.85 -27.68 66.86 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.208 0.528 . . . . 0.0 110.386 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -112.44 85.23 2.11 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 167.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -49.27 -60.15 3.07 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.936 1.295 . . . . 0.0 112.519 -168.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -80.2 117.09 20.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -59.35 -22.43 61.3 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.063 0.945 . . . . 0.0 111.996 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 79.6 t60 . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 124.861 1.264 . . . . 0.0 110.886 174.163 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -78.77 140.9 38.18 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -171.8 66.91 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.721 1.208 . . . . 0.0 108.339 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.86 74.81 8.97 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.796 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -110.34 100.97 9.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.036 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.99 128.79 17.3 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -149.34 122.26 8.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.126 0.57 . . . . 0.0 110.114 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -129.75 92.47 3.33 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.012 0.925 . . . . 0.0 108.608 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t -140.06 39.56 1.95 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.534 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.02 42.15 1.07 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.043 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -74.19 107.82 6.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.882 0.873 . . . . 0.0 109.233 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.56 117.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.857 0.863 . . . . 0.0 110.476 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -133.58 120.02 20.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.262 0.625 . . . . 0.0 109.362 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.02 92.91 0.1 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -154.59 147.24 24.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.736 0.815 . . . . 0.0 109.721 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -109.54 102.9 51.49 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 46' ' ' PHE . 30.0 Cg_endo -91.12 -173.08 0.53 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.261 2.641 . . . . 0.0 114.323 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -88.63 143.37 26.98 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.731 165.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 22' ' ' VAL . 6.2 p-10 -70.59 -26.39 63.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.073 0.549 . . . . 0.0 112.228 -171.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -83.31 -23.25 32.67 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HA ' HG22 ' A' ' 24' ' ' VAL . 56.0 tp -74.17 -41.7 61.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.346 0.659 . . . . 0.0 111.413 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 19' ' ' ASP . 15.6 m -45.76 -41.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.3 p -80.5 -51.22 9.05 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.073 0.549 . . . . 0.0 111.091 -174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 128' ' ' ILE . 16.7 m -59.52 -35.53 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.933 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -59.17 -39.53 82.79 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 124.476 1.11 . . . . 0.0 111.734 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.21 -27.95 69.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.636 0.775 . . . . 0.0 110.719 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 193' ' ' GLN . 87.7 mm-40 -90.17 -7.66 53.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.691 0.796 . . . . 0.0 112.634 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' VAL . 68.0 mt -87.41 136.26 33.52 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 123.05 0.54 . . . . 0.0 110.895 177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.01 134.68 43.21 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.778 2.985 . . . . 0.0 113.752 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -77.61 27.89 0.16 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.99 -134.67 5.52 Favored Glycine 0 N--CA 1.475 1.258 0 CA-C-O 119.764 -0.464 . . . . 0.0 112.874 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.98 112.35 18.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.202 0.501 . . . . 0.0 109.734 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG22 HG12 ' A' ' 99' ' ' VAL . 18.6 mt -115.04 129.46 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -170.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 89' ' ' ASP . 66.1 tp -94.37 114.44 26.49 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.716 0.406 . . . . 0.0 110.836 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 36.2 t -94.35 140.13 30.19 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -90.91 173.71 7.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.777 0.322 . . . . 0.0 111.554 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . . . -57.64 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.653 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -91.84 -21.39 20.66 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.973 0.909 . . . . 0.0 109.603 173.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.23 90.58 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.73 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -95.25 -49.37 5.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.117 0.567 . . . . 0.0 110.041 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.79 -28.38 5.46 Favored Glycine 0 CA--C 1.54 1.641 0 O-C-N 123.812 0.695 . . . . 0.0 112.875 -174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -70.65 -35.7 73.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.98 1.312 . . . . 0.0 111.68 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -64.28 -50.18 68.92 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.597 0.56 . . . . 0.0 110.824 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.75 -50.04 69.38 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.208 0.942 . . . . 0.0 111.508 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.717 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 73.5 m -55.93 -49.02 74.64 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.09 0.956 . . . . 0.0 113.513 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 41.4 t80 -58.16 -43.17 87.25 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 123.703 0.627 . . . . 0.0 111.011 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.444 HD13 HG11 ' A' ' 99' ' ' VAL . 60.9 mt -67.92 -32.61 73.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.778 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.06 -33.6 65.76 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.92 0.488 . . . . 0.0 111.448 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.592 ' HA ' HG11 ' A' ' 76' ' ' VAL . 19.3 m -65.47 -15.3 62.51 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.06 0.944 . . . . 0.0 111.738 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.1 mt -82.7 3.11 30.44 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.553 0.741 . . . . 0.0 110.831 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.92 16.81 62.55 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-O 119.798 -0.446 . . . . 0.0 113.928 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -103.09 155.11 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.695 0.748 . . . . 0.0 110.881 -173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.1 87.69 6.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.533 0.733 . . . . 0.0 109.207 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.88 103.18 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HA ' ' A' ' 34' ' ' LEU . 3.3 t -86.01 106.74 17.39 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.928 0.891 . . . . 0.0 109.287 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.56 131.32 53.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.469 0.708 . . . . 0.0 110.438 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -95.46 146.68 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 29.9 t0 -150.14 135.34 17.95 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 163.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.11 -11.1 60.42 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.825 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.3 t -113.65 164.48 13.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.033 0.933 . . . . 0.0 109.268 169.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.9 m -78.2 -26.57 47.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.991 0.516 . . . . 0.0 112.187 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.8 m -56.87 -43.95 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.83 -34.71 62.22 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.203 0.314 . . . . 0.0 112.474 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 94.3 mt -67.86 -59.46 3.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.702 0.801 . . . . 0.0 111.322 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.16 -40.46 73.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.109 0.964 . . . . 0.0 112.934 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.24 -45.58 92.68 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.839 0.855 . . . . 0.0 110.416 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.717 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -64.11 -46.51 83.89 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.92 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -71.76 -35.22 70.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.231 1.012 . . . . 0.0 111.02 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.43 -61.23 2.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.397 0.679 . . . . 0.0 111.152 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.37 -22.6 66.25 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.567 0.542 . . . . 0.0 111.17 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -65.6 -63.63 1.05 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.984 174.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.93 -30.59 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.04 0.536 . . . . 0.0 110.824 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.39 -31.51 71.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.255 1.022 . . . . 0.0 111.474 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -102.25 1.69 36.15 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.116 0.566 . . . . 0.0 111.417 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.48 67.76 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 122.355 -0.216 . . . . 0.0 113.233 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.592 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.7 m -124.08 -179.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 108.182 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -135.78 131.92 36.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.749 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.7 mm -106.96 166.88 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 166.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -129.42 105.75 8.31 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.3 p -85.69 119.83 26.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.092 0.557 . . . . 0.0 110.924 -168.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.9 124.18 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.044 1.337 . . . . 0.0 109.264 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -100.24 91.7 4.86 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 172.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -142.57 -177.6 5.37 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.237 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -146.33 136.91 24.05 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -162.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 14.2 mt -76.19 -8.46 57.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 123.543 0.527 . . . . 0.0 112.389 -166.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -94.77 -0.32 54.3 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.834 0.454 . . . . 0.0 112.144 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -123.42 -44.17 2.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.824 0.449 . . . . 0.0 110.685 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -169.46 124.52 0.83 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.514 ' O ' HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -134.96 -72.41 0.47 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.059 0.944 . . . . 0.0 109.308 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' HB ' HD13 ' A' ' 98' ' ' ILE . 10.7 pt -129.55 122.74 56.0 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 C-N-CA 123.199 0.599 . . . . 0.0 111.616 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.92 94.64 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.698 1.199 . . . . 0.0 108.816 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.25 -0.52 2.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -73.49 -48.05 36.45 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.883 0.473 . . . . 0.0 110.291 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.05 61.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.11 0.564 . . . . 0.0 112.259 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.498 ' CD1' HD22 ' A' ' 34' ' ' LEU . 13.7 m95 -113.17 139.08 49.06 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.009 0.524 . . . . 0.0 109.847 -170.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.97 -40.12 79.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.121 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.33 174.65 29.66 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.025 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.546 HD13 ' HB ' ' A' ' 90' ' ' ILE . 64.3 mt -132.12 140.56 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 6.2 p -124.84 108.48 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.749 0.82 . . . . 0.0 109.1 167.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.493 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 42.7 m -108.89 89.49 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 32.1 mm -70.59 149.83 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.943 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -17.66 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 127.394 2.278 . . . . 0.0 112.61 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 29.8 p -99.78 104.78 16.5 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.848 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -96.57 98.07 9.91 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -116.61 147.83 40.61 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.916 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 149' ' ' LEU . 46.8 Cg_exo -59.05 149.28 80.78 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.282 1.988 . . . . 0.0 110.099 160.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 11.7 t -57.78 -22.72 48.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.421 0.688 . . . . 0.0 112.187 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t -52.87 -55.82 20.39 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.566 0.746 . . . . 0.0 111.363 168.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.9 mt -81.0 -27.47 35.87 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.472 0.709 . . . . 0.0 110.824 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.65 HH11 ' HB3' ' A' ' 151' ' ' PRO . 11.3 ttp180 -68.48 -56.27 8.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.966 0.906 . . . . 0.0 110.334 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -37.52 63.73 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.45 1.1 . . . . 0.0 111.328 170.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 6.2 tp-100 -70.38 -31.9 69.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.107 0.563 . . . . 0.0 110.22 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 117' ' ' VAL . 45.6 tp -76.46 -33.84 58.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.945 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -55.1 -47.33 98.77 Favored Pre-proline 0 CA--C 1.569 1.695 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.79 -29.67 90.5 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.247 1.965 . . . . 0.0 112.672 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -75.26 -31.73 60.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.735 0.814 . . . . 0.0 111.142 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 1.6 t -88.37 -27.23 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.363 0.601 . . . . 0.0 110.735 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.61 -64.61 1.15 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -81.29 -49.76 10.35 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.69 -33.58 63.36 Favored Glycine 0 N--CA 1.479 1.543 0 N-CA-C 113.711 0.245 . . . . 0.0 113.711 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 49.5 tp -78.69 131.22 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.297 0.57 . . . . 0.0 109.791 171.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -114.82 161.71 27.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.797 1.239 . . . . 0.0 107.988 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -36.4 114.72 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 124.305 3.337 . . . . 0.0 115.529 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.543 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.52 -0.85 5.97 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.678 172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -100.3 148.62 18.45 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 166.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.92 131.7 65.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 C-N-CA 124.493 1.117 . . . . 0.0 109.103 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.7 t80 -109.33 109.13 19.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 175.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.569 HD13 HG21 ' A' ' 24' ' ' VAL . 43.8 mt -111.34 108.07 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.298 1.039 . . . . 0.0 108.608 -170.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 95.1 mt -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.774 0.83 . . . . 0.0 111.144 -172.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.4 101.78 4.93 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.8 118.39 6.06 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 168.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.459 ' HA ' HD22 ' A' ' 187' ' ' LEU . 27.1 m-85 -78.83 169.4 18.29 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.415 1.086 . . . . 0.0 109.873 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.15 133.87 39.96 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.584 . . . . 0.0 111.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.83 -17.56 44.21 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.621 2.881 . . . . 0.0 112.337 174.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 138' ' ' GLN . 34.4 tt0 -54.35 -31.02 53.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.825 1.25 . . . . 0.0 111.484 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.718 ' HB3' HD22 ' A' ' 147' ' ' LEU . 61.1 tp60 -60.08 -58.55 8.05 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 123.639 0.587 . . . . 0.0 110.757 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 14.9 mt -57.75 -35.54 70.85 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.245 0.545 . . . . 0.0 111.5 172.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 135' ' ' GLU . 31.8 tt0 -71.54 -15.51 62.29 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.933 -170.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -55.91 -43.62 77.47 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 123.003 0.521 . . . . 0.0 110.901 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.426 HD22 ' H ' ' A' ' 140' ' ' ASN . 0.1 OUTLIER -103.72 169.75 8.33 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 172.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -79.12 2.86 19.36 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.29 133.25 1.55 Allowed Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.791 -0.524 . . . . 0.0 111.791 174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.61 64.32 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.222 -0.765 . . . . 0.0 111.553 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.14 -169.53 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.332 2.688 . . . . 0.0 112.389 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 tptm 90.37 1.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.812 1.245 . . . . 0.0 109.777 171.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -131.32 -90.77 0.43 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 136' ' ' GLN . 4.8 mp -80.65 22.88 0.55 Allowed 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.556 0.946 . . . . 0.0 113.556 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.42 ' N ' HD11 ' A' ' 137' ' ' LEU . 31.3 t70 -85.08 -29.44 24.88 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 164.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 106' ' ' PRO . 13.9 mt -84.69 24.41 1.03 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.045 2.138 . . . . 0.0 111.931 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.626 HD11 ' HB3' ' A' ' 147' ' ' LEU . 95.7 mt -74.99 113.25 22.92 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 123.351 0.407 . . . . 0.0 110.481 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.65 ' HB3' HH11 ' A' ' 110' ' ' ARG . 93.4 Cg_endo -87.01 129.55 2.9 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.258 1.972 . . . . 0.0 111.405 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -81.36 164.37 22.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.718 0.807 . . . . 0.0 111.54 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 188' ' ' ILE . 81.1 mt -60.62 -41.47 94.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.155 0.582 . . . . 0.0 110.478 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.51 -39.49 67.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.398 0.679 . . . . 0.0 111.471 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.4 p -81.48 -53.6 6.14 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.486 0.314 . . . . 0.0 110.732 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -61.63 -50.59 71.92 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.576 1.15 . . . . 0.0 111.93 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -65.48 -30.81 71.63 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.787 0.835 . . . . 0.0 111.702 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 36.6 t -73.19 -29.43 62.82 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 122.812 0.445 . . . . 0.0 111.08 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.03 -10.66 58.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.087 0.555 . . . . 0.0 111.021 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 96.5 mt -141.34 71.03 27.06 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.459 0.704 . . . . 0.0 109.559 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.59 7.38 4.69 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.065 2.51 . . . . 0.0 111.298 170.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.0 t -90.71 -41.17 11.44 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.4 tp -91.82 71.18 5.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.024 1.33 . . . . 0.0 110.626 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB3' HD22 ' A' ' 195' ' ' LEU . 4.0 t-20 -59.89 129.77 43.47 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 190' ' ' LEU . 28.9 m95 -95.54 141.37 29.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.014 0.926 . . . . 0.0 110.765 -164.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.15 -36.81 72.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.172 0.589 . . . . 0.0 110.345 170.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 68.1 mt -126.88 125.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.24 84.26 1.13 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.664 0.785 . . . . 0.0 109.916 176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -155.92 155.59 33.11 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.485 0.314 . . . . 0.0 111.475 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.08 110.98 13.52 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 172.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.8 mt -101.55 130.37 47.83 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.275 0.63 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 146.09 24.07 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -133.75 138.99 46.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.49 0.716 . . . . 0.0 109.666 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.46 117.1 18.59 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.133 0.573 . . . . 0.0 110.552 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.64 170.4 9.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.835 0.854 . . . . 0.0 110.373 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.81 106.52 0.5 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.38 119.97 20.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.13 0.572 . . . . 0.0 109.791 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -66.32 -67.48 1.99 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.24 -72.86 0.03 OUTLIER 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.463 0.705 . . . . 0.0 109.963 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -86.7 -38.26 17.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.147 0.579 . . . . 0.0 110.076 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -71.95 126.2 29.14 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -65.72 140.03 58.42 Favored 'General case' 0 C--O 1.242 0.682 0 O-C-N 124.35 1.031 . . . . 0.0 110.638 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -85.21 63.04 4.42 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.861 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.12 161.75 28.51 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.84 0.856 . . . . 0.0 111.28 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.78 134.37 38.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.429 1.091 . . . . 0.0 109.061 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.18 100.38 12.48 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 132' ' ' PHE . 56.4 mt -116.71 163.86 15.49 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 153' ' ' LEU . 44.4 pt -135.93 139.79 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -132.69 151.28 52.01 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.976 0.893 . . . . 0.0 111.365 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 165' ' ' TRP . 64.5 mt -136.29 138.26 41.55 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 113.329 -1.76 . . . . 0.0 108.791 -177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.514 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -129.71 107.52 9.49 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 168.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.03 139.84 17.26 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 27' ' ' GLN . 8.3 tp-100 -140.32 153.02 46.3 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.438 0.695 . . . . 0.0 109.693 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.543 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 18.1 pttp -58.17 128.43 37.09 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.806 0.691 . . . . 0.0 109.254 170.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 164' ' ' ASN . 4.5 mt -69.6 111.05 5.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -50.04 70.69 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.872 0.733 . . . . 0.0 109.493 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -107.73 112.33 24.95 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 167.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -77.43 76.49 3.97 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -79.39 121.9 25.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.481 -170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -139.48 96.83 3.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 64.88 101.27 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.439 1.496 . . . . 0.0 110.262 -169.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.702 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -85.81 170.33 12.51 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.243 0.617 . . . . 0.0 110.057 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -144.67 144.75 31.39 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.73 0.412 . . . . 0.0 110.196 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.6 71.42 7.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -87.94 150.6 23.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.042 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -163.11 127.51 2.97 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.1 m -129.67 105.07 7.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 108.922 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.05 179.12 4.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.231 0.612 . . . . 0.0 111.512 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -137.55 127.6 25.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.094 0.558 . . . . 0.0 110.341 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -124.21 100.86 6.91 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.981 0.912 . . . . 0.0 109.784 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -151.41 95.27 2.12 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.4 m -91.91 137.31 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.114 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -163.76 147.08 9.98 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 0.0 109.51 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.76 89.08 0.11 Allowed Glycine 0 C--N 1.339 0.703 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 t -62.39 123.54 18.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.534 0.734 . . . . 0.0 110.98 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.05 98.79 40.49 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 124.059 0.944 . . . . 0.0 108.583 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.52 112.4 3.45 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.384 2.056 . . . . 0.0 109.934 174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -51.96 116.97 2.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.187 0.995 . . . . 0.0 111.056 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 22' ' ' VAL . 32.3 t70 -155.88 173.74 16.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.954 0.502 . . . . 0.0 110.867 -167.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 24' ' ' VAL . 43.4 t80 -63.99 -41.04 97.64 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.509 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 24' ' ' VAL . 37.4 tp -62.22 -47.51 84.11 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.806 0.842 . . . . 0.0 112.065 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 19' ' ' ASP . 5.9 m -54.81 -33.67 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -70.39 -50.95 33.42 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.621 0.768 . . . . 0.0 110.903 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.676 HG21 HD11 ' A' ' 128' ' ' ILE . 2.7 m -64.46 -30.13 49.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.911 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.558 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 50' ' ' LEU . . . -59.49 -38.17 80.16 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.625 1.17 . . . . 0.0 111.243 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -70.13 -29.07 65.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.383 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -87.93 -7.23 57.43 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.632 0.773 . . . . 0.0 112.41 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 24' ' ' VAL . 89.9 mt -82.51 123.45 78.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -52.34 133.49 48.32 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.175 2.583 . . . . 0.0 113.131 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -67.1 31.0 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 126.928 2.091 . . . . 0.0 116.138 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.4 -154.34 10.95 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.663 -0.52 . . . . 0.0 112.483 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -74.09 120.65 19.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.128 0.571 . . . . 0.0 110.572 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.1 mt -109.07 135.88 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 0.0 110.07 -167.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 55' ' ' THR . 67.9 tp -110.4 118.26 35.8 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.002 0.521 . . . . 0.0 109.714 171.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 42.3 t -96.58 130.86 43.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.227 1.011 . . . . 0.0 109.462 176.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -95.1 117.56 30.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 164.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.9 163.72 13.59 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.55 0.691 . . . . 0.0 111.012 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.71 21.53 3.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.879 -175.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.19 134.9 7.43 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 76.37 -47.77 0.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.851 1.661 . . . . 0.0 112.988 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 32.63 84.84 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 113.341 0.096 . . . . 0.0 113.341 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -60.6 -34.37 74.11 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.679 0.752 . . . . 0.0 109.903 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.0 p30 -56.15 -48.08 76.97 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.163 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.3 93.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.748 0.819 . . . . 0.0 111.324 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.571 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 14.4 m -61.79 -42.27 98.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.668 0.787 . . . . 0.0 112.465 176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -64.61 -44.74 89.6 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.791 0.682 . . . . 0.0 109.876 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 43' ' ' ASN . 81.2 mt -67.51 -32.7 73.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 -34.39 67.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.174 0.59 . . . . 0.0 111.59 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.749 ' HA ' HG11 ' A' ' 76' ' ' VAL . 28.4 t -68.71 -9.93 53.39 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.831 0.852 . . . . 0.0 111.7 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 25' ' ' ALA . 85.4 mt -78.54 6.73 7.99 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.329 0.652 . . . . 0.0 111.105 170.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.52 27.69 26.6 Favored Glycine 0 C--N 1.359 1.808 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.962 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -130.52 163.05 27.9 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.492 0.646 . . . . 0.0 111.016 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.97 93.06 6.39 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.61 112.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.7 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 34' ' ' LEU . 57.6 m -86.09 108.84 18.46 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.053 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.4 130.14 47.55 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.957 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.2 t -102.6 116.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' H ' HD21 ' A' ' 64' ' ' LEU . 14.0 t0 -123.17 124.87 44.01 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.08 -25.71 46.58 Favored 'General case' 0 CA--C 1.562 1.41 0 O-C-N 124.593 1.183 . . . . 0.0 111.678 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.7 t -112.31 121.64 45.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.404 1.082 . . . . 0.0 108.786 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HA ' HD12 ' A' ' 64' ' ' LEU . 34.8 p -69.03 -15.28 63.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 112.406 -173.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.5 m -56.48 -44.25 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 O-C-N 123.434 0.459 . . . . 0.0 110.82 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.86 -30.08 66.36 Favored Glycine 0 C--N 1.358 1.792 0 O-C-N 123.654 0.596 . . . . 0.0 113.036 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 91.1 mt -64.85 -45.96 83.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.749 0.82 . . . . 0.0 110.695 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' GLN . . . -62.6 -39.42 93.72 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.593 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 73.4 mmtt -64.98 -43.44 92.59 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.715 0.406 . . . . 0.0 109.914 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.571 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -57.62 -40.68 79.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -70.6 -36.42 73.52 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.68 0.792 . . . . 0.0 111.488 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 65' ' ' ALA . 26.4 mt-30 -57.6 -58.27 9.04 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.594 0.757 . . . . 0.0 111.718 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 38.2 tp -67.41 -24.94 65.71 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.213 -176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.35 7.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.481 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.39 -27.82 68.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.832 0.453 . . . . 0.0 111.108 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.35 -44.42 92.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.279 1.032 . . . . 0.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 6.19 46.48 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.659 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.52 39.28 50.35 Favored Glycine 0 C--N 1.356 1.65 0 N-CA-C 113.936 0.334 . . . . 0.0 113.936 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.749 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.7 m -136.31 175.45 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.117 0.967 . . . . 0.0 109.524 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -129.52 142.67 50.71 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.025 0.44 . . . . 0.0 112.131 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 45' ' ' CYS . 17.7 mm -105.53 169.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 125.13 1.372 . . . . 0.0 107.43 170.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 m -121.47 105.87 10.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 164.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' LEU . 70.0 p -93.05 111.16 22.7 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.224 0.61 . . . . 0.0 110.655 -165.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.9 t -108.64 124.81 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.6 1.16 . . . . 0.0 110.082 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.51 95.28 6.61 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 m -144.34 -174.66 4.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.848 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -144.87 127.52 16.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -158.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 105' ' ' LEU . 26.5 mt -68.81 -6.06 24.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.151 0.58 . . . . 0.0 112.542 -172.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 112' ' ' GLN . . . -96.9 9.98 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.267 1.027 . . . . 0.0 112.6 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.9 -46.44 0.27 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.207 0.603 . . . . 0.0 110.379 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -155.37 122.87 5.59 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 125.983 1.713 . . . . 0.0 106.594 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 1.9 p-10 -135.39 -71.8 0.47 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 117' ' ' VAL . 14.5 pt -143.25 123.01 9.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.497 0.719 . . . . 0.0 109.904 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.92 84.91 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.18 -5.97 15.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -171.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.91 -39.27 93.79 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.562 0.745 . . . . 0.0 109.111 170.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.99 -20.46 24.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.029 0.932 . . . . 0.0 111.9 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CD1' HD22 ' A' ' 34' ' ' LEU . 51.9 m95 -121.7 114.08 20.62 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 0.0 109.946 -170.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.2 -43.83 81.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.584 0.754 . . . . 0.0 110.337 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.16 151.3 18.24 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.042 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 121' ' ' LEU . 73.1 mt -132.07 148.17 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 173.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.4 p -135.49 120.79 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.246 1.018 . . . . 0.0 108.417 169.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.4 m -108.69 93.23 4.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.639 HD13 HD12 ' A' ' 128' ' ' ILE . 23.3 mm -70.44 140.48 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.829 0.852 . . . . 0.0 109.512 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -14.0 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 127.03 2.132 . . . . 0.0 113.691 -171.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.77 107.1 19.46 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.923 -1.49 . . . . 0.0 109.25 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -105.5 101.15 10.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.484 HD11 HD12 ' A' ' 85' ' ' LEU . 82.4 mt -121.35 138.8 28.63 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.47 163.53 35.92 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.158 2.572 . . . . 0.0 110.717 171.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -35.98 -43.46 0.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 126.105 1.762 . . . . 0.0 114.875 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.8 p -57.0 -56.49 21.1 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.641 0.776 . . . . 0.0 110.957 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 94.1 mt -84.39 -22.85 30.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.768 0.827 . . . . 0.0 110.555 -172.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -73.51 -61.26 1.89 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.956 0.903 . . . . 0.0 109.656 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.82 -9.62 15.82 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.226 0.611 . . . . 0.0 112.159 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 24.6 tp60 -87.43 -37.77 16.71 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.673 0.389 . . . . 0.0 110.748 170.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 117' ' ' VAL . 62.7 tp -85.56 -61.27 1.8 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 115' ' ' PRO . 77.6 m-85 -68.48 -39.57 16.09 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -160.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 114' ' ' TYR . 45.9 Cg_endo -66.35 -23.96 50.78 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 121.908 1.738 . . . . 0.0 111.894 170.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -83.12 -19.74 36.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.955 0.902 . . . . 0.0 109.286 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 127' ' ' PHE . 39.1 t -77.0 -38.81 28.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 171.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -49.67 -57.83 6.46 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 120.998 0.428 . . . . 0.0 111.003 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.5 -46.81 62.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.093 0.957 . . . . 0.0 113.004 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.04 -37.65 28.5 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 114.822 0.689 . . . . 0.0 114.822 -166.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -77.1 109.62 11.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 109.109 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -79.79 163.83 56.36 Favored Pre-proline 0 C--O 1.247 0.931 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.98 115.41 0.87 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.72 2.28 . . . . 0.0 113.542 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.571 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 127.6 12.87 2.92 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.943 172.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -107.91 148.91 16.71 Favored Glycine 0 C--O 1.244 0.77 0 CA-C-N 117.482 0.641 . . . . 0.0 112.508 166.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.4 139.5 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.126 0.97 . . . . 0.0 109.024 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.49 121.07 41.6 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.676 HD11 HG21 ' A' ' 24' ' ' VAL . 55.1 mt -110.91 109.04 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.758 0.823 . . . . 0.0 109.201 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 156' ' ' LEU . 47.5 mt -125.8 144.0 50.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.933 0.893 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -132.23 102.5 5.8 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.94 -173.37 46.58 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.566 ' HB2' HD22 ' A' ' 150' ' ' LEU . 71.5 m-85 -135.31 158.98 43.0 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.0 161.91 56.41 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.594 0.758 . . . . 0.0 111.648 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.03 -24.05 71.61 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.159 2.572 . . . . 0.0 113.431 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.39 -14.25 57.38 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.516 -0.766 . . . . 0.0 113.053 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 132' ' ' PHE . 9.1 tp-100 -70.91 -60.66 2.11 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -169.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 3.7 mt -75.32 -8.6 57.09 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.127 0.489 . . . . 0.0 110.071 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.65 -17.01 61.2 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.563 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -61.17 -54.62 42.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -170.54 -162.07 0.27 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -75.72 3.48 9.69 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.843 1.202 . . . . 0.0 112.191 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.18 98.7 0.06 OUTLIER Glycine 0 C--N 1.358 1.78 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 171.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.73 -170.99 39.26 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -166.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.96 -57.47 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.91 2.407 . . . . 0.0 111.04 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.0 mmmm -157.42 -44.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.727 1.211 . . . . 0.0 109.594 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -167.92 152.3 6.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.586 0.755 . . . . 0.0 109.509 -166.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 1.0 OUTLIER -61.09 -6.79 2.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -168.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.91 -36.85 78.51 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.065 0.46 . . . . 0.0 110.346 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.37 12.04 1.36 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.02 0.928 . . . . 0.0 113.048 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.566 HD22 ' HB2' ' A' ' 132' ' ' PHE . 48.1 mt -88.38 110.59 37.56 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.599 ' HB2' HD11 ' A' ' 156' ' ' LEU . 5.1 Cg_exo -76.41 104.28 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.581 2.187 . . . . 0.0 109.387 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 188' ' ' ILE . 53.6 mtpt -94.93 160.24 14.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.171 0.588 . . . . 0.0 111.287 -171.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 HD21 ' A' ' 190' ' ' LEU . 71.9 mt -53.26 -37.57 62.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.911 0.884 . . . . 0.0 110.929 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.06 -54.36 20.87 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.057 1.343 . . . . 0.0 111.74 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -76.24 -45.93 30.53 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.306 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.645 HD13 HD13 ' A' ' 129' ' ' LEU . 82.7 mt -71.38 -49.73 39.17 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.714 0.806 . . . . 0.0 112.411 -168.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -58.75 -37.69 76.8 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.922 0.489 . . . . 0.0 111.637 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.0 t -76.62 -17.58 59.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.294 0.238 . . . . 0.0 111.421 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.99 -5.54 55.24 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.644 0.378 . . . . 0.0 110.619 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 39.3 mt -145.71 59.1 5.42 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.488 1.115 . . . . 0.0 108.532 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.04 -26.34 21.7 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.06 2.507 . . . . 0.0 112.731 -171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -90.24 -14.41 33.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.485 0.714 . . . . 0.0 110.209 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 17.7 tp -89.75 69.28 7.64 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 124.596 1.158 . . . . 0.0 108.628 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.568 ' HB3' HD21 ' A' ' 195' ' ' LEU . 28.2 t30 -61.93 124.62 21.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -88.68 143.53 26.87 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.429 1.091 . . . . 0.0 109.594 -165.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.14 -39.07 72.18 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.172 0.589 . . . . 0.0 109.976 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 75.6 mt -129.14 119.08 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.73 86.05 1.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.747 0.819 . . . . 0.0 109.328 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -160.19 157.96 29.25 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 188' ' ' ILE . 26.0 p-10 -75.35 104.93 6.12 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 26.9 mt -102.04 135.44 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 159.02 18.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.651 0.263 . . . . 0.0 110.753 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -141.88 134.78 28.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -69.32 114.85 7.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.671 0.788 . . . . 0.0 110.5 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 59.6 mt -82.43 167.44 18.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.465 0.706 . . . . 0.0 109.601 168.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.14 -19.9 19.03 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 160.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -76.66 124.64 27.95 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.032 0.933 . . . . 0.0 110.709 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 182' ' ' GLN . . . -87.5 67.52 3.26 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.43 -148.38 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.214 1.006 . . . . 0.0 110.867 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -51.58 -43.09 62.32 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.584 0.754 . . . . 0.0 109.393 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -104.26 120.28 40.82 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 178' ' ' GLY . 35.8 tt0 -67.66 103.56 1.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.561 0.745 . . . . 0.0 110.968 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.09 18.61 62.74 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.435 -0.802 . . . . 0.0 114.517 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -130.9 146.97 52.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.427 0.691 . . . . 0.0 109.419 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.52 140.58 44.87 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.841 0.856 . . . . 0.0 110.137 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.48 114.8 28.69 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 33.5 mt -126.56 174.88 8.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 152' ' ' LYS . 23.8 pt -139.23 139.05 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -127.22 149.94 49.76 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.783 0.802 . . . . 0.0 110.804 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 67.7 mt -133.57 136.53 45.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.648 -1.614 . . . . 0.0 109.395 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.478 HD22 HG12 ' A' ' 24' ' ' VAL . 27.9 tp -137.25 108.26 6.73 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.7 147.39 22.02 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -142.55 150.88 40.99 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.551 0.74 . . . . 0.0 110.127 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 13.1 ptmm? -59.96 143.08 52.57 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 164' ' ' ASN . 9.8 mt -88.56 161.44 16.95 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' HB2' ' NZ ' ' A' ' 194' ' ' LYS . 22.5 tt0 -157.29 55.32 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.283 1.04 . . . . 0.0 109.895 173.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -143.5 38.69 1.38 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -65.66 170.46 5.13 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.329 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 67.49 81.19 0.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.163 1.385 . . . . 0.0 111.208 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -103.22 174.47 5.85 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 165.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -80.01 151.32 30.04 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.737 0.415 . . . . 0.0 110.848 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 36.9 m80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.856 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -62.13 127.04 29.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.055 0.542 . . . . 0.0 110.693 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -91.68 143.98 25.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.622 0.769 . . . . 0.0 112.098 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -140.11 80.65 1.77 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.044 1.338 . . . . 0.0 108.54 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -73.12 137.69 45.34 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.575 0.75 . . . . 0.0 109.866 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -146.4 137.98 24.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.252 0.621 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -150.67 107.62 3.56 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -78.71 86.85 4.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.457 0.703 . . . . 0.0 110.675 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -82.89 69.62 9.73 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.008 0.908 . . . . 0.0 109.265 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.6 7.74 19.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.397 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.09 136.34 34.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.976 0.91 . . . . 0.0 109.379 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.87 64.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.926 0.869 . . . . 0.0 109.03 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -87.3 71.88 9.92 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.095 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.0 24.22 0.08 OUTLIER Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.239 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.9 p -70.77 101.84 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.68 0.792 . . . . 0.0 110.082 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.79 123.92 66.66 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 123.571 0.748 . . . . 0.0 110.028 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.34 -168.24 0.42 Allowed 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.862 2.375 . . . . 0.0 111.478 166.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -113.31 121.75 45.35 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.64 0.776 . . . . 0.0 110.125 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -176.95 -177.84 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.579 1.152 . . . . 0.0 108.519 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.86 -34.99 20.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 165.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.627 HD21 ' HG ' ' A' ' 47' ' ' LEU . 24.3 tp -62.78 -47.01 85.33 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.553 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -45.68 -33.78 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.6 t -68.76 -51.5 40.53 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.34 0.656 . . . . 0.0 110.135 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 128' ' ' ILE . 2.5 m -62.4 -32.9 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.466 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.75 74.53 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.519 1.128 . . . . 0.0 112.534 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.58 -21.53 61.13 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.306 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.705 ' HB3' HE21 ' A' ' 193' ' ' GLN . 84.1 mm-40 -84.1 -23.4 30.76 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.392 0.677 . . . . 0.0 111.207 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 24' ' ' VAL . 63.2 mt -82.23 135.22 47.72 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -52.99 145.61 40.63 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.82 2.347 . . . . 0.0 112.043 168.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -65.5 29.81 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 96' ' ' GLU . . . -115.6 -167.39 15.12 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 118.999 0.818 . . . . 0.0 111.818 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -73.36 127.7 33.4 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.852 0.358 . . . . 0.0 110.309 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.492 HG22 HG12 ' A' ' 99' ' ' VAL . 5.2 mt -113.77 135.93 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.439 -168.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.515 HD22 ' CD1' ' A' ' 95' ' ' TRP . 54.2 tp -98.76 119.99 38.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 6.8 p -110.83 118.64 36.68 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.768 0.827 . . . . 0.0 109.983 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD11 HG23 ' A' ' 90' ' ' ILE . 58.2 mt -78.27 135.98 37.66 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.692 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 168.91 23.66 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.417 1.087 . . . . 0.0 108.808 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 10.76 0.97 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.965 0.506 . . . . 0.0 111.652 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.39 -31.85 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 C-N-CA 121.944 -0.169 . . . . 0.0 113.276 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.89 151.75 20.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.996 0.918 . . . . 0.0 110.171 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.17 65.26 0.31 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 113.366 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -69.68 -42.64 73.87 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.526 0.73 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD13 ' A' ' 21' ' ' LEU . 14.3 m120 -73.07 -32.76 65.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.203 0.601 . . . . 0.0 110.367 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' HB1' ' SG ' ' A' ' 35' ' ' CYS . . . -58.01 -51.8 68.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.668 0.787 . . . . 0.0 110.569 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.642 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 31.0 m -65.9 -32.89 74.65 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.575 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 38.2 t80 -67.81 -32.14 72.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.224 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.627 ' HG ' HD21 ' A' ' 21' ' ' LEU . 37.0 mt -65.84 -33.53 76.05 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.309 0.644 . . . . 0.0 110.531 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.75 -33.29 70.65 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.862 0.363 . . . . 0.0 110.896 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.63 ' HA ' HG11 ' A' ' 76' ' ' VAL . 35.6 t -65.75 -18.23 65.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.654 0.782 . . . . 0.0 111.579 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 47' ' ' LEU . 55.9 mt -89.15 18.93 4.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.914 0.885 . . . . 0.0 110.794 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.88 19.61 78.68 Favored Glycine 0 C--N 1.362 1.974 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -104.06 148.42 26.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.092 0.557 . . . . 0.0 109.941 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -88.56 88.98 7.8 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.8 t -94.59 109.94 22.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.611 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 79' ' ' THR . 69.6 p -84.31 112.62 20.48 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.312 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.594 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -106.43 111.65 24.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.834 0.854 . . . . 0.0 111.047 -172.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.49 HG23 HD11 ' A' ' 34' ' ' LEU . 22.3 t -81.24 126.82 39.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.35 119.58 11.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.46 -18.18 65.12 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.617 0.573 . . . . 0.0 111.957 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' ' 62' ' ' VAL . 19.1 m -97.45 130.39 44.56 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.7 p -65.59 -27.71 68.61 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 18.4 m -63.27 -41.0 91.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.3 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.54 -40.81 94.33 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.647 0.592 . . . . 0.0 112.328 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.5 -42.16 83.3 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.537 0.735 . . . . 0.0 111.287 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.22 90.73 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.782 0.833 . . . . 0.0 112.328 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 2.8 mmmp? -65.85 -41.97 91.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.845 0.458 . . . . 0.0 110.134 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -61.0 -55.4 33.29 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.607 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.37 -23.41 50.81 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -61.69 -44.52 96.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' A' ' 45' ' ' CYS . 35.2 tp -69.11 -24.25 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.651 0.594 . . . . 0.0 111.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.14 -51.63 68.25 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.484 0.659 . . . . 0.0 109.434 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -72.58 -30.29 64.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.005 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.22 -53.62 10.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.598 0.759 . . . . 0.0 110.804 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -93.36 -1.4 55.95 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.5 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.62 38.77 78.43 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.846 -0.161 . . . . 0.0 113.299 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -112.97 173.99 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.734 0.814 . . . . 0.0 109.849 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -111.65 121.1 44.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.15 0.58 . . . . 0.0 111.152 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 71' ' ' ALA . 19.2 mm -107.26 163.41 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 164.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 55' ' ' THR . 29.7 m -133.59 106.13 7.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 165.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.1 p -87.04 112.85 22.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.436 0.694 . . . . 0.0 111.083 -166.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.13 126.41 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.013 1.325 . . . . 0.0 109.303 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -104.77 92.34 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -134.21 -176.83 4.33 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.004 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -141.14 110.1 6.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.734 -1.121 . . . . 0.0 107.999 -158.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 105' ' ' LEU . 17.7 mt -65.87 -7.69 17.84 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.507 1.123 . . . . 0.0 111.733 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.649 ' HA ' HE22 ' A' ' 112' ' ' GLN . . . -57.97 -41.91 83.93 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.325 1.05 . . . . 0.0 112.218 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -151.67 12.36 0.61 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.27 110.24 1.58 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.438 ' O ' HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -138.26 -73.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.493 HG23 HD11 ' A' ' 36' ' ' LEU . 17.7 pt -119.72 117.79 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.49 87.05 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.405 0.682 . . . . 0.0 109.537 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.57 -30.04 4.89 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.231 1.413 . . . . 0.0 114.153 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.51 -46.11 80.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.431 0.692 . . . . 0.0 109.272 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.35 -25.71 51.33 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.515 ' CD1' HD22 ' A' ' 34' ' ' LEU . 47.9 m95 -117.5 166.32 12.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -169.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HG2' ' HA3' ' A' ' 31' ' ' GLY . 11.3 tp10 -94.07 -74.63 0.53 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.855 0.862 . . . . 0.0 109.836 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.87 162.11 17.46 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.495 HD12 HD12 ' A' ' 121' ' ' LEU . 54.1 mt -128.7 147.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 33' ' ' ILE . 7.2 p -139.24 141.31 36.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.893 1.277 . . . . 0.0 107.87 167.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB3' ' SG ' ' A' ' 103' ' ' CYS . 50.5 m -136.97 92.31 2.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 128' ' ' ILE . 40.7 mm -62.28 133.51 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' HA ' HD23 ' A' ' 129' ' ' LEU . 14.6 p90 -20.93 102.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 126.123 2.139 . . . . 0.0 114.148 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 71.0 m -77.95 103.42 7.88 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 112.844 -1.98 . . . . 0.0 109.058 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -91.09 96.94 10.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 85' ' ' LEU . 86.8 mt -125.65 142.33 41.7 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.201 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -63.01 159.88 36.48 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.534 2.156 . . . . 0.0 110.707 170.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 45.3 p -41.87 -43.14 2.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.5 1.52 . . . . 0.0 113.668 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -55.77 -50.93 69.1 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.209 0.943 . . . . 0.0 112.172 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.7 mt -80.92 -33.94 33.74 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.284 0.634 . . . . 0.0 111.714 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.42 -43.63 31.88 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.583 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.44 -35.0 18.1 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.693 0.797 . . . . 0.0 111.967 165.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.649 HE22 ' HA ' ' A' ' 86' ' ' ALA . 24.9 tt0 -79.47 -33.03 42.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.64 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 117' ' ' VAL . 48.1 tp -71.21 -48.61 50.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.891 0.476 . . . . 0.0 111.581 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -60.93 -42.77 88.67 Favored Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -167.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.43 -25.45 48.61 Favored 'Trans proline' 0 C--N 1.396 3.076 0 CA-C-N 121.364 1.523 . . . . 0.0 111.984 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -81.7 -21.17 38.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 122.995 0.518 . . . . 0.0 110.357 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 113' ' ' LEU . 19.3 t -85.03 -35.74 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 161' ' ' PRO . 42.4 t80 -48.9 -61.6 1.96 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.125 0.97 . . . . 0.0 112.256 -176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.425 ' HG3' ' HD1' ' A' ' 118' ' ' TYR . 47.9 mt-30 -95.46 -22.3 17.77 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 172.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -83.21 -23.86 53.49 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD12 HD12 ' A' ' 98' ' ' ILE . 39.7 tp -61.05 124.89 21.81 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.394 0.678 . . . . 0.0 110.884 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -67.11 133.11 93.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -46.65 106.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.596 2.197 . . . . 0.0 112.297 168.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.16 14.76 8.17 Favored Glycine 0 C--O 1.248 1.005 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.433 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -95.87 135.56 12.39 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.5 m -109.4 130.4 62.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.002 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.17 111.59 24.08 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 24' ' ' VAL . 58.1 mt -106.98 108.27 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 102' ' ' PHE . 69.8 mt -124.25 117.49 24.68 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.423 0.689 . . . . 0.0 109.381 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -99.55 98.71 9.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 170.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.61 169.16 53.26 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.905 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.439 ' HD1' HD22 ' A' ' 187' ' ' LEU . 7.7 m-85 -133.06 156.02 48.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.0 171.75 4.15 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.898 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.652 ' HA ' HD22 ' A' ' 147' ' ' LEU . 90.7 Cg_exo -45.27 -21.29 0.64 Allowed 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 124.169 3.246 . . . . 0.0 116.247 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -76.54 -6.67 52.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.134 0.974 . . . . 0.0 111.915 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.409 ' O ' HG22 ' A' ' 141' ' ' THR . 8.6 tp-100 -76.34 -63.61 1.29 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -173.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.89 -11.92 59.88 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.404 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -63.62 -39.74 95.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.173 0.989 . . . . 0.0 111.78 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.72 11.85 8.3 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.237 0.615 . . . . 0.0 111.085 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.5 p30 42.84 43.93 3.66 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 126.358 1.863 . . . . 0.0 113.485 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 136' ' ' GLN . 15.1 t -89.48 3.22 53.07 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.003 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.46 159.08 20.84 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.35 74.77 0.08 OUTLIER Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.04 -19.12 45.91 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.973 2.449 . . . . 0.0 112.559 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -163.12 -60.27 0.04 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.915 0.886 . . . . 0.0 108.764 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -177.2 166.08 2.33 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.288 -171.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.692 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -60.64 -2.29 0.5 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.977 1.311 . . . . 0.0 112.435 173.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.71 -33.33 72.73 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.905 1.282 . . . . 0.0 111.34 168.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.5 1.79 44.05 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.478 0.711 . . . . 0.0 112.685 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.692 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 29.0 mt -86.89 102.81 3.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.882 ' HB2' HD11 ' A' ' 156' ' ' LEU . 93.1 Cg_endo -75.69 123.68 7.66 Favored 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.858 2.372 . . . . 0.0 112.618 -168.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -102.78 151.37 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.795 0.838 . . . . 0.0 111.839 -168.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 190' ' ' LEU . 32.5 mt -61.0 -54.39 45.58 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.429 0.692 . . . . 0.0 111.829 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -52.51 -39.54 61.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.93 0.892 . . . . 0.0 111.181 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 29.3 m -74.7 -57.12 4.12 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.882 HD11 ' HB2' ' A' ' 151' ' ' PRO . 88.8 mt -63.92 -46.43 84.8 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.251 1.021 . . . . 0.0 112.631 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.602 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.5 tt0 -53.38 -35.57 60.48 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 111.837 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.5 t -84.44 -20.88 31.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.694 . . . . 0.0 112.062 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 155' ' ' THR . 41.6 mm-40 -79.53 -16.53 55.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.221 0.608 . . . . 0.0 110.875 174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 82.1 mt -142.12 66.53 20.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.768 0.827 . . . . 0.0 109.461 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.591 ' HD2' ' HE2' ' A' ' 118' ' ' TYR . 13.8 Cg_exo -72.24 -3.84 14.08 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 123.115 2.543 . . . . 0.0 112.635 173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 p -85.62 -33.87 21.52 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.8 tp -99.59 70.49 1.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.361 1.464 . . . . 0.0 111.257 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.402 ' HB3' HD22 ' A' ' 195' ' ' LEU . 26.5 t-20 -53.03 126.96 22.32 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.602 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 17.4 m95 -91.08 133.26 35.47 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.81 -35.56 77.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.985 0.514 . . . . 0.0 109.7 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 78.1 mt -126.45 123.04 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.22 69.69 1.01 Allowed 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -129.48 145.93 51.38 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.327 -169.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -92.17 112.1 23.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.436 1.094 . . . . 0.0 109.493 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 44.8 mt -117.25 125.42 51.1 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.456 0.702 . . . . 0.0 110.316 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -88.5 124.9 34.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -90.16 125.45 35.46 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -80.28 96.9 6.77 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 37.8 mt -68.67 145.83 53.53 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.915 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -78.91 2.39 20.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.003 0.521 . . . . 0.0 110.63 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -49.51 -38.1 29.11 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.48 -82.96 0.33 Allowed Glycine 0 N--CA 1.476 1.321 0 CA-C-O 119.493 -0.615 . . . . 0.0 112.592 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . 63.94 163.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.072 1.349 . . . . 0.0 113.402 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -67.3 -48.98 66.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.65 0.78 . . . . 0.0 112.358 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -88.03 -59.77 2.15 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.03 138.47 1.71 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.288 0.993 . . . . 0.0 109.138 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -73.61 98.32 0.94 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -132.17 170.43 15.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.83 0.824 . . . . 0.0 111.508 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -157.28 131.2 8.19 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 113.186 -1.825 . . . . 0.0 106.486 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -80.72 130.38 35.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.439 HD22 ' HD1' ' A' ' 132' ' ' PHE . 52.1 mt -135.36 173.65 11.48 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 151' ' ' PRO . 9.8 pt -145.88 135.72 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.931 0.892 . . . . 0.0 109.257 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.4 142.25 33.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.664 0.386 . . . . 0.0 110.442 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 153' ' ' LEU . 39.5 mt -129.36 131.42 46.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.7 1.2 . . . . 0.0 109.069 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.86 105.74 7.97 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.07 138.16 15.24 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 176.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.705 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.0 tp-100 -142.55 149.7 39.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.587 0.693 . . . . 0.0 110.219 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -66.34 138.93 57.96 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 164' ' ' ASN . 5.6 mt -61.25 101.34 0.16 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.557 1.161 . . . . 0.0 109.169 -171.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 65.93 80.92 0.21 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.06 1.344 . . . . 0.0 110.724 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -81.65 -29.01 33.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.532 0.733 . . . . 0.0 112.241 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -138.1 37.45 2.33 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.478 0.656 . . . . 0.0 109.458 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.56 70.15 7.22 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.035 0.921 . . . . 0.0 109.32 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -155.78 -178.2 7.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.72 1.608 . . . . 0.0 107.799 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -74.6 124.19 26.22 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.747 0.419 . . . . 0.0 110.878 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 . . . . . 0 N--CA 1.481 1.109 0 C-N-CA 123.094 0.558 . . . . 0.0 109.853 172.254 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -123.41 35.15 4.92 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.417 0.687 . . . . 0.0 110.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -125.19 29.61 6.05 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.198 0.599 . . . . 0.0 110.934 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.38 101.68 0.25 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.52 0.728 . . . . 0.0 110.22 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -143.2 87.92 1.99 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.509 0.724 . . . . 0.0 109.963 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -160.57 119.2 2.59 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.92 0.888 . . . . 0.0 108.801 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.0 t -148.76 85.83 1.5 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -71.0 92.16 0.92 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.157 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.8 p -78.34 109.49 12.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.805 0.842 . . . . 0.0 110.989 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.65 141.23 26.64 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.301 0.64 . . . . 0.0 111.193 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -172.07 127.85 0.59 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.748 1.219 . . . . 0.0 108.092 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.47 135.65 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.167 0.508 . . . . 0.0 110.724 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.24 150.09 9.07 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.008 1.323 . . . . 0.0 108.07 175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.59 90.74 0.08 OUTLIER Glycine 0 C--O 1.239 0.451 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -135.57 158.42 44.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.765 0.826 . . . . 0.0 108.85 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.42 160.77 66.65 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.463 1.105 . . . . 0.0 109.628 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.38 17.6 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 123.402 2.734 . . . . 0.0 114.727 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -138.36 44.3 2.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.343 1.068 . . . . 0.0 109.047 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.58 84.71 0.86 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.319 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -177.4 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.69 1.596 . . . . 0.0 106.721 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.474 HD21 ' HG ' ' A' ' 47' ' ' LEU . 37.5 tp -62.95 -36.54 83.78 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.763 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 m -44.13 -36.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.239 1.016 . . . . 0.0 113.584 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.4 m -74.89 -52.43 11.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.521 0.729 . . . . 0.0 110.84 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 128' ' ' ILE . 2.1 m -62.3 -37.06 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.588 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.0 83.54 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.314 1.446 . . . . 0.0 112.057 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.99 -28.05 68.59 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.813 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.18 -14.6 28.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.211 0.605 . . . . 0.0 112.194 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' VAL . 76.1 mt -77.71 130.58 73.12 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.72 140.71 46.14 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.266 2.644 . . . . 0.0 112.65 171.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.45 28.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.66 -147.12 8.66 Favored Glycine 0 N--CA 1.468 0.777 0 CA-C-N 118.455 0.571 . . . . 0.0 112.905 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -80.43 119.34 23.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -110.27 139.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.218 1.007 . . . . 0.0 108.555 -171.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 26.1 tp -115.42 128.65 56.19 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.968 0.804 . . . . 0.0 111.498 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 32.7 m -94.05 138.0 32.62 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.051 0.94 . . . . 0.0 110.239 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.6 108.95 17.08 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.986 0.514 . . . . 0.0 111.152 171.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 43.45 63.91 1.4 Allowed 'General case' 0 N--CA 1.485 1.282 0 O-C-N 125.482 1.738 . . . . 0.0 112.501 168.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.81 -58.43 3.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.44 0.638 . . . . 0.0 111.086 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.39 100.39 2.49 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 78.11 4.4 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.069 1.348 . . . . 0.0 113.9 170.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.6 19.24 41.14 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -62.13 -49.09 77.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.336 1.054 . . . . 0.0 111.297 -177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.455 HD22 HG21 ' A' ' 101' ' ' ILE . 93.5 m-20 -77.69 -32.78 53.23 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.804 -172.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.43 77.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.577 0.751 . . . . 0.0 110.101 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -68.85 -30.47 69.01 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.526 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 21' ' ' LEU . 57.4 t80 -62.93 -43.53 98.55 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HG ' HD21 ' A' ' 21' ' ' LEU . 89.4 mt -70.36 -30.78 67.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.85 76.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.88 0.472 . . . . 0.0 111.197 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.784 ' HA ' HG11 ' A' ' 76' ' ' VAL . 23.6 p -75.85 -2.44 30.08 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.303 0.641 . . . . 0.0 111.985 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 94.4 mt -86.32 14.97 5.75 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.314 0.646 . . . . 0.0 110.427 164.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.29 47.31 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 123.223 0.44 . . . . 0.0 113.523 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -125.29 157.03 37.66 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.337 0.589 . . . . 0.0 111.065 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -95.76 88.57 5.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.12 116.57 36.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.237 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 27.1 m -84.95 112.78 20.89 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 124.761 1.224 . . . . 0.0 107.977 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -102.27 133.85 46.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 111.174 -176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 81' ' ' VAL . 15.1 t -115.66 120.1 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 162.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.64 143.8 50.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.05 -20.98 66.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.506 0.722 . . . . 0.0 111.263 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 62' ' ' VAL . 46.1 m -111.75 124.52 52.51 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.716 1.206 . . . . 0.0 109.003 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.5 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.907 0.883 . . . . 0.0 110.062 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 60' ' ' SER . 19.1 m -66.26 -26.35 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.468 169.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.67 -35.1 33.06 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.157 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.3 -44.79 82.47 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.031 0.933 . . . . 0.0 110.449 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.26 91.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.924 0.889 . . . . 0.0 111.528 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -66.81 -40.28 87.99 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.295 0.638 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.08 88.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.294 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -70.02 -36.87 75.41 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.431 1.092 . . . . 0.0 111.476 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -61.08 -52.15 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.553 0.741 . . . . 0.0 110.91 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.23 -28.77 69.96 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.984 0.803 . . . . 0.0 110.715 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.32 -62.24 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.981 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -65.77 -26.24 67.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.902 0.881 . . . . 0.0 111.559 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.52 -46.28 90.72 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.162 0.985 . . . . 0.0 109.786 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -98.81 -0.71 41.99 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.553 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.85 51.23 8.03 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.366 0.506 . . . . 0.0 114.366 176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.2 m -138.42 176.29 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.932 0.893 . . . . 0.0 110.618 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -114.74 140.88 48.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.832 0.853 . . . . 0.0 111.937 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.5 157.61 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 55' ' ' THR . 85.6 m -119.12 103.23 9.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 t -94.62 114.89 26.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.278 0.561 . . . . 0.0 110.535 -163.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 57' ' ' VAL . 61.7 t -109.92 139.69 32.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.683 1.193 . . . . 0.0 108.883 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -78.87 132.26 36.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.639 0.775 . . . . 0.0 109.902 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 p -63.61 106.07 0.89 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 111.515 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -144.21 89.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 165.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -78.87 -16.36 57.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.804 0.442 . . . . 0.0 111.047 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.419 ' HA ' ' NE2' ' A' ' 112' ' ' GLN . . . -72.22 -27.3 62.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.565 0.746 . . . . 0.0 111.333 174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -104.52 -37.12 7.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.262 0.625 . . . . 0.0 111.654 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -161.34 126.25 3.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.378 1.071 . . . . 0.0 108.323 -170.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.01 -70.55 0.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 117' ' ' VAL . 2.9 pt -143.5 118.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.582 0.753 . . . . 0.0 109.778 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.879 0.872 . . . . 0.0 109.685 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 122' ' ' LYS . . . -44.88 -26.67 0.43 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 -44.42 71.29 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.991 0.516 . . . . 0.0 110.761 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.68 74.31 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -140.89 -165.32 1.92 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.223 0.609 . . . . 0.0 111.25 -171.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -118.01 -37.16 3.44 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.752 0.821 . . . . 0.0 112.42 -169.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.36 172.21 23.94 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 122.369 -0.207 . . . . 0.0 112.862 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.536 ' H ' ' HA2' ' A' ' 125' ' ' GLY . 42.6 mt -134.35 145.83 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.881 0.873 . . . . 0.0 109.233 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.2 p -127.3 105.09 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 159.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.9 t -104.19 88.03 2.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 43' ' ' ASN . 34.4 mm -71.58 146.16 11.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.656 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -17.54 99.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 126.563 2.414 . . . . 0.0 112.261 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.558 ' SG ' HD21 ' A' ' 129' ' ' LEU . 28.8 p -99.15 104.83 16.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.158 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -96.67 96.71 8.81 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 83.4 mt -112.19 139.27 22.28 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.717 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 105' ' ' LEU . 11.7 Cg_exo -71.19 162.03 43.87 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.937 2.425 . . . . 0.0 110.981 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 149' ' ' LEU . 14.0 m -34.98 -42.56 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 126.199 1.8 . . . . 0.0 115.368 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 55.3 m -70.61 -46.52 63.22 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.241 0.338 . . . . 0.0 110.692 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.52 -35.72 34.2 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.632 0.373 . . . . 0.0 110.427 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -69.14 -62.73 1.26 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.679 0.792 . . . . 0.0 109.945 -172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -51.87 -34.06 39.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.918 0.887 . . . . 0.0 113.135 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 53.8 tt0 -78.64 -32.58 47.36 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 117' ' ' VAL . 55.9 tp -71.92 -39.27 69.6 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 119.03 -0.509 . . . . 0.0 111.457 -172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -62.86 -38.86 47.55 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.94 -30.89 67.35 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.819 1.679 . . . . 0.0 111.792 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.08 -15.71 56.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.787 0.835 . . . . 0.0 110.209 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.616 ' HA ' HD11 ' A' ' 90' ' ' ILE . 22.3 t -83.84 -40.92 16.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -57.8 -52.39 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -69.95 -42.7 72.88 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.3 -39.86 14.65 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 25.8 tp -69.78 111.84 5.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.916 0.886 . . . . 0.0 110.61 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 19.4 ptmt -85.42 157.95 58.11 Favored Pre-proline 0 C--O 1.247 0.948 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.106 167.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.588 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 83.1 Cg_exo -50.8 112.29 0.73 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.343 2.029 . . . . 0.0 112.291 168.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.579 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 126.61 12.73 3.27 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.319 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -104.78 147.53 16.37 Favored Glycine 0 C--O 1.246 0.862 0 O-C-N 122.545 -0.385 . . . . 0.0 112.303 168.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 35.1 m -109.44 131.57 59.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 123.548 0.739 . . . . 0.0 110.076 177.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.93 112.54 24.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 24' ' ' VAL . 59.6 mt -115.44 112.26 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.132 0.973 . . . . 0.0 109.543 -171.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' SG ' ' A' ' 103' ' ' CYS . 96.5 mt -133.33 153.42 51.6 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.8 0.84 . . . . 0.0 110.965 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 37.7 tt0 -132.49 100.76 5.08 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 164.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 151' ' ' PRO . . . -80.23 166.58 49.96 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.779 175.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.413 ' HB2' HD22 ' A' ' 150' ' ' LEU . 58.0 m-85 -127.29 157.43 39.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 109.383 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -89.35 164.59 29.5 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.796 0.838 . . . . 0.0 109.649 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.571 ' HA ' HD22 ' A' ' 147' ' ' LEU . 38.5 Cg_exo -61.01 -0.83 1.36 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.96 2.44 . . . . 0.0 114.248 173.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.02 -19.62 47.25 Favored 'General case' 0 CA--C 1.571 1.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.625 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -67.52 -63.18 1.11 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 113.126 -168.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.571 HD12 ' HG ' ' A' ' 147' ' ' LEU . 15.5 mt -71.01 -11.49 61.0 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -73.46 -40.86 63.83 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.185 0.994 . . . . 0.0 111.136 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -68.69 -58.03 4.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.155 0.502 . . . . 0.0 110.189 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -127.93 134.36 49.32 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -84.99 40.18 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.819 0.847 . . . . 0.0 111.76 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.37 53.93 2.76 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 121.61 0.561 . . . . 0.0 111.926 169.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.23 125.65 7.88 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 118.46 -1.189 . . . . 0.0 111.83 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.76 -35.1 90.49 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.445 2.097 . . . . 0.0 110.671 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -169.92 -40.86 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.076 1.35 . . . . 0.0 108.638 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -169.71 158.83 7.78 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.281 -173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.571 ' HG ' HD12 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -61.32 -7.25 2.74 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.326 1.45 . . . . 0.0 112.847 175.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.5 -37.31 83.21 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.377 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 107' ' ' SER . 71.8 mt -83.88 8.61 14.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.514 0.726 . . . . 0.0 112.261 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 132' ' ' PHE . 56.3 mt -85.63 108.52 16.76 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.511 ' HB2' HD11 ' A' ' 156' ' ' LEU . 12.2 Cg_exo -70.22 122.63 9.18 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.977 2.451 . . . . 0.0 112.53 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -96.61 150.11 21.02 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.1 0.96 . . . . 0.0 111.282 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.583 HD22 HD21 ' A' ' 190' ' ' LEU . 37.9 mt -57.55 -36.87 72.2 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 122.987 0.515 . . . . 0.0 109.696 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -50.9 -51.37 52.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.534 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -69.75 -48.84 57.88 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.579 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.55 -58.73 3.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.396 1.078 . . . . 0.0 112.516 -166.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.27 -31.28 72.35 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.455 0.702 . . . . 0.0 112.091 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.0 t -84.54 -13.85 50.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.065 0.393 . . . . 0.0 111.519 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.85 -45.35 10.94 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.675 0.75 . . . . 0.0 109.317 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.9 mt -104.85 78.89 0.4 Allowed Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.702 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.37 -4.06 7.63 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 123.002 2.468 . . . . 0.0 111.367 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.0 m -85.52 -28.62 24.83 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.49 1.116 . . . . 0.0 108.115 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.83 70.81 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.78 1.632 . . . . 0.0 109.015 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.572 ' HB3' HD21 ' A' ' 195' ' ' LEU . 6.8 t30 -60.46 121.42 12.05 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.425 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 16.7 m95 -87.85 141.51 28.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.516 1.126 . . . . 0.0 108.998 -167.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.4 mt -73.42 -35.72 65.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.077 0.551 . . . . 0.0 109.809 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 82.2 mt -126.11 118.09 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.81 76.5 1.07 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -141.3 143.03 33.84 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -169.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.11 112.23 20.49 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.473 174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.4 mt -103.86 131.27 51.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.409 1.083 . . . . 0.0 108.884 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -94.74 122.99 37.91 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -120.23 131.6 55.02 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -77.72 133.02 38.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.446 0.699 . . . . 0.0 109.635 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 183' ' ' GLY . 17.4 mt -105.68 170.33 7.96 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.253 1.421 . . . . 0.0 108.788 -174.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.32 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.323 0.649 . . . . 0.0 111.062 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 183' ' ' GLY . 10.2 tp10 -162.18 157.74 23.55 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.44 1.096 . . . . 0.0 109.382 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -64.43 154.39 48.1 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.461 0.476 . . . . 0.0 112.802 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.7 70.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.346 1.058 . . . . 0.0 112.855 -172.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -66.1 -27.81 68.34 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.121 0.569 . . . . 0.0 112.048 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -101.3 -61.17 1.41 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.883 0.473 . . . . 0.0 110.924 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 47.6 mt-30 64.08 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.891 1.276 . . . . 0.0 109.85 -167.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 175' ' ' LEU . . . -67.66 99.27 0.52 Allowed Glycine 0 C--O 1.208 -1.531 0 O-C-N 123.645 0.591 . . . . 0.0 112.966 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 182' ' ' GLN . 53.9 mttp -87.76 147.91 24.97 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -149.42 132.86 16.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.03 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -79.03 109.64 13.52 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.0 mt -122.16 144.03 49.2 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 13.4 pt -133.02 116.61 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.15 0.432 . . . . 0.0 110.025 -170.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.61 137.77 36.76 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.067 0.46 . . . . 0.0 109.779 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 153' ' ' LEU . 62.9 mt -125.98 146.0 50.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.388 1.075 . . . . 0.0 110.343 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 23.7 tp -149.88 106.15 3.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -88.48 142.36 17.22 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -142.65 156.76 45.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.649 0.725 . . . . 0.0 111.04 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 68.2 tttt -55.34 135.26 50.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.322 1.449 . . . . 0.0 110.368 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 164' ' ' ASN . 3.5 mt -86.17 125.04 33.23 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 164.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.491 ' HA ' ' HE2' ' A' ' 194' ' ' LYS . 9.2 tp10 -58.15 107.83 0.53 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.511 0.672 . . . . 0.0 110.21 -171.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -93.58 46.15 1.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.923 1.289 . . . . 0.0 109.128 -166.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . 0.254 28.8 p-80 41.72 79.31 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.505 1.922 . . . . 0.0 113.372 -168.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -129.1 159.58 35.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.716 1.207 . . . . 0.0 109.209 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -67.33 -2.96 6.87 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.938 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 63.92 32.24 13.32 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.788 1.235 . . . . 0.0 111.836 165.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 . . . . . 0 C--O 1.252 1.189 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.351 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -143.94 135.73 26.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.427 1.091 . . . . 0.0 108.408 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -100.01 100.96 11.91 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.77 0.795 . . . . 0.0 110.778 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -98.61 165.88 11.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.661 0.785 . . . . 0.0 109.923 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.48 73.19 8.53 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -73.63 132.45 42.78 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 p -66.98 101.04 0.8 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.944 0.898 . . . . 0.0 111.03 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.79 119.07 4.16 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 124.002 0.921 . . . . 0.0 109.945 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.5 t -84.63 67.88 10.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.458 0.703 . . . . 0.0 112.115 -164.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.31 72.05 8.13 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 167.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' LYS . 38.8 t80 -69.99 125.29 26.32 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.46 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.46 136.51 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 165.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -66.01 93.51 0.2 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.043 0.537 . . . . 0.0 111.028 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.34 53.06 0.75 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.421 HG23 HD22 ' A' ' 50' ' ' LEU . 85.2 m -112.75 99.16 7.7 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.149 0.98 . . . . 0.0 109.326 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' H ' ' HZ ' ' A' ' 46' ' ' PHE . 5.1 tp10 -147.32 70.55 11.81 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.48 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.42 -74.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.928 2.418 . . . . 0.0 111.472 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 54.72 76.0 0.27 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.665 1.186 . . . . 0.0 111.941 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -167.76 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.764 0.425 . . . . 0.0 111.639 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.1 t80 174.24 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.976 1.31 . . . . 0.0 107.65 -165.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.0 tp -61.61 -17.91 57.14 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.695 1.198 . . . . 0.0 112.443 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.69 -37.92 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -71.84 -41.15 68.48 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.031 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.4 m -66.8 -43.5 89.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -57.27 -38.41 73.86 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.18 0.992 . . . . 0.0 112.253 176.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.61 -21.32 63.59 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.626 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -91.1 -21.86 21.0 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.41 0.684 . . . . 0.0 110.54 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 92.3 mt -74.09 134.2 77.77 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 123.532 0.733 . . . . 0.0 110.51 176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.66 136.42 49.68 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.36 2.707 . . . . 0.0 112.111 167.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.44 28.62 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.7 -132.81 4.98 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -84.33 112.41 20.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HG12 ' A' ' 99' ' ' VAL . 8.9 mt -111.59 119.11 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.691 0.796 . . . . 0.0 109.197 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 90' ' ' ILE . 28.7 tp -89.95 108.0 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.667 0.212 . . . . 0.0 110.743 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 49.3 t -94.92 110.39 22.29 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.265 0.626 . . . . 0.0 110.689 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.2 mt -79.02 126.35 30.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 166.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.51 154.96 38.57 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.791 0.682 . . . . 0.0 109.816 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.25 32.74 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.23 -76.28 0.02 OUTLIER Glycine 0 C--N 1.353 1.477 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.504 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -80.9 -60.46 2.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.901 0.481 . . . . 0.0 111.351 -167.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 -51.43 4.37 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.881 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -49.78 -38.32 33.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.417 1.487 . . . . 0.0 112.2 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.422 ' ND2' HG13 ' A' ' 101' ' ' ILE . 29.1 p-10 -64.2 -41.0 97.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.81 -41.0 72.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.51 0.724 . . . . 0.0 110.719 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 9.9 m -59.55 -38.89 82.27 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.627 0.771 . . . . 0.0 111.099 173.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' HZ ' ' H ' ' A' ' 16' ' ' GLU . 73.0 t80 -73.2 -33.5 65.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.592 0.757 . . . . 0.0 110.906 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HG11 ' A' ' 99' ' ' VAL . 50.6 mt -64.03 -32.36 73.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 110.421 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.17 -31.24 58.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.879 0.472 . . . . 0.0 110.763 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 m -68.37 -6.09 22.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.809 0.844 . . . . 0.0 111.835 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD22 HG23 ' A' ' 15' ' ' THR . 38.8 mt -83.89 12.38 6.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 123.596 0.758 . . . . 0.0 110.646 168.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 34.72 25.44 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 123.285 0.469 . . . . 0.0 113.985 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -127.4 162.16 26.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.882 0.473 . . . . 0.0 111.387 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -92.99 91.07 7.2 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 165.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 33' ' ' ILE . 85.7 t -88.4 112.12 23.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 34' ' ' LEU . 2.2 t -83.3 104.4 13.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.28 134.75 42.76 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.985 -168.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.3 t -113.71 118.22 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -133.68 142.48 48.03 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -54.31 -32.2 55.98 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.191 0.997 . . . . 0.0 112.364 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' HG22 ' A' ' 62' ' ' VAL . 9.1 t -109.03 130.33 55.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.631 0.772 . . . . 0.0 110.005 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 t -74.98 -16.86 60.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.929 0.892 . . . . 0.0 110.991 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.461 HG22 ' OG ' ' A' ' 60' ' ' SER . 9.6 m -63.85 -32.98 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.544 0.337 . . . . 0.0 110.511 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.42 -33.21 56.75 Favored Glycine 0 C--N 1.351 1.382 0 O-C-N 123.538 0.523 . . . . 0.0 112.646 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.09 -48.03 59.38 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.779 0.832 . . . . 0.0 110.413 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.55 86.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.712 0.805 . . . . 0.0 112.047 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -63.35 -39.41 94.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.861 0.864 . . . . 0.0 110.748 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -60.92 -46.71 89.57 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.942 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -71.08 -37.14 72.46 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.635 0.774 . . . . 0.0 111.652 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.63 -55.72 31.25 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.93 0.892 . . . . 0.0 109.849 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 23.2 tp -66.61 -25.19 66.49 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.221 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.09 -52.09 52.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.973 0.509 . . . . 0.0 110.495 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -60.85 -33.83 73.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.026 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.6 -48.22 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.545 0.528 . . . . 0.0 110.723 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 ttmp? -87.68 -13.5 42.4 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -173.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.96 44.83 13.04 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 121.054 0.252 . . . . 0.0 112.674 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.24 172.83 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.394 1.078 . . . . 0.0 108.124 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -121.77 141.26 51.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.706 0.403 . . . . 0.0 110.896 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 71' ' ' ALA . 15.8 mm -109.24 165.17 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 171.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.469 ' HB ' ' HB ' ' A' ' 55' ' ' THR . 45.0 m -131.13 104.02 6.84 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 164.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.2 p -86.74 114.33 23.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.884 0.474 . . . . 0.0 111.108 -168.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' HB ' HG22 ' A' ' 57' ' ' VAL . 53.3 t -104.63 139.01 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.746 1.218 . . . . 0.0 108.108 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -78.9 136.35 37.26 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 p -50.47 101.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.5 1.12 . . . . 0.0 111.838 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 6.6 m-20 -134.65 91.1 2.73 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 89' ' ' ASP . 65.7 mt -100.46 -6.71 25.15 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.691 0.758 . . . . 0.0 110.68 -170.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.27 3.44 29.98 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.189 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 32.2 t70 -139.64 -46.38 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -168.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -163.86 100.5 0.88 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.634 ' HB3' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -132.84 -58.28 0.92 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.522 0.729 . . . . 0.0 109.343 -164.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 34' ' ' LEU . 4.7 pt -134.35 110.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 123.039 0.535 . . . . 0.0 111.028 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 t -129.2 84.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.559 0.744 . . . . 0.0 109.346 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.529 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.65 -1.02 14.61 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.897 0.479 . . . . 0.0 112.176 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -76.16 -45.95 30.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.53 -26.98 61.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.614 0.766 . . . . 0.0 112.57 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.508 ' CD1' HD22 ' A' ' 34' ' ' LEU . 44.8 m95 -113.79 -177.71 3.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.254 0.622 . . . . 0.0 110.486 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -92.49 -55.83 3.25 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.69 0.796 . . . . 0.0 109.994 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.77 173.84 21.34 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.521 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.8 mt -132.68 139.3 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.687 HG11 HD13 ' A' ' 47' ' ' LEU . 7.5 p -124.06 106.94 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 121.64 0.734 . . . . 0.0 109.233 165.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.2 m -103.82 94.11 5.25 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.449 HD13 HD12 ' A' ' 128' ' ' ILE . 41.6 mm -68.52 141.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.359 1.063 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HB3' ' H ' ' A' ' 130' ' ' GLU . 8.2 p90 -21.63 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 126.032 1.733 . . . . 0.0 113.85 -172.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.494 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 35.8 t -94.53 109.56 21.44 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 112.888 -1.96 . . . . 0.0 110.615 -168.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -108.52 98.69 8.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.494 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 62.5 mt -114.62 145.53 34.06 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.809 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.73 150.55 69.79 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.833 2.355 . . . . 0.0 110.269 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.6 t -44.9 -33.88 2.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.771 1.228 . . . . 0.0 113.324 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.0 m -59.4 -59.81 4.85 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.312 0.645 . . . . 0.0 111.399 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.66 -24.41 53.26 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.992 0.517 . . . . 0.0 110.537 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -68.84 -54.62 14.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.416 1.086 . . . . 0.0 109.57 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -55.75 -28.67 57.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.387 1.075 . . . . 0.0 112.436 173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.65 -22.95 24.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.842 0.457 . . . . 0.0 111.078 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 117' ' ' VAL . 65.5 tp -71.9 -45.42 61.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.133 0.573 . . . . 0.0 111.172 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -58.58 -41.52 89.48 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -52.79 -38.05 77.22 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 122.449 2.099 . . . . 0.0 112.811 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -75.55 -23.61 56.62 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.391 0.677 . . . . 0.0 111.595 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 t -85.46 -28.08 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.362 0.601 . . . . 0.0 110.142 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -75.04 -61.09 2.01 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.291 174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -76.99 -47.36 20.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.501 1.12 . . . . 0.0 113.584 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.62 -36.72 22.22 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 114.14 0.416 . . . . 0.0 114.14 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 41.2 tp -75.36 108.5 8.18 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 1.2 mptm? -82.59 159.53 63.73 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.529 168.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -41.29 113.05 0.23 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.305 2.67 . . . . 0.0 113.813 166.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 14.22 3.24 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.235 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -112.32 144.43 17.8 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 121.766 -0.843 . . . . 0.0 111.146 165.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 33.9 m -107.59 132.16 55.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.834 0.854 . . . . 0.0 109.96 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.56 112.79 25.95 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.449 HD12 HD13 ' A' ' 101' ' ' ILE . 57.9 mt -104.21 109.43 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 156' ' ' LEU . 51.7 mt -124.59 120.71 32.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 110.088 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 102' ' ' PHE . 37.8 tt0 -112.28 102.6 10.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.57 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -86.65 169.08 40.5 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.668 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.635 ' HD1' HD22 ' A' ' 187' ' ' LEU . 57.1 m-85 -137.73 165.97 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.78 0.832 . . . . 0.0 109.445 -172.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.572 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -76.91 164.15 60.98 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.833 0.853 . . . . 0.0 110.072 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.564 ' HA ' HD22 ' A' ' 147' ' ' LEU . 38.1 Cg_endo -63.88 -2.3 4.37 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.237 1.958 . . . . 0.0 113.03 169.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.9 -6.75 59.34 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.506 1.122 . . . . 0.0 111.846 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -63.68 -59.93 3.96 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.209 -0.307 . . . . 0.0 111.177 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.47 HD12 ' HG ' ' A' ' 147' ' ' LEU . 14.5 mt -73.07 -12.3 60.86 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.363 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -68.59 -29.03 67.47 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -61.16 -30.05 70.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 61.08 42.39 12.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.001 1.321 . . . . 0.0 110.004 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 76.1 p -109.19 -6.58 15.52 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.94 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.18 153.6 14.93 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.75 98.8 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.222 -0.765 . . . . 0.0 111.848 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.22 -36.4 36.56 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.721 2.28 . . . . 0.0 112.1 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -168.14 -55.04 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.201 1.0 . . . . 0.0 108.718 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -162.64 159.24 24.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.343 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 134' ' ' PRO . 0.5 OUTLIER -61.04 -3.18 0.74 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.52 1.528 . . . . 0.0 112.903 175.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.3 -38.0 79.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.91 0.884 . . . . 0.0 109.746 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 105' ' ' LEU . 24.0 mt -87.61 9.46 21.2 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.158 -173.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 79.3 mt -81.24 106.02 5.04 Favored Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.57 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 15.3 Cg_exo -68.29 110.77 2.32 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 123.203 2.602 . . . . 0.0 112.651 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -95.51 147.67 23.3 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.926 0.891 . . . . 0.0 111.311 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 33.6 mt -59.84 -45.26 92.97 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.52 0.6 . . . . 0.0 110.428 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.63 -46.77 77.37 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.261 0.976 . . . . 0.0 110.942 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.7 p -71.95 -53.73 12.15 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.677 HD13 HD13 ' A' ' 129' ' ' LEU . 40.6 mt -70.01 -51.29 33.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.533 1.133 . . . . 0.0 113.274 -169.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.406 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 30.0 tt0 -59.98 -35.06 74.19 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.679 0.392 . . . . 0.0 111.38 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.7 t -78.04 -28.1 48.92 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 122.703 0.401 . . . . 0.0 110.864 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -78.39 -24.15 46.46 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.911 0.885 . . . . 0.0 110.768 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.7 mt -131.84 73.27 78.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -82.71 -9.18 11.12 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.252 2.634 . . . . 0.0 112.606 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 t -91.84 -29.86 16.5 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp -88.4 72.44 8.91 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.624 1.17 . . . . 0.0 110.29 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -53.6 125.69 19.07 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.108 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.406 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 41.9 m95 -91.76 125.12 36.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.541 1.137 . . . . 0.0 108.899 -172.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.96 -34.13 75.98 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.089 0.556 . . . . 0.0 109.983 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 72.7 mt -127.54 122.99 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.63 76.26 1.01 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -145.98 145.76 30.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.277 -172.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.548 ' H ' HD22 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -74.97 115.54 14.7 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.493 0.717 . . . . 0.0 110.432 174.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.1 mt -107.84 114.56 28.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 45.7 mt-10 -91.83 127.33 37.25 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.082 0.553 . . . . 0.0 111.1 -171.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -101.57 134.5 44.6 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.342 0.657 . . . . 0.0 110.784 -176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -64.34 108.31 1.57 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.105 0.962 . . . . 0.0 111.655 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 185' ' ' ALA . 46.7 mt -92.87 167.87 11.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.583 0.753 . . . . 0.0 111.73 177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -149.83 41.69 0.85 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.0 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -33.3 66.49 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.902 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.87 47.39 83.44 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.284 0.365 . . . . 0.0 113.398 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -127.54 -69.91 0.72 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.193 0.597 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -167.12 -35.71 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 0.0 109.832 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -58.82 147.64 32.83 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.905 . . . . 0.0 111.66 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -58.44 156.27 10.63 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.739 0.816 . . . . 0.0 111.604 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.7 17.88 2.54 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.8 178.47 6.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 110.508 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -126.41 134.24 51.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.484 0.713 . . . . 0.0 109.795 -170.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -78.89 99.74 6.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.635 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.3 mt -127.61 160.68 30.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 16.3 pt -140.39 142.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -129.42 150.13 50.91 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.555 0.693 . . . . 0.0 111.147 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 40.7 mt -132.25 140.7 48.74 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.608 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 167' ' ' ILE . 34.2 tp -134.03 104.16 6.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.94 136.54 14.07 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.34 155.58 44.48 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.462 0.705 . . . . 0.0 109.883 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -57.1 144.95 32.62 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.476 0.71 . . . . 0.0 110.36 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.59 138.26 54.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 57.22 72.23 0.53 Allowed 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.322 1.014 . . . . 0.0 110.653 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -75.09 70.03 2.03 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 122.165 0.983 . . . . 0.0 108.665 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -164.5 131.68 3.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.977 1.711 . . . . 0.0 107.404 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -70.81 125.56 27.18 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -73.44 131.73 42.15 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 111.063 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -128.59 129.43 45.92 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 61.2 t60 . . . . . 0 C--O 1.25 1.118 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.285 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -136.21 43.95 2.47 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.307 1.051 . . . . 0.0 108.396 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -62.78 116.67 5.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.42 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.66 104.08 13.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.841 0.857 . . . . 0.0 110.217 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 53.63 0.79 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.388 0.675 . . . . 0.0 109.282 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -81.25 98.17 7.98 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.197 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -152.29 139.85 19.7 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -133.57 104.57 6.44 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.912 0.885 . . . . 0.0 108.712 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -92.09 98.33 11.48 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -166.64 125.87 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.934 0.493 . . . . 0.0 110.105 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -157.87 150.39 22.56 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.014 0.526 . . . . 0.0 110.883 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -167.05 122.4 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.051 0.94 . . . . 0.0 109.801 170.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -162.29 142.95 10.19 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.823 0.849 . . . . 0.0 109.029 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.27 173.23 32.83 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 123.439 0.462 . . . . 0.0 112.409 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.5 p -123.99 68.38 1.05 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.318 1.047 . . . . 0.0 109.164 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.71 126.46 92.2 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.502 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.98 121.17 8.77 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.182 2.588 . . . . 0.0 112.562 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.28 151.31 26.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.458 0.703 . . . . 0.0 110.517 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -168.07 175.66 6.52 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -52.42 -25.29 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.633 1.173 . . . . 0.0 111.169 165.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.1 tp -57.69 -19.68 28.73 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.902 1.281 . . . . 0.0 112.838 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.73 -27.8 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 118.973 0.806 . . . . 0.0 108.897 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -72.32 -43.14 64.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.361 1.064 . . . . 0.0 110.615 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.6 m -68.84 -37.47 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.309 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -26.2 68.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.907 0.883 . . . . 0.0 112.63 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -70.34 -28.31 65.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.688 0.795 . . . . 0.0 109.572 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -84.75 -24.08 28.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.783 0.833 . . . . 0.0 111.393 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 33' ' ' ILE . 63.7 mt -72.85 131.42 84.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 CA-C-O 119.157 -0.449 . . . . 0.0 110.263 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -64.72 144.33 83.56 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.817 2.345 . . . . 0.0 112.003 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -69.14 27.49 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' HA3' ' HG3' ' A' ' 96' ' ' GLU . . . -116.61 -140.95 6.94 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 119.065 0.848 . . . . 0.0 112.832 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 41.5 mtpt -83.63 118.48 23.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.378 0.671 . . . . 0.0 109.682 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.571 HD13 HG21 ' A' ' 28' ' ' ILE . 9.7 mt -115.43 131.92 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.409 HD22 ' NE1' ' A' ' 95' ' ' TRP . 33.0 tp -97.89 113.85 25.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 44.8 t -95.34 133.82 38.83 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.881 0.872 . . . . 0.0 108.68 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 50.9 mt -101.53 159.06 15.61 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.566 0.346 . . . . 0.0 111.053 170.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.77 113.82 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 125.023 1.452 . . . . 0.0 113.061 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 -33.14 3.76 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.191 0.996 . . . . 0.0 111.235 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 165.47 -65.67 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -121.91 121.15 36.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.789 0.836 . . . . 0.0 108.889 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.8 -0.24 2.74 Favored Glycine 0 CA--C 1.548 2.133 0 N-CA-C 114.288 0.475 . . . . 0.0 114.288 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.667 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 51.1 mtp180 -56.43 -34.92 67.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.37 1.068 . . . . 0.0 111.787 168.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.66 -45.25 89.76 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.901 0.88 . . . . 0.0 110.293 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.7 75.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.331 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 42' ' ' ARG . 22.7 p -73.8 -19.78 60.66 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.363 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -68.61 -50.15 53.72 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.98 -30.55 69.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.399 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.96 -35.33 62.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.05 0.54 . . . . 0.0 111.956 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.646 ' HA ' HG11 ' A' ' 76' ' ' VAL . 87.7 p -73.56 -3.85 30.39 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.836 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.02 12.08 3.6 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.758 0.823 . . . . 0.0 111.219 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.02 15.97 60.17 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 123.173 0.416 . . . . 0.0 113.932 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -112.86 157.93 20.8 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.788 0.835 . . . . 0.0 109.869 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 45.1 mt-10 -97.34 90.83 5.22 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 33' ' ' ILE . 61.9 t -94.84 110.97 24.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.596 0.712 . . . . 0.0 110.06 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -86.18 114.82 23.32 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.528 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.53 144.65 29.27 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 123.877 0.871 . . . . 0.0 111.268 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -119.89 117.25 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 165.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -129.64 148.17 51.51 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.229 0.922 . . . . 0.0 111.195 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -56.1 -34.18 65.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.129 1.772 . . . . 0.0 112.473 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.3 p -123.72 140.42 53.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.085 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -73.54 -15.75 61.29 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.086 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.2 m -63.84 -38.59 82.74 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -41.18 55.31 Favored Glycine 0 C--N 1.357 1.725 0 O-C-N 123.551 0.532 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.45 -41.67 98.91 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.518 0.727 . . . . 0.0 110.435 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.03 76.93 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.016 0.926 . . . . 0.0 112.532 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 75.0 mmtt -62.61 -39.37 93.58 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.603 0.361 . . . . 0.0 110.357 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 78' ' ' ILE . . . -62.5 -51.34 67.81 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.593 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -71.21 -32.48 68.88 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.305 0.642 . . . . 0.0 111.849 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -58.41 -48.88 79.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.2 0.6 . . . . 0.0 110.703 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.8 tp -68.63 -25.88 65.06 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 123.269 0.355 . . . . 0.0 110.64 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.79 -59.29 5.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.023 0.529 . . . . 0.0 110.897 177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -58.33 -48.33 80.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.81 0.844 . . . . 0.0 111.839 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 -41.96 88.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.82 0.848 . . . . 0.0 111.191 -172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -105.56 -12.06 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.137 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.31 44.39 22.45 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 121.907 -0.187 . . . . 0.0 113.509 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.646 HG11 ' HA ' ' A' ' 49' ' ' SER . 34.5 m -124.55 160.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.996 0.918 . . . . 0.0 109.695 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -104.77 126.4 51.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.674 0.79 . . . . 0.0 110.775 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.643 HG21 ' HB1' ' A' ' 67' ' ' ALA . 5.1 mm -117.84 164.89 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.6 m -133.98 108.04 8.15 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 p -94.5 125.92 39.45 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.942 0.497 . . . . 0.0 111.303 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.35 140.74 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.359 1.464 . . . . 0.0 107.882 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -82.98 144.17 30.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -62.8 102.9 0.38 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.714 0.806 . . . . 0.0 112.903 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -142.27 89.63 2.18 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.93 -8.39 51.89 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.39 0.676 . . . . 0.0 111.792 -169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.79 -16.64 50.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.901 0.881 . . . . 0.0 110.763 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -113.55 -38.42 4.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.416 0.687 . . . . 0.0 110.544 -175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -151.02 130.16 12.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.667 1.187 . . . . 0.0 107.91 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.98 -75.32 0.51 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -174.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.2 pt -143.27 119.45 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.026 0.93 . . . . 0.0 109.473 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.31 79.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 0.0 108.955 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -74.98 0.33 16.21 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.354 0.662 . . . . 0.0 112.089 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.79 -40.32 83.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 167.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.21 -25.09 57.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.409 ' NE1' HD22 ' A' ' 34' ' ' LEU . 23.7 m95 -113.4 176.77 4.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.256 0.622 . . . . 0.0 111.211 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 52.2 mm-40 -90.18 -51.73 5.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.022 0.929 . . . . 0.0 109.883 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -142.88 178.56 21.12 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.622 HD12 HD12 ' A' ' 121' ' ' LEU . 69.4 mt -131.59 145.26 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.85 0.86 . . . . 0.0 108.777 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 8.3 p -130.87 133.61 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 166.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 m -142.41 95.76 2.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.51 HG22 ' HD1' ' A' ' 102' ' ' PHE . 8.7 mm -74.3 153.78 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HD1' HG22 ' A' ' 101' ' ' ILE . 20.5 p90 -16.02 103.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.202 1.801 . . . . 0.0 115.004 -163.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.4 t -75.41 105.49 6.46 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.984 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -105.13 97.66 7.48 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -125.33 145.76 51.93 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.541 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -56.13 150.7 46.8 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.022 2.481 . . . . 0.0 110.666 163.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 28.3 t -48.53 -37.82 18.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.652 1.181 . . . . 0.0 112.006 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.6 t -53.57 -57.01 12.26 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.905 0.753 . . . . 0.0 111.113 174.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.71 -24.99 56.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.894 0.478 . . . . 0.0 110.636 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -75.44 -53.91 7.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.737 0.815 . . . . 0.0 110.637 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -60.41 -28.18 68.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.957 0.503 . . . . 0.0 111.723 172.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -75.74 -30.37 59.2 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 117' ' ' VAL . 60.5 tp -74.56 -36.54 63.09 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.839 0.712 . . . . 0.0 111.888 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -54.87 -49.69 90.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.41 -24.92 70.96 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.05 1.833 . . . . 0.0 112.186 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.1 -29.59 61.93 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.011 0.524 . . . . 0.0 111.142 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 113' ' ' LEU . 5.0 t -85.75 -26.3 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.153 0.581 . . . . 0.0 110.064 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -69.95 -61.69 1.68 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -71.41 -49.74 38.85 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.92 -18.11 51.88 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 115.122 0.809 . . . . 0.0 115.122 -163.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD12 HD12 ' A' ' 98' ' ' ILE . 13.3 tp -76.52 102.41 6.04 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.661 0.73 . . . . 0.0 109.076 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -75.86 145.44 77.91 Favored Pre-proline 0 C--O 1.247 0.951 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -44.19 111.93 0.3 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.059 2.506 . . . . 0.0 113.242 174.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.24 11.64 5.6 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.105 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.09 140.61 15.15 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 19.3 m -109.84 129.47 64.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -110.2 108.8 19.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -116.13 113.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.901 -166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 102' ' ' PHE . 3.6 mp -130.06 147.42 51.8 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.041 0.448 . . . . 0.0 111.13 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.94 98.47 6.5 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 165.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.85 -179.79 52.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.721 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.6 m-85 -137.9 158.4 44.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.933 -0.634 . . . . 0.0 109.429 -173.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.39 169.14 8.12 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.642 0.777 . . . . 0.0 110.45 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.624 ' HA ' HD22 ' A' ' 147' ' ' LEU . 36.9 Cg_exo -41.63 -26.16 0.38 Allowed 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 124.628 3.552 . . . . 0.0 115.972 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.48 -19.26 62.95 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.559 0.744 . . . . 0.0 112.839 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -67.68 -53.44 27.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.093 0.406 . . . . 0.0 111.832 -165.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.434 HD12 ' HG ' ' A' ' 147' ' ' LEU . 7.7 mt -82.87 -16.86 45.93 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.348 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.75 -45.41 86.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.576 0.751 . . . . 0.0 109.228 170.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.38 -26.28 60.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.8 t30 61.87 39.52 13.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.098 1.359 . . . . 0.0 110.11 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -96.17 37.13 1.26 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.072 0.949 . . . . 0.0 110.183 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.38 144.5 9.72 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA3' HD22 ' A' ' 137' ' ' LEU . . . 169.33 145.43 4.63 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.724 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HB2' HD12 ' A' ' 149' ' ' LEU . 16.3 Cg_exo -70.22 -59.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.219 2.612 . . . . 0.0 112.389 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -158.14 -32.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.695 0.398 . . . . 0.0 111.625 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -158.37 153.61 25.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 1.4 mt -57.09 -13.47 2.92 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.865 1.666 . . . . 0.0 113.567 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.24 -38.24 85.93 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.078 172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 144' ' ' PRO . 56.0 mt -90.25 13.79 14.34 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.41 0.684 . . . . 0.0 112.306 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 53.1 mt -78.99 112.58 28.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 166.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HB2' HD11 ' A' ' 156' ' ' LEU . 60.4 Cg_endo -71.71 93.63 0.69 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.26 1.973 . . . . 0.0 111.274 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.573 ' HA ' HD11 ' A' ' 188' ' ' ILE . 42.9 mtmt -96.78 156.06 16.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.608 -166.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 188' ' ' ILE . 35.3 mt -61.69 -49.85 74.82 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.345 0.658 . . . . 0.0 110.333 -176.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.19 -40.33 73.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.887 0.742 . . . . 0.0 110.977 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.1 m -65.65 -64.27 0.9 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.696 174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 151' ' ' PRO . 83.5 mt -72.58 -45.16 60.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.704 0.802 . . . . 0.0 112.481 -164.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 64.0 tt0 -57.84 -42.02 83.55 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.04 0.536 . . . . 0.0 111.877 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -76.83 -26.23 54.11 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -84.66 -12.76 53.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.929 0.892 . . . . 0.0 111.25 -178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 70.0 mt -134.57 71.6 70.88 Favored Pre-proline 0 N--CA 1.475 0.792 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.56 -3.31 13.21 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 123.198 2.599 . . . . 0.0 111.002 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.5 t -83.86 -42.26 16.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.677 1.191 . . . . 0.0 107.912 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.6 tp -95.11 71.76 3.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.863 1.265 . . . . 0.0 110.487 -176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -56.31 127.86 32.96 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.58 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 36.8 m95 -91.5 137.83 32.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 0.0 109.226 -167.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 36.1 mt -73.81 -32.24 63.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.761 0.424 . . . . 0.0 110.83 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 83.0 mt -132.81 128.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.87 77.63 0.96 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.91 1.284 . . . . 0.0 107.771 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.36 133.42 36.77 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 -169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -80.69 113.5 18.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.343 0.657 . . . . 0.0 110.773 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.3 mt -108.39 135.67 49.31 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.605 0.762 . . . . 0.0 109.981 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.92 123.6 36.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.524 ' HB3' ' HB3' ' A' ' 185' ' ' ALA . 37.5 ttt180 -98.64 122.7 42.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -85.53 98.01 10.38 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.4 144.6 49.74 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.485 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.86 153.44 41.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 164.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 66.38 77.78 0.28 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.897 0.879 . . . . 0.0 109.585 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.23 78.53 0.04 OUTLIER Glycine 0 C--N 1.344 0.972 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.738 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 105.8 4.12 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.353 0.661 . . . . 0.0 110.44 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 51.3 t80 73.25 -78.5 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.161 1.384 . . . . 0.0 110.769 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -72.21 124.5 25.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.902 0.881 . . . . 0.0 111.05 -172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 59.26 18.8 6.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.673 1.589 . . . . 0.0 112.768 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -99.39 15.54 60.0 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -97.37 163.29 12.95 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.95 0.9 . . . . 0.0 111.218 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . . . -131.06 130.39 43.17 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 164.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.436 ' HB2' ' HE2' ' A' ' 184' ' ' LYS . . . -89.77 104.29 16.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.89 163.67 19.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.632 0.773 . . . . 0.0 109.122 -169.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.573 HD11 ' HA ' ' A' ' 152' ' ' LYS . 7.6 pt -143.82 125.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -97.72 141.55 30.6 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.941 -0.475 . . . . 0.0 111.061 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 37.6 mt -127.57 130.13 48.54 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.387 1.475 . . . . 0.0 108.997 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.419 HD22 HG12 ' A' ' 24' ' ' VAL . 29.9 tp -125.64 105.08 8.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -93.23 131.35 10.73 Favored Glycine 0 C--O 1.212 -1.221 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 173.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.614 ' HA ' HE21 ' A' ' 193' ' ' GLN . 0.0 OUTLIER -141.51 156.55 45.72 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 108.859 176.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -54.49 153.86 5.26 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.975 0.91 . . . . 0.0 110.957 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.96 165.97 16.71 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.78 0.432 . . . . 0.0 110.22 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -167.57 115.86 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -64.92 88.93 0.07 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.084 0.945 . . . . 0.0 108.507 170.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -123.41 145.01 49.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.048 -167.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -73.93 74.11 1.65 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.626 . . . . 0.0 109.407 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -78.65 152.15 31.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.556 -171.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -68.56 138.3 55.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.661 -173.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--O 1.255 1.392 0 C-N-CA 124.03 0.932 . . . . 0.0 108.523 173.22 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -87.53 76.16 9.01 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.179 0.591 . . . . 0.0 109.516 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -149.34 101.71 3.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.638 0.775 . . . . 0.0 109.691 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -94.58 96.34 9.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.451 0.701 . . . . 0.0 109.528 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 97.22 8.99 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -125.22 98.37 5.62 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -144.62 80.69 1.64 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.517 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -86.16 125.77 33.75 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.858 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.4 p -62.25 123.49 18.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.962 0.905 . . . . 0.0 110.96 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 21.8 13.28 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.786 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 1.4 p90 -52.02 145.26 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.136 1.374 . . . . 0.0 112.296 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -156.89 134.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.874 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.15 101.26 7.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.281 0.632 . . . . 0.0 110.02 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.99 74.8 1.58 Allowed Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.846 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 t -139.55 153.17 47.38 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.095 0.958 . . . . 0.0 108.971 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -158.58 108.12 1.64 Allowed Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 119.105 -0.474 . . . . 0.0 109.747 -176.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.29 161.84 32.67 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.879 2.386 . . . . 0.0 112.357 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -132.62 -8.08 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.727 0.811 . . . . 0.0 111.74 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -106.3 -156.92 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.405 0.682 . . . . 0.0 109.47 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.44 -25.09 67.78 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 118.564 0.62 . . . . 0.0 111.747 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD22 HD22 ' A' ' 43' ' ' ASN . 14.1 tp -60.2 -22.52 63.07 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.77 0.828 . . . . 0.0 112.286 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 m -40.48 -56.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 124.489 1.116 . . . . 0.0 113.853 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 p -74.93 -50.62 16.18 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.599 0.76 . . . . 0.0 110.681 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.2 m -66.93 -41.4 87.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.364 -171.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -60.9 -37.26 81.61 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.918 0.887 . . . . 0.0 111.541 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -68.63 -26.78 65.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HB3' ' OE1' ' A' ' 193' ' ' GLN . 12.7 mm100 -92.86 -13.26 29.25 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 24' ' ' VAL . 73.7 mt -77.68 134.43 65.34 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.237 0.615 . . . . 0.0 110.87 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.77 132.38 47.55 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.326 2.684 . . . . 0.0 111.894 171.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -74.23 29.51 0.08 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.88 -145.68 9.54 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 12.3 mmmm -85.63 118.7 25.3 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -170.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.3 mt -114.15 134.29 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.8 0.84 . . . . 0.0 110.04 -165.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.511 HD22 ' NE1' ' A' ' 95' ' ' TRP . 50.8 tp -106.92 127.01 53.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.243 0.617 . . . . 0.0 110.607 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 36.1 m -98.89 137.47 37.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.578 0.751 . . . . 0.0 110.16 175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 89' ' ' ASP . 15.7 mt -114.58 116.05 28.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.181 0.593 . . . . 0.0 110.928 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . 46.98 78.65 0.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 125.38 1.675 . . . . 0.0 113.657 165.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.3 -77.06 0.26 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.41 -68.39 0.26 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.24 -36.05 4.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.126 0.97 . . . . 0.0 109.759 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 44.79 7.57 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 114.355 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -69.37 -35.45 75.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.481 0.658 . . . . 0.0 109.469 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.449 HD22 HD22 ' A' ' 21' ' ' LEU . 26.3 m120 -80.8 -31.51 35.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.813 1.245 . . . . 0.0 110.426 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.24 82.73 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.936 0.772 . . . . 0.0 109.682 175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 55.9 m -58.62 -43.18 89.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.462 171.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.4 -31.55 68.81 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.4 0.437 . . . . 0.0 111.096 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.14 -37.02 85.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.145 0.578 . . . . 0.0 109.953 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.24 73.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.767 0.427 . . . . 0.0 111.227 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.672 ' HA ' HG11 ' A' ' 76' ' ' VAL . 11.7 m -65.99 -15.77 63.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.951 0.9 . . . . 0.0 112.155 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.79 8.72 5.0 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.039 0.535 . . . . 0.0 110.767 172.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.09 8.66 61.4 Favored Glycine 0 C--N 1.362 1.996 0 CA-C-O 119.69 -0.506 . . . . 0.0 114.326 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -105.65 152.37 23.21 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.428 0.614 . . . . 0.0 110.129 -172.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 35.5 mt-10 -94.89 90.8 6.14 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.2 t -88.86 118.43 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.354 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.648 HG22 ' HB ' ' A' ' 79' ' ' THR . 77.1 p -86.04 113.0 21.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -112.3 122.35 47.48 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.862 0.465 . . . . 0.0 111.196 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.6 t -99.25 144.19 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 163.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t70 -124.77 178.19 5.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -87.24 -27.02 23.2 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.719 0.808 . . . . 0.0 109.851 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 62' ' ' VAL . 50.4 m -119.43 135.97 54.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.954 -1.476 . . . . 0.0 110.559 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -68.64 -22.51 64.41 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.153 0.981 . . . . 0.0 110.689 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 60' ' ' SER . 17.7 m -64.84 -34.37 69.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.62 174.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -36.43 73.68 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -68.24 -43.13 78.59 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.016 0.927 . . . . 0.0 110.835 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 112.278 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -66.75 -37.06 83.89 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.299 0.239 . . . . 0.0 110.813 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -59.83 -48.49 81.47 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.877 0.736 . . . . 0.0 110.631 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.45 -44.8 74.11 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.006 0.922 . . . . 0.0 111.237 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.95 -50.87 71.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.337 1.055 . . . . 0.0 111.507 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 15.0 tp -69.61 -23.74 63.56 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.991 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -68.26 -51.27 46.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.728 173.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.17 -36.11 80.85 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.702 0.801 . . . . 0.0 111.191 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -59.07 -54.55 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.995 0.809 . . . . 0.0 110.511 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -85.18 -6.43 59.28 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.15 -169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.17 39.18 58.51 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 120.877 0.154 . . . . 0.0 112.892 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 49' ' ' SER . 35.7 m -127.66 167.41 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.568 1.147 . . . . 0.0 109.279 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -115.78 135.4 54.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.457 0.703 . . . . 0.0 112.265 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.7 mm -111.41 168.48 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 163.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HB ' HG22 ' A' ' 55' ' ' THR . 60.9 m -132.95 105.59 7.18 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 163.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.4 p -88.27 121.17 30.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.267 0.627 . . . . 0.0 110.119 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.683 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.6 t -103.13 137.52 31.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -77.32 135.52 38.4 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.93 0.395 . . . . 0.0 110.321 -174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -43.63 96.03 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.909 1.684 . . . . 0.0 112.233 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -145.32 97.47 3.0 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 84.3 mt -102.1 -8.59 21.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.024 0.53 . . . . 0.0 111.193 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.09 -17.31 43.57 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.305 0.642 . . . . 0.0 112.093 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -137.34 -3.2 1.95 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.711 0.404 . . . . 0.0 112.046 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 87.3 t80 -156.49 143.87 19.08 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' O ' HD21 ' A' ' 36' ' ' LEU . 7.5 p-10 -150.79 -70.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 36' ' ' LEU . 13.5 pt -142.68 125.55 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.404 0.682 . . . . 0.0 109.538 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.5 t -130.56 84.33 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -72.51 0.23 10.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.248 0.619 . . . . 0.0 112.374 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.85 -34.09 77.15 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.444 0.697 . . . . 0.0 109.235 168.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.61 -18.81 22.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.316 1.046 . . . . 0.0 112.452 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.511 ' NE1' HD22 ' A' ' 34' ' ' LEU . 24.3 m95 -118.69 134.51 55.07 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.821 0.448 . . . . 0.0 110.856 -171.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -73.58 -28.56 61.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.451 0.7 . . . . 0.0 111.137 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.09 163.67 28.64 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.668 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 92' ' ' ALA . 75.5 mt -133.9 155.59 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.22 142.89 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.533 1.133 . . . . 0.0 109.225 172.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.1 t -143.62 103.99 4.15 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.566 HD13 HD12 ' A' ' 128' ' ' ILE . 17.7 mm -75.31 145.72 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 118.229 -0.891 . . . . 0.0 108.716 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -16.16 102.83 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 126.843 2.057 . . . . 0.0 113.891 -171.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 24.4 p -119.77 149.76 41.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.879 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -145.16 101.58 3.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.016 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -98.24 147.37 33.01 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.347 0.659 . . . . 0.0 111.114 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.19 162.15 37.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.965 2.443 . . . . 0.0 110.767 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.2 t -39.12 -39.42 0.58 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.094 1.758 . . . . 0.0 114.274 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.1 m -64.01 -53.17 54.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.026 0.53 . . . . 0.0 111.591 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.9 -22.16 31.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.222 0.609 . . . . 0.0 110.714 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.421 HH22 ' HB3' ' A' ' 151' ' ' PRO . 75.2 ttt180 -77.88 -55.3 5.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 0.0 109.827 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -60.88 -22.12 63.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.035 0.534 . . . . 0.0 112.289 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.64 -33.84 53.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.7 tp -77.88 -52.7 8.45 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.613 -172.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -56.15 -51.96 76.62 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -168.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.28 -23.35 62.13 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 121.807 1.681 . . . . 0.0 112.109 178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -86.99 -25.5 24.24 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.262 1.025 . . . . 0.0 110.557 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 10.9 t -80.9 -37.73 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.363 -0.836 . . . . 0.0 109.403 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.36 -62.12 2.12 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -74.63 -36.64 62.9 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.36 -34.1 7.25 Favored Glycine 0 N--CA 1.479 1.565 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 -166.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 40.2 tp -69.42 104.32 2.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 117.593 0.697 . . . . 0.0 109.954 175.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.07 141.19 88.91 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 164.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.47 125.5 12.46 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.753 2.302 . . . . 0.0 112.326 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 194' ' ' LYS . . . 129.31 -2.51 6.2 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.711 -177.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.504 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -95.03 139.68 14.63 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 165.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 34.6 m -108.53 129.76 62.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 123.302 0.641 . . . . 0.0 109.555 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 110.97 22.71 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 101' ' ' ILE . 77.4 mt -106.77 106.77 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -171.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 85.7 mt -129.23 153.68 47.54 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.16 0.984 . . . . 0.0 110.193 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.08 106.73 4.86 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.91 134.67 23.77 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.669 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.7 m-85 -89.61 160.04 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.004 0.522 . . . . 0.0 110.95 -172.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.94 152.39 94.99 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.771 1.228 . . . . 0.0 113.064 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.611 ' HA ' HD22 ' A' ' 147' ' ' LEU . 30.7 Cg_endo -64.1 -17.36 59.49 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 C-N-CA 121.814 1.676 . . . . 0.0 111.122 162.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -73.83 -25.19 59.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.321 1.048 . . . . 0.0 111.287 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -64.06 -61.61 2.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.729 0.412 . . . . 0.0 111.799 -165.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.6 mt -79.21 -16.43 56.55 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -60.43 -35.25 75.37 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.183 0.993 . . . . 0.0 110.492 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -74.25 15.6 0.31 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.922 0.889 . . . . 0.0 112.846 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 65.74 35.77 6.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.402 1.081 . . . . 0.0 111.245 172.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.1 p -80.39 -24.45 39.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.649 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.18 64.39 3.28 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.772 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.2 -159.85 1.05 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HB2' HD12 ' A' ' 149' ' ' LEU . 25.7 Cg_endo -58.17 -25.48 71.85 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.75 2.966 . . . . 0.0 114.254 -170.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -173.13 -48.35 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.468 0.707 . . . . 0.0 109.187 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.55 157.87 2.15 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.403 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.5 mt -58.63 -9.2 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.923 1.289 . . . . 0.0 113.228 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.38 -40.02 92.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.765 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 144' ' ' PRO . 17.3 mt -80.91 17.76 1.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 132' ' ' PHE . 25.6 mt -99.71 103.26 20.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HB3' HH22 ' A' ' 110' ' ' ARG . 89.7 Cg_endo -81.22 129.33 6.72 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.611 2.208 . . . . 0.0 112.417 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -92.54 165.58 12.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.013 0.925 . . . . 0.0 112.173 -177.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 188' ' ' ILE . 75.6 mt -56.81 -40.48 76.05 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.942 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.9 -43.57 59.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 0.0 111.037 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 32.5 m -78.41 -54.57 6.04 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.128 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.4 HD13 HD13 ' A' ' 129' ' ' LEU . 85.9 mt -72.03 -46.47 56.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.051 0.94 . . . . 0.0 112.577 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -60.31 -44.05 95.78 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.657 0.783 . . . . 0.0 109.784 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.9 t -72.3 -21.41 61.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.056 0.543 . . . . 0.0 111.819 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -76.9 -23.52 52.55 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.247 0.619 . . . . 0.0 110.542 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 76.3 mt -130.3 75.21 79.51 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.38 -19.48 17.03 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.196 2.598 . . . . 0.0 113.355 -172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -87.87 -42.09 12.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 28.8 tp -69.03 71.16 0.23 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.549 172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.03 131.29 45.87 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -91.29 135.62 33.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.591 1.156 . . . . 0.0 109.317 -169.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.479 HD11 ' HG2' ' A' ' 193' ' ' GLN . 79.1 mt -72.39 -30.01 64.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.064 0.546 . . . . 0.0 110.13 171.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 69.9 mt -131.04 120.85 48.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -155.5 73.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -143.77 152.31 41.09 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.13 0.491 . . . . 0.0 111.982 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -77.94 105.08 8.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.924 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.21 123.75 50.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.549 0.74 . . . . 0.0 109.595 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -86.34 122.7 30.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -98.04 125.06 42.83 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.52 98.31 8.23 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.6 mt -50.53 120.26 4.5 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.131 1.372 . . . . 0.0 110.556 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.82 108.95 1.9 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.737 0.648 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -164.19 -55.0 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.668 0.787 . . . . 0.0 109.202 -173.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.76 52.54 14.77 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.892 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -168.9 1.7 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.085 0.954 . . . . 0.0 111.338 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.62 0.724 . . . . 0.0 109.543 174.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -87.64 159.08 18.69 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.477 169.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.35 -25.43 67.15 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.632 0.373 . . . . 0.0 111.926 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.33 70.83 0.99 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 124.251 0.97 . . . . 0.0 111.48 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -111.88 176.05 5.18 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.954 0.902 . . . . 0.0 110.794 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -157.59 132.67 8.8 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.647 0.779 . . . . 0.0 109.006 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.67 108.82 16.33 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 77.0 mt -117.67 167.66 11.14 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.531 ' HB ' HD21 ' A' ' 153' ' ' LEU . 8.2 pt -142.68 118.62 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.32 145.18 28.45 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 38.3 mt -131.47 131.18 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.889 1.276 . . . . 0.0 109.723 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.09 106.13 6.3 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -86.03 139.46 16.95 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.516 HE21 ' H ' ' A' ' 194' ' ' LYS . 32.7 tp60 -136.11 157.54 46.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.516 ' H ' HE21 ' A' ' 193' ' ' GLN . 59.6 tttp -56.02 120.13 6.97 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 113.325 -1.761 . . . . 0.0 108.961 165.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.56 135.33 54.96 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 172.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -150.48 166.0 31.51 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.02 -8.03 45.8 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.134 0.574 . . . . 0.0 111.854 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -67.99 101.12 1.06 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 168.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -85.98 141.87 29.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.325 0.65 . . . . 0.0 109.638 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -83.51 -49.39 9.31 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -146.95 -167.57 2.81 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.715 1.206 . . . . 0.0 109.636 174.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 62.0 t60 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 124.984 1.314 . . . . 0.0 110.057 178.168 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 54.9 t90 -162.92 141.29 8.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.755 0.822 . . . . 0.0 109.279 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.28 122.35 33.11 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.745 0.818 . . . . 0.0 109.276 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -65.71 101.21 0.6 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -77.38 95.91 4.53 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.733 0.778 . . . . 0.0 111.116 -173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -61.77 -21.7 64.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.07 0.948 . . . . 0.0 112.309 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -66.53 100.7 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -158.48 151.51 22.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 m -70.09 92.66 0.76 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.126 0.57 . . . . 0.0 111.108 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -69.67 -15.46 63.18 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.538 0.735 . . . . 0.0 110.553 172.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -54.59 -19.61 6.32 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.168 1.387 . . . . 0.0 113.199 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.28 97.77 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -66.4 -59.36 3.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.357 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.46 74.49 0.49 Allowed Glycine 0 C--N 1.35 1.358 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -166.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -42.54 110.95 0.2 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.518 1.527 . . . . 0.0 112.999 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.8 99.41 5.7 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.601 1.16 . . . . 0.0 109.059 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.573 ' HD2' ' HE2' ' A' ' 46' ' ' PHE . 77.5 Cg_endo -78.9 -179.26 5.3 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.992 2.461 . . . . 0.0 113.477 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.8 65.67 6.03 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.033 171.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -88.77 153.71 20.86 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -58.58 -30.68 67.36 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 122.954 0.502 . . . . 0.0 110.934 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.681 HD21 ' HG ' ' A' ' 47' ' ' LEU . 20.1 tp -61.81 -33.31 73.89 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.566 1.146 . . . . 0.0 113.077 -174.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -45.9 -40.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -75.87 -46.65 29.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.749 . . . . 0.0 109.85 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -63.23 -35.59 72.63 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.549 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.9 81.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.397 1.079 . . . . 0.0 111.781 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.87 -29.01 70.43 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.448 172.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.604 ' HB3' HE22 ' A' ' 193' ' ' GLN . 27.1 mm-40 -89.75 -21.37 22.7 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.451 1.1 . . . . 0.0 112.557 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 24' ' ' VAL . 77.1 mt -79.08 136.13 57.82 Favored Pre-proline 0 N--CA 1.485 1.31 0 CA-C-O 119.301 -0.38 . . . . 0.0 110.307 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.35 133.96 20.09 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 123.776 2.984 . . . . 0.0 113.537 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.18 27.99 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.16 -139.26 6.15 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 118.716 0.689 . . . . 0.0 112.619 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 40.9 ttmt -86.55 114.89 23.66 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.53 HD13 HG21 ' A' ' 28' ' ' ILE . 11.9 mt -110.64 126.83 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -171.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.519 HD23 HG22 ' A' ' 90' ' ' ILE . 54.2 tp -89.97 114.05 25.82 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 m -88.9 135.22 33.65 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -99.14 152.29 20.03 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.725 0.41 . . . . 0.0 110.186 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . -30.84 104.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 125.671 1.857 . . . . 0.0 114.219 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 7.3 pt-20 -103.75 -157.15 0.6 Allowed 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.975 0.91 . . . . 0.0 109.659 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.21 -65.1 2.16 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.541 -0.299 . . . . 0.0 112.721 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 -19.7 10.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -162.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.21 21.11 59.37 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -166.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -72.32 -52.25 17.04 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 124.421 1.088 . . . . 0.0 110.249 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 101' ' ' ILE . 18.7 m120 -76.07 -29.19 57.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.649 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.43 -57.84 11.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.67 0.788 . . . . 0.0 111.189 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.782 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 25.5 p -69.57 -26.98 64.74 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.362 0.665 . . . . 0.0 112.341 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD1' HD23 ' A' ' 21' ' ' LEU . 38.2 t80 -60.14 -45.55 92.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.454 0.702 . . . . 0.0 109.465 174.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.681 ' HG ' HD21 ' A' ' 21' ' ' LEU . 68.9 mt -65.45 -32.63 74.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.863 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -38.56 74.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.394 0.278 . . . . 0.0 111.515 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.594 ' HA ' HG11 ' A' ' 76' ' ' VAL . 81.3 p -71.62 -6.6 42.14 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 123.245 0.34 . . . . 0.0 111.214 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' LEU . 50.0 mt -90.04 11.97 19.08 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.727 0.811 . . . . 0.0 111.124 168.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.63 21.31 66.75 Favored Glycine 0 C--N 1.351 1.407 0 N-CA-C 114.549 0.58 . . . . 0.0 114.549 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.59 141.2 36.84 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.943 0.872 . . . . 0.0 110.917 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 45.6 mt-10 -77.47 88.53 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -90.63 107.31 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.592 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 34' ' ' LEU . 5.5 t -85.22 103.64 14.36 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 170.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.71 131.93 45.38 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.623 -169.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 81' ' ' VAL . 38.5 t -110.61 134.33 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 20.5 t70 -145.85 140.58 27.15 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 83' ' ' SER . 12.6 pt20 -68.52 -20.78 64.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.591 0.756 . . . . 0.0 111.661 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 m -112.9 141.49 46.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.959 0.904 . . . . 0.0 109.406 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.9 p -72.13 -15.95 61.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.646 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.38 -32.97 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.824 0.449 . . . . 0.0 111.113 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.17 -36.72 23.63 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.621 0.575 . . . . 0.0 113.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.72 -52.03 14.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.625 0.77 . . . . 0.0 111.25 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.38 -36.71 69.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.683 0.793 . . . . 0.0 112.302 172.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -64.3 -45.83 86.24 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.106 0.562 . . . . 0.0 110.572 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.782 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -58.69 -47.91 82.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 124.03 0.831 . . . . 0.0 110.59 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -68.82 -31.83 71.1 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.504 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HA ' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -63.55 -51.93 63.3 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.365 0.666 . . . . 0.0 112.474 176.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 27.8 tp -67.97 -23.27 65.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.314 0.384 . . . . 0.0 110.49 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' A' ' 76' ' ' VAL . . . -61.45 -57.74 10.99 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 122.874 0.47 . . . . 0.0 110.187 172.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.21 -30.55 71.03 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.887 0.875 . . . . 0.0 112.247 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.02 -53.42 26.0 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.121 0.569 . . . . 0.0 111.257 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -98.04 1.72 48.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.616 0.367 . . . . 0.0 111.437 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.56 43.2 69.65 Favored Glycine 0 C--N 1.353 1.517 0 O-C-N 122.321 -0.237 . . . . 0.0 113.484 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 49' ' ' SER . 27.7 m -118.55 169.85 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.579 1.152 . . . . 0.0 109.478 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -112.15 128.7 56.3 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.891 0.476 . . . . 0.0 111.983 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.8 163.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.637 1.575 . . . . 0.0 107.573 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.5 m -136.53 105.18 5.81 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 166.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.0 p -87.34 121.44 29.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.287 -168.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.648 ' HB ' HG22 ' A' ' 57' ' ' VAL . 47.5 t -114.59 135.73 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.261 1.425 . . . . 0.0 108.834 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.11 130.64 35.13 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 59' ' ' GLN . 32.5 t -69.21 118.04 11.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.891 0.476 . . . . 0.0 111.961 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -142.99 86.79 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 167.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.1 mt -78.19 -20.93 50.91 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.13 -13.46 61.19 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 112.187 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.57 -29.39 4.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.285 0.634 . . . . 0.0 111.518 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -159.03 125.41 4.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.524 1.13 . . . . 0.0 108.313 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -70.02 0.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.519 HG22 HD23 ' A' ' 34' ' ' LEU . 7.3 pt -140.2 119.22 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.134 0.974 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -130.8 98.33 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.91 0.884 . . . . 0.0 108.722 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.29 -9.53 5.32 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.85 -52.83 21.58 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.196 0.598 . . . . 0.0 110.812 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.62 -29.34 66.82 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -169.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.441 ' CZ3' HG12 ' A' ' 98' ' ' ILE . 11.1 p-90 -133.62 176.28 8.69 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.673 0.789 . . . . 0.0 110.938 -172.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.15 -90.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.301 0.64 . . . . 0.0 111.229 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.87 172.13 41.89 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 118.448 0.567 . . . . 0.0 113.509 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 121' ' ' LEU . 5.9 mt -123.09 150.86 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.55 0.74 . . . . 0.0 109.025 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.408 HG12 HG22 ' A' ' 33' ' ' ILE . 14.1 p -144.46 134.53 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 163.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -133.02 99.2 4.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 30.4 mm -74.88 154.75 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.258 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -18.42 104.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.067 2.147 . . . . 0.0 113.592 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.8 p -139.05 148.96 44.06 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.63 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.419 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 6.3 p-80 -147.16 101.64 3.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.09 143.29 26.18 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.544 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.2 158.57 47.68 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.652 2.234 . . . . 0.0 110.732 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 t -45.59 -36.41 4.69 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.38 1.472 . . . . 0.0 113.737 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 p -56.28 -58.81 6.37 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.355 1.062 . . . . 0.0 111.997 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.25 -19.09 37.03 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.859 0.864 . . . . 0.0 111.07 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -77.94 -47.25 19.06 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.647 0.779 . . . . 0.0 109.438 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -52.79 -34.49 53.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.903 0.881 . . . . 0.0 111.783 164.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -75.67 -44.27 43.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 117' ' ' VAL . 49.2 tp -92.19 -55.56 3.38 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -170.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.67 -40.02 6.24 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 119.623 1.101 . . . . 0.0 112.479 -161.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.37 -28.92 87.71 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 122.281 1.987 . . . . 0.0 112.044 166.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 113' ' ' LEU . 5.5 tppp? -77.42 -24.77 50.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.396 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 113' ' ' LEU . 41.6 t -72.13 -34.18 49.23 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.364 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -53.93 -62.39 1.69 Allowed 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.69 -33.66 35.24 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.74 -27.22 57.28 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 114.139 0.416 . . . . 0.0 114.139 -171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 98' ' ' ILE . 26.8 tp -60.7 128.37 36.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.882 0.473 . . . . 0.0 110.604 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 148.56 34.68 Favored Pre-proline 0 C--O 1.248 1.011 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.74 113.28 1.76 Allowed 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.74 1.626 . . . . 0.0 111.201 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.566 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 128.31 6.15 4.88 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.017 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -101.53 143.59 16.14 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 164.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.2 m -110.78 130.67 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.566 0.746 . . . . 0.0 109.16 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CE2' HD11 ' A' ' 129' ' ' LEU . 8.8 t80 -106.61 112.55 25.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.599 HD11 HG21 ' A' ' 24' ' ' VAL . 55.6 mt -115.43 109.01 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.995 0.918 . . . . 0.0 110.25 -168.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 127' ' ' PHE . 89.0 mt -128.96 133.91 47.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.354 0.662 . . . . 0.0 110.073 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -113.09 98.84 7.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 168.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.522 ' HA2' ' HD2' ' A' ' 151' ' ' PRO . . . -88.92 -174.49 46.78 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.721 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.408 ' HB2' HD22 ' A' ' 150' ' ' LEU . 64.6 m-85 -138.56 159.54 41.84 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.08 0.952 . . . . 0.0 108.565 -177.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.28 162.96 22.95 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.743 0.817 . . . . 0.0 110.454 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -59.45 -12.77 18.08 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.22 2.614 . . . . 0.0 114.347 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.21 -11.86 59.88 Favored 'General case' 0 CA--C 1.563 1.452 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.46 -57.71 4.18 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.368 0.667 . . . . 0.0 112.459 -167.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.472 HD22 ' H ' ' A' ' 143' ' ' GLY . 12.4 mt -75.42 -13.45 60.39 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -69.15 -23.98 64.02 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.657 0.783 . . . . 0.0 110.336 171.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -80.27 9.9 5.18 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.749 0.82 . . . . 0.0 112.722 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 64.98 33.99 9.3 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.272 1.029 . . . . 0.0 110.21 177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -77.55 -27.56 51.59 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.917 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.32 58.97 7.82 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.614 0.571 . . . . 0.0 112.075 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.472 ' H ' HD22 ' A' ' 137' ' ' LEU . . . -63.9 -170.46 1.83 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 114.521 0.568 . . . . 0.0 114.521 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.05 -36.83 77.81 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.876 3.05 . . . . 0.0 114.453 -167.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -163.53 -54.47 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.364 0.666 . . . . 0.0 109.384 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -160.37 156.66 26.56 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.964 -167.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.661 ' HA ' ' HG ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -58.17 -8.54 1.12 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.141 1.377 . . . . 0.0 113.536 179.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.35 -35.11 79.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.049 0.94 . . . . 0.0 110.707 170.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.9 mt -88.58 13.37 12.27 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.078 0.951 . . . . 0.0 112.053 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.661 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 36.4 mt -89.75 103.85 7.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD2' ' HA2' ' A' ' 131' ' ' GLY . 14.5 Cg_exo -67.74 103.58 0.86 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.079 2.52 . . . . 0.0 111.729 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 188' ' ' ILE . 16.4 ptpt -100.43 152.4 20.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 118.284 0.493 . . . . 0.0 112.185 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.3 -38.05 87.9 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.79 0.836 . . . . 0.0 110.881 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -48.23 -52.63 20.21 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.267 1.027 . . . . 0.0 111.143 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 40.0 p -76.41 -61.91 1.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.201 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.69 -46.84 86.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.307 1.043 . . . . 0.0 112.787 -166.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -64.87 -33.27 75.61 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 123.229 0.33 . . . . 0.0 111.185 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.2 t -78.61 -23.32 45.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.568 0.347 . . . . 0.0 111.098 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -86.72 -12.3 48.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.684 0.794 . . . . 0.0 111.251 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.89 64.53 42.47 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.684 0.794 . . . . 0.0 109.156 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.13 4.34 7.15 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.814 2.343 . . . . 0.0 111.786 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 t -87.52 -34.58 18.57 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.498 HD13 HD21 ' A' ' 121' ' ' LEU . 25.7 tp -97.97 73.6 2.26 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 125.973 1.709 . . . . 0.0 110.878 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -57.36 124.28 18.35 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 12.4 m95 -89.33 139.77 30.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.591 1.156 . . . . 0.0 109.561 -170.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.658 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 96.3 mt -68.09 -44.98 75.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 169.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 191' ' ' LEU . 79.0 mt -126.4 120.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.37 78.2 1.27 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -143.62 152.57 41.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.004 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.626 ' H ' HD22 ' A' ' 170' ' ' ASN . 0.1 OUTLIER -87.05 120.42 28.3 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.87 173.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.05 106.36 17.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -85.88 123.51 31.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.878 0.871 . . . . 0.0 109.558 -173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -96.13 130.26 43.22 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.673 1.189 . . . . 0.0 110.486 -177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -81.0 106.41 12.97 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.1 mt -82.76 160.15 22.36 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.0 125.44 44.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.73 177.24 11.2 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.362 0.665 . . . . 0.0 109.852 176.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.07 59.17 0.55 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -149.91 -170.57 3.68 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.815 0.846 . . . . 0.0 109.941 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -92.78 9.81 33.54 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.35 0.66 . . . . 0.0 110.892 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -75.25 148.95 39.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.154 0.982 . . . . 0.0 110.071 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -63.01 94.85 0.07 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.8 34.77 2.94 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.887 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -109.64 -177.31 3.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.238 1.015 . . . . 0.0 109.155 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -147.82 131.12 16.54 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.25 111.54 22.37 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 41.5 mt -122.33 151.7 40.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 152' ' ' LYS . 9.2 pt -139.19 142.84 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -124.94 145.29 49.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.591 0.71 . . . . 0.0 110.5 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.56 135.74 48.21 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.013 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 24' ' ' VAL . 16.6 tp -140.24 105.12 4.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -86.67 133.2 11.63 Favored Glycine 0 C--O 1.219 -0.783 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.658 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 7.8 tp60 -120.18 146.44 46.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.566 0.683 . . . . 0.0 111.35 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.566 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -62.12 138.17 58.36 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.581 0.551 . . . . 0.0 109.559 168.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.1 mt -72.99 146.24 46.12 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.81 -3.49 6.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.607 0.763 . . . . 0.0 112.152 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -51.22 -36.77 43.29 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.946 1.299 . . . . 0.0 111.028 165.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -93.35 133.69 36.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.44 0.696 . . . . 0.0 110.085 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -69.23 147.07 51.77 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.753 0.658 . . . . 0.0 110.478 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -84.08 -49.76 8.59 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.9 t60 58.35 78.22 0.26 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.274 1.43 . . . . 0.0 110.219 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 . . . . . 0 CA--C 1.549 0.913 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.138 179.21 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.925 0.393 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -93.5 154.22 18.02 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.547 0.739 . . . . 0.0 109.92 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -94.53 147.17 23.55 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.184 0.594 . . . . 0.0 110.758 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -90.13 118.37 29.61 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.759 0.824 . . . . 0.0 109.395 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -68.12 106.77 2.5 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.607 0.763 . . . . 0.0 109.759 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.55 117.93 19.47 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.4 t -67.08 152.95 44.83 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.992 0.917 . . . . 0.0 110.586 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 -114.19 142.61 46.03 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.1 t -150.65 85.77 1.38 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.024 0.53 . . . . 0.0 109.745 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.21 95.55 4.73 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.659 0.783 . . . . 0.0 109.197 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -80.43 67.71 6.37 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.13 113.21 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -163.86 89.7 0.58 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.89 78.1 0.36 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -139.53 105.1 5.1 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.267 0.627 . . . . 0.0 110.43 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -151.81 71.91 8.02 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.933 0.893 . . . . 0.0 109.021 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' O ' HG21 ' A' ' 22' ' ' VAL . 1.6 Cg_endo -84.24 161.17 13.27 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.009 2.473 . . . . 0.0 110.616 172.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.84 78.61 1.16 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.728 0.775 . . . . 0.0 109.535 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.682 ' HB2' HG13 ' A' ' 22' ' ' VAL . 12.2 m-20 -124.63 163.17 22.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.188 0.995 . . . . 0.0 109.789 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -66.15 -34.54 78.28 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.5 tp -68.46 -21.39 64.63 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.383 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG13 ' HB2' ' A' ' 19' ' ' ASP . 11.2 m -86.46 -28.91 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 119.007 0.822 . . . . 0.0 109.434 -177.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -74.83 -44.67 48.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.993 0.917 . . . . 0.0 110.001 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 28' ' ' ILE . 19.0 m -64.16 -37.04 78.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.6 171.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.14 -26.02 67.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.16 -26.6 65.84 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.129 0.572 . . . . 0.0 109.728 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.721 ' HB3' HE21 ' A' ' 193' ' ' GLN . 24.0 mm-40 -88.74 -25.96 22.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.973 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 24' ' ' VAL . 47.9 mt -73.71 130.25 83.87 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.26 132.95 29.58 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.231 2.621 . . . . 0.0 112.835 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -74.58 27.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.96 -134.91 5.76 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -82.15 114.91 21.0 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.7 151.2 11.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 95' ' ' TRP . 66.9 tp -119.61 120.45 36.73 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 56' ' ' ALA . 28.5 p -108.7 126.68 53.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.86 -172.42 1.3 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.632 0.373 . . . . 0.0 111.297 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . . . -48.84 88.69 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.599 0.76 . . . . 0.0 111.056 166.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.666 ' HB3' HD22 ' A' ' 43' ' ' ASN . 7.7 mm-40 -67.0 154.69 40.55 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.375 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -24.42 54.16 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 123.591 0.557 . . . . 0.0 113.105 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 42' ' ' ARG . 43.7 tt0 -150.43 145.86 26.31 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.23 1.012 . . . . 0.0 109.247 175.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.5 -22.92 66.27 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 123.214 0.435 . . . . 0.0 113.769 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.529 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 70.8 mtt180 -61.98 -35.14 77.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.386 0.674 . . . . 0.0 112.049 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.666 HD22 ' HB3' ' A' ' 38' ' ' GLU . 53.5 m-20 -56.15 -52.31 64.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.876 0.735 . . . . 0.0 111.099 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.51 -54.16 50.04 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 124.317 1.011 . . . . 0.0 111.8 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 6.2 p -67.89 -28.93 67.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.791 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 84.1 t80 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.446 0.698 . . . . 0.0 110.079 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.572 HD13 HG11 ' A' ' 99' ' ' VAL . 50.9 mt -65.03 -35.85 82.51 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.829 0.852 . . . . 0.0 111.228 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.45 63.65 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.394 0.278 . . . . 0.0 111.247 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.527 ' HA ' HG11 ' A' ' 76' ' ' VAL . 50.4 m -61.71 -23.05 65.88 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.355 0.662 . . . . 0.0 111.092 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.0 mt -78.23 12.39 1.92 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.988 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.51 66.59 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.475 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -103.41 152.98 20.97 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.252 0.526 . . . . 0.0 111.274 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -90.96 91.06 8.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.5 t -98.87 126.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.403 0.681 . . . . 0.0 109.985 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 m -99.77 111.69 24.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.738 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -96.68 139.53 32.61 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.814 0.446 . . . . 0.0 110.304 -172.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.0 t -118.28 150.09 20.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 164.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 27.8 t0 -157.99 144.57 17.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.288 0.495 . . . . 0.0 109.893 172.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.33 -20.47 66.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.073 0.858 . . . . 0.0 112.02 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 62' ' ' VAL . 1.9 m -108.92 140.32 42.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.158 0.983 . . . . 0.0 109.325 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 m -69.44 -29.23 66.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.784 0.434 . . . . 0.0 110.85 169.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 60' ' ' SER . 11.0 m -61.66 -35.25 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.829 0.706 . . . . 0.0 111.976 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.01 -35.37 35.01 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.53 0.519 . . . . 0.0 112.81 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.84 -50.97 62.68 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.56 0.744 . . . . 0.0 110.435 174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.13 76.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.158 0.983 . . . . 0.0 112.589 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -62.93 -43.81 97.77 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.429 0.692 . . . . 0.0 110.141 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -63.61 -46.02 87.67 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.28 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -67.24 -42.96 83.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.674 0.79 . . . . 0.0 110.782 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.49 -54.52 42.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.31 1.044 . . . . 0.0 111.627 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.513 HD23 ' SG ' ' A' ' 45' ' ' CYS . 30.5 tp -65.95 -28.82 69.19 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.923 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -63.78 -62.94 1.32 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.457 0.473 . . . . 0.0 111.062 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.62 -25.57 67.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.145 0.578 . . . . 0.0 111.274 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.79 -54.74 14.13 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.739 0.415 . . . . 0.0 109.904 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -82.28 -5.32 58.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.98 0.512 . . . . 0.0 112.083 -171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.58 34.15 40.64 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 121.923 -0.179 . . . . 0.0 113.064 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.0 m -125.21 170.46 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.633 1.173 . . . . 0.0 108.416 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -121.45 138.28 54.35 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 71' ' ' ALA . 9.2 mm -116.61 167.2 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 167.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -133.99 105.49 6.76 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 165.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.3 p -89.72 137.25 32.5 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.667 0.746 . . . . 0.0 111.576 -167.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 57' ' ' VAL . 58.8 t -125.05 135.0 65.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.324 1.849 . . . . 0.0 107.845 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -83.18 139.84 32.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 p -48.98 109.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.246 1.018 . . . . 0.0 113.144 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -136.58 93.7 2.91 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 90.8 mt -103.15 -35.25 8.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.141 0.577 . . . . 0.0 111.822 -170.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.09 -5.83 50.44 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.045 0.538 . . . . 0.0 112.117 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -116.23 -28.64 6.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.983 0.913 . . . . 0.0 111.174 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 47.3 t80 -157.79 156.09 30.93 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 125.166 1.387 . . . . 0.0 107.696 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.56 -70.58 0.17 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.407 1.458 . . . . 0.0 108.927 163.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.648 ' HB ' HD13 ' A' ' 98' ' ' ILE . 13.5 pt -139.5 118.77 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.359 0.664 . . . . 0.0 110.268 -172.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 82.0 t -128.42 86.56 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HB3' ' H ' ' A' ' 122' ' ' LYS . . . -72.2 1.96 6.74 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.29 -47.87 69.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 165.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.35 -11.79 39.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.066 0.947 . . . . 0.0 111.962 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 34' ' ' LEU . 60.4 m95 -120.3 117.77 28.67 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.612 0.765 . . . . 0.0 110.119 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -58.46 -47.62 83.4 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.677 0.791 . . . . 0.0 111.366 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.97 156.28 18.11 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.924 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.648 HD13 ' HB ' ' A' ' 90' ' ' ILE . 55.3 mt -129.47 148.52 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 171.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 47' ' ' LEU . 4.3 p -135.27 143.12 37.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.759 1.224 . . . . 0.0 107.99 161.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.425 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 50.0 m -143.63 102.17 3.89 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.66 83.96 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 27.1 t80 -74.54 117.84 16.82 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.345 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.5 p -113.49 173.65 6.3 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -55.56 101.23 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.514 0.726 . . . . 0.0 110.721 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.16 139.81 42.37 Favored Pre-proline 0 C--O 1.247 0.961 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.61 144.9 24.16 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.838 2.359 . . . . 0.0 110.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -43.33 -34.61 1.27 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.713 1.205 . . . . 0.0 113.495 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 t -56.55 -64.25 0.93 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.45 1.1 . . . . 0.0 111.506 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.78 -30.74 65.87 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.728 0.411 . . . . 0.0 111.324 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -63.62 -62.4 1.69 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.682 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.49 -30.77 67.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -73.77 -33.95 64.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.178 0.591 . . . . 0.0 110.516 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.18 -48.48 62.08 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.855 0.722 . . . . 0.0 111.314 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -57.63 -44.31 99.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -166.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.41 -28.08 83.46 Favored 'Trans proline' 0 C--N 1.393 2.89 0 CA-C-N 122.077 1.778 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -88.18 -12.38 44.05 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.026 0.931 . . . . 0.0 111.296 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 3.4 t -85.32 -33.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 165.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -66.07 -61.5 2.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.697 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.8 -47.78 16.04 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.83 -39.34 39.51 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 -166.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.595 ' HB3' ' O ' ' A' ' 117' ' ' VAL . 28.4 tp -70.9 96.2 1.25 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.383 0.611 . . . . 0.0 109.429 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.555 ' H ' ' HB3' ' A' ' 92' ' ' ALA . 30.0 mmmt -67.0 130.13 93.93 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HB3' ' HG3' ' A' ' 194' ' ' LYS . 27.5 Cg_exo -39.85 123.44 1.23 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.422 3.415 . . . . 0.0 114.547 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.99 14.78 2.98 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.704 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -121.88 150.47 17.04 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 167.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 20.4 m -109.84 131.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 123.264 0.626 . . . . 0.0 109.943 -174.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.3 t80 -110.37 113.06 25.43 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.51 111.7 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.792 0.837 . . . . 0.0 109.865 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.584 HD22 HD13 ' A' ' 156' ' ' LEU . 2.1 mp -129.18 149.5 50.96 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.302 0.641 . . . . 0.0 110.068 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 45.2 tt0 -135.67 103.64 5.5 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.803 0.689 . . . . 0.0 109.253 175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.6 148.33 27.59 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 170.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.44 ' HB2' HD22 ' A' ' 150' ' ' LEU . 29.1 m-85 -111.04 168.28 9.62 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.609 0.763 . . . . 0.0 110.39 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -76.35 164.07 62.2 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.25 1.02 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.742 ' HA ' HD22 ' A' ' 147' ' ' LEU . 83.5 Cg_exo -50.29 -21.84 7.61 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.398 2.732 . . . . 0.0 113.715 165.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.01 -24.76 62.44 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.752 1.221 . . . . 0.0 112.092 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -71.27 -57.72 4.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -163.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.418 ' HG ' ' HG ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -61.36 -37.09 82.08 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.543 0.737 . . . . 0.0 110.273 177.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -60.0 -43.33 95.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 124.66 1.225 . . . . 0.0 110.842 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -78.36 -21.34 49.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.439 0.696 . . . . 0.0 110.409 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.71 20.76 12.39 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.369 1.468 . . . . 0.0 111.057 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.5 p -88.13 8.43 26.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.17 0.988 . . . . 0.0 111.908 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.87 52.66 0.02 OUTLIER Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.31 3.7 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.121 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -71.75 -71.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.7 2.267 . . . . 0.0 112.907 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -128.04 -52.21 1.32 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.908 0.883 . . . . 0.0 109.517 -173.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.82 150.92 25.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.099 0.959 . . . . 0.0 108.551 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.742 HD22 ' HA ' ' A' ' 134' ' ' PRO . 1.1 mt -52.4 -9.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.18 1.792 . . . . 0.0 113.812 173.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.46 -39.25 79.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.129 0.571 . . . . 0.0 110.206 171.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.69 1.65 22.21 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 123.41 0.684 . . . . 0.0 112.491 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 59.5 mt -81.72 108.17 10.32 Favored Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.718 ' HB2' HD11 ' A' ' 156' ' ' LEU . 65.3 Cg_endo -83.34 123.88 3.55 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.315 2.01 . . . . 0.0 111.79 -175.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -86.65 159.09 19.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.141 0.976 . . . . 0.0 111.95 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 188' ' ' ILE . 71.7 mt -61.61 -36.63 81.27 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 166.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.23 -50.45 72.82 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.01 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 159' ' ' GLU . 73.5 p -68.75 -62.33 1.43 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.299 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 151' ' ' PRO . 70.8 mt -61.84 -49.93 74.31 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.81 1.244 . . . . 0.0 112.952 -166.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.664 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.5 tt0 -58.47 -43.19 88.85 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 123.685 0.616 . . . . 0.0 111.426 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 t -73.13 -23.23 60.46 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.463 0.305 . . . . 0.0 111.594 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 155' ' ' THR . 53.9 mt-10 -80.86 -18.04 48.68 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.684 0.793 . . . . 0.0 111.399 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 97.0 mt -133.65 66.73 74.17 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.311 0.644 . . . . 0.0 110.507 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.35 2.97 7.89 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.783 2.322 . . . . 0.0 112.309 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 41.1 m -86.02 -35.23 20.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.4 tp -102.14 70.19 1.19 Allowed 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.002 1.721 . . . . 0.0 110.663 -176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -64.98 136.88 57.32 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.664 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 19.3 m95 -96.98 136.92 36.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.512 0.725 . . . . 0.0 110.545 -163.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 46.2 mt -68.33 -30.02 68.9 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.634 0.584 . . . . 0.0 109.729 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 67.0 mt -132.01 125.09 54.29 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.38 66.38 0.7 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -128.97 143.71 50.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.655 -162.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -89.96 99.32 12.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.386 1.075 . . . . 0.0 109.535 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 74.7 mt -108.19 129.92 55.16 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.359 1.064 . . . . 0.0 111.56 -174.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.81 131.14 41.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.113 0.565 . . . . 0.0 109.946 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 184' ' ' LYS . 21.4 ttt180 -107.63 131.94 53.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.98 0.912 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -71.93 104.53 3.53 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.696 0.623 . . . . 0.0 111.709 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 185' ' ' ALA . 17.4 mt -83.66 169.23 15.54 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.594 165.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.36 141.83 58.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.469 0.308 . . . . 0.0 110.672 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 182' ' ' GLN . 35.5 tt0 -94.59 143.73 26.19 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.444 0.698 . . . . 0.0 110.254 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.48 -64.42 0.01 OUTLIER Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.58 -172.36 3.56 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.909 0.884 . . . . 0.0 110.156 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -53.39 -33.22 52.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.192 0.597 . . . . 0.0 110.569 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.402 ' HE1' HD12 ' A' ' 175' ' ' LEU . 57.6 t-80 -59.66 93.7 0.02 OUTLIER 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.737 -1.12 . . . . 0.0 107.991 167.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.589 ' HA ' ' HG3' ' A' ' 177' ' ' GLU . 9.4 pt20 -70.69 3.15 3.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.781 0.832 . . . . 0.0 112.907 -174.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.22 61.22 1.2 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.078 167.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -127.03 172.03 10.84 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.336 0.589 . . . . 0.0 110.177 158.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -145.3 132.36 20.35 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.193 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -74.99 107.31 6.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.058 0.849 . . . . 0.0 108.959 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.97 149.48 40.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 19.8 pt -132.54 117.24 30.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -98.55 144.58 27.72 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.375 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 167' ' ' ILE . 48.6 mt -128.63 137.21 51.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.53 -1.213 . . . . 0.0 109.525 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.475 HD22 HG12 ' A' ' 24' ' ' VAL . 33.3 tp -135.11 105.08 6.17 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -90.92 138.14 14.21 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 176.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.721 HE21 ' HB3' ' A' ' 27' ' ' GLN . 7.1 tp-100 -143.52 157.43 44.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.299 0.64 . . . . 0.0 110.752 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 123' ' ' PRO . 62.9 tttm -56.29 120.74 8.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.265 1.026 . . . . 0.0 109.207 172.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.99 116.14 10.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.58 0.352 . . . . 0.0 111.536 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.51 132.87 12.79 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.732 0.645 . . . . 0.0 109.835 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -163.64 32.02 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.673 1.189 . . . . 0.0 107.98 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.504 ' O ' ' HB3' ' A' ' 201' ' ' HIS . 34.1 t60 68.35 114.71 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.693 1.597 . . . . 0.0 109.056 -166.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -74.02 150.86 40.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.035 0.534 . . . . 0.0 109.795 174.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 15.3 m170 70.77 11.35 7.16 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.818 1.247 . . . . 0.0 111.749 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 198' ' ' HIS . 16.5 t-80 -109.66 110.51 21.58 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.564 1.145 . . . . 0.0 107.975 172.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.646 0.778 . . . . 0.0 109.084 -179.168 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.075 0.464 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -159.12 156.21 28.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.682 0.793 . . . . 0.0 110.099 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' HB2' ' NH1' ' A' ' 5' ' ' ARG . 8.0 p-10 -160.58 142.66 12.65 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.476 1.11 . . . . 0.0 108.686 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -150.45 125.06 9.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 111.876 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -133.67 155.7 49.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.278 1.431 . . . . 0.0 107.544 165.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -156.14 127.65 7.21 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 111.38 23.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.561 0.745 . . . . 0.0 109.437 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -87.56 152.59 22.08 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.711 0.804 . . . . 0.0 108.854 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.0 t -145.91 98.3 3.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -84.4 83.42 8.0 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.12 0.568 . . . . 0.0 109.513 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -61.44 125.22 22.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.335 1.054 . . . . 0.0 111.532 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.27 111.95 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.715 0.806 . . . . 0.0 109.33 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -93.13 108.5 20.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.262 1.025 . . . . 0.0 109.34 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.54 105.49 2.83 Favored Glycine 0 N--CA 1.467 0.761 0 O-C-N 123.624 0.577 . . . . 0.0 111.963 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -90.24 79.92 6.31 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.294 0.568 . . . . 0.0 110.302 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -93.16 114.84 63.89 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 123.416 0.687 . . . . 0.0 110.546 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.01 -177.31 3.56 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.745 2.297 . . . . 0.0 111.906 169.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -155.45 139.59 16.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.089 0.956 . . . . 0.0 108.987 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -162.07 177.49 9.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.217 0.607 . . . . 0.0 109.768 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.3 -23.51 65.75 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.486 1.114 . . . . 0.0 110.245 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.7 tp -56.98 -17.73 10.88 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.811 1.244 . . . . 0.0 112.747 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.55 -27.46 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.516 1.053 . . . . 0.0 109.398 -171.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 17.4 m -66.68 -52.69 41.9 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.473 0.709 . . . . 0.0 109.422 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 HD22 ' A' ' 191' ' ' LEU . 19.3 m -65.98 -37.09 79.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.9 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 28' ' ' ILE . . . -58.68 -42.18 87.9 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.273 1.029 . . . . 0.0 112.25 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.51 -23.65 64.58 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.858 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.756 ' HB3' HE22 ' A' ' 193' ' ' GLN . 12.5 mm100 -83.91 -14.24 51.52 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.263 0.625 . . . . 0.0 111.366 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 42.1 mt -82.89 128.94 63.7 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.275 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -51.15 140.05 41.82 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 123.122 2.548 . . . . 0.0 113.063 169.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.21 27.41 0.05 Allowed 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.42 -136.77 6.56 Favored Glycine 0 N--CA 1.476 1.302 0 CA-C-O 119.397 -0.669 . . . . 0.0 112.919 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -75.21 112.7 11.75 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -107.92 116.04 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.64 113.79 26.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.01 0.524 . . . . 0.0 110.208 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 8.8 t -104.05 108.57 19.99 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 122.451 0.3 . . . . 0.0 111.531 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 90' ' ' ILE . 61.7 mt -81.26 123.41 28.46 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.646 174.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 45.85 68.82 0.53 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 125.153 1.533 . . . . 0.0 111.255 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.567 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -68.87 169.11 12.14 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.156 -169.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.45 68.83 3.48 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.75 -174.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 60.79 74.4 0.45 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.561 1.144 . . . . 0.0 113.5 166.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.2 -73.81 0.54 Allowed Glycine 0 N--CA 1.478 1.497 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtm105 -55.64 -26.69 45.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.786 1.234 . . . . 0.0 113.557 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.466 HD22 ' HB2' ' A' ' 38' ' ' GLU . 4.8 t30 -63.72 -54.63 32.51 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.351 0.661 . . . . 0.0 111.304 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.35 74.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.983 0.802 . . . . 0.0 110.808 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 26.5 m -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.906 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 89.0 t80 -66.14 -51.88 53.7 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.697 0.623 . . . . 0.0 109.6 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD13 HG11 ' A' ' 99' ' ' VAL . 93.4 mt -61.38 -37.02 81.89 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.437 1.086 . . . . 0.0 110.901 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.71 66.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.312 0.645 . . . . 0.0 112.078 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.633 ' HA ' HG11 ' A' ' 76' ' ' VAL . 96.1 p -70.32 -2.78 14.54 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 49.2 mt -82.76 12.96 4.17 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.028 0.531 . . . . 0.0 110.501 168.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.44 32.82 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 119.846 -0.419 . . . . 0.0 113.925 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -126.8 158.87 35.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.352 0.576 . . . . 0.0 111.141 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.4 91.31 6.15 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.755 0.822 . . . . 0.0 108.98 174.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.95 110.45 23.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.993 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 79' ' ' THR . 47.4 p -84.88 105.48 15.69 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.073 173.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -100.0 129.2 46.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.245 0.618 . . . . 0.0 110.772 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.25 123.62 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.32 134.44 25.72 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -67.03 -2.45 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.66 1.184 . . . . 0.0 113.329 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 m -119.93 119.61 33.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.453 1.101 . . . . 0.0 108.788 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.2 m -73.44 -24.95 60.31 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.306 0.642 . . . . 0.0 110.291 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.25 -35.88 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.776 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.01 -35.16 58.03 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.747 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.63 -49.71 69.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.494 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.414 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.611 0.764 . . . . 0.0 112.043 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -66.23 -46.28 77.75 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.874 0.87 . . . . 0.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.531 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -63.59 -40.92 98.17 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.99 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 65' ' ' ALA . 36.6 ttpt -65.49 -45.05 85.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.462 1.105 . . . . 0.0 110.938 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 -51.55 68.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.105 0.962 . . . . 0.0 110.872 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.37 -30.59 70.63 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.172 0.92 . . . . 0.0 111.022 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.602 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -64.05 -61.37 2.31 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.505 0.503 . . . . 0.0 111.256 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.12 -24.39 65.01 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.341 0.656 . . . . 0.0 110.842 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.44 -35.24 75.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.932 0.893 . . . . 0.0 110.44 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.83 -10.41 45.47 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.39 0.676 . . . . 0.0 111.251 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.63 36.16 20.48 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 113.633 0.213 . . . . 0.0 113.633 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 49' ' ' SER . 19.4 m -132.32 174.58 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.373 1.069 . . . . 0.0 110.048 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.25 129.46 54.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.0 0.92 . . . . 0.0 111.814 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 71' ' ' ALA . 14.1 mm -108.68 166.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 162.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 55' ' ' THR . 90.3 m -134.06 110.59 9.74 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 160.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.4 p -81.94 120.47 25.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 44.9 t -95.65 153.46 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.727 1.211 . . . . 0.0 109.693 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -85.81 103.59 14.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.6 p -46.9 99.92 0.02 OUTLIER 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.55 1.14 . . . . 0.0 112.672 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -141.0 96.57 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 91.9 mt -103.79 -15.02 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.033 0.933 . . . . 0.0 112.424 -176.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.48 -18.18 32.32 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.533 0.733 . . . . 0.0 112.651 -174.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.42 -10.9 3.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.759 0.823 . . . . 0.0 111.495 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.2 t80 -151.68 157.62 42.33 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -153.84 -57.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.37 -0.831 . . . . 0.0 109.86 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 117' ' ' VAL . 3.1 pt -151.81 134.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.885 1.274 . . . . 0.0 109.322 -168.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 93' ' ' ASP . 84.4 t -123.64 150.99 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.305 1.042 . . . . 0.0 108.215 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.27 -29.63 19.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.296 0.57 . . . . 0.0 110.27 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' H ' HG12 ' A' ' 91' ' ' VAL . 23.3 t70 -70.34 -51.66 28.36 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.262 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.34 -25.9 33.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.161 0.584 . . . . 0.0 112.362 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.425 ' HD1' ' H ' ' A' ' 91' ' ' VAL . 57.1 m95 -111.81 107.08 16.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.06 0.457 . . . . 0.0 110.865 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.83 -56.88 12.07 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.165 1.386 . . . . 0.0 109.525 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.22 143.06 15.63 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.47 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.557 HD13 ' HB ' ' A' ' 90' ' ' ILE . 87.7 mt -124.9 127.26 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 168.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 7.7 p -123.12 102.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.308 1.052 . . . . 0.0 109.732 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.415 ' HB2' ' HD1' ' A' ' 127' ' ' PHE . 46.6 m -97.33 91.59 5.57 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 31.7 mm -72.37 150.36 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.869 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -17.92 105.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 127.258 2.223 . . . . 0.0 113.46 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 19.8 p -111.38 106.26 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.549 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -98.09 99.53 10.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.2 mt -114.81 146.07 35.29 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.735 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.583 ' HA ' HD13 ' A' ' 149' ' ' LEU . 35.8 Cg_exo -61.69 155.4 54.06 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.963 2.442 . . . . 0.0 110.715 167.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 94.6 p -46.3 -38.66 8.96 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.979 0.912 . . . . 0.0 112.752 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.8 m -56.0 -52.41 64.31 Favored 'General case' 0 CA--C 1.552 1.022 0 O-C-N 123.925 0.766 . . . . 0.0 111.986 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.96 -22.04 31.57 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.236 0.615 . . . . 0.0 111.039 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -76.08 -52.43 10.18 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.4 -14.23 62.85 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.746 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.2 -39.56 25.23 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 117' ' ' VAL . 64.2 tp -75.52 -60.25 2.39 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.033 0.533 . . . . 0.0 111.933 -171.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -58.94 -43.72 97.99 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -164.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.8 -23.38 26.13 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 121.774 1.649 . . . . 0.0 112.04 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -86.17 -14.65 43.4 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.783 0.833 . . . . 0.0 110.16 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.598 ' HA ' HD11 ' A' ' 90' ' ' ILE . 28.9 t -75.27 -40.18 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 166.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.78 -54.16 50.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.109 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.2 -46.79 63.83 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.313 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.58 -57.27 3.92 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.376 0.511 . . . . 0.0 114.376 -172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' A' ' 90' ' ' ILE . 6.0 tt -74.6 138.28 42.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.553 0.741 . . . . 0.0 109.817 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -120.05 168.54 10.17 Favored Pre-proline 0 C--O 1.247 0.933 0 C-N-CA 124.622 1.169 . . . . 0.0 108.583 172.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.07 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 122.003 1.802 . . . . 0.0 112.042 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.72 -2.05 4.42 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.176 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 98' ' ' ILE . . . -114.52 145.03 18.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 159.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.2 131.5 58.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.87 1.268 . . . . 0.0 109.447 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 1.2 t80 -106.37 111.71 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.24 107.82 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 91.3 mt -118.35 141.02 48.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.753 0.821 . . . . 0.0 110.669 -174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -127.15 101.43 6.51 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 164.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 179.6 53.19 Favored Glycine 0 C--O 1.238 0.401 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 164.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.495 ' H ' HD22 ' A' ' 150' ' ' LEU . 36.0 m-85 -130.16 169.37 15.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 186' ' ' ALA . . . -100.9 154.31 37.23 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 123.116 0.566 . . . . 0.0 110.174 172.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.08 -6.77 5.38 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.409 2.74 . . . . 0.0 114.023 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -25.59 7.94 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.099 0.96 . . . . 0.0 112.535 171.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.564 ' HB3' HD22 ' A' ' 147' ' ' LEU . 56.4 tp60 -78.42 -50.75 11.14 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 118.797 -0.62 . . . . 0.0 110.388 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.712 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 32.3 mt -61.38 -13.24 18.33 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 119.136 0.88 . . . . 0.0 112.797 171.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.68 -33.73 76.29 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.03 -50.1 5.47 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.624 0.77 . . . . 0.0 109.939 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.48 86.88 2.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 p -82.05 -25.37 34.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.871 -166.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -114.44 65.92 0.28 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.682 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.78 59.24 0.51 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-O 119.369 -0.684 . . . . 0.0 112.567 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.74 144.18 34.77 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.296 1.997 . . . . 0.0 109.396 170.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 84.44 22.87 0.11 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.86 1.264 . . . . 0.0 108.707 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -119.13 -74.46 0.61 Allowed 'General case' 0 C--N 1.347 0.496 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.712 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 5.7 mp -104.6 6.52 34.58 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.913 -0.492 . . . . 0.0 111.916 171.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.29 -31.15 67.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.349 -1.469 . . . . 0.0 109.97 161.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.583 HD13 ' HA ' ' A' ' 106' ' ' PRO . 23.9 mt -92.34 25.37 2.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.451 -174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 147' ' ' LEU . 88.2 mt -72.88 115.35 39.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 123.307 0.379 . . . . 0.0 110.554 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . 55.6 Cg_endo -93.79 114.11 0.23 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 122.647 2.231 . . . . 0.0 109.988 167.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -73.09 167.93 20.12 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.776 0.43 . . . . 0.0 111.761 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.634 HD21 ' HB ' ' A' ' 188' ' ' ILE . 67.8 mt -61.14 -30.58 70.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 0.0 110.9 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -56.8 -59.38 5.11 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.425 0.69 . . . . 0.0 110.73 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.1 p -65.57 -38.42 89.49 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.592 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 151' ' ' PRO . 38.1 mt -79.2 -43.68 23.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -173.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.477 ' HA ' ' NE1' ' A' ' 165' ' ' TRP . 29.6 tt0 -58.96 -40.02 83.47 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 120.927 0.394 . . . . 0.0 110.905 173.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -80.47 -13.3 59.23 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.438 0.695 . . . . 0.0 111.258 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -74.37 -31.77 62.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.464 0.706 . . . . 0.0 109.861 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 79.8 mt -134.08 74.25 68.55 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.99 -33.58 31.86 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.289 2.659 . . . . 0.0 113.407 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t -82.78 -35.43 26.53 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 20.5 tp -66.89 71.77 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.674 1.19 . . . . 0.0 111.799 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -51.8 120.93 5.78 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.797 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 157' ' ' GLN . 55.3 m95 -87.94 119.7 28.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.508 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.615 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 79.8 mt -68.08 -33.76 75.15 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.846 0.458 . . . . 0.0 110.276 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.6 128.33 69.53 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -172.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -150.63 81.67 1.34 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 170.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -137.62 144.43 41.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.899 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -89.36 125.53 35.17 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 45.7 mt -105.75 107.12 17.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.8 119.33 28.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -98.81 129.6 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 110.109 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -73.38 104.03 4.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.001 0.92 . . . . 0.0 110.469 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 185' ' ' ALA . 13.5 mt -75.03 108.53 7.82 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 33.5 t70 61.31 94.59 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.295 1.038 . . . . 0.0 110.506 -170.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.65 30.37 4.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.796 0.838 . . . . 0.0 110.413 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.91 -67.45 2.19 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.758 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.47 -52.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.016 0.526 . . . . 0.0 111.862 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -98.74 -36.52 9.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -164.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -63.09 -68.55 0.33 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 118.13 0.423 . . . . 0.0 110.433 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 58.59 18.32 5.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.421 1.088 . . . . 0.0 112.105 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.0 142.52 34.69 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -123.16 -172.59 2.53 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.049 0.94 . . . . 0.0 110.877 -172.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 175' ' ' LEU . . . -166.9 131.52 2.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . . . -83.5 138.71 33.31 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.422 HD22 ' HD1' ' A' ' 132' ' ' PHE . 25.7 mt -120.92 144.07 48.63 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.634 ' HB ' HD21 ' A' ' 153' ' ' LEU . 27.3 pt -124.12 116.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.8 1.182 . . . . 0.0 109.944 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -100.04 146.74 26.4 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.692 0.758 . . . . 0.0 110.586 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 46.0 mt -137.07 141.26 42.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.073 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.542 HD22 HG12 ' A' ' 24' ' ' VAL . 40.9 tp -134.19 106.35 7.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 168.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.31 140.59 19.2 Favored Glycine 0 CA--C 1.505 -0.551 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.756 HE22 ' HB3' ' A' ' 27' ' ' GLN . 7.4 tp-100 -123.75 148.37 46.68 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 193' ' ' GLN . 0.7 OUTLIER -57.11 115.92 2.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.371 161.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.3 mt -61.22 116.13 4.35 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 167.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -58.66 132.55 54.17 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.023 0.827 . . . . 0.0 109.777 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.59 83.17 0.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 124.058 0.849 . . . . 0.0 109.313 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -82.58 78.63 9.18 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.39 1.076 . . . . 0.0 109.461 -177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -77.27 109.89 11.53 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.764 174.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -145.87 176.43 9.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.288 0.635 . . . . 0.0 110.359 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -73.09 87.76 1.4 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.407 0.683 . . . . 0.0 109.775 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 . . . . . 0 C--O 1.245 0.849 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 171.703 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -79.76 157.17 27.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.6 99.67 7.44 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.539 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -90.17 69.14 7.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -157.11 145.15 19.27 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.104 -171.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -138.23 157.67 45.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.673 0.789 . . . . 0.0 111.061 -173.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 p -91.86 103.21 15.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.998 0.919 . . . . 0.0 108.877 171.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -67.55 115.95 7.72 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.141 0.576 . . . . 0.0 109.94 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 t -123.24 30.49 6.3 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 110.262 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.5 105.01 2.48 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.422 0.689 . . . . 0.0 109.73 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -91.67 159.65 15.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.387 0.675 . . . . 0.0 110.127 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.63 116.37 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -109.21 139.06 44.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.091 0.556 . . . . 0.0 110.444 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.06 148.51 5.94 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.587 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -172.03 112.37 0.3 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.547 1.939 . . . . 0.0 107.579 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -120.79 73.73 24.54 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.192 0.597 . . . . 0.0 110.83 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.03 124.75 0.94 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.819 2.346 . . . . 0.0 110.961 167.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -68.91 110.6 4.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.162 0.585 . . . . 0.0 109.907 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 22' ' ' VAL . 22.3 t70 -142.13 170.69 15.24 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.596 0.758 . . . . 0.0 110.302 -172.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.85 -34.19 77.58 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.983 0.913 . . . . 0.0 110.773 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 24' ' ' VAL . 33.7 tp -67.62 -54.4 20.0 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.131 0.572 . . . . 0.0 111.208 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 19' ' ' ASP . 14.4 m -47.39 -25.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 m -68.36 -49.07 62.78 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.862 0.865 . . . . 0.0 110.767 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.786 HG21 HD11 ' A' ' 128' ' ' ILE . 1.5 m -64.77 -36.48 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.032 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -24.54 66.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -68.1 -35.24 77.82 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.855 171.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -82.86 -18.25 41.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.143 0.977 . . . . 0.0 112.466 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 24' ' ' VAL . 74.1 mt -77.02 135.64 66.82 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.965 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.59 142.48 90.38 Favored 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.467 2.778 . . . . 0.0 112.331 171.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' TYR . 28.2 pt20 -70.73 28.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.63 -141.87 6.76 Favored Glycine 0 N--CA 1.478 1.447 0 CA-C-N 118.769 0.713 . . . . 0.0 113.338 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 62.0 mttp -76.91 115.32 16.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 54' ' ' VAL . 21.0 mt -107.63 121.45 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 55' ' ' THR . 55.6 tp -90.69 111.62 23.04 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.02 0.528 . . . . 0.0 111.289 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 98.6 m -87.19 134.9 33.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -94.83 152.63 18.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.749 0.419 . . . . 0.0 110.469 167.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.47 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.685 1.241 . . . . 0.0 111.779 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HG3' HD22 ' A' ' 43' ' ' ASN . 0.6 OUTLIER -89.08 -165.92 1.46 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.423 1.089 . . . . 0.0 109.858 175.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.26 -56.68 20.32 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.239 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -135.67 129.13 32.27 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.926 0.89 . . . . 0.0 109.397 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.76 36.86 2.47 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.43 0.538 . . . . 0.0 114.152 -174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -81.24 -26.38 35.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.257 1.023 . . . . 0.0 109.617 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.56 ' ND2' HG21 ' A' ' 101' ' ' ILE . 79.8 m-20 -67.25 -35.08 78.8 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.943 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 56' ' ' ALA . . . -53.42 -57.55 10.23 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.418 1.087 . . . . 0.0 111.813 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.918 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 8.3 p -66.03 -34.13 77.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.976 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.96 -43.09 88.93 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.57 0.544 . . . . 0.0 111.29 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.41 HD13 HG11 ' A' ' 99' ' ' VAL . 84.9 mt -67.35 -30.78 70.68 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.47 -36.71 74.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.724 0.41 . . . . 0.0 110.542 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 m -63.95 -14.63 55.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.207 1.003 . . . . 0.0 112.341 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.0 mt -85.26 17.19 3.17 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.934 0.894 . . . . 0.0 110.705 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.82 37.73 25.39 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 123.563 0.601 . . . . 0.0 114.436 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 30' ' ' GLN . 25.2 m-85 -126.69 154.36 44.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.998 0.519 . . . . 0.0 111.318 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' HG2' ' A' ' 32' ' ' LYS . 33.5 mt-10 -89.6 86.9 6.84 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 33' ' ' ILE . 71.2 t -93.23 108.49 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.783 0.802 . . . . 0.0 110.376 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 34' ' ' LEU . 1.8 t -83.69 108.71 16.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.957 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . . . -96.42 132.41 41.99 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.748 0.819 . . . . 0.0 111.359 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.29 120.51 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 22.4 t0 -136.27 134.91 38.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.238 0.472 . . . . 0.0 109.972 174.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -53.8 -24.03 14.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.771 1.628 . . . . 0.0 112.837 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 t -123.3 164.23 19.19 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 111.081 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.2 p -77.36 -18.35 57.46 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.096 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -59.51 -44.39 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.62 -34.01 40.91 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.275 0.359 . . . . 0.0 112.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 58' ' ' ASP . 93.5 mt -69.02 -47.67 64.88 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.558 0.743 . . . . 0.0 111.61 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -54.31 -55.67 26.07 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.815 0.846 . . . . 0.0 111.855 171.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -54.35 -39.16 66.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.619 0.767 . . . . 0.0 110.842 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.918 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . . . -59.98 -52.51 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.293 177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -69.01 -38.75 79.42 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 -174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 5.7 mm100 -62.51 -45.44 92.97 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.496 0.318 . . . . 0.0 111.395 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 45' ' ' CYS . 32.1 tp -70.92 -27.39 63.73 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.359 0.412 . . . . 0.0 110.785 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -61.15 -62.4 1.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 110.546 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.97 -30.21 70.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.586 0.754 . . . . 0.0 111.617 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -65.77 -54.58 25.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.06 0.544 . . . . 0.0 110.718 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' HE2' HD11 ' A' ' 70' ' ' LEU . 24.8 ttmm -83.87 -15.71 47.12 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.48 0.712 . . . . 0.0 111.727 -170.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.93 41.97 7.88 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 121.828 -0.225 . . . . 0.0 113.284 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.53 175.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.591 1.156 . . . . 0.0 109.109 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.14 140.69 51.65 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.031 0.378 . . . . 0.0 111.896 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.658 HG12 ' HB2' ' A' ' 71' ' ' ALA . 20.1 mm -115.56 160.75 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.004 1.322 . . . . 0.0 107.555 167.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.8 m -127.49 110.12 12.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 164.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.8 p -84.24 111.63 19.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.044 0.538 . . . . 0.0 109.822 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 157.25 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.177 1.391 . . . . 0.0 110.698 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -86.38 103.81 15.3 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 t -60.87 99.26 0.08 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.018 0.437 . . . . 0.0 111.618 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -142.64 91.54 2.32 Favored 'General case' 0 C--O 1.214 -0.784 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.57 -17.26 61.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.349 0.522 . . . . 0.0 110.839 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.34 -0.9 51.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.543 1.137 . . . . 0.0 112.295 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.04 -32.8 0.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -167.32 107.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.04 -63.4 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.483 1.113 . . . . 0.0 108.21 -171.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.624 ' HB ' HD13 ' A' ' 98' ' ' ILE . 29.8 pt -138.64 122.62 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.609 0.763 . . . . 0.0 110.8 -176.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.44 87.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.719 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.95 -1.84 13.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.477 0.711 . . . . 0.0 112.744 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.86 -48.06 67.19 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.08 -24.41 30.37 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.923 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.481 ' CD2' HG21 ' A' ' 55' ' ' THR . 17.9 m95 -112.85 161.78 16.56 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.113 0.565 . . . . 0.0 109.682 -172.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.74 -58.1 2.85 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -124.54 169.82 16.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.257 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.624 HD13 ' HB ' ' A' ' 90' ' ' ILE . 80.6 mt -134.36 119.36 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 47' ' ' LEU . 11.6 p -109.11 133.27 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -125.96 90.9 3.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.56 HG21 ' ND2' ' A' ' 43' ' ' ASN . 12.2 mm -69.29 155.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.877 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -19.28 103.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 126.215 1.806 . . . . 0.0 113.501 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 7.6 p -136.28 114.55 11.61 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.271 -173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -97.76 100.24 11.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.9 mt -93.47 148.76 36.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.708 0.403 . . . . 0.0 110.279 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.57 156.71 55.29 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.156 1.904 . . . . 0.0 110.193 167.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.8 m -50.83 -33.0 21.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.033 0.933 . . . . 0.0 112.585 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t -58.84 -52.99 63.36 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.899 0.88 . . . . 0.0 111.623 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.7 mt -83.42 -18.66 37.96 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.978 0.511 . . . . 0.0 111.283 -177.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -63.71 -62.88 1.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -67.78 -10.52 53.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.617 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -77.84 -54.18 6.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.786 0.434 . . . . 0.0 109.926 166.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 117' ' ' VAL . 59.3 tp -74.71 -49.85 19.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -165.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -67.25 -35.34 8.47 Favored Pre-proline 0 N--CA 1.486 1.37 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.53 -33.68 96.85 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 122.194 1.929 . . . . 0.0 112.794 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 113' ' ' LEU . 34.3 mmtp -72.64 -27.39 62.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.627 0.771 . . . . 0.0 110.894 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 127' ' ' PHE . 15.0 t -84.01 -34.75 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 122.727 0.411 . . . . 0.0 110.427 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.48 -61.76 2.35 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -67.94 -49.2 63.18 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.808 0.843 . . . . 0.0 113.247 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.27 24.07 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -164.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 125' ' ' GLY . 44.7 tp -70.82 104.37 2.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.463 0.632 . . . . 0.0 110.43 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.71 153.21 78.22 Favored Pre-proline 0 C--O 1.247 0.929 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -48.69 116.03 1.92 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.954 2.436 . . . . 0.0 113.277 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 194' ' ' LYS . . . 129.86 12.23 2.46 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.318 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -102.24 146.67 16.99 Favored Glycine 0 N--CA 1.441 -0.975 0 O-C-N 122.539 -0.389 . . . . 0.0 112.437 163.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.6 m -116.64 130.88 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.825 0.85 . . . . 0.0 108.767 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -111.9 113.07 25.17 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.786 HD11 HG21 ' A' ' 24' ' ' VAL . 14.7 mt -107.62 108.93 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 49.8 mt -113.49 150.3 33.07 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.515 0.726 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -135.42 138.95 43.76 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 161.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.54 -176.44 14.37 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.405 ' HB2' HD21 ' A' ' 150' ' ' LEU . 53.3 m-85 -102.62 166.69 10.37 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 134' ' ' PRO . . . -116.2 169.26 7.28 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 133' ' ' ALA . 37.0 Cg_endo -63.78 60.76 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.635 2.224 . . . . 0.0 112.915 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.678 ' HG3' ' H ' ' A' ' 186' ' ' ALA . 2.7 tm-20 -97.12 -63.98 1.08 Allowed 'General case' 0 C--N 1.349 0.575 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.451 ' HB3' HD22 ' A' ' 147' ' ' LEU . 53.7 tp60 -65.64 -49.17 69.67 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.963 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.721 ' HG ' ' HB2' ' A' ' 147' ' ' LEU . 7.3 mt -66.59 -10.15 42.66 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 118.748 0.704 . . . . 0.0 111.394 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -80.06 -46.45 16.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.824 0.45 . . . . 0.0 110.51 173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -84.56 -15.58 45.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -113.28 152.08 30.3 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 166.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 m -80.95 -27.76 35.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -153.72 116.96 0.77 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.46 69.04 0.41 Allowed Glycine 0 CA--C 1.535 1.337 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.29 130.37 12.92 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.562 2.175 . . . . 0.0 110.594 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.557 ' H ' ' HB3' ' A' ' 148' ' ' ASP . 94.4 mttt 86.56 15.19 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.453 1.501 . . . . 0.0 110.855 172.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -110.41 -89.66 0.49 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.721 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . 4.2 mp -96.62 27.0 4.09 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 118.514 0.597 . . . . 0.0 110.614 168.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.557 ' HB3' ' H ' ' A' ' 145' ' ' LYS . 23.6 t70 -87.07 -34.61 19.09 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.24 25.16 0.62 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.497 1.919 . . . . 0.0 113.096 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 147' ' ' LEU . 95.1 mt -68.57 118.88 64.52 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 123.684 0.615 . . . . 0.0 112.194 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -94.71 98.28 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.916 2.411 . . . . 0.0 109.88 166.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 167.87 20.58 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.285 0.634 . . . . 0.0 111.335 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 188' ' ' ILE . 29.8 mt -67.07 -31.54 72.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.243 0.617 . . . . 0.0 110.984 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -55.49 -45.88 76.98 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.84 0.713 . . . . 0.0 111.058 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -84.26 -35.69 23.2 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.698 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 129' ' ' LEU . 40.8 mt -75.21 -47.24 29.16 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.464 0.706 . . . . 0.0 112.022 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 9.5 tt0 -60.68 -35.81 77.19 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.72 0.408 . . . . 0.0 111.154 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -71.86 -26.83 62.51 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.362 0.665 . . . . 0.0 111.11 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.57 -15.0 44.05 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.247 1.019 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 78.0 mt -135.67 68.18 65.83 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.03 3.09 8.09 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 123.049 2.499 . . . . 0.0 112.226 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 t -90.21 -36.36 14.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.407 1.083 . . . . 0.0 108.59 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.2 tp -94.75 72.32 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.35 1.46 . . . . 0.0 111.715 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -51.78 124.72 13.13 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.283 0.564 . . . . 0.0 110.172 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 192' ' ' GLY . 24.9 m95 -93.66 132.88 37.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.665 1.186 . . . . 0.0 109.839 -170.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.612 ' HG ' ' HB2' ' A' ' 193' ' ' GLN . 85.9 mt -70.64 -35.99 73.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.415 0.686 . . . . 0.0 110.787 173.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.05 121.61 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.44 85.17 1.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.644 0.778 . . . . 0.0 109.165 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -150.52 149.06 29.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.941 0.401 . . . . 0.0 110.811 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -76.22 113.39 13.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.0 128.01 53.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.392 0.677 . . . . 0.0 109.508 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 9.5 pt-20 -92.23 120.37 32.73 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -96.64 125.17 40.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.096 0.558 . . . . 0.0 109.987 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -72.37 121.02 18.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.813 0.845 . . . . 0.0 111.023 -175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.25 159.22 15.72 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.322 1.049 . . . . 0.0 110.785 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -54.08 137.76 39.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.788 1.235 . . . . 0.0 112.404 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.82 90.08 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.969 0.907 . . . . 0.0 110.159 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.2 43.19 0.05 OUTLIER Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.807 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -147.41 148.39 31.25 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.592 0.757 . . . . 0.0 109.999 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -65.45 -39.91 92.6 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -62.64 117.84 6.81 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.076 0.951 . . . . 0.0 108.612 166.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -59.34 149.98 27.48 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.907 0.483 . . . . 0.0 110.562 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.79 74.78 0.76 Allowed Glycine 0 C--N 1.345 1.04 0 O-C-N 124.167 0.917 . . . . 0.0 115.253 -168.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -152.49 164.47 37.5 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.55 0.74 . . . . 0.0 110.698 162.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -143.64 129.23 19.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.014 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.678 ' H ' ' HG3' ' A' ' 135' ' ' GLU . . . -76.38 108.65 9.48 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 65.8 mt -121.94 172.37 8.25 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.563 ' HB ' HD21 ' A' ' 153' ' ' LEU . 38.1 pt -135.6 144.9 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -137.17 154.17 50.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.761 0.791 . . . . 0.0 110.945 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 129' ' ' LEU . 65.0 mt -139.12 146.25 40.44 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.007 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 27.6 tp -143.37 111.89 6.37 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 165' ' ' TRP . . . -90.18 148.56 19.79 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.612 ' HB2' ' HG ' ' A' ' 166' ' ' LEU . 8.6 tp-100 -134.78 151.16 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.472 0.636 . . . . 0.0 111.242 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.588 ' HB3' ' N ' ' A' ' 124' ' ' GLY . 17.1 pttp -55.99 136.26 52.08 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.64 116.84 10.51 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 167.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 200' ' ' HIS . 2.6 tp10 -66.22 92.67 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 123.86 0.725 . . . . 0.0 110.217 -171.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -89.45 52.53 2.37 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 122.176 0.988 . . . . 0.0 110.154 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -176.84 -169.57 0.27 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.262 2.225 . . . . 0.0 106.596 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -61.63 147.02 47.13 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.923 0.783 . . . . 0.0 109.831 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 196' ' ' GLU . 19.4 p-80 -56.12 154.17 8.11 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.531 0.732 . . . . 0.0 112.3 -172.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -54.52 107.83 0.32 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.899 0.749 . . . . 0.0 110.277 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.1 p80 . . . . . 0 C--O 1.255 1.369 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.18 176.407 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -81.69 81.97 7.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.599 0.759 . . . . 0.0 110.486 -171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -86.87 88.49 7.7 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -132.51 141.97 49.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.36 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -166.92 102.75 0.55 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -127.56 120.78 28.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.666 0.786 . . . . 0.0 109.563 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.7 t -152.64 97.98 2.3 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.301 0.64 . . . . 0.0 110.576 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -100.98 89.86 3.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.301 1.04 . . . . 0.0 109.636 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.4 p -84.39 93.53 8.29 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.13 144.31 27.71 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.533 0.733 . . . . 0.0 111.333 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -165.35 131.69 2.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.763 0.825 . . . . 0.0 109.354 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 m -86.44 86.76 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 122.186 0.993 . . . . 0.0 110.923 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -144.96 117.51 8.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.324 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.53 47.91 0.28 Allowed Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.118 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.7 p -81.19 148.68 29.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.719 0.807 . . . . 0.0 110.282 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -151.88 67.39 7.13 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.098 0.559 . . . . 0.0 109.696 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 22' ' ' VAL . 77.5 Cg_endo -99.21 124.3 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.928 2.419 . . . . 0.0 112.382 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -103.64 86.46 2.63 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.433 0.635 . . . . 0.0 109.752 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.83 161.16 42.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.597 1.159 . . . . 0.0 108.445 -177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -64.23 -54.3 35.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.471 0.708 . . . . 0.0 111.535 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 24' ' ' VAL . 41.6 tp -69.88 -51.71 30.96 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.837 0.455 . . . . 0.0 111.098 -171.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 17' ' ' PRO . 11.3 m -45.56 -29.51 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.0 m -72.43 -44.18 62.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.436 0.695 . . . . 0.0 110.564 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 28' ' ' ILE . 1.2 m -67.98 -33.75 63.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.004 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.15 73.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.554 1.141 . . . . 0.0 112.241 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -69.07 -23.95 64.1 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.281 0.632 . . . . 0.0 110.632 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.51 -14.29 25.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.63 0.772 . . . . 0.0 111.788 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 24' ' ' VAL . 96.3 mt -83.93 125.77 72.08 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 18.3 Cg_exo -67.04 157.85 59.71 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.423 2.749 . . . . 0.0 112.848 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -72.54 28.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -117.4 -144.56 7.8 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 118.364 0.529 . . . . 0.0 113.716 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 95' ' ' TRP . 31.1 mmmt -70.7 115.44 9.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.65 0.78 . . . . 0.0 109.666 -175.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 50.2 mt -107.21 121.85 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 90' ' ' ILE . 55.3 tp -101.54 111.18 23.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HA ' HG13 ' A' ' 99' ' ' VAL . 51.1 t -102.61 110.12 21.96 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 123.445 0.698 . . . . 0.0 109.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.0 164.08 26.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 120.809 0.337 . . . . 0.0 111.695 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -37.51 118.31 0.63 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.238 1.815 . . . . 0.0 114.814 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.673 ' HB3' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -124.36 -18.44 5.78 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.14 0.976 . . . . 0.0 110.837 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.69 -37.29 3.52 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -79.37 -44.78 20.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 0.0 112.439 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.97 85.84 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.398 -162.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -83.14 -52.95 6.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.819 1.248 . . . . 0.0 110.338 -174.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 15.1 m120 -61.32 -40.43 94.18 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.815 -174.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.25 -57.45 11.76 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.203 0.94 . . . . 0.0 111.524 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 70' ' ' LEU . 33.7 m -63.04 -33.78 76.17 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.782 0.833 . . . . 0.0 112.954 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 79.4 t80 -63.34 -50.12 71.25 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.723 0.639 . . . . 0.0 110.218 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD13 HG11 ' A' ' 99' ' ' VAL . 63.9 mt -68.45 -29.48 68.13 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.579 -176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.44 -40.79 66.78 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.326 0.651 . . . . 0.0 112.006 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.727 ' HA ' HG11 ' A' ' 76' ' ' VAL . 58.1 p -72.2 -3.84 25.85 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.384 0.674 . . . . 0.0 112.762 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 85.2 mt -80.61 7.3 10.38 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 122.955 0.502 . . . . 0.0 110.735 165.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.68 24.35 39.17 Favored Glycine 0 C--N 1.361 1.939 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -126.04 162.4 25.37 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.059 0.929 . . . . 0.0 111.951 -172.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -88.94 91.45 8.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.24 1.016 . . . . 0.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.28 107.08 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.824 0.821 . . . . 0.0 110.727 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.6 m -87.27 108.89 19.15 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.188 1.395 . . . . 0.0 108.982 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.18 129.57 48.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.987 0.515 . . . . 0.0 109.643 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 81' ' ' VAL . 3.8 t -111.94 118.52 57.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 172.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' H ' HD21 ' A' ' 64' ' ' LEU . 32.6 t70 -128.53 145.76 51.03 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.729 1.149 . . . . 0.0 110.621 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.02 -31.06 62.76 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.853 1.661 . . . . 0.0 113.211 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.8 m -116.13 144.1 44.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 0.0 110.252 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.6 p -68.65 -24.63 64.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.481 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.02 -33.94 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.497 0.719 . . . . 0.0 111.821 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 -30.82 67.62 Favored Glycine 0 C--N 1.353 1.52 0 O-C-N 123.371 0.419 . . . . 0.0 112.237 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 58' ' ' ASP . 81.5 mt -76.19 -42.31 46.75 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.983 0.913 . . . . 0.0 111.244 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.09 93.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.872 0.869 . . . . 0.0 111.93 173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -67.02 -40.15 87.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.86 0.464 . . . . 0.0 110.755 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . . . -56.95 -52.76 63.96 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 124.069 0.856 . . . . 0.0 110.406 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -65.0 -51.14 63.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 111.856 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.47 -47.45 81.74 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.918 0.887 . . . . 0.0 111.971 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 20.8 tp -64.52 -33.38 75.77 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.423 0.452 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.29 -51.03 49.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.413 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -66.52 -29.23 69.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.67 0.788 . . . . 0.0 110.257 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -63.18 -44.94 93.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.949 0.899 . . . . 0.0 110.276 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -85.05 -6.17 59.33 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.438 0.695 . . . . 0.0 111.569 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 40.07 12.32 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 120.391 -0.116 . . . . 0.0 113.226 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.727 HG11 ' HA ' ' A' ' 49' ' ' SER . 33.2 m -139.64 174.22 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 124.452 1.101 . . . . 0.0 109.443 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -123.69 144.13 49.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.182 0.593 . . . . 0.0 112.316 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.4 mm -114.88 161.07 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 166.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.2 m -121.8 104.66 9.73 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 p -92.57 123.19 35.68 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.679 -0.638 . . . . 0.0 110.487 -167.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 57' ' ' VAL . 62.1 t -115.61 141.07 34.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.192 1.397 . . . . 0.0 107.819 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -80.06 134.31 36.19 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.2 p -55.24 105.11 0.15 Allowed 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.146 0.978 . . . . 0.0 111.493 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -141.71 87.04 2.03 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.467 ' HB2' HD22 ' A' ' 109' ' ' LEU . 88.8 mt -94.24 -9.82 34.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.928 0.491 . . . . 0.0 110.537 -171.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.36 4.38 43.21 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.903 0.881 . . . . 0.0 110.319 170.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -130.96 -41.49 1.14 Allowed 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.773 0.829 . . . . 0.0 110.812 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -156.76 121.72 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.234 1.014 . . . . 0.0 108.275 -169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.21 -69.6 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.652 -0.655 . . . . 0.0 109.626 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 117' ' ' VAL . 18.1 pt -149.88 131.27 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.899 0.879 . . . . 0.0 109.958 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.79 145.63 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.813 1.245 . . . . 0.0 109.171 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -88.41 -30.71 19.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.13 0.572 . . . . 0.0 110.743 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -78.95 -61.26 2.07 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.712 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.67 -29.27 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' NE1' HD22 ' A' ' 34' ' ' LEU . 37.3 m95 -113.63 144.69 42.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.842 0.457 . . . . 0.0 109.871 -171.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 29' ' ' PRO . 15.8 tp10 -98.19 -46.3 5.89 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.479 1.112 . . . . 0.0 109.494 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -114.58 141.52 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.354 171.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 90' ' ' ILE . 63.7 mt -117.99 150.62 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 169.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG11 HD13 ' A' ' 47' ' ' LEU . 7.0 p -145.9 129.15 10.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 124.121 0.968 . . . . 0.0 109.01 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.3 m -129.57 94.2 3.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.673 ' HB ' ' HB3' ' A' ' 38' ' ' GLU . 22.1 mm -70.73 143.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -15.26 104.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.404 1.882 . . . . 0.0 114.834 -170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.506 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 45.6 t -100.64 115.78 31.0 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 112.658 -2.064 . . . . 0.0 110.006 -174.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -121.71 98.41 5.94 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HG ' ' SG ' ' A' ' 103' ' ' CYS . 95.0 mt -108.79 155.75 40.14 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.386 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.02 143.33 83.54 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.589 2.193 . . . . 0.0 110.681 162.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.605 ' H ' HD22 ' A' ' 149' ' ' LEU . 41.4 m -50.14 -24.75 2.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.533 1.133 . . . . 0.0 113.288 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 52.3 m -56.39 -57.61 11.54 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.414 0.685 . . . . 0.0 110.336 171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 85' ' ' LEU . 89.2 mt -79.71 -32.8 41.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.69 0.796 . . . . 0.0 110.032 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.561 ' HD3' ' HG3' ' A' ' 151' ' ' PRO . 8.4 tmm_? -74.02 -58.84 3.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.003 1.321 . . . . 0.0 109.959 -170.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -68.55 -10.3 54.87 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.256 0.622 . . . . 0.0 112.373 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -88.5 -33.67 17.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 171.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' VAL . 66.3 tp -67.86 -47.74 68.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.708 0.803 . . . . 0.0 111.514 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.49 -39.14 45.86 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -171.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -57.2 -32.08 92.46 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.919 165.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -81.24 -17.89 47.92 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.528 0.731 . . . . 0.0 111.249 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.537 ' HA ' HD11 ' A' ' 90' ' ' ILE . 9.5 t -83.96 -43.07 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 172.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -62.03 -48.9 78.22 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.27 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -79.08 -43.68 23.66 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.05 -20.4 16.3 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 116.711 1.444 . . . . 0.0 116.711 -164.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.511 HD12 HD12 ' A' ' 98' ' ' ILE . 16.7 tp -62.26 128.94 38.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.188 0.994 . . . . 0.0 110.025 176.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 16.7 tttp -70.65 142.39 88.64 Favored Pre-proline 0 C--O 1.246 0.875 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.94 109.05 0.3 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.347 1.365 . . . . 0.0 109.494 160.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.08 10.1 6.41 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.559 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 98' ' ' ILE . . . -97.8 143.02 16.45 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 170.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 27.0 m -108.55 129.6 62.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 123.973 0.909 . . . . 0.0 109.466 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -112.5 112.19 23.55 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 101' ' ' ILE . 95.8 mt -110.25 113.97 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.883 0.873 . . . . 0.0 109.304 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 190' ' ' LEU . 96.2 mt -124.34 114.91 20.16 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.34 107.96 4.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.29 1.036 . . . . 0.0 108.952 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.0 86.06 0.09 OUTLIER Glycine 0 N--CA 1.479 1.512 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.172 169.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.506 ' O ' HD23 ' A' ' 187' ' ' LEU . 95.3 m-85 -143.29 150.36 39.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 136' ' ' GLN . . . -175.51 167.65 1.73 Allowed Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.74 -46.24 9.34 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 121.392 1.395 . . . . 0.0 110.572 165.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -3.88 57.58 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -176.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 133' ' ' ALA . 26.2 tp60 -45.95 -63.58 0.94 Allowed 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -170.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.546 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 9.9 mt -82.49 -15.22 53.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.587 0.755 . . . . 0.0 111.57 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.56 -20.13 62.94 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 123.531 0.732 . . . . 0.0 111.296 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 141' ' ' THR . 6.7 m-30 -53.66 -34.96 60.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.869 1.268 . . . . 0.0 112.503 172.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.3 t30 71.45 -0.81 2.99 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.159 1.383 . . . . 0.0 111.834 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.437 HG22 ' HB3' ' A' ' 139' ' ' TYR . 12.0 t -112.61 -8.93 13.79 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.26 1.024 . . . . 0.0 109.95 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -143.94 74.53 0.32 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.523 ' HA2' HD22 ' A' ' 137' ' ' LEU . . . 177.4 117.47 0.52 Allowed Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.282 -1.288 . . . . 0.0 111.524 -173.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.5 -20.32 65.81 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.7 2.267 . . . . 0.0 114.548 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' A' ' 149' ' ' LEU . 11.7 ptmm? -168.22 -38.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.929 0.786 . . . . 0.0 111.43 170.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.517 ' O ' ' HG ' ' A' ' 149' ' ' LEU . 31.8 t70 178.79 151.41 0.3 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.39 0.676 . . . . 0.0 110.3 -174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.546 ' HG ' ' HB2' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -52.62 -6.95 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 126.411 1.884 . . . . 0.0 115.786 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.94 -30.42 58.73 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.398 0.679 . . . . 0.0 111.224 168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.637 HD11 ' HG2' ' A' ' 145' ' ' LYS . 13.6 mt -79.53 8.49 6.28 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.766 1.226 . . . . 0.0 112.449 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 132' ' ' PHE . 41.1 mt -104.93 98.1 14.6 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.223 0.609 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.621 ' HG2' HD21 ' A' ' 156' ' ' LEU . 90.1 Cg_endo -84.0 126.58 3.89 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.871 165.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -72.82 173.13 9.59 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.749 0.819 . . . . 0.0 111.708 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.571 HD22 HD21 ' A' ' 190' ' ' LEU . 20.1 mt -55.95 -38.53 70.47 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.106 0.562 . . . . 0.0 112.212 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.02 -37.31 74.07 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.705 0.628 . . . . 0.0 110.935 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.2 m -73.39 -51.95 15.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.219 0.608 . . . . 0.0 109.914 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.621 HD21 ' HG2' ' A' ' 151' ' ' PRO . 82.7 mt -65.7 -55.65 16.28 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.576 1.151 . . . . 0.0 112.008 -170.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.612 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 52.3 tt0 -59.03 -34.81 72.33 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 175.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.9 t -81.06 -13.25 58.96 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 118.144 0.429 . . . . 0.0 111.889 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.86 -7.67 29.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.945 0.498 . . . . 0.0 110.315 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 163' ' ' LEU . 89.2 mt -139.46 59.95 15.52 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.946 1.298 . . . . 0.0 108.079 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.55 -22.58 32.84 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.726 2.284 . . . . 0.0 113.745 -172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.5 p -81.83 -40.08 23.02 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 18.6 tp -70.8 68.5 0.42 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.814 1.246 . . . . 0.0 111.602 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -65.13 140.35 58.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.612 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 22.0 m95 -100.88 135.29 42.56 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.742 0.817 . . . . 0.0 109.349 -167.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 56.9 mt -72.03 -30.81 65.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.64 0.776 . . . . 0.0 110.44 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.9 mt -130.46 125.45 59.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.39 79.97 1.29 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -131.15 142.45 50.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.806 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -88.59 132.44 34.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.878 0.871 . . . . 0.0 109.955 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 34.2 mt -110.05 114.24 27.6 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.1 121.06 15.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.703 ' HB3' ' HB3' ' A' ' 185' ' ' ALA . 52.5 ttt180 -90.2 121.53 32.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -90.33 99.87 12.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.24 141.16 28.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.611 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -73.35 122.67 22.41 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.926 0.766 . . . . 0.0 109.708 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.62 139.62 58.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.404 0.682 . . . . 0.0 110.272 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.62 -49.83 0.09 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.82 -39.65 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.07 170.78 11.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.614 1.165 . . . . 0.0 109.54 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -64.66 -30.12 71.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.73 0.812 . . . . 0.0 109.6 168.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -104.57 177.58 4.81 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 124.602 1.161 . . . . 0.0 110.354 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.52 113.81 0.3 Allowed Glycine 0 C--N 1.334 0.471 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -159.66 178.52 9.75 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . . . -155.71 173.91 16.06 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -130.22 114.78 16.1 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 27.8 mt -104.27 158.04 16.73 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.519 ' HB ' HD21 ' A' ' 153' ' ' LEU . 3.7 pt -146.36 124.68 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.944 0.793 . . . . 0.0 110.473 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -93.27 145.56 24.35 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.986 0.914 . . . . 0.0 110.091 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 129' ' ' LEU . 54.9 mt -134.0 143.91 48.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.062 0.945 . . . . 0.0 110.391 172.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.2 tp -142.96 108.29 5.02 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -92.98 146.43 18.1 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.429 HE21 HG12 ' A' ' 126' ' ' VAL . 5.9 tp-100 -147.25 155.83 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.15 0.98 . . . . 0.0 109.683 174.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.581 ' HD2' ' HB3' ' A' ' 197' ' ' HIS . 23.1 pttm -61.64 121.45 12.83 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.26 97.7 0.2 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 120.491 0.186 . . . . 0.0 111.32 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 29.33 37.66 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.754 2.022 . . . . 0.0 115.884 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 194' ' ' LYS . 10.3 t-80 -64.57 107.58 1.44 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -40.05 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 125.702 1.877 . . . . 0.0 113.088 -158.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -125.64 154.47 42.27 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.837 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -48.7 126.81 12.58 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 124.48 1.113 . . . . 0.0 109.502 162.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -50.72 -31.34 16.3 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.462 1.105 . . . . 0.0 111.99 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 C--O 1.257 1.497 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.723 172.915 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -156.34 52.27 0.53 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.66 85.64 3.31 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.086 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -94.85 26.32 3.64 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.135 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 mtt85 -81.44 34.04 0.37 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.544 1.138 . . . . 0.0 112.054 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -74.85 84.85 2.2 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.5 p -106.49 23.9 13.45 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.518 1.127 . . . . 0.0 109.706 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -73.01 92.54 1.67 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.378 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 p -160.94 147.93 15.26 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.854 -172.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -154.86 130.74 10.09 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -135.89 68.97 1.43 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.477 0.711 . . . . 0.0 109.847 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.95 98.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.87 116.17 23.17 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.13 175.29 44.29 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.191 0.307 . . . . 0.0 112.877 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.607 HG23 ' HD3' ' A' ' 17' ' ' PRO . 8.8 t -170.03 -31.86 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.827 1.251 . . . . 0.0 109.319 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 55.39 78.48 0.38 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 125.522 1.529 . . . . 0.0 112.433 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.607 ' HD3' HG23 ' A' ' 15' ' ' THR . 74.0 Cg_endo -72.81 151.09 50.88 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.902 1.734 . . . . 0.0 110.519 163.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -73.2 83.12 1.34 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.283 0.633 . . . . 0.0 109.782 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -142.48 177.59 8.18 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.063 0.945 . . . . 0.0 111.696 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -88.51 -30.2 19.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.737 1.215 . . . . 0.0 110.156 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tp -68.59 -43.53 76.3 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.736 0.814 . . . . 0.0 111.505 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.5 m -45.74 -35.32 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -74.36 -46.65 39.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.641 0.776 . . . . 0.0 110.979 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.608 HG21 HD11 ' A' ' 128' ' ' ILE . 2.2 m -64.64 -37.14 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.082 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.36 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.313 1.045 . . . . 0.0 111.881 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -58.02 -38.97 77.18 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -82.4 -22.76 35.25 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.727 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 24' ' ' VAL . 54.6 mt -75.59 129.31 82.08 Favored Pre-proline 0 N--CA 1.486 1.351 0 CA-C-N 118.238 0.472 . . . . 0.0 109.949 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.07 130.65 28.48 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.755 2.97 . . . . 0.0 112.296 166.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -77.62 27.71 0.17 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.306 1.443 . . . . 0.0 114.28 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.85 -133.5 5.3 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.675 -0.514 . . . . 0.0 112.498 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -78.0 113.51 15.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 28' ' ' ILE . 34.7 mt -114.24 130.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -172.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 95' ' ' TRP . 52.7 tp -100.09 114.27 27.5 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 53.6 t -101.48 109.73 21.61 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.29 0.636 . . . . 0.0 109.548 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.23 103.45 3.36 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 167.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.49 111.38 22.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.744 -172.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -139.11 -54.8 0.59 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.312 1.045 . . . . 0.0 108.232 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.13 -77.95 0.17 Allowed Glycine 0 C--N 1.353 1.512 0 O-C-N 123.956 0.785 . . . . 0.0 112.638 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 42' ' ' ARG . 46.0 mt-10 -138.67 128.95 25.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.609 0.763 . . . . 0.0 110.343 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.13 -17.48 77.3 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . 31.5 ttt180 -48.79 -45.03 39.59 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.868 1.667 . . . . 0.0 111.217 167.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.546 HD22 HD12 ' A' ' 101' ' ' ILE . 2.7 m-20 -64.75 -41.76 95.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.007 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.98 98.66 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.199 0.6 . . . . 0.0 110.92 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.421 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.9 m -60.46 -39.27 86.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.965 0.906 . . . . 0.0 112.696 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 88.7 t80 -64.92 -46.64 80.81 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.826 0.703 . . . . 0.0 110.199 177.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 99' ' ' VAL . 70.1 mt -67.62 -33.18 74.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.872 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.67 -37.21 70.78 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.145 0.578 . . . . 0.0 111.804 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.745 ' HA ' HG11 ' A' ' 76' ' ' VAL . 93.2 p -72.06 -4.8 30.92 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 81.7 mt -83.84 11.14 8.05 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.265 168.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.09 19.15 78.9 Favored Glycine 0 C--N 1.366 2.218 0 CA-C-N 117.64 0.2 . . . . 0.0 113.174 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -106.44 133.1 51.65 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 109.257 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.79 90.71 2.91 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.574 0.702 . . . . 0.0 109.263 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.1 t -92.91 108.59 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.814 -175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' THR . 31.8 p -87.14 111.84 21.34 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.513 1.125 . . . . 0.0 108.607 172.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.72 126.98 53.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.268 0.627 . . . . 0.0 110.873 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 81' ' ' VAL . 10.9 t -101.69 114.72 41.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' H ' HD21 ' A' ' 64' ' ' LEU . 8.5 t70 -116.17 116.21 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.92 -10.67 2.62 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.678 0.791 . . . . 0.0 112.566 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -115.79 124.15 50.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.374 1.07 . . . . 0.0 108.595 169.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.3 m -72.06 -16.57 62.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.232 0.613 . . . . 0.0 111.568 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 31.5 m -62.97 -35.84 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.198 0.599 . . . . 0.0 111.508 170.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 -35.25 56.45 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' H ' ' A' ' 58' ' ' ASP . 99.2 mt -63.28 -42.65 99.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.085 0.954 . . . . 0.0 111.011 174.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.4 81.13 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.864 0.728 . . . . 0.0 111.756 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 30.3 mmmt -68.08 -45.03 74.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.04 0.536 . . . . 0.0 111.464 177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.33 -48.5 81.39 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.973 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -69.45 -42.3 75.12 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.144 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.45 -43.44 77.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.256 0.222 . . . . 0.0 110.939 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.8 tp -65.38 -28.12 69.04 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.559 0.744 . . . . 0.0 110.609 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 78' ' ' ILE . . . -66.08 -53.78 33.91 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.164 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.4 -35.28 75.39 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.817 0.847 . . . . 0.0 110.618 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.97 -37.93 89.29 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.009 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -86.5 -0.32 55.82 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.94 0.896 . . . . 0.0 110.842 -177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.82 33.37 33.93 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-N 116.376 -0.375 . . . . 0.0 112.394 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.745 HG11 ' HA ' ' A' ' 49' ' ' SER . 32.6 m -142.2 -177.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.887 1.275 . . . . 0.0 109.892 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 87.2 tttt -141.16 145.69 36.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.914 0.486 . . . . 0.0 111.587 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.421 HD11 ' HA ' ' A' ' 45' ' ' CYS . 10.8 mm -101.71 167.68 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 55' ' ' THR . 46.1 m -123.21 104.3 9.07 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -91.85 125.98 36.76 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.107 0.479 . . . . 0.0 111.253 -165.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 57' ' ' VAL . 84.8 t -101.06 124.01 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.778 1.231 . . . . 0.0 109.401 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -97.85 89.3 4.54 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.8 m -145.25 -176.01 4.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.188 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -142.97 122.63 13.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -158.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.0 mt -68.75 -8.03 39.3 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.773 0.671 . . . . 0.0 111.894 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.96 60.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.436 1.094 . . . . 0.0 112.459 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -130.45 -24.67 2.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.148 0.579 . . . . 0.0 112.084 -166.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -162.76 127.02 3.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.695 1.198 . . . . 0.0 108.168 -172.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.34 -65.89 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.41 HG22 HD23 ' A' ' 34' ' ' LEU . 20.1 pt -140.42 127.88 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.361 0.664 . . . . 0.0 110.994 -172.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 93' ' ' ASP . 46.8 t -115.55 148.96 17.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 124.546 1.138 . . . . 0.0 109.639 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 122' ' ' LYS . . . -90.25 -35.71 15.15 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.149 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' H ' HG12 ' A' ' 91' ' ' VAL . 24.0 t70 -77.31 -44.33 30.0 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.645 -171.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.03 44.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.483 ' CD1' HD22 ' A' ' 34' ' ' LEU . 11.6 m95 -123.26 134.13 54.12 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -169.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.39 -55.79 6.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.396 0.678 . . . . 0.0 109.971 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -115.63 164.44 12.19 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.109 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 121' ' ' LEU . 84.7 mt -134.45 145.44 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 47' ' ' LEU . 10.1 p -128.09 128.8 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 166.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.3 m -113.4 91.34 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.587 HD13 HD12 ' A' ' 128' ' ' ILE . 49.9 mm -68.56 136.13 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.104 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -14.03 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 126.413 2.321 . . . . 0.0 112.888 -171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HG ' ' A' ' 105' ' ' LEU . 29.1 t -95.18 106.13 18.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 112.324 -2.216 . . . . 0.0 109.93 -169.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.45 99.73 9.8 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . 75.7 mt -118.11 145.91 38.04 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.682 0.793 . . . . 0.0 110.585 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.63 158.15 58.12 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.693 2.262 . . . . 0.0 110.144 168.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 110' ' ' ARG . 33.4 t -45.02 -30.58 1.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.822 1.649 . . . . 0.0 113.246 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 p -57.07 -58.27 8.9 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.2 1.0 . . . . 0.0 110.86 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 105' ' ' LEU . 80.9 mt -83.29 -22.46 32.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.74 0.816 . . . . 0.0 110.236 -175.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 29.1 ttt180 -69.02 -65.13 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.129 1.372 . . . . 0.0 109.717 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -55.41 -29.64 58.91 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.113 0.565 . . . . 0.0 111.642 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.54 -42.35 64.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.864 0.466 . . . . 0.0 110.699 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 117' ' ' VAL . 51.2 tp -67.99 -44.99 75.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.47 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -61.2 -41.67 81.7 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -167.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.81 -28.03 75.65 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 122.016 1.811 . . . . 0.0 112.292 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -84.87 -14.88 46.53 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 0.0 110.971 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.695 ' HB ' HD21 ' A' ' 160' ' ' LEU . 4.7 t -86.51 -42.82 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.1 -56.17 24.12 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 122.511 0.324 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -83.5 -39.85 19.96 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.3 -25.7 25.52 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -166.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.617 HD11 ' HA3' ' A' ' 125' ' ' GLY . 16.1 tp -66.24 117.65 8.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.803 0.802 . . . . 0.0 109.188 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 62.0 tttm -69.67 133.93 88.5 Favored Pre-proline 0 C--O 1.246 0.883 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.54 112.3 0.66 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.629 2.219 . . . . 0.0 111.143 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . 125.08 13.21 3.67 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.864 -173.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.617 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . -100.48 139.85 14.62 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 168.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 192' ' ' GLY . 32.7 m -109.08 138.88 34.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.762 0.825 . . . . 0.0 109.932 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.53 113.37 25.49 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.608 HD11 HG21 ' A' ' 24' ' ' VAL . 24.3 mt -107.88 108.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 190' ' ' LEU . 79.7 mt -130.87 152.04 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.815 0.846 . . . . 0.0 111.315 -174.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 188' ' ' ILE . 43.9 tt0 -140.61 104.05 4.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.51 167.16 54.79 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -131.08 167.62 18.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.494 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.584 ' HB2' ' H ' ' A' ' 186' ' ' ALA . . . -59.4 155.09 39.36 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.41 1.484 . . . . 0.0 113.123 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -56.6 -25.16 57.83 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.933 2.422 . . . . 0.0 113.579 166.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -69.07 -30.06 68.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.302 1.041 . . . . 0.0 113.586 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.674 ' HG3' HD23 ' A' ' 137' ' ' LEU . 54.6 tp60 -54.57 -62.97 1.31 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -161.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.674 HD23 ' HG3' ' A' ' 136' ' ' GLN . 7.0 mt -90.41 -10.33 44.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.038 0.835 . . . . 0.0 110.643 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -49.98 -24.17 2.43 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.925 1.69 . . . . 0.0 114.929 -164.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -52.91 -33.55 50.96 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.684 1.194 . . . . 0.0 110.809 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -115.48 148.5 39.38 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.5 m -134.81 -3.58 2.55 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 123.083 0.553 . . . . 0.0 110.84 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.06 -95.63 0.13 Allowed Glycine 0 C--N 1.356 1.661 0 CA-C-N 116.789 -0.187 . . . . 0.0 112.658 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.39 -157.76 32.7 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-O 118.202 -1.332 . . . . 0.0 111.192 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -41.55 137.09 2.72 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.56 2.84 . . . . 0.0 112.828 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.487 ' HA ' HD13 ' A' ' 137' ' ' LEU . 52.8 mtmt 76.55 66.44 0.05 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.73 1.612 . . . . 0.0 108.144 -154.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -149.78 15.0 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.18 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 137' ' ' LEU . 0.5 OUTLIER 62.93 -1.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 126.098 1.759 . . . . 0.0 115.744 -175.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.59 -24.37 60.06 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 120.985 0.421 . . . . 0.0 109.945 171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.18 -7.36 51.06 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.947 0.899 . . . . 0.0 112.762 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 147' ' ' LEU . 45.8 mt -97.88 100.92 9.43 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.86 120.76 4.34 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.573 1.515 . . . . 0.0 110.245 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.419 ' HA ' HD11 ' A' ' 188' ' ' ILE . 32.6 mmtp -87.89 171.58 10.25 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.684 0.794 . . . . 0.0 111.775 -173.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD22 HD21 ' A' ' 190' ' ' LEU . 32.2 mt -59.23 -40.97 87.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -48.54 -50.9 30.11 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.74 1.216 . . . . 0.0 110.857 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 26.6 m -65.88 -62.36 1.54 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.701 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.429 HD13 HD13 ' A' ' 129' ' ' LEU . 25.2 mt -72.57 -46.56 53.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 112.707 -162.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.537 ' HA ' ' HE1' ' A' ' 165' ' ' TRP . 50.1 tt0 -53.4 -46.11 69.59 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 123.44 0.462 . . . . 0.0 111.025 171.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.3 t -70.77 -32.42 69.54 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.525 0.33 . . . . 0.0 111.841 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -85.7 -5.61 59.24 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.131 0.572 . . . . 0.0 111.951 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.695 HD21 ' HB ' ' A' ' 117' ' ' VAL . 82.7 mt -140.51 74.68 28.04 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 -45.72 24.03 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.859 3.039 . . . . 0.0 113.156 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 m -84.85 -29.82 24.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.778 0.431 . . . . 0.0 110.499 -171.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.614 ' HB3' ' HB3' ' A' ' 160' ' ' LEU . 14.1 tp -70.21 68.54 0.34 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.054 0.942 . . . . 0.0 111.455 170.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -62.63 133.38 54.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.537 ' HE1' ' HA ' ' A' ' 157' ' ' GLN . 32.2 m95 -95.77 129.65 42.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.811 0.844 . . . . 0.0 109.401 -167.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.1 mt -65.43 -33.73 76.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.67 0.788 . . . . 0.0 110.378 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 190' ' ' LEU . 80.6 mt -132.7 121.93 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -154.23 84.57 1.13 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -150.42 148.66 29.03 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.08 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -86.35 116.48 24.54 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.089 0.956 . . . . 0.0 108.691 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.5 mt -110.68 125.06 53.06 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.351 1.06 . . . . 0.0 108.362 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.34 124.07 35.26 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 122.85 0.46 . . . . 0.0 110.004 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -94.03 139.68 30.65 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.168 0.587 . . . . 0.0 110.146 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.34 98.91 11.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.681 0.792 . . . . 0.0 109.664 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.22 169.59 17.16 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.116 0.966 . . . . 0.0 109.186 169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -66.63 120.2 13.04 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.61 146.97 53.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.71 -45.38 0.15 Allowed Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.79 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.52 96.41 0.37 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 0.0 110.333 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 26.0 t80 59.93 47.8 9.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.664 1.186 . . . . 0.0 109.398 -172.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 69.03 3.29 3.97 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.37 1.468 . . . . 0.0 113.116 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.56 155.69 50.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.86 0.464 . . . . 0.0 111.32 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.36 69.3 0.52 Allowed Glycine 0 C--O 1.219 -0.835 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -93.44 157.02 16.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.972 0.909 . . . . 0.0 111.032 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.08 130.1 23.27 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 167.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.584 ' H ' ' HB2' ' A' ' 133' ' ' ALA . . . -89.13 103.85 16.44 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -112.64 149.53 32.71 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 130' ' ' GLU . 22.1 pt -134.17 118.7 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.354 0.525 . . . . 0.0 110.062 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.68 138.6 31.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.834 0.349 . . . . 0.0 110.323 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 153' ' ' LEU . 49.5 mt -129.51 128.38 42.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.532 1.133 . . . . 0.0 109.41 173.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.7 tp -125.13 106.23 9.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 166.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -87.11 139.97 16.56 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 171.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -144.68 152.64 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HE2' ' HB3' ' A' ' 196' ' ' GLU . 19.5 pttm -57.64 155.19 10.23 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 123.75 0.656 . . . . 0.0 110.089 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 mt -79.7 130.92 35.77 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 165.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.583 ' HB3' ' HE2' ' A' ' 194' ' ' LYS . 0.9 OUTLIER -120.07 48.89 1.48 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 122.54 1.162 . . . . 0.0 108.826 174.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -77.05 75.28 3.62 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.279 -1.782 . . . . 0.0 109.199 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 55.53 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.711 1.604 . . . . 0.0 112.393 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 196' ' ' GLU . 11.3 m-70 -91.97 176.99 6.31 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.423 0.63 . . . . 0.0 111.204 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -65.5 -22.97 66.78 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.858 167.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -62.17 105.89 0.66 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.409 0.683 . . . . 0.0 109.716 168.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 CA--C 1.551 0.996 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.285 . . . . . . . . 0 0 . 1 stop_ save_